Clustering O 0 1.2994053122383775e-07
of O 0 4.874318193515137e-08
missense O 0 1.3217133698617545e-07
mutations O 0 8.690629882401879e-10
in O 0 3.921840630027873e-09
the O 0 1.1271221183051239e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 5.882595360162668e-06
in O 0 4.532060771111901e-08
a O 0 8.997564471258102e-09
sporadic B-Disease 0 2.1408732209238224e-06
T I-Disease 0 0.0003288819862063974
- I-Disease 0 7.509401621064171e-05
cell I-Disease 0 3.696727435453795e-05
leukaemia I-Disease 1 0.999990701675415
. O 0 3.198838840035023e-06

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.646288314484991e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.6154960702507992e-09
is O 0 7.351452779857937e-11
a O 0 9.449017263074566e-11
recessive B-Disease 0 5.374577227712507e-09
multi I-Disease 0 2.041805964836385e-05
- I-Disease 1 0.9989593029022217
system I-Disease 0 0.00026696056011132896
disorder I-Disease 1 0.9881046414375305
caused O 0 2.0919424525978059e-10
by O 0 5.628716351520346e-13
mutations O 0 2.0778233734281004e-12
in O 0 1.5315833670759282e-11
the O 0 3.761609357333384e-10
ATM O 0 8.224301950576773e-08
gene O 0 2.2760124895881972e-09
at O 0 8.315218025245485e-08
11q22 O 0 1.4552457514582784e-06
- O 0 1.1558653341126046e-06
q23 O 0 3.030498419320793e-06
( O 0 4.800621011824546e-10
ref O 0 2.6751283144221816e-07
. O 0 1.6071274311357797e-09
3 O 0 1.3219371375328137e-08
) O 0 1.4950303217631244e-09
. O 0 2.4963959788237844e-08

The O 0 5.684141513029317e-08
risk O 0 3.73155693011995e-08
of O 0 1.4338378262479523e-09
cancer B-Disease 0 1.0946375361697847e-08
, O 0 2.581052038763687e-10
especially O 0 8.793441530485779e-10
lymphoid B-Disease 0 7.643524213563069e-07
neoplasias I-Disease 0 0.019969003275036812
, O 0 1.3223198092049415e-09
is O 0 6.3583157836055726e-12
substantially O 0 5.081646214932789e-11
elevated O 0 4.795395192047636e-10
in O 0 1.1425360657568717e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.4844884788089985e-07
and O 0 1.0926048260584409e-10
has O 0 2.0590140703546922e-11
long O 0 6.569866612543551e-12
been O 0 2.0301718639537114e-11
associated O 0 5.766725430511599e-10
with O 0 5.41836020495623e-10
chromosomal O 1 1.0
instability O 1 1.0
. O 0 1.0546506928221788e-05

By O 0 3.791243763373586e-09
analysing O 0 7.09403821019805e-07
tumour B-Disease 1 1.0
DNA O 0 6.886787140558681e-09
from O 0 1.7474258151572997e-11
patients O 0 3.615003695695007e-12
with O 0 7.774153770821052e-14
sporadic B-Disease 0 2.5817770143987673e-09
T I-Disease 0 4.802691364602651e-07
- I-Disease 0 7.352048669417854e-06
cell I-Disease 0 0.0228288471698761
prolymphocytic I-Disease 1 0.9999719858169556
leukaemia I-Disease 1 1.0
( O 0 1.2396387250035446e-09
T B-Disease 0 1.3700407919259305e-07
- I-Disease 0 5.0104329574196527e-08
PLL I-Disease 0 1.4556094356521498e-06
) O 0 1.7839524302232235e-10
, O 0 5.357182752963041e-11
a O 0 2.0385075572004752e-10
rare O 0 1.3206008508959144e-09
clonal B-Disease 0 7.953315872555322e-08
malignancy I-Disease 0 1.1958394452449284e-07
with O 0 1.6741891076602067e-12
similarities O 0 1.319593045945311e-10
to O 0 4.6210024695625407e-10
a O 0 1.6755078435792825e-09
mature B-Disease 0 4.521268337498441e-08
T I-Disease 0 2.0754754359586514e-07
- I-Disease 0 4.193478275738016e-08
cell I-Disease 0 2.517660391276877e-08
leukaemia I-Disease 0 2.4494616468473396e-07
seen O 0 3.4696426287617044e-10
in O 0 3.930555325659668e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999903440475464
T I-Disease 1 1.0
, O 0 2.0881076034928725e-10
we O 0 7.314388678070216e-11
demonstrate O 0 1.5189523250302983e-10
a O 0 2.406175432512203e-11
high O 0 2.6586338686129807e-10
frequency O 0 1.2541897298490312e-08
of O 0 2.975168555963137e-09
ATM O 0 2.043981567112496e-06
mutations O 0 4.0439434911831995e-08
in O 0 4.979651180292421e-07
T B-Disease 0 6.906346243340522e-05
- I-Disease 0 1.642519055167213e-05
PLL I-Disease 0 0.00022286064631771296
. O 0 3.151715418425738e-06

In O 0 1.0505202929778079e-08
marked O 0 2.625817563384203e-09
contrast O 0 1.0039776648929077e-10
to O 0 3.895997691127917e-10
the O 0 2.2061290294583813e-10
ATM O 0 6.004760422229083e-08
mutation O 0 3.75845188305135e-11
pattern O 0 3.700196746225792e-11
in O 0 2.192329651151681e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 2.1650201631473465e-09
the O 0 2.354076100719027e-10
most O 0 4.340164512506295e-12
frequent O 0 1.919844491715672e-12
nucleotide O 0 3.838493967123213e-10
changes O 0 5.753519327633683e-10
in O 0 5.474194986199166e-10
this O 0 2.058482051481292e-09
leukaemia B-Disease 0 3.632214884419227e-06
were O 0 5.1250470534114356e-08
missense O 0 6.640846663685807e-07
mutations O 0 4.231796779663455e-08
. O 0 2.8984459277126007e-07

These O 0 9.746758955486712e-09
clustered O 0 1.008850114558868e-09
in O 0 2.3280043170981202e-10
the O 0 2.8392382889208534e-10
region O 0 2.6195531854789067e-10
corresponding O 0 2.2202293337159063e-09
to O 0 4.6996898817042165e-08
the O 0 4.829260547012382e-08
kinase O 0 9.911776999160793e-08
domain O 0 5.409991032934158e-08
, O 0 2.219364275690694e-10
which O 0 8.53621080071365e-12
is O 0 9.45041354200038e-13
highly O 0 5.087152053773192e-12
conserved O 0 5.041312159392852e-11
in O 0 6.469904612060873e-10
ATM O 0 1.634456339161261e-07
- O 0 1.2650152925175462e-08
related O 0 4.192492575327833e-09
proteins O 0 6.469654673102454e-11
in O 0 1.2513886593623624e-09
mouse O 0 4.881985304905356e-08
, O 0 5.376594724992856e-10
yeast O 0 1.934982396534224e-09
and O 0 1.7181752687278617e-09
Drosophila O 0 5.529586815100629e-07
. O 0 1.9407389117986895e-07

The O 0 3.5800374575956084e-07
resulting O 0 1.5511270490264906e-08
amino O 0 4.1691933461152075e-08
- O 0 2.3923224290456346e-08
acid O 0 7.994498396612926e-09
substitutions O 0 2.0667288325171285e-08
are O 0 1.6388056189864386e-10
predicted O 0 4.884553650441603e-09
to O 0 1.2772345847622546e-08
interfere O 0 1.4308217259895173e-06
with O 0 4.359618888116756e-09
ATP O 0 1.4964287402108312e-05
binding O 0 2.4184254243664327e-07
or O 0 1.758136569662838e-08
substrate O 0 4.1272123496582935e-08
recognition O 0 2.94081786478273e-07
. O 0 2.851153908522974e-07

Two O 0 2.2502312901906407e-08
of O 0 8.68397265207932e-09
seventeen O 0 3.925494951317887e-08
mutated O 0 9.278416257529898e-09
T B-Disease 0 1.6128284130445536e-07
- I-Disease 0 5.3459022097968045e-08
PLL I-Disease 0 4.0775685192784294e-06
samples O 0 1.922607673066068e-08
had O 0 6.746230241105877e-10
a O 0 3.211330160124426e-11
previously O 0 2.816498423374725e-10
reported O 0 6.0630149789631105e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 2.840725528585608e-06
. O 0 3.6233851119504834e-07

In O 0 3.554271188477287e-08
contrast O 0 6.965242604906052e-09
, O 0 3.751878807634057e-10
no O 0 1.2996854703573035e-09
mutations O 0 1.6976064998175389e-10
were O 0 1.1344796213563768e-09
detected O 0 8.563110220904946e-10
in O 0 1.6603679542370742e-09
the O 0 1.2735613452719008e-08
p53 O 0 5.181166162770978e-09
gene O 0 5.573368433431369e-09
, O 0 1.965716478480317e-09
suggesting O 0 1.1557972356968094e-08
that O 0 1.405691119060748e-10
this O 0 7.798466317154862e-10
tumour B-Disease 1 1.0
suppressor O 0 2.0447810129553545e-06
is O 0 1.846689190454498e-10
not O 0 5.385151005676825e-11
frequently O 0 5.308178202545477e-11
altered O 0 8.69218808041694e-10
in O 0 9.47300460296674e-10
this O 0 2.9271887136417263e-09
leukaemia B-Disease 0 6.584948550880654e-06
. O 0 1.842314958366842e-07

Occasional O 0 3.3344408620905597e-06
missense O 0 1.2925979717692826e-06
mutations O 0 8.826043895737712e-09
in O 0 2.7881927877615453e-09
ATM O 0 2.7162968763150275e-07
were O 0 1.2769472590434816e-08
also O 0 6.652923767447305e-10
found O 0 6.603513569292119e-11
in O 0 2.4749971516691005e-10
tumour B-Disease 1 1.0
DNA O 0 4.1949879125979805e-09
from O 0 7.278622149442526e-11
patients O 0 4.341309256528092e-11
with O 0 1.0968423435134267e-12
B B-Disease 0 3.9932871231940226e-08
- I-Disease 0 2.488062911254474e-08
cell I-Disease 0 5.771006271970691e-06
non I-Disease 1 1.0
- I-Disease 1 1.0
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999505281448364
( O 0 8.970600651192484e-11
B B-Disease 0 8.077758906210875e-09
- I-Disease 0 4.6080467219766774e-10
NHL I-Disease 0 4.500129691109578e-08
) O 0 2.4899818318324662e-11
and O 0 6.950411773898324e-11
a O 0 2.1390296200962666e-09
B B-Disease 0 3.2265126037600567e-07
- I-Disease 0 4.935624176027886e-08
NHL I-Disease 0 1.7854403040473699e-06
cell O 0 4.7094709998418693e-07
line O 0 8.942355407270952e-07
. O 0 2.562205452250055e-07

The O 0 5.438317884909338e-08
evidence O 0 2.0386496046853608e-08
of O 0 4.965788891198031e-10
a O 0 2.930045789328872e-11
significant O 0 2.781497254744636e-11
proportion O 0 3.2127394494763095e-11
of O 0 3.9891340231079653e-10
loss O 0 1.5480552395530367e-09
- O 0 4.53847945891539e-08
of O 0 8.633586503492552e-07
- O 0 3.79919420367969e-08
function O 0 2.921822561674503e-09
mutations O 0 6.779713596083425e-11
and O 0 4.16765103330996e-12
a O 0 5.7566892225358046e-11
complete O 0 1.160934193222829e-08
absence O 0 2.7152816528541734e-07
of O 0 6.902923121998583e-09
the O 0 8.004320539711784e-10
normal O 0 8.320034106112928e-10
copy O 0 3.389284941590631e-08
of O 0 2.3297954676593235e-09
ATM O 0 3.968995443415224e-08
in O 0 2.141585131454349e-09
the O 0 5.428987037703337e-09
majority O 0 3.3690691902954484e-10
of O 0 4.467108905004125e-09
mutated O 0 1.9253477034908428e-07
tumours B-Disease 1 1.0
establishes O 0 9.607187045901355e-09
somatic O 0 2.593317205423773e-08
inactivation O 0 9.636148945446621e-08
of O 0 4.331107472665963e-09
this O 0 4.5617135069342396e-11
gene O 0 8.71241273570078e-12
in O 0 2.334717662255681e-11
the O 0 4.727589500430618e-11
pathogenesis O 0 1.9903838577306487e-08
of O 0 7.063895579584312e-10
sporadic B-Disease 0 1.1248580733536073e-07
T I-Disease 0 1.2655418686335906e-05
- I-Disease 0 2.5503148208372295e-05
PLL I-Disease 1 0.99854975938797
and O 0 3.4358171774329094e-07
suggests O 0 1.794236368368729e-07
that O 0 4.6470476772197955e-11
ATM O 0 2.6700096356080394e-08
acts O 0 5.674812175726629e-09
as O 0 1.7140452612807167e-08
a O 0 1.3105537277624535e-07
tumour B-Disease 1 1.0
suppressor O 0 0.00012303763651289046
. O 0 1.5422023125211126e-06

As O 0 2.1687063167519227e-07
constitutional O 0 5.560215186051209e-07
DNA O 0 2.77326943631806e-08
was O 0 7.444049376914563e-09
not O 0 1.6620432807812335e-10
available O 0 2.6379354256533816e-09
, O 0 6.500169152934276e-11
a O 0 5.114202950018409e-10
putative O 0 6.798459253332112e-07
hereditary O 0 0.20062841475009918
predisposition O 1 0.9999595880508423
to O 0 0.14173968136310577
T B-Disease 0 0.0006161579512991011
- I-Disease 0 7.022631507425103e-06
PLL I-Disease 0 2.841705827449914e-05
will O 0 9.886811369597126e-09
require O 0 3.4406215654314565e-09
further O 0 3.7633482996568546e-09
investigation O 0 1.313286257520474e-09
. O 0 2.7088185028389944e-09
. O 0 5.156089244451323e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 1.2377333291624382e-07
kinase O 0 1.511413927346439e-08
is O 0 1.8824500985781256e-11
involved O 0 1.3450743340318039e-12
in O 0 4.3094542691302085e-12
the O 0 5.1609418127984696e-11
modulation O 0 2.2074602146204825e-09
of O 0 7.027316506480474e-10
the O 0 3.1413258660961674e-09
Ca2 O 0 5.59675299882656e-07
+ O 0 2.3171680822997587e-06
homeostasis O 0 3.009276042575948e-06
in O 0 6.440570388122069e-08
skeletal O 0 5.408414835983422e-06
muscle O 0 1.210266731277443e-07
cells O 0 1.2587555886511836e-07
. O 0 8.188708022771607e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.162564775673673e-07
DM B-Disease 1 1.0
) O 0 8.622476954656122e-09
, O 0 4.913376927540014e-10
the O 0 1.1202067051740983e-09
most O 0 2.2215158879124175e-10
prevalent O 0 3.452864305586445e-08
muscular B-Disease 0 1.7805650287527897e-08
disorder I-Disease 0 4.913407902762401e-09
in O 0 6.516629597053125e-11
adults O 0 3.1144992834741814e-11
, O 0 4.484278399996544e-12
is O 0 6.667181997460636e-12
caused O 0 2.4104013923720302e-11
by O 0 1.3009689679710501e-11
( O 0 8.333052303743926e-11
CTG O 0 3.7567229327351015e-08
) O 0 3.559204667102911e-11
n O 0 3.463070663567436e-10
- O 0 2.3569696194769563e-10
repeat O 0 2.254559455794336e-10
expansion O 0 4.81861051060406e-10
in O 0 4.4572574797729914e-11
a O 0 2.0191582780770823e-11
gene O 0 8.65033565611295e-12
encoding O 0 2.411901789400872e-10
a O 0 3.2590934395670956e-09
protein O 0 9.84267067849487e-09
kinase O 0 4.411886038724333e-07
( O 0 9.850897875196551e-09
DM B-Disease 1 1.0
protein O 0 3.069267222599592e-07
kinase O 0 1.603572457042901e-07
; O 0 5.349446441371697e-10
DMPK O 0 9.658594990469282e-07
) O 0 3.602258769053179e-11
and O 0 8.431886265591881e-12
involves O 0 2.6056788671180442e-11
changes O 0 5.249682355490393e-10
in O 0 1.7559976805969768e-09
cytoarchitecture O 0 2.685298795768176e-06
and O 0 6.898767423990648e-08
ion O 0 7.08850275259465e-05
homeostasis O 1 0.9352420568466187
. O 0 0.00016326420882251114

To O 0 2.2895374485187858e-08
obtain O 0 6.262664697942455e-08
clues O 0 5.682439763177172e-08
to O 0 1.7663538409706803e-09
the O 0 5.785233958555125e-10
normal O 0 2.1255273097153804e-09
biological O 0 7.749804353807122e-09
role O 0 3.225416733698694e-08
of O 0 1.7070266267182888e-07
DMPK O 0 0.00038667465560138226
in O 0 5.432164016383467e-07
cellular O 0 1.9019292949451483e-06
ion O 0 1.9456811060081236e-06
homeostasis O 0 4.754896508529782e-05
, O 0 2.3140263039067577e-08
we O 0 2.4394044118025704e-08
have O 0 3.314913898933014e-10
compared O 0 3.3954800082725e-10
the O 0 5.589185225751692e-10
resting O 0 1.0691986851441015e-08
[ O 0 3.298437079024552e-08
Ca2 O 0 6.56296563761316e-08
+ O 0 5.0377920501887274e-08
] O 0 3.684398919290288e-08
i O 0 9.73861968844858e-09
, O 0 7.904683158033166e-11
the O 0 8.882238000662568e-11
amplitude O 0 2.2781483643985467e-10
and O 0 1.453624720593183e-10
shape O 0 1.134828675475319e-08
of O 0 2.3249759451005048e-08
depolarization O 0 7.454509898252581e-08
- O 0 2.186059155917519e-08
induced O 0 1.5344276960149728e-08
Ca2 O 0 9.221253982616417e-09
+ O 0 9.31913746171631e-09
transients O 0 4.222723948288376e-09
, O 0 1.0613340067910926e-11
and O 0 3.7255185915407996e-12
the O 0 3.7026534616124707e-11
content O 0 2.5624610766605826e-10
of O 0 1.370114577348147e-10
ATP O 0 1.1555416179476197e-08
- O 0 5.2962501051467825e-09
driven O 0 2.3041607732920966e-08
ion O 0 2.2155051127015213e-08
pumps O 0 4.4631253359739276e-08
in O 0 7.00011026921743e-09
cultured O 0 7.63431380619295e-05
skeletal O 0 0.16302764415740967
muscle O 0 1.7410268071671453e-07
cells O 0 7.675900803860713e-08
of O 0 7.907205445967236e-10
wild O 0 5.013506831907932e-10
- O 0 3.2903027524788797e-10
type O 0 1.0752045920270348e-09
and O 0 2.7136781710623836e-10
DMPK O 0 2.095810032187728e-06
[ O 0 1.3670089060724422e-07
- O 0 3.0593662359024165e-07
/ O 0 4.893414370599203e-06
- O 0 3.4997497095901053e-06
] O 0 1.5838884337426862e-06
knockout O 0 6.2724589042773005e-06
mice O 0 8.063696441240609e-06
. O 0 7.161032726799021e-07

In O 0 2.4853176228134544e-07
vitro O 0 5.32207536707574e-07
- O 0 5.5593464054481956e-08
differentiated O 0 7.13790555550986e-08
DMPK O 0 3.5884299904864747e-06
[ O 0 7.498545784301314e-08
- O 0 7.348799613282608e-08
/ O 0 2.0701362757336028e-07
- O 0 1.3437235679703008e-07
] O 0 3.871733156302071e-08
myotubes O 0 1.0043678599913619e-07
exhibit O 0 2.8265421114781475e-09
a O 0 1.5505544070926192e-10
higher O 0 3.834602857466507e-09
resting O 0 9.103055020887041e-08
[ O 0 1.5791073337823036e-07
Ca2 O 0 4.8792674078868e-07
+ O 0 8.176096457646054e-07
] O 0 1.697079596851836e-07
i O 0 3.2925598247857124e-08
than O 0 4.657316754475005e-10
do O 0 2.3212038957609593e-09
wild O 0 4.132251874011672e-09
- O 0 3.3080560513099044e-09
type O 0 8.812587104500835e-09
myotubes O 0 1.2856592093157815e-06
because O 0 1.6296827221040644e-09
of O 0 9.674040457596789e-10
an O 0 2.2493909512810717e-11
altered O 0 2.301603352350412e-09
open O 0 1.1816500666839147e-08
probability O 0 2.3152966210915338e-09
of O 0 1.1374691466503606e-10
voltage O 0 1.357499224141634e-09
- O 0 1.1226541474229634e-08
dependent O 0 6.334251878570285e-08
l O 0 4.200739311954749e-08
- O 0 5.790358859059097e-09
type O 0 3.018011618394212e-09
Ca2 O 0 4.011417331639677e-08
+ O 0 3.554833938324009e-08
and O 0 9.978271542365746e-10
Na O 0 2.9052705485810293e-07
+ O 0 2.910592229454778e-07
channels O 0 9.945618018036839e-08
. O 0 6.048762912769234e-08

The O 0 2.9357786388573004e-06
mutant O 0 9.226902761838573e-07
myotubes O 0 2.402985955995973e-06
exhibit O 0 5.4740961985544345e-08
smaller O 0 4.843083156735872e-10
and O 0 3.0340668866202236e-10
slower O 0 1.9543001883448596e-08
Ca2 O 0 1.8798110090756381e-07
+ O 0 1.3693562550542993e-07
responses O 0 2.9320950112321498e-09
upon O 0 4.419354215912108e-09
triggering O 0 5.595043095496521e-09
by O 0 7.328451040455874e-11
acetylcholine O 0 6.048138434522343e-09
or O 0 1.906874658175184e-08
high O 0 8.530124517847071e-08
external O 0 3.254936586927215e-07
K O 0 1.4759311852685641e-06
+ O 0 1.449392584618181e-06
. O 0 6.629381488210129e-08

In O 0 1.1183780657120224e-07
addition O 0 4.5055749353650754e-08
, O 0 1.5705811096111688e-09
we O 0 3.031407569409339e-09
observed O 0 4.567705935709654e-10
that O 0 3.2815455214274536e-11
these O 0 3.016617233786434e-10
Ca2 O 0 6.384930770764186e-07
+ O 0 3.5605789889814332e-06
transients O 0 8.843351224641083e-07
partially O 0 4.6869605085930743e-08
result O 0 1.7080516168110904e-10
from O 0 4.171032963462551e-11
an O 0 5.791929436060883e-12
influx O 0 1.2935663651347795e-10
of O 0 5.673907871317496e-11
extracellular O 0 4.81329871793168e-11
Ca2 O 0 5.855720797143249e-09
+ O 0 4.190557678640516e-09
through O 0 1.6394371971095723e-10
the O 0 4.6398318520601833e-10
l O 0 2.5409891968308784e-09
- O 0 7.302738413983434e-10
type O 0 8.732468637084878e-10
Ca2 O 0 7.577015992410452e-08
+ O 0 2.67749953763996e-07
channel O 0 1.929080610807432e-07
. O 0 6.913058570034991e-08

Neither O 0 2.9792699933750555e-06
the O 0 1.987121756030774e-08
content O 0 3.786546631801002e-09
nor O 0 6.503837113314148e-08
the O 0 5.167780647852283e-10
activity O 0 1.280463401975851e-09
of O 0 4.0207509544032405e-10
Na O 0 4.855583668472718e-08
+ O 0 8.553912067554847e-08
/ O 0 1.4195013875450968e-07
K O 0 5.3179451953155876e-08
+ O 0 5.0847756227767604e-08
ATPase O 0 5.303248258314852e-07
and O 0 5.122268831314614e-09
sarcoplasmic O 0 7.481382908736123e-06
reticulum O 0 3.932246954718721e-07
Ca2 O 0 3.1171492764769937e-07
+ O 0 2.031041219652252e-07
- O 0 2.9104885612696307e-08
ATPase O 0 2.8957327913303743e-07
are O 0 1.5455173252298948e-10
affected O 0 1.8967015458226655e-10
by O 0 5.2283850859868863e-11
DMPK O 0 1.7585827663424425e-05
absence O 0 1.1788044957938837e-06
. O 0 2.1160148833132553e-07

In O 0 2.4102854823127018e-08
conclusion O 0 4.294373567859111e-08
, O 0 2.3700801321524523e-09
our O 0 1.9183586275062225e-08
data O 0 1.0761180391227754e-08
suggest O 0 3.641014156841038e-09
that O 0 9.807804568495726e-11
DMPK O 0 5.520134891412454e-07
is O 0 6.951299952318024e-11
involved O 0 2.6069911854276206e-11
in O 0 5.71593328224651e-11
modulating O 0 1.775362790112922e-08
the O 0 1.679360828177323e-08
initial O 0 4.8093022897433e-09
events O 0 9.272643763935662e-10
of O 0 3.1060534699811626e-10
excitation O 0 1.1903255625611564e-07
- O 0 5.35440278781607e-07
contraction O 0 7.77975106558415e-09
coupling O 0 2.4489505978664283e-09
in O 0 4.357656457898429e-09
skeletal O 0 2.553944966621202e-07
muscle O 0 1.571612884276874e-08
. O 0 1.4066420028768789e-08
. O 0 2.118494002445459e-08

Constitutional O 0 5.5973454436752945e-05
RB1 O 0 0.0034428874496370554
- O 0 6.228230631677434e-06
gene O 0 1.225187862274879e-08
mutations O 0 1.9038137732962923e-09
in O 0 4.692429778074825e-10
patients O 0 1.8381708655201834e-10
with O 0 3.5863243798284206e-12
isolated O 0 3.806184256660572e-09
unilateral B-Disease 0 7.73220835981192e-06
retinoblastoma I-Disease 1 0.9999997615814209
. O 1 0.9999996423721313

In O 0 4.9135227442320684e-08
most O 0 8.268303264280519e-10
patients O 0 8.017671249138658e-11
with O 0 1.2639177898732257e-12
isolated O 0 1.119595749443647e-09
unilateral B-Disease 0 4.117748176213354e-06
retinoblastoma I-Disease 1 0.9999967813491821
, O 0 2.920126007666113e-07
tumor B-Disease 0 4.0261838876176625e-06
development O 0 2.4682091748218227e-07
is O 0 5.312351253339287e-11
initiated O 0 3.0129601591433186e-10
by O 0 9.993728067314578e-12
somatic O 0 7.19781123592611e-09
inactivation O 0 7.629033405009977e-08
of O 0 1.9387366378964543e-08
both O 0 2.1339359168592864e-09
alleles O 0 1.034927588072776e-09
of O 0 1.8069005180976205e-09
the O 0 7.501374632568059e-09
RB1 O 0 1.5301837265724316e-05
gene O 0 6.667792717962584e-08
. O 0 5.22237314726226e-07

However O 0 1.4194000641509774e-06
, O 0 1.0241437031766054e-08
some O 0 7.517699796011357e-10
of O 0 5.308869455156184e-10
these O 0 1.1402321448139574e-10
patients O 0 9.829753677692565e-11
can O 0 2.7532595647805636e-10
transmit O 0 3.1266640831972836e-08
retinoblastoma B-Disease 0 1.6910419162741164e-06
predisposition O 0 1.8508221728552599e-06
to O 0 8.618633728474379e-06
their O 0 3.375592996235355e-06
offspring O 0 5.293629783409415e-06
. O 0 1.0384675306340796e-06

To O 0 1.1128006072169683e-08
determine O 0 1.6809174052667686e-09
the O 0 7.710522775816742e-10
frequency O 0 3.678718130117886e-08
and O 0 5.241068135042326e-10
nature O 0 8.023767428255724e-09
of O 0 7.868603546512531e-09
constitutional O 0 6.437230126721261e-07
RB1 O 0 3.967716475017369e-05
- O 0 4.065846894718561e-07
gene O 0 1.2918952574381137e-09
mutations O 0 4.528236952072717e-10
in O 0 1.1486273043814776e-10
patients O 0 1.50913087582083e-10
with O 0 2.8807362311561446e-12
isolated O 0 2.1420183404785575e-09
unilateral B-Disease 0 3.988898811257968e-07
retinoblastoma I-Disease 0 0.08559688925743103
, O 0 1.4603311626615323e-07
we O 0 7.991361883341597e-08
analyzed O 0 9.095433739503278e-09
DNA O 0 3.199997378189323e-09
from O 0 2.2749535588673098e-09
peripheral O 0 2.405367638402822e-07
blood O 0 3.639891232865011e-08
and O 0 8.902294013068968e-09
from O 0 1.4020349325960524e-08
tumor B-Disease 0 7.147522751438373e-07
tissue O 0 1.9953829166752257e-07
. O 0 4.178898791451502e-07

The O 0 2.783553725294041e-07
analysis O 0 3.810544413340722e-08
of O 0 2.0150292101561718e-08
tumors B-Disease 1 1.0
from O 0 1.4740069165242176e-09
54 O 0 1.2056778686542202e-08
( O 0 1.2172113317276967e-10
71 O 0 2.4781453333844183e-08
% O 0 2.0305679360177464e-10
) O 0 4.524203581213193e-11
of O 0 4.566504119285497e-10
76 O 0 1.01697450460847e-08
informative O 0 8.580935961788327e-09
patients O 0 9.832458180980552e-10
showed O 0 8.163141274053487e-10
loss O 0 4.059224900654357e-10
of O 0 3.736198461723461e-09
constitutional O 0 3.5754085274675163e-06
heterozygosity O 0 0.0007040683995001018
( O 0 1.1204314205315313e-06
LOH O 1 1.0
) O 0 1.2193317466824283e-08
at O 0 2.737997988333518e-07
intragenic O 0 1.0906552233791444e-05
loci O 0 6.012851940795372e-07
. O 0 4.6758705707361514e-07

Three O 0 9.295938951936478e-08
of O 0 1.7338132707322984e-08
13 O 0 3.139836053378531e-07
uninformative O 0 9.964037599274889e-05
patients O 0 1.901760953160192e-07
had O 0 7.199077600716919e-08
constitutional O 0 8.617261300969403e-06
deletions O 0 1.2542884178401437e-05
. O 0 3.5910661608795635e-06

For O 0 2.4838854528752563e-08
39 O 0 1.0343088518993682e-07
randomly O 0 1.6389634538427345e-08
selected O 0 8.852751420818095e-07
tumors B-Disease 1 1.0
, O 0 1.9376781779101293e-07
SSCP O 0 9.692611638456583e-05
, O 0 1.10883862092237e-08
hetero O 0 1.2360511902897997e-07
- O 0 5.8905476052473205e-09
duplex O 0 3.1737460659542194e-08
analysis O 0 2.0401189626539917e-09
, O 0 5.337088843787585e-12
sequencing O 0 1.0763592100948571e-10
, O 0 5.25534962769747e-11
and O 0 1.0604057215646279e-10
Southern O 0 3.236707257769922e-08
blot O 0 9.71750822031936e-08
analysis O 0 5.249942702789667e-10
were O 0 1.292269208308383e-10
used O 0 5.821973458886021e-10
to O 0 7.50104689473119e-09
identify O 0 7.241396815516055e-08
mutations O 0 1.455577347542203e-07
. O 0 2.6580642042972613e-06

Mutations O 0 1.6817062942209304e-07
were O 0 1.3335511361844965e-08
detected O 0 2.8086462044996097e-09
in O 0 3.3380215258560497e-10
21 O 0 3.4544651583701125e-08
( O 0 1.923955716964798e-10
91 O 0 5.14743234703019e-08
% O 0 3.271061199683345e-10
) O 0 1.4534583259173672e-10
of O 0 3.515971513934346e-09
23 O 0 3.674171239254065e-06
tumors B-Disease 1 1.0
with O 0 2.997375304403249e-06
LOH O 1 1.0
. O 0 7.162320980569348e-05

In O 0 5.751375198315145e-08
6 O 0 8.420556696364656e-08
( O 0 1.3658536801575138e-10
38 O 0 8.200427004112498e-09
% O 0 1.8822463032641679e-10
) O 0 1.8294685211195372e-10
of O 0 2.058686110473218e-09
16 O 0 4.433705385054054e-07
tumors B-Disease 1 1.0
without O 0 0.00037729463656432927
LOH O 1 1.0
, O 0 9.036691395181151e-09
one O 0 5.928733060045488e-10
mutation O 0 2.345730831798676e-10
was O 0 1.0395252436623537e-09
detected O 0 9.416115664961922e-10
, O 0 1.2252841102844414e-11
and O 0 4.276203089542685e-12
in O 0 7.245890693008405e-11
9 O 0 8.541028329034361e-09
( O 0 9.659819472096487e-11
56 O 0 3.6574683281997977e-09
% O 0 1.244433028846359e-10
) O 0 1.8771875720524633e-10
of O 0 2.9742608376182034e-09
the O 0 6.56792451536603e-08
tumors B-Disease 1 1.0
without O 0 0.003823146689683199
LOH O 1 1.0
, O 0 1.3439178658813944e-08
both O 0 1.4606459375343661e-09
mutations O 0 1.590635068104973e-09
were O 0 1.750396383393138e-09
found O 0 1.3721316305392861e-09
. O 0 2.4681217070110506e-08

Thus O 0 1.5965051503030736e-08
, O 0 1.3741002780065514e-10
a O 0 9.777769566232664e-11
total O 0 2.2109564179473296e-10
of O 0 1.7798161555671044e-10
45 O 0 4.099562467274609e-09
mutations O 0 4.668006536867608e-10
were O 0 6.546660547002148e-09
identified O 0 1.2015895833883405e-07
in O 0 1.5493446881009731e-07
tumors B-Disease 1 1.0
of O 0 2.2876828609241784e-07
36 O 0 4.7444522977002634e-08
patients O 0 2.0677688450376763e-09
. O 0 2.5811285553345442e-08

Thirty O 0 3.8979231931079994e-07
- O 0 9.287236935051624e-08
nine O 0 1.048310505069594e-08
of O 0 1.344050537532837e-09
the O 0 5.552494575233879e-10
mutations O 0 1.267496801959922e-10
- O 0 4.083571703006328e-09
including O 0 1.114214498443289e-09
34 O 0 7.184015657912823e-07
small O 0 9.18043419062542e-09
mutations O 0 1.2895916334798585e-08
, O 0 5.37676125844655e-09
2 O 0 1.8504797481000423e-06
large O 0 1.7634705784530524e-07
structural O 0 2.3884367692517117e-05
alterations O 0 1.7763199139153585e-05
, O 0 3.50420181760569e-09
and O 0 6.466092661305822e-10
hypermethylation O 0 2.0333275188022526e-06
in O 0 3.3929065779148004e-08
3 O 0 1.7439942894270644e-06
tumors O 1 1.0
- O 0 3.933731917982186e-08
were O 0 9.887862750801446e-10
not O 0 1.594546855665513e-10
detected O 0 1.566404089770046e-10
in O 0 8.082835789569032e-11
the O 0 5.605401698360879e-10
corresponding O 0 1.0944455119954455e-08
peripheral O 0 2.3235047308389767e-07
blood O 0 2.1109109127337433e-08
DNA O 0 4.1529155225816794e-08
. O 0 2.9990772532073606e-07

In O 0 2.153547207228712e-08
6 O 0 7.152856085212989e-08
( O 0 8.229750908528288e-11
17 O 0 2.451736147435213e-09
% O 0 2.0040259382514414e-11
) O 0 4.877508119616181e-12
of O 0 3.278667962125503e-11
the O 0 8.579454507939843e-11
36 O 0 3.3390656906107097e-10
patients O 0 1.3300899270873856e-10
, O 0 2.6739910632955777e-11
a O 0 4.2496681174064577e-10
mutation O 0 6.595033408274276e-10
was O 0 5.342494890925309e-09
detected O 0 4.029359068624672e-09
in O 0 5.19463083659133e-10
constitutional O 0 1.5167188394116238e-08
DNA O 0 1.002600447108648e-09
, O 0 5.965185984058152e-11
and O 0 5.998067320600597e-11
1 O 0 4.357874772153991e-08
of O 0 3.7075615910708848e-09
these O 0 5.723190810158485e-10
mutations O 0 1.7006430985677667e-10
is O 0 6.4737252017388336e-12
known O 0 7.17061757193882e-11
to O 0 3.518887958797734e-10
be O 0 3.337970455596917e-10
associated O 0 1.3925836039874184e-09
with O 0 4.1436600678457225e-11
reduced O 0 2.4048485869343494e-08
expressivity O 0 8.118598771034158e-07
. O 0 2.709221007535234e-07

The O 0 7.787474487486179e-08
presence O 0 1.4099727607685963e-08
of O 0 1.1496103624608622e-08
a O 0 4.92993912359907e-09
constitutional O 0 9.616472880225047e-07
mutation O 0 2.1898136637332755e-09
was O 0 9.427653102633826e-10
not O 0 1.1792530840715187e-10
associated O 0 8.016508984409754e-11
with O 0 1.2341776906010793e-12
an O 0 3.3641342749718417e-12
early O 0 7.091651155199941e-10
age O 0 2.3454174713499754e-10
at O 0 8.715130839220819e-10
treatment O 0 4.989793023213451e-09
. O 0 3.9386947037201026e-08

In O 0 4.432187239444829e-08
1 O 0 3.9887999037091504e-07
patient O 0 5.61917339325646e-08
, O 0 9.927245692153974e-10
somatic O 0 4.65433316776398e-07
mosaicism O 0 8.444458217127249e-06
was O 0 1.1443101755048701e-07
demonstrated O 0 1.2379571145970658e-08
by O 0 4.50904973081645e-11
molecular O 0 4.114381058073491e-10
analysis O 0 1.3923598385368052e-10
of O 0 1.8571870430417192e-10
DNA O 0 1.3128699516418152e-10
and O 0 1.1319070680748666e-10
RNA O 0 2.2393507048690253e-09
from O 0 6.548034114928214e-09
peripheral O 0 3.388352752153878e-06
blood O 0 7.521980478486512e-07
. O 0 1.207021455229551e-06

In O 0 4.929819397148094e-08
2 O 0 7.786568545498085e-08
patients O 0 1.5567842570618495e-09
without O 0 6.476608693795072e-10
a O 0 1.8495948106433957e-09
detectable O 0 7.287285939128196e-07
mutation O 0 5.535621294683324e-09
in O 0 4.79461137459225e-09
peripheral O 0 2.7904450234927936e-06
blood O 0 5.071182727078849e-07
, O 0 7.296337756201865e-09
mosaicism O 0 2.2968126813793788e-06
was O 0 1.7658798867614678e-08
suggested O 0 1.4545573634450193e-09
because O 0 3.7775043509880035e-11
1 O 0 2.6124491459000865e-09
of O 0 2.683710476070189e-10
the O 0 4.2013839629539973e-10
patients O 0 6.611204916850966e-10
showed O 0 1.1686098311258775e-08
multifocal O 0 0.028604548424482346
tumors B-Disease 1 1.0
and O 0 1.4071564180540008e-07
the O 0 3.341834542425204e-07
other O 0 2.612239979882247e-09
later O 0 2.6867761349080865e-08
developed O 0 1.029046714506876e-08
bilateral B-Disease 0 1.1466338946775068e-05
retinoblastoma I-Disease 0 0.0019993798341602087
. O 0 4.51392861577915e-06

In O 0 7.269750135208142e-09
conclusion O 0 2.635090545766161e-08
, O 0 6.858404399956441e-10
our O 0 1.0356113300247216e-08
results O 0 3.2861211529677803e-09
emphasize O 0 2.7035499172711752e-08
that O 0 2.791469277951819e-10
the O 0 1.2279596228736978e-09
manifestation O 0 7.6490962896969e-08
and O 0 6.472978264504547e-10
transmissibility O 0 3.554722809440136e-07
of O 0 3.196550801831677e-09
retinoblastoma B-Disease 0 9.245328946860809e-09
depend O 0 2.8654842942898995e-09
on O 0 2.8636157889394553e-09
the O 0 1.9655091443304684e-10
nature O 0 1.0167271885519469e-10
of O 0 1.1304873703821272e-10
the O 0 1.1903535102053553e-10
first O 0 2.3868051979292204e-10
mutation O 0 1.1478076301918438e-11
, O 0 4.5660033913541564e-12
its O 0 1.3447108010433695e-11
time O 0 6.569168126135949e-11
in O 0 3.4199299642212466e-11
development O 0 7.205334662252483e-10
, O 0 2.1870940822288354e-11
and O 0 3.5854642171928575e-11
the O 0 1.3631086259735525e-09
number O 0 1.407363225958136e-09
and O 0 2.5669910641568094e-10
types O 0 1.2239686597581567e-08
of O 0 2.413762301145539e-09
cells O 0 8.210392365981534e-10
that O 0 4.613840212663867e-11
are O 0 1.4583950366797716e-11
affected O 0 1.631320772910172e-10
. O 0 2.380604824381294e-09
. O 0 2.8178939714962326e-07

Hereditary B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999990463256836
of I-Disease 1 0.9688438773155212
the I-Disease 0 1.120856813940918e-05
fifth I-Disease 0 1.4905857597113936e-06
component I-Disease 0 6.323701740029719e-08
of I-Disease 0 5.726721319376793e-09
complement I-Disease 0 1.0672895456309561e-08
in O 0 1.7155244336208852e-07
man O 0 3.9375186133838724e-06
. O 0 7.821479812264442e-06

I O 0 0.012118415907025337
. O 0 2.2261334379436448e-05

Clinical O 0 1.5520079614361748e-05
, O 0 5.123323987277217e-09
immunochemical O 0 1.9059129954257514e-06
, O 0 2.1228370172821087e-09
and O 0 1.166722829459843e-09
family O 0 5.709020811650589e-09
studies O 0 5.487058629682906e-08
. O 0 8.481227808943004e-08

The O 0 8.160313313965162e-07
first O 0 4.865234259909812e-08
recognized O 0 2.551806765893616e-08
human O 0 9.924409738459872e-09
kindred O 0 8.166046609403566e-05
with O 0 1.7287806741705936e-08
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 0.9514341950416565
fifth I-Disease 0 1.243597398570273e-05
component I-Disease 0 6.735089073117706e-07
of I-Disease 0 1.9814015672636742e-07
complement I-Disease 0 2.4308271804329706e-06
( O 0 4.576885359597327e-08
C5 O 1 0.7600933313369751
) O 0 1.1300400615255057e-08
is O 0 2.7794846424455955e-09
described O 0 2.589274217257298e-08
. O 0 9.039987247660974e-08

The O 0 5.175776323085302e-07
proband O 0 1.0701395694923121e-05
, O 0 8.734118428499471e-10
a O 0 8.058149147949223e-10
20 O 0 1.320359044321151e-09
- O 0 9.113609866773231e-10
year O 0 1.585703679474193e-09
- O 0 1.112117331558693e-08
old O 0 1.595893373007584e-08
black O 0 7.958437242550076e-10
female O 0 1.776994995594805e-09
with O 0 1.5349413406973156e-10
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 1.0
age O 0 0.3488788902759552
11 O 0 1.9075750969932415e-06
, O 0 3.3837863622210307e-09
lacked O 0 1.8675225987863087e-07
serum O 0 9.145742829730352e-09
hemolytic O 0 2.518365072035067e-09
complement O 0 2.049608260890068e-09
activity O 0 4.393562491600278e-08
, O 0 2.6648530604411746e-10
even O 0 2.348519712036534e-10
during O 0 1.2156898820947504e-09
remission O 0 8.938862805507597e-08
. O 0 1.0264904481971371e-08

C5 O 0 0.000472821993753314
was O 0 2.4687772111064987e-06
undetectable O 0 6.630209554714384e-07
in O 0 1.8881192165309812e-09
her O 0 9.49594292087852e-10
serum O 0 2.167428903021573e-09
by O 0 1.0443898523782025e-10
both O 0 4.352523230721772e-09
immunodiffusion O 0 1.8289142644789536e-06
and O 0 3.105890655774601e-08
hemolytic O 0 4.723513484350406e-06
assays O 0 2.3273345505003817e-05
. O 0 1.9401797544560395e-05

Other O 0 3.488784372507325e-08
complement O 0 1.3033602641598918e-08
components O 0 3.680662175042926e-08
were O 0 5.228848909410999e-09
normal O 0 5.767259381173062e-08
during O 0 2.778632968158945e-08
remission O 0 3.22875933989053e-07
of O 0 2.4706541257302206e-09
lupus O 0 6.695166376857742e-08
, O 0 1.602725396843141e-09
but O 0 4.470654957344777e-09
C1 O 0 5.946969031356275e-05
, O 0 4.090972183234953e-08
C4 O 0 7.167295552790165e-05
, O 0 2.6869708236176848e-08
C2 O 0 1.082506150851259e-05
, O 0 2.5299389250221793e-09
and O 0 1.5453854862457206e-09
C3 O 0 8.504312063450925e-06
levels O 0 7.601587276440114e-05
fell O 0 4.972503120370675e-06
during O 0 4.157782882430183e-07
exacerbations O 0 0.0009122563060373068
. O 0 2.1511921204364626e-06

A O 0 1.5238092601066455e-06
younger O 0 4.088085958642296e-08
half O 0 3.6353793309018556e-09
- O 0 7.773403254418554e-09
sister O 0 3.413652649442156e-08
, O 0 9.559255609303818e-10
who O 0 1.3417887911870707e-09
had O 0 1.669702420770136e-08
no O 0 1.7051392831035628e-07
underlying O 0 0.03372384235262871
disease O 0 2.2121994902590814e-07
, O 0 1.0806049804967799e-10
was O 0 1.798971638322655e-08
also O 0 9.720803717527815e-09
found O 0 2.120781106285108e-09
to O 0 8.740791912487111e-08
lack O 0 4.4871198952023406e-06
immunochemically O 0 0.00010337038111174479
detectable O 0 4.1368522943230346e-05
C5 O 0 4.45897712779697e-05
. O 0 5.0428379836375825e-06

By O 0 6.345134551111187e-08
hemolytic O 0 5.613320809061406e-06
assay O 0 3.8054458855185658e-06
, O 0 1.4477658183409403e-08
she O 0 7.655131528672143e-10
exhibited O 0 3.0125710814843387e-09
1 O 0 1.1935625821024587e-08
- O 0 1.1443796132937223e-08
2 O 0 8.285388375384173e-09
% O 0 2.498770634851155e-10
of O 0 1.406726402031211e-10
the O 0 1.746783551137554e-10
normal O 0 7.966353798849468e-09
serum O 0 2.6531505881166595e-08
C5 O 0 1.2423549833329162e-07
level O 0 3.719548047342869e-08
and O 0 7.009632874144245e-10
normal O 0 1.4566182038322495e-08
concentrations O 0 3.178622876021109e-08
of O 0 9.779062004611205e-10
other O 0 9.600784056651435e-11
complement O 0 2.3423651906995246e-09
components O 0 1.7613494662782614e-07
. O 0 2.643823222570063e-07

C5 O 0 7.537335932283895e-06
levels O 0 2.741697926467168e-07
of O 0 1.6989678552903342e-09
other O 0 5.193310712026111e-11
family O 0 3.788934443971215e-11
members O 0 2.6578924824938177e-11
were O 0 7.596279161248276e-11
either O 0 1.9846273235923917e-10
normal O 0 1.3136776999544963e-08
or O 0 2.405570742602947e-10
approximately O 0 4.091518356758028e-12
half O 0 3.586722932547026e-11
- O 0 1.7000149066248582e-09
normal O 0 2.949906452442974e-08
, O 0 1.9121839667235463e-09
consistent O 0 1.0964015473291511e-07
with O 0 3.412484184117659e-10
autosomal O 0 2.50242237598286e-07
codominant O 0 7.22124525509571e-07
inheritance O 0 1.6025184734758113e-08
of O 0 6.303263244689106e-09
the O 0 1.858513343222512e-09
gene O 0 1.5353762705672125e-08
determining O 0 7.671825187571812e-06
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0001257226977031678

Normal O 0 3.0082261218922213e-05
hemolytic O 0 1.9161373074894072e-06
titers O 0 1.8140411839340231e-06
were O 0 1.168993257749662e-08
restored O 0 9.134814860090046e-08
to O 0 1.2481449651602361e-08
both O 0 1.0479467071888848e-08
homozygous O 1 0.9928172826766968
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 2.8100174631617847e-07
C5D B-Disease 1 1.0
) O 0 4.056471603064438e-09
sera O 0 1.148324528799094e-07
by O 0 2.541185491200526e-11
addition O 0 9.525185085124122e-10
of O 0 3.596426934038277e-09
highly O 0 2.7385663514678527e-08
purified O 0 4.428056001870573e-07
human O 0 4.1060289390770777e-07
C5 O 0 0.00015468457422684878
. O 0 3.306463668195647e-06

In O 0 3.9829424736126384e-07
specific O 0 4.3031960217376763e-07
C5 O 0 1.8223110600956716e-05
titrations O 0 2.641376568135456e-06
, O 0 1.0355950541551806e-09
however O 0 3.042249230311711e-10
, O 0 4.9302627952441114e-11
it O 0 1.2191949706752414e-11
was O 0 6.183855649766201e-10
noted O 0 1.4347377730317135e-09
that O 0 1.4513910906455152e-11
when O 0 3.222017791459919e-11
limited O 0 9.530490840958805e-10
amounts O 0 8.981031474064594e-10
of O 0 9.958440738699892e-10
C5 O 0 7.68597985256747e-08
were O 0 2.441567392708066e-09
assayed O 0 7.597854789764824e-08
in O 0 1.68204639106051e-09
the O 0 1.1204630556704842e-09
presence O 0 9.337050022040216e-10
of O 0 8.208842494639157e-10
low O 0 4.965525768341195e-09
dilutions O 0 2.3332216869675904e-07
of O 0 6.596722723628545e-09
either O 0 9.012149604359365e-08
C5D B-Disease 1 1.0
serum O 0 4.3898936041841807e-07
, O 0 4.952688259507454e-10
curving O 0 9.862284322537107e-10
rather O 0 5.801178426523279e-10
than O 0 4.963730815266132e-11
linear O 0 2.7032945326688207e-10
dose O 0 3.9477043856095406e-08
- O 0 1.3788880259824055e-08
response O 0 7.261435008842909e-09
plots O 0 6.830835008742042e-09
were O 0 1.3817155419815208e-08
consistently O 0 1.4342596443839284e-08
obtained O 0 1.2278875693993996e-08
, O 0 9.481897489393987e-10
suggesting O 0 6.311901667999109e-09
some O 0 8.125095041222608e-11
inhibitory O 0 4.8842206723520576e-08
effect O 0 1.7999674639668228e-07
. O 0 5.502926114786533e-07

Further O 0 1.014860458781186e-06
studies O 0 1.06728386128907e-07
suggested O 0 1.8422477765511758e-08
that O 0 2.0803081479670027e-10
low O 0 9.047314897259184e-09
dilutions O 0 1.2023660929116886e-06
of O 0 1.0458724375439488e-07
C5D B-Disease 1 1.0
serum O 0 3.3155879464175086e-07
contain O 0 3.755675326289065e-09
a O 0 2.799702136790927e-10
factor O 0 3.3039429525594244e-10
( O 0 1.9686184973832788e-11
or O 0 1.4178244689411201e-10
factors O 0 4.145100929164869e-10
) O 0 2.139766142050803e-11
interfering O 0 1.5797023689145817e-09
at O 0 1.0981215048389004e-08
some O 0 1.6674921166082157e-10
step O 0 2.8018884989933213e-09
in O 0 6.909005589861295e-10
the O 0 5.759265064853025e-09
hemolytic O 0 2.6725885504674807e-07
assay O 0 2.9733234896411886e-06
of O 0 1.4638488210039213e-05
C5 O 0 3.402446236577816e-05
, O 0 3.0924351968053543e-09
rather O 0 1.2572333174531991e-09
than O 0 1.3484176275557758e-10
a O 0 8.174328436361122e-10
true O 0 8.335003798265461e-08
C5 O 0 2.676547183000366e-06
inhibitor O 0 3.2909846936490794e-07
or O 0 3.481465782328996e-08
inactivator O 0 1.3767122254648712e-05
. O 0 5.089151500214939e-07

Of O 0 4.039783561893273e-06
clinical O 0 3.7713118672400014e-06
interest O 0 4.5316372165871144e-07
are O 0 4.928309982332735e-10
( O 0 1.4615286758612456e-10
a O 0 4.500290362585702e-09
) O 0 3.8575620475711503e-10
the O 0 3.906468926118123e-09
documentation O 0 3.4872527976403944e-06
of O 0 1.570257808225506e-07
membranous O 1 0.9725866913795471
glomerulonephritis B-Disease 1 1.0
, O 0 9.303437764174305e-06
vasculitis B-Disease 1 1.0
, O 0 1.8685733849110875e-08
and O 0 1.9359052139122923e-09
arthritis B-Disease 1 1.0
in O 0 1.2021410533691324e-09
an O 0 7.087996856114387e-11
individual O 0 1.2530311510605685e-10
lacking O 0 4.737137260235613e-07
C5 O 0 3.194357304892037e-06
( O 0 7.039174798606496e-10
and O 0 5.472201025646939e-10
its O 0 9.234163433902154e-11
biologic O 0 5.176937989403996e-09
functions O 0 6.920374273633456e-10
) O 0 7.0075538254055214e-12
, O 0 5.847575462042398e-12
and O 0 7.073434286214431e-12
( O 0 3.955165622099299e-12
b O 0 9.830658509457635e-10
) O 0 2.6153170341186582e-12
a O 0 4.241357612344565e-11
remarkable O 0 7.220881115266309e-10
propensity O 0 2.7398202817607853e-08
to O 0 5.982237816226643e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 9.955643948122983e-11
the O 0 1.4609795317976904e-10
proband O 0 6.266796859222268e-09
, O 0 1.6853780523962136e-11
even O 0 2.004691031232131e-11
during O 0 1.6473548913875646e-10
periods O 0 6.299657684394333e-09
of O 0 3.003756410269176e-10
low O 0 8.885190916352315e-10
- O 0 1.4968386252700583e-10
dose O 0 1.2329044452030757e-09
or O 0 9.091902231084248e-11
alternate O 0 3.063798104108173e-08
- O 0 9.882856488729885e-08
day O 0 3.240833379436481e-08
corticosteroid O 0 3.5265129554318264e-05
therapy O 0 3.776652738451958e-05
. O 0 7.8615869369969e-08

Other O 0 3.535852499680914e-08
observations O 0 1.4062933040293046e-08
indicate O 0 3.039756668599125e-09
that O 0 4.2401686328741306e-11
the O 0 1.2814846961362036e-09
C5D B-Disease 1 1.0
state O 0 1.8392589673510429e-09
is O 0 5.1977307874429e-11
compatible O 0 2.6953772547244625e-09
with O 0 3.7893295272428684e-12
normal O 0 2.424383582777523e-09
coagulation O 0 8.320363148461851e-11
function O 0 4.4561801471054707e-10
and O 0 4.1857847049575625e-11
the O 0 2.196618720251564e-10
capacity O 0 4.819492582797125e-10
to O 0 3.3210667549354866e-09
mount O 0 2.8096953883505194e-06
a O 0 5.3166775870749916e-08
neutrophilic O 0 0.0003581971686799079
leukocytosis O 0 4.734553658636287e-05
during O 0 4.463834102352848e-06
pyogenic B-Disease 0 0.0006321637192741036
infection I-Disease 0 1.588685591968897e-07
. O 0 1.6216334941532295e-09
. O 0 1.1262788035537596e-08

Susceptibility O 0 3.204851054761093e-06
to O 0 2.0061072518728906e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 3.184345871432015e-07
twins O 0 5.906830580215683e-08
: O 0 2.8276389910097954e-11
the O 0 1.6347338413491563e-11
role O 0 1.2236925917008534e-09
of O 0 1.1152696544058927e-08
genes O 0 2.647835950497779e-09
, O 0 2.2724122583639428e-09
HLA O 0 3.308390887468704e-06
, O 0 1.7637658444868975e-08
and O 0 4.971932199282492e-09
the O 0 7.064790565891599e-07
environment O 0 1.1092192835349124e-06
. O 0 3.10641240730547e-07

OBJECTIVE O 0 3.259846607761574e-06
To O 0 3.0640536774484417e-09
determine O 0 4.217441673670663e-10
the O 0 1.4701649619919266e-10
relative O 0 1.6670739455548755e-08
effects O 0 4.097814212400408e-07
of O 0 3.474884735510386e-08
genetic O 0 1.850215647358766e-09
and O 0 1.730534049393384e-10
environmental O 0 2.0719842508398756e-10
factors O 0 1.060828577759132e-10
in O 0 1.4305316653473454e-10
susceptibility O 0 4.860707747411652e-08
to O 0 1.4624163213738939e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 1.2624921907899989e-07
AS B-Disease 1 1.0
) O 0 2.1293415919387826e-09
. O 0 1.1808569233551225e-08

METHODS O 0 1.1018329132639337e-05
Twins O 0 1.4148887430565082e-06
with O 0 1.6712939365781665e-10
AS B-Disease 1 1.0
were O 0 1.9814426488462544e-10
identified O 0 7.070470597891898e-11
from O 0 3.652612587390358e-11
the O 0 5.567256100569296e-10
Royal O 0 1.1465368743301951e-06
National O 0 2.581552507763263e-06
Hospital O 0 7.659135007997975e-06
for O 0 6.169568411706905e-09
Rheumatic B-Disease 0 5.561727903113933e-06
Diseases I-Disease 0 7.376474059128668e-06
database O 0 9.374245735216391e-08
. O 0 8.111759797202467e-08

Clinical O 0 1.13214873636025e-05
and O 0 5.691700444288017e-09
radiographic O 0 2.5533313419146e-07
examinations O 0 2.8634269710892113e-07
were O 0 7.405625002121496e-10
performed O 0 1.8482441133116367e-09
to O 0 1.425360274254217e-09
establish O 0 4.50587585021367e-08
diagnoses O 0 6.93178037636244e-07
, O 0 8.599937983966299e-10
and O 0 1.984083342065901e-09
disease O 0 1.993590537097134e-08
severity O 0 8.46719814262542e-08
was O 0 7.686034919629492e-09
assessed O 0 1.612390931882146e-08
using O 0 6.106175565179228e-09
a O 0 6.855346956768926e-09
combination O 0 9.862515248926229e-09
of O 0 9.6942525118493e-09
validated O 0 8.245883975632751e-08
scoring O 0 3.038077522887761e-08
systems O 0 1.1684386436172645e-07
. O 0 3.489583946247876e-07

HLA O 0 2.5549819838488474e-05
typing O 0 2.5340170850540744e-06
for O 0 3.518507041277985e-09
HLA O 0 5.143281356367879e-08
- O 0 2.7664754043144058e-08
B27 O 0 5.695579829989583e-07
, O 0 1.0059578170462657e-10
HLA O 0 2.3090562795147207e-09
- O 0 2.3037991514485157e-09
B60 O 0 1.440912171801756e-07
, O 0 3.6840138578631e-11
and O 0 1.499915816549624e-11
HLA O 0 3.4673115578698344e-07
- O 0 9.239686733053531e-06
DR1 O 1 0.9999887943267822
was O 0 5.427260134638345e-07
performed O 0 1.683542905084323e-08
by O 0 1.9441931398134216e-10
polymerase O 0 4.669665099044096e-09
chain O 0 5.653884915801655e-09
reaction O 0 4.0166805992392085e-10
with O 0 4.4267293823618825e-12
sequence O 0 1.0382962545296692e-10
- O 0 9.812861634372894e-10
specific O 0 1.723988840574009e-09
primers O 0 4.384939700230461e-08
, O 0 6.518696693547099e-10
and O 0 3.0252139682218626e-10
zygosity O 0 1.2050185205225716e-07
was O 0 5.713236106430486e-09
assessed O 0 1.3935727238845175e-08
using O 0 8.099449111398371e-09
microsatellite O 0 5.942154075455619e-07
markers O 0 1.7170269472899236e-07
. O 0 4.945396199218521e-07

Genetic O 0 1.3679925814358285e-06
and O 0 1.4202611309244162e-09
environmental O 0 2.968738865849474e-10
variance O 0 2.3226863488101657e-10
components O 0 2.055868808525929e-09
were O 0 9.556120339482277e-10
assessed O 0 1.179567110654034e-08
with O 0 7.725593081930882e-11
the O 0 2.7663153989720968e-09
program O 0 2.3594761699996525e-09
Mx O 0 3.963178230037556e-08
, O 0 1.6978257341704328e-11
using O 0 1.826963927364922e-11
data O 0 9.883804191757051e-11
from O 0 4.119308193162308e-12
this O 0 9.39260908633388e-12
and O 0 1.6150723120000876e-11
previous O 0 4.6356032901151423e-10
studies O 0 6.753774761669717e-10
of O 0 1.3577886037730025e-10
twins O 0 2.1873312050502136e-08
with O 0 1.5445064671659736e-10
AS B-Disease 1 1.0
. O 0 5.96888241943816e-07

RESULTS O 0 3.2699423968551855e-07
Six O 0 2.2823172685093596e-08
of O 0 1.5600272185167796e-09
8 O 0 1.4648043134002364e-07
monozygotic O 0 2.2137239739095094e-06
( O 0 8.56259241288626e-09
MZ O 0 0.00010056754399556667
) O 0 5.5368456486348805e-09
twin O 0 3.497546572361898e-07
pairs O 0 2.1536784799991437e-08
were O 0 1.0661135974032732e-08
disease O 0 4.650572371645012e-09
concordant O 0 3.119930980233221e-09
, O 0 3.340044907318429e-11
compared O 0 5.844913442132338e-11
with O 0 2.203544638423871e-12
4 O 0 2.574098090235566e-08
of O 0 7.046808914168423e-09
15 O 0 2.054654579808357e-08
B27 O 0 7.174184020186658e-07
- O 0 3.856275441194157e-07
positive O 0 8.700983045173416e-09
dizygotic O 0 2.7775577109423466e-06
( O 0 2.749891869768817e-09
DZ O 0 0.00019243948918301612
) O 0 1.5444925338670146e-09
twin O 0 1.9272489737431897e-07
pairs O 0 1.282927653001309e-09
( O 0 1.6287551168892023e-11
27 O 0 9.724178795522676e-09
% O 0 6.610218622471464e-11
) O 0 5.1754299630613065e-12
and O 0 1.3386049213526263e-11
4 O 0 4.6952974841474315e-09
of O 0 5.078879983244633e-09
32 O 0 2.0107184184325888e-07
DZ O 0 0.00015067483764141798
twin O 0 7.848594805182074e-07
pairs O 0 3.478868526585188e-09
overall O 0 1.4099835965453167e-08
( O 0 1.2266035409602694e-10
12 O 0 5.280454296041626e-09
. O 0 2.29620433778166e-10
5 O 0 2.504693563665228e-09
% O 0 1.5988470269956423e-10
) O 0 3.181057917078789e-10
. O 0 1.2493907242117075e-08

Nonsignificant O 0 9.707760000310373e-07
increases O 0 1.5118255536350489e-09
in O 0 4.636591457995998e-11
similarity O 0 1.59669170246568e-11
with O 0 2.264373177894921e-13
regard O 0 2.814930233352442e-10
to O 0 4.1043485277114655e-10
age O 0 1.1584936343567165e-09
at O 0 2.4287620803420396e-09
disease O 0 1.5407079778650967e-10
onset O 0 7.594168072166951e-10
and O 0 1.5486622401139627e-11
all O 0 2.6399474273297585e-10
of O 0 3.3044850189511976e-10
the O 0 5.741001007919522e-10
disease O 0 2.1942027361721017e-10
severity O 0 2.674150623160898e-10
scores O 0 1.449355132437935e-11
assessed O 0 1.1036932479058237e-10
were O 0 6.827393095321099e-10
noted O 0 7.493023979066038e-09
in O 0 3.319357011477564e-09
disease O 0 1.1261929167005746e-08
- O 0 5.230976540815391e-08
concordant O 0 6.251720492400636e-07
MZ O 0 6.042884342605248e-05
twins O 0 1.6988836648579309e-07
compared O 0 2.2223010098798568e-09
with O 0 1.9540299933673566e-10
concordant O 0 6.749982276232913e-06
DZ O 1 0.9998036026954651
twins O 0 0.00036763353273272514
. O 0 4.270948466000846e-06

HLA O 0 2.575466396592674e-06
- O 0 3.564897212982032e-07
B27 O 0 1.2649135214815033e-06
and O 0 2.0690539559442556e-10
B60 O 0 2.7566306570747656e-08
were O 0 1.4418670424287683e-10
associated O 0 1.5403787967382954e-10
with O 0 1.0360068705694836e-11
the O 0 2.341078886303194e-09
disease O 0 7.684242131489327e-10
in O 0 6.91010929032565e-11
probands O 0 3.088416633545421e-08
, O 0 5.12797269924814e-11
and O 0 6.044257455650737e-11
the O 0 1.6647853096074527e-09
rate O 0 5.586110418676071e-08
of O 0 2.18313589428476e-10
disease O 0 8.440709242663047e-11
concordance O 0 5.510651379658782e-10
was O 0 3.4610897481357483e-10
significantly O 0 9.710180437494387e-10
increased O 0 2.4107209561918808e-09
among O 0 8.4231510655286e-10
DZ O 0 3.935350105166435e-05
twin O 0 2.099634031083042e-07
pairs O 0 5.604802733039094e-10
in O 0 2.672717880347619e-10
which O 0 2.848409182132361e-11
the O 0 1.678430450180457e-10
co O 0 8.996272615746648e-10
- O 0 1.84779747058883e-08
twin O 0 4.886046767182961e-08
was O 0 9.256496902310118e-09
positive O 0 3.613656318623981e-10
for O 0 4.338859133090622e-11
both O 0 2.92762258879975e-10
B27 O 0 3.7221354887151392e-06
and O 0 5.4512366176595606e-08
DR1 O 1 0.8525009751319885
. O 0 6.02222735324176e-06

Additive O 0 1.1997065030300291e-06
genetic O 0 1.8144993063629045e-08
effects O 0 5.854949858274949e-09
were O 0 2.727554015979905e-10
estimated O 0 1.0437740949331697e-11
to O 0 3.5812339205243404e-11
contribute O 0 3.123609149113804e-10
97 O 0 6.147065079176173e-08
% O 0 1.9749264723589732e-10
of O 0 7.61008478455949e-11
the O 0 4.25422370942119e-11
population O 0 1.0698329158329023e-12
variance O 0 9.870221306940152e-11
. O 0 1.817776507095914e-08

CONCLUSION O 0 2.80026114296561e-07
Susceptibility O 0 1.865690819613519e-07
to O 0 2.4605258275300912e-08
AS B-Disease 1 1.0
is O 0 1.0519795035079937e-09
largely O 0 1.4252427016359093e-10
genetically O 0 6.010951458801372e-11
determined O 0 1.573735031179524e-10
, O 0 2.5414145787827636e-10
and O 0 7.221734876772246e-10
the O 0 3.6555993787601437e-09
environmental O 0 1.0520477822240082e-09
trigger O 0 8.186924027597797e-09
for O 0 4.165612854656331e-10
the O 0 5.264142899363833e-09
disease O 0 5.63135893472122e-09
is O 0 6.04250469105061e-11
probably O 0 5.410917047754538e-09
ubiquitous O 0 1.7588332923423877e-07
. O 0 1.532784494884254e-07

HLA O 0 1.6473304640385322e-06
- O 0 7.791113887378742e-08
B27 O 0 1.5622723026353924e-07
accounts O 0 4.790970398182992e-10
for O 0 2.0377600648546768e-11
a O 0 2.568424466165009e-11
minority O 0 2.6907605917697586e-12
of O 0 1.257518117414591e-10
the O 0 8.50306991484473e-10
overall O 0 5.105942690875054e-08
genetic O 0 4.987442459025715e-09
susceptibility O 0 6.742554514715948e-09
to O 0 1.603324761845215e-07
AS B-Disease 1 1.0
. O 0 3.950560494558886e-05

Cell O 0 1.5724801016858692e-07
cycle O 0 1.3400119236450792e-08
- O 0 1.1813661160431366e-08
dependent O 0 1.223277834583314e-08
colocalization O 0 8.384031389141455e-07
of O 0 9.98006566277354e-09
BARD1 O 0 4.596911821863614e-06
and O 0 9.981207860221275e-09
BRCA1 O 0 7.664744949842373e-10
proteins O 0 1.3029630326066854e-11
in O 0 4.5676626370116935e-10
discrete O 0 1.1995351378857322e-08
nuclear O 0 4.508884785536793e-07
domains O 0 1.6136773410835303e-06
. O 0 1.507831143499061e-06

Germ O 0 9.487453098699916e-06
- O 0 1.6674466962740553e-07
line O 0 1.8739484630714287e-08
mutations O 0 9.839775660935857e-10
of O 0 1.525273352065426e-09
the O 0 9.568600134457483e-09
BRCA1 O 0 2.3121996761688024e-08
gene O 0 2.2900514817791873e-09
predispose O 0 3.0780430648746915e-08
women O 0 3.527146075210652e-10
to O 0 2.3564974971357344e-10
early O 0 3.398153580747021e-07
- O 0 7.1345275500789285e-06
onset O 1 0.9884483218193054
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 8.406431106777745e-09
compromising O 0 1.6086316634300601e-07
the O 0 1.3808566734496708e-08
genes O 0 9.202028028454379e-10
presumptive O 0 1.50006457033669e-07
function O 0 8.943889184820364e-09
as O 0 6.357282256175267e-09
a O 0 6.213499048612903e-09
tumor B-Disease 0 6.178154876579356e-08
suppressor O 0 6.055868198018288e-06
. O 0 1.392580998071935e-06

Although O 0 2.954186584247509e-07
the O 0 2.7232838206714405e-08
biochemical O 0 1.3785650310182973e-07
properties O 0 6.937243597349152e-06
of O 0 5.475703801494092e-07
BRCA1 O 0 8.559391417861661e-09
polypeptides O 0 1.5733006009099881e-09
are O 0 8.22168201575213e-12
not O 0 6.357239040744034e-11
understood O 0 1.3088899963875633e-09
, O 0 4.105301515400228e-11
their O 0 2.123994313762978e-10
expression O 0 3.117069935498762e-09
pattern O 0 2.121694486767467e-10
and O 0 7.190284478930664e-11
subcellular O 0 2.2080534733959212e-07
localization O 0 2.3885165774117922e-06
suggest O 0 3.213160582049568e-08
a O 0 7.928287470981843e-10
role O 0 5.9220228720846535e-09
in O 0 1.0525701199526338e-08
cell O 0 1.1825264323306328e-07
- O 0 7.167059123958097e-08
cycle O 0 3.863168984707954e-08
regulation O 0 4.361068306479865e-07
. O 0 8.064337464475102e-08

When O 0 1.1079802106905845e-06
resting O 0 1.6564107454541954e-06
cells O 0 1.4663634750888832e-08
are O 0 3.4078836974593685e-11
induced O 0 2.6141927511602603e-10
to O 0 5.93323237763066e-11
proliferate O 0 6.447398170905672e-10
, O 0 2.6053506574363894e-11
the O 0 3.359911515676828e-10
steady O 0 7.433124782352252e-09
- O 0 3.4809644056110756e-10
state O 0 2.4359970637877204e-11
levels O 0 1.5980551326677528e-09
of O 0 1.0950374634832727e-10
BRCA1 O 0 2.0558745678078694e-11
increase O 0 1.3410455038109781e-11
in O 0 1.267898286361202e-10
late O 0 1.280716190876774e-07
G1 O 0 7.93522136888214e-09
and O 0 5.6357158523256956e-11
reach O 0 3.610129140074747e-10
a O 0 1.4280284420242761e-11
maximum O 0 6.449501488425824e-10
during O 0 2.684859001789164e-09
S O 0 1.4996211916695756e-07
phase O 0 5.1303871373420407e-08
. O 0 5.417796842266398e-07

Moreover O 0 1.2648288816308195e-07
, O 0 1.0379918036207414e-09
in O 0 7.084756670217018e-10
S O 0 5.7340578507592e-08
phase O 0 1.3169893620101902e-08
cells O 0 1.6387728507538668e-08
, O 0 1.0208477618789402e-08
BRCA1 O 0 3.6470610975669615e-09
polypeptides O 0 3.3764557816340357e-09
are O 0 2.468759363605244e-10
hyperphosphorylated O 0 2.1072583678005685e-08
and O 0 3.1264760225191424e-10
accumulate O 0 2.2597224091924772e-09
into O 0 5.59017609980117e-10
discrete O 0 2.7521284806653057e-08
subnuclear O 0 1.8658080307432101e-06
foci O 0 7.286216145985236e-07
termed O 0 2.7947331204813963e-07
" O 0 3.8794104284534114e-07
BRCA1 O 0 6.509135630494711e-08
nuclear O 0 5.339064728104859e-07
dots O 0 7.769579610794608e-07
. O 0 1.1215004178666277e-06

" O 0 1.1487222764117178e-05
BRCA1 O 0 1.740971583785722e-06
associates O 0 5.375308020916236e-08
in O 0 6.932822760319368e-09
vivo O 0 1.2490069138948456e-06
with O 0 2.2312444947214516e-10
a O 0 2.6567901212359857e-09
structurally O 0 5.31690069749402e-08
related O 0 1.3984552538204298e-07
protein O 0 4.0860444983081834e-07
termed O 0 3.3366547995683504e-06
BARD1 O 0 0.0010490432614460588
. O 0 2.7808680442831246e-06

Here O 0 2.199973891947593e-07
we O 0 6.039181599248877e-09
show O 0 2.1457229326671268e-09
that O 0 7.436233052937613e-12
the O 0 7.386788403174194e-11
steady O 0 4.257637353788368e-09
- O 0 8.050560218464398e-10
state O 0 3.805701240255921e-11
levels O 0 5.918319168074504e-09
of O 0 6.604713997937495e-10
BARD1 O 0 6.284454343585821e-07
, O 0 1.1771991714759622e-10
unlike O 0 6.395760032695819e-10
those O 0 2.688352318536147e-10
of O 0 5.345305309489845e-10
BRCA1 O 0 1.6147906345409524e-09
, O 0 1.3028345069443503e-10
remain O 0 2.8064186530230018e-09
relatively O 0 3.46810774543016e-10
constant O 0 3.078387766919377e-09
during O 0 3.612018018017693e-09
cell O 0 9.549182777846e-09
cycle O 0 1.811034877619022e-08
progression O 0 1.1371042063501591e-07
. O 0 1.693748856723687e-07

However O 0 3.541394448802748e-07
, O 0 9.22355880561554e-09
immunostaining O 0 1.9425328900979366e-06
revealed O 0 5.676838910062543e-08
that O 0 7.755509012774553e-10
BARD1 O 0 1.417922703694785e-06
resides O 0 3.992212782577553e-08
within O 0 1.6948961123475215e-09
BRCA1 O 0 6.059230894805978e-10
nuclear O 0 3.4739751075818504e-09
dots O 0 2.0703891934203966e-09
during O 0 5.2457838961572634e-08
S O 0 9.116121901797669e-08
phase O 0 2.2645732400405905e-08
of O 0 3.4938572035514426e-09
the O 0 1.1792358201034858e-09
cell O 0 3.472820642169694e-10
cycle O 0 1.1779628661390262e-10
, O 0 7.571135558770425e-12
but O 0 3.5871589986608e-12
not O 0 2.2730905699375192e-11
during O 0 5.730476648757588e-10
the O 0 1.274603311784972e-09
G1 O 0 3.295324546570555e-08
phase O 0 2.8119925943315138e-08
. O 0 1.303376819805635e-07

Nevertheless O 0 3.54048352164682e-05
, O 0 4.735881731221525e-08
BARD1 O 0 2.4060886971710715e-06
polypeptides O 0 1.963963569551197e-08
are O 0 5.756853674321327e-11
found O 0 8.877220139535957e-12
exclusively O 0 4.7496423460913206e-11
in O 0 7.204108143366028e-11
the O 0 1.6060570928733142e-10
nuclear O 0 4.918302209944159e-09
fractions O 0 9.356540431326721e-09
of O 0 4.427605393431122e-09
both O 0 3.687558869369667e-10
G1 O 0 1.474772481913078e-08
- O 0 1.1810642241982805e-08
and O 0 1.021026374559142e-09
S O 0 3.1434012726094807e-08
- O 0 1.1484285744600697e-09
phase O 0 3.572750095770516e-09
cells O 0 9.466940120717027e-09
. O 0 4.652615359646006e-08

Therefore O 0 9.434173620093134e-08
, O 0 3.2751942824482683e-10
progression O 0 7.941999835558988e-10
to O 0 1.2089240719603822e-09
S O 0 1.822254525052358e-08
phase O 0 3.280985705345074e-09
is O 0 7.389183015460432e-11
accompanied O 0 1.3173605539762434e-09
by O 0 6.477347130884326e-11
the O 0 6.175451261469789e-10
aggregation O 0 2.493504847045358e-10
of O 0 2.1232247904290347e-10
nuclear O 0 1.1017214696096289e-08
BARD1 O 0 2.433011786706629e-06
polypeptides O 0 1.5012123810720368e-07
into O 0 3.756579758373846e-08
BRCA1 O 0 5.70465843452439e-08
nuclear O 0 6.792782301090483e-07
dots O 0 4.311970656090125e-07
. O 0 8.613569093540718e-07

This O 0 1.606855448699207e-08
cell O 0 5.905937960903884e-09
cycle O 0 2.3587831687876815e-09
- O 0 4.94845053822246e-09
dependent O 0 1.4872467701820824e-08
colocalization O 0 8.881926305548404e-07
of O 0 2.147259259288603e-08
BARD1 O 0 1.6062620488810353e-05
and O 0 1.4771259770895995e-08
BRCA1 O 0 1.488032719265675e-08
indicates O 0 1.7632502125053406e-09
a O 0 3.910378618132704e-11
role O 0 3.3090011286596166e-10
for O 0 1.728074350282327e-09
BARD1 O 0 2.200568087573629e-05
in O 0 3.2804777561068477e-07
BRCA1 O 0 2.1771058982267277e-06
- O 0 1.4755962638446363e-06
mediated O 0 1.2138134479755536e-06
tumor B-Disease 0 2.194938679167535e-05
suppression O 0 0.00011469798482721671
. O 0 9.263386004931817e-07

Ethnic O 0 4.52292248098729e-09
differences O 0 2.0212256313101307e-09
in O 0 1.2984441299934701e-09
the O 0 6.4255738507768e-09
HFE O 0 1.9295608581160195e-05
codon O 0 1.6358831089746673e-06
282 O 0 2.604242581583094e-07
( O 0 1.948813554975004e-08
Cys O 0 0.005115474108606577
/ O 0 0.00020419420616235584
Tyr O 0 0.0001183746790047735
) O 0 3.7110283734875793e-09
polymorphism O 0 4.016026480258006e-07
. O 0 1.848880231136718e-07

Recent O 0 2.389699993443628e-08
studies O 0 2.074203475643799e-09
have O 0 1.041616723429506e-10
shown O 0 1.6669269298219547e-09
that O 0 1.3803009402124644e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 1.347006843843701e-07
HH B-Disease 0 0.0019255280494689941
) O 0 1.7261364559928438e-10
is O 0 5.896249200693093e-12
likely O 0 1.8173022114931214e-11
to O 0 5.784038872858055e-11
be O 0 2.4416083044265235e-10
caused O 0 1.5183528045970007e-10
by O 0 2.315373587302716e-11
homozygosity O 0 6.475725911059271e-08
for O 0 2.1130610594610744e-09
a O 0 3.894706779306034e-09
Cys282Tyr O 0 4.882078314949467e-07
mutation O 0 8.482060609438236e-10
in O 0 3.3788635778186915e-10
the O 0 1.898157409030432e-09
HFE O 0 6.389099326042924e-06
gene O 0 2.9802933454448066e-08
located O 0 4.711636236720551e-08
4 O 0 9.397695066581946e-07
. O 0 7.388517246909032e-07

5 O 0 1.1415504559408873e-05
Mb O 0 0.00020821832004003227
telomeric O 0 1.1701257790264208e-05
to O 0 8.279165513158659e-07
HLA O 0 6.6196034822496586e-06
- O 0 3.6822884794673882e-06
A O 0 2.5215924779331544e-06
. O 0 1.2378974645343988e-07

Population O 0 3.999611752902865e-09
studies O 0 1.0832619246059494e-08
of O 0 1.36368605296866e-09
this O 0 1.2525629144999328e-10
polymorphism O 0 1.5048201573719666e-09
are O 0 1.1994463582076786e-11
facilitated O 0 4.4680695254761815e-10
by O 0 2.0343659049015805e-11
the O 0 6.785978445833507e-10
fact O 0 3.4701455597918596e-10
that O 0 3.7614928533047376e-11
the O 0 5.317807860727441e-10
Cys282Tyr O 0 1.719246938591823e-06
mutation O 0 9.057571581649881e-09
creates O 0 1.5563685895614299e-09
a O 0 6.121077866794167e-09
Rsal O 0 6.479138392023742e-06
restriction O 0 1.8380311530563631e-06
site O 0 2.389899123045325e-07
. O 0 9.806564804648588e-08

We O 0 1.1872668181922563e-07
have O 0 4.448231505360667e-10
studied O 0 1.6068484320896914e-09
the O 0 7.980721639100352e-10
codon O 0 1.8278834446050496e-08
282 O 0 1.068554489336293e-08
( O 0 3.793993119671768e-09
Cys O 0 0.0009236320038326085
/ O 0 4.097932833246887e-05
Tyr O 0 1.7560474589117803e-05
) O 0 1.0150143919807064e-10
polymorphism O 0 1.1137130107030657e-09
in O 0 5.6227671824116143e-11
different O 0 1.3414624445984291e-11
ethnic O 0 6.397473696628797e-12
groups O 0 6.091814552799946e-11
. O 0 7.56646922894788e-09

In O 0 1.3841263246661129e-08
agreement O 0 1.389273407426117e-08
with O 0 4.5361187028802874e-11
previous O 0 3.2260075499834784e-08
observations O 0 4.9747995944926515e-08
the O 0 7.742181118430835e-09
Tyr O 0 2.422114675937337e-06
allele O 0 1.7324216727843122e-08
appeared O 0 1.1328672222532532e-08
to O 0 2.0157047142532747e-09
be O 0 1.2349848921289208e-09
rare O 0 1.8027077608451236e-09
or O 0 1.1508735076048993e-09
absent O 0 4.092533245625418e-08
in O 0 1.2129429682872228e-09
Asiatic O 0 1.1915272324358739e-07
( O 0 9.311434956416065e-11
Indian O 0 6.707879252054738e-10
, O 0 4.916552581724076e-11
Chinese O 0 3.016335514693935e-10
) O 0 6.08358224907235e-11
populations O 0 1.4886784860390634e-10
. O 0 3.470729703636266e-09

The O 0 1.3762740991296596e-07
highest O 0 1.4703115880365658e-07
allele O 0 1.2032564278285918e-08
frequency O 0 1.1848367620359568e-08
( O 0 1.4717073046344176e-11
7 O 0 1.9776076332078674e-09
. O 0 1.0744721085087505e-10
5 O 0 8.31647972709959e-10
% O 0 2.4600715561873265e-11
) O 0 1.538387472965752e-11
was O 0 4.6516435148191704e-10
found O 0 1.4879263099398798e-10
in O 0 4.914249007725857e-10
Swedes O 0 6.160681209621544e-07
. O 0 2.42267987005107e-07

Saamis O 0 8.055115176830441e-05
( O 0 7.18107795449896e-10
2 O 0 1.5911911788180078e-08
% O 0 4.639008621687424e-10
) O 0 6.677889491379929e-11
and O 0 7.629269438425013e-11
Mordvinians O 0 3.5766106520895846e-08
( O 0 6.5018524418591905e-12
1 O 0 5.689103632633419e-10
. O 0 7.904155108207078e-11
8 O 0 2.1212585021856967e-09
% O 0 5.658572221900471e-11
) O 0 1.4362695928415992e-11
had O 0 8.561309994270516e-11
significantly O 0 2.0760904106964517e-10
lower O 0 7.274073565710637e-10
frequencies O 0 2.6118067708580384e-09
of O 0 3.5861655867108766e-09
the O 0 2.1586382459304332e-08
Tyr O 0 3.584573642001487e-05
allele O 0 5.170064127923979e-07
. O 0 5.283066570882511e-07

Comparisons O 0 1.4859203645301022e-07
with O 0 1.2485300571185576e-09
allele O 0 1.3291174383311954e-08
frequencies O 0 2.964055667575849e-09
based O 0 1.665927951144397e-10
on O 0 1.6436303429401278e-09
prevalence O 0 3.93719057356634e-09
estimates O 0 2.907666885043625e-10
of O 0 3.49364204232927e-10
HH B-Disease 1 0.9822163581848145
showed O 0 8.868165423336904e-06
some O 0 8.281596741710473e-09
disagreements O 0 1.162332186055437e-08
with O 0 1.918583486526515e-10
the O 0 1.5801552066818658e-08
RFLP O 0 9.55335622165876e-07
data O 0 9.01252406038111e-09
, O 0 5.434887262456556e-11
particularly O 0 7.206337748755232e-10
in O 0 3.6245992873773503e-09
Finns O 0 1.6027804576879134e-06
. O 0 2.651145507570618e-07

The O 0 1.6592533711445867e-06
newly O 0 1.9920339582313318e-06
described O 0 1.2101848767542833e-07
HFE O 0 0.0009255653130821884
marker O 0 1.4878348792990437e-06
provides O 0 6.425598275683342e-09
a O 0 3.9598550133357335e-11
new O 0 4.7255338531115854e-11
approach O 0 6.485558756708087e-10
to O 0 9.34171739963574e-10
the O 0 5.14023545949982e-10
screening O 0 5.327566832136199e-09
of O 0 1.4468327869110453e-08
HH B-Disease 0 6.584687798749655e-05
as O 0 1.8523280687077204e-08
well O 0 1.0921885618131455e-09
as O 0 4.120905700011335e-11
studies O 0 7.471680218973376e-11
of O 0 1.4044898057063993e-11
the O 0 1.5971576491913275e-11
relationship O 0 3.788363373002923e-11
between O 0 2.648895269796725e-10
the O 0 1.3068127913129501e-08
HFE O 0 0.000577277154661715
Tyr O 0 4.8600431910017505e-05
allele O 0 3.3380626263124213e-08
and O 0 5.378810175038495e-10
different O 0 2.728835601928381e-09
disorders O 0 4.301228727854323e-06
including O 0 2.124239628642499e-08
cancer B-Disease 0 4.574154900183203e-06

Autosomal B-Disease 1 0.9999992847442627
dominant I-Disease 1 0.9987050294876099
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9676574468612671
associated O 0 4.0494700925819416e-08
with O 0 4.9928533529808306e-11
a O 0 4.78516470892032e-09
missense O 0 1.5632679151167395e-07
mutation O 0 7.436553040029992e-10
encoding O 0 3.5213874038930726e-09
Gly23 O 0 2.0012880668218713e-06
- O 0 2.082271066683461e-06
- O 0 9.238066809302836e-07
> O 0 1.238429263139551e-06
Val O 0 4.83888697999646e-07
in O 0 1.8680673008475424e-08
neurophysin O 0 6.036608738213545e-06
II O 0 0.005054419860243797
. O 0 4.321861524658743e-06

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 2.353183869985287e-09
ADNDI B-Disease 0 0.00012978569429833442
) O 0 1.6988965789721533e-09
is O 0 6.26791729629872e-10
an O 0 1.109540459509617e-09
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 6.265144065764616e-07
by O 0 2.9866750739238057e-10
progressive O 0 4.127231022721389e-06
degeneration O 0 1.1673459084704518e-05
of O 0 6.893608350821978e-09
the O 0 9.270044731835014e-10
magnocellular O 0 2.8666775619967666e-08
neurons O 0 4.024059752083531e-09
of O 0 5.837220484750105e-09
the O 0 1.020306505949975e-08
hypothalamus O 0 7.860642625701075e-08
leading O 0 4.7963584215438004e-09
to O 0 8.666743434027069e-10
decreased O 0 1.6581368500467875e-09
ability O 0 2.4595098180313357e-10
to O 0 3.224480238372962e-09
produce O 0 1.445732156213353e-08
the O 0 8.808322604636487e-08
hormone O 0 1.4988850125519093e-06
arginine O 0 2.8894864954054356e-06
vasopressin O 0 1.6289353879983537e-05
( O 0 1.0700882846492732e-08
AVP O 0 6.265460979193449e-05
) O 0 4.4967896073444535e-09
. O 0 8.774333082328667e-08

Affected O 0 4.977253524884873e-07
individuals O 0 8.58390650226859e-11
are O 0 1.4155646273217304e-11
not O 0 1.362229495871503e-10
symptomatic O 0 3.3448808167690913e-09
at O 0 8.179709687361481e-10
birth O 0 1.9243394433487993e-08
, O 0 2.833476786534561e-10
but O 0 1.0515677217881603e-10
usually O 0 1.2360334977756793e-09
develop O 0 2.5911514711651762e-08
diabetes B-Disease 0 2.3775126010150416e-06
insipidus I-Disease 0 1.3607710798169137e-06
at O 0 1.482562250743058e-08
1 O 0 1.8760982811727445e-07
- O 0 3.5351220049051335e-06
6 O 0 8.672936019138433e-06
yr O 0 0.00010982324602082372
of O 0 2.4559168920745833e-08
age O 0 2.7102101896048225e-08
. O 0 5.175025918902065e-08

The O 0 2.341009093242974e-07
genetic O 0 1.181323217025465e-08
locus O 0 2.4770725914891045e-08
of O 0 2.6336823832906475e-09
the O 0 1.1070756533726467e-09
disease O 0 6.984888778482912e-10
is O 0 1.405390213926605e-11
the O 0 9.7243602059649e-10
AVP O 0 6.715561903547496e-05
- O 0 3.913417458534241e-06
neurophysin O 0 0.0002935717930085957
II O 1 0.9999716281890869
( O 0 3.749906163363903e-09
NPII O 0 6.718686563544907e-06
) O 0 2.590886949427329e-10
gene O 0 1.4236539724876707e-09
, O 0 3.5715286283988235e-10
and O 0 2.194956161272188e-10
mutations O 0 6.521830853145616e-10
that O 0 3.0987913623992114e-11
cause O 0 4.3920836412247866e-10
ADNDI B-Disease 0 6.18383808159706e-07
have O 0 4.030187017445286e-10
been O 0 1.9193814593254643e-10
found O 0 1.0606782813171733e-11
in O 0 8.108618811120127e-12
both O 0 1.589590264972074e-11
the O 0 1.398070548219721e-10
signal O 0 4.160016775500708e-09
peptide O 0 1.718722608679002e-09
of O 0 6.152059750519356e-09
the O 0 2.5120051816429623e-08
prepro O 0 4.471845750231296e-05
- O 0 1.0447819477121811e-05
AVP O 0 0.0006615439197048545
- O 0 9.466742199037981e-07
NPII O 0 8.847899152897298e-06
precursor O 0 5.578065724876069e-07
and O 0 1.6097289057270814e-09
within O 0 1.7521000206244253e-09
NPII O 0 5.213622443989152e-06
itself O 0 1.0399144656503267e-08
. O 0 4.044653323376224e-08

An O 0 2.033708534909806e-09
affected O 0 5.629498533998856e-10
girl O 0 2.8495694692765028e-09
who O 0 6.213943248845055e-11
presented O 0 3.1830121871578854e-10
at O 0 8.729687528408192e-10
9 O 0 5.176720829780379e-09
months O 0 3.856119867862162e-10
of O 0 3.741386367384081e-11
age O 0 6.028218896281246e-11
and O 0 4.098330702584363e-11
her O 0 3.6416508697456607e-10
similarly O 0 1.1563170421169389e-09
affected O 0 1.930579723863346e-10
younger O 0 1.221582057731041e-09
brother O 0 5.8714142880944564e-08
and O 0 9.818183599463737e-09
father O 0 1.8002128854277544e-07
were O 0 1.2178302810639252e-08
all O 0 1.1571548580446844e-10
found O 0 1.0266377158119067e-11
to O 0 6.206622715776433e-11
have O 0 4.8087745591063324e-11
a O 0 5.604105374201751e-11
novel O 0 1.1241234609826734e-09
missense O 0 3.920466440376913e-08
mutation O 0 1.8788426370264233e-10
( O 0 3.902657710885826e-12
G1758 O 0 4.833017541727713e-09
- O 0 1.5720618140591114e-09
- O 0 2.336123072765872e-09
> O 0 8.22266699174179e-09
T O 0 2.126662845824967e-09
) O 0 1.3804482730528367e-12
encoding O 0 8.39267683128142e-11
the O 0 2.2547184952426136e-10
amino O 0 3.9732631074151925e-10
acid O 0 2.966627499212393e-10
substitution O 0 4.970036382445642e-09
Gly23 O 0 2.1563682821579278e-06
- O 0 5.679096375388326e-07
- O 0 5.449011268865434e-07
> O 0 1.8611447103467071e-06
Val O 0 1.483489540987648e-06
within O 0 7.296925730315706e-08
NPII O 0 0.00018397548410575837
. O 0 3.180436749516957e-07

The O 0 1.8675063984119333e-06
mutation O 0 5.0119144390237125e-08
was O 0 2.9352969832530107e-08
confirmed O 0 4.64314497961027e-09
by O 0 1.784830616635702e-10
restriction O 0 1.2739214128032472e-07
endonuclease O 0 1.062037085830525e-06
analysis O 0 5.238124956008505e-08
. O 0 1.3468437032315705e-07

A O 0 2.5722729333210737e-06
T1 O 0 3.8718590076314285e-06
- O 0 1.843884689378683e-07
weighted O 0 1.4550859361861512e-07
magnetic O 0 7.30171478835473e-08
resonance O 0 1.676789764815112e-07
imaging O 0 9.123071504291147e-05
of O 0 1.0553421816439368e-06
the O 0 3.4344845971645555e-06
fathers O 0 0.001654761959798634
pituitary O 0 0.004079146776348352
gland O 0 1.0951012882287614e-05
demonstrates O 0 9.614373084332328e-07
an O 0 2.0045785031896912e-09
attenuated O 0 1.7267004182031087e-07
posterior O 0 2.2046341996428964e-07
pituitary O 1 0.9978274703025818
bright O 1 0.886738121509552
spot O 0 0.0008857938228175044
. O 0 1.4705291278005461e-06

This O 0 1.407855734214536e-07
mutation O 0 2.9232105624998894e-09
may O 0 1.0367018354884294e-09
be O 0 6.755977999262086e-10
valuable O 0 1.8820724534407418e-08
for O 0 1.122447482182487e-10
developing O 0 4.197138747663587e-10
models O 0 2.8859778566925343e-08
of O 0 1.903988966489578e-08
dominantly B-Disease 0 7.042316156002926e-06
inherited I-Disease 0 0.002590706804767251
neurodegeneration I-Disease 1 1.0
, O 0 3.6293776317641857e-10
as O 0 6.712786576601459e-12
the O 0 4.328574391282425e-12
early O 0 3.6327000435543155e-11
age O 0 3.355900626833552e-11
of O 0 6.100941973841145e-11
onset O 0 1.9168777498634881e-07
of O 0 3.42443939871373e-08
symptoms O 0 1.9492081548833085e-07
suggests O 0 1.1677408373600429e-08
that O 0 6.45039646696155e-11
this O 0 5.543151493370146e-10
mutation O 0 2.5878990617123065e-10
may O 0 4.251305973923536e-10
be O 0 8.95880758466916e-10
particularly O 0 5.058150565062647e-10
deleterious O 0 1.974969876528121e-08
to O 0 7.324283046727942e-08
the O 0 1.071739106350833e-07
magnocellular O 0 1.96996415979811e-06
neuron O 0 2.707761552755983e-07
. O 0 4.285111643298478e-08
. O 0 2.6768381644615147e-07

Frequent O 0 1.0905513647685439e-07
inactivation O 0 4.953655206918484e-06
of O 0 2.6673126285459148e-06
PTEN O 0 0.0017183282179757953
/ O 0 4.490340143092908e-05
MMAC1 O 0 7.753773388685659e-05
in O 0 5.446040063361579e-08
primary O 0 0.0008815699256956577
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.1537833163165487e-05

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.9210719983675517e-06
the O 0 5.622569076990658e-09
most O 0 4.714676565820142e-11
common O 0 1.4221897097488334e-11
male B-Disease 0 7.068605683419049e-12
cancer I-Disease 0 2.2307359952289385e-12
in O 0 3.909004630403556e-12
the O 0 2.1775922731670505e-10
Western O 0 1.3146001620611969e-08
world O 0 2.8458380096907376e-09
, O 0 5.5661177056354205e-11
yet O 0 8.452243765999512e-11
many O 0 4.527040634721979e-12
of O 0 1.7691674514264122e-11
the O 0 8.468025586294559e-11
major O 0 6.792971185554109e-10
genetic O 0 1.1140227629269361e-10
events O 0 9.057942590429136e-11
involved O 0 1.8730879694506264e-11
in O 0 9.803578088218856e-11
the O 0 8.058917422282263e-10
progression O 0 1.4350588273259746e-08
of O 0 1.5660395202843347e-10
this O 0 1.348975792181406e-10
often O 0 7.236544696809233e-10
fatal O 0 1.0946981099380082e-08
cancer B-Disease 0 5.637089728338651e-08
remain O 0 1.0985115039829907e-07
to O 0 2.4527569308929742e-08
be O 0 4.1319303534237406e-08
elucidated O 0 3.87533782486571e-06
. O 0 3.561740868462948e-06

Numerous O 0 5.311974859978363e-07
cytogenetic O 0 2.806043266900815e-05
and O 0 6.837251476099482e-08
allelotype O 0 1.196267589875788e-06
studies O 0 8.825269404155733e-09
have O 0 1.4635231915249847e-10
reported O 0 2.3485767150499548e-11
frequent O 0 5.5705041274167755e-11
loss O 0 6.943048358465376e-10
of O 0 8.598171064022608e-09
heterozygosity O 0 8.134337804222014e-06
on O 0 1.402646830683807e-06
chromosomal O 0 1.6390112023145775e-07
arm O 0 1.474219146757605e-07
10q O 0 1.2516790093286545e-06
in O 0 4.56360034206682e-08
sporadic B-Disease 1 0.9955018162727356
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.230082777212374e-05

Deletion O 0 6.865510840725619e-06
mapping O 0 3.7293159493856365e-07
studies O 0 2.2783897435374456e-08
have O 0 2.4573015844353563e-10
unambiguously O 0 2.6321658186390096e-09
identified O 0 8.426428999008806e-10
a O 0 7.429350468157736e-10
region O 0 1.1238324937323796e-08
of O 0 4.7207485920353065e-08
chromosome O 0 6.577816691333283e-08
10q23 O 0 2.4983518187582376e-07
to O 0 1.7237093974387108e-09
be O 0 6.314812006635862e-10
the O 0 6.964017140731471e-10
minimal O 0 3.152058525301982e-08
area O 0 4.826965493975877e-09
of O 0 4.53752502238558e-09
loss O 0 1.4250076674215961e-08
. O 0 1.8736452034318063e-07

A O 0 8.266763416031608e-07
new O 0 3.210906385220369e-08
tumor B-Disease 0 6.432627230879007e-08
suppressor O 0 5.475630473483761e-07
gene O 0 3.3289133227754064e-08
, O 0 4.3951779993278706e-09
PTEN O 0 1.2962103937752545e-05
/ O 0 5.157415671419585e-06
MMAC1 O 0 2.8774624297511764e-05
, O 0 7.356422138116159e-10
was O 0 4.328134739495226e-09
isolated O 0 7.829406567516628e-10
recently O 0 2.4819035715495374e-10
at O 0 1.2174226904360097e-10
this O 0 1.826622360312502e-11
region O 0 3.018608696336855e-10
of O 0 1.0185949861352128e-09
chromosome O 0 5.143504289151224e-09
10q23 O 0 9.565976455405689e-08
and O 0 3.390820124682392e-10
found O 0 7.347359526344022e-11
to O 0 9.326454886160462e-11
be O 0 3.438964737978445e-11
inactivated O 0 1.158071749607359e-09
by O 0 2.8069296886812367e-11
mutation O 0 1.0217856422078953e-10
in O 0 8.574027043906085e-10
three O 0 6.242152750246532e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 7.175744798360029e-08
lines O 0 7.977925875479741e-09
. O 0 1.4753118193766568e-07

We O 0 2.006642034757533e-07
screened O 0 8.38222433685587e-07
80 O 0 2.5999174795288127e-06
prostate B-Disease 0 0.02463630959391594
tumors I-Disease 1 1.0
by O 0 2.1417159157266497e-09
microsatellite O 0 1.127151350033273e-08
analysis O 0 1.5100041217408489e-09
and O 0 5.82087156253408e-11
found O 0 1.3992017267039358e-10
chromosome O 0 1.6950286729766617e-09
10q23 O 0 4.350168225641937e-08
to O 0 1.8148030855869024e-09
be O 0 1.5194572267063222e-09
deleted O 0 3.277559557091081e-08
in O 0 4.090892069541496e-09
23 O 0 5.715287798579993e-08
cases O 0 1.8793595568666888e-09
. O 0 2.2599046189952787e-08

We O 0 2.7655572054641198e-08
then O 0 2.3501328660913146e-10
proceeded O 0 1.8023423031809926e-10
with O 0 3.1646527846179717e-13
sequence O 0 1.5520263026147507e-12
analysis O 0 1.1349070121180471e-11
of O 0 1.9579688564919095e-11
the O 0 1.1394582499768546e-10
entire O 0 3.437184536991822e-09
PTEN O 0 2.0374878658913076e-05
/ O 0 3.638507769210264e-05
MMAC1 O 0 8.045803406275809e-05
coding O 0 1.6953969179667183e-06
region O 0 1.0616554746434304e-08
and O 0 4.261681285644414e-10
tested O 0 4.6807668852011375e-09
for O 0 4.372607831371056e-10
homozygous O 0 6.479417447025071e-09
deletion O 0 1.6650520962002702e-09
with O 0 1.851315281631294e-11
new O 0 4.8029038524077805e-09
intragenic O 0 2.1883852241444401e-07
markers O 0 9.429846903330485e-10
in O 0 7.677544017203886e-11
these O 0 1.7685398284728038e-11
23 O 0 5.071849606963497e-10
cases O 0 4.403570823957592e-12
with O 0 1.7580391352758906e-12
10q23 O 0 7.615409458594513e-07
loss O 0 1.2091811640857486e-07
of O 0 1.910925220727222e-06
heterozygosity O 0 0.004225929267704487
. O 0 2.7392788979341276e-05

The O 0 2.9710646387570705e-08
identification O 0 3.27772227137757e-08
of O 0 5.148480308747594e-09
the O 0 3.544115001474779e-09
second O 0 1.9114994032065624e-08
mutational O 0 2.2047289860438468e-07
event O 0 4.40557679226572e-09
in O 0 1.8626263864618409e-09
10 O 0 5.908145972455259e-09
( O 0 2.6781063477976375e-10
43 O 0 3.184642949349836e-08
% O 0 6.18507378646882e-09
) O 0 3.726400521486539e-08
tumors B-Disease 1 1.0
establishes O 0 3.461903588686255e-06
PTEN O 0 0.00010406000365037471
/ O 0 6.402872259059222e-06
MMAC1 O 0 3.211514695067308e-06
as O 0 1.8208985430590019e-09
a O 0 2.193160930641369e-10
main O 0 2.2922443110307e-10
inactivation O 0 6.880786607155187e-09
target O 0 2.9180353688929017e-09
of O 0 1.616312861330016e-09
10q O 0 4.1351401591782633e-07
loss O 0 2.2936372801041216e-08
in O 0 2.5818572169100662e-08
sporadic B-Disease 0 0.18355782330036163
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.887167909193522e-07
. O 0 2.1159179652840976e-07

Risk O 0 2.5503554752503987e-06
reversals O 0 1.612202424894349e-07
in O 0 3.1567559677370127e-09
predictive O 0 2.212679994784139e-08
testing O 0 5.180019968520355e-09
for O 0 4.343185366906255e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 7.015831329226785e-07

The O 0 6.606282454413304e-08
first O 0 2.5049753382688777e-09
predictive O 0 3.6517315837869546e-09
testing O 0 1.5173285961012084e-09
for O 0 1.672315175227368e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.4570668283031551e-10
HD B-Disease 0 4.4929001319360395e-07
) O 0 9.492841235303473e-11
was O 0 8.833550557696412e-10
based O 0 5.905300554109871e-11
on O 0 2.269544774335941e-09
analysis O 0 1.6242801548216335e-09
of O 0 2.2486629225326737e-10
linked O 0 4.3551784401074656e-10
polymorphic O 0 3.849873475569865e-10
DNA O 0 7.171907512315556e-10
markers O 0 9.875908424383795e-11
to O 0 2.3205919130742103e-10
estimate O 0 5.429958149782976e-10
the O 0 8.762396364048186e-11
likelihood O 0 2.4999826653271384e-09
of O 0 1.4429296646412126e-09
inheriting O 0 1.2578904318161221e-07
the O 0 2.750040835053369e-07
mutation O 0 2.909942953266409e-09
for O 0 2.898222328795441e-09
HD B-Disease 0 3.38163627020549e-05
. O 0 7.010881972746574e-07

Limits O 0 3.5004831033802475e-07
to O 0 1.1758225504365782e-08
accuracy O 0 2.5702517447712125e-08
included O 0 8.936552609029036e-10
recombination O 0 2.373031458835495e-11
between O 0 3.8395901041932134e-11
the O 0 3.1645308595784627e-10
DNA O 0 2.0891592622529487e-10
markers O 0 5.626610288800293e-10
and O 0 8.055352496150192e-10
the O 0 1.1326164894853719e-08
mutation O 0 3.2113702808089784e-09
, O 0 4.838475731183678e-10
pedigree O 0 8.76287220563654e-09
structure O 0 1.8161960824158996e-08
, O 0 7.310863581189153e-10
and O 0 7.986930561365568e-11
whether O 0 1.5613987880414015e-10
DNA O 0 1.9312067500720786e-09
samples O 0 1.895331891432761e-09
were O 0 4.353475913099203e-10
available O 0 1.760136392192635e-08
from O 0 1.4671964754242595e-09
family O 0 5.518290269179715e-09
members O 0 2.1516532999754645e-09
. O 0 9.753679819368699e-08

With O 0 3.041315255192245e-10
direct O 0 1.5329175706568776e-09
tests O 0 2.65255595266467e-10
for O 0 1.3785025898549463e-10
the O 0 4.090509708731815e-09
HD B-Disease 0 3.275495328125544e-05
mutation O 0 6.4673049138264105e-09
, O 0 1.425220913509051e-10
we O 0 4.986726587219437e-10
have O 0 1.686629134967088e-11
assessed O 0 8.597904610496698e-10
the O 0 2.4394436470842606e-10
accuracy O 0 2.6189065138737533e-08
of O 0 2.4352841965225025e-09
results O 0 1.1460412618902183e-09
obtained O 0 5.265900604456419e-09
by O 0 5.211886824896261e-11
linkage O 0 2.802535092882863e-09
approaches O 0 6.1365899028942295e-09
when O 0 3.6133049330366873e-10
requested O 0 2.6627880345131416e-08
to O 0 1.0163831554166336e-08
do O 0 9.623692953653062e-09
so O 0 3.580013230308765e-10
by O 0 4.673580619729556e-11
the O 0 9.32720678470389e-10
test O 0 6.878237979179858e-10
individuals O 0 5.6963649075481015e-11
. O 0 7.209946772945841e-08

For O 0 4.230029730933893e-07
six O 0 8.522997418936029e-09
such O 0 5.060078051011274e-11
individuals O 0 2.2444539282684417e-11
, O 0 4.7314051981883765e-11
there O 0 3.1906755015853605e-11
was O 0 5.651801249229038e-10
significant O 0 1.4841459172743043e-09
disparity O 0 4.957309562847456e-10
between O 0 2.1590973453555762e-10
the O 0 1.330380516861851e-08
tests O 0 6.723111845019503e-09
. O 0 4.1826222485497055e-08

Three O 0 3.325277120325154e-08
went O 0 2.36854038604406e-08
from O 0 5.070282527164238e-10
a O 0 5.605808039987892e-10
decreased O 0 3.838810602729836e-09
risk O 0 3.641706658452648e-10
to O 0 5.342797870788729e-10
an O 0 3.4069087828658695e-11
increased O 0 4.716945167793085e-10
risk O 0 4.884979643016152e-10
, O 0 1.569405716494998e-11
while O 0 3.2270547345447653e-11
in O 0 7.297806109418659e-11
another O 0 2.0139052925305378e-10
three O 0 6.632901172753947e-11
the O 0 2.2980402303307557e-10
risk O 0 1.3163934386994924e-09
was O 0 5.9843605626497265e-09
decreased O 0 7.443001948104211e-08
. O 0 1.1643429331797961e-07

Knowledge O 0 3.2902075872698333e-06
of O 0 2.885152206033581e-08
the O 0 8.752278346513265e-10
potential O 0 1.313601311059287e-10
reasons O 0 3.1377924702979954e-09
for O 0 5.7121404828386346e-11
these O 0 1.2545084762671799e-11
changes O 0 3.9479117197593894e-10
in O 0 1.6857711060414005e-10
results O 0 3.184542629597331e-10
and O 0 6.399564211889697e-11
impact O 0 5.640711453480662e-09
of O 0 4.943863651796221e-10
these O 0 1.6292366761261334e-11
risk O 0 3.348151964011059e-11
reversals O 0 2.864160575377639e-10
on O 0 6.160557619594442e-10
both O 0 1.2359922980931248e-11
patients O 0 1.2906427662717768e-11
and O 0 3.0092354389582576e-12
the O 0 2.380054486827987e-10
counseling O 0 2.102976903728404e-09
team O 0 1.2103255897510934e-11
can O 0 1.098693293462294e-12
assist O 0 1.1000076405309756e-09
in O 0 2.3757409928215623e-10
the O 0 2.9439188864444077e-09
development O 0 1.9065110379301586e-08
of O 0 1.6933507374083945e-10
strategies O 0 6.716135980688875e-10
for O 0 3.977742787930616e-11
the O 0 5.213935186376695e-11
prevention O 0 2.1574682040892412e-09
and O 0 3.736485079675056e-12
, O 0 4.135714774117227e-12
where O 0 1.3915413960008394e-11
necessary O 0 1.377334513108508e-08
, O 0 1.0948828649270936e-10
management O 0 1.1333334271057538e-09
of O 0 4.6310877355182356e-10
a O 0 2.3378826652376006e-10
risk O 0 5.25286703023653e-10
reversal O 0 8.737450207796371e-10
in O 0 5.791858104231551e-10
any O 0 3.836868600615162e-10
predictive O 0 3.529638137322877e-09
testing O 0 4.774987072408976e-10
program O 0 1.6629383425836863e-09
. O 0 2.3859461073527655e-09
. O 0 3.842819751298521e-08

A O 0 1.8975759985551122e-07
novel O 0 1.5464800995346195e-08
common O 0 7.901088672213064e-09
missense O 0 2.182268588057923e-07
mutation O 0 1.542340699600686e-09
G301C O 0 3.0823198216012315e-08
in O 0 8.854366129185109e-10
the O 0 1.2615617439593052e-09
N O 0 1.2458830411787858e-08
- O 0 9.590818805804702e-09
acetylgalactosamine O 0 5.727673624278395e-07
- O 0 3.7156336674115664e-08
6 O 0 1.283930117779164e-07
- O 0 6.211665493083274e-08
sulfate O 0 1.1882636385962542e-07
sulfatase O 0 1.9241724658058956e-06
gene O 0 1.6423181037339418e-08
in O 0 1.097618973489034e-08
mucopolysaccharidosis B-Disease 0 3.5460358049022034e-05
IVA I-Disease 0 0.0007031604181975126
. O 0 5.06279729961534e-06

Mucopolysaccharidosis B-Disease 0 0.0012536186259239912
IVA I-Disease 1 0.8287853598594666
( O 0 2.4503920030838344e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.4372726298006455e-07
is O 0 1.453900733139335e-08
an O 0 1.243053660004989e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 5.6487674982008684e-08
by O 0 1.3878312388193592e-10
a O 0 1.5972414075804409e-06
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 3.7023878007858e-07
N O 0 1.897076771228967e-07
- O 0 3.092719680353184e-08
acetylgalactosamine O 0 7.118347298273875e-07
- O 0 1.105780782495458e-07
6 O 0 9.479769573772501e-07
- O 0 1.775290343175584e-06
sulfate O 0 6.548449391630129e-07
sulfatase O 0 1.0995802767865825e-05
( O 0 7.466143259193814e-10
GALNS O 0 3.6326271128928056e-06
) O 0 1.6176019412839082e-09
. O 0 3.0161256603378206e-08

In O 0 1.6228322863298672e-07
previous O 0 5.4232977220181056e-08
studies O 0 8.029922504704246e-09
, O 0 1.4009161886097132e-10
we O 0 5.820007809020922e-10
have O 0 1.284920364552633e-10
found O 0 1.5578766054957782e-10
two O 0 1.3283710242895097e-10
common O 0 5.566375138599255e-10
mutations O 0 3.198909470647493e-10
in O 0 2.715697666744177e-10
Caucasians O 0 5.119270785058916e-09
and O 0 2.2164664548185442e-10
Japanese O 0 5.944874601482297e-07
, O 0 1.7100376670242667e-09
respectively O 0 2.658859976634176e-08
. O 0 7.085763087388841e-08

To O 0 7.5594918769184e-08
characterize O 0 1.238015414628535e-07
the O 0 1.4912917123410807e-08
mutational O 0 1.579060608492e-06
spectrum O 0 7.067295637597226e-09
in O 0 8.905121778868264e-11
various O 0 2.367226900612529e-11
ethnic O 0 7.87447364258842e-13
groups O 0 4.095138670442283e-13
, O 0 1.859070839979604e-12
mutations O 0 5.1364667727482605e-12
in O 0 5.2599327671210006e-11
the O 0 3.894415068206314e-10
GALNS O 0 3.483478394628037e-08
gene O 0 1.0687408596998793e-10
in O 0 1.053589993027515e-09
Colombian O 0 1.1387234735593665e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 3.3856090908557235e-07
were O 0 2.174671331900413e-09
investigated O 0 1.2070026089716634e-09
, O 0 2.0556795155002305e-10
and O 0 1.9344648105601436e-10
genetic O 0 1.7490306425393953e-10
backgrounds O 0 9.494814656729744e-11
were O 0 3.4187838671151383e-10
extensively O 0 6.991220380392349e-10
analyzed O 0 9.452176819024771e-10
to O 0 8.179256716367433e-10
identify O 0 4.286122567975781e-09
racial O 0 3.558093264466322e-10
origin O 0 2.4994617486839843e-10
, O 0 1.4056421825114906e-11
based O 0 8.495296480171e-12
on O 0 3.340760168502044e-10
mitochondrial O 0 4.303240541680964e-10
DNA O 0 1.5099004269103489e-09
( O 0 4.5023229588991853e-10
mtDNA O 0 6.504296123921449e-08
) O 0 3.5023575151171826e-09
lineages O 0 5.3017004120192723e-08
. O 0 1.1180282655232077e-07

Three O 0 1.5224468086216802e-07
novel O 0 1.4216419685908477e-07
missense O 0 3.360971277288627e-06
mutations O 0 1.9177367249767485e-08
never O 0 1.646173188873945e-07
identified O 0 3.258852743215357e-08
previously O 0 3.862086117578656e-08
in O 0 4.2416190004779253e-10
other O 0 2.249511167617957e-11
populations O 0 2.4346859164164902e-12
and O 0 1.2955848416665305e-12
found O 0 2.503629248362671e-12
in O 0 1.6744456515782602e-11
16 O 0 6.030924648570135e-10
out O 0 3.7589754225964e-11
of O 0 9.503511866348902e-11
19 O 0 2.2598614535240813e-08
Colombian O 0 1.368593530060025e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 4.649652680654981e-07
alleles O 0 1.4043305407440698e-09
account O 0 2.3485824396374255e-10
for O 0 3.487383715139458e-10
84 O 0 8.100163029212126e-08
. O 0 1.2572212426675833e-07

2 O 0 1.546262495821793e-07
% O 0 1.957634498950256e-09
of O 0 5.19095599837982e-10
the O 0 3.9410802399331146e-10
alleles O 0 1.407719496526738e-10
in O 0 4.967872779815252e-10
this O 0 5.575290229486995e-10
study O 0 1.238655622515239e-09
. O 0 1.4255705060861601e-08

The O 0 3.6391625712894893e-07
G301C O 0 1.7082770682463888e-06
and O 0 2.350819983121255e-09
S162F O 0 1.993425797763848e-07
mutations O 0 8.632872194880292e-10
account O 0 4.212296345063038e-10
for O 0 1.2583680764066685e-09
68 O 0 2.3593608489136386e-07
. O 0 5.574539727604133e-07

4 O 0 1.2907391919725342e-06
% O 0 6.165616017739239e-09
and O 0 9.276854284756553e-10
10 O 0 4.084080273969448e-08
. O 0 7.262712387046122e-08

5 O 0 5.705114745069295e-07
% O 0 9.419713897784732e-09
of O 0 2.825981226806107e-09
mutations O 0 2.1483098633368058e-10
, O 0 1.215851586078287e-10
respectively O 0 1.3278700361496476e-09
, O 0 9.154476482420293e-11
whereas O 0 9.970680947546384e-10
the O 0 4.756573801500963e-09
remaining O 0 3.7901468630252566e-08
F69V O 0 2.2314056877803523e-06
is O 0 8.933958434154121e-11
limited O 0 4.2681483347628557e-10
to O 0 1.1251359843811315e-09
a O 0 2.056574688324986e-09
single O 0 2.233490548064765e-08
allele O 0 1.931175290792453e-07
. O 0 3.3129234111584083e-07

The O 0 2.5320025542896474e-07
skewed O 0 1.4951658044992655e-07
prevalence O 0 9.235920117589558e-08
of O 0 4.1708600462264656e-10
G301C O 0 1.7651052175438053e-08
in O 0 1.9730288236541327e-10
only O 0 3.0634386694039506e-10
Colombian O 0 1.3276832966369057e-08
patients O 0 1.357706391758029e-09
and O 0 1.6726078855278104e-10
haplotype O 0 8.007347673810727e-09
analysis O 0 7.339099883374445e-10
by O 0 4.264224390260196e-11
restriction O 0 4.079827142788872e-09
fragment O 0 1.253958881175521e-10
length O 0 2.6509057102219735e-11
polymorphisms O 0 3.201700682353703e-09
in O 0 8.880310931047575e-10
the O 0 4.542521470085603e-09
GALNS O 0 2.5821336748776957e-06
gene O 0 1.4963120520405937e-08
suggest O 0 2.1693200125127987e-08
that O 0 1.421574941096182e-10
G301C O 0 2.3346588662320755e-08
originated O 0 3.842905549333864e-09
from O 0 2.6438576328224883e-10
a O 0 5.709028805256366e-10
common O 0 5.866706564994217e-10
ancestor O 0 1.4138485937564838e-07
. O 0 1.9096395931228471e-07

Investigation O 0 3.5777574680651014e-07
of O 0 5.200098840418832e-08
the O 0 1.0309680220643713e-08
genetic O 0 1.3295173850735864e-09
background O 0 1.1126216614698592e-09
by O 0 2.5682482182598498e-11
means O 0 4.320903101984186e-08
of O 0 3.445128271550857e-08
mtDNA O 0 2.7294831284052634e-07
lineages O 0 2.3210457555933317e-08
indicate O 0 7.196413776000554e-08
that O 0 1.0631660135596022e-10
all O 0 1.8231843812444026e-10
our O 0 1.720825149043037e-09
patients O 0 3.1881750711670875e-11
are O 0 5.54560683398847e-13
probably O 0 4.7390185525797435e-11
of O 0 1.4552503646569903e-10
native O 0 4.5856385355591556e-09
American O 0 1.7810290273700957e-06
descent O 0 4.5733930164715275e-05

Low O 0 4.562921844808443e-07
frequency O 0 1.7829395915214263e-07
of O 0 1.9409419849125698e-08
BRCA1 O 0 2.1567780450482132e-08
germline O 0 2.0646000109536544e-07
mutations O 0 5.813284853495304e-10
in O 0 1.0481695372765998e-10
45 O 0 5.902649036215735e-09
German O 0 0.0002909960749093443
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.2472257771587465e-07
. O 0 1.93274871662652e-07

In O 0 2.7010294445517502e-08
this O 0 4.3742093280840777e-10
study O 0 3.3501257323820255e-11
we O 0 2.3929120837595796e-11
investigated O 0 1.9989077060245108e-10
45 O 0 2.328067738588402e-09
German O 0 0.0001486495602875948
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4181821272885031e-09
for O 0 6.543373620715442e-10
germline O 0 2.711745850092484e-08
mutations O 0 1.4950324311868712e-10
in O 0 1.3504490858906593e-09
the O 0 2.5744023801621552e-08
BRCA1 O 0 2.534586585056786e-08
gene O 0 3.141219551139329e-08
. O 0 9.338845075035351e-07

We O 0 4.722000213064348e-08
identified O 0 1.1326036108982862e-08
four O 0 1.1039253955402728e-09
germline O 0 5.84512235946022e-07
mutations O 0 4.755675409029436e-09
in O 0 4.882336313016822e-09
three O 0 5.996082741432929e-09
breast B-Disease 0 1.4883171672863682e-07
cancer I-Disease 0 2.7233342247967585e-09
families O 0 4.739115783830572e-12
and O 0 3.687203320446031e-12
in O 0 7.074277830199094e-10
one O 0 1.8366787116974592e-05
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.0009565690997987986
. O 0 9.176986282000144e-09
among O 0 3.638495321006685e-12
these O 0 6.035441677681996e-12
were O 0 7.988027600491776e-11
one O 0 2.5240190493214243e-10
frameshift O 0 1.0168294295453961e-07
mutation O 0 3.14007353452439e-09
, O 0 2.4285675692681252e-09
one O 0 1.0462171573522028e-08
nonsense O 0 1.1588422239583451e-06
mutation O 0 2.0721758531294654e-08
, O 0 1.071078115089108e-09
one O 0 2.4138807619422664e-10
novel O 0 1.6323177254307097e-09
splice O 0 1.0208442091652614e-07
site O 0 5.6025641015367e-08
mutation O 0 2.046299796276685e-09
, O 0 1.8618510899681695e-10
and O 0 3.8325534412742e-10
one O 0 7.442601646090452e-09
missense O 0 1.1680608622555155e-05
mutation O 0 8.40508562305331e-07
. O 0 4.9211762416234706e-06

The O 0 3.1791919354873244e-06
missense O 0 1.0303497219865676e-05
mutation O 0 6.48000124670034e-08
was O 0 6.563591625763365e-08
also O 0 1.3153368394469567e-09
found O 0 5.053095095131077e-11
in O 0 2.728147152630811e-10
2 O 0 1.6464117891246133e-07
. O 0 2.7145927106175805e-07

8 O 0 2.302834616330074e-07
% O 0 1.9715062915537374e-09
of O 0 5.412544856753243e-10
the O 0 2.612183802597201e-10
general O 0 2.159287859626602e-09
population O 0 3.481719773601455e-11
, O 0 4.807848563714856e-11
suggesting O 0 2.484632943833276e-09
that O 0 4.101646453036345e-11
it O 0 2.7873071906103775e-11
is O 0 3.0098912945364376e-11
not O 0 1.0658020022091819e-09
disease O 0 6.618724457396752e-10
associated O 0 8.547530683244986e-09
. O 0 3.936269479254406e-07

The O 0 4.018493271473744e-08
average O 0 6.332183666302171e-09
age O 0 1.233021906799081e-09
of O 0 7.12500447530573e-10
disease O 0 6.562659859987718e-10
onset O 0 1.782749947665252e-08
in O 0 6.821613829366413e-10
those O 0 9.39611277672725e-10
families O 0 3.4140140714455924e-10
harbouring O 0 9.821857815950352e-08
causative O 0 2.3541010918393113e-08
mutations O 0 6.671632135635264e-09
was O 0 1.7216139625020332e-08
between O 0 9.935693379148347e-10
32 O 0 5.395110065364861e-07
. O 0 1.508327329702297e-07

3 O 0 1.9387387055758154e-06
and O 0 2.3756889788728586e-08
37 O 0 6.536244541166525e-07
. O 0 2.4524817376914143e-07

4 O 0 2.591038708033011e-07
years O 0 6.910063632403762e-09
, O 0 1.210150868402593e-10
whereas O 0 8.913163540569258e-10
the O 0 9.77682379499356e-10
family O 0 4.279587795252837e-09
harbouring O 0 7.203656423371285e-06
the O 0 3.410630426969874e-07
missense O 0 2.5951039788196795e-06
mutation O 0 1.6368196797955648e-09
had O 0 5.574248285178385e-10
an O 0 1.1632263728633685e-11
average O 0 8.172718751753294e-11
age O 0 1.4433253203716134e-10
of O 0 4.630222039114784e-10
onset O 0 1.2473731203499483e-07
of O 0 5.753415877052248e-08
51 O 0 8.408341045651468e-07
. O 0 1.7402727507942473e-06

2 O 0 3.8871717151778284e-06
years O 0 2.0861219240941864e-07
. O 0 3.971881312736514e-07

These O 0 3.360402089924719e-08
findings O 0 1.5591623991895176e-08
show O 0 3.7273885311606136e-08
that O 0 1.6422576631924812e-09
BRCA1 O 0 2.4696378275734787e-08
is O 0 4.998820801738191e-10
implicated O 0 1.3708680857149602e-09
in O 0 2.504396134916931e-10
a O 0 1.207011157688953e-10
small O 0 6.0832302736790744e-12
fraction O 0 3.7319236589894444e-10
of O 0 2.6271514741438295e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.5092505023517333e-08
suggesting O 0 5.346447728982184e-10
the O 0 6.661224349890915e-11
involvement O 0 3.6662947677790214e-10
of O 0 9.764686281776846e-11
another O 0 5.240735623246451e-11
susceptibility O 0 3.921344915447378e-10
gene O 0 9.097875230956731e-10
( O 0 8.961205111290838e-09
s O 0 1.7544070942676626e-05
) O 0 5.238245535110764e-07

Paternal O 0 0.0008575079846195877
transmission O 0 0.2000073790550232
of O 0 4.4989730668021366e-05
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9984538555145264

We O 0 1.4035487083674525e-06
report O 0 2.354163797235742e-08
a O 0 4.5505058055006486e-10
rare O 0 4.619803983807458e-10
case O 0 8.615534952127746e-10
of O 0 1.4628994904342107e-08
paternally O 1 0.9999979734420776
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 7.300531734699689e-08
DM B-Disease 1 1.0
) O 0 2.1277429596011643e-08
. O 0 1.6683884496160317e-07

The O 0 1.1734452982636867e-06
proband O 0 3.907569862349192e-06
is O 0 3.754470068173532e-10
a O 0 1.2540736504806915e-10
23 O 0 2.0906192332859064e-09
year O 0 4.76645223290717e-10
old O 0 5.4218705969333314e-08
, O 0 7.845734728562093e-09
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 6.09171684118337e-06
who O 0 2.725316221585672e-07
suffers O 0 1.7049667349056108e-06
severe O 0 6.951462182769319e-06
muscular B-Disease 1 0.999961256980896
weakness I-Disease 1 1.0
. O 0 0.40654265880584717

He O 0 1.1590086046453507e-07
presented O 0 5.6002136261668056e-08
with O 0 1.2279526284686426e-09
respiratory O 0 2.1616484957576176e-07
and O 0 5.88899484732508e-10
feeding O 0 1.023831153190713e-08
difficulties O 0 3.534717629705142e-09
at O 0 1.243044636112245e-07
birth O 0 4.603172328643268e-06
. O 0 3.6426145015866496e-06

His O 0 6.4350228967668954e-06
two O 0 1.6467635077788145e-07
sibs O 0 8.234044071286917e-05
suffer O 0 4.505463380155561e-08
from O 0 3.2187779108738823e-09
childhood O 0 3.71404858015012e-05
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.005398198962211609

Their O 0 3.039816220962166e-08
late O 0 2.3497104848502204e-06
father O 0 1.8575278204480128e-07
had O 0 4.206519932381525e-08
the O 0 1.2248414504867355e-09
adult O 0 9.93660376202854e-10
type O 0 1.5849719314786626e-09
of O 0 6.832347132501582e-09
DM B-Disease 1 1.0
, O 0 1.8512404054149556e-08
with O 0 1.137434452180841e-10
onset O 0 4.9996165216725785e-06
around O 0 1.8010100077958668e-09
30 O 0 1.503389590595816e-08
years O 0 3.3323486192671226e-09
. O 0 2.8946548269459527e-08

Only O 0 4.750954474275204e-08
six O 0 5.353815168973597e-10
other O 0 1.45525453666695e-12
cases O 0 9.330751232425327e-13
of O 0 1.349747223711173e-11
paternal O 0 8.756892930250615e-05
transmission O 1 1.0
of O 1 0.8561285734176636
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 2.1142019249964505e-05
been O 0 1.754070311221767e-08
reported O 0 1.1072402994471986e-09
recently O 0 4.640223316698666e-09
. O 0 2.2719280678984433e-08

We O 0 9.961223668142338e-08
review O 0 1.2773807789301372e-08
the O 0 9.990764882061853e-10
sex O 0 1.4313723817327428e-10
related O 0 4.5960363986852215e-11
effects O 0 5.671065284040822e-10
on O 0 6.996132562164803e-09
transmission O 0 4.37146979948011e-07
of O 0 5.453805584920701e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.1030111238360405

Decreased O 0 1.5534562862740131e-06
fertility O 0 3.23553450698455e-08
of O 0 1.1576537645163754e-10
males O 0 1.9972792517086724e-11
with O 0 2.6902511793790163e-13
adult O 0 1.981322883537473e-09
onset O 0 3.740867953183624e-07
DM B-Disease 1 1.0
and O 0 3.332528208943586e-08
contraction O 0 1.1520099718609345e-07
of O 0 1.153581119517355e-09
the O 0 2.843205115787839e-10
repeat O 0 2.5986271467992594e-10
upon O 0 5.554994797485335e-10
male O 0 2.2246748887511103e-10
transmission O 0 6.443731659366847e-11
contribute O 0 1.901830255779391e-11
to O 0 2.555018419059252e-10
the O 0 1.001134730671538e-09
almost O 0 1.029584084655255e-09
absent O 0 1.9290800068461067e-08
occurrence O 0 4.8624486659321065e-09
of O 0 3.8363345833403173e-10
paternal O 0 4.844057457376039e-06
transmission O 0 4.930429713567719e-05
of O 0 7.500505034840899e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.000593924371059984

Also O 0 5.1607727868940856e-08
the O 0 1.0249483484159327e-09
fathers O 0 4.506477324639491e-08
of O 0 1.9459711619873588e-09
the O 0 1.5720678092634444e-09
reported O 0 2.4557236244504566e-09
congenitally O 0 5.238473022473045e-06
affected O 0 1.991970366432838e-09
children O 0 7.450011163534498e-10
showed O 0 7.758585995887302e-10
, O 0 4.4478563193672827e-11
on O 0 5.941868330694433e-09
average O 0 2.2508179764457736e-09
, O 0 1.0297583619145456e-10
shorter O 0 2.840768864587062e-08
CTG O 0 1.2326909200055525e-06
repeat O 0 9.221328411967988e-08
lengths O 0 6.279542219544965e-08
and O 0 3.175663954024799e-09
hence O 0 9.937821232597344e-09
less O 0 1.03371633475291e-09
severe O 0 5.93736781961951e-10
clinical O 0 1.3495632389393108e-09
symptoms O 0 2.01086147733065e-10
than O 0 1.4663352997101864e-12
the O 0 3.752148591829041e-11
mothers O 0 3.072338772280858e-10
of O 0 4.928551664007408e-11
children O 0 2.589281289377965e-10
with O 0 4.3781656078323294e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9998997449874878

We O 0 2.5121016733464785e-07
conclude O 0 1.6758355059209862e-07
that O 0 1.824085327228886e-10
paternal O 0 1.1400112498449744e-06
transmission O 0 3.098810702795163e-05
of O 0 8.126376087602694e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 2.9472752771653177e-07
rare O 0 1.848543762505983e-09
and O 0 5.4556983930531544e-12
preferentially O 0 6.475886233509032e-12
occurs O 0 1.6673408530579192e-12
with O 0 7.139709152668636e-14
onset O 0 2.1755850454496795e-08
of O 0 1.9735916012564303e-08
DM B-Disease 1 1.0
past O 0 3.228161915558303e-08
30 O 0 2.1185777576704368e-09
years O 0 7.196732793035565e-11
in O 0 3.17543699668299e-11
the O 0 2.3711416163862964e-10
father O 0 6.524845108657473e-09
. O 0 6.585735512487645e-09
. O 0 6.106922967319406e-08

The O 0 2.837644387909677e-06
RB1 O 0 0.0002345865359529853
gene O 0 1.0448615483937829e-07
mutation O 0 3.6747327403219288e-09
in O 0 2.1095212243693595e-09
a O 0 1.2866237852904305e-08
child O 0 1.208140815833758e-06
with O 0 4.6848153800738146e-08
ectopic B-Disease 1 0.9999986886978149
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 1 0.9385270476341248

The O 0 2.3021855213301023e-06
RB1 O 0 0.0007645342266187072
gene O 0 3.451146426414198e-07
mutation O 0 5.6521054503377854e-09
was O 0 3.109486890195967e-09
investigated O 0 1.7984834732587274e-09
in O 0 1.4793808400526132e-09
a O 0 1.4576243323460858e-08
child O 0 6.974590291974891e-07
with O 0 7.328611939527718e-09
ectopic B-Disease 0 0.0009807588066905737
intracranial I-Disease 1 0.8643679618835449
retinoblastoma I-Disease 0 8.611627708887681e-05
using O 0 2.7221931375720487e-08
DNA O 0 1.1969244484433261e-09
obtained O 0 3.2844356123717944e-09
from O 0 3.164488671103527e-10
both O 0 4.3959386131220413e-10
the O 0 3.426619654689489e-09
pineal B-Disease 0 6.104464318923419e-06
and I-Disease 0 7.762708520431261e-08
retinal I-Disease 0 0.013143467716872692
tumours I-Disease 1 1.0
of O 0 3.3493518003524514e-07
the O 0 1.0048791132533097e-08
patient O 0 2.1874772215824123e-08
. O 0 2.1641460179466776e-08

A O 0 2.1572816422121832e-06
nonsense O 0 7.175052587626851e-07
mutation O 0 3.0057121236382045e-09
in O 0 1.5644938677894515e-09
exon O 0 3.844205309633253e-08
17 O 0 1.6642471223349276e-07
( O 0 3.508667245633035e-10
codon O 0 2.6819837017910686e-08
556 O 0 5.403171687845543e-09
) O 0 5.980090311830111e-10
of O 0 5.191453933406365e-09
the O 0 1.2059262921582103e-08
RB1 O 0 1.1046957297367044e-05
gene O 0 1.3759140493618816e-08
was O 0 6.579196565326129e-08
found O 0 4.4578973845688097e-10
to O 0 2.3829022088861507e-10
be O 0 2.0088028462872387e-10
present O 0 1.1133344940406076e-10
homozygously O 0 7.839306448431671e-08
in O 0 3.958500194300996e-09
both O 0 2.7790076906342165e-09
the O 0 7.711114413666564e-09
retinal B-Disease 0 1.6361265409159387e-07
and I-Disease 0 1.0172057329782547e-07
the I-Disease 0 1.3902933915233007e-06
pineal I-Disease 1 0.9999797344207764
tumours I-Disease 1 1.0
. O 0 2.369275762248435e-06

The O 0 5.537809855127307e-08
same O 0 6.189535106670974e-09
mutation O 0 5.815613546289455e-10
was O 0 8.337349144404982e-10
present O 0 7.337640217652819e-11
heterozygously O 0 2.6583018453152363e-08
in O 0 1.1163843183226163e-09
the O 0 7.228405096704194e-10
DNA O 0 6.581938882810334e-10
from O 0 3.598044084895946e-10
the O 0 2.2021697798635387e-09
constitutional O 0 2.609402827147278e-08
cells O 0 1.2173188013164804e-09
of O 0 3.436999296280163e-10
the O 0 4.0208505969197006e-10
patient O 0 3.1859779259235665e-09
, O 0 7.25129678524894e-11
proving O 0 4.659717944832664e-09
it O 0 3.166310616475876e-11
to O 0 4.893045968401566e-10
be O 0 2.8347431069164486e-09
of O 0 7.942186464049428e-09
germline O 0 1.6960244693109416e-06
origin O 0 6.432958343793871e-08
. O 0 3.827480838936026e-07

The O 0 1.9143659812925762e-07
initial O 0 3.011308535860735e-08
mutation O 0 1.0121786742089967e-09
was O 0 1.632937340900753e-09
shown O 0 4.023090749427638e-10
to O 0 8.841641863099881e-10
have O 0 1.457055726072909e-10
occurred O 0 7.9188267054775e-10
in O 0 2.7133106872412327e-10
the O 0 1.9857755440000346e-09
paternally O 0 3.8699101878592046e-07
derived O 0 4.658294017190201e-07
RB1 O 0 0.0005893775960430503
allele O 0 1.5988631503205397e-06
. O 0 5.061331194156082e-07

The O 0 1.628196031333573e-07
mutation O 0 1.2758315515171148e-09
is O 0 5.500544030673238e-12
in O 0 2.448265114946002e-12
an O 0 1.2133807413688968e-12
area O 0 4.9253191802822727e-11
of O 0 2.708507029769436e-10
the O 0 1.0702509989357623e-09
gene O 0 9.557870050969086e-10
that O 0 2.3756152600640235e-09
encodes O 0 5.244300549378522e-09
the O 0 1.2953676353788524e-08
protein O 0 3.649104907132994e-10
- O 0 7.810404545338656e-10
binding O 0 1.2624331580113335e-09
region O 0 1.712809005738336e-09
known O 0 1.4849387275361892e-09
as O 0 3.876561849303073e-10
the O 0 3.82431641909875e-10
pocket O 0 9.513442478237266e-07
region O 0 3.941232673554396e-09
and O 0 9.424273583746867e-10
has O 0 3.292255079667683e-10
been O 0 1.9374002402372525e-10
detected O 0 5.878199038633625e-10
in O 0 1.8576476468190606e-10
other O 0 2.850883695781903e-10
cases O 0 2.3962976047897655e-10
of O 0 5.78205705537016e-10
retinoblastoma B-Disease 0 1.3359496620068967e-07
. O 0 3.857028829656883e-08
. O 0 2.8080970082555723e-07

Low O 0 2.404125098109944e-06
levels O 0 3.0507766979326334e-08
of O 0 1.7497421289647264e-09
beta O 0 1.6365518717975647e-08
hexosaminidase O 0 3.7532572605414316e-07
A O 0 1.8026673487270273e-08
in O 0 6.329692880946425e-10
healthy O 0 1.914074010400668e-09
individuals O 0 1.6696035829918965e-12
with O 0 1.5678080361736235e-11
apparent O 0 2.2448176650868845e-07
deficiency O 0 9.032049092638772e-06
of O 0 2.0935165593982674e-05
this O 0 4.37609983805487e-08
enzyme O 0 5.863848784315451e-08
. O 0 1.3481776761636866e-07

Appreciable O 0 2.604344672363368e-06
beta O 0 6.671544952041586e-07
hexosaminidase O 0 9.79635751718888e-06
A O 0 9.505779416940641e-07
( O 0 2.717699176812971e-09
hex O 0 9.411686505700345e-07
A O 0 2.185005996580003e-06
) O 0 1.549626871266696e-09
activity O 0 3.296040773648201e-08
has O 0 8.530794820549303e-11
been O 0 6.577418470987695e-11
detected O 0 8.642592752572398e-10
in O 0 6.46008047056057e-09
cultured O 1 0.9999992847442627
skin O 1 1.0
fibroblasts O 1 1.0
and O 0 9.19070043892134e-06
melanoma B-Disease 1 0.9368294477462769
tissue O 0 2.015452160719633e-08
from O 0 1.2342354915872988e-10
healthy O 0 5.74709280165564e-10
individuals O 0 9.612372746728437e-13
previously O 0 2.133454524155809e-10
reported O 0 1.1268921906726348e-10
as O 0 6.089412307730413e-10
having O 0 1.288812683242213e-07
deficiency B-Disease 0 4.092185008630622e-06
of I-Disease 0 3.0578426049032714e-06
hex I-Disease 0 2.7070641408499796e-06
A I-Disease 0 1.3051318603629625e-07
activity O 0 6.359780257980674e-09
indistinguishable O 0 6.788178907868314e-10
from O 0 3.2628702257425646e-12
that O 0 4.450737196327881e-13
of O 0 8.266208897933502e-13
patients O 0 6.837864476028077e-12
with O 0 1.0506274322752418e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 7.906289845038827e-09
TSD B-Disease 0 0.08139292150735855
) O 0 1.8351459019072536e-08
. O 0 2.525765410155145e-07

Identification O 0 2.584836238384014e-06
and O 0 1.438670871323211e-08
quantitation O 0 0.00038267532363533974
of O 0 1.4941815607016906e-05
hex O 0 1.1788104529841803e-05
A O 0 2.0022962416987866e-06
, O 0 7.904551457826869e-10
amounting O 0 1.3395360376478038e-09
to O 0 5.0826014508231765e-09
3 O 0 2.0393017052811047e-07
. O 0 2.8933587259416527e-07

5 O 0 6.668892069683352e-07
% O 0 1.0814432016559294e-08
- O 0 7.84897125072348e-08
6 O 0 2.457862251503684e-07
. O 0 2.1238228953279759e-07

9 O 0 8.208910458051832e-07
% O 0 1.0404343164793772e-08
of O 0 2.6507667172381844e-09
total O 0 1.2394685278138695e-09
beta O 0 3.2540143024561985e-08
hexosaminidase O 0 3.46744400303578e-07
activity O 0 7.524363354605157e-08
, O 0 1.2535672500035844e-09
has O 0 1.0144376311194137e-10
been O 0 1.260185567009131e-10
obtained O 0 3.1803679689801356e-09
by O 0 2.809052157548564e-10
cellulose O 0 2.2588967851788766e-07
acetate O 0 1.6079030729088117e-06
gel O 0 1.5939638160489267e-06
electrophoresis O 0 2.218621730776249e-08
, O 0 2.7074689712414113e-10
DEAE O 0 2.5458422214796883e-07
- O 0 1.9101935588849983e-09
cellulose O 0 1.1299840174672227e-08
ion O 0 5.981269879384854e-08
- O 0 1.8202176477188914e-07
exchange O 0 1.3486500165527104e-06
chromatography O 0 1.0512442827348423e-07
, O 0 1.1864280669016125e-09
radial O 0 4.1031920083867135e-09
immunodiffusion O 0 3.8319291206789785e-07
, O 0 9.049485050205419e-10
and O 0 8.317272981450685e-10
radioimmunoassay O 0 4.053445081808604e-06
. O 0 1.7250332007279212e-07

Previous O 0 0.0012832590145990252
family O 0 1.8890716546593467e-07
studies O 0 2.388771065398032e-07
suggested O 0 5.1148912660892165e-08
that O 0 9.617406870887635e-11
these O 0 1.6726706825176407e-11
individuals O 0 2.3392808957273248e-12
may O 0 6.736737556689576e-11
be O 0 1.4242888812798782e-10
compound O 0 4.330529268514738e-09
heterozygotes O 0 1.3958684874637584e-08
for O 0 2.942199817113078e-10
the O 0 4.91589879914045e-10
common O 0 3.258445457898773e-10
mutant O 0 8.56259241288626e-09
TSD B-Disease 0 4.2685684320531436e-07
gene O 0 1.4021571681510636e-09
and O 0 3.387355396178293e-10
a O 0 3.1875948547366306e-09
rare O 0 9.341579065846872e-09
( O 0 6.126389395788578e-10
allelic O 0 1.053964737707247e-07
) O 0 9.103672815591324e-10
mutant O 0 4.5138410342815405e-08
gene O 0 2.0494724140007747e-08
. O 0 1.9733437284230604e-07

Thus O 0 1.4217246757652902e-07
, O 0 2.5633863920404565e-09
the O 0 1.203301791541378e-09
postulated O 0 2.7481419806463236e-08
rate O 0 1.1247546005677123e-08
mutant O 0 1.1858625192928685e-09
gene O 0 2.0186817495382314e-10
appears O 0 3.2343153155700577e-10
to O 0 1.737479604635439e-10
code O 0 6.273655206445738e-11
for O 0 4.351456348028471e-11
the O 0 4.2124892463135666e-10
expression O 0 3.597682374234523e-09
of O 0 3.3489519490892405e-10
low O 0 4.549481902316188e-10
amounts O 0 1.1908371511104576e-10
of O 0 1.2089356182798383e-09
hex O 0 2.371565130943054e-07
A O 0 1.406610522280971e-06
. O 0 2.1250029931252357e-06

Heterozygotes O 0 7.102017661964055e-06
for O 0 4.252713381447393e-08
the O 0 2.3678854432773733e-08
rare O 0 1.0452358090162761e-08
mutant O 0 2.6635499139615604e-08
may O 0 2.2849382386169736e-09
be O 0 2.697114476202245e-10
indistinguishable O 0 7.030855897482979e-10
from O 0 1.7809222846443262e-11
heterozygotes O 0 8.57082760319372e-09
for O 0 1.7279688790949876e-09
the O 0 7.556388403884284e-09
common O 0 1.8101095733413786e-08
TSD B-Disease 0 3.468783324933611e-05
mutant O 0 9.482030236540595e-07
. O 0 3.8716046901754453e-07

However O 0 3.1513377507508267e-07
, O 0 9.04061825401925e-10
direct O 0 1.730297349844534e-09
visualization O 0 8.78526904557475e-08
and O 0 7.342684238409447e-10
quantitation O 0 3.928915612050332e-05
of O 0 9.889811281027505e-07
hex O 0 4.7261949021049077e-07
A O 0 7.155858128271575e-08
by O 0 1.5133537478728698e-10
the O 0 1.1260031795856662e-09
methods O 0 2.0021454716356857e-08
described O 0 7.897272835677427e-10
may O 0 6.844003697104029e-10
prevent O 0 8.839280973838015e-10
false O 0 1.6025918370132786e-08
- O 0 1.2496696122354933e-08
positive O 0 1.232478896717737e-09
prenatal O 0 1.745370639127941e-07
diagnosis O 0 1.8368116627698328e-07
of O 0 1.2067700172480045e-09
TSD B-Disease 0 4.361643732408993e-06
in O 0 1.5378500251017613e-08
fetuses O 0 2.7600250973591756e-07
having O 0 1.3053274017238436e-09
the O 0 3.813698246091235e-09
incomplete O 0 2.997584047648161e-08
hex B-Disease 0 2.0679296994785545e-06
A I-Disease 0 6.1106561588530894e-06
deficiency I-Disease 0 3.945406206184998e-05
of O 0 5.151379082235508e-05
the O 0 5.29696023932047e-07
type O 0 2.2389379239484697e-07
described O 0 1.907786817412216e-09
in O 0 9.715979132352004e-10
the O 0 2.8884448610710933e-08
four O 0 1.9357031533218105e-08
healthy O 0 3.3383940944986534e-08
individuals O 0 1.4144353466249981e-09

The O 0 9.022966196425841e-07
tumor B-Disease 0 6.315239602372458e-07
suppressor O 0 3.9416477193299215e-06
gene O 0 1.8209122742973705e-07
Smad4 O 0 2.285068876517471e-05
/ O 0 8.927376256906427e-06
Dpc4 O 0 9.27041946852114e-06
is O 0 2.597195236653249e-10
required O 0 2.346576266631928e-10
for O 0 1.610787753181242e-10
gastrulation O 0 5.364983124422906e-08
and O 0 1.2716813713176123e-10
later O 0 3.404340143120521e-09
for O 0 3.634739731417369e-10
anterior O 0 7.109000055294246e-10
development O 0 8.33110931353076e-08
of O 0 8.40819502911927e-09
the O 0 5.941743541626465e-09
mouse O 0 2.166698287453528e-08
embryo O 0 3.12824504078435e-08
. O 0 1.4526152369853662e-07

Mutations O 0 1.274538252715729e-08
in O 0 2.6964879218382976e-09
the O 0 1.3306901358589585e-08
SMAD4 O 0 0.0001979424705496058
/ O 0 4.480335701373406e-05
DPC4 O 0 7.539451326010749e-05
tumor B-Disease 0 6.032990427229379e-07
suppressor O 0 1.920584935533043e-07
gene O 0 2.491913342339558e-09
, O 0 1.839208924048208e-10
a O 0 9.364212738560695e-10
key O 0 3.0743706247449154e-07
signal O 0 4.206205630907789e-06
transducer O 0 9.646508942751097e-07
in O 0 3.0838907605357235e-07
most O 0 3.5094338102226175e-08
TGFbeta O 0 6.695749561913544e-06
- O 0 1.0041936349125535e-07
related O 0 9.509649956385147e-09
pathways O 0 2.480153860062728e-09
, O 0 5.813168089258136e-12
are O 0 1.026069013825362e-13
involved O 0 5.332547554567912e-13
in O 0 1.1713438378968544e-11
50 O 0 1.2215104483459527e-08
% O 0 9.865243733031548e-09
of O 0 1.4165127026899427e-07
pancreatic B-Disease 0 0.0036835188511759043
cancers I-Disease 1 0.9998340606689453
. O 0 0.028567392379045486

Homozygous O 0 1.5575056750094518e-05
Smad4 O 0 1.0446883607073687e-05
mutant O 0 1.1134464017459322e-07
mice O 0 8.303042697832552e-09
die O 0 4.7934407554350855e-09
before O 0 2.914942509590901e-09
day O 0 3.7405929020906115e-08
7 O 0 1.0154490155400708e-06
. O 0 6.999150627962081e-07

5 O 0 5.616233465843834e-06
of O 0 4.025685882425023e-07
embryogenesis O 0 1.5531362805631943e-05
. O 0 1.6323267573170597e-06

Mutant O 0 1.9055408984058886e-07
embryos O 0 1.2008857019907282e-08
have O 0 2.5498678168922595e-10
reduced O 0 6.348130354716375e-10
size O 0 1.2787841896511054e-09
, O 0 1.0045413390002977e-09
fail O 0 2.1561079677212547e-07
to O 0 3.437173035081287e-08
gastrulate O 0 9.838392998062773e-07
or O 0 2.588793845959003e-09
express O 0 1.5715760914858379e-09
a O 0 5.013085502270087e-10
mesodermal O 0 7.860342066123849e-08
marker O 0 5.591397567172862e-08
, O 0 1.5505552397598876e-09
and O 0 2.9855826699787258e-09
show O 0 6.507131047328585e-07
abnormal O 0 2.1355113233312295e-07
visceral O 0 8.938825999393885e-07
endoderm O 0 0.00013755544205196202
development O 0 5.098613655718509e-06
. O 0 1.646651867304172e-06

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 1.9868436140768608e-07
the O 0 1.0521586268907868e-08
Smad4 O 0 1.5473630128326477e-06
- O 0 9.826017333125492e-08
deficient O 0 2.0126401878428624e-08
embryos O 0 8.971807297086798e-09
results O 0 3.5945888487987077e-09
from O 0 3.091967792911987e-10
reduced O 0 1.0865189636888317e-08
cell O 0 3.8914858890848336e-08
proliferation O 0 6.681159447907703e-07
rather O 0 3.472107268365221e-09
than O 0 3.1031635594480633e-10
increased O 0 1.279574779466941e-09
apoptosis O 0 6.493510795735347e-08
. O 0 1.9050266075737454e-07

Aggregation O 0 2.7628797738543653e-07
of O 0 8.093739012338119e-08
mutant O 0 1.528443362985854e-07
Smad4 O 0 4.279371751181316e-06
ES O 0 7.633015229657758e-06
cells O 0 3.505057133423861e-09
with O 0 2.6728997487568407e-11
wild O 0 6.424127896309528e-09
- O 0 7.824707992654112e-09
type O 0 3.7876610292642e-08
tetraploid O 0 2.546391669966397e-06
morulae O 0 2.2425021597882733e-05
rescues O 0 2.063642796201748e-06
the O 0 1.5160355815169169e-07
gastrulation B-Disease 0 7.411446858895943e-05
defect I-Disease 0 4.996803909307346e-06
. O 0 5.671795406669844e-07

These O 0 1.7228663296009472e-07
results O 0 6.519995565668069e-08
indicate O 0 6.285137743589075e-08
that O 0 3.50025869400028e-10
Smad4 O 0 1.9780259208346251e-07
is O 0 6.692961462828606e-11
initially O 0 1.8679692515011226e-10
required O 0 3.6108865897332976e-10
for O 0 3.6390401803032546e-10
the O 0 1.3535590426272393e-09
differentiation O 0 1.2384248293528799e-08
of O 0 6.320841183793391e-09
the O 0 3.353050503918098e-09
visceral O 0 1.4686083460446753e-08
endoderm O 0 2.626270543260034e-07
and O 0 2.8600663504185775e-10
that O 0 4.274085252387039e-11
the O 0 1.6439712091642633e-10
gastrulation B-Disease 0 1.751211300415889e-07
defect I-Disease 0 2.3314191466283773e-08
in O 0 1.009870520540801e-09
the O 0 8.018902875051026e-09
epiblast O 0 6.449270131270168e-06
is O 0 1.7666459961596104e-10
secondary O 0 4.675350773197806e-09
and O 0 1.3902527740139448e-10
non O 0 3.4071973686877755e-07
- O 0 1.1038926572837227e-07
cell O 0 6.898858373460826e-07
autonomous O 0 6.279919375629106e-07
. O 0 1.4009676760906586e-06

Rescued O 0 9.292530194215942e-06
embryos O 0 1.0467704214534024e-07
show O 0 2.747078724496532e-07
severe O 0 2.4545071752868353e-08
anterior O 0 6.83480010366111e-08
truncations O 0 0.00030858395621180534
, O 0 1.4816569660069945e-07
indicating O 0 4.0426715486319154e-07
a O 0 7.834639603743199e-09
second O 0 4.1864192112939236e-09
important O 0 2.2888899664508244e-09
role O 0 5.565337524160441e-09
for O 0 6.028697097093527e-09
Smad4 O 0 1.5604675809299806e-06
in O 0 8.259732453552715e-09
anterior O 0 1.1291420776160521e-07
patterning O 0 2.3461512682843022e-05
during O 0 0.0006979249883443117
embryogenesis O 0 7.287761400220916e-05
. O 0 1.853249500527454e-07

Prevalence O 0 1.9390938632568577e-06
of O 0 2.7246849221285174e-09
p16 O 0 6.523316642415011e-08
and O 0 5.791795043563752e-09
CDK4 O 0 0.00032285359338857234
germline O 0 0.00018705417460296303
mutations O 0 3.316789332075132e-08
in O 0 6.345265202156725e-09
48 O 0 2.701375194646971e-07
melanoma B-Disease 0 2.0430695713002933e-06
- O 0 5.03780142935284e-07
prone O 0 1.4734847120223549e-08
families O 0 7.641254295975841e-11
in O 0 1.4980418017174202e-09
France O 0 2.2610844041537348e-07
. O 0 4.0203644857683685e-07

The O 0 1.9479797629173845e-05
French O 0 0.000144526973599568
Familial B-Disease 0 0.0028786815237253904
Melanoma I-Disease 1 0.9999938011169434
Study O 0 8.255089767317259e-08
Group O 0 1.1444728498233303e-09
. O 0 2.5697992622752963e-09

Germline O 0 1.7782349459594116e-05
mutations O 0 1.6690465898250295e-08
in O 0 5.415697224009364e-09
the O 0 5.194762398019748e-09
p16 O 0 2.699464403121965e-07
and O 0 7.917441813276582e-09
CDK4 O 0 3.1263057280739304e-06
genes O 0 1.371333491206883e-09
have O 0 9.343315704457567e-11
been O 0 6.998020218862422e-11
reported O 0 4.5127322018112537e-11
in O 0 9.384841515025499e-11
a O 0 1.7619962155990265e-09
subset O 0 9.985249249666595e-08
of O 0 5.3079407535960854e-09
melanoma B-Disease 0 2.1094385260767012e-07
pedigrees O 0 5.019941440309594e-08
, O 0 6.052335854711544e-10
but O 0 2.9264837775322405e-10
their O 0 1.7490848769341483e-09
prevalence O 0 6.91315094059064e-08
is O 0 6.610442228327518e-12
not O 0 1.0130107169770142e-10
well O 0 1.3928013187225474e-09
known O 0 5.332785235623305e-08
. O 0 4.5108802737559017e-07

We O 0 1.7302065202784433e-07
searched O 0 6.99987268149016e-08
for O 0 6.177477973601242e-10
such O 0 8.020245023665495e-10
germline O 0 7.0975420385366306e-06
mutations O 0 4.954079368957309e-09
in O 0 4.8837707211646375e-09
48 O 0 8.476689572489704e-07
French O 0 1.923829358929652e-06
melanoma B-Disease 0 0.0005898248055018485
- O 0 3.1905881314742146e-06
prone O 0 7.677595448285501e-09
families O 0 3.3094537527089685e-11
selected O 0 3.1888092166809656e-10
according O 0 2.279068600508083e-11
to O 0 2.2088826601152078e-10
two O 0 2.2569031712937893e-11
major O 0 6.660182821915939e-11
criteria O 0 4.824293742267116e-10
families O 0 1.6337417529932452e-12
with O 0 2.9441824412473894e-13
at O 0 5.657042612128294e-10
least O 0 2.343463201270879e-10
three O 0 4.4278289368371304e-11
affected O 0 1.899568974339516e-10
members O 0 2.4997715009078547e-10
( O 0 1.622563750025563e-10
n O 0 2.359063344670176e-08
= O 0 5.977039307936138e-08
20 O 0 2.6039723710624685e-09
) O 0 9.1321845918646e-12
or O 0 1.4773829729031185e-11
families O 0 1.5741176808206636e-12
with O 0 8.574664280480357e-14
two O 0 1.7978496295867341e-12
affected O 0 8.797709956376298e-12
members O 0 8.020083729076699e-12
, O 0 1.6686365830742567e-11
one O 0 3.763868036688045e-11
of O 0 3.423349798081787e-11
them O 0 2.3200230798992028e-12
affected O 0 4.009848442870778e-12
before O 0 4.927762017881143e-11
the O 0 2.1119719861850683e-10
age O 0 1.0877334588599297e-09
of O 0 4.2062187066704837e-10
50 O 0 1.95788851797829e-09
( O 0 3.1868375993671094e-11
n O 0 5.853621143359078e-09
= O 0 8.907155546467038e-08
28 O 0 5.23435019772478e-08
) O 0 6.719236833596653e-10
, O 0 2.934135157062201e-10
and O 0 5.982642853341602e-11
one O 0 2.0061905262047652e-11
additional O 0 2.45465481274465e-10
minor O 0 6.45803543974921e-09
criterion O 0 1.3194808161642868e-05
. O 0 3.641561988843023e-06

Sixteen O 0 5.706322667720087e-07
different O 0 7.406546487231935e-09
p16 O 0 1.111453684643493e-06
germline O 0 1.200528231493081e-06
mutations O 0 2.6284132648157765e-09
were O 0 4.2174333469979786e-10
found O 0 2.6507135028608353e-11
in O 0 9.581881295350758e-12
21 O 0 6.571026500701294e-10
families O 0 6.112761338772366e-12
, O 0 1.0394251431788959e-11
while O 0 5.5964892442528225e-11
one O 0 1.4580405771624783e-09
germline O 0 1.1014127267117146e-05
mutation O 0 2.5604949271951227e-08
, O 0 1.4574094153729789e-09
Arg24His O 0 1.5138451772145345e-06
, O 0 2.4610455895412997e-09
was O 0 1.9737836254307695e-08
detected O 0 3.594451847277469e-09
in O 0 1.4243248802614517e-09
the O 0 2.1047116049999204e-08
CDK4 O 0 1.2431539289536886e-05
gene O 0 5.970920113895772e-08
. O 0 7.24626659120986e-07

The O 0 3.5058143055266555e-08
frequency O 0 9.605247441868414e-08
of O 0 1.3662790898649746e-09
p16 O 0 1.2129088844403668e-08
gene O 0 2.8472006974311626e-09
mutation O 0 3.261199921222868e-10
in O 0 3.446780916238623e-10
our O 0 8.780641103101061e-09
sample O 0 4.3278519656908543e-10
( O 0 6.14172462887197e-11
44 O 0 1.951885320039537e-09
% O 0 1.701016272281919e-10
) O 0 3.010373547662759e-11
is O 0 4.887901281641627e-12
among O 0 3.803520541058314e-13
the O 0 4.8668209219615566e-12
highest O 0 3.227073469558306e-11
rates O 0 9.37548441659608e-11
yet O 0 2.4855310518101525e-11
reported O 0 6.47756917548925e-11
and O 0 8.861897327072654e-11
the O 0 2.332143145267196e-09
CDK4 O 0 2.119380724252551e-06
mutation O 0 2.703923474012271e-10
is O 0 5.968688650964671e-12
the O 0 1.4158733907532195e-10
second O 0 3.4680298632849826e-09
mutation O 0 3.766907896718408e-10
detected O 0 7.697034121179058e-10
in O 0 2.1441835806879084e-10
this O 0 3.871463427618238e-10
gene O 0 2.7935851409921497e-09
worldwide O 0 1.3749930971584945e-08
. O 0 2.553808542415936e-07

In O 0 1.8579967786536145e-08
summary O 0 6.208005061125732e-07
, O 0 2.7871280283697786e-10
our O 0 1.1255351095584842e-09
results O 0 3.8969785731701734e-10
show O 0 1.3947419885695922e-09
frequent O 0 3.2189234611124107e-10
involvement O 0 5.1668269662741295e-09
of O 0 6.245008510319394e-09
the O 0 1.3234307871812234e-08
p16 O 0 8.826165753816895e-08
gene O 0 3.513385493647547e-08
in O 0 1.5103159611840056e-08
familial B-Disease 0 1.4416228566460632e-07
melanoma I-Disease 0 1.3495905477611814e-06
and O 0 5.439740671797644e-11
confirm O 0 1.0027195074258088e-08
the O 0 4.540520404106019e-09
role O 0 2.9092350928294763e-07
of O 0 5.404119292506948e-06
the O 0 3.3438047353229194e-07
CDK4 O 0 3.730295429704711e-05
gene O 0 1.155673867714313e-08
as O 0 1.3616178407005464e-08
a O 0 2.655352737690464e-08
melanoma B-Disease 0 5.5425298342015594e-06
- O 0 6.997829586907756e-07
predisposing O 0 1.7533028540128726e-06
gene O 0 1.3692172728951846e-08
. O 0 2.7844954786360177e-08
. O 0 1.356465162416498e-07

Progression O 0 2.1419434688141337e-06
of O 0 5.8561813176538635e-08
somatic O 0 2.894009867304703e-07
CTG O 0 7.479561077161634e-07
repeat O 0 3.283378546825588e-08
length O 0 7.726599360324826e-10
heterogeneity O 0 2.2736608151774362e-09
in O 0 8.271678897386892e-10
the O 0 1.374827252043076e-09
blood O 0 8.189633693422849e-11
cells O 0 2.1405317518485845e-09
of O 0 3.105284918092366e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 3.6075730349693913e-06
. O 0 3.132672645733692e-07

The O 0 8.011323870960041e-08
genetic O 0 3.1346938378362665e-09
basis O 0 3.0999899536254816e-08
of O 0 8.47466239406458e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.106668474283651e-07
DM B-Disease 1 1.0
) O 0 1.5976467926392957e-09
is O 0 5.885431725305423e-11
the O 0 3.1117681348336035e-11
expansion O 0 1.4776099233060336e-09
of O 0 4.4404330212799437e-10
an O 0 3.9380200489436135e-11
unstable O 0 6.953717046620511e-10
CTG O 0 5.163884253533979e-08
repeat O 0 2.2601878146844e-09
in O 0 7.061147777598364e-10
the O 0 7.166984228312856e-10
34 O 0 2.4548618693387425e-09
UTR O 0 1.690676185717166e-07
of O 0 6.440052047196332e-09
the O 0 2.207031890577582e-08
DM B-Disease 1 1.0
protein O 0 4.67626257716347e-08
kinase O 0 4.893676219808185e-08
gene O 0 3.773511281224273e-09
on O 0 2.3051892839021093e-08
chromosome O 0 5.462518970489327e-08
19 O 0 1.7469889144194894e-06
. O 0 4.826824806514196e-07

One O 0 1.124656350270925e-07
of O 0 1.0041472542354768e-08
the O 0 1.9001278328545368e-09
principal O 0 1.3082592786872738e-08
features O 0 1.6990464146715567e-08
of O 0 2.287546863044554e-08
the O 0 1.1498557341838023e-06
DM B-Disease 1 1.0
mutation O 0 1.9568055620311497e-07
is O 0 2.7141025538135466e-10
an O 0 4.253996460645837e-11
extraordinarily O 0 1.817554640126673e-08
high O 0 2.698661205613462e-07
level O 0 7.5491261668503284e-06
of O 0 8.361531200762329e-08
somatic O 0 1.2691972415268538e-06
mosaicism O 0 9.631442026147852e-07
, O 0 1.659445775237245e-10
due O 0 1.6717730533244435e-09
to O 0 1.6003366409833575e-09
an O 0 5.188775797915213e-11
extremely O 0 2.789563857685806e-10
high O 0 3.7803099539601703e-10
degree O 0 4.1992734622908756e-08
of O 0 2.3721300479451202e-08
somatic O 0 1.665110630710842e-06
instability O 0 1.530686830619743e-07
both O 0 7.321035999652281e-10
within O 0 1.9293870667791424e-10
and O 0 3.20033582967838e-11
between O 0 1.2590773909582076e-11
different O 0 3.7290276422297097e-10
tissues O 0 3.176453589048833e-08
. O 0 1.4001408032982e-07

This O 0 1.6195423313547508e-07
instability O 0 3.3132425869553117e-07
appears O 0 1.024682450001535e-09
to O 0 1.3579284918741052e-10
be O 0 4.982882856330306e-11
biased O 0 2.6988331014443645e-10
towards O 0 3.3835714785546145e-10
further O 0 1.514812164593593e-10
expansion O 0 2.9768873477387103e-10
and O 0 4.8567153770884275e-11
continuous O 0 1.1304578384496722e-09
throughout O 0 6.230808230478502e-11
the O 0 1.1969056301630587e-10
life O 0 6.872048485817572e-10
of O 0 1.79945697231787e-10
an O 0 1.980036100357463e-11
individual O 0 5.697712093799545e-11
, O 0 1.3335700599359512e-10
features O 0 2.1791806137372305e-09
that O 0 1.121257166974976e-11
could O 0 1.538566496428473e-11
be O 0 1.6449019230035944e-11
associated O 0 1.3070283744198719e-10
with O 0 7.488983391756854e-12
the O 0 2.763720585718943e-09
progressive O 0 1.1794854515301267e-07
nature O 0 2.908361551590133e-09
of O 0 3.9071301749515897e-10
the O 0 1.0274459061321295e-09
disease O 0 1.0276672846032398e-09
. O 0 1.1226498841665489e-08

Although O 0 5.115749601714015e-08
increasing O 0 6.864899315672801e-09
measured O 0 2.0046548865337854e-09
allele O 0 3.5525751229670277e-09
size O 0 2.4133006704119e-10
between O 0 4.5770005840939376e-11
patients O 0 6.77788447589478e-09
clearly O 0 1.1184367876282408e-09
correlates O 0 1.6317751316829998e-10
with O 0 9.507599785588128e-13
an O 0 1.5773155351284096e-12
increased O 0 4.1030630282268277e-11
severity O 0 1.1448003656155947e-09
of O 0 4.180431001366003e-11
symptoms O 0 1.6650067435897142e-10
and O 0 3.580692166382793e-12
an O 0 1.6759399857485535e-12
earlier O 0 3.418566818513824e-11
age O 0 2.0917388654506652e-10
of O 0 2.565595791370612e-10
onset O 0 8.81097328431224e-09
, O 0 1.519907984193214e-11
this O 0 1.1176019311387453e-11
correlation O 0 5.85255455209932e-11
is O 0 9.040781144553645e-12
not O 0 1.4389492375421753e-10
precise O 0 1.624463585869762e-08
and O 0 7.601940410495445e-09
measured O 0 1.4701868167321663e-07
allele O 0 5.822823112566766e-08
length O 0 2.009348021303481e-09
cannot O 0 1.181586917198274e-08
be O 0 7.853845906957702e-10
used O 0 1.68575597925269e-09
as O 0 3.3959332568223033e-10
an O 0 1.0657317910112152e-11
accurate O 0 2.4365014450467015e-09
predictor O 0 1.9971604814372768e-08
of O 0 8.130075501711076e-10
age O 0 1.1548188183496677e-08
of O 0 1.4650663793247531e-08
onset O 0 3.6226149404683383e-06
. O 0 2.0084262075670267e-07

In O 0 1.0422973595325402e-08
order O 0 1.0616386658668375e-09
to O 0 2.035857593618573e-10
further O 0 2.0254851962331344e-10
characterize O 0 2.769086959730771e-09
the O 0 1.413585803966555e-09
dynamics O 0 8.24701285040419e-09
of O 0 7.498660181681771e-08
DM B-Disease 1 1.0
CTG O 0 1.8726834241533652e-05
repeat O 0 8.870837291397038e-07
somatic O 0 5.236444849288091e-06
instability O 0 3.1496369956585113e-07
, O 0 1.0759774321522642e-10
we O 0 9.865008115950147e-11
have O 0 5.203272708531603e-12
studied O 0 8.139117158023623e-11
repeat O 0 3.0476271506429953e-10
length O 0 1.2104879598684448e-10
changes O 0 2.931478393364273e-10
over O 0 7.239200992131822e-12
time O 0 1.6864047658327053e-10
in O 0 3.8667258284164063e-10
111 O 0 4.062102902935294e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.1487511386576443e-08
with O 0 7.438058957816296e-13
varying O 0 1.9242777510308784e-11
clinical O 0 6.787609918568194e-10
severity O 0 1.7140051600250672e-09
and O 0 8.706087933907369e-11
CTG O 0 1.3984646329845418e-07
repeat O 0 9.527479249982207e-09
size O 0 2.300172496916275e-09
over O 0 9.86762338506253e-11
time O 0 2.5213967025372597e-10
intervals O 0 1.0045139720027407e-10
of O 0 2.81167727989029e-11
1 O 0 5.639073652474735e-10
- O 0 6.0550062741526745e-09
7 O 0 2.6282942044986157e-08
years O 0 1.3912037744034933e-08
. O 0 6.581166900332391e-08

We O 0 4.398912665237731e-07
have O 0 1.7083131576001165e-09
found O 0 7.413945152245915e-11
a O 0 1.868021709539036e-11
direct O 0 3.2857935816643646e-10
progression O 0 6.008172181992677e-09
of O 0 7.62818141986088e-10
the O 0 1.226356238781534e-09
size O 0 1.1254256415682562e-09
heterogeneity O 0 5.811525038978971e-09
over O 0 1.3063156112380625e-10
time O 0 8.432506359845604e-10
related O 0 9.966307779052386e-10
to O 0 2.0052937088621547e-09
initial O 0 5.784166479116948e-09
CTG O 0 1.6393894952670962e-07
repeat O 0 9.581858861906767e-09
size O 0 2.4900224104840163e-09
and O 0 1.2739883592516321e-09
the O 0 2.546466815189774e-09
time O 0 5.930998359104933e-09
interval O 0 3.5203597814614795e-09
and O 0 1.3473712423550666e-10
always O 0 1.1954780498868445e-09
biased O 0 2.1352388746009865e-09
towards O 0 9.715053206349467e-10
further O 0 2.053799352808028e-09
expansion O 0 7.033276716583714e-08
. O 0 3.15726396138416e-07

Attempts O 0 4.7535471026094456e-07
to O 0 1.7657416861993624e-08
mathematically O 0 2.180499691917248e-08
model O 0 1.0268198025187303e-07
the O 0 2.4862838898798145e-08
dynamics O 0 4.8697462062818886e-08
have O 0 1.0846513021078863e-08
proved O 0 9.3545629908931e-08
only O 0 1.5280192666722314e-09
partially O 0 8.77078232264239e-09
successful O 0 7.384203914995169e-09
suggesting O 0 5.537057035098769e-09
that O 0 1.131459769626586e-11
individual O 0 3.163876062181603e-12
specific O 0 2.123791698060984e-10
genetic O 0 7.47800044109681e-10
and O 0 5.10445741230825e-10
/ O 0 1.5073112990648951e-05
or O 0 2.500022056040052e-08
environmental O 0 5.893312060578637e-09
factors O 0 1.615671707533295e-09
also O 0 2.56625665162602e-10
play O 0 3.471623877260299e-09
a O 0 7.635299614783264e-10
role O 0 5.521037849121058e-09
in O 0 2.2016671152869094e-08
somatic O 0 1.1390603731342708e-06
mosaicism O 0 4.002169134764699e-06
. O 0 5.630438693060569e-08
. O 0 2.2526924681187666e-07

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 3.64273873287857e-08
Palestinian O 0 9.793589015316684e-07
Arabs O 0 8.250318046520988e-07
. O 0 9.13126143586851e-08

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 5.080809387436602e-06
AGU B-Disease 1 1.0
) O 0 1.6041697747937178e-08
is O 0 5.314126916289297e-10
a O 0 1.9209498436367767e-09
rare O 0 8.433254805595425e-08
disorder B-Disease 1 0.965949535369873
of I-Disease 0 1.5705776604590937e-05
glycoprotein I-Disease 0 5.8403247749083675e-06
metabolism I-Disease 0 0.0001731355587253347
caused O 0 2.5925457336484214e-08
by O 0 1.6073320452392181e-10
the O 0 4.5395527337177555e-08
deficiency B-Disease 0 3.5864005099028873e-07
of I-Disease 0 2.2702954538544873e-07
the I-Disease 0 4.9680291880349614e-08
lysosomal I-Disease 0 5.457717406898155e-07
enzyme I-Disease 0 2.2508363173301404e-08
aspartylglucosaminidase I-Disease 0 1.1951113947361591e-06
( O 0 6.53404497175103e-10
AGA O 0 3.0735780001123203e-06
) O 0 1.814935579602661e-08
. O 0 1.6267510716261313e-07

AGU B-Disease 1 1.0
is O 0 2.1250019699436962e-07
inherited O 0 4.217779974169389e-07
as O 0 1.8852490768495045e-07
an O 0 1.939824301189219e-08
autosomal O 0 0.1864146739244461
recessive O 0 0.00011234898556722328
trait O 0 8.685242391948123e-07
and O 0 5.166184147142872e-10
occurs O 0 1.6834504276697082e-11
with O 0 1.5931459168387618e-13
a O 0 2.0035214806646273e-11
high O 0 1.5415642096172633e-09
frequency O 0 4.5155978511957073e-08
in O 0 6.703520849526967e-09
Finland O 0 7.371584587190227e-08
because O 0 2.1297477115211905e-09
of O 0 9.337552953070372e-09
a O 0 6.485500581021597e-09
founder O 0 1.4711433493630466e-07
effect O 0 5.977677375312851e-08
. O 0 2.4081862193270354e-07

While O 0 8.152817798645628e-08
very O 0 1.5559352695149187e-09
few O 0 1.5929487728882918e-09
patients O 0 6.465574742264835e-10
with O 0 4.995768382309862e-11
AGU B-Disease 1 1.0
have O 0 1.8446211669242984e-08
been O 0 9.064998751640019e-10
reported O 0 9.12106570827298e-11
from O 0 1.1216165149430246e-11
non O 0 8.50987280642812e-09
- O 0 2.973977286657714e-09
Finnish O 0 8.827997000082632e-09
origin O 0 1.7395619666960016e-10
, O 0 1.3511742072425115e-11
we O 0 1.3532097664636922e-10
diagnosed O 0 1.9851594146302887e-08
the O 0 2.3838853113744563e-09
disorder O 0 6.664384955001879e-08
in O 0 1.801050281136085e-10
8 O 0 3.0704421227767398e-09
patients O 0 1.0439790525118564e-11
originating O 0 9.599332613519085e-12
from O 0 5.5985576417894034e-12
3 O 0 2.708813395813081e-09
unrelated O 0 1.6808981984084426e-09
families O 0 2.3217682984522092e-11
, O 0 1.1228944857277767e-11
all O 0 7.973744928224669e-12
Palestinian O 0 1.1392762289119673e-09
Arabs O 0 4.94763674474541e-10
from O 0 2.734031924467306e-11
the O 0 4.7007585324276846e-11
region O 0 1.0062341238015193e-10
of O 0 1.3846214452772898e-10
Jerusalem O 0 1.5288384247469367e-06
. O 0 7.079035668766664e-08

The O 0 1.1352015150123407e-07
clinical O 0 1.9114615668058832e-07
diagnosis O 0 0.0009621026110835373
of O 0 3.3308872389170574e-06
AGU B-Disease 1 1.0
is O 0 2.7130290902732668e-08
often O 0 1.297911084163772e-10
difficult O 0 2.2685223144414124e-10
, O 0 1.1306075867190124e-11
in O 0 1.9175033089124938e-11
particular O 0 6.485086079255353e-11
early O 0 6.152572895601338e-10
in O 0 2.7859678106145758e-11
the O 0 9.684041069046856e-11
course O 0 8.033932408224587e-10
of O 0 1.644887004381701e-10
the O 0 2.1705760799850538e-10
disease O 0 5.1682318147339146e-11
, O 0 3.3528214926636934e-12
and O 0 4.76037828947562e-12
most O 0 4.035538569979735e-11
of O 0 1.1818156175902317e-10
the O 0 1.1007667694018508e-10
patients O 0 1.2443635531711461e-11
are O 0 1.1752417615473743e-12
diagnosed O 0 5.567423605468136e-11
after O 0 2.350599159761657e-10
the O 0 9.364963249325342e-10
age O 0 3.4577856133921614e-09
of O 0 2.2851995851169704e-09
5 O 0 1.465111054699264e-08
years O 0 1.0984084752863055e-08
. O 0 9.936763234463797e-08

However O 0 6.309689410954888e-07
, O 0 3.728495734378612e-09
since O 0 2.0897898966865114e-09
these O 0 3.286790284384722e-10
patients O 0 6.815952663385971e-11
excrete O 0 9.035549530800324e-10
early O 0 1.147410388924186e-09
large O 0 5.5101017498726534e-11
amounts O 0 1.8576202798215036e-09
of O 0 7.049605343922849e-09
aspartylglucosamine O 0 1.7512140857434133e-06
in O 0 6.964979348822453e-08
urine O 0 1.2555636530464653e-08
, O 0 3.026633943470358e-10
biochemical O 0 3.579550655885555e-09
screening O 0 1.0228591307281931e-08
is O 0 1.560036211323279e-09
easy O 0 2.6159259647329236e-08
by O 0 1.3591054948136616e-09
urine O 0 3.0791806882035644e-09
chromatography O 0 3.851160279566557e-09
. O 0 1.9722406818800664e-08
. O 0 1.34561773279529e-07

Detection O 0 3.737747647392098e-06
of O 0 2.5133470415994452e-08
heterozygous O 0 2.039160923450467e-10
carriers O 0 8.695367342825833e-11
of O 0 1.2455425579815937e-09
the O 0 2.5233481437680894e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.7059074980684272e-08
ATM O 0 3.3900980724865803e-06
) O 0 3.9833858433979685e-10
gene O 0 1.21072804559752e-10
by O 0 7.537337420870927e-11
G2 O 0 1.2247174652202375e-07
phase O 0 6.685557707442058e-08
chromosomal O 0 3.9441079024982173e-07
radiosensitivity O 0 1.2965739188075531e-05
of O 0 7.193573026142985e-08
peripheral O 0 1.656969971008948e-06
blood O 0 1.3502699403034057e-07
lymphocytes O 0 1.0777329606526109e-07
. O 0 3.273311577345339e-08

In O 0 7.11078200765769e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.250969141139649e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.3250263108943727e-09
patients O 0 5.495182975323587e-09
, O 0 2.3238107618728243e-11
mutations O 0 1.1789692486163794e-11
in O 0 1.0821064183597073e-10
a O 0 3.3742267313563445e-10
single O 0 9.41859479297591e-10
gene O 0 3.161025885489721e-10
, O 0 2.2124750642671387e-10
ATM O 0 2.4484753780029678e-08
, O 0 2.3509116528486196e-11
result O 0 1.4759747243853205e-11
in O 0 1.9740867274187224e-10
an O 0 6.276811603811439e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.8668028900492573e-08
embraces O 0 4.687081278653693e-10
a O 0 2.937387486023901e-11
variety O 0 8.497261227979891e-11
of O 0 1.9258943051436717e-10
clinical O 0 1.351464162802074e-09
features O 0 3.0263123118601243e-09
and O 0 1.7973919574920671e-10
manifests O 0 8.864758926918626e-10
extreme O 0 2.879059879390411e-09
radiosensitivity O 0 5.453337337257835e-08
and O 0 1.8701830362122251e-10
a O 0 1.1498756613548267e-08
strong O 0 3.381175162076033e-08
pre O 0 2.333223346795421e-05
- O 0 3.503078914945945e-06
disposition O 0 3.570551780285314e-05
to O 0 4.752477252623066e-06
malignancy B-Disease 0 0.00043131643906235695
. O 0 3.689188190492132e-07

Heterozygotes O 0 6.124716946942499e-06
for O 0 5.196985242150731e-08
the O 0 2.203868554317978e-08
ATM O 0 1.091876697500993e-06
gene O 0 9.245258780765653e-09
have O 0 8.025324849114668e-10
no O 0 1.5464549085741908e-10
clinical O 0 1.491204937309476e-10
expression O 0 2.1466715904860934e-10
of O 0 1.7372816518701484e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 1.479674383020324e-09
may O 0 1.466849530729064e-09
be O 0 9.2750845892553e-10
cancer B-Disease 0 2.362628537255773e-09
prone O 0 6.330896917816631e-11
with O 0 8.345736753588573e-13
a O 0 1.9933985018205647e-10
moderate O 0 6.559343623813163e-10
increase O 0 2.1110295456150396e-10
in O 0 9.509899534521082e-10
in O 0 1.4603262599166555e-08
vitro O 0 2.1146604467503494e-06
radiosensitivity O 0 3.293108420621138e-06
. O 0 6.507751777462545e-07

We O 0 4.0241999954560015e-08
performed O 0 1.5987511758908113e-08
a O 0 9.789311583574545e-09
blind O 0 1.4427423877805268e-07
chromosomal O 0 3.505981638340927e-08
analysis O 0 1.617257261443683e-08
on O 0 3.78806364054185e-09
G2 O 0 1.11321185602975e-09
- O 0 2.4100624274048243e-10
phase O 0 1.2328008613948782e-09
lymphocytes O 0 2.621167727312468e-10
from O 0 1.9973469492923224e-12
7 O 0 4.0241038279376085e-10
unrelated O 0 2.190863490625361e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.8539329949571766e-08
, O 0 4.295216526201129e-12
13 O 0 1.2140163874185816e-10
obligate O 0 1.8122379685792112e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 2.0301768017816357e-06
( O 0 1.901111906787989e-11
parents O 0 5.016698861881608e-11
of O 0 1.2366643299677182e-11
the O 0 1.1104793300187321e-11
patients O 0 3.386628434284833e-12
) O 0 2.305064776206289e-13
, O 0 1.1855011330247356e-12
and O 0 9.262876923821217e-12
14 O 0 6.6554908251248435e-09
normal O 0 7.086255777721817e-07
controls O 0 2.9871426932004397e-07
following O 0 5.563597138547038e-09
X O 0 1.4714744622779108e-07
- O 0 4.696577793339429e-09
irradiation O 0 1.0198202282651891e-08
with O 0 3.034568776816293e-11
1 O 0 7.618414343824043e-09
Gy O 0 1.6093206340883626e-06
in O 0 7.674264002055509e-11
order O 0 1.2588595443840944e-10
to O 0 2.2496840501595727e-10
evaluate O 0 3.9398946327651174e-09
this O 0 3.8183253781021165e-10
cytogenetic O 0 2.571277093466051e-07
method O 0 3.740970910826036e-08
as O 0 2.847613700396323e-09
a O 0 9.685210411447542e-10
tool O 0 3.638162837660275e-08
for O 0 3.0459709754460107e-10
detection O 0 6.843879418738652e-08
of O 0 9.908842635297788e-09
ATM O 0 3.086879132752074e-06
carriers O 0 6.779231398468255e-08
. O 0 9.104372225010593e-07

Both O 0 3.398315584490774e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 2.392092937952839e-05
and O 0 3.2587703646669297e-09
heterozygotes O 0 5.146431476532598e-07
showed O 0 2.4359112504868108e-09
significantly O 0 3.330262732248457e-10
increased O 0 3.711260188055121e-10
levels O 0 2.32696217850048e-09
of O 0 5.325542784540005e-10
radiation O 0 4.099184479855467e-06
- O 0 2.168630999221932e-06
induced O 0 1.1168895071023144e-06
chromatid O 0 3.4009968885584385e-07
damage O 0 2.9561302739011808e-08
relative O 0 1.5117857188329253e-08
to O 0 1.7762223913919684e-09
that O 0 5.0850497423926555e-11
of O 0 3.592736108615213e-10
normal O 0 7.137089141906472e-08
controls O 0 7.795713372615865e-07
. O 0 5.525755000235222e-07

These O 0 6.285926446025769e-09
results O 0 2.074591165523998e-09
show O 0 3.7931533469759415e-09
that O 0 6.110957573302045e-11
the O 0 3.0379931903468105e-10
G2 O 0 7.676983670990012e-08
- O 0 1.4217165755781025e-07
phase O 0 6.389194595612935e-07
chromosomal O 0 4.220079517835984e-06
radiosensitivity O 0 2.8014977942802943e-05
assay O 0 3.162186956728874e-08
can O 0 3.7185088341828987e-10
be O 0 3.290432856739578e-11
used O 0 2.0650077134365397e-11
for O 0 6.8048561577271904e-12
the O 0 8.81243862604908e-12
detection O 0 3.260075986943889e-09
of O 0 3.329782005678794e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 0.0002787906560115516
. O 0 1.885865344775084e-06

In O 0 5.897464561144261e-08
combination O 0 3.3461777348975374e-08
with O 0 1.8615847752201375e-10
molecular O 0 2.114065900116202e-08
genetic O 0 2.3541986138297943e-09
analyses O 0 2.2128772148022335e-09
, O 0 8.279282120993159e-11
this O 0 7.795279699518431e-11
test O 0 2.901417717193766e-10
may O 0 5.894452287380503e-11
be O 0 7.662285389509194e-11
of O 0 1.2317607871181746e-11
value O 0 7.851026079253032e-11
in O 0 2.0267362441095393e-11
studies O 0 1.891680589949374e-09
of O 0 2.0967759473133896e-10
familial B-Disease 0 4.008784415532318e-09
and I-Disease 0 1.16495491031543e-09
sporadic I-Disease 0 6.159928744864374e-08
cancers I-Disease 0 8.7788665226185e-09
aimed O 0 1.7753290393329735e-08
at O 0 3.566118955689035e-09
determination O 0 2.6250775775338298e-08
of O 0 1.190736131917447e-08
the O 0 2.1586616938407133e-09
potential O 0 1.5575446488114153e-09
involvement O 0 1.9743408685712893e-08
of O 0 3.1738490946509046e-08
ATM O 0 2.8996924811508507e-05
mutations O 0 7.796406720217419e-08
in O 0 1.0596527211248485e-08
tumor B-Disease 0 1.242894541064743e-06
risk O 0 1.0927392324333596e-08
or O 0 1.1698440827156986e-10
development O 0 1.5284565835216313e-09
. O 0 2.1716042297725835e-09
. O 0 2.1225060820029285e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 2.758703772087756e-07
identification O 0 6.867717416980668e-08
and O 0 4.293400357457955e-11
detection O 0 3.2979023956158926e-08
of O 0 6.2504543762997855e-09
founder O 0 9.496186237356596e-08
- O 0 3.1258828414593154e-08
effect O 0 2.988945979609525e-08
mutations O 0 6.72369826482111e-10
in O 0 8.925412631199947e-10
the O 0 2.0175356940654865e-09
ATM O 0 8.727182176926362e-08
gene O 0 7.285347880525705e-10
in O 0 8.14956047090476e-10
ethnic O 0 8.985225063984359e-11
populations O 0 2.1995073817837607e-10
. O 0 1.2495741330553756e-08

To O 0 1.7042914635112538e-08
facilitate O 0 1.4169552642329108e-08
the O 0 2.1105073244598316e-09
evaluation O 0 2.8031887921997622e-08
of O 0 1.0616878931557494e-08
ATM O 0 3.041602212761063e-06
heterozygotes O 0 1.391999489896989e-06
for O 0 2.8710973598577993e-09
susceptibility O 0 2.036395585491846e-08
to O 0 9.87589920953269e-09
other O 0 7.524212364273808e-10
diseases O 0 3.4994525055509484e-09
, O 0 8.980731956709231e-12
such O 0 4.206746409551876e-11
as O 0 6.523252160661741e-09
breast B-Disease 0 9.559500568911972e-08
cancer I-Disease 0 1.7062625090602523e-08
, O 0 2.3597809817310633e-10
we O 0 1.342823185979114e-09
have O 0 4.4249416630837146e-11
attempted O 0 9.22768861322254e-10
to O 0 6.52653431298944e-10
define O 0 1.6542584191370224e-08
the O 0 5.293180116439089e-09
most O 0 7.099582588487863e-10
common O 0 2.966741019516661e-10
mutations O 0 1.3748336670504901e-11
and O 0 8.584389167391737e-13
their O 0 1.174493748784533e-11
frequencies O 0 1.884790767903155e-09
in O 0 7.57799512030033e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 8.087185960903298e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.055083603291763e-10
homozygotes O 0 5.263142099920515e-08
from O 0 1.8624229936037295e-10
10 O 0 5.924324364414701e-10
ethnic O 0 2.129761818292497e-11
populations O 0 2.0574800196904164e-10
. O 0 6.384318851360149e-09

Both O 0 1.1709820313399177e-07
genomic O 0 1.9644454596345895e-07
mutations O 0 2.9094266995599583e-09
and O 0 9.933660144456624e-11
their O 0 1.7743116698110128e-10
effects O 0 3.199118747687635e-09
on O 0 3.094679001947043e-08
cDNA O 0 1.5907399131265265e-07
were O 0 8.031656761886552e-08
characterized O 0 6.256588136466235e-08
. O 0 2.48416569093024e-07

Protein O 0 8.154403730031845e-08
- O 0 2.0060252126086198e-08
truncation O 0 8.356174419077433e-08
testing O 0 1.0875909062235678e-08
of O 0 6.966806576080842e-10
the O 0 6.12251083165205e-10
entire O 0 1.0399456851217792e-09
ATM O 0 6.623340453870696e-08
cDNA O 0 5.4232149437893895e-08
detected O 0 1.8657527078858038e-08
92 O 0 3.208775822827192e-08
( O 0 1.101791852198275e-10
66 O 0 6.063824109503457e-09
% O 0 1.658142373406335e-10
) O 0 5.287614790461248e-11
truncating O 0 1.517621761593091e-08
mutations O 0 5.65546720565635e-10
in O 0 4.5510439861118357e-10
140 O 0 4.2133989630599444e-09
mutant O 0 5.898957766703461e-09
alleles O 0 7.296528381495193e-10
screened O 0 6.461413448732856e-08
. O 0 7.036200599941367e-07

The O 0 3.167668864989537e-07
haplotyping O 0 2.1150792235857807e-05
of O 0 4.848088153153185e-08
patients O 0 7.060020124072253e-09
with O 0 3.0072860868202156e-11
identical O 0 3.4927261083339545e-08
mutations O 0 1.9043195464973905e-08
indicates O 0 3.217060751126155e-08
that O 0 1.4021725447399547e-10
almost O 0 8.735767664802552e-10
all O 0 1.0621369339602893e-09
of O 0 7.095507514875976e-10
these O 0 5.0609273716251124e-11
represent O 0 2.158825479492421e-10
common O 0 7.96426868898692e-10
ancestry O 0 2.163356604967248e-09
and O 0 1.6333445707061856e-10
that O 0 1.260919008094774e-10
very O 0 3.5082656224538766e-10
few O 0 3.7710936595658495e-09
spontaneously O 0 2.1860162568998476e-09
recurring O 0 3.4022512807041494e-08
ATM O 0 1.0108961760124657e-05
mutations O 0 6.64601742528248e-08
exist O 0 5.383053007790295e-07
. O 0 7.590111863464699e-07

Assays O 0 2.5783685941860313e-06
requiring O 0 5.126591773318978e-08
minimal O 0 3.0392661187761405e-07
amounts O 0 5.376556089231599e-09
of O 0 4.228905670089489e-09
genomic O 0 3.1856863813573e-09
DNA O 0 7.883983466072664e-10
were O 0 4.1564540698146857e-10
designed O 0 1.1725834747622343e-09
to O 0 6.321319578894702e-10
allow O 0 8.028631648393514e-10
rapid O 0 4.81008899377855e-10
screening O 0 3.490418232221515e-10
for O 0 3.300541784323485e-10
common O 0 1.272341898506113e-09
ethnic O 0 2.0531559785652576e-10
mutations O 0 1.4363614742052278e-09
. O 0 4.2909348962894e-08

These O 0 7.13465269086555e-08
rapid O 0 9.383046517541516e-08
assays O 0 1.6540776925921818e-07
detected O 0 1.7559649734266713e-08
mutations O 0 2.1585619403019507e-10
in O 0 3.615731603012762e-10
76 O 0 3.658293223907094e-08
% O 0 4.828841215775981e-10
of O 0 1.00334263120061e-09
Costa O 0 2.4594466907501555e-08
Rican O 0 2.7584724193729926e-07
patients O 0 5.880781195344298e-09
( O 0 1.1401598415394787e-11
3 O 0 7.786754019356579e-10
) O 0 2.9270520035540315e-11
, O 0 1.872298670269057e-11
50 O 0 4.2327127913743823e-10
% O 0 1.982840454328727e-11
of O 0 4.253964194789184e-11
Norwegian O 0 5.164639382826408e-09
patients O 0 1.340890842804754e-09
( O 0 3.467059105088932e-12
1 O 0 7.241708344096764e-10
) O 0 2.979879537567953e-11
, O 0 2.2654253473142205e-11
25 O 0 3.549512073153238e-10
% O 0 4.0811073270807796e-11
of O 0 6.18818329911619e-11
Polish O 0 9.06968988800827e-09
patients O 0 1.8937167389765364e-09
( O 0 6.378259899408878e-12
4 O 0 8.718987754008367e-10
) O 0 3.3975319085888245e-11
, O 0 1.3369310866706563e-11
and O 0 5.603172439916371e-12
14 O 0 2.4302901358019824e-10
% O 0 2.8331132578829354e-11
of O 0 3.384705710152147e-11
Italian O 0 3.9394493223099403e-10
patients O 0 4.0779427057380246e-10
( O 0 4.706677322191544e-12
1 O 0 3.147178961881991e-09
) O 0 3.1681182677267827e-10
, O 0 5.9467833435356e-11
as O 0 4.804181705231336e-11
well O 0 1.6605024646954014e-11
as O 0 6.820293028259039e-12
in O 0 3.4520144989030888e-12
patients O 0 8.462418266130811e-12
of O 0 1.388185226491867e-11
Amish O 0 9.245631815701927e-08
/ O 0 1.0565244110694039e-06
Mennonite O 0 1.8544157001088024e-06
and O 0 6.688807285826215e-09
Irish O 0 1.3800246279060957e-08
English O 0 1.3439204415988115e-08
backgrounds O 0 2.2423563450502115e-08
. O 0 4.994822688786371e-08

Additional O 0 6.832909207332705e-07
mutations O 0 7.274132851620152e-09
were O 0 1.6537465841182097e-09
observed O 0 4.537782372082688e-10
in O 0 2.9179117455591097e-10
Japanese O 0 5.1385743660148364e-08
, O 0 1.2126231963005552e-10
Utah O 0 2.635828222352643e-09
Mormon O 0 1.5166052858006651e-09
, O 0 3.360518807671298e-11
and O 0 1.655177557513543e-11
African O 0 3.705495354999755e-10
American O 0 1.3580896407461296e-09
patients O 0 4.521910623722647e-10
. O 0 9.188808824944772e-09

These O 0 3.07442853397788e-08
assays O 0 1.0602834166206776e-08
should O 0 1.8262331924479014e-10
facilitate O 0 7.501367582651852e-11
screening O 0 1.0891009621927239e-10
for O 0 3.0271551931804197e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 4.7569255912094377e-07
in O 0 5.340780595552985e-10
the O 0 1.5297448030526795e-10
populations O 0 8.6139489638426e-12
studied O 0 5.580609863109487e-10
. O 0 1.4934827818890994e-09
. O 0 5.7632124850215405e-08

The O 0 1.954850449692458e-05
von B-Disease 1 0.9999973773956299
Hippel I-Disease 1 0.9999990463256836
- I-Disease 0 0.2489437311887741
Lindau I-Disease 0 0.0017562704160809517
tumor I-Disease 0 6.520054739667103e-05
suppressor O 0 2.874564870580798e-06
gene O 0 1.0661847404946911e-08
is O 0 4.145399301602737e-11
required O 0 1.1009452377530593e-10
for O 0 8.460147166156062e-11
cell O 0 7.152999859094678e-10
cycle O 0 1.5752372739541443e-09
exit O 0 3.324717612329664e-09
upon O 0 3.6709149053848478e-09
serum O 0 5.149022896944189e-08
withdrawal O 0 1.3318475566848065e-06
. O 0 8.965932352111849e-07

The O 0 4.699931821505743e-07
inactivation O 0 1.5486102711292915e-05
of O 0 4.542577244137647e-06
the O 0 1.0347681609346182e-06
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999977350234985
( I-Disease 0 3.296431145827228e-07
VHL I-Disease 0 0.010332822799682617
) I-Disease 0 1.8357941655722243e-07
tumor I-Disease 0 3.514876152621582e-05
suppressor O 0 0.0003977386513724923
gene O 0 1.2559117976707057e-06
predisposes O 0 2.1269117667088722e-07
affected O 0 7.602646290294501e-10
individuals O 0 2.7171247023172196e-12
to O 0 3.3604435900613794e-10
the O 0 3.2998135335304823e-09
human O 0 1.119453685305416e-07
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 0.9999996423721313
and O 0 1.4949761428795227e-09
is O 0 1.7137158012103804e-11
associated O 0 1.294993279277179e-10
with O 0 2.0847320397754387e-11
sporadic B-Disease 0 1.5211912796075922e-06
renal I-Disease 1 0.9581938982009888
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 2.387404549608618e-07
RCC B-Disease 0 0.11950309574604034
) O 0 6.928357265678642e-08
and O 0 6.583502454304835e-08
brain B-Disease 0 6.033948011463508e-05
hemangioblastomas I-Disease 0 0.0001185939836432226
. O 0 5.009659389543231e-07

VHL O 0 0.00011555360833881423
- O 0 9.180155302601634e-07
negative O 0 9.315995441738778e-08
786 O 0 5.689228146366077e-07
- O 0 2.1685875708499225e-06
0 O 0 1.965065621334361e-07
RCC B-Disease 0 2.981941861435189e-06
cells O 0 1.189091207720594e-07
are O 0 8.46948344790377e-10
tumorigenic O 0 1.0340096423533396e-06
in O 0 9.52234060491719e-08
nude O 0 0.00010254676453769207
mice O 0 3.341452270433365e-07
which O 0 1.253834536196763e-10
is O 0 5.572456558688987e-12
suppressed O 0 1.8364397502690366e-10
by O 0 1.3878039342718473e-11
the O 0 8.050836663997529e-10
reintroduction O 0 2.710076500989089e-07
of O 0 2.1961895413369348e-08
VHL B-Disease 0 4.0947921661427245e-05
. O 0 3.5390751236263895e-06

Remarkably O 0 1.8736571291810833e-05
, O 0 1.2388824410791699e-09
this O 0 3.3244604985549486e-11
occurs O 0 1.3512979797625224e-11
without O 0 4.36999568476093e-11
affecting O 0 9.573336567925139e-11
the O 0 5.857110629836626e-11
growth O 0 4.186601065825357e-10
rate O 0 2.550637479004081e-09
and O 0 3.07515124475799e-11
cell O 0 1.5478545112301845e-09
cycle O 0 3.7061052005071815e-09
profile O 0 1.0703455011196183e-08
of O 0 1.5988844692671478e-09
these O 0 7.978252086759952e-11
cells O 0 5.970650363007479e-11
in O 0 2.1724522181187922e-10
culture O 0 3.2222807533344167e-08
. O 0 5.6339192866516896e-08

The O 0 2.3330835574597586e-07
786 O 0 1.870654529056992e-07
- O 0 2.984243963055633e-07
0 O 0 3.381516933131934e-08
cell O 0 1.3798746145710084e-08
line O 0 1.9931722050614553e-08
, O 0 2.9514174437750285e-10
like O 0 4.2757344886901194e-10
many O 0 1.1881486072784497e-10
cancer B-Disease 0 3.3959463019428426e-10
cells O 0 3.584714192150784e-10
, O 0 1.5387227603191889e-10
fails O 0 8.074399815427569e-09
to O 0 1.7680568120681528e-08
exit O 0 2.9647139854205307e-07
the O 0 3.553986616111615e-08
cell O 0 4.375404483170087e-09
cycle O 0 7.353279651844957e-10
upon O 0 3.5468064041310754e-09
serum O 0 2.2447826708571483e-08
withdrawal O 0 2.6530651098255476e-07
. O 0 6.448818226090225e-07

Here O 0 2.0451554973988095e-06
, O 0 1.2015541894783155e-09
it O 0 1.1438300827337766e-11
is O 0 7.660173493781453e-13
shown O 0 9.037126082189761e-12
that O 0 7.869969324662829e-13
reintroduction O 0 2.288571332442757e-09
of O 0 6.635916260933072e-10
the O 0 2.5672810544108415e-09
wild O 0 2.2408043420796275e-08
- O 0 2.1760001800430473e-08
type O 0 9.518959842580443e-09
VHL B-Disease 0 2.8699000722554047e-06
gene O 0 1.1123931109580099e-08
restores O 0 1.9665783383970847e-06
the O 0 2.4011725940908946e-08
ability O 0 3.326304565121063e-08
of O 0 6.384004791470943e-08
VHL O 0 0.0009925998747348785
- O 0 0.00016991629672702402
negative O 0 1.4506120749047113e-07
RCC B-Disease 0 2.763179736575694e-06
cancer I-Disease 0 2.188144776482659e-08
cells O 0 2.3369287061036914e-10
to O 0 1.1277226930062056e-09
exit O 0 5.810959713414832e-09
the O 0 1.8204263652066288e-09
cell O 0 6.704233834753381e-10
cycle O 0 5.309335193715015e-10
and O 0 1.2219940337399038e-10
enter O 0 1.2343149080606963e-07
G0 O 0 1.4021108654560521e-05
/ O 0 5.367569247027859e-05
quiescence O 0 1.540276934974827e-05
in O 0 9.26810770351949e-08
low O 0 2.4575999191256415e-07
serum O 0 9.095835906691718e-08
. O 0 4.816786969286113e-08

Both O 0 8.083677585091209e-07
VHL O 0 0.00045315807801671326
- O 0 1.1775588063756004e-05
positive O 0 4.8967105925612486e-08
and O 0 2.3758099931825427e-09
VHL O 0 1.3100294381729327e-05
- O 0 1.169048914562154e-06
negative O 0 1.4092952582700491e-08
RCC B-Disease 0 1.4815030908721383e-06
cells O 0 6.510620096378261e-07
exit O 0 1.3387930266617332e-06
the O 0 1.4807536530270227e-08
cell O 0 4.250221508073082e-09
cycle O 0 5.114583201404344e-10
by O 0 1.0746155354457443e-10
contact O 0 9.1552578851406e-08
inhibition O 0 9.210725693264976e-07
. O 0 3.342510410675459e-07

The O 0 1.2651677934627514e-05
cyclin O 0 1.487144527345663e-05
- O 0 2.0964996565453475e-06
dependent O 0 5.350962055672426e-07
kinase O 0 8.786287821749283e-07
inhibitor O 0 1.658954573713345e-07
, O 0 9.138361733995737e-10
p27 O 0 8.385678711420042e-07
, O 0 4.02480992978127e-10
accumulates O 0 6.743502423134373e-10
upon O 0 4.481837123648802e-10
serum O 0 2.6692039689635294e-09
withdrawal O 0 1.8398317536139075e-08
, O 0 4.420327298637616e-11
only O 0 3.1706255676500206e-11
in O 0 2.4975636142565705e-11
the O 0 1.4316207941345027e-10
presence O 0 6.753542725057571e-10
of O 0 2.8769848725573866e-09
VHL B-Disease 0 5.490070179803297e-06
, O 0 1.604266941512833e-09
as O 0 6.154497467214526e-10
a O 0 9.36095714831886e-11
result O 0 5.196313171418332e-11
of O 0 2.0108345544223027e-10
the O 0 2.2188986759097418e-10
stabilization O 0 2.1422354166134028e-06
of O 0 4.358523995051655e-07
the O 0 2.2334103277898976e-07
protein O 0 4.490372873533488e-08
. O 0 9.720621108044725e-08

We O 0 2.418104294577006e-08
propose O 0 7.417290781575048e-09
that O 0 6.991589945881671e-11
the O 0 2.1819286655233583e-10
loss O 0 1.507385549714968e-09
of O 0 2.847809099648657e-09
wild O 0 3.1315625648176137e-09
- O 0 2.205086779838439e-09
type O 0 8.869786682907943e-09
VHL B-Disease 0 2.0952540580765344e-05
gene O 0 7.631783915940105e-08
results O 0 6.210065350842342e-08
in O 0 2.913958629946478e-09
a O 0 5.894976062847945e-09
specific O 0 1.0848606279978412e-07
cellular O 0 4.335449261816393e-07
defect O 0 2.4899767936403805e-07
in O 0 7.117917366628035e-09
serum O 0 7.70152013274128e-08
- O 0 9.618887730766801e-08
dependent O 0 1.3048681068994483e-07
growth O 0 4.73520387345161e-08
control O 0 7.853704175886378e-08
, O 0 5.758614141093688e-10
which O 0 3.996808786710382e-11
may O 0 5.251775125891811e-10
initiate O 0 1.2827081619093406e-08
tumor B-Disease 0 5.3053522464097114e-08
formation O 0 2.3800520665417935e-08
. O 0 2.287150664415094e-07

This O 0 3.983549490271798e-08
is O 0 3.870053166821208e-10
corrected O 0 1.3149662692057973e-08
by O 0 3.8488143228043725e-11
the O 0 4.662409347488961e-10
reintroduction O 0 5.267098757144595e-08
of O 0 2.4409763099697557e-09
wild O 0 1.61584505775636e-08
- O 0 3.1926955301742055e-08
type O 0 1.2766335544256435e-07
VHL B-Disease 0 0.33621495962142944
, O 0 2.6919320816887193e-07
implicating O 0 2.3153294023359194e-05
VHL B-Disease 1 0.9983265995979309
as O 0 3.516342701459507e-07
the O 0 2.642842034106252e-08
first O 0 3.137583304280156e-09
tumor B-Disease 0 1.2328855714116571e-09
suppressor O 0 1.687571149489031e-08
involved O 0 7.064461793326871e-10
in O 0 2.9435369697239366e-09
the O 0 1.2586116326929186e-07
regulation O 0 4.27258191848523e-06
of O 0 2.5278950488427654e-08
cell O 0 3.800757930605414e-09
cycle O 0 3.952675520224602e-09
exit O 0 1.9054711586363737e-08
, O 0 3.0520017069157745e-10
which O 0 2.689268946420853e-11
is O 0 8.388895481048486e-12
consistent O 0 2.72769445919252e-10
with O 0 7.227374081153481e-13
its O 0 4.000607137233381e-11
gatekeeper O 0 5.8428679672317685e-09
function O 0 1.245725522736052e-09
in O 0 5.55715640171428e-10
the O 0 4.363795103046186e-09
kidney O 0 1.4105322243551655e-08
. O 0 1.64435540739305e-08
. O 0 9.60777697400772e-08

Piebaldism B-Disease 1 1.0
with O 0 8.51331278681755e-05
deafness B-Disease 1 1.0
: O 0 3.3397057563888666e-08
molecular O 0 1.7633209337120093e-09
evidence O 0 2.9610255913858907e-10
for O 0 7.675479002378083e-11
an O 0 2.34352592887177e-10
expanded O 0 9.23709012567997e-05
syndrome O 1 0.9999995231628418
. O 0 1.1575748430914246e-05

In O 0 1.710915298325233e-09
a O 0 3.4704830675913456e-10
South O 0 1.3806136234251198e-09
African O 0 1.4224055266964797e-09
girl O 0 2.6170574596307006e-09
of O 0 5.01407027009293e-10
Xhosa O 0 1.2762585299697093e-07
stock O 0 2.990206127151396e-08
with O 0 1.557697547338588e-11
severe O 0 8.773571869014063e-10
piebaldism B-Disease 0 2.693832357181236e-07
and O 0 1.921407921656737e-09
profound O 0 5.482347660290543e-06
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 9.515692909189966e-07
identified O 0 2.670212051469889e-09
a O 0 8.690459463167599e-11
novel O 0 9.405125983574791e-11
missense O 0 1.6387188273014885e-09
substitution O 0 1.8757497777244225e-09
at O 0 3.3319434322720554e-08
a O 0 2.3386865777297317e-09
highly O 0 2.097933160527532e-09
conserved O 0 3.943180004739588e-09
residue O 0 1.8038132054698508e-07
in O 0 2.3354292721933234e-08
the O 0 7.419359349114529e-08
intracellular O 0 3.5075007076557085e-07
kinase O 0 4.7312499873441993e-07
domain O 0 5.3435265101597906e-08
of O 0 6.788661632839421e-09
the O 0 9.61389545750535e-09
KIT O 0 4.4443226215662435e-05
proto O 0 0.00014697712322231382
- O 0 1.621595970391354e-06
oncogene O 0 9.8552176496014e-05
, O 0 6.799378393651523e-09
R796G O 0 2.069069751087227e-06
. O 0 7.324548789711116e-08

Though O 0 8.01045018761215e-07
auditory B-Disease 0 1.3567018868343439e-05
anomalies I-Disease 0 4.265160441718763e-06
have O 0 4.9600732410226556e-09
been O 0 7.611017927011687e-10
observed O 0 1.8161248893644455e-10
in O 0 4.131634756543434e-10
mice O 0 8.922829586310854e-09
with O 0 2.794067407996259e-11
dominant O 0 1.6236180400142075e-08
white O 0 1.2041656560768388e-08
spotting O 0 4.045926971230074e-07
( O 0 1.7578607458546003e-09
W O 0 0.00012579094618558884
) O 0 6.604764513085115e-10
due O 0 3.54977274241719e-08
to O 0 5.319659734936977e-08
KIT O 0 0.00118664326146245
mutations O 0 5.708957360184286e-07
, O 0 5.105534128801992e-08
deafness B-Disease 1 1.0
is O 0 2.107932495221121e-09
not O 0 2.4754076566324557e-10
typical O 0 4.5368822587654734e-10
in O 0 1.066905869206991e-10
human O 0 2.667217835483626e-10
piebaldism B-Disease 0 2.7821388925985957e-07
. O 0 4.6245251184018343e-08

Thus O 0 3.3958588829818837e-08
, O 0 1.382494396739986e-10
the O 0 4.5071838622456895e-11
occurrence O 0 3.144862814608018e-09
of O 0 7.411747660057699e-09
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.00018726367852650583
this O 0 7.317745520651897e-09
patient O 0 4.397330832794921e-10
extends O 0 5.1239030379734984e-12
considerably O 0 2.4952257274279965e-11
the O 0 1.102090224636143e-10
phenotypic O 0 2.4410691246146143e-09
range O 0 5.242980272157638e-09
of O 0 1.28455346359857e-09
piebaldism B-Disease 0 1.9784637572684005e-07
due O 0 3.087863120754264e-08
to O 0 4.873584202869097e-08
KIT O 0 5.047745617048349e-06
gene O 0 1.2606268029458079e-08
mutation O 0 7.433234028297875e-10
in O 0 1.5781295714667465e-10
humans O 0 5.446075812542972e-10
and O 0 1.205179983587712e-10
tightens O 0 1.4523182656489553e-08
the O 0 1.2432427309860827e-09
clinical O 0 2.751707306458684e-09
similarity O 0 1.5514124707127763e-10
between O 0 2.5921164520381623e-11
piebaldism B-Disease 0 2.32389414378531e-08
and O 0 8.489663833044503e-11
the O 0 1.4941373138732672e-10
various O 0 5.383384710233585e-11
forms O 0 3.3025884804693817e-10
of O 0 4.2284624690580586e-09
Waardenburg B-Disease 1 0.9999997615814209
syndrome I-Disease 0 8.864756091497838e-05
. O 0 2.2331455795665534e-08
. O 0 8.960216746345395e-08

Cycloheximide O 0 2.2266015093919123e-06
facilitates O 0 1.2926501646859379e-08
the O 0 6.464933588468114e-10
identification O 0 1.4864017572335797e-08
of O 0 1.0794647842260474e-08
aberrant O 0 7.514208988368409e-08
transcripts O 0 8.565650233549604e-08
resulting O 0 2.594750636575327e-09
from O 0 9.530709554894656e-10
a O 0 8.152234443059569e-10
novel O 0 1.4591367003546907e-09
splice O 0 3.0816146079359896e-08
- O 0 1.1212289763307126e-08
site O 0 1.3950566923881524e-08
mutation O 0 3.439137030714079e-10
in O 0 1.4323855990205914e-10
COL17A1 O 0 6.564642944795196e-07
in O 0 4.745807746786568e-09
a O 0 9.847665793927263e-09
patient O 0 3.11345900172455e-08
with O 0 8.566180542679547e-10
generalized O 0 0.22083353996276855
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999663829803467
. O 0 7.528708010795526e-06

Patients O 0 1.0601605026749894e-05
with O 0 5.515133238986891e-09
generalized O 0 5.4552219808101654e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 0 0.1273275762796402
often O 0 3.2411904271612e-09
show O 0 1.0900990110584985e-09
decreased O 0 2.2069803762292395e-09
expression O 0 2.0108357201564786e-09
of O 0 1.3828511669089494e-09
type O 0 1.0068590405865052e-08
XVII O 0 1.2711953786492813e-05
collagen O 0 3.149418148495897e-07
, O 0 1.3066706827657981e-08
a O 0 1.2216410105736486e-08
transmembrane O 0 4.608593950905515e-09
hemidesmosomal O 0 8.201525503181983e-08
protein O 0 3.0108518456195554e-10
encoded O 0 9.393796157608492e-11
by O 0 2.953084443646503e-10
COL17A1 O 0 2.734106601565145e-05
. O 0 5.986515247968782e-07

This O 0 5.6946465321061623e-08
report O 0 1.2327546095036723e-08
documents O 0 8.560109954203199e-09
a O 0 2.5454081065134915e-09
novel O 0 5.388773427483784e-09
splice O 0 2.664640419425268e-07
- O 0 6.786179085338517e-08
site O 0 2.5491070587690956e-08
mutation O 0 4.362428196458268e-10
in O 0 1.849191633152003e-10
COL17A1 O 0 3.3002672807924682e-06
in O 0 1.0831502805785931e-08
a O 0 1.527437198944881e-08
patient O 0 2.0378097431716924e-08
with O 0 2.662582099244304e-10
generalized O 0 0.00016525866521988064
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9994396567344666
, O 0 4.412918919172171e-09
and O 0 6.729494045343287e-11
applies O 0 8.2694701086794e-10
a O 0 1.9415129226540984e-11
new O 0 5.833719618486555e-11
methodology O 0 5.369195643645241e-10
to O 0 1.954566786199763e-10
define O 0 2.7429563065339835e-09
and O 0 4.911315798494797e-10
characterize O 0 5.841455674726603e-08
the O 0 1.1156142676327363e-08
resulting O 0 2.437877233418817e-09
mRNA O 0 5.394573232564426e-09
splice O 0 1.614932187976592e-07
variants O 0 1.5993465751762415e-07
. O 0 2.93898409609028e-07

Mutational O 0 2.9181675927247852e-05
analysis O 0 7.413645164433547e-08
of O 0 1.681206818204828e-08
COL17A1 O 0 2.6468369469512254e-05
identified O 0 4.613702060396463e-07
a O 0 7.378012867320649e-08
maternally O 0 2.072419192700181e-06
inherited O 0 3.4024769774987362e-06
G O 0 2.386619826211245e-06
- O 0 1.3512578789232066e-07
to O 0 1.1099731977992633e-07
- O 0 2.6097220029441814e-07
T O 0 5.646774781098429e-08
transversion O 0 2.9188887751274706e-08
at O 0 6.667355001432895e-10
the O 0 7.919366551423224e-11
- O 0 3.007804005861203e-10
1 O 0 3.932912218118645e-09
position O 0 6.302472144170679e-08
of O 0 7.986025174488987e-09
exon O 0 3.2089138812807505e-07
32 O 0 3.7323653145904245e-07
. O 0 2.685539755020727e-07

This O 0 9.152600455308857e-09
acceptor O 0 3.7909115846446184e-09
splice O 0 1.747385880435104e-07
- O 0 8.014930585886759e-08
site O 0 4.872961056889835e-08
mutation O 0 3.5299188572146534e-10
led O 0 9.891668734107739e-11
to O 0 2.1090335033946417e-10
the O 0 9.46698941461932e-10
formation O 0 2.8505480198504074e-09
of O 0 1.5290520849475797e-08
aberrant O 0 4.0775187670760715e-08
transcripts O 0 1.8262461765061744e-07
present O 0 1.0511557846371034e-08
at O 0 1.5422832575495704e-06
extremely O 0 4.88766374928673e-07
low O 0 4.3071457866972196e-07
levels O 0 9.98959208686756e-08
. O 0 9.901252440158714e-08

Based O 0 6.444868638766366e-09
on O 0 9.82732650811613e-09
our O 0 2.781701757825772e-09
recent O 0 1.534771754130304e-10
finding O 0 2.957649958279518e-10
that O 0 1.692187535928813e-11
cycloheximide O 0 4.633893624372831e-08
stabilized O 0 5.795200763714092e-07
mutant O 0 4.5496253875398907e-08
COL17A1 O 0 4.303003322547738e-07
transcripts O 0 2.484368799571257e-08
in O 0 1.7666502705182552e-09
keratinocytes O 0 3.439538147631538e-07
homozygous O 0 8.466515488692039e-09
for O 0 1.0493262925237445e-09
a O 0 2.8073072755319117e-09
frameshift O 0 4.3168833485651703e-07
mutation O 0 2.1961674701032052e-09
, O 0 8.561277381469168e-11
the O 0 2.97464525234048e-10
effects O 0 6.192347967726164e-08
of O 0 1.1013353429234485e-07
the O 0 1.4670908932146176e-08
splice O 0 2.167334933744769e-08
- O 0 5.5502953344443995e-09
site O 0 3.414849292227018e-09
mutation O 0 3.474687204629845e-11
on O 0 1.6869163010913013e-10
splicing O 0 4.018284371909431e-09
of O 0 1.29121611180949e-08
COL17A1 O 0 1.632779913052218e-06
transcripts O 0 5.653596346633094e-08
were O 0 1.7787922246270682e-09
determined O 0 1.095850743482174e-09
using O 0 7.802602453033103e-10
reverse O 0 2.4811710463978898e-09
transcriptase O 0 1.4353646049514168e-09
polymerase O 0 3.012822491488265e-10
chain O 0 1.4439263118504186e-09
reaction O 0 6.416213671478488e-10
of O 0 6.933268958952965e-10
total O 0 1.2441743468816213e-10
RNA O 0 8.460034062185429e-11
from O 0 1.0647184522927233e-10
keratinocytes O 0 1.2542853866648329e-08
incubated O 0 2.3336514942684516e-09
for O 0 2.2126861454196955e-10
2 O 0 8.300968801222552e-09
. O 0 4.668500608318027e-08

5 O 0 3.932847221221891e-07
h O 0 5.8060656726866e-08
in O 0 8.18339174202265e-10
the O 0 4.969332167981122e-10
presence O 0 6.172790611991275e-10
or O 0 3.795679326401569e-09
absence O 0 4.2225974539178424e-07
of O 0 1.3586034519619261e-08
10 O 0 2.239505292322974e-08
microg O 0 4.7468060415667424e-07
cycloheximide O 0 3.092525844294869e-07
per O 0 1.596320089447545e-07
ml O 0 4.097128567082109e-06
. O 0 1.874975055216055e-07

Using O 0 3.5854426982950827e-08
this O 0 3.775395551741667e-10
approach O 0 8.089506842168248e-09
, O 0 7.749904051834733e-10
an O 0 3.8462769080815917e-10
abnormally O 0 2.335300131051099e-08
spliced O 0 2.5983277751606693e-08
transcript O 0 8.441669478997937e-07
was O 0 5.476973115037254e-07
identified O 0 4.185016422297849e-08
that O 0 5.2279559153989297e-11
contains O 0 4.6264303152354636e-12
an O 0 5.458922159792823e-13
extra O 0 1.366752683251704e-10
264 O 0 2.991589198586553e-10
bases O 0 1.4735148656797037e-09
upstream O 0 6.043384126463991e-10
from O 0 4.816588794476218e-10
exon O 0 9.60619761514181e-09
32 O 0 8.893604963589041e-09
, O 0 6.573793592812294e-11
resulting O 0 2.9299340731370194e-11
in O 0 5.894857518784491e-11
a O 0 3.2079461309564294e-10
premature O 0 1.014276040933737e-08
termination O 0 1.9338322942985542e-08
codon O 0 1.8780531263473677e-07
27 O 0 1.2329660421528388e-06
bp O 0 3.3721460113156354e-07
downstream O 0 2.1616871848095798e-08
from O 0 1.4065669518004142e-08
the O 0 1.5409409570565913e-07
cryptic O 0 6.141347057564417e-07
splice O 0 8.469763770335703e-07
site O 0 6.604203122151375e-07
. O 0 1.2547704386633995e-07

Three O 0 6.188386691974301e-07
other O 0 1.8683550262466042e-09
splice O 0 1.791069692558267e-08
variants O 0 4.4150993971925345e-09
, O 0 8.24238108321218e-11
including O 0 8.279388459542236e-12
one O 0 2.954940545724094e-12
derived O 0 9.213193402635156e-11
from O 0 8.774504733910504e-11
the O 0 1.3059973102969025e-09
skipping O 0 2.7475653752162543e-08
of O 0 1.192995835452848e-08
exon O 0 3.1280002588118805e-08
32 O 0 1.3073456273104966e-07
, O 0 1.9559773800637004e-09
were O 0 7.2903145742486686e-09
also O 0 2.692464029507846e-09
identified O 0 9.813952317472285e-09
. O 0 5.477522080354902e-08

These O 0 3.2665756322103334e-08
results O 0 4.95502394670666e-09
indicate O 0 5.764682953213196e-09
the O 0 6.393394147430342e-10
usefulness O 0 9.637215470092997e-08
of O 0 1.0227376723292991e-09
cycloheximide O 0 4.659291175101998e-09
treatment O 0 4.542129450335608e-10
in O 0 1.9036956039331088e-11
evaluating O 0 5.01818475662219e-10
the O 0 1.204215616112947e-09
abnormal O 0 8.19354806225192e-09
processing O 0 8.71603660357323e-08
of O 0 7.779428301546432e-08
mRNA O 0 4.655704444189723e-08
due O 0 2.29293004849751e-06
to O 0 7.979359395449137e-08
splice O 0 2.3691147532645118e-07
- O 0 1.3132611798027938e-07
site O 0 4.065163849986675e-08
mutations O 0 1.286083239904201e-09
, O 0 1.1456341431070882e-10
because O 0 1.0958313423348187e-10
( O 0 2.0104204412341176e-10
i O 0 1.3070625470845698e-07
) O 0 7.16162740221904e-10
aberrant O 0 2.3426121487091223e-08
splicing O 0 1.503644675437954e-08
often O 0 2.3638621615695854e-10
generates O 0 1.8540714102899258e-11
a O 0 5.399478086864917e-11
premature O 0 2.288348843748622e-09
termination O 0 5.814917880542225e-09
codon O 0 3.100504386566172e-08
, O 0 1.8100878573790169e-09
( O 0 5.105526418303086e-11
ii O 0 1.6731142693515721e-07
) O 0 7.893462550256913e-10
transcripts O 0 5.874024111562903e-08
with O 0 9.228071778943914e-11
premature O 0 1.2555521777812828e-07
termination O 0 5.908690070555167e-08
codons O 0 3.6584609119927336e-08
can O 0 1.1392611298788324e-09
occur O 0 1.9963406483469726e-09
at O 0 1.797064719255559e-08
low O 0 6.843801259037718e-08
or O 0 2.1593125065777485e-09
undetectable O 0 4.835666800317995e-08
levels O 0 3.134490889067365e-09
due O 0 2.0104444775626007e-09
to O 0 6.3125997762369934e-09
nonsense O 0 2.2019694512209753e-08
- O 0 1.861678033954206e-09
mediated O 0 1.0453689025524682e-09
mRNA O 0 3.288351535513101e-10
decay O 0 8.058506750785455e-09
, O 0 6.963734450193826e-11
and O 0 1.781564479275133e-11
( O 0 4.296331086034444e-12
iii O 0 1.4371240197874613e-08
) O 0 1.2339370636382796e-09
the O 0 1.493127399498917e-08
levels O 0 1.302240093536966e-07
of O 0 9.094942576837184e-10
these O 0 1.9592098776666234e-10
transcripts O 0 5.330748287235565e-09
can O 0 6.973799870912956e-10
be O 0 9.54562651145352e-10
increased O 0 1.2144337757646895e-09
by O 0 3.938359915967027e-10
cycloheximide O 0 3.653618932730751e-06
. O 0 2.9586752248178527e-07

A O 0 1.2498493333623628e-06
deletion O 0 1.545210039921585e-07
mutation O 0 8.805021711744132e-10
in O 0 6.023452847614408e-10
COL17A1 O 0 7.121178668967332e-07
in O 0 3.1389417731730873e-09
five O 0 1.1948214639900812e-09
Austrian O 0 1.5651364648761046e-08
families O 0 8.013180119448293e-10
with O 0 2.7348678877103794e-10
generalized O 0 5.996118488837965e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9951512813568115
represents O 0 1.207689415139157e-08
propagation O 0 5.863647345449863e-08
of O 0 3.391928071749817e-09
an O 0 3.746586652031425e-10
ancestral O 0 1.964977400348289e-06
allele O 0 1.5269092727976386e-06
. O 0 3.08689180883448e-07

Patients O 0 4.109227575099794e-06
with O 0 2.263268239488525e-09
generalized O 0 5.099685222376138e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999995231628418
, O 0 3.496431943972311e-08
a O 0 1.6754087006631835e-09
usually O 0 2.332680160144207e-10
nonlethal O 0 3.424844976507302e-07
form O 0 4.166265998861718e-09
of O 0 1.0881199159484822e-06
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999845027923584
, O 0 4.337235282037e-08
have O 0 2.678087307472765e-09
generalized O 0 9.633134823161527e-08
blistering B-Disease 0 2.9852830607524083e-07
, O 0 1.0001523165215076e-08
nail B-Disease 1 0.9999247789382935
dystrophy I-Disease 1 0.9999059438705444
, O 0 7.862319080231828e-07
patchy B-Disease 1 0.5946548581123352
alopecia I-Disease 1 0.9908480644226074
, O 0 7.715443928191235e-08
and O 0 3.8252255762927234e-07
dental B-Disease 1 1.0
abnormalities I-Disease 1 0.9995821118354797
. O 0 3.9152302633738145e-05

Skin B-Disease 1 1.0
fragility I-Disease 0 0.000355533353285864
in O 0 2.7770683530548013e-09
most O 0 8.629900613565944e-12
cases O 0 2.9490155434817866e-13
is O 0 7.752269149969432e-14
due O 0 1.3451417063548021e-11
to O 0 7.175300353878811e-10
mutations O 0 4.746038284597631e-11
in O 0 8.914013416294608e-10
the O 0 5.914662981609808e-09
gene O 0 6.476955083378755e-10
encoding O 0 2.0248846155368483e-08
type O 0 1.4281920357461786e-06
XVII O 0 0.0004264307499397546
collagen O 0 1.4195002222550102e-06
( O 0 5.398299141035068e-09
COL17A1 O 0 1.9456107111182064e-05
) O 0 5.677063708020569e-09
. O 0 4.662458508164491e-08

Recently O 0 3.7594936657114886e-06
, O 0 3.3687173051077934e-09
we O 0 5.799101643333415e-09
reported O 0 1.228022794563799e-09
five O 0 1.9452538191355728e-10
Austrian O 0 1.5543106357540637e-08
families O 0 7.992970174619529e-10
with O 0 1.8975410132071602e-10
generalized O 0 1.5296905985451303e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9998825788497925
who O 0 6.382020245609965e-08
share O 0 9.982121795815146e-09
the O 0 6.993651435749371e-09
same O 0 4.2773947939167556e-08
COL17A1 O 0 0.00018068750796373934
mutation O 0 2.0614561435650103e-07
. O 0 2.1165337216189073e-07

Affected O 0 9.890493402053835e-08
individuals O 0 8.040090815342182e-11
in O 0 3.106219170767588e-10
three O 0 6.503381166922395e-11
families O 0 5.277164122352573e-12
are O 0 1.3189073314393007e-12
homozygous O 0 1.1899312091223635e-10
for O 0 1.367057855805598e-10
4003delTC O 0 3.1700135849632716e-08
, O 0 1.550513051284952e-10
whereas O 0 8.178804300484899e-10
those O 0 2.248075475774769e-10
in O 0 3.167598683351258e-10
two O 0 8.302972198670489e-11
others O 0 1.698778895331543e-10
are O 0 3.222337327524194e-11
compound O 0 3.0174376774994016e-08
heterozygotes O 0 2.8316078442003345e-06
. O 0 4.3372276081754535e-07

To O 0 3.380194968372052e-08
determine O 0 6.982908029584678e-09
if O 0 1.618608136411126e-09
the O 0 2.528699027948278e-09
occurrence O 0 2.7793962686928353e-08
of O 0 1.7034943455840335e-09
4003delTC O 0 4.1473825262983155e-08
in O 0 5.532430624732854e-10
these O 0 1.8316752281588577e-10
unrelated O 0 2.509196461719654e-10
families O 0 5.565807363605568e-12
signifies O 0 3.0337543588387916e-10
propagation O 0 1.1620085338392983e-08
of O 0 8.172411081197595e-10
an O 0 1.2422891881858078e-10
ancestral O 0 9.201822877002996e-07
allele O 0 1.5079994852840173e-07
or O 0 3.3158134016275653e-09
a O 0 1.1589827764169058e-08
mutational O 0 1.6259215044556186e-05
hot O 0 1.9605895431595854e-05
spot O 0 9.56528879214602e-07
, O 0 2.1441028952295937e-09
haplotypes O 0 2.644995333866973e-08
were O 0 6.842597599643341e-09
determined O 0 1.055016163320488e-08
for O 0 5.148559356626947e-09
polymorphisms O 0 1.5616318194133783e-07
both O 0 1.9810213913729058e-08
within O 0 9.332585371168989e-09
and O 0 7.302185078827961e-09
flanking O 0 1.6410457419624436e-06
COL17A1 O 0 0.00017749601101968437
. O 0 7.573532343485567e-07

Five O 0 5.164682193026238e-07
intragenic O 0 6.228464144442114e-07
polymorphisms O 0 5.2064002886709204e-08
were O 0 1.874397970169639e-09
chosen O 0 7.559743941953911e-10
based O 0 2.09804826289961e-10
on O 0 9.132964606806127e-09
their O 0 9.128942046743305e-09
informativeness O 0 9.553734344081022e-06
. O 0 4.2629866925381066e-07

One O 0 7.43705612649137e-08
of O 0 2.285535094515012e-09
these O 0 3.178248289548158e-11
, O 0 7.263765543913392e-12
not O 0 2.708392191075326e-11
previously O 0 2.8013685815508893e-10
reported O 0 2.93821800223526e-10
, O 0 5.468494754246045e-11
was O 0 4.884106452607284e-09
2988 O 0 4.6468554160128406e-07
A O 0 2.7024526616514777e-07
or O 0 1.236229962842117e-08
C O 0 3.7230407201604976e-07
that O 0 2.251786430929048e-11
introduces O 0 4.666154684862533e-10
a O 0 1.4527710978651243e-10
new O 0 3.0437119491466547e-10
restriction O 0 7.262016765707813e-09
site O 0 1.4028206374305796e-09
for O 0 1.4393171376969605e-10
Eco0109 O 0 4.2178402281933813e-07
I O 0 2.980167892019381e-06
. O 0 4.10490912372552e-07

All O 0 4.7699856509098026e-08
the O 0 7.137793911482504e-09
4003delTC O 0 1.915357614734603e-07
alleles O 0 6.514150996395074e-09
showed O 0 8.162226450281196e-09
the O 0 7.165097959394018e-10
same O 0 1.417695294492205e-09
haplotype O 0 4.502610906342852e-08
for O 0 2.9327213990626433e-09
these O 0 2.595354375856118e-09
five O 0 2.249878061633126e-09
polymorphic O 0 1.0563271146679654e-08
markers O 0 8.690107478059872e-08
. O 0 6.300182917584607e-07

Fourteen O 0 1.3328792647371301e-06
microsatellite O 0 1.0062815647415846e-07
polymorphisms O 0 2.153111644531691e-08
were O 0 6.908952854267625e-10
selected O 0 2.4877994109218093e-10
based O 0 4.655307042633616e-11
on O 0 9.038496617819192e-10
their O 0 2.911362817492602e-10
high O 0 5.610260256361244e-09
heterozygosity O 0 1.960169271342238e-07
and O 0 4.830812971867715e-10
their O 0 1.5082195492510664e-09
location O 0 3.133948567324296e-08
within O 0 1.434576346603933e-09
10q23 O 0 1.7868444501800695e-07
- O 0 2.7874392571902717e-08
q25 O 0 8.963393156591337e-07
near O 0 2.9137166279724624e-07
COL17A1 O 0 6.319995736703277e-05
. O 0 6.323351158243895e-07

Three O 0 1.0949549711369855e-08
families O 0 2.666322440614266e-10
shared O 0 9.13456255080547e-10
microsatellite O 0 2.1635845115497432e-08
polymorphisms O 0 7.841354943138867e-08
covering O 0 3.59902259106093e-08
at O 0 1.9199472234276982e-08
most O 0 1.1783634068507354e-09
19 O 0 8.147733865371265e-08
cM O 0 2.8648738492620396e-08
, O 0 2.539587706795743e-10
whereas O 0 2.820746969334209e-09
the O 0 2.975395707593975e-09
others O 0 2.4759376771044117e-09
shared O 0 7.853606653895895e-10
smaller O 0 8.848284605011969e-11
regions O 0 5.6513776297562046e-11
consistent O 0 2.003607502132354e-09
with O 0 8.554869594841474e-13
cross O 0 1.9016570262930799e-10
- O 0 6.5163381357535854e-09
over O 0 1.4037593309979002e-10
events O 0 1.227050544505559e-10
during O 0 2.1505607017413553e-10
passage O 0 5.972452532532202e-10
of O 0 2.5474698739369472e-11
this O 0 9.936214177830305e-12
mutation O 0 4.5395263069403224e-12
through O 0 7.646747818279565e-12
several O 0 3.396559769552887e-11
generations O 0 4.174745882323805e-09
. O 0 7.819116376595048e-08

These O 0 1.0316569643009643e-07
results O 0 3.446449170496635e-08
indicate O 0 1.1097738727983142e-08
that O 0 2.508171274839821e-11
4003delTC O 0 3.736697617995333e-09
occurs O 0 4.23873748600645e-11
on O 0 5.872752284474814e-10
a O 0 3.386218527801077e-10
single O 0 4.678678333647213e-09
ancestral O 0 7.033974043224589e-07
allele O 0 2.248052481945706e-07
. O 0 2.8190813239348245e-08
. O 0 1.426188305231335e-07

The O 0 1.0007372566178674e-06
haptoglobin O 0 3.806900349445641e-05
- O 0 7.225984859360324e-07
gene O 0 1.3537920118267266e-08
deletion O 0 4.267021225246026e-08
responsible O 0 1.992301967845833e-08
for O 0 1.632978730015111e-08
anhaptoglobinemia B-Disease 0 5.8585286751622334e-05
. O 0 1.609541413927218e-06

We O 0 4.603720356044505e-07
have O 0 1.2159635520703205e-09
found O 0 8.469899087648614e-11
an O 0 1.3812838026150409e-11
allelic O 0 3.016275229583698e-08
deletion O 0 3.709607554469585e-08
of O 0 1.34889404534988e-07
the O 0 3.5781809515356144e-07
haptoglobin O 0 4.765646008308977e-05
( O 0 9.916117926778156e-10
Hp O 0 4.3801584581615316e-08
) O 0 1.3705667156749257e-10
gene O 0 4.185523039268446e-10
from O 0 3.109289770097945e-10
an O 0 1.0702422975628068e-10
individual O 0 5.7358097438342526e-11
with O 0 5.105253372827967e-11
anhaptoglobinemia B-Disease 0 4.612527845893055e-06
. O 0 5.554608151214779e-07

The O 0 8.59589363244595e-07
Hp O 0 2.5023985017469386e-07
gene O 0 2.6455238000266945e-09
cluster O 0 5.678024717070684e-10
consists O 0 1.854298936621035e-10
of O 0 2.339515525751068e-10
coding O 0 2.376060592723661e-08
regions O 0 2.195987169884006e-09
of O 0 3.177077871896472e-07
the O 0 1.5441847267538833e-07
alpha O 0 6.068315627771881e-08
chain O 0 1.5040885203987386e-09
and O 0 1.568268778728843e-11
beta O 0 5.363586241813323e-10
chain O 0 4.856922086737825e-10
of O 0 1.8663488809966822e-10
the O 0 5.251985513154978e-10
haptoglobin O 0 1.239707358990927e-07
gene O 0 2.138809573892786e-09
( O 0 5.096419813943598e-11
Hp O 0 3.733491293900215e-09
) O 0 1.0857879699510686e-11
and O 0 5.6370706713604335e-11
of O 0 4.356457972143346e-10
the O 0 7.638781274188489e-10
alpha O 0 4.709261869351167e-09
chain O 0 2.5414725879358e-10
and O 0 1.0316647709729398e-11
beta O 0 2.3593051956538602e-09
chain O 0 2.617731365006648e-09
of O 0 4.2957204460236653e-10
the O 0 1.1007106337501682e-09
haptoglobin O 0 1.9272688405180816e-06
- O 0 1.1515069076040163e-07
related O 0 3.553498473252148e-08
gene O 0 3.6386258450704645e-09
( O 0 7.731622286843987e-11
Hpr O 0 5.681139469970731e-08
) O 0 1.3529595499495173e-10
, O 0 4.5257655262309626e-11
in O 0 4.797707717218991e-11
tandem O 0 2.5004451842391973e-09
from O 0 2.538028398557657e-10
the O 0 4.515027018925366e-09
5 O 0 8.621132252528696e-08
side O 0 8.67123262082714e-08
. O 0 4.998329927730083e-07

Southern O 0 3.076038183280616e-06
blot O 0 6.977996235946193e-06
and O 0 5.395808244657019e-09
PCR O 0 7.715281924447481e-08
analyses O 0 3.791251312890154e-09
have O 0 1.743867411585498e-10
indicated O 0 5.724840046461566e-10
that O 0 1.0720192095137193e-11
the O 0 1.2197538812319664e-10
individual O 0 3.303235809881677e-11
with O 0 7.553221936795751e-12
anhaptoglobinemia B-Disease 0 5.6259725766949487e-08
was O 0 4.5652348568125944e-09
homozygous O 0 1.6119041656992295e-09
for O 0 5.77361491949091e-10
the O 0 1.1998846360938842e-09
gene O 0 1.1511457342905373e-09
deletion O 0 8.136486151499867e-09
and O 0 4.4323095194087614e-10
that O 0 5.798586957816987e-11
the O 0 2.151549494122662e-10
gene O 0 1.260144766312976e-10
deletion O 0 1.45482925706375e-09
was O 0 2.368448770440068e-09
included O 0 2.3019446071526062e-10
at O 0 1.0234948444320935e-09
least O 0 1.8390957159941657e-11
from O 0 4.607092918967881e-12
the O 0 7.781465055645143e-11
promoter O 0 2.1713235653919583e-08
region O 0 1.1681779454875141e-07
of O 0 6.811906700932013e-07
Hp O 0 9.749994660523953e-07
to O 0 1.353527920855413e-07
Hpr O 0 2.2343350281062158e-07
alpha O 0 6.204039948443096e-08
but O 0 9.356820873662741e-10
not O 0 1.1884734307798794e-09
to O 0 3.8785903377913655e-09
Hpr O 0 5.8902923427694986e-08
beta O 0 1.0090549551478034e-07
( O 0 9.040445614338921e-10
Hpdel O 0 2.9694328986806795e-06
) O 0 3.1471070194299955e-09
. O 0 4.768930850218567e-08

In O 0 1.918197511940889e-08
addition O 0 4.188072999511405e-09
, O 0 2.2264066978916475e-10
we O 0 7.579263328061359e-10
found O 0 5.759522719861465e-11
seven O 0 1.1379090378293988e-11
individuals O 0 7.009635385156476e-13
with O 0 1.5880378609334223e-12
hypohaptoglobinemia B-Disease 0 1.0505227265866779e-07
in O 0 2.926842768147253e-09
three O 0 9.335673900601194e-11
families O 0 6.4788144467364805e-12
, O 0 5.1711673137999625e-12
and O 0 8.830206531251772e-12
the O 0 3.550967853094278e-10
genotypes O 0 1.882243916284665e-09
of O 0 2.038415214400402e-09
six O 0 2.677086330393763e-09
of O 0 1.8505474930208266e-09
the O 0 2.801006759867164e-09
seven O 0 2.5748711496298426e-10
individuals O 0 4.523311846610367e-12
were O 0 2.74006844991348e-10
found O 0 9.446404769519745e-11
to O 0 3.2195270893708994e-09
be O 0 5.948403014599535e-08
Hp2 O 0 0.0005477081867866218
/ O 0 0.0026112424675375223
Hpdel O 0 0.003807354485616088
. O 0 5.086045348434709e-06

The O 0 8.295415341308399e-07
phenotypes O 0 1.0719598719788337e-07
and O 0 4.4626444206663507e-10
genotypes O 0 2.9044644467290937e-09
in O 0 3.8810007985112804e-10
one O 0 1.4097185918604538e-10
of O 0 5.012213213917427e-11
these O 0 2.7070273106444276e-12
three O 0 1.4071382947733468e-12
families O 0 1.8176341508302496e-12
showed O 0 1.5098622352383018e-10
the O 0 3.5545386078972285e-10
father O 0 3.169856199747301e-08
to O 0 1.056534983945312e-07
be O 0 9.106250331569754e-08
hypohaptoglobinemic B-Disease 0 2.516648464734317e-06
( O 0 6.482417935771423e-10
Hp2 O 0 2.4900959942897316e-06
) O 0 2.371856322458399e-10
and O 0 1.8071547036591085e-10
Hp2 O 0 7.165951387833047e-07
/ O 0 1.540259262355903e-07
Hpdel O 0 1.0617202406137949e-06
, O 0 2.2150635492490522e-10
the O 0 5.927399127081401e-10
mother O 0 9.126691624672389e-10
to O 0 1.001430716129903e-09
be O 0 5.362706390066307e-10
Hp2 O 0 4.954988597205556e-08
- O 0 1.019151252279471e-08
1 O 0 1.0418978568793591e-08
and O 0 1.0860128352163656e-09
Hp1 O 0 6.913704169164703e-07
/ O 0 1.0545036133180474e-07
Hp2 O 0 3.3830914958343783e-07
, O 0 5.676202563531518e-11
one O 0 1.3087590039484454e-11
of O 0 8.758848681067466e-12
the O 0 4.662353489393034e-11
two O 0 4.815251929829456e-12
children O 0 1.5973068354102615e-11
to O 0 1.362336077281867e-10
be O 0 2.1552719609019277e-09
hypohaptoglobinemic B-Disease 0 3.6324818211141974e-06
( O 0 3.261257486286695e-09
Hp2 O 0 1.9469916878733784e-05
) O 0 1.1329768234702442e-09
and O 0 5.639804734336451e-10
Hp2 O 0 3.360932851137477e-06
/ O 0 4.509594191404176e-07
Hpdel O 0 1.558254780320567e-06
, O 0 2.2910465191650076e-10
and O 0 4.7978631484424383e-11
the O 0 1.6026605043073516e-10
other O 0 9.409446312391712e-12
child O 0 2.0961921087803148e-10
to O 0 3.1457730864659084e-10
be O 0 1.5405325903827816e-09
Hp1 O 0 7.620930659868463e-07
and O 0 6.654500506186878e-09
Hp1 O 0 2.0346993551356718e-05
/ O 0 4.677619926951593e-06
Hpdel O 0 7.213410299300449e-06
, O 0 1.3894582151507961e-09
showing O 0 3.371757983927637e-09
an O 0 7.145414815390438e-11
anomalous O 0 6.48704983063908e-08
inheritance O 0 6.486969255092845e-07
of O 0 6.673048574157292e-06
Hp O 0 5.681518473465985e-07
phenotypes O 0 1.4438994888621437e-08
in O 0 5.277048242824378e-10
the O 0 1.17005671818049e-09
child O 0 3.41080030885621e-09
with O 0 5.575776299004964e-11
Hp1 O 0 1.670919664320536e-05
. O 0 8.551535870537919e-07

The O 0 9.67025880527217e-06
Hp2 O 0 0.0034144010860472918
/ O 0 6.089091766625643e-05
Hpdel O 0 1.307171714870492e-05
individuals O 0 7.150258163335366e-10
had O 0 1.04438298009768e-08
an O 0 1.4659005953543414e-10
extremely O 0 3.1203295502990613e-09
low O 0 1.498812025602092e-07
level O 0 7.458633604073839e-07
of O 0 6.601433000241741e-08
Hp O 0 1.0740310329993008e-07
( O 0 1.1459488219456304e-10
mean O 0 1.2826022466327913e-09
+ O 0 7.871947538262702e-10
/ O 0 2.7412145886529515e-09
- O 0 6.751536663074376e-09
SD O 0 1.9155619668254076e-07
= O 0 2.422739520113737e-08
0 O 0 1.6331772600963745e-09
. O 0 5.956954374219947e-11
049 O 0 3.7791529905462085e-08
+ O 0 2.7038837835391405e-09
/ O 0 5.108511835771878e-09
- O 0 6.420244780258599e-09
0 O 0 1.7837694654687652e-09
. O 0 1.6995989338131068e-10
043 O 0 6.189596319927659e-07
mg O 0 4.894693574897246e-07
/ O 0 5.066817010401792e-08
ml O 0 5.985652506979022e-08
; O 0 6.552675069215752e-11
n O 0 9.078702789544479e-10
= O 0 1.8167080062525542e-09
6 O 0 4.247253659883654e-10
) O 0 2.814261844397148e-12
, O 0 9.45353279165062e-13
compared O 0 2.7042923022441157e-12
with O 0 5.920791201069475e-13
the O 0 9.724873684113788e-11
level O 0 1.5183795332163186e-09
( O 0 2.846447253249118e-12
1 O 0 3.1479580053783707e-10
. O 0 1.3607778792668057e-10
64 O 0 1.4014399363215801e-10
+ O 0 1.5045985291006758e-10
/ O 0 6.018101572635715e-10
- O 0 1.2696654838606491e-09
1 O 0 6.264857521642853e-10
. O 0 3.403377579758171e-10
07 O 0 7.867857476639983e-08
mg O 0 1.0271410388895674e-07
/ O 0 2.6387521501192168e-08
ml O 0 1.832704299431498e-08
) O 0 5.523420262831813e-12
obtained O 0 8.798524686604026e-10
from O 0 1.4906872958242445e-10
52 O 0 9.451713189889688e-09
healthy O 0 1.8466980833409252e-08
volunteers O 0 1.2309876673555209e-08
having O 0 1.3976188206754614e-08
phenotype O 0 1.40647884450118e-07
Hp2 O 0 4.137840733164921e-06
, O 0 1.826373385860336e-09
whereas O 0 3.089239974940483e-09
the O 0 1.0916262338511729e-09
serum O 0 4.264220532235186e-09
Hp O 0 1.6042921657799525e-08
level O 0 2.469237436741878e-08
of O 0 3.3828165268978694e-10
an O 0 1.8567964873983378e-11
individual O 0 1.4167370401829693e-11
with O 0 1.9416055568877155e-11
Hp1 O 0 7.931143954920117e-06
/ O 0 6.559219855262199e-06
Hpdel O 0 8.391299161303323e-06
was O 0 2.3199619647584768e-07
0 O 0 1.776533906650002e-07
. O 0 4.885524873543545e-08

50 O 0 3.3856135814858135e-06
mg O 0 1.1374938367225695e-05
/ O 0 2.7421160666563082e-06
ml O 0 2.538433818699559e-06
, O 0 3.423665240198659e-10
which O 0 6.5132959789493405e-12
was O 0 4.991862825876048e-11
approximately O 0 5.842265148221781e-13
half O 0 9.004366696707677e-12
the O 0 7.32782168277879e-11
level O 0 2.718922642586108e-09
of O 0 3.209678356430601e-10
Hp O 0 5.170267769472048e-09
in O 0 8.642296323024823e-10
control O 0 5.481430775944318e-08
sera O 0 1.0492271940165665e-07
from O 0 1.4642491386052114e-10
the O 0 5.669724134627074e-10
Hp1 O 0 2.946522101865412e-07
phenotype O 0 6.74031386260765e-10
( O 0 5.106007847435756e-13
1 O 0 5.00878227782664e-11
. O 0 1.6099883579090424e-11
26 O 0 2.0284852964014277e-10
+ O 0 3.5932229414115113e-10
/ O 0 8.915101434858741e-10
- O 0 1.943853078500979e-09
0 O 0 4.937408260019538e-10
. O 0 2.9806525303488485e-11
33 O 0 9.053939820091728e-10
mg O 0 1.831928564399732e-08
/ O 0 1.5903264483085877e-08
ml O 0 1.440933772300923e-08
; O 0 2.2216841213951177e-11
n O 0 3.392165714988238e-10
= O 0 1.4817417293144786e-09
9 O 0 9.505040088342298e-10
) O 0 4.2006526729254645e-11
, O 0 1.1587759918274543e-10
showing O 0 6.78105216422864e-09
a O 0 2.1919199788555943e-09
gene O 0 6.949636421893501e-09
- O 0 7.657241951619653e-08
dosage O 0 1.858498421825061e-06
effect O 0 2.3864393483563617e-07
. O 0 4.678457798945601e-07

The O 0 7.634483267793257e-07
other O 0 1.3738213233693841e-08
allele O 0 2.3576777863354437e-08
( O 0 1.1983493364287057e-10
Hp2 O 0 4.481833286718029e-07
) O 0 2.5508406498175873e-10
of O 0 2.1996415799918623e-10
individuals O 0 9.617476086354326e-12
with O 0 2.551306561848765e-11
Hp2 O 0 7.398079469567165e-05
/ O 0 3.9017006201902404e-05
Hpdel O 0 4.9199275963474065e-05
was O 0 1.1158297041902188e-07
found O 0 3.4658723113700773e-10
to O 0 2.8116250994081327e-10
have O 0 5.191171797980232e-11
, O 0 1.0621318061176943e-11
in O 0 9.961172164896226e-11
all O 0 4.464960345895719e-10
exons O 0 4.029251599035888e-09
, O 0 7.964329751253274e-10
no O 0 1.0387686266710716e-08
mutation O 0 2.206718141550823e-10
, O 0 3.8556033365999554e-11
by O 0 1.9285619975994983e-11
DNA O 0 5.188679486067826e-10
sequencing O 0 2.3520680514366177e-08
. O 0 3.241044339574728e-07

On O 0 6.240950938263268e-07
the O 0 3.6954044269066344e-09
basis O 0 6.853046130572693e-09
of O 0 2.2191697091056284e-10
the O 0 2.371114415922193e-10
present O 0 6.994417545147513e-11
study O 0 4.0913272769671494e-10
, O 0 3.760811106978679e-11
the O 0 5.08162956158742e-10
mechanism O 0 4.5768331347062485e-08
of O 0 7.868814044798e-09
anhaptoglobinemia B-Disease 0 5.724353400182736e-07
and O 0 1.786326531139082e-09
the O 0 1.0094222346879178e-08
mechanism O 0 1.902156441246916e-07
of O 0 1.7929896456436722e-09
anomalous O 0 5.967095262349176e-08
inheritance O 0 3.5443983392724476e-07
of O 0 1.2751676194966421e-06
Hp O 0 7.051839929772541e-07
phenotypes O 0 2.780801366952801e-08
were O 0 1.3222694050796235e-09
well O 0 1.925483772424741e-09
explained O 0 5.3585196724270645e-08
. O 0 8.707462484380812e-08

However O 0 4.564236348869599e-07
, O 0 2.7206397135159932e-09
the O 0 1.29124000380898e-09
mechanism O 0 6.513755579362623e-08
of O 0 1.7106257743648712e-08
hypohaptoglobinemia B-Disease 0 2.0270259483368136e-05
remains O 0 1.1585273114178563e-06
unknown O 0 1.471336781833088e-05

ATM O 0 0.00014240795280784369
mutations O 0 1.9288064834199758e-07
and O 0 4.420543042726877e-09
phenotypes O 0 1.0543025297238273e-07
in O 0 1.8087415298850829e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 2.3321803155340604e-07
in O 0 1.7117084416540251e-09
the O 0 8.083240743417264e-10
British O 0 6.48134523828503e-09
Isles O 0 6.3895356561261e-07
: O 0 2.025718037756974e-09
expression O 0 2.089343587030612e-09
of O 0 1.9110307780678681e-10
mutant O 0 5.729755558903094e-10
ATM O 0 2.7090111487382273e-08
and O 0 2.5407506654140377e-10
the O 0 1.227252521829314e-09
risk O 0 5.414798831537837e-09
of O 0 9.474993012403843e-10
leukemia B-Disease 0 8.76731428434141e-06
, O 0 4.359720762181496e-08
lymphoma B-Disease 1 1.0
, O 0 7.034684585960349e-07
and O 0 9.040985560204717e-07
breast B-Disease 0 0.2958846390247345
cancer I-Disease 0 0.00020312404376454651
. O 0 0.00040928859380073845

We O 0 5.4557094841811704e-08
report O 0 2.0181747384384607e-09
the O 0 1.3176011670612553e-10
spectrum O 0 2.0393795541195914e-09
of O 0 4.749400317471952e-10
59 O 0 4.83821027685849e-09
ATM O 0 2.038949702409809e-07
mutations O 0 6.30051955052835e-10
observed O 0 1.752002987132073e-09
in O 0 3.8260566270764684e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.00015718037320766598
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.750674770763851e-11
patients O 0 5.706477998468351e-11
in O 0 7.95973530143268e-12
the O 0 3.6266373237836547e-10
British O 0 8.02068029770453e-08
Isles O 0 2.090783164021559e-05
. O 0 1.4964539332140703e-06

Of O 0 4.9172072067449335e-06
51 O 0 2.3256734493770637e-06
ATM O 0 7.78960657044081e-06
mutations O 0 4.826164357041307e-09
identified O 0 1.7045214129041142e-09
in O 0 6.237526467556265e-11
families O 0 4.521035022048148e-12
native O 0 1.6994976606565793e-11
to O 0 3.2714045361537103e-10
the O 0 1.0713355758085186e-09
British O 0 2.4230168094163673e-08
Isles O 0 5.063117782810878e-07
, O 0 6.923489559440554e-10
11 O 0 2.498514506399374e-09
were O 0 1.5146425225154303e-09
founder O 0 1.5495508876028907e-08
mutations O 0 6.286883236228391e-10
, O 0 3.076283325298412e-11
and O 0 2.8104654020699726e-11
2 O 0 6.853438261344991e-09
of O 0 1.925803294611228e-09
these O 0 2.2508213348704231e-10
11 O 0 1.1491537721397549e-09
conferred O 0 6.758987325383714e-08
a O 0 1.1187040627191891e-08
milder O 0 2.299313983655793e-08
clinical O 0 1.1900913143847447e-08
phenotype O 0 2.6430105326546993e-10
with O 0 7.634126837630095e-12
respect O 0 3.424998951118141e-09
to O 0 9.538715595169833e-09
both O 0 1.906965607645361e-08
cerebellar B-Disease 0 0.0002179995644837618
degeneration I-Disease 1 0.9999978542327881
and O 0 1.0675155870387698e-08
cellular O 0 6.124280105268554e-08
features O 0 3.6097748790098194e-08
. O 0 6.954585529683754e-08

We O 0 2.6899758864828982e-08
report O 0 7.054470896328269e-10
, O 0 1.803262075251999e-12
in O 0 3.6073238580264233e-12
two O 0 1.8134585846873996e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999138116836548
T I-Disease 1 1.0
families O 0 1.87545187713134e-10
, O 0 1.9890297742186647e-11
an O 0 1.4345584616048956e-11
ATM O 0 2.3202019292511977e-06
mutation O 0 1.2770178692278478e-08
( O 0 8.736595474845288e-11
7271T O 0 2.059508688034839e-07
- O 0 4.202798891128623e-07
- O 0 4.782648943546519e-07
> O 0 5.606678996628034e-07
G O 0 7.244423017027657e-08
) O 0 2.5232956349374724e-11
that O 0 6.83642649868671e-13
may O 0 1.0257921248535418e-11
be O 0 2.1245482803577964e-11
associated O 0 6.67648783481134e-11
with O 0 9.470388882826253e-13
an O 0 1.8259597393127658e-12
increased O 0 8.891187786019827e-11
risk O 0 9.434003578334682e-10
of O 0 2.4469335446752893e-09
breast B-Disease 0 6.400525762728648e-07
cancer I-Disease 0 5.9109783734356824e-08
in O 0 1.0019031826402625e-08
both O 0 3.1341873096835116e-08
homozygotes O 0 7.445883056789171e-07
and O 0 6.536927887879074e-09
heterozygotes O 0 1.1429904844817429e-07
( O 0 4.277755233372815e-11
relative O 0 6.673210428687071e-09
risk O 0 5.407200243112698e-10
12 O 0 8.44428346691295e-11
. O 0 7.837257752496551e-12
7 O 0 6.146543829466111e-10
; O 0 1.2815280781008909e-10
P O 0 3.470936960070503e-08
= O 0 1.263987936539479e-08
. O 0 1.3775301732632528e-10
0025 O 0 4.841397753807541e-07
) O 0 2.2375007402430924e-10
, O 0 2.3547263097722926e-11
although O 0 3.748815494142299e-11
there O 0 3.824429488374914e-12
is O 0 3.876245299131581e-13
a O 0 1.740111093412322e-12
less O 0 4.6978899936878094e-11
severe O 0 2.6209852066472195e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.3280632593648534e-08
in O 0 4.1172523723709276e-11
terms O 0 1.2602265064831641e-10
of O 0 9.492184815940163e-12
the O 0 7.997017978378373e-12
degree O 0 3.5297726963534615e-09
of O 0 4.037560064062973e-09
cerebellar B-Disease 0 1.0329725228075404e-05
degeneration I-Disease 0 0.0002558573323767632
. O 0 1.3547445121275814e-07

This O 0 2.7609088348867772e-08
mutation O 0 1.3764066553179077e-09
( O 0 1.0662258402571734e-11
7271T O 0 1.5412503273637412e-08
- O 0 1.4217850896613982e-08
- O 0 2.4185103697504928e-08
> O 0 8.02692454726639e-08
G O 0 4.509005080421957e-08
) O 0 1.9670796241877397e-11
also O 0 1.4238780293718278e-11
allows O 0 2.65143670907797e-11
expression O 0 3.6588060359221686e-10
of O 0 5.5590618913692325e-11
full O 0 4.460346814116889e-10
- O 0 7.412874758472299e-10
length O 0 1.2847170549612486e-10
ATM O 0 9.592139349479112e-08
protein O 0 9.893013075412682e-10
at O 0 5.579399164901133e-09
a O 0 1.7320473943982506e-09
level O 0 3.3386724496153874e-09
comparable O 0 4.041844192670396e-09
with O 0 5.8242889677817544e-12
that O 0 1.8236703813734323e-11
in O 0 2.0441141834748322e-10
unaffected O 0 3.491194178195656e-08
individuals O 0 2.806374299613168e-10
. O 0 3.911995705152549e-08

In O 0 1.2391808468237286e-08
addition O 0 2.2197719218297607e-09
, O 0 3.471785706143926e-11
we O 0 2.935550413862842e-11
have O 0 8.261480150158207e-13
studied O 0 7.568800447499413e-11
18 O 0 4.2494942675830316e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.6936827879353586e-08
, O 0 2.3038309541340007e-12
in O 0 1.513317574551587e-12
15 O 0 3.812966956062702e-11
families O 0 3.4586443951878376e-12
, O 0 1.1466654015190869e-11
who O 0 1.0587182519561367e-10
developed O 0 7.580019278918826e-09
leukemia B-Disease 1 1.0
, O 0 9.981247330870247e-07
lymphoma B-Disease 1 1.0
, O 0 2.680680495359411e-07
preleukemic O 0 0.0761094018816948
T O 0 2.6678095309762284e-05
- O 0 6.894280772939965e-07
cell O 0 4.996514348931669e-07
proliferation O 0 0.41077476739883423
, O 0 2.59369308253099e-08
or O 0 1.965279125215602e-06
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.9214828334289678e-09
mostly O 0 1.7209327018985476e-10
in O 0 1.5100148909041877e-10
childhood O 0 5.674273850786449e-08
. O 0 5.854751705669514e-08

A O 0 1.0774225302156992e-05
wide O 0 1.1494551444002354e-07
variety O 0 5.258526414309017e-08
of O 0 5.528859858827673e-08
ATM O 0 2.831172605510801e-05
mutation O 0 1.406819194471609e-08
types O 0 7.0110406369394696e-09
, O 0 6.842829081143975e-10
including O 0 1.653147285729517e-09
missense O 0 2.9599988238260266e-07
mutations O 0 2.819660505082311e-09
and O 0 3.300793804950075e-10
in O 0 3.39128125581567e-09
- O 0 8.066967893682886e-08
frame O 0 2.465369561832631e-07
deletions O 0 7.895382481137858e-08
, O 0 3.6265959679759874e-10
were O 0 2.55466758858347e-10
seen O 0 1.8264152412683643e-09
in O 0 2.0290193136762724e-10
these O 0 5.304001127193203e-10
patients O 0 4.605867354179338e-10
. O 0 8.802171436173012e-09

We O 0 1.1003484701177513e-07
also O 0 7.636188348314477e-10
show O 0 9.464836553396694e-11
that O 0 3.6697313482263183e-13
25 O 0 2.5163843231368332e-11
% O 0 4.2692108528918915e-12
of O 0 1.9033614961916356e-11
all O 0 1.3347049854228743e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.5491550909891885e-08
carried O 0 5.093021004931586e-10
in O 0 1.7626541892745706e-10
- O 0 2.3208777122363244e-08
frame O 0 5.813301413581939e-07
deletions O 0 3.6877918319078162e-06
or O 0 2.325291319493772e-07
missense O 0 8.494857297591807e-07
mutations O 0 1.0345827305968669e-08
, O 0 1.5710298340021467e-10
many O 0 3.6499522154676e-11
of O 0 7.050270089958843e-11
which O 0 2.1258322793066275e-12
were O 0 3.263121023389104e-11
also O 0 2.4792716490917854e-11
associated O 0 8.148390295836805e-11
with O 0 2.2379478478717907e-11
expression O 0 1.0803693584193752e-07
of O 0 4.085326921199339e-08
mutant O 0 3.9157136200174136e-08
ATM O 0 1.2591905260705971e-06
protein O 0 5.3314632708634235e-08
. O 0 2.214512875298169e-07

The O 0 4.100933779227489e-07
DMPK O 0 3.722069232026115e-05
gene O 0 1.351275926708695e-07
of O 0 4.8736861657516783e-08
severely O 0 5.4671065299771726e-05
affected O 0 5.977529326628428e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.828920176194515e-05
is O 0 1.0034033326444813e-10
hypermethylated O 0 3.311812601936026e-09
proximal O 0 6.2181704230113155e-09
to O 0 1.344979594364304e-08
the O 0 8.827660380461566e-09
largely O 0 1.1160315338543114e-08
expanded O 0 3.510906765313848e-08
CTG O 0 5.620948741125176e-06
repeat O 0 9.725923746373155e-07
. O 0 8.540557132619142e-07

Using O 0 4.6955773314039106e-07
methylation O 0 9.020917786983773e-06
- O 0 2.4621307602501474e-05
sensitive O 0 4.905254900222644e-05
restriction O 0 1.697869379313488e-06
enzymes O 0 3.401458448237804e-09
, O 0 8.331654116622289e-11
we O 0 2.0236240461102284e-10
characterized O 0 2.361238635173457e-11
the O 0 3.269556500540283e-11
methylation O 0 1.6761630972084163e-09
pattern O 0 2.7394728152607684e-10
on O 0 2.976133339771536e-09
the O 0 5.66051761019537e-10
5 O 0 1.975745123061756e-09
side O 0 6.957723841516383e-10
of O 0 4.4181128200371234e-10
the O 0 6.960245713116819e-10
CTG O 0 9.28126979715671e-08
repeat O 0 7.407493285427336e-09
in O 0 3.961476036096201e-09
the O 0 1.1236545915949137e-08
DMPK O 0 4.952606559527339e-06
gene O 0 1.3448204327914937e-08
of O 0 3.8870182628159e-09
normal O 0 1.7261250206956902e-08
individuals O 0 2.196366352680279e-11
and O 0 5.3729624915899166e-11
of O 0 1.6815129844083287e-10
patients O 0 6.679264780151684e-11
affected O 0 7.201703816628324e-11
with O 0 3.157880346105202e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.738595223343964e-08
showing O 0 2.098457629884365e-09
expansions O 0 6.597855595202873e-09
of O 0 3.339786891487506e-09
the O 0 2.0307004966468867e-09
repetitive O 0 3.17942183691855e-09
sequence O 0 1.6983425776828653e-09
. O 0 1.4510035839521152e-07

The O 0 1.9377429794076306e-07
gene O 0 1.6461840779413706e-09
segment O 0 4.433377220891543e-09
analyzed O 0 1.192139942318704e-09
corresponds O 0 6.920823358846917e-10
to O 0 3.9944958452053925e-09
the O 0 6.0457621131604355e-09
genomic O 0 1.5380207685211644e-07
SacI O 0 3.939606813219143e-06
- O 0 5.623955345868126e-08
HindIII O 0 2.867247133053752e-07
fragment O 0 4.737884751193633e-09
carrying O 0 1.0805600858532216e-09
exons O 0 9.879347118157966e-09
11 O 0 8.394398065547648e-09
- O 0 5.416691806203744e-08
15 O 0 2.125567419852814e-07
. O 0 2.9139391699573025e-07

There O 0 3.8887851161462095e-08
is O 0 3.059006659089647e-10
constitutive O 0 1.8821801006652095e-08
methylation O 0 6.918744333006543e-08
in O 0 2.7274214886574555e-08
intron O 0 1.4332911177916685e-06
12 O 0 3.4842298646253766e-07
at O 0 3.5760038485932455e-08
restriction O 0 5.690411697401032e-08
sites O 0 6.263618068658161e-09
of O 0 1.0789537041588915e-09
SacII O 0 3.652374971352401e-07
and O 0 2.3433841533915256e-09
HhaI O 0 1.7070915419026278e-06
, O 0 2.1957852203158268e-10
localized O 0 1.3977006219079158e-09
1 O 0 1.5653326412845558e-09
, O 0 2.813780111687869e-11
159 O 0 1.7655950312889246e-10
- O 0 8.641340421000621e-10
1 O 0 1.0948547846112433e-08
, O 0 4.0910774767866087e-10
232 O 0 8.659654660014837e-10
bp O 0 6.3976424158340706e-09
upstream O 0 3.764827116725655e-09
of O 0 3.769784928664421e-09
the O 0 1.5395992036815187e-08
CTG O 0 7.2185507633548696e-06
repeat O 0 6.598033905902412e-07
, O 0 2.009125754653951e-09
whereas O 0 2.7428201931911644e-09
most O 0 3.0362653363757985e-11
, O 0 1.9651587215147037e-12
if O 0 3.450710854210892e-12
not O 0 2.194896521479084e-11
all O 0 1.3429191786373806e-11
, O 0 2.7717156694806455e-11
of O 0 1.4859012631429636e-10
the O 0 2.125704612332413e-10
other O 0 2.203226490138377e-11
sites O 0 1.0070775324777514e-09
of O 0 3.657563973913369e-10
SacII O 0 3.8363535281860095e-07
, O 0 4.664081343364046e-10
HhaI O 0 2.343652340641711e-06
, O 0 3.058329978156138e-10
and O 0 7.18249903997048e-11
HpaII O 0 1.584405140420131e-07
in O 0 2.3198483412034676e-10
this O 0 1.46693546199117e-10
region O 0 6.770593530269764e-10
are O 0 5.932462854296716e-11
unmethylated O 0 2.1560545349075255e-07
, O 0 2.0188511973273648e-10
in O 0 2.0334438299851598e-10
normal O 0 4.908443429485487e-09
individuals O 0 1.0054009708104772e-11
and O 0 3.728008526882043e-11
most O 0 1.3339872262374541e-10
of O 0 1.853492637149401e-10
the O 0 5.283866677530114e-10
patients O 0 7.71317010261896e-10
. O 0 1.3438000046051002e-08

In O 0 9.588111637981456e-09
a O 0 5.918180390196426e-10
number O 0 8.105096455102156e-11
of O 0 5.6093133610213286e-11
young O 0 1.2674726546091364e-10
and O 0 1.798650672846236e-10
severely O 0 8.96455816246089e-08
affected O 0 2.0238952735951443e-09
patients O 0 2.126971043736603e-09
, O 0 4.18322286532824e-11
however O 0 5.747783360376957e-10
, O 0 1.4714723883813008e-10
complete O 0 6.911829775191336e-09
methylation O 0 5.325303931158487e-08
of O 0 6.552332010301143e-09
these O 0 3.220790578684074e-10
restriction O 0 5.711580097766955e-09
sites O 0 7.352732867005329e-10
was O 0 9.793752475673045e-10
found O 0 9.17489348384315e-11
in O 0 1.886894251956761e-10
the O 0 2.3611419486258e-09
mutated O 0 3.3942271215892106e-08
allele O 0 3.8276084524113685e-07
. O 0 6.024848744345945e-07

In O 0 9.904596254273201e-08
most O 0 2.0061390326731043e-09
of O 0 1.8965351511468498e-10
these O 0 5.529597613129766e-12
patients O 0 4.017289539220981e-12
, O 0 6.815880325417023e-13
the O 0 2.6049780388337496e-11
onset O 0 1.0297362251776576e-07
of O 0 1.7761079718070505e-08
the O 0 3.605481069257621e-08
disease O 0 1.2441708108212879e-08
was O 0 2.795426325974404e-07
congenital O 1 0.9999828338623047
. O 0 7.909970736363903e-05

Preliminary O 0 9.2965740350337e-07
in O 0 2.645409722390468e-07
vivo O 0 0.0004831934638787061
footprinting O 0 0.00149678869638592
data O 0 3.7888898418714234e-07
gave O 0 2.7451559247992918e-08
evidence O 0 5.418455906180952e-09
for O 0 1.8136672719215596e-10
protein O 0 1.549886330387551e-10
- O 0 2.2153392453816423e-09
DNA O 0 1.0267940275809906e-08
contact O 0 2.2285466627636197e-07
in O 0 9.600463535264225e-09
normal O 0 3.8229791243793443e-07
genes O 0 2.5383879442841817e-09
at O 0 3.5727314440237024e-08
an O 0 6.47179310142576e-10
Sp1 O 0 5.599765273700541e-08
consensus O 0 2.8640979365945896e-08
binding O 0 1.7626516912727652e-09
site O 0 4.6632386840883555e-09
upstream O 0 7.911520327752442e-10
of O 0 4.0321398997456015e-10
the O 0 1.5139377529393983e-09
CTG O 0 6.091056548029883e-07
repeat O 0 2.2257593101926432e-08
and O 0 2.3016986927526517e-10
for O 0 1.2839111718232488e-10
a O 0 1.0752137027947306e-11
significant O 0 9.05702162573574e-12
reduction O 0 8.933587758441774e-10
of O 0 5.222576815455682e-10
this O 0 1.678059219356598e-10
interaction O 0 4.1959302699012824e-10
in O 0 1.9670505502222824e-10
cells O 0 2.857705183600956e-10
with O 0 3.079095312052971e-11
a O 0 3.9750012170713944e-09
hypermethylated O 0 5.092293235975376e-07
DMPK O 0 2.8883405320812017e-06
gene O 0 9.597296291019575e-09
. O 0 2.8492232573285037e-08
. O 0 2.1620503787289636e-07

The O 0 2.4322172976098955e-05
hemochromatosis B-Disease 1 1.0
gene O 0 6.345848646560626e-08
product O 0 1.2554384198892876e-09
complexes O 0 1.8119591937981738e-10
with O 0 1.588741638247626e-11
the O 0 9.545044754588616e-10
transferrin O 0 3.674769644135267e-08
receptor O 0 4.148124066460923e-09
and O 0 2.1876638278683913e-09
lowers O 0 1.4627019595536694e-07
its O 0 6.447029576861496e-10
affinity O 0 6.813057895627139e-10
for O 0 2.341425942020692e-10
ligand O 0 3.7896970006556785e-09
binding O 0 4.582528134733366e-08
. O 0 2.8600646828635945e-07

We O 0 1.0629120339444853e-07
recently O 0 2.2954228739990867e-08
reported O 0 2.0008732448673072e-09
the O 0 5.338112174513299e-10
positional O 0 1.7457985279634158e-07
cloning O 0 6.947015407376966e-08
of O 0 1.3174409341232263e-09
a O 0 6.456726264758572e-10
candidate O 0 8.90569129552432e-09
gene O 0 1.2050507791627751e-07
for O 0 1.6575721019762568e-05
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999994039535522
HFE O 1 0.655337393283844
. O 0 1.2639103488254477e-06

The O 0 1.2079051714408706e-07
gene O 0 2.53339516032014e-10
product O 0 1.5694424926326889e-10
, O 0 9.835562919668916e-12
a O 0 5.56192591982807e-11
member O 0 6.617651426843452e-10
of O 0 5.174029027443794e-08
the O 0 4.150220149767847e-07
major O 0 2.600155539767002e-07
histocompatibility O 0 3.954075964429649e-06
complex O 0 5.275614967104048e-07
class O 0 1.2031692975256192e-08
I O 0 2.3272392013495846e-07
- O 0 6.629315763007071e-09
like O 0 2.956533351472501e-10
family O 0 9.685741098053313e-11
, O 0 8.579286586707369e-12
was O 0 7.375919319763113e-11
found O 0 5.776825632436422e-12
to O 0 2.570925417000325e-10
have O 0 1.0667579042333841e-09
a O 0 2.8466469181864795e-09
mutation O 0 5.844815187394659e-10
, O 0 8.908332405077601e-11
Cys O 0 1.8388641365163494e-07
- O 0 6.76778455499516e-08
282 O 0 1.1427768953353734e-07
- O 0 1.5247542251017876e-06
- O 0 3.916890705113474e-07
> O 0 3.160291441872687e-07
Tyr O 0 1.3695459983864566e-06
( O 0 5.089034662425496e-12
C282Y O 0 3.4361880008049184e-09
) O 0 6.95590883070113e-13
, O 0 2.9797567408298975e-13
in O 0 1.9355517622693386e-12
85 O 0 9.334361061874574e-10
% O 0 1.3152007261041376e-10
of O 0 5.989655993410281e-10
patient O 0 1.0395734051371619e-08
chromosomes O 0 7.550845282366936e-08
. O 0 9.41306893764704e-07

This O 0 1.2331982190971758e-07
mutation O 0 1.170086338930787e-08
eliminates O 0 1.148269301864957e-08
the O 0 4.453029944784248e-09
ability O 0 2.4731921399734347e-08
of O 0 4.461610458861287e-08
HFE O 0 0.00010369212395744398
to O 0 2.985698870361375e-07
associate O 0 2.669417256129236e-07
with O 0 1.381835340596993e-10
beta2 O 0 2.2037813323549926e-05
- O 0 1.4879312857374316e-06
microglobulin O 0 1.0512324479350355e-05
( O 0 3.372405688040203e-10
beta2m O 0 2.1433329493447673e-06
) O 0 3.603785880823551e-10
and O 0 1.0046213166914342e-10
prevents O 0 6.63062771355527e-10
cell O 0 1.8206183227675865e-08
- O 0 8.661414341304408e-08
surface O 0 1.2138141869399988e-07
expression O 0 5.482473170559388e-06
. O 0 5.569996233134589e-07

A O 0 2.7853968276758678e-05
second O 0 1.1763495422201231e-06
mutation O 0 5.5938906839969604e-09
that O 0 5.531140129244605e-11
has O 0 7.110280680205916e-12
no O 0 1.982095390595795e-11
effect O 0 3.6728392549534306e-10
on O 0 1.7414494735135122e-08
beta2m O 0 1.2228787227286375e-06
association O 0 5.574442241140787e-09
, O 0 3.6388184132540857e-10
H63D O 0 4.996819598090951e-07
, O 0 9.0902375904367e-11
was O 0 3.4908578805392665e-10
found O 0 8.427867778659781e-12
in O 0 1.0660692814634665e-11
eight O 0 4.476179496504251e-11
out O 0 8.035854967558542e-12
of O 0 3.336835668887872e-11
nine O 0 1.0927652532854992e-10
patients O 0 1.591276936607766e-11
heterozygous O 0 5.950504672336265e-11
for O 0 4.68338146042413e-10
the O 0 2.8030605392359575e-08
C282Y O 0 8.43696398078464e-06
mutant O 0 1.0388240525571746e-06
. O 0 1.9930998860218097e-06

In O 0 5.056995711072432e-09
this O 0 1.5828593991074058e-10
report O 0 2.220126443797099e-10
, O 0 5.574774149252892e-12
we O 0 5.702713301580786e-11
demonstrate O 0 7.447156225026674e-10
in O 0 4.532056119277428e-10
cultured O 0 1.828602336217955e-07
293 O 0 3.4803569803898426e-08
cells O 0 6.582096290230766e-08
overexpressing O 0 4.345779416325968e-06
wild O 0 1.5145889165069093e-07
- O 0 1.2376554536785989e-07
type O 0 1.2767785051437386e-07
or O 0 6.97226312240673e-08
mutant O 0 1.5129445785078133e-07
HFE O 0 1.2722463225145475e-06
proteins O 0 3.7909869687879905e-11
that O 0 1.897236014125614e-11
both O 0 8.634647163940912e-11
the O 0 3.51197670944714e-09
wild O 0 1.0824795282360355e-07
- O 0 6.793340645572243e-08
type O 0 4.413720589013792e-08
and O 0 2.018606792830724e-08
H63D O 0 5.4086332966107875e-05
HFE O 0 2.2303813238977455e-05
proteins O 0 8.842113707885346e-10
form O 0 3.3296532198079376e-10
stable O 0 1.4814089510650774e-08
complexes O 0 3.1728775162775946e-10
with O 0 1.499835672325034e-11
the O 0 9.608482898215698e-10
transferrin O 0 3.2862356391660796e-08
receptor O 0 2.8329107948366072e-09
( O 0 1.0390212995536885e-10
TfR O 0 7.41150984140404e-07
) O 0 2.0192680860731116e-09
. O 0 4.2326362859057554e-08

The O 0 1.6626511296635726e-06
C282Y O 0 4.904058005195111e-05
mutation O 0 2.3227819667681615e-08
nearly O 0 5.369912292607637e-10
completely O 0 1.1264156274393144e-09
prevents O 0 1.1981504677294197e-10
the O 0 2.7779198386035375e-10
association O 0 7.496036569243358e-10
of O 0 1.8752204233862813e-09
the O 0 3.698175099486889e-09
mutant O 0 1.1605068905851113e-08
HFE O 0 1.4231111435947241e-06
protein O 0 1.3564069867300077e-09
with O 0 1.6052447565639838e-11
the O 0 3.550732374790755e-09
TfR O 0 2.1604115318041295e-05
. O 0 4.992865569874994e-07

Studies O 0 3.2308724939866806e-07
on O 0 3.540096926712977e-08
cell O 0 4.080387583371703e-09
- O 0 2.731439074921127e-09
associated O 0 7.115850686467695e-10
transferrin O 0 1.75894818710276e-08
at O 0 9.441226467288288e-09
37 O 0 7.180971817177806e-09
degrees O 0 8.694152597854554e-08
C O 0 7.292376125178635e-08
suggest O 0 6.658865125963587e-10
that O 0 2.0234027994781023e-11
the O 0 5.964757021637013e-10
overexpressed O 0 1.3037700909990235e-06
wild O 0 9.592704373062588e-07
- O 0 2.18089553527534e-07
type O 0 1.1464467064570272e-07
HFE O 0 1.8398710381006822e-05
protein O 0 5.757342602663584e-09
decreases O 0 1.1338306959984834e-09
the O 0 1.0809883543849708e-10
affinity O 0 6.518049988635255e-10
of O 0 3.183426855457583e-09
the O 0 4.575599898970495e-09
TfR O 0 9.287481930186914e-07
for O 0 4.846938850278093e-09
transferrin O 0 1.2916934792883694e-06
. O 0 7.27154144897213e-07

The O 0 3.244756953790784e-05
overexpressed O 0 0.015164260752499104
H63D O 0 0.31185299158096313
protein O 0 3.004905479997433e-08
does O 0 7.623977560378137e-10
not O 0 3.050605046350796e-10
have O 0 3.443230769950567e-11
this O 0 8.25789263358967e-12
effect O 0 3.806370774128709e-10
, O 0 2.4440017717952678e-11
providing O 0 1.155318507528591e-09
the O 0 1.920952702461065e-10
first O 0 2.1058900456782936e-10
direct O 0 4.4066000848275166e-10
evidence O 0 1.0742164935351184e-09
for O 0 1.813833250263741e-10
a O 0 3.564804562650181e-10
functional O 0 1.2785606351428669e-08
consequence O 0 5.6477983179092917e-08
of O 0 2.7717130812732194e-09
the O 0 1.406473071341452e-08
H63D O 0 0.00012009614874841645
mutation O 0 1.6256034029993316e-07
. O 0 1.4730933628470666e-07

Addition O 0 1.8608253640195471e-06
of O 0 1.4704490070016618e-07
soluble O 0 1.651160346227698e-07
wild O 0 3.855653218920452e-08
- O 0 1.0980502729296404e-08
type O 0 1.105599451989292e-07
HFE O 1 1.0
/ O 1 0.9999998807907104
beta2m O 1 0.9920067191123962
heterodimers O 0 2.1431822460726835e-05
to O 0 2.7470107966109936e-07
cultured O 0 4.60523551737424e-07
cells O 0 2.8191886158879242e-08
also O 0 1.932067977827856e-10
decreased O 0 3.5896677297309054e-10
the O 0 3.489444844184675e-11
apparent O 0 1.2378117975053726e-10
affinity O 0 2.612961236270195e-10
of O 0 1.6003520730833998e-09
the O 0 7.552393710419381e-10
TfR O 0 5.0148791785886715e-08
for O 0 5.340950945398326e-11
its O 0 4.805407374103288e-12
ligand O 0 8.591998640339327e-11
under O 0 5.511218703624365e-10
steady O 0 7.961417303192775e-09
- O 0 5.528970059565097e-10
state O 0 1.0021864414733184e-11
conditions O 0 1.6628749488489802e-09
, O 0 1.9843916440609455e-11
both O 0 9.185990509918973e-12
in O 0 3.155242039865058e-11
293 O 0 5.7592923485838554e-11
cells O 0 1.0363098573717977e-10
and O 0 2.596561299306188e-10
in O 0 6.4923946219153095e-09
HeLa O 0 1.0466820867804927e-06
cells O 0 5.789058477034814e-08
. O 0 5.466134780363063e-07

Furthermore O 0 8.818812347044513e-08
, O 0 2.1715119979948128e-10
at O 0 3.7686903597844434e-10
4 O 0 1.935787086182472e-09
degrees O 0 1.064687467078329e-07
C O 0 4.536017570444528e-07
, O 0 8.190856326528717e-10
the O 0 6.180486789020279e-09
added O 0 3.821783067792239e-08
soluble O 0 2.869620807643969e-08
complex O 0 1.6420612425349645e-08
of O 0 1.2986578035167895e-08
HFE O 0 0.00057750113774091
/ O 0 1.5405061276396737e-05
beta2m O 0 2.2361180072039133e-06
inhibited O 0 5.206331010754184e-08
binding O 0 1.0429696217784112e-08
of O 0 6.171639643781646e-09
transferrin O 0 2.2836110247226316e-07
to O 0 6.747239922333392e-08
HeLa O 0 1.2615128071047366e-06
cell O 0 6.535496765991411e-08
TfR O 0 6.630772304561106e-07
in O 0 1.270474614400996e-09
a O 0 1.3282601685205009e-09
concentration O 0 6.468195579145686e-08
- O 0 4.777652407028654e-08
dependent O 0 8.963532849293188e-08
manner O 0 4.886503575107781e-07
. O 0 6.872106723676552e-07

Scatchard O 0 0.0011178646236658096
plots O 0 9.758422265804256e-07
of O 0 2.963956262647116e-07
these O 0 6.665831886465412e-09
data O 0 1.9879101031961e-08
indicate O 0 1.4054299057875141e-08
that O 0 9.815931401035982e-10
the O 0 1.4789414137794665e-08
added O 0 6.243652705961722e-08
heterodimer O 0 6.277061093129532e-09
substantially O 0 1.9331610090489448e-08
reduced O 0 5.489400489722129e-09
the O 0 9.713423398949317e-10
affinity O 0 5.52876233683719e-09
of O 0 5.579867679017525e-09
TfR O 0 4.351529696577927e-07
for O 0 2.631282303156013e-09
transferrin O 0 6.023389573783788e-07
. O 0 4.4734721882377926e-07

These O 0 1.3950372590443294e-07
results O 0 2.424643952281258e-08
establish O 0 1.0994463650604303e-07
a O 0 2.3663264681061946e-09
molecular O 0 4.312642687409607e-09
link O 0 7.553693670558914e-09
between O 0 1.8938457746475734e-10
HFE O 1 0.5954508781433105
and O 0 3.021838210770511e-07
a O 0 3.7532785768235044e-07
key O 0 4.820205504074693e-06
protein O 0 5.496346489053394e-09
involved O 0 1.8453872874246713e-09
in O 0 1.3373151475093437e-09
iron O 0 2.753833143742668e-07
transport O 0 1.313000694835864e-07
, O 0 1.084363154824075e-09
the O 0 1.5526505636742627e-09
TfR O 0 3.081647435010382e-07
, O 0 4.6109630003066115e-11
and O 0 9.235321708767064e-12
raise O 0 1.1135177224730342e-09
the O 0 4.903406569667368e-10
possibility O 0 2.085935202345013e-09
that O 0 5.4407575666992614e-11
alterations O 0 6.76236311392131e-09
in O 0 2.7975894933973677e-09
this O 0 2.0725138272226218e-10
regulatory O 0 6.737357893804585e-10
mechanism O 0 6.176314570893737e-09
may O 0 4.143140552859137e-10
play O 0 1.443350772234453e-09
a O 0 7.257799916615681e-11
role O 0 1.886462375200182e-10
in O 0 1.642974367666028e-10
the O 0 6.508186212172973e-10
pathogenesis O 0 2.1917217964073643e-05
of O 0 1.3473113824602478e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 2.436145041428972e-05
. O 0 5.8657839474562934e-08

Genomic O 0 1.3070126669845195e-07
organization O 0 6.834614652007076e-09
of O 0 2.680949240385644e-09
the O 0 6.840692456933084e-09
UBE3A O 0 0.0006469347863458097
/ O 0 6.49172579869628e-05
E6 O 0 5.9364724620536435e-06
- O 0 1.5576244550175034e-05
AP O 0 0.0005653732805512846
gene O 0 1.1170409486283006e-08
and O 0 4.076636250793797e-10
related O 0 1.1118204135129872e-08
pseudogenes O 0 2.0929198853991693e-06
. O 0 8.434305982518708e-07

The O 0 4.62809879309134e-07
UBE3A O 0 1.7019616279867478e-05
gene O 0 1.2251224923431892e-08
encodes O 0 1.6336009212025715e-09
the O 0 2.0499524300277017e-09
E6 O 0 4.754226878844747e-08
- O 0 1.978537227387278e-07
AP O 0 2.8522781576612033e-05
ubiquitin O 0 3.122063674254605e-08
- O 0 5.736100483488826e-09
protein O 0 4.7224526372735554e-11
ligase O 0 7.139042690340602e-10
and O 0 3.862214714711598e-10
has O 0 9.585651716825794e-11
recently O 0 1.3564659118170397e-10
been O 0 6.199075280877153e-11
shown O 0 1.1675525823928723e-10
to O 0 1.4763471001266737e-10
be O 0 3.354065636340664e-10
mutated O 0 1.4282811378052429e-08
in O 0 1.056262988186063e-07
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 4.6573299528063217e-07
who O 0 2.8176591615469704e-10
lack O 0 1.7566039733907246e-09
15q11 O 0 2.690584608444624e-07
- O 0 2.5200847630912904e-07
q13 O 0 2.465377292537596e-06
deletions O 0 7.459260586983874e-08
or O 0 1.3026544287697561e-08
chromosome O 0 1.477467606036953e-07
15 O 0 1.3208883729021181e-06
paternal O 0 0.016706842929124832
uniparental B-Disease 1 0.9999959468841553
disomy I-Disease 0 0.007171237375587225
. O 0 6.685125754302135e-06

Previous O 0 6.679056809844042e-07
UBE3A O 0 2.1402920538093895e-05
cDNA O 0 2.3630988721379254e-07
analysis O 0 1.1210492978364073e-08
has O 0 4.4691670503249625e-11
shown O 0 5.27716655096544e-11
a O 0 1.1712864012025648e-10
coding O 0 7.101075727433681e-09
region O 0 1.9902688386252976e-09
of O 0 1.933359250472222e-09
approximately O 0 9.32289800914532e-11
2 O 0 2.861318826319348e-08
. O 0 6.813570507802069e-08

6 O 0 1.5052886737976223e-05
kb O 0 1.4683481822430622e-05
and O 0 6.396752016968321e-09
a O 0 7.4118888804264316e-09
3 O 0 8.269130802318614e-08
- O 0 2.754991612619051e-07
untranslated O 0 4.829532190342434e-05
region O 0 1.1930087850942073e-07
( O 0 1.9852179622414923e-10
UTR O 0 1.2900783303848584e-06
) O 0 4.827091504289172e-10
of O 0 4.698403888170333e-10
< O 0 5.323029483861319e-08
50 O 0 2.2824476531013715e-08
bp O 0 5.401739500143776e-09
, O 0 3.27395575927536e-11
whereas O 0 5.510882861159416e-10
Northern O 0 2.2581023717549442e-09
analysis O 0 8.239225968154074e-10
has O 0 1.7002822760847636e-11
indicated O 0 2.6436346167724167e-11
mRNA O 0 3.435345757862862e-11
sizes O 0 1.2153769102241085e-09
of O 0 8.70028216137797e-10
5 O 0 2.0099854225463787e-08
- O 0 2.2159473189731216e-07
8 O 0 6.177955356179154e-07
kb O 0 7.0475711254403e-05
. O 0 1.5521028444709373e-06

We O 0 3.7762602005386725e-06
have O 0 1.2136331051237903e-08
analyzed O 0 9.121266408840256e-09
additional O 0 4.087710170352921e-09
cDNA O 0 7.729141771051218e-08
clones O 0 6.48985860607354e-08
and O 0 1.9622587998924246e-09
provide O 0 3.29306693025444e-09
evidence O 0 1.8536126800139385e-10
for O 0 2.9246969429630454e-11
an O 0 1.1767181846977781e-11
additional O 0 1.004434091456119e-09
0 O 0 9.359416708321078e-08
. O 0 1.205915225455101e-07

5 O 0 2.643833795445971e-06
kb O 0 1.1869731679325923e-05
of O 0 1.2735411303310684e-07
5 O 0 2.554816944666527e-07
- O 0 1.6486303877627506e-07
UTR O 0 1.0305069736205041e-05
and O 0 7.972054127947104e-09
> O 0 1.3057767489499383e-07
2 O 0 5.128509172891427e-08
kb O 0 1.6392501720474684e-06
of O 0 4.023340238745732e-08
3 O 0 2.958398681585095e-07
- O 0 5.469112238642992e-07
UTR O 0 0.00010353067773394287
. O 0 2.1330840809241636e-06

We O 0 4.74134083106037e-07
have O 0 7.011892733110869e-10
established O 0 8.975090115548312e-10
the O 0 4.06297384625276e-10
genomic O 0 5.041605799505078e-09
organization O 0 1.6396130009255216e-09
of O 0 4.789417751283054e-10
UBE3A O 0 8.679131155986397e-07
and O 0 1.2419960615517311e-09
the O 0 6.647561612282971e-09
sequence O 0 1.778212022074399e-09
of O 0 8.926063443936982e-09
intron O 0 2.668941192496277e-07
- O 0 1.9106796855794528e-07
exon O 0 1.874955444236548e-07
borders O 0 9.749792440061356e-08
. O 0 2.934214649030764e-07

We O 0 2.587951712484937e-06
have O 0 1.7996166334910413e-08
also O 0 6.677615349559574e-09
mapped O 0 3.633849132711475e-08
two O 0 1.557310058686312e-09
highly O 0 3.192791364625691e-09
homologous O 0 3.321269703704388e-09
processed O 0 3.4624534350768954e-08
pseudogenes O 0 2.516525796636415e-07
, O 0 3.6339788955785934e-09
UBE3AP1 O 0 1.0119381386175519e-06
and O 0 1.3243491858716538e-09
UBE3AP2 O 0 1.3635926734423265e-06
, O 0 1.7628827564397653e-10
to O 0 5.249521928263334e-10
chromosomes O 0 2.5599158903766295e-10
2 O 0 6.318282008699327e-10
and O 0 9.445936394181231e-11
21 O 0 7.3013772805552435e-09
, O 0 2.6513821693718853e-10
respectively O 0 3.2241851410930167e-09
, O 0 1.1172911901224936e-10
and O 0 7.045780625603015e-11
determined O 0 2.8123934292523245e-09
their O 0 5.5184585789902485e-09
genomic O 0 1.6176235817511042e-07
organization O 0 7.396132417625267e-08
. O 0 2.3803342230621638e-07

These O 0 4.891566973697081e-08
results O 0 1.4845875639935002e-09
will O 0 6.540014363398683e-11
form O 0 4.188665473497943e-12
the O 0 3.0873404527342885e-11
basis O 0 1.2497708423708787e-10
for O 0 1.2466418522483202e-11
studies O 0 2.998444548207857e-10
of O 0 4.329618885634545e-10
mutation O 0 2.788489161797969e-10
and O 0 3.759758615551334e-10
imprinting O 0 4.879215794062475e-06
of O 0 2.076821147056762e-06
UBE3A O 0 0.0020218724384903908
. O 0 1.3546656191465445e-05

Mutation O 0 8.254505132754275e-07
spectrum O 0 6.806816088555934e-08
and O 0 3.1787426024720844e-09
genotype O 0 4.802105308954197e-07
- O 0 2.4447758733003866e-06
phenotype O 0 1.1354548234976392e-07
analyses O 0 2.2749720329784395e-08
in O 0 1.1641264618944547e-09
Cowden B-Disease 0 7.666164492547978e-06
disease I-Disease 0 1.8462049666823077e-08
and O 0 7.571302473863284e-10
Bannayan B-Disease 1 0.999963641166687
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 7.929441103726731e-09
two O 0 3.239843060498515e-09
hamartoma B-Disease 0 0.000565932656172663
syndromes I-Disease 0 3.302691538920044e-06
with O 0 3.6271252668029774e-08
germline O 1 0.998857855796814
PTEN O 1 0.9708059430122375
mutation O 0 1.01141131381155e-06
. O 0 5.36245636340027e-07

The O 0 1.9884120774804614e-05
tumour B-Disease 1 1.0
suppressor O 0 0.00042199023300781846
gene O 0 7.360505378528615e-07
PTEN O 0 1.1214352525712457e-05
, O 0 2.591604708612749e-09
which O 0 2.2838638966127256e-11
maps O 0 1.4528604985741822e-09
to O 0 5.1166448855610724e-09
10q23 O 0 5.892443368793465e-06
. O 0 4.354626810254558e-07

3 O 0 2.864303780825139e-07
and O 0 2.0727997096514628e-09
encodes O 0 6.176417710612725e-10
a O 0 3.9870193258018105e-10
403 O 0 8.926910322060166e-10
amino O 0 1.1832981261505893e-09
acid O 0 2.6924384943782798e-09
dual O 0 1.233408823964055e-07
specificity O 0 2.7169185159436893e-06
phosphatase O 0 0.020274408161640167
( O 0 5.7507936190859255e-08
protein O 0 6.90246579893028e-08
tyrosine O 0 1.8402869272904354e-07
phosphatase O 0 2.5867080921671004e-07
; O 0 2.291212636285067e-10
PTPase O 0 6.933196061709168e-08
) O 0 1.80965450957693e-11
, O 0 6.046906031453858e-12
was O 0 1.6778223255187186e-10
shown O 0 1.9804376194532125e-10
recently O 0 5.608117858990624e-10
to O 0 7.38765160157584e-10
play O 0 6.386160578131239e-08
a O 0 6.2609304407601485e-09
broad O 0 2.7962239190770788e-09
role O 0 1.3098247819698372e-08
in O 0 2.905274953945991e-08
human O 0 3.4984331875875796e-08
malignancy B-Disease 0 1.2691920346696861e-05
. O 0 1.2683064198881766e-07

Somatic O 0 0.000339164980687201
PTEN O 0 0.0006098562735132873
deletions O 0 2.205421651524375e-06
and O 0 1.0731849187095577e-08
mutations O 0 5.369154010281818e-10
were O 0 2.723696546080845e-10
observed O 0 1.2119895365092503e-10
in O 0 2.4370810924878583e-10
sporadic B-Disease 0 3.8511225852744246e-07
breast I-Disease 0 3.2345738873118535e-05
, I-Disease 0 3.3885808647937665e-07
brain I-Disease 1 0.9999977350234985
, I-Disease 0 8.193985195248388e-06
prostate I-Disease 1 1.0
and I-Disease 0 0.025402415543794632
kidney I-Disease 0 0.006144678685814142
cancer I-Disease 0 7.262891585924081e-07
cell O 0 1.1768523933142205e-08
lines O 0 1.2255495507318415e-09
and O 0 6.960976239867023e-10
in O 0 2.7015021331067146e-09
several O 0 1.9588708433104784e-09
primary O 0 2.0960709434802993e-07
tumours B-Disease 1 1.0
such O 0 7.373018462430991e-08
as O 0 9.177570973406546e-06
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.009787878021597862
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 0 2.0769080947502516e-05
thyroid B-Disease 1 0.9999996423721313
tumours I-Disease 1 1.0
. O 0 0.0015009420458227396

In O 0 5.167529693039796e-08
addition O 0 2.1078292888887518e-08
, O 0 4.431145672612047e-09
PTEN O 0 7.574538358312566e-06
was O 0 1.2384559511247062e-07
identified O 0 2.8877162883134133e-09
as O 0 4.430204814109828e-10
the O 0 1.870133076176117e-10
susceptibility O 0 3.029128892162447e-10
gene O 0 1.6070100805620768e-10
for O 0 1.5581982371060121e-09
two O 0 4.5306258300570335e-08
hamartoma B-Disease 1 0.9999998807907104
syndromes I-Disease 1 0.9999880790710449
Cowden B-Disease 1 0.9999991655349731
disease I-Disease 0 0.0001407171512255445
( O 0 4.0612829071973167e-11
CD B-Disease 0 8.353918019565754e-07
; O 0 5.754971166282985e-09
MIM O 0 2.044151733571198e-05
158350 O 0 7.114892355275515e-07
) O 0 2.962652623228479e-10
and O 0 3.390484004661687e-10
Bannayan B-Disease 0 1.602333395567257e-05
- I-Disease 0 4.211949544696836e-06
Zonana I-Disease 0 0.0031705028377473354
( I-Disease 0 3.080496302487745e-09
BZS I-Disease 0 1.9248045646236278e-05
) I-Disease 0 1.029428986498715e-09
or I-Disease 0 8.444335786172985e-10
Ruvalcaba I-Disease 0 4.290470315027051e-06
- I-Disease 0 9.668640359450364e-07
Riley I-Disease 0 0.00012355692160781473
- I-Disease 1 0.9999942779541016
Smith I-Disease 0 0.020506354048848152
syndrome I-Disease 1 0.9999995231628418
( O 0 8.203492996017303e-09
MIM O 0 0.0002328557166038081
153480 O 0 1.0796852620842401e-05
) O 0 3.882691057555121e-09
. O 0 4.340703085858877e-08

Constitutive O 0 1.4459949397860328e-06
DNA O 0 6.208052383271934e-08
from O 0 1.4903525080711688e-09
37 O 0 9.793906130539654e-09
CD B-Disease 0 3.8548449765585246e-07
families O 0 4.785573048948777e-10
and O 0 1.960159257130556e-10
seven O 0 8.082115532381806e-10
BZS B-Disease 0 1.9747510577872163e-06
families O 0 3.513569435398267e-10
was O 0 1.6187284845869954e-09
screened O 0 1.4145412841060079e-08
for O 0 4.93830825121222e-08
germline O 0 0.00012711768795270473
PTEN O 0 0.0003251437155995518
mutations O 0 4.913316615784424e-07
. O 0 8.845122465572786e-07

PTEN O 0 0.0004993155598640442
mutations O 0 7.379138367014093e-08
were O 0 2.021372180749381e-09
identified O 0 5.257156932003682e-10
in O 0 1.0424116431151376e-10
30 O 0 1.191595000449297e-08
of O 0 2.719441338783213e-09
37 O 0 2.8998826451243076e-08
( O 0 5.453206775030139e-10
81 O 0 8.805213980167537e-08
% O 0 3.861006792060806e-10
) O 0 3.5580031976234494e-11
CD B-Disease 0 1.1638666563840161e-07
families O 0 2.1916846115743738e-10
, O 0 2.951697566921929e-11
including O 0 2.635634419045907e-11
missense O 0 8.43700291852656e-08
and O 0 5.359845900443361e-09
nonsense O 0 1.499668428550649e-06
point O 0 6.630911002503126e-07
mutations O 0 7.994239936692793e-09
, O 0 1.175808561626468e-09
deletions O 0 2.9532110090713104e-08
, O 0 1.7315552325314343e-09
insertions O 0 3.652207070103941e-08
, O 0 9.571989867396269e-10
a O 0 3.5621694483012334e-09
deletion O 0 1.9730408951090794e-07
/ O 0 4.051176802022383e-06
insertion O 0 2.868343642603577e-07
and O 0 1.7104627048070142e-08
splice O 0 1.957409722308512e-06
site O 0 8.787109209151822e-07
mutations O 0 1.6740807851078898e-08
. O 0 1.3993825120905967e-07

These O 0 3.3674790955728895e-08
mutations O 0 9.560459091062512e-10
were O 0 5.189115248604992e-10
scattered O 0 5.224736268627517e-11
over O 0 1.597864549007788e-11
the O 0 4.372023854060103e-10
entire O 0 3.698464645651711e-09
length O 0 3.6488978505389014e-09
of O 0 3.616485111379575e-09
PTEN O 0 4.0611695339975995e-07
, O 0 1.952014799799784e-10
with O 0 2.6543548175411713e-12
the O 0 1.5683473963967742e-10
exception O 0 3.0848457122090167e-10
of O 0 3.186071892424813e-11
the O 0 2.769353496523408e-11
first O 0 1.6885322307036432e-10
, O 0 2.5922451685200798e-11
fourth O 0 1.607145749815686e-09
and O 0 2.7553925807666246e-10
last O 0 1.519452297316093e-08
exons O 0 4.5544661020358035e-07
. O 0 4.1749711954253144e-07

A O 0 1.356422399112489e-05
hot O 0 2.4798326194286346e-05
spot O 0 1.173583996205707e-06
for O 0 6.842910682536285e-09
PTEN O 0 1.4852000276732724e-05
mutation O 0 8.962435238402122e-09
in O 0 1.7313142031127882e-09
CD B-Disease 0 5.534817773877876e-06
was O 0 9.169168890821311e-08
identified O 0 4.227663996658748e-09
in O 0 4.867698466526349e-10
exon O 0 7.835176951687117e-09
5 O 0 2.7952657077889853e-08
that O 0 3.7264466512532124e-10
contains O 0 4.93651342026169e-10
the O 0 6.545882724751095e-10
PTPase O 0 2.883428464883764e-07
core O 0 5.8044381745503415e-08
motif O 0 2.4671835685552423e-09
, O 0 1.4508485558784034e-11
with O 0 3.732408804767162e-13
13 O 0 1.0577297926417373e-09
of O 0 3.784097479808679e-10
30 O 0 9.18425246965171e-09
( O 0 9.825442542910068e-11
43 O 0 1.3436461721028081e-08
% O 0 3.1366062525073346e-10
) O 0 1.5501346040114328e-10
CD B-Disease 0 9.047885782820231e-07
mutations O 0 3.5749518900729527e-09
identified O 0 3.2271749716983322e-09
in O 0 1.1940628485973548e-09
this O 0 4.316411672533604e-09
exon O 0 2.3752727429382503e-07
. O 0 3.376348729489109e-07

Seven O 0 1.2878763300250284e-07
of O 0 3.7130747365665684e-09
30 O 0 2.6925835783231378e-08
( O 0 9.606150597196716e-11
23 O 0 2.43306139680044e-08
% O 0 2.5177010476440387e-10
) O 0 3.805977061288601e-11
were O 0 3.387536362531307e-10
within O 0 1.5853218737760244e-10
the O 0 2.9562852166264975e-10
core O 0 1.6492515131361074e-09
motif O 0 2.876719973343711e-10
, O 0 1.2730906606694958e-11
the O 0 4.324425539881105e-11
majority O 0 9.175396553651183e-12
( O 0 1.002232324909258e-11
five O 0 1.0621323959236761e-10
of O 0 5.1774466658383034e-11
seven O 0 2.6992125548574997e-11
) O 0 2.4614234261921553e-11
of O 0 2.636787177490163e-10
which O 0 8.478174412518413e-11
were O 0 4.219527838245085e-09
missense O 0 1.191301137737355e-07
mutations O 0 2.9485494046355143e-09
, O 0 2.556734546299566e-10
possibly O 0 8.525891992405832e-09
pointing O 0 2.3295168460890636e-08
to O 0 1.0763889335407839e-08
the O 0 9.797156863555756e-09
functional O 0 1.0375256209727013e-07
significance O 0 4.284637356022358e-08
of O 0 1.4662284719690888e-09
this O 0 2.993884307134209e-10
region O 0 4.037714163018791e-09
. O 0 5.1272959211701163e-08

Germline O 0 0.005371836945414543
PTEN O 0 0.00011025145067833364
mutations O 0 2.364320117465013e-08
were O 0 1.4431719153051858e-09
identified O 0 6.955308551326311e-10
in O 0 1.70223654616386e-10
four O 0 2.375097618578792e-10
of O 0 3.796568059932781e-10
seven O 0 6.425031062740061e-10
( O 0 1.5590061186454562e-10
57 O 0 8.73450929361752e-08
% O 0 5.07948083594556e-09
) O 0 3.330709263948961e-09
BZS B-Disease 0 6.267612479859963e-05
families O 0 9.284735646986064e-09
studied O 0 4.0140585610970447e-07
. O 0 5.958349333923252e-07

Interestingly O 0 8.159917115335702e-07
, O 0 5.877775599572033e-09
none O 0 2.576023305778108e-08
of O 0 1.88904114573063e-09
these O 0 2.0587480331624164e-10
mutations O 0 3.3647151731486247e-10
was O 0 8.42578984361353e-09
observed O 0 4.522887842028922e-09
in O 0 4.283720045350492e-09
the O 0 4.7535831271261486e-08
PTPase O 0 7.81338349042926e-06
core O 0 1.7420095446141204e-06
motif O 0 6.705300847897888e-07
. O 0 2.2632201535088825e-07

It O 0 3.2851701803338074e-08
is O 0 9.839470210826207e-11
also O 0 7.376928061464394e-12
worthy O 0 4.927313557168134e-10
of O 0 5.169022987416838e-10
note O 0 8.232333925661806e-09
that O 0 4.513903140157538e-11
a O 0 2.366663809372227e-10
single O 0 5.941687142296814e-09
nonsense O 0 1.607391055813423e-07
point O 0 7.261937184921408e-08
mutation O 0 4.715470236504871e-10
, O 0 1.1170696312401418e-10
R233X O 0 7.254848100046729e-08
, O 0 2.1665391702896386e-10
was O 0 1.3272877241732317e-09
observed O 0 2.398474197029543e-10
in O 0 1.550785194703863e-10
the O 0 1.4532041126003037e-09
germline O 0 1.884488654013694e-07
DNA O 0 6.130366436707391e-09
from O 0 8.467771483999798e-10
two O 0 1.4040700546669171e-10
unrelated O 0 5.477871489745212e-10
CD B-Disease 0 5.212461360315501e-07
families O 0 1.786438080797481e-10
and O 0 1.720555087292297e-10
one O 0 2.1510990766415716e-09
BZS B-Disease 0 0.00034704277641139925
family O 0 4.1297568031950505e-07
. O 0 1.3245137324702227e-06

Genotype O 0 5.066931407782249e-06
- O 0 2.997195224452298e-06
phenotype O 0 1.8839724447161643e-08
studies O 0 4.0082031027566245e-09
were O 0 8.918022570414408e-11
not O 0 1.7504648772148634e-11
performed O 0 5.054948681859628e-10
on O 0 2.6511814965601843e-09
this O 0 1.56527804606732e-10
small O 0 3.232298873001582e-10
group O 0 1.5875185888081234e-10
of O 0 1.2147812755713971e-09
BZS B-Disease 0 4.091911614523269e-05
families O 0 5.212769949025642e-08
. O 0 4.7181018203446e-07

However O 0 1.0374385084332971e-07
, O 0 2.3325834597187622e-09
genotype O 0 4.9740595642333574e-08
- O 0 1.2785403669113293e-07
phenotype O 0 2.5173147122359296e-08
analysis O 0 3.955420879719895e-09
inthe O 0 2.1868018507120723e-07
group O 0 7.765988963015502e-10
of O 0 5.917435985658415e-10
CD B-Disease 0 1.5190694284683559e-05
families O 0 2.4387796226932323e-09
revealed O 0 2.614414640333962e-08
two O 0 2.1378823711337702e-10
possible O 0 7.107047728105442e-10
associations O 0 7.811666591361899e-11
worthy O 0 2.1186233212233674e-08
of O 0 2.3188377440419572e-08
follow O 0 3.2339301014872035e-08
- O 0 2.562756939994415e-08
up O 0 2.16649054252116e-09
in O 0 9.243930620961294e-10
independent O 0 2.423985900890102e-09
analyses O 0 1.216142067050896e-07
. O 0 1.9692510022650822e-07

The O 0 1.855872397982239e-07
first O 0 4.244342477477403e-08
was O 0 1.9562769182357442e-08
an O 0 6.166009369756864e-11
association O 0 2.7926395571031826e-11
noted O 0 2.268479015743452e-10
in O 0 3.346940502524376e-10
the O 0 3.89578413972913e-09
group O 0 1.0489055457529872e-10
of O 0 2.15049103524656e-10
CD B-Disease 0 1.5425261153723113e-05
families O 0 1.043337682915535e-08
with O 0 6.950472197786439e-09
breast B-Disease 0 0.052031002938747406
disease I-Disease 0 1.8866025129682384e-05
. O 0 8.225601050071418e-06

A O 0 7.649941835552454e-07
correlation O 0 1.7521909256856816e-08
was O 0 2.7734212704189076e-09
observed O 0 1.4887267807406346e-10
between O 0 1.692619135129636e-12
the O 0 8.559154773823963e-11
presence O 0 1.0013199158720454e-09
/ O 0 3.357577952556312e-05
absence O 0 9.53498329181457e-06
of O 0 6.717769451825006e-08
a O 0 1.382680370198841e-08
PTEN O 0 2.868318688342697e-06
mutation O 0 1.753172940155423e-09
and O 0 1.720299319662999e-10
the O 0 9.73958136363251e-10
type O 0 3.153760275154127e-08
of O 0 2.632920192979782e-08
breast O 0 1.2223376870679203e-06
involvement O 0 3.4734475207187643e-07
( O 0 1.3759900774346079e-08
unaffected O 0 0.0007888530963100493
versus O 1 0.999988317489624
benign O 1 0.9999939203262329
versus O 0 5.0389244279358536e-05
malignant O 0 1.2764596704073483e-06
) O 0 5.368204547551159e-09
. O 0 6.759321991012257e-08

Specifically O 0 5.999174277349084e-07
and O 0 4.431193745269013e-10
more O 0 7.110525276216029e-12
directly O 0 6.397831570081891e-11
, O 0 2.1699001970243437e-11
an O 0 2.7079271117114168e-11
association O 0 2.992902037313172e-10
was O 0 1.0862081012419367e-08
also O 0 7.961716841364819e-10
observed O 0 7.795636358665092e-11
between O 0 2.6720830409443508e-12
the O 0 1.181851699838532e-10
presence O 0 4.196954728197255e-10
of O 0 8.025478059892066e-10
a O 0 8.187985400809339e-09
PTEN O 0 0.17132292687892914
mutation O 0 1.2829161278204992e-05
and O 0 6.891861517033249e-07
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 0 0.0001967239659279585
. O 0 2.440577873130678e-07

Secondly O 0 2.43125014094403e-05
, O 0 4.2954383161486476e-08
there O 0 1.1001922706199707e-09
appeared O 0 7.409089786136747e-09
to O 0 3.022528005658387e-09
be O 0 6.450132428170718e-09
an O 0 7.125099399374335e-10
interdependent O 0 2.6992611878995376e-07
association O 0 1.8294564085863385e-08
between O 0 1.7548257291721825e-09
mutations O 0 1.595177323565622e-09
upstream O 0 5.863529661809253e-10
and O 0 2.649057084802564e-10
within O 0 1.6339031239098745e-09
the O 0 5.917958123546896e-09
PTPase O 0 3.3904299812093086e-07
core O 0 5.071815678547864e-08
motif O 0 1.7067215196675534e-08
, O 0 3.557719951974292e-10
the O 0 6.980719891025444e-10
core O 0 7.860998962883059e-09
motif O 0 2.913274954607914e-09
containing O 0 2.6191834812117065e-10
the O 0 6.883969783100241e-11
majority O 0 5.514097164982523e-11
of O 0 7.711820515510226e-09
missense O 0 3.9560345044264977e-07
mutations O 0 8.181304522736355e-09
, O 0 1.350629275087556e-09
and O 0 1.4030988593205507e-09
the O 0 1.70017855793958e-07
involvement O 0 5.146272451383993e-05
of O 0 3.559978267730912e-06
all O 0 1.194491794365149e-08
major O 0 7.604405105610113e-09
organ O 0 1.0673286965356965e-07
systems O 0 6.054165737623407e-07
( O 0 1.2184040443230515e-08
central O 1 1.0
nervous O 1 0.9999310970306396
system O 1 0.9999531507492065
, O 0 5.255618162891551e-08
thyroid O 0 9.319421224063262e-06
, O 0 1.211699895975471e-07
breast O 0 0.22908492386341095
, O 0 1.5942845266181394e-06
skin O 1 0.9973898530006409
and O 0 2.6399361559015233e-06
gastrointestinal O 0 3.23611093335785e-05
tract O 0 4.2286018242521095e-07
) O 0 1.710288799472437e-09
. O 0 4.9370456167707744e-08

However O 0 4.636342225694534e-07
, O 0 1.7895970261250227e-09
these O 0 1.1202658939390986e-10
observations O 0 6.754676817877225e-10
would O 0 8.88769405293921e-11
need O 0 8.74787242644004e-10
to O 0 1.1779949238288623e-09
be O 0 2.8598059476081517e-09
confirmed O 0 1.6207830633163667e-09
by O 0 5.5124568104636396e-11
studying O 0 7.203635021824084e-09
a O 0 8.154317776565279e-10
larger O 0 3.7343586556382036e-10
number O 0 7.509302069053092e-10
of O 0 1.1131178617729276e-10
CD B-Disease 0 8.718495223547507e-07
families O 0 2.7632569565838594e-09
. O 0 9.364684672164003e-08

Molecular O 0 2.2814156181993894e-05
defects O 0 0.0003075307176914066
leading O 0 6.052040646409296e-08
to O 0 2.5745139353716695e-09
human O 0 7.735520002327689e-10
complement B-Disease 0 2.8261797524464782e-06
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.3305479384939645e-08
an O 0 3.168704465483785e-10
African O 0 7.958153247500377e-09
- O 0 4.856257174168377e-09
American O 0 1.3879332350086315e-08
family O 0 6.063350266316547e-09
. O 0 2.154216716121482e-08

Complement B-Disease 0 2.2526439806824783e-06
component I-Disease 1 0.9999654293060303
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 6.244811612265977e-11
C6D B-Disease 0 8.470751566846957e-08
) O 0 1.747095870752169e-11
was O 0 7.328888051993943e-10
diagnosed O 0 1.146859673895051e-08
in O 0 2.3673996096817973e-10
a O 0 3.148702409916382e-10
16 O 0 3.1988484083811386e-10
- O 0 1.5632821426248e-10
year O 0 3.8104389088466917e-10
- O 0 1.0865639499257895e-09
old O 0 7.361197873478886e-09
African O 0 1.3078376603914421e-08
- O 0 1.0422611662619374e-09
American O 0 2.3889185074565944e-10
male O 0 3.621004329712463e-10
with O 0 2.946820218396873e-11
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 7.205932206488797e-08

The O 0 3.0559540675767494e-08
patients O 0 5.226944210789952e-09
father O 0 6.0995399842056486e-09
and O 0 1.3262956288784267e-09
two O 0 6.204164404444157e-10
brothers O 0 1.5037672085327358e-07
also O 0 1.4445227236592473e-07
had O 0 1.5570010702958825e-07
C6D B-Disease 0 0.000804250652436167
, O 0 1.3397967180139858e-09
but O 0 8.006427187901011e-10
gave O 0 6.82560008513633e-09
no O 0 4.776155915209301e-09
history O 0 9.698876368702258e-09
of O 0 5.6701487949339935e-09
meningitis B-Disease 1 0.9999549388885498
or O 0 9.504931286485885e-10
other O 0 1.797276438786355e-09
neisserial B-Disease 0 1.0181672223552596e-05
infection I-Disease 0 2.021302378807377e-07
. O 0 6.805660746067588e-08

By O 0 1.9826156272273465e-09
using O 0 1.062315235778044e-09
exon O 0 3.889094823961159e-09
- O 0 2.103193619262811e-09
specific O 0 6.303284005859666e-10
polymerase O 0 1.6251354706398047e-09
chain O 0 2.535170295914213e-09
reaction O 0 2.948727650942118e-10
( O 0 1.2585539381493316e-11
PCR O 0 4.8143871111960834e-09
) O 0 3.29359768624915e-11
/ O 0 1.944442606927055e-09
single O 0 8.41383740457502e-10
- O 0 1.284513606591986e-10
strand O 0 1.3119537400907433e-10
conformation O 0 9.419183488734717e-11
polymorphism O 0 2.3726706710469614e-10
as O 0 1.0107597051001171e-11
a O 0 5.5569602738780866e-12
screening O 0 1.9748839716338118e-11
step O 0 2.754583228181673e-10
and O 0 6.776012476811255e-12
nucleotide O 0 2.0813559209464927e-10
sequencing O 0 7.014033243102347e-10
of O 0 7.622756315051049e-10
target O 0 7.075712016302305e-09
exons O 0 6.612746794587565e-09
, O 0 2.4669519205211543e-10
we O 0 6.715829004022567e-10
determined O 0 5.786359169590582e-10
that O 0 4.354296090358645e-11
the O 0 3.4801275750062644e-10
proband O 0 2.78871624459498e-07
was O 0 1.739397781364005e-08
a O 0 5.115529666532836e-10
compound O 0 7.2217662960838425e-09
heterozygote O 0 3.263082248849969e-08
for O 0 4.882576010167838e-10
two O 0 8.993184530403653e-10
C6 O 0 1.2609722944034729e-05
gene O 0 1.4609885568006575e-07
mutations O 0 1.4956221150441706e-07
. O 0 9.367022357764654e-07

The O 0 3.3921955377991253e-07
first O 0 2.824183020777582e-08
, O 0 1.4255199798363094e-10
1195delC O 0 8.73977068494014e-09
located O 0 2.4199936499158525e-10
in O 0 2.3965945894488527e-10
exon O 0 8.678476604018215e-09
7 O 0 1.1811535927108707e-07
, O 0 7.222961673214456e-10
is O 0 2.3549868652383843e-11
a O 0 8.211354339537902e-12
novel O 0 3.217148075718157e-11
mutation O 0 8.512813717831413e-12
, O 0 2.421247013648098e-12
while O 0 5.044820464150668e-12
the O 0 8.730132589063189e-11
second O 0 5.243557810175048e-10
, O 0 2.6131144123531236e-11
1936delG O 0 1.1575881364578322e-09
in O 0 7.49925052612177e-11
exon O 0 3.798569458979273e-09
12 O 0 1.767173607447603e-08
, O 0 3.364470924083207e-10
has O 0 1.7065852203623777e-11
been O 0 5.845567953299824e-12
described O 0 1.1765565952059909e-11
before O 0 1.911439062585174e-10
to O 0 1.1068307381734144e-09
cause O 0 1.64221702902978e-09
C6D B-Disease 0 7.477079293494171e-07
in O 0 1.153649287211067e-09
an O 0 1.156896592413581e-10
unrelated O 0 7.682283253984679e-09
African O 0 4.631171890423502e-08
- O 0 1.5561408162056978e-08
American O 0 6.823412945777818e-09
individual O 0 7.143864944048062e-10
. O 0 1.4679836901621002e-08

Both O 0 1.8386448630280938e-07
mutations O 0 7.766496779026966e-09
result O 0 1.1560216117700861e-09
in O 0 2.0334138817190706e-09
premature O 0 9.877956586024084e-08
termination O 0 9.743379081328385e-08
codons O 0 3.874644391999027e-07
and O 0 9.848458404349003e-08
C6 O 0 0.00018920419097412378
null O 0 5.364100161386887e-06
alleles O 0 1.4299443762411101e-07
. O 0 4.4789021558244713e-07

Allele O 0 7.461566298161415e-08
- O 0 4.624232108341175e-09
specific O 0 9.449292459606795e-10
PCR O 0 4.3910993952067656e-08
indicated O 0 2.912925012310552e-09
that O 0 1.2126363281572683e-11
the O 0 2.5867835651283144e-10
probands O 0 1.657338373206585e-07
two O 0 8.208638213602626e-10
brothers O 0 2.454516767613768e-08
also O 0 2.311440150393196e-09
inherited O 0 2.5554307114816766e-08
the O 0 1.226144519250738e-07
1195delC O 0 1.40021015226921e-07
mutation O 0 1.0840814357315764e-10
from O 0 1.7228137319524883e-11
their O 0 4.1998374222806945e-10
heterozygous O 0 1.7055522549824786e-09
mother O 0 9.982192850088722e-10
and O 0 4.2613074180408717e-10
the O 0 2.3222843648085245e-09
1936delG O 0 3.4326657072369926e-08
mutation O 0 9.98851140687762e-11
from O 0 3.9985167954448286e-11
their O 0 1.0654320758973768e-09
homozygous O 0 4.3380712355656215e-08
father O 0 1.5682269349781564e-07
. O 0 6.599632484949325e-08
. O 0 2.0507633280431037e-07

PAX6 O 0 0.003606492420658469
mutations O 0 3.2603563795419177e-06
reviewed O 0 1.649819387239404e-05
. O 0 3.7453658023878234e-06

Mutations O 0 3.2718202191972523e-07
in O 0 1.8374926469277852e-08
PAX6 O 0 6.657017820543842e-06
are O 0 5.146955639467876e-10
responsible O 0 2.0877302109312268e-09
for O 0 4.20402335166159e-09
human O 0 1.5776367945363745e-07
aniridia B-Disease 1 1.0
and O 0 7.228439358186733e-08
have O 0 8.904603276960188e-09
also O 0 8.573111665022282e-10
been O 0 1.0557418134160557e-10
found O 0 1.3605384180381819e-11
in O 0 1.0655732372855109e-11
patients O 0 1.748842910764825e-11
with O 0 3.5263489177317364e-12
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 3.6723875496136316e-08
with O 0 2.0680142043261185e-08
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 1.1310680037013299e-07
with O 0 3.4287117589570926e-09
autosomal B-Disease 0 0.039043594151735306
dominant I-Disease 0 0.014948638156056404
keratitis I-Disease 1 1.0
, O 0 3.4651868041635225e-09
and O 0 1.1644041286729134e-09
with O 0 6.4053464754465494e-09
isolated B-Disease 1 0.99998939037323
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9999947547912598

No O 0 2.882877879528678e-06
locus O 0 1.3945771115686512e-07
other O 0 3.9512113025885753e-10
than O 0 5.108039338730386e-11
chromosome O 0 9.49891809653991e-09
11p13 O 0 1.1676382882797043e-06
has O 0 8.184172228808961e-10
been O 0 6.651223460885092e-10
implicated O 0 3.0919280469277055e-09
in O 0 1.4894468769455216e-08
aniridia B-Disease 1 1.0
, O 0 4.587615176632198e-09
and O 0 3.53138712716472e-10
PAX6 O 0 4.702775186160579e-05
is O 0 1.519358749924038e-09
clearly O 0 3.1897597896346497e-09
the O 0 1.167152485770373e-09
major O 0 5.8584350703938526e-09
, O 0 1.6153565984833307e-10
if O 0 2.328652548566623e-10
not O 0 8.072424950711365e-10
only O 0 5.548895232188045e-10
, O 0 2.184989689180128e-10
gene O 0 1.0666113547941336e-09
responsible O 0 7.260011614107498e-08
. O 0 2.0215677523083286e-06

Twenty O 0 5.8284790327434166e-08
- O 0 1.3814204002926544e-08
eight O 0 2.0020602953252364e-09
percent O 0 2.074025395870649e-09
of O 0 1.8536021328952046e-10
identified O 0 6.751536663074376e-09
PAX6 O 0 4.2969688365701586e-05
mutations O 0 3.934339787292629e-08
are O 0 7.43377304157633e-10
C O 0 3.235576514271088e-06
- O 0 1.4270088968260097e-06
T O 0 2.2581975827051792e-06
changes O 0 3.776897727902906e-08
at O 0 4.047261370487831e-08
CpG O 0 2.0083381002677925e-07
dinucleotides O 0 2.7252224299445515e-07
, O 0 3.414626081887917e-10
20 O 0 2.0492367802660283e-09
% O 0 1.108689459683454e-10
are O 0 1.0087701507455193e-11
splicing O 0 4.170654932522666e-09
errors O 0 1.0435032749001039e-07
, O 0 9.990384075564407e-10
and O 0 9.559743274767385e-11
more O 0 7.593900334945669e-12
than O 0 4.440276271666654e-12
30 O 0 6.980347411200682e-10
% O 0 9.397702754876391e-11
are O 0 3.551108365695832e-11
deletion O 0 2.6235198458124387e-09
or O 0 1.0132121808226202e-09
insertion O 0 4.993886637549849e-09
events O 0 4.402857456398124e-08
. O 0 1.2190288600777421e-07

There O 0 1.1771064833965283e-07
is O 0 6.879130043380144e-10
a O 0 5.239558231728836e-10
noticeably O 0 4.292653699167204e-08
elevated O 0 7.298456239368534e-08
level O 0 1.4675855197765486e-07
of O 0 2.671521448505132e-09
mutation O 0 2.4398763565081083e-10
in O 0 5.450149775931834e-10
the O 0 3.656129177187495e-09
paired O 0 1.9801402739716423e-09
domain O 0 2.531290288487753e-09
compared O 0 5.5825979256018954e-11
with O 0 9.457735159271174e-13
the O 0 1.6343604247737176e-10
rest O 0 1.1183663994884796e-09
of O 0 5.357717047793642e-10
the O 0 6.923384643364727e-10
gene O 0 3.759882627463185e-09
. O 0 3.62472604820141e-07

Increased O 0 1.5950662657360226e-07
mutation O 0 1.393385962167315e-09
in O 0 5.271836855946788e-10
the O 0 2.6220539073307236e-09
homeodomain O 0 3.3406742261377076e-08
is O 0 4.807903380976697e-11
accounted O 0 7.735796725416577e-11
for O 0 2.7692795973033313e-11
by O 0 1.4326990982471699e-11
the O 0 2.5671833547846745e-09
hypermutable O 0 6.105176453274908e-07
CpG O 0 6.75700107422017e-07
dinucleotide O 0 1.8008756796916714e-06
in O 0 5.2081979617923935e-08
codon O 0 8.192798759409925e-07
240 O 0 2.3557591077860707e-07
. O 0 9.310506499105031e-08

Very O 0 3.5000559250875085e-07
nearly O 0 1.6243799194626263e-08
all O 0 2.576551472177613e-10
mutations O 0 6.453989426224993e-11
appear O 0 3.8804381929935516e-10
to O 0 7.760628806252612e-10
cause O 0 2.405948551498227e-09
loss O 0 4.733368363929458e-09
of O 0 6.734071966718602e-09
function O 0 6.528479978840096e-09
of O 0 2.977280422200579e-09
the O 0 2.42498487956766e-09
mutant O 0 3.7363573568427455e-08
allele O 0 3.4924645397893528e-09
, O 0 5.0074350915751964e-11
and O 0 1.3345057697788931e-11
more O 0 2.2376564576959135e-12
than O 0 3.372222206338149e-12
80 O 0 1.2412565419950283e-10
% O 0 5.99189239891551e-11
of O 0 4.164357747526992e-10
exonic O 0 1.572909127389721e-07
substitutions O 0 1.1612862671483981e-08
result O 0 2.214350702800516e-09
in O 0 1.112147085535753e-08
nonsense O 0 2.788660538044496e-07
codons O 0 6.941689889572444e-07
. O 0 3.654395754892903e-07

In O 0 1.5143132259254344e-07
a O 0 1.4472135489995708e-08
gene O 0 1.16393328308817e-09
with O 0 2.9744279955723485e-11
such O 0 1.1021245027720283e-09
extraordinarily O 0 8.395714701237011e-08
high O 0 2.8204580004853597e-08
sequence O 0 7.020296566295769e-10
conservation O 0 3.6581802032031874e-09
throughout O 0 1.9668329465094558e-10
evolution O 0 1.1270453459388818e-09
, O 0 4.219893531831609e-11
there O 0 2.658384276599257e-11
are O 0 4.459153879476929e-11
presumed O 0 8.498876695739455e-07
undiscovered O 0 0.00014718552120029926
missense O 0 7.14384950697422e-05
mutations O 0 1.6517005860805511e-06
, O 0 9.166682524153202e-09
these O 0 8.980843846373432e-10
are O 0 2.4817602833904218e-11
hypothesized O 0 8.341962676183812e-10
to O 0 6.64370503056233e-10
exist O 0 2.8379620875540468e-09
in O 0 6.48380238388313e-10
as O 0 3.0447699916891224e-09
- O 0 2.5308187545647343e-08
yet O 0 4.994896496413048e-09
unidentified O 0 3.3743329908020314e-08
phenotypes O 0 2.451564284911001e-08
. O 0 3.633881862086241e-09
. O 0 1.94415790133462e-08

Genetic O 0 3.550030669430271e-07
heterogeneity O 0 6.951628250817521e-08
and O 0 1.1004271938119814e-09
penetrance O 0 1.2539916838250065e-07
analysis O 0 6.647092654077369e-09
of O 0 1.1052848414294658e-08
the O 0 3.642613677357076e-08
BRCA1 O 0 5.918322187881131e-08
and O 0 9.521847310622888e-09
BRCA2 O 0 5.912771072758005e-08
genes O 0 3.501716250298159e-09
in O 0 2.2568720225990546e-08
breast B-Disease 0 1.5727366644568974e-06
cancer I-Disease 0 2.704195196656656e-07
families O 0 6.957766807147436e-09
. O 0 6.773240102120326e-07

The O 0 0.0024845683947205544
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 1.5589058648401988e-06
Consortium O 0 1.0907817760141825e-08
. O 0 3.8346193775851134e-08

The O 0 1.3611400895285897e-08
contribution O 0 2.629427342526469e-08
of O 0 9.899265407398161e-09
BRCA1 O 0 1.0172306552647115e-08
and O 0 2.550530453504507e-09
BRCA2 O 0 9.37808545131702e-06
to O 0 0.00036763513344340026
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9607784748077393
assessed O 0 1.8661677358977613e-07
by O 0 1.5733395697381525e-09
linkage O 0 2.5460266783738916e-07
and O 0 2.1584187770429253e-09
mutation O 0 6.185658235624558e-11
analysis O 0 6.234276116179327e-12
in O 0 2.213857569488553e-12
237 O 0 6.7053012448026195e-12
families O 0 1.7866509053471313e-12
, O 0 1.972865013716296e-12
each O 0 4.526693147925698e-13
with O 0 2.5801374383370435e-13
at O 0 5.128709124058162e-10
least O 0 6.183003414816923e-11
four O 0 2.3410228616738138e-11
cases O 0 5.11755707255368e-11
of O 0 4.227712402382622e-09
breast B-Disease 0 3.84390159524628e-06
cancer I-Disease 0 2.5417378424208437e-07
, O 0 2.1476309619572476e-09
collected O 0 2.603917748089657e-09
by O 0 3.0335882694743077e-09
the O 0 0.00010848957754205912
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 1.9623932701051672e-07
Consortium O 0 7.889478403910744e-09
. O 0 1.038925674379243e-07

Families O 0 5.3806799016342666e-09
were O 0 7.466940399325495e-10
included O 0 1.334867910651738e-10
without O 0 1.017276193837624e-10
regard O 0 7.733912399388032e-10
to O 0 7.274600921647334e-10
the O 0 1.7564497634126042e-09
occurrence O 0 5.5307259572146e-07
of O 0 8.814386660560558e-07
ovarian B-Disease 1 0.9999833106994629
or I-Disease 0 5.607143975794315e-05
other I-Disease 0 2.326046114831115e-06
cancers I-Disease 0 6.321997352642938e-05
. O 0 1.3957081819171435e-06

Overall O 0 1.2101818356313743e-05
, O 0 1.271614635811602e-08
disease O 0 9.412619128568167e-09
was O 0 2.8275020103052384e-09
linked O 0 7.30076443744565e-09
to O 0 1.3459547254512927e-08
BRCA1 O 0 2.591693970543929e-09
in O 0 1.8404933133098211e-10
an O 0 4.5875386822658015e-12
estimated O 0 1.9611595333812737e-12
52 O 0 5.165156843900398e-11
% O 0 1.0237788915234969e-11
of O 0 1.21658863538876e-11
families O 0 4.640181034548663e-12
, O 0 9.494991598524294e-12
to O 0 6.014888032090937e-10
BRCA2 O 0 3.821357896782729e-09
in O 0 2.2207449767996934e-10
32 O 0 2.901386242371018e-09
% O 0 9.741135675866985e-11
of O 0 3.7705075173199987e-11
families O 0 2.0674185020191915e-12
, O 0 3.043581012218688e-12
and O 0 4.462622979484188e-12
to O 0 3.276506566063375e-10
neither O 0 1.5419906462810218e-09
gene O 0 8.394229755737115e-11
in O 0 8.019082065047201e-10
16 O 0 6.680850983542541e-09
% O 0 7.779832333909553e-11
( O 0 6.414481792949012e-12
95 O 0 8.111632254781398e-09
% O 0 3.378038959667151e-10
confidence O 0 2.523877107307726e-08
interval O 0 2.85677481670632e-09
[ O 0 7.061478157766032e-08
CI O 0 3.989046035712818e-06
] O 0 7.134230628480509e-08
6 O 0 1.0386280280272331e-08
% O 0 2.557329348285009e-10
- O 0 2.3532558124372827e-09
28 O 0 4.398498898439129e-09
% O 0 3.7071495873064464e-10
) O 0 9.486487984045056e-11
, O 0 7.737935986407152e-11
suggesting O 0 1.2061787124650891e-09
other O 0 2.337196269852626e-10
predisposition O 0 6.659747242565572e-08
genes O 0 3.692207783956292e-08
. O 0 5.344383566807664e-07

The O 0 1.507461604433047e-07
majority O 0 5.725909746345792e-10
( O 0 5.032886260525338e-11
81 O 0 4.189534941190232e-09
% O 0 2.141117491638589e-11
) O 0 2.62837885137146e-12
of O 0 1.2124104498134614e-10
the O 0 1.064892600766143e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.7714964484791835e-09
were O 0 2.9869484663436197e-10
due O 0 9.245887944153708e-10
to O 0 1.204792887676831e-08
BRCA1 O 0 4.667848330086599e-09
, O 0 1.888856571152786e-10
with O 0 4.812139835913554e-12
most O 0 5.557811155743053e-11
others O 0 4.60129920276664e-11
( O 0 7.418453872032327e-12
14 O 0 1.088297896245649e-09
% O 0 7.419349162818278e-11
) O 0 4.856011773246571e-11
due O 0 7.344620467364393e-09
to O 0 3.4170213325523946e-07
BRCA2 O 0 4.716073817689903e-06
. O 0 1.0853485719053424e-06

Conversely O 0 5.323293521541927e-07
, O 0 6.227496296418167e-10
the O 0 2.721754210899263e-10
majority O 0 1.0650937597167509e-11
of O 0 1.35151514979448e-10
families O 0 1.0155948131085335e-11
with O 0 1.6294595880927965e-12
male B-Disease 0 9.225436525817088e-10
and I-Disease 0 9.745303453101428e-10
female I-Disease 0 2.0388911536883825e-07
breast I-Disease 0 1.37786332743417e-06
cancer I-Disease 0 5.338861228665337e-07
were O 0 4.7376795464515453e-07
due O 0 0.00018819625256583095
to O 1 0.8159298300743103
BRCA2 O 0 1.4272185353547684e-06
( O 0 1.3403385068500029e-09
76 O 0 3.268879140705394e-07
% O 0 1.8353760733447189e-09
) O 0 1.0771196157222107e-09
. O 0 2.566127221825809e-08

The O 0 2.1052341026006616e-07
largest O 0 7.083053588097243e-10
proportion O 0 1.0069425848691083e-10
( O 0 1.634481265611054e-11
67 O 0 5.858748153286797e-09
% O 0 6.657375345442418e-11
) O 0 1.4288620633906568e-11
of O 0 9.657811356200696e-11
families O 0 1.786109975199235e-11
due O 0 2.1839825503633392e-09
to O 0 6.118871631599632e-09
other O 0 2.3963386830416766e-10
genes O 0 1.1857080595145675e-10
was O 0 1.2089426126848934e-09
found O 0 2.8645743763155984e-11
in O 0 1.3687059298439497e-11
families O 0 8.405776942554954e-12
with O 0 1.3630182052470907e-12
four O 0 2.22635885421818e-11
or O 0 1.8901854040298538e-11
five O 0 3.232765791172376e-11
cases O 0 2.3411658028882343e-11
of O 0 5.74529479546726e-10
female O 0 1.1342481798237714e-07
breast B-Disease 0 1.7789203411666676e-05
cancer I-Disease 0 3.2493182970938506e-06
only O 0 5.782188736702665e-07
. O 0 8.75379737408366e-06

These O 0 1.461097998145533e-08
estimates O 0 2.899538387168832e-09
were O 0 2.815402910805176e-10
not O 0 1.3271730936459392e-10
substantially O 0 1.8997075024174137e-09
affected O 0 8.863081102372661e-11
either O 0 4.096806921483065e-11
by O 0 1.8414615318707028e-11
changing O 0 1.1023920443165025e-08
the O 0 4.14712708618481e-09
assumed O 0 1.0381075554732888e-07
penetrance O 0 4.276072829156874e-08
model O 0 1.0265844174739414e-08
for O 0 2.127750198255285e-09
BRCA1 O 0 2.220597705715477e-09
or O 0 1.372177926839413e-10
by O 0 1.1328871001026197e-11
including O 0 5.965414273667591e-11
or O 0 5.459149243769446e-10
excluding O 0 5.268063318908389e-07
BRCA1 O 0 6.750554462087166e-07
mutation O 0 2.0760369423555858e-08
data O 0 3.500582579363254e-08
. O 0 8.466147960461967e-08

Among O 0 9.924197019728354e-10
those O 0 4.430592004389666e-11
families O 0 5.708489236866399e-12
with O 0 1.4385252971454987e-12
disease O 0 1.4989327834502575e-10
due O 0 4.1351707835701745e-08
to O 0 2.276905206599622e-06
BRCA1 O 0 8.684109786827321e-08
that O 0 4.090010552459944e-09
were O 0 2.1309911613087706e-09
tested O 0 6.423707676894708e-10
by O 0 1.3066289369922934e-11
one O 0 1.7837788190977477e-10
of O 0 1.2534709381561981e-10
the O 0 1.0215712997752036e-10
standard O 0 3.8677433478184753e-10
screening O 0 6.500503607620445e-11
methods O 0 1.3803931331324293e-08
, O 0 4.741408377029188e-10
mutations O 0 1.769735330503508e-10
were O 0 2.438034218954499e-10
detected O 0 1.0157120700071687e-09
in O 0 6.794552143141175e-10
the O 0 6.780754624458041e-09
coding O 0 8.931091599606589e-08
sequence O 0 1.8972234894221174e-09
or O 0 9.703571279828793e-10
splice O 0 5.990755891360777e-09
sites O 0 1.0477663181518437e-09
in O 0 3.680235283187727e-11
an O 0 2.3194345749599776e-12
estimated O 0 9.45912792538195e-12
63 O 0 9.20422238426255e-10
% O 0 1.0990507115504755e-10
( O 0 3.2695065405041746e-11
95 O 0 5.5708948565325045e-08
% O 0 7.904883414511232e-10
CI O 0 1.0582508593870443e-06
51 O 0 3.0312875765048375e-08
% O 0 7.771234211695344e-10
- O 0 1.1975646252437855e-08
77 O 0 1.2611944377738382e-08
% O 0 2.9875521501132596e-10
) O 0 4.269418429903027e-10
. O 0 1.1010093281527134e-08

The O 0 3.094607947673467e-08
estimated O 0 1.829706830491773e-09
sensitivity O 0 1.855800846328748e-08
was O 0 1.5160651400947245e-08
identical O 0 5.764328459001433e-10
for O 0 1.800019994169233e-10
direct O 0 7.985411776267881e-10
sequencing O 0 2.330457826715815e-09
and O 0 1.7298420473821352e-09
other O 0 1.4023845418265068e-09
techniques O 0 3.862679477606434e-06
. O 0 6.611538196921174e-07

The O 0 1.1285968639640487e-06
penetrance O 0 3.2363237551180646e-05
of O 0 1.215310021507321e-06
BRCA2 O 0 4.3334819110896206e-07
was O 0 4.309896439735894e-09
estimated O 0 5.148020898460004e-12
by O 0 2.928701660527555e-13
maximizing O 0 1.052987252947446e-09
the O 0 1.8147927605127734e-09
LOD O 0 1.0264971933793277e-05
score O 0 2.302092525496846e-07
in O 0 1.957340600711177e-08
BRCA2 O 0 5.780485139439406e-07
- O 0 1.2024653983644384e-07
mutation O 0 1.5789665408494358e-10
families O 0 1.815774267055481e-11
, O 0 1.0885937117011135e-11
over O 0 3.148435071681499e-12
all O 0 8.678732038580605e-11
possible O 0 2.954550604172823e-09
penetrance O 0 2.2666135635063256e-07
functions O 0 1.333993395746802e-06
. O 0 3.1309098176279804e-06

The O 0 3.651496527368181e-08
estimated O 0 4.05790900881442e-10
cumulative O 0 6.022456311427504e-09
risk O 0 3.6613997167478374e-08
of O 0 5.943231684568673e-08
breast B-Disease 0 6.481981472461484e-06
cancer I-Disease 0 1.7782477357286552e-07
reached O 0 2.052156418130835e-07
28 O 0 1.2036655050451373e-07
% O 0 3.3900249274410044e-10
( O 0 2.5293092273392936e-11
95 O 0 1.8489254571818492e-08
% O 0 1.5308657119739166e-10
CI O 0 6.191733348259731e-08
9 O 0 5.9570286481402945e-09
% O 0 1.0095040081647966e-10
- O 0 8.051512234708014e-10
44 O 0 2.0392269817204323e-10
% O 0 8.028899593781613e-12
) O 0 5.920180795246366e-13
by O 0 2.067551587835864e-13
age O 0 1.221713702426186e-11
50 O 0 9.900200104162593e-11
years O 0 5.237595079865542e-12
and O 0 8.607970239382645e-12
84 O 0 1.1052104786912764e-09
% O 0 4.9989515998882794e-11
( O 0 8.484009501874556e-12
95 O 0 1.2682527028573531e-08
% O 0 2.8013472097576653e-10
CI O 0 2.738935620527627e-07
43 O 0 1.3213876215445453e-08
% O 0 1.121706963425062e-10
- O 0 9.29064880583752e-10
95 O 0 5.348550935480034e-09
% O 0 2.216748659633616e-11
) O 0 1.9159706373533814e-12
by O 0 2.005072540292585e-12
age O 0 1.8013594782484432e-10
70 O 0 3.0350870705575517e-09
years O 0 2.270098997669834e-09
. O 0 3.556407079940982e-08

The O 0 4.024962890980532e-06
corresponding O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 5.557935196520702e-07
were O 0 8.017388530845437e-09
0 O 0 1.8982240135301254e-07
. O 0 9.507586185009131e-08

4 O 0 9.368218911731674e-07
% O 0 3.2631242152802997e-09
( O 0 4.0811461848866415e-11
95 O 0 1.6321628493187745e-08
% O 0 2.4614435489844766e-10
CI O 0 3.7415779274851957e-07
0 O 0 5.066572494882848e-09
% O 0 3.22810146669017e-11
- O 0 1.5590061186454562e-10
1 O 0 2.958981670797556e-10
% O 0 1.029968037941087e-11
) O 0 7.323929874028523e-13
by O 0 2.1866791146893383e-13
age O 0 6.0897315835861665e-12
50 O 0 8.299947534817775e-11
years O 0 6.123345754061038e-12
and O 0 5.704886216206795e-12
27 O 0 7.533690338235033e-10
% O 0 3.200360115807044e-11
( O 0 4.463474295030023e-12
95 O 0 5.0920911931484625e-09
% O 0 1.0933928068501686e-10
CI O 0 8.145293861616665e-08
0 O 0 2.8871325330470654e-09
% O 0 3.9463435991260454e-11
- O 0 3.9412756391854487e-10
47 O 0 5.596726415646458e-10
% O 0 1.1096112743913533e-11
) O 0 1.486347611830141e-12
by O 0 7.901615017673336e-13
age O 0 1.1670360511306654e-10
70 O 0 2.507666740925174e-09
years O 0 1.132423710359376e-09
. O 0 2.6283892395895236e-08

The O 0 2.1185666554401905e-08
lifetime O 0 1.7984231703849218e-07
risk O 0 3.191526900536701e-07
of O 0 1.3305445634159696e-07
breast B-Disease 0 2.435550413792953e-05
cancer I-Disease 0 1.1110237352340846e-07
appears O 0 1.1693762624886972e-09
similar O 0 4.8136657854191967e-11
to O 0 2.792823305952652e-09
the O 0 3.8865604068405446e-08
risk O 0 1.2041982699884102e-07
in O 0 1.86856627948373e-08
BRCA1 O 0 3.0418734198178754e-09
carriers O 0 4.881626214370272e-10
, O 0 1.3927156650161976e-10
but O 0 8.571766907383704e-11
there O 0 7.465598278466601e-11
was O 0 8.585220312440356e-10
some O 0 2.641003908621098e-11
suggestion O 0 2.9071693941062904e-09
of O 0 3.6539593573081675e-10
a O 0 3.229846112784429e-10
lower O 0 3.729548669895166e-09
risk O 0 3.931936998213814e-09
in O 0 2.4260489173144606e-09
BRCA2 O 0 1.6920576939583043e-08
carriers O 0 5.529276481119894e-10
< O 0 6.682930830947953e-08
50 O 0 2.8804510776581083e-08
years O 0 1.5619774362818362e-09
of O 0 6.096943505617958e-10
age O 0 7.76888153808386e-09
. O 0 6.70363817789621e-08

Eye B-Disease 1 0.9947732090950012
movement I-Disease 0 6.184538506204262e-05
abnormalities I-Disease 0 9.34851141209947e-06
correlate O 0 1.1307379566005693e-07
with O 0 1.0993903704070718e-10
genotype O 0 2.625624233587587e-07
in O 0 2.165998438385941e-07
autosomal O 0 0.001835291157476604
dominant O 0 0.000499780522659421
cerebellar B-Disease 1 0.9999942779541016
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 0.00011784320668084547

We O 0 7.715972287769546e-07
compared O 0 6.070411018299637e-08
horizontal O 0 1.0829963912328822e-06
eye O 0 0.11763247847557068
movements O 0 1.2128080015827436e-05
( O 0 4.534687292334638e-09
visually O 0 6.304047417415859e-08
guided O 0 2.375015128563973e-06
saccades O 0 1.4821693184785545e-05
, O 0 3.1220799279196854e-09
antisaccades O 0 1.945640519807057e-07
, O 0 8.629016251537891e-11
and O 0 1.988142289688355e-11
smooth O 0 4.977337986211694e-10
pursuit O 0 1.022127804617412e-08
) O 0 4.1593541111328847e-11
in O 0 2.3217518185791874e-10
control O 0 3.226979927717366e-08
subjects O 0 5.602477699540032e-07
( O 0 1.143518751911543e-10
n O 0 5.711972228539253e-09
= O 0 4.3646629421800753e-08
14 O 0 3.0520146410140114e-09
) O 0 6.280479608600231e-11
and O 0 2.958980283018775e-11
patients O 0 8.15232326090154e-11
with O 0 2.454285689609814e-13
three O 0 5.439592786621317e-12
forms O 0 8.862370559636901e-11
of O 0 6.726780465982074e-09
autosomal O 0 6.318743089650525e-06
dominant O 0 1.0843453310371842e-05
cerebellar B-Disease 0 0.29432982206344604
ataxias I-Disease 0 0.05600091442465782
type I-Disease 0 7.327475759666413e-05
I I-Disease 0 0.00029413378797471523
spinocerebellar B-Disease 0 0.008069301024079323
ataxias I-Disease 0 4.386243017506786e-05
1 I-Disease 0 1.9515407245762617e-07
and I-Disease 0 1.4219687649585921e-09
2 I-Disease 0 2.2234679875055008e-08
( O 0 2.9292648862089266e-10
SCA1 B-Disease 0 2.1911118892603554e-06
, O 0 1.971990487570352e-10
n O 0 7.796414069893842e-10
= O 0 4.9111590350037204e-09
11 O 0 4.83446283006117e-10
; O 0 2.98109002760949e-11
SCA2 B-Disease 0 2.5032099415511766e-07
, O 0 7.899407516998025e-11
n O 0 5.857326290659159e-10
= O 0 5.2320614507550545e-09
10 O 0 9.37527500077806e-10
) O 0 7.865325057920813e-11
and O 0 7.141480184991167e-10
SCA3 B-Disease 1 1.0
/ O 0 1.1259607163083274e-05
Machado B-Disease 0 3.970552029386454e-07
- I-Disease 0 2.601442758987105e-07
Joseph I-Disease 0 3.469110936293873e-07
disease I-Disease 0 2.713966068768059e-06
( O 0 1.9758533698066572e-10
MJD B-Disease 1 1.0
) O 0 3.507369117361492e-10
( O 0 2.1014913767491983e-11
n O 0 3.117789582063324e-09
= O 0 2.642489072002263e-08
16 O 0 4.734939551553907e-09
) O 0 1.2286389683424659e-09
. O 0 2.7534358792991043e-08

In O 0 4.0239623899651633e-07
SCA1 B-Disease 0 1.8556524082669057e-05
, O 0 2.903589368941084e-09
saccade O 0 1.0256272844344494e-06
amplitude O 0 2.0232437947242943e-08
was O 0 5.131950420178555e-09
significantly O 0 2.362569917480073e-09
increased O 0 1.5614650683559717e-09
, O 0 4.3224875068137436e-11
resulting O 0 8.391812938990384e-11
in O 0 6.190287171747855e-10
hypermetria B-Disease 0 1.21510947792558e-06
. O 0 2.1634178892782074e-07

The O 0 8.300733611577016e-07
smooth O 0 1.4929502185623278e-06
pursuit O 0 1.8007932567343232e-06
gain O 0 1.6143100083354511e-06
was O 0 4.733010072754951e-08
decreased O 0 8.28656183671228e-08
. O 0 4.4331340376402295e-08

In O 0 7.675503752579971e-07
SCA2 B-Disease 0 3.272794128861278e-05
, O 0 5.334023445158209e-09
saccade O 0 1.2586215234478004e-06
velocity O 0 8.623747049796293e-08
was O 0 5.182790019375716e-08
markedly O 0 3.275485482845397e-07
decreased O 0 2.8476213742578693e-07
. O 0 7.93778269780887e-08

The O 0 2.9772479592793388e-08
percentage O 0 8.153874375693704e-08
of O 0 3.4531919546054723e-09
errors O 0 5.5021391887066784e-08
in O 0 1.568396612583456e-08
antisaccades O 0 7.327339972107438e-06
was O 0 2.4161542100387123e-08
greatly O 0 2.595177583941677e-08
increased O 0 6.752554515543352e-09
and O 0 1.0773491820881276e-10
was O 0 4.1549000351359666e-10
significantly O 0 4.846908985278731e-10
correlated O 0 1.1785252773677257e-09
with O 0 8.09018910891135e-12
age O 0 4.328927438734809e-09
at O 0 2.323136172321938e-08
disease O 0 5.815660841790304e-09
onset O 0 1.0126141347654993e-07
. O 0 8.237898185825543e-08

In O 0 3.0284386554058074e-08
addition O 0 5.214377818418825e-09
, O 0 1.2561228446283934e-10
a O 0 5.845002259974308e-11
correlation O 0 4.6851834911709744e-11
between O 0 3.2606570221638265e-11
smooth O 0 1.4911096357650422e-08
pursuit O 0 2.023765546255163e-07
gain O 0 9.851633819835115e-08
and O 0 1.8832663206680422e-10
the O 0 3.826943484330769e-10
number O 0 2.8495952819618253e-10
of O 0 4.0141534540794055e-10
trinucleotide O 0 7.444889433827484e-07
repeats O 0 5.9028327115129287e-08
was O 0 1.507982290149812e-07
found O 0 2.4347745153363576e-08
. O 0 1.892779266654543e-07

In O 0 9.193419714392803e-07
SCA3 B-Disease 1 1.0
, O 0 1.124787232242852e-07
gaze B-Disease 0 7.581874524476007e-05
- I-Disease 0 1.2346918992989231e-05
evoked I-Disease 0 1.4332172213471495e-06
nystagmus I-Disease 0 1.784136111382395e-05
was O 0 2.7859616835712586e-08
often O 0 6.690970000278185e-11
present O 0 2.3558401757162173e-11
as O 0 1.3954704058960488e-10
was O 0 2.162024115293093e-09
saccade O 0 6.066609330446227e-07
hypometria O 0 1.0688723932616995e-06
and O 0 2.2780972663838384e-09
smooth O 0 2.1558696516876807e-07
pursuit O 0 1.3845245803167927e-06
gain O 0 1.9999333744635805e-06
was O 0 1.9300884446238342e-08
markedly O 0 8.985648491943721e-08
decreased O 0 5.8214684628410396e-08
. O 0 1.655524073385095e-08

Three O 0 4.338452086471989e-08
major O 0 1.6503221900165954e-08
criteria O 0 6.998484280984485e-08
, O 0 9.775984466386944e-10
saccade O 0 1.608476736691955e-06
amplitude O 0 4.418201626776863e-08
, O 0 1.3418016697741564e-09
saccade O 0 4.819401056010975e-07
velocity O 0 3.224604938623088e-08
, O 0 1.9884466295749803e-10
and O 0 1.2484507871945993e-10
presence O 0 4.287987298567941e-09
of O 0 2.9097336096128856e-08
gaze B-Disease 0 2.3401938960887492e-05
- I-Disease 0 5.714291091862833e-06
evoked I-Disease 0 7.045567826935439e-07
nystagmus I-Disease 0 1.6394815247622319e-06
, O 0 6.569018246027625e-11
permitted O 0 9.591033522937664e-10
the O 0 1.3008703836359103e-10
correct O 0 2.7295954385664345e-09
assignment O 0 4.45373515844949e-09
of O 0 2.2762371154616545e-10
90 O 0 8.052326583296576e-10
% O 0 1.060929746832251e-10
of O 0 1.6949922021503028e-10
the O 0 1.8587534289515872e-10
SCA1 B-Disease 0 1.6726166052194458e-07
, O 0 5.552428308797097e-11
90 O 0 8.254058547763066e-10
% O 0 6.27504298522652e-11
of O 0 2.003491816893188e-10
the O 0 2.7720079009974086e-10
SCA2 B-Disease 0 2.67612335846934e-07
, O 0 3.1371193837115285e-11
and O 0 9.587292765234068e-12
93 O 0 2.0755370755409785e-09
% O 0 3.869866926908827e-11
of O 0 5.430545596540881e-11
the O 0 3.1883454210124285e-11
patients O 0 2.8006246627354514e-11
with O 0 3.373895130290294e-12
SCA3 B-Disease 1 1.0
to O 0 1.0149150853067113e-07
their O 0 1.4486827737414387e-08
genetically O 0 1.2480664501879346e-08
confirmed O 0 1.8182548799927645e-08
patient O 0 1.0558903085211568e-07
group O 0 4.436725153933452e-10
and O 0 1.1879883743404207e-09
, O 0 3.744586585252563e-10
therefore O 0 2.6982320822099837e-09
, O 0 1.0636792835416742e-10
may O 0 1.0951005657844348e-09
help O 0 1.9730721945165897e-08
orient O 0 2.5379886210430413e-06
diagnoses O 0 2.902320738940034e-05
of O 0 4.2707423375532017e-08
SCA1 B-Disease 0 1.2712682291748933e-05
, O 0 1.481433642425145e-09
SCA2 B-Disease 0 2.7549651804292807e-06
, O 0 5.86968362803475e-10
and O 0 4.3853368159041395e-10
SCA3 B-Disease 1 1.0
at O 0 3.420581151658553e-08
early O 0 1.3333374404567166e-08
clinical O 0 2.835008006130124e-09
stages O 0 2.549470412560595e-09
of O 0 3.502397483146069e-09
the O 0 1.1944780275996436e-08
diseases O 0 1.3270150311939233e-08
. O 0 5.986735107654795e-09
. O 0 1.0667954342125086e-07

Genetic O 0 2.153257980808121e-07
basis O 0 4.054601632219601e-08
and O 0 1.1197318766642539e-10
molecular O 0 1.2912745317450458e-09
mechanism O 0 8.81432171695451e-08
for O 0 1.5957691346102365e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9846306443214417

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 0 1.4961671013224986e-07
more O 0 1.4644103638050687e-11
than O 0 2.210743307168306e-12
300 O 0 9.639665454752588e-11
, O 0 9.111724395827192e-12
000 O 0 2.3385005931686464e-08
sudden O 0 2.3840944773922956e-09
deaths O 0 7.495046250305393e-11
each O 0 1.2932789604860884e-12
year O 0 6.568266069928441e-11
in O 0 3.1209890227756887e-10
the O 0 4.589926216880258e-09
USA O 0 5.635723709929152e-07
alone O 0 8.426918896020652e-08
. O 0 9.022297575711491e-08

In O 0 1.2638817992183249e-08
approximately O 0 8.683152807886785e-11
5 O 0 1.6972382388402707e-09
- O 0 7.963056880555541e-09
12 O 0 1.1688460865855177e-08
% O 0 1.793249548853737e-09
of O 0 2.133023202510742e-10
these O 0 1.0529681293558468e-11
cases O 0 1.323756902704698e-11
, O 0 8.967705050766384e-12
there O 0 2.053452720363058e-11
are O 0 2.0175028314639576e-11
no O 0 2.4857893521357255e-09
demonstrable O 0 2.4030061467783526e-05
cardiac O 1 0.9999969005584717
or O 0 3.2181462756852852e-06
non O 1 1.0
- O 1 0.9999679327011108
cardiac O 1 1.0
causes O 0 9.782726806406572e-08
to O 0 3.6258765434560303e-10
account O 0 9.330048539313296e-11
for O 0 7.750107500203995e-11
the O 0 2.1608617117863105e-09
episode O 0 7.160814163853502e-08
, O 0 1.2608810662229075e-09
which O 0 7.117991612792807e-11
is O 0 3.9157279849155735e-12
therefore O 0 4.473106954283601e-11
classified O 0 7.83137776849685e-10
as O 0 2.0684089108158332e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 3.732850917259611e-09
IVF B-Disease 1 1.0
) O 0 1.0016715235039442e-09
. O 0 8.626622083340862e-09

A O 0 1.334881631009921e-06
distinct O 0 3.4260836390132e-09
group O 0 6.095780546999663e-10
of O 0 1.36841771247731e-09
IVF B-Disease 1 1.0
patients O 0 5.447266104852133e-08
has O 0 1.5084050328240117e-11
been O 0 7.461351848869757e-12
found O 0 5.613077710964198e-12
to O 0 1.661285831122683e-10
present O 0 2.1941148897752782e-10
with O 0 7.53549722620761e-11
a O 0 1.956224693344666e-08
characteristic O 0 7.854393402340065e-08
electrocardiographic O 0 3.104255711150472e-06
pattern O 0 3.980549223570051e-08
. O 0 1.903668049862972e-07

Because O 0 9.342686979607606e-08
of O 0 3.7970064425962846e-08
the O 0 1.0269604722168424e-08
small O 0 6.201395508220742e-10
size O 0 3.6388896340611154e-09
of O 0 2.311105085084364e-09
most O 0 3.858634245457182e-11
pedigrees O 0 6.427568477462842e-10
and O 0 3.5867503411779467e-11
the O 0 1.976588476226837e-10
high O 0 6.944796404617648e-10
incidence O 0 6.209088798669882e-10
of O 0 6.811157193808981e-11
sudden B-Disease 0 1.6101957545089363e-09
death I-Disease 0 5.934868596568776e-09
, O 0 4.3527453863489995e-10
however O 0 1.999328258506239e-09
, O 0 3.4801808657114464e-10
molecular O 0 9.25684640051827e-10
genetic O 0 1.736174259914236e-10
studies O 0 2.633194995382837e-09
of O 0 6.2334652994877615e-09
IVF B-Disease 1 1.0
have O 0 1.801151583435967e-08
not O 0 1.325324516798787e-09
yet O 0 6.67929322961669e-10
been O 0 1.0436933539637039e-09
done O 0 5.064894637030193e-08
. O 0 3.158341712605761e-07

Because O 0 3.4807129623004585e-07
IVF B-Disease 1 1.0
causes O 0 1.550159026919573e-06
cardiac O 1 0.9930325746536255
rhythm O 0 0.005711499135941267
disturbance O 0 1.0134986041521188e-06
, O 0 2.662399190000997e-10
we O 0 1.8160773995745672e-09
investigated O 0 1.97047622663149e-09
whether O 0 6.375679095782516e-09
malfunction O 0 1.7956510419026017e-05
of O 0 4.2632141372678234e-08
ion O 0 4.594807023750036e-08
channels O 0 1.8648952604394253e-08
could O 0 3.460985942282946e-09
cause O 0 2.6290447596721833e-09
the O 0 1.214897182855168e-09
disorder O 0 1.4097810696611646e-09
by O 0 2.3807919611457118e-12
studying O 0 1.2669555682354172e-10
mutations O 0 7.2711259756219615e-12
in O 0 2.5398188760461515e-11
the O 0 4.737250036690455e-10
cardiac O 0 9.380162850902707e-07
sodium O 0 2.3162436946222442e-07
channel O 0 4.031344502664069e-08
gene O 0 2.576701518819391e-08
SCN5A O 0 2.3446526029147208e-05
. O 0 2.0663881059590494e-06

We O 0 1.2727458909012057e-07
have O 0 6.332083746229955e-10
now O 0 1.7090749648840386e-10
identified O 0 2.061849579959585e-09
a O 0 6.144460495960402e-09
missense O 0 1.0769002756205737e-06
mutation O 0 1.4637535628025944e-08
, O 0 9.264936040587202e-10
a O 0 1.3946011012677673e-09
splice O 0 3.901697809283178e-08
- O 0 2.61958579272914e-08
donor O 0 1.8142779723007152e-08
mutation O 0 1.9619332825016045e-09
, O 0 7.419094505412005e-11
and O 0 6.780127154160098e-11
a O 0 7.513227262556654e-10
frameshift O 0 1.95776994615926e-08
mutation O 0 3.7944234559939005e-11
in O 0 7.989505584893308e-11
the O 0 6.676491581814048e-10
coding O 0 1.4883932308862313e-08
region O 0 6.418714004752246e-09
of O 0 4.236090589415653e-09
SCN5A O 0 5.126836981617089e-07
in O 0 1.042702479914226e-09
three O 0 3.9021924580495693e-10
IVF B-Disease 1 1.0
families O 0 1.1097160967921127e-09
. O 0 1.0272601436156492e-08

We O 0 2.041527693563694e-07
show O 0 1.1219605688950196e-08
that O 0 2.6498338245861675e-11
sodium O 0 2.509722707433326e-10
channels O 0 1.2739438670639203e-10
with O 0 4.72278336230425e-12
the O 0 1.71864722453563e-09
missense O 0 5.210781637288164e-07
mutation O 0 8.232961867804534e-09
recover O 0 6.626435578027667e-08
from O 0 1.1867993254810472e-09
inactivation O 0 2.1867727184599062e-07
more O 0 2.259350623257106e-10
rapidly O 0 2.4475252380362633e-10
than O 0 2.890858559478904e-12
normal O 0 6.175708555655746e-11
and O 0 1.2691388738550469e-11
that O 0 1.5496727165387192e-11
the O 0 4.830057465099458e-10
frameshift O 0 4.165879943229811e-07
mutation O 0 1.576995978247453e-09
causes O 0 1.4183113017374183e-10
the O 0 2.3270986526657822e-10
sodium O 0 5.874659869675725e-09
channel O 0 3.87022502934542e-09
to O 0 1.0673338879385597e-09
be O 0 1.988857301071789e-09
non O 0 4.5034875029159593e-07
- O 0 1.5412187792662735e-07
functional O 0 6.437433057726594e-07
. O 0 2.802024141601578e-07

Our O 0 4.969659812559257e-07
results O 0 3.704976236917901e-08
indicate O 0 1.2523251768925547e-08
that O 0 1.0138283268457116e-10
mutations O 0 1.6807530367479728e-10
in O 0 6.598632196208598e-10
cardiac O 0 5.694753895113536e-07
ion O 0 2.2796920973178203e-07
- O 0 4.9833270168164745e-06
channel O 0 1.6043372852436733e-07
genes O 0 2.816563093865909e-10
contribute O 0 5.703172933912981e-10
to O 0 2.1307391406821807e-09
the O 0 1.9568691111970793e-09
risk O 0 3.410397075853666e-09
of O 0 3.8045711026057916e-10
developing O 0 7.701149051797529e-09
IVF B-Disease 1 1.0
. O 0 1.6421481063844112e-07
. O 0 3.5594823089013516e-07

Molecular O 0 1.426898563750001e-07
heterogeneity O 0 3.0141357854063244e-08
in O 0 4.192812319558925e-09
mucopolysaccharidosis B-Disease 0 1.4125374718787498e-06
IVA I-Disease 0 5.434596459963359e-06
in O 0 5.307528283537977e-08
Australia O 0 5.1467132777816005e-09
and O 0 2.956870165382597e-11
Northern O 0 5.020970306190975e-10
Ireland O 0 6.430793675349378e-10
: O 0 2.880673477534401e-10
nine O 0 1.4957483862598764e-10
novel O 0 9.965218927820985e-11
mutations O 0 4.21509147030541e-11
including O 0 3.054247826872469e-11
T312S O 0 3.02567343624105e-07
, O 0 8.935632789253134e-10
a O 0 2.713798519238253e-09
common O 0 5.3682969181068074e-09
allele O 0 1.0837083230796907e-08
that O 0 1.2576810426434548e-10
confers O 0 1.5171058009855187e-07
a O 0 5.452900353475343e-08
mild O 0 1.6416704795574333e-07
phenotype O 0 1.2034233520807902e-07
. O 0 2.1229743651929311e-07

Mucopolysaccharidosis B-Disease 0 0.0008975736564025283
IVA I-Disease 0 0.4729422926902771
( O 0 2.0009217678307323e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 9.385964716557282e-08
is O 0 6.078530567776852e-09
an O 0 4.012188359325819e-09
autosomal B-Disease 1 0.9999897480010986
recessive I-Disease 1 0.9999997615814209
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 2.9466955098200742e-08
by O 0 6.502313965039974e-11
a O 0 1.1143349638587097e-06
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.519432686336586e-07
N O 0 6.951959363732385e-08
- O 0 1.3356154404675635e-08
acetylgalactosamine O 0 2.679908561731281e-07
- O 0 1.0356927759858081e-07
6 O 0 6.551109663632815e-07
- O 0 1.574082489241846e-06
sulfate O 0 6.086979738029186e-07
sulfatase O 0 1.5190071280812845e-05
( O 0 4.775114748056808e-10
GALNS O 0 6.112381470302353e-06
) O 0 1.9043113752559293e-09
. O 0 2.9599782180866896e-08

Previous O 0 5.1074042772825123e-08
studies O 0 4.005505260806785e-09
of O 0 1.7755506787064945e-10
patients O 0 8.133759291095721e-12
from O 0 1.7235357021791464e-12
a O 0 2.6624993876289693e-11
British O 0 8.969989750973184e-10
- O 0 5.151368220879249e-09
Irish O 0 6.200023827673817e-10
population O 0 6.121710343504061e-12
showed O 0 2.7000828656253972e-11
that O 0 3.5248139042959314e-13
the O 0 8.257329542349368e-11
I113F O 0 1.5190647673080093e-07
mutation O 0 5.445536244153004e-10
is O 0 4.083466551008108e-11
the O 0 2.835774670639779e-10
most O 0 7.553845049468322e-11
common O 0 1.1582147046995672e-10
single O 0 2.794784181858745e-09
mutation O 0 1.7690274800585826e-09
among O 0 4.1814535167716826e-10
MPS B-Disease 1 0.999997615814209
IVA I-Disease 1 1.0
patients O 0 2.1978987660986604e-06
and O 0 8.694824304988913e-10
produces O 0 2.797951037525337e-10
a O 0 9.984783000405173e-10
severe O 0 2.5967903383161683e-09
clinical O 0 5.5613401883647384e-08
phenotype O 0 5.245903977879607e-08
. O 0 3.27714445802485e-07

We O 0 4.975872229806555e-07
studied O 0 8.849681165656875e-08
mutations O 0 6.830001453295154e-09
in O 0 3.809096593698769e-09
the O 0 5.258834256949285e-09
GALNS O 0 6.973659196773951e-07
gene O 0 6.199456503708234e-10
from O 0 2.6142424336406123e-10
23 O 0 2.586904734869222e-08
additional O 0 7.961965593494824e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.3573881005868316e-06
( O 0 2.2714566338954967e-11
15 O 0 1.214741862654023e-09
from O 0 1.0882247186705385e-10
Australia O 0 5.187145712959307e-10
, O 0 4.260767086372574e-12
8 O 0 1.379944214452422e-10
from O 0 2.513180288876704e-11
Northern O 0 9.391113442447363e-10
Ireland O 0 4.8158260712583e-10
) O 0 1.2368135682283565e-10
, O 0 3.551575353255565e-11
with O 0 1.0221823387723816e-12
various O 0 1.1640882008334685e-10
clinical O 0 8.956180685970594e-09
phenotypes O 0 1.1417289158544008e-07
( O 0 6.717571499059716e-10
severe O 0 2.943949368727772e-07
, O 0 1.0856462395736344e-09
16 O 0 7.545528646346611e-09
cases O 0 4.9661649792476226e-11
; O 0 1.0875207852312219e-11
intermediate O 0 7.364424070566145e-10
, O 0 1.0447300143046068e-11
4 O 0 3.0870705991503655e-10
cases O 0 3.524588954029184e-11
; O 0 2.08559197689695e-10
mild O 0 7.78004771717633e-09
, O 0 7.788651668061419e-11
3 O 0 1.8990771177840315e-09
cases O 0 1.4219192490116939e-10
) O 0 3.892773881020162e-10
. O 0 3.805997295103225e-08

We O 0 2.6183727186435135e-06
found O 0 2.493221984423144e-08
two O 0 1.612300848385928e-09
common O 0 2.3113342351166466e-09
mutations O 0 7.545900015948348e-10
that O 0 1.993100823272087e-11
together O 0 4.1221613795994205e-12
accounted O 0 2.888993211325186e-10
for O 0 1.3150101840775363e-10
32 O 0 8.652047966961618e-09
% O 0 3.240619994571148e-10
of O 0 1.0358794932940896e-09
the O 0 1.3382438490694426e-09
44 O 0 3.4621874256401952e-09
unrelated O 0 4.606502290727121e-09
alleles O 0 8.119042105292351e-10
in O 0 9.43906064421185e-10
these O 0 2.41449904514468e-09
patients O 0 4.125227270890264e-09
. O 0 1.7065129753746078e-08

One O 0 5.8624959109465635e-08
is O 0 4.970801548154213e-10
the O 0 9.303540160487955e-10
T312S O 0 9.211534006681177e-07
mutation O 0 7.699122228643773e-09
, O 0 3.652628477457398e-10
a O 0 5.114085821489311e-10
novel O 0 4.837435341187302e-09
mutation O 0 6.644199079808288e-10
found O 0 3.892786440418128e-11
exclusively O 0 3.9356418124469883e-10
in O 0 2.2767147889179995e-10
milder O 0 1.8004749691158395e-08
patients O 0 6.805242591667593e-09
. O 0 4.428798661137989e-08

The O 0 3.247250504045951e-07
other O 0 1.218563805416295e-09
is O 0 6.691480702869512e-11
the O 0 1.685812878182702e-10
previously O 0 7.953707026331358e-09
described O 0 7.92165621987806e-09
I113F O 0 1.1150249292768422e-06
that O 0 3.8418335179812857e-10
produces O 0 1.8273969837334647e-10
a O 0 1.0894775082093133e-09
severe O 0 1.37715066017563e-08
phenotype O 0 1.0195599742246486e-07
. O 0 5.709894139727112e-07

The O 0 1.2739593557853368e-06
I113F O 0 1.4665876733488403e-05
and O 0 3.523062019894496e-08
T312S O 0 2.9736495434917742e-06
mutations O 0 1.5192660463014818e-09
accounted O 0 1.3223475647805571e-09
for O 0 2.223177475446647e-10
8 O 0 2.4566618961330278e-08
( O 0 1.5837894884462855e-10
18 O 0 4.735942304989749e-09
% O 0 3.541300586107354e-11
) O 0 4.952975529715076e-12
and O 0 5.212998002018798e-12
6 O 0 5.639546607483226e-10
( O 0 1.2740113651543705e-11
14 O 0 7.143401425935281e-10
% O 0 2.0836186942485568e-11
) O 0 1.9273485585280525e-11
of O 0 1.1655945653110678e-10
44 O 0 7.418702319128556e-10
unrelated O 0 1.1611749339834887e-09
alleles O 0 1.8362199538657364e-09
, O 0 1.1134964061909614e-09
respectively O 0 3.9848337962666847e-08
. O 0 9.63401731723934e-08

The O 0 7.051409056657576e-07
relatively O 0 6.112656336654254e-08
high O 0 1.5747813719713122e-08
residual O 0 3.103836263562698e-07
GALNS O 0 1.1825246701846481e-06
activity O 0 1.4077102150622522e-08
seen O 0 2.2681514444400364e-09
when O 0 3.072959942063136e-10
the O 0 5.537730274340902e-10
T312S O 0 1.999294774179816e-08
mutant O 0 1.6819373671594917e-09
cDNA O 0 2.509399976702298e-08
is O 0 8.819812657989701e-10
overexpressed O 0 8.828371278468694e-08
in O 0 3.777428592144361e-09
mutant O 0 9.99126470446754e-09
cells O 0 1.4225981503912521e-09
provides O 0 1.5806117525940522e-10
an O 0 7.407054028289728e-13
explanation O 0 3.630926809217172e-11
for O 0 2.0745535497801448e-11
the O 0 7.284166603227504e-10
mild O 0 3.4514799907015004e-09
phenotype O 0 2.236422380619274e-09
in O 0 1.93645086077332e-10
patients O 0 3.3394970816447156e-11
with O 0 1.7924526338024271e-13
this O 0 7.271212798531934e-11
mutation O 0 4.2917075449011577e-10
. O 0 1.5894956462148002e-08

The O 0 7.56866391782296e-09
distribution O 0 3.80626745399848e-11
and O 0 2.937850700560074e-12
relative O 0 1.7101184357493082e-10
frequencies O 0 1.1774647923346038e-09
of O 0 2.8890703718253974e-10
the O 0 4.43320574694539e-10
I113F O 0 3.0368202175168335e-08
and O 0 3.3120825526644637e-10
T312S O 0 7.180536698569995e-08
mutations O 0 3.955765714991344e-10
in O 0 1.5869343339414144e-10
Australia O 0 1.7918537487116026e-10
corresponded O 0 2.1536054189974507e-11
to O 0 8.072420509819267e-11
those O 0 2.081807295994942e-11
observed O 0 9.875927159397335e-11
in O 0 4.88167978263121e-11
Northern O 0 2.5324493613254617e-09
Ireland O 0 1.2016045936036335e-09
and O 0 1.193629639573146e-10
are O 0 7.181728302330104e-12
unique O 0 5.037554054454496e-11
to O 0 1.7356710513283247e-10
these O 0 2.2526454659943518e-11
two O 0 3.0979739173292442e-12
populations O 0 6.4618453816944754e-12
, O 0 8.156020997462932e-12
suggesting O 0 3.762613831614914e-10
that O 0 5.6140439519403174e-11
both O 0 1.5989812252037439e-10
mutations O 0 1.9756084268518492e-10
were O 0 3.38858968662592e-10
probably O 0 3.507891199738822e-10
introduced O 0 9.598133399180142e-10
to O 0 8.594723266419635e-10
Australia O 0 2.429761669642261e-10
by O 0 4.2670454843130035e-12
Irish O 0 1.8295243098265246e-10
migrants O 0 9.26610232987457e-10
during O 0 1.684846262506312e-09
the O 0 3.859954023077705e-10
19th O 0 2.0666895750309777e-08
century O 0 6.688682674393931e-08
. O 0 7.719859951293984e-08

Haplotype O 0 2.5510196337563684e-06
analysis O 0 2.26837748584785e-08
using O 0 3.577380169872413e-09
6 O 0 8.008909446743928e-08
RFLPs O 0 1.0583618177406606e-06
provides O 0 2.0557902047357857e-09
additional O 0 7.959439773941313e-10
data O 0 3.3582028269307784e-09
that O 0 1.378626240944314e-10
the O 0 3.812839821648595e-09
I113F O 0 6.094856530580728e-07
mutation O 0 9.436000869555983e-10
originated O 0 1.2600084309255521e-09
from O 0 1.7855079914586014e-10
a O 0 8.497784143024489e-10
common O 0 1.0109825199222655e-09
ancestor O 0 1.0343641321242103e-07
. O 0 1.4855577035177703e-07

The O 0 2.209066707337115e-07
other O 0 3.7815070519364724e-10
9 O 0 1.2530373183494703e-08
novel O 0 1.6094404697852838e-09
mutations O 0 8.554359998136363e-10
identified O 0 9.62062207676695e-10
in O 0 1.0691242335880702e-10
these O 0 8.77490649586754e-11
23 O 0 8.790041583495167e-09
patients O 0 1.1055768106560393e-10
were O 0 6.38946534570195e-11
each O 0 7.501435236867415e-12
limited O 0 1.3193269809974595e-09
to O 0 2.8949627139951417e-09
a O 0 6.8192238522613025e-09
single O 0 1.7349637460029044e-07
family O 0 1.1121431953142746e-07
. O 0 7.697333330725087e-07

These O 0 1.0400260208598411e-07
data O 0 1.680193939535002e-08
provide O 0 3.497715728162376e-10
further O 0 7.816331609733496e-11
evidence O 0 1.116055858840781e-10
for O 0 4.427297070619396e-11
extensive O 0 3.6592406882363093e-09
allelic O 0 2.3040069407898045e-08
heterogeneity O 0 1.4498382938654686e-08
in O 0 3.5404415399398204e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 5.067039410278085e-08
British O 0 3.6722968843605486e-07
- O 0 3.444872334057436e-07
Irish O 0 1.3214020988527864e-09
patients O 0 1.8102733201352805e-10
and O 0 3.321820357844729e-13
provide O 0 2.547454001217142e-12
evidence O 0 3.797578137371138e-12
for O 0 1.3858783044773393e-11
their O 0 4.5035342122190514e-10
transmission O 0 9.011909440914678e-08
to O 0 2.2401378529934846e-08
Australia O 0 1.1285366419144793e-08
by O 0 1.802218652091625e-10
British O 0 3.0030153652660374e-07
- O 0 1.4416463045563432e-07
Irish O 0 4.477891391019284e-09
migrants O 0 1.844662311789591e-09
. O 0 3.3420985423582295e-10
. O 0 6.262686369495896e-09

Identification O 0 4.277494554116856e-06
of O 0 4.675915192819957e-07
constitutional O 0 6.298114749370143e-05
WT1 O 0 0.00888848677277565
mutations O 0 1.916921661404558e-07
, O 0 8.475495305582115e-10
in O 0 1.9859450195447437e-10
patients O 0 6.78268829990003e-11
with O 0 9.14058412293528e-12
isolated O 0 3.897272193853496e-08
diffuse B-Disease 0 7.550647569587454e-05
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 1.807673655207509e-08
and O 0 1.4504730749820283e-10
analysis O 0 7.777550825593949e-10
of O 0 1.4886196719743339e-09
genotype O 0 5.6119542790611376e-08
/ O 0 3.1157335342868464e-06
phenotype O 0 7.460367434930504e-09
correlations O 0 1.5505544070926192e-10
by O 0 7.512976352153089e-12
use O 0 2.934825271694308e-09
of O 0 1.7890917636265158e-09
a O 0 4.734461267474899e-09
computerized O 0 4.383309146760439e-07
mutation O 0 1.0398470529082715e-08
database O 0 2.6769036765017518e-08
. O 0 9.878898765691702e-08

Constitutional O 0 5.210118615650572e-06
mutations O 0 1.6291956228542404e-08
of O 0 9.882286988727174e-09
the O 0 7.071043750528361e-09
WT1 O 0 2.005686383199645e-06
gene O 0 8.70085070658888e-09
, O 0 3.9513994853912493e-10
encoding O 0 2.839445567559551e-09
a O 0 9.60370538649613e-09
zinc O 0 5.3069329624122474e-06
- O 0 1.2173621144029312e-05
finger O 0 2.1319369807315525e-06
transcription O 0 1.179083255919977e-06
factor O 0 6.234823501927167e-08
involved O 0 2.9777291743471324e-09
in O 0 6.892674875302873e-09
renal O 1 0.9999984502792358
and O 0 2.681907744772616e-06
gonadal O 1 1.0
development O 1 0.9999997615814209
, O 0 9.118165666954781e-10
are O 0 1.414684775574715e-11
found O 0 1.2494508032367957e-11
in O 0 9.113253554571266e-12
most O 0 6.74295601993391e-12
patients O 0 4.055954790777028e-12
with O 0 6.752454064645752e-12
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 9.200242345741572e-09
DDS B-Disease 1 1.0
) O 0 4.317762591909968e-09
, O 0 5.380985101943736e-10
or O 0 6.164769139616055e-09
diffuse B-Disease 0 0.00010963792738039047
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 1.3250244457196914e-08
DMS B-Disease 0 5.49689466424752e-05
) O 0 1.8485711572591157e-10
associated O 0 3.350755228836988e-09
with O 0 1.4897323652451888e-10
pseudohermaphroditism B-Disease 1 1.0
and O 0 2.873328597274849e-08
/ O 0 2.4379156457143836e-05
or O 0 1.3564897471951554e-07
Wilms B-Disease 0 0.11072173714637756
tumor I-Disease 0 3.2340220059268177e-05
( O 0 5.812411885131041e-09
WT B-Disease 1 1.0
) O 0 8.636829917918476e-09
. O 0 7.9518748918872e-08

Most O 0 8.348273183855781e-08
mutations O 0 1.1076083161754013e-08
in O 0 8.471651824493165e-09
DDS B-Disease 1 1.0
patients O 0 3.4816632705769734e-06
lie O 0 1.2063472887291482e-08
in O 0 3.2993083265431267e-10
exon O 0 1.1375006714331448e-08
8 O 0 6.161045007502253e-08
or O 0 3.866417852549375e-09
exon O 0 2.706062218749139e-08
9 O 0 1.136927423317502e-07
, O 0 1.8162159554080404e-09
encoding O 0 1.183127693593633e-07
zinc O 0 0.00010559477232163772
finger O 0 2.4765000489423983e-05
2 O 0 3.6147191622148966e-06
or O 0 3.265246277806e-07
zinc O 0 9.807891910895705e-05
finger O 0 1.7796809288483928e-06
3 O 0 1.510297948925654e-07
, O 0 4.007834064623239e-10
respectively O 0 1.194074172872206e-09
, O 0 2.1273746653172054e-11
with O 0 2.5010518829582384e-12
a O 0 2.3869064502690662e-09
hot O 0 3.9483643377025146e-07
spot O 0 4.2141007128293495e-08
( O 0 2.383483965751054e-10
R394W O 0 1.6053505191848672e-07
) O 0 1.5722349810953773e-10
in O 0 8.453602262648019e-10
exon O 0 6.055343249045109e-08
9 O 0 3.804756829595135e-07
. O 0 3.9917108551890124e-07

We O 0 3.1624168173038925e-07
analyzed O 0 4.223845806450299e-08
a O 0 2.146181454776297e-09
series O 0 8.159172226740452e-10
of O 0 1.2532511139973224e-10
24 O 0 4.69941863201484e-09
patients O 0 2.8551117026154316e-10
, O 0 4.1930962174641095e-11
10 O 0 3.944466531180524e-09
with O 0 9.612131091074616e-10
isolated B-Disease 0 2.041112338702078e-06
DMS I-Disease 1 0.7316425442695618
( O 0 6.84573322473625e-08
IDMS B-Disease 1 0.8485080599784851
) O 0 2.9529505507497333e-09
, O 0 3.7705022437606317e-10
10 O 0 1.2333583043755425e-09
with O 0 4.502338085687896e-11
DDS B-Disease 1 1.0
, O 0 2.996342063354973e-09
and O 0 1.4136659898245085e-10
4 O 0 1.4408293225187663e-08
with O 0 3.309846841048625e-10
urogenital B-Disease 0 4.39553041360341e-05
abnormalities I-Disease 0 0.0005926453159190714
and O 0 9.550770840860423e-08
/ O 1 0.8677842020988464
or O 0 1.2691557458310854e-05
WT B-Disease 1 1.0
. O 0 2.2888052626512945e-06

We O 0 1.410450977346045e-06
report O 0 1.7541748320581974e-07
WT1 O 0 0.00015246027032844722
heterozygous O 0 1.38999354248881e-07
mutations O 0 1.166949870068379e-09
in O 0 3.516264779346301e-10
16 O 0 2.2652546505241844e-09
patients O 0 2.4363655537484874e-10
, O 0 2.668366222424723e-11
4 O 0 4.995029723176003e-09
of O 0 4.2805998745620855e-09
whom O 0 2.5982435758464817e-08
presented O 0 6.345400720420002e-07
with O 0 4.02890769635178e-08
IDMS B-Disease 1 0.9999997615814209
. O 0 0.0003176171740051359

One O 0 1.0335831746033364e-07
male O 0 6.707971955677294e-09
and O 0 5.258831703436329e-10
two O 0 3.3281166711418564e-10
female O 0 2.411010724401308e-09
IDMS B-Disease 0 5.474629870150238e-05
patients O 0 4.786810592349866e-08
with O 0 1.9813453100425704e-09
WT1 O 1 0.9999990463256836
mutations O 0 2.9546637961175293e-05
underwent O 1 0.842246949672699
normal O 0 3.6812692997045815e-05
puberty O 0 8.955208613770083e-06
. O 0 3.0532834216501215e-07

Two O 0 1.1663684063023538e-06
mutations O 0 4.324646596387538e-08
associated O 0 7.985632777263163e-08
with O 0 5.692110671695616e-10
IDMS B-Disease 0 0.00070306466659531
are O 0 3.8828518178490867e-10
different O 0 4.903534869815651e-11
from O 0 1.7947714148203175e-10
those O 0 3.7096251070956043e-10
described O 0 1.100425195410537e-09
in O 0 1.3223002248707871e-08
DDS B-Disease 1 1.0
patients O 0 7.221665327961091e-07
. O 0 5.992654905639938e-08

No O 0 8.073068784142379e-06
WT1 O 0 7.347360951825976e-05
mutations O 0 4.234219019849661e-08
were O 0 6.926399009898887e-09
detected O 0 1.884859157641472e-09
in O 0 1.0273772943492077e-09
the O 0 8.862683920085601e-09
six O 0 4.050966673219136e-09
other O 0 8.337381340872696e-10
IDMS B-Disease 1 0.5445405840873718
patients O 0 2.0847774351295811e-07
, O 0 9.070516004960893e-10
suggesting O 0 2.0143568590924588e-08
genetic O 0 4.364244521326555e-09
heterogeneity O 0 1.2565458895608117e-08
of O 0 1.2942537708227064e-08
this O 0 5.7713060996889e-09
disease O 0 9.167766101825237e-09
. O 0 2.6803217423321257e-08

We O 0 3.971395926782861e-06
analyzed O 0 2.519722329452634e-06
genotype O 0 1.0613724043651018e-05
/ O 0 7.620887481607497e-05
phenotype O 0 6.341904423834421e-08
correlations O 0 5.198664831951305e-10
, O 0 1.7978368793691857e-11
on O 0 1.2694420514769433e-10
the O 0 1.2243450177307214e-11
basis O 0 6.679214126226185e-11
of O 0 1.5143462872568847e-11
the O 0 6.05260980224287e-11
constitution O 0 1.7669377072593306e-08
of O 0 7.734181295404596e-09
a O 0 6.498737992188808e-09
WT1 O 0 3.709341399371624e-05
mutation O 0 5.746568998432622e-09
database O 0 4.5436046036684274e-09
of O 0 1.292494222759899e-09
84 O 0 4.312875390155568e-08
germ O 0 2.578155545052141e-05
- O 0 3.0828468879917637e-05
line O 0 2.9732468647125643e-06
mutations O 0 4.812707121715221e-09
, O 0 5.3479436157299887e-11
to O 0 1.6804999058983583e-10
compare O 0 3.2029650043341462e-09
the O 0 1.0374335834839599e-09
distribution O 0 6.574411570703376e-10
and O 0 5.172317019130901e-10
type O 0 1.1340728889308593e-07
of O 0 3.021434125116684e-08
mutations O 0 4.5591935782240967e-10
, O 0 3.5769397860319074e-11
according O 0 7.646897004498499e-11
to O 0 4.3109299463495176e-10
the O 0 2.833914769517776e-10
different O 0 1.0658264271157236e-09
symptoms O 0 7.510669064458853e-08
. O 0 8.801067252761641e-08

This O 0 1.596678878001967e-08
demonstrated O 0 3.228617373451925e-08
( O 0 4.01350827572422e-11
1 O 0 4.453471813548049e-09
) O 0 3.663065684111899e-10
the O 0 2.3214872246768437e-09
association O 0 4.4525608200451927e-10
between O 0 5.054309401564261e-11
mutations O 0 1.3695189426954357e-10
in O 0 4.732165770349184e-10
exons O 0 2.700245138598234e-09
8 O 0 2.728450354538836e-09
and O 0 3.9086284209233213e-10
9 O 0 2.4920572272435493e-08
and O 0 3.261120706810061e-09
DMS B-Disease 0 1.022707920128596e-06
; O 0 6.80394129926043e-10
( O 0 3.753580432586112e-11
2 O 0 2.6651136852962054e-09
) O 0 5.5845678775812146e-11
among O 0 9.658303670723178e-12
patients O 0 4.3388258263998836e-11
with O 0 8.419379559851392e-13
DMS B-Disease 0 1.8715289229476184e-07
, O 0 1.7812833152941465e-10
a O 0 1.3513604124604228e-10
higher O 0 2.6514037632097143e-09
frequency O 0 7.738933049949992e-09
of O 0 6.712614353254764e-10
exon O 0 1.241004454755057e-08
8 O 0 6.441479882823842e-08
mutations O 0 1.4204182274824007e-09
among O 0 6.71628655468659e-11
46 O 0 5.74562664112932e-09
, O 0 2.2618784623062993e-09
XY O 0 1.9645836800918914e-05
patients O 0 3.093762801498201e-09
with O 0 1.7641971217230434e-11
female O 0 7.106071842066797e-10
phenotype O 0 3.802293202515017e-10
than O 0 3.212175664346617e-11
among O 0 8.735225216771614e-12
46 O 0 6.31720054045104e-09
, O 0 4.816830045939469e-09
XY O 0 0.00014414216275326908
patients O 0 1.0938361327816892e-08
with O 0 2.8644539865063656e-11
sexual O 0 1.0812652995184635e-09
ambiguity O 0 1.5575565281977788e-09
or O 0 2.3363859735781034e-09
male O 0 3.9498342374599815e-09
phenotype O 0 4.230113759273735e-10
; O 0 4.913721513011282e-11
and O 0 1.593406656619223e-10
( O 0 3.190596398194856e-11
3 O 0 9.010084234262195e-09
) O 0 2.22656393322751e-10
statistically O 0 1.3601220150150084e-09
significant O 0 1.0888350637783262e-10
evidence O 0 5.526018531654131e-10
that O 0 4.5888015609563126e-11
mutations O 0 6.176803513113782e-11
in O 0 4.684265753063244e-10
exons O 0 2.975117485704004e-09
8 O 0 1.0830160768193764e-08
and O 0 7.907416388341915e-10
9 O 0 2.52676226608628e-08
preferentially O 0 3.551463789719378e-09
affect O 0 1.2360931833654831e-08
amino O 0 2.170974511273016e-09
acids O 0 1.3668577381054092e-09
with O 0 1.502641761019774e-11
different O 0 1.072592362150182e-10
functions O 0 6.619460535262078e-09
. O 0 5.933691316073464e-09
. O 0 3.4160237305513874e-08

The O 0 1.1440257594586e-06
185delAG O 0 3.356780871399678e-05
BRCA1 O 0 6.941280616956647e-08
mutation O 0 1.3079536065330188e-10
originated O 0 1.1166350483149401e-10
before O 0 1.1365149793496343e-10
the O 0 5.6696779215936743e-11
dispersion O 0 1.3968345369264057e-09
of O 0 3.307215334924507e-10
Jews O 0 4.5016448901868955e-10
in O 0 1.5145087961521142e-10
the O 0 1.4614505439158876e-10
diaspora O 0 1.1645573394503117e-09
and O 0 5.6078801324854766e-11
is O 0 6.17598767266303e-12
not O 0 3.0147981333605856e-11
limited O 0 1.3185369462931362e-09
to O 0 4.919148821613817e-08
Ashkenazim O 0 3.2918662327574566e-05
. O 0 2.7942826363869244e-06

The O 0 3.273955258009664e-07
185delAG O 0 1.417828002558963e-06
mutation O 0 6.696951881934865e-09
in O 0 5.974757577575929e-09
BRCA1 O 0 2.514473607106993e-08
is O 0 2.957176170603759e-10
detected O 0 4.688010535325304e-10
in O 0 2.4876523063710465e-10
Ashkenazi O 0 6.587569600924326e-09
Jews O 0 1.0847396314517255e-09
both O 0 3.546654289698914e-11
in O 0 3.1289221213981477e-10
familial B-Disease 0 0.0001364029012620449
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 6.722832495142939e-07
in O 0 1.900088975048675e-08
the O 0 1.225075685340471e-08
general O 0 1.2667151771950103e-08
population O 0 4.442794049319687e-11
. O 0 8.393581829579944e-09

All O 0 1.8955299765366362e-06
tested O 0 9.698802614366286e-07
Ashkenazi O 0 5.021593665333057e-07
mutation O 0 6.06254879631507e-10
carriers O 0 5.0481053365247774e-11
share O 0 3.073510890239106e-10
the O 0 2.4992757863273596e-10
same O 0 9.677011414410686e-10
allelic O 0 2.563148093770451e-08
pattern O 0 3.0473266132702292e-09
at O 0 7.100333476728338e-08
the O 0 1.5091691807356256e-07
BRCA1 O 0 2.314004632353317e-07
locus O 0 5.071951818536036e-07
. O 0 4.5821698790859955e-07

Our O 0 9.020195079756377e-07
previous O 0 3.7439335187627876e-08
study O 0 1.296479146262186e-09
showed O 0 9.845125825691525e-10
that O 0 2.0955237545194905e-11
this O 0 4.59849380796129e-10
Ashkenazi O 0 5.033436423218518e-07
mutation O 0 4.50059101098077e-09
also O 0 1.4989613716931416e-10
occurs O 0 6.460760312160252e-12
in O 0 8.619602427650808e-12
Iraqi O 0 3.723826802470853e-09
Jews O 0 2.290615030986487e-09
with O 0 7.843193976231344e-12
a O 0 1.410670746881948e-10
similar O 0 2.4409935184266374e-10
allelic O 0 1.0691624652281462e-07
pattern O 0 2.81479355379588e-08
. O 0 4.2862885152317176e-07

We O 0 2.9212679919510265e-07
extended O 0 9.504503850621404e-08
our O 0 8.774915016829254e-09
analysis O 0 6.283478182211866e-10
to O 0 3.4138969429164945e-10
other O 0 1.206201111214611e-10
non O 0 5.88563153769428e-08
- O 0 2.561432665970642e-08
Ashkenazi O 0 8.399639028766615e-08
subsets O 0 3.2719991160945483e-09
354 O 0 4.1504035763750835e-09
of O 0 3.9158515319215326e-10
Moroccan O 0 5.290366971166804e-07
origin O 0 5.266624025779265e-09
, O 0 3.6990835394767885e-10
200 O 0 2.3171253804576963e-09
Yemenites O 0 2.851583644769562e-07
and O 0 3.2676381045426695e-10
150 O 0 2.449464409082225e-09
Iranian O 0 2.4357127870189288e-08
Jews O 0 1.0722645527039276e-07
. O 0 1.2598269449881627e-07

Heteroduplex O 0 1.4796893992752302e-05
analysis O 0 1.5341409920210936e-08
complemented O 0 3.3930862564091058e-09
by O 0 3.1600843469759e-11
direct O 0 5.2019377694279e-10
DNA O 0 4.030171751878697e-10
sequencing O 0 9.033192860385952e-09
of O 0 5.8110045664250265e-09
abnormally O 0 8.995950651069506e-09
migrating O 0 2.613102179083171e-09
bands O 0 1.2805007720828598e-08
were O 0 9.423811064834808e-09
employed O 0 2.2189058768162795e-07
. O 0 1.4451219954025873e-07

Four O 0 1.8555466851921665e-07
of O 0 1.1699032853584868e-08
Moroccan O 0 1.3368650797929149e-05
origin O 0 3.484799115938131e-09
( O 0 9.488057908790815e-12
1 O 0 2.3151894290585062e-10
. O 0 1.4227214892303941e-11
1 O 0 4.3452297315837995e-10
% O 0 1.2480621570942763e-11
) O 0 4.188090412665657e-12
and O 0 5.1986895691080726e-12
none O 0 8.256105799020474e-10
of O 0 2.350361294478631e-10
the O 0 3.4544023197469187e-10
Yemenites O 0 2.2711640212946804e-07
or O 0 6.73454347843716e-10
Iranians O 0 2.896135065100225e-08
was O 0 8.67677130145239e-09
a O 0 2.6763039007171585e-10
carrier O 0 2.4635052331412055e-10
of O 0 2.583066260886113e-10
the O 0 1.8201624651936754e-09
185delAG O 0 1.1022217449863092e-06
mutation O 0 3.997363862140446e-08
. O 0 5.4823715345264645e-08

BRCA1 O 0 3.437913255766034e-05
allelic O 0 1.8583268968086486e-07
patterns O 0 4.053716251561923e-10
were O 0 8.659931105547969e-11
determined O 0 1.551903605623295e-10
for O 0 4.495158412165523e-10
four O 0 1.2370618973633896e-09
of O 0 3.1765892694046727e-10
these O 0 1.7651833120191363e-11
individuals O 0 8.098738151461615e-13
and O 0 6.197014689596214e-12
for O 0 1.2440817820369432e-10
12 O 0 3.8928722467801435e-09
additional O 0 1.4786848190340152e-08
non O 0 2.2414853901864262e-06
- O 0 1.1834249562525656e-06
Ashkenazi O 0 1.2642141200558399e-06
185delAG O 0 2.4347102112187713e-07
mutation O 0 2.0433657543783568e-10
carriers O 0 4.0485371999299247e-11
who O 0 1.1836344127047482e-09
had O 0 2.6060563413921045e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999959468841553

Six O 0 7.532784707109386e-07
non O 0 5.645897999784211e-06
- O 0 2.9462327688634105e-07
Ashkenazi O 0 1.891177134893951e-07
individuals O 0 2.7370700150797234e-10
shared O 0 1.5486695259525618e-09
the O 0 1.0586823639968657e-09
common O 0 1.1230455454480648e-09
Ashkenazi O 0 3.1190288041216263e-07
haplotype O 0 5.020545472689264e-07
, O 0 1.9139718698824026e-09
four O 0 2.669249710152144e-09
had O 0 9.20027787287836e-09
a O 0 1.4506841283790095e-09
closely O 0 5.102491207331639e-10
related O 0 7.565831294797931e-10
pattern O 0 3.035166840081871e-10
, O 0 1.3916051470885815e-11
and O 0 1.007330156788111e-11
the O 0 5.542358794130564e-10
rest O 0 1.5323621260776576e-09
( O 0 4.508843298722809e-11
n O 0 4.1628345215372065e-09
= O 0 2.843251678541492e-08
6 O 0 3.865282316439789e-09
) O 0 6.175260303109553e-11
displayed O 0 9.758812424820462e-09
a O 0 4.560622102189882e-09
distinct O 0 1.1398507027138294e-08
BRCA1 O 0 7.020115049272135e-07
allelic O 0 7.463827387255151e-07
pattern O 0 6.799640317467492e-08
. O 0 4.71874102458969e-07

We O 0 4.157472943688845e-08
conclude O 0 7.204296537111077e-08
that O 0 2.509363827840616e-10
the O 0 2.467531734495765e-09
185delAG O 0 5.958615929557709e-06
BRCA1 O 0 9.913636631608824e-07
mutation O 0 2.270679200222503e-09
occurs O 0 4.247850682315146e-11
in O 0 5.23833684762387e-11
some O 0 6.925282569625324e-11
non O 0 2.2522327469687298e-07
- O 0 3.317966559279739e-07
Ashkenazi O 0 2.8467036372603616e-07
populations O 0 2.7468931573793043e-09
at O 0 7.443335392487427e-10
rates O 0 9.438196890698691e-10
comparable O 0 3.077265109396876e-10
with O 0 3.4065042453512717e-12
that O 0 1.853810854823834e-10
of O 0 5.0511439475542375e-09
Ashkenazim O 0 5.691264050255995e-06
. O 0 5.956871973467059e-07

The O 0 2.6474845071788877e-07
majority O 0 9.465238592909486e-10
of O 0 6.391373208458617e-09
Jewish O 0 1.539595473332156e-07
185delAG O 0 4.816336627300188e-07
mutation O 0 3.7787672990674537e-10
carriers O 0 5.425027441163799e-11
have O 0 2.311765223694806e-10
a O 0 8.260231942891494e-10
common O 0 5.3767408303428965e-09
allelic O 0 4.3647627734344496e-08
pattern O 0 3.1288863167056036e-10
, O 0 3.378997082137403e-11
supporting O 0 1.8330146289713412e-09
the O 0 5.2689745899670015e-09
founder O 0 8.26225701189287e-08
effect O 0 1.3043325530759375e-08
notion O 0 1.2018069206476412e-08
, O 0 7.068474972005134e-11
but O 0 1.4364312690695602e-11
dating O 0 1.17389931109102e-09
the O 0 2.046786629072983e-10
mutations O 0 2.144460824193839e-11
origin O 0 3.933508380127293e-11
to O 0 2.479206839822723e-10
an O 0 1.3490626150913787e-11
earlier O 0 1.2002365767926904e-10
date O 0 4.3861945187018136e-08
than O 0 6.180683742584847e-10
currently O 0 7.829376591494963e-10
estimated O 0 2.529272069562438e-10
. O 0 3.8772309807200145e-08

However O 0 3.8074059460768694e-08
, O 0 3.102571810575938e-10
the O 0 7.163426796186201e-11
different O 0 1.1883882766738907e-11
allelic O 0 5.64687940851627e-09
pattern O 0 9.68674362944455e-10
at O 0 1.3492704731277172e-08
the O 0 2.2756230677600797e-08
BRCA1 O 0 2.0665476441195096e-08
locus O 0 8.111755711581736e-09
even O 0 1.5576396839023232e-09
in O 0 6.678886332878164e-10
some O 0 1.6730161700451163e-10
Jewish O 0 4.175008339046826e-09
mutation O 0 1.6722569162741507e-10
carriers O 0 3.863052586150495e-11
, O 0 4.473636044943774e-11
might O 0 3.5640177475926293e-09
suggest O 0 1.6395324209383944e-08
that O 0 3.62409297016697e-10
the O 0 1.909989499893072e-09
mutation O 0 1.277433159252439e-10
arose O 0 3.1770680530840423e-10
independently O 0 3.621475563875265e-09
. O 0 4.829193933630904e-09
. O 0 7.705810389779799e-08

Crystal O 0 2.3015347494492744e-07
structure O 0 2.1197152477725467e-07
of O 0 7.424328032357153e-07
the O 0 1.1610092087721569e-06
hemochromatosis B-Disease 1 1.0
protein O 0 2.6697225052885187e-07
HFE O 0 6.128409950179048e-06
and O 0 8.616702351638139e-10
characterization O 0 2.4969674328190195e-08
of O 0 6.123065077190404e-08
its O 0 2.435107671061587e-09
interaction O 0 1.355414003256783e-09
with O 0 2.333052848135786e-11
transferrin O 0 1.800121935957577e-07
receptor O 0 2.3926599368451207e-08
. O 0 1.906209661228786e-07

HFE O 1 0.8932442665100098
is O 0 2.2240624275582377e-07
an O 0 1.6502615940439114e-09
MHC O 0 6.449999432334153e-07
- O 0 4.898635597783141e-05
related O 0 4.4407974201021716e-05
protein O 0 2.2238751284930913e-08
that O 0 2.2634472421345642e-11
is O 0 1.1377761796951824e-12
mutated O 0 3.173444493298483e-11
in O 0 2.967102952222689e-10
the O 0 5.9015714981569545e-08
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.00033236239687539637

HFE O 0 4.285542308934964e-05
binds O 0 2.9083519592632e-08
to O 0 1.1846830183515067e-08
transferrin O 0 4.620619264983361e-08
receptor O 0 6.094551530111403e-09
( O 0 1.2715987984801558e-10
TfR O 0 5.474466320265492e-07
) O 0 1.712396613395839e-10
and O 0 3.1116137444442415e-11
reduces O 0 5.621075271911025e-10
its O 0 7.230510634670395e-11
affinity O 0 4.189548430399981e-10
for O 0 1.1101543018199322e-09
iron O 0 7.030352833226061e-08
- O 0 8.347254265572701e-08
loaded O 0 2.910360841212878e-08
transferrin O 0 2.598464732272987e-07
, O 0 5.566749727847764e-09
implicating O 0 8.558339459341369e-07
HFE O 0 0.00018195391749031842
in O 0 5.200257646720274e-07
iron O 0 0.00026602274738252163
metabolism O 1 0.9921960830688477
. O 0 1.6944788967521163e-06

The O 0 2.273186510137748e-06
2 O 0 2.557752850407269e-06
. O 0 5.469482857733965e-07

6 O 0 3.236122938687913e-05
A O 0 1.6171513834706275e-06
crystal O 0 3.5220271143998616e-08
structure O 0 5.996051299916871e-07
of O 0 8.666872872709064e-07
HFE O 0 0.1144578605890274
reveals O 0 1.5702651978699578e-07
the O 0 2.129621812230198e-09
locations O 0 6.9566290505918e-08
of O 0 1.2094417911612254e-07
hemochromatosis B-Disease 1 1.0
mutations O 0 5.62532882497635e-08
and O 0 1.5504311168257345e-09
a O 0 1.3165077916710288e-07
patch O 0 0.017093421891331673
of O 0 4.7712717787362635e-05
histidines O 0 8.733493450563401e-05
that O 0 4.86903573015951e-10
could O 0 4.381407181508479e-10
be O 0 5.398317348692672e-10
involved O 0 4.0669903556000975e-10
in O 0 1.0560167851281221e-08
pH O 0 4.718660420621745e-06
- O 0 2.0791743793324713e-07
dependent O 0 1.1879667738412536e-07
interactions O 0 2.9528619549523683e-08
. O 0 7.30660474346223e-08

We O 0 6.639468210778432e-06
also O 0 4.6063814096442e-08
demonstrate O 0 1.6628796117856837e-07
that O 0 3.5145633070499116e-09
soluble O 0 7.323417605675786e-08
TfR O 0 1.2827101727452828e-06
and O 0 3.184993602189934e-09
HFE O 0 3.1282741019822424e-06
bind O 0 1.656531800620087e-08
tightly O 0 2.699587398069525e-08
at O 0 5.363837374261493e-08
the O 0 7.715939887020795e-09
basic O 0 1.1784493381128414e-06
pH O 0 4.660129206968122e-07
of O 0 5.072277708961792e-09
the O 0 8.971670517610164e-09
cell O 0 1.5654975982215547e-08
surface O 0 2.064434845294727e-09
, O 0 1.9257399841432488e-10
but O 0 7.269770202489312e-11
not O 0 1.6766139587787166e-09
at O 0 1.718825082264175e-08
the O 0 3.066633524895224e-08
acidic O 0 6.921673048054799e-07
pH O 0 7.816855941200629e-06
of O 0 1.5787971108238708e-07
intracellular O 0 1.1319901886963635e-06
vesicles O 0 1.952093225554563e-05
. O 0 1.3389757214099518e-06

TfR O 0 0.00012799145770259202
HFE O 0 4.786788849742152e-05
stoichiometry O 0 5.115749672768288e-07
( O 0 4.3656578352369024e-10
2 O 0 7.046069949723233e-09
1 O 0 1.68464779903843e-08
) O 0 1.037567670669759e-10
differs O 0 1.1181786607750155e-09
from O 0 1.0143640788440322e-10
TfR O 0 5.702765903947693e-08
transferrin O 0 5.379756640166988e-09
stoichiometry O 0 1.1772289809641734e-09
( O 0 1.0157225754925392e-11
2 O 0 6.192023005446856e-10
2 O 0 2.0555825930301808e-09
) O 0 1.193959792145094e-10
, O 0 6.156490595099484e-11
implying O 0 8.63287752395081e-09
a O 0 2.1253072912674753e-10
different O 0 1.4098658004946252e-11
mode O 0 1.6336732855393166e-08
of O 0 3.3911176644529917e-10
binding O 0 1.0786759263581303e-09
for O 0 3.747846921697828e-09
HFE O 0 2.7171539841219783e-05
and O 0 1.7364278903642116e-08
transferrin O 0 2.2164947210967512e-07
to O 0 3.52818609883343e-08
TfR O 0 1.939879894052865e-06
, O 0 7.174971727863522e-10
consistent O 0 4.506406359183757e-09
with O 0 5.885283146239706e-12
our O 0 6.4874927652169845e-09
demonstration O 0 1.6911736011593348e-08
that O 0 3.31105309836488e-10
HFE O 0 5.990157660562545e-06
, O 0 1.0438372832766163e-08
transferrin O 0 1.8389097533599852e-07
, O 0 4.983477186470964e-09
and O 0 7.600978735311514e-10
TfR O 0 5.288072202347394e-07
form O 0 3.916187651942238e-10
a O 0 1.876411914736309e-09
ternary O 0 2.367826823501673e-08
complex O 0 1.431619011782459e-06
. O 0 1.7005837662509293e-06

Identification O 0 2.0969034721929347e-06
of O 0 9.868013961522593e-08
three O 0 4.3407652472460256e-10
novel O 0 5.627319166201517e-10
mutations O 0 1.1759222762197652e-10
and O 0 1.0645798478869928e-11
a O 0 8.40990263539787e-11
high O 0 2.592771775056235e-09
frequency O 0 6.883166037141564e-08
of O 0 1.0615137213676462e-08
the O 0 1.0432918529090784e-08
Arg778Leu O 0 1.4870475979478215e-06
mutation O 0 6.988393752571653e-10
in O 0 1.816159583833965e-10
Korean O 0 3.456527863932024e-08
patients O 0 4.6484063820351196e-10
with O 0 1.6717523199094586e-11
Wilson B-Disease 0 3.633742267084017e-07
disease I-Disease 0 2.0338374540074255e-08
. O 0 5.329693664180013e-08

Four O 0 4.847949597319712e-08
mutations O 0 1.964471085802444e-10
- O 0 1.3735638182410526e-09
- O 0 4.518826202115633e-09
R778L O 0 2.5368413503201737e-07
, O 0 2.5118490620812395e-10
A874V O 0 8.272443352552727e-08
, O 0 1.4436062067968436e-10
L1083F O 0 3.045811425295142e-08
, O 0 4.5868760178979784e-11
and O 0 2.728009224767236e-12
2304delC O 0 1.5796111640931088e-10
- O 0 3.162176423487928e-11
- O 0 3.0969904418753913e-10
in O 0 1.772319513371201e-10
the O 0 3.746808419080594e-10
copper O 0 9.361462716128699e-10
- O 0 7.042854632821616e-10
transporting O 0 4.3982029129807643e-10
enzyme O 0 1.9164048126185662e-09
, O 0 4.405205089597075e-10
P O 0 2.3228932377605815e-07
- O 0 4.389726271369909e-08
type O 0 2.6839385824928286e-08
ATPase O 0 2.2011481632944196e-06
( O 0 3.3997504811367207e-10
ATP7B O 0 1.035487798617396e-06
) O 0 3.4011175820136685e-11
, O 0 5.381153855843479e-12
were O 0 8.585899352597792e-12
identified O 0 2.948985153294892e-11
in O 0 3.237430462599278e-11
Korean O 0 2.7241044975312434e-08
Patients O 0 1.0258186522449364e-09
with O 0 1.0592004703879887e-11
Wilson B-Disease 0 8.71108170485968e-07
disease I-Disease 0 1.7662628692960425e-07
. O 0 3.567012356597843e-07

Arg778Leu O 0 8.446632818959188e-06
, O 0 3.1875826422833597e-09
the O 0 1.0445497800048997e-09
most O 0 3.925968231066612e-11
frequently O 0 1.3835389778282803e-10
reported O 0 2.4847074397982283e-10
mutation O 0 4.183256518963674e-10
of O 0 1.6170467187492932e-09
this O 0 2.959941458602344e-10
enzyme O 0 2.3084606448620093e-10
, O 0 4.6612245313548684e-11
was O 0 8.920136296275416e-10
found O 0 2.224962228347671e-11
in O 0 2.179693925352666e-11
six O 0 1.1364283125647745e-10
of O 0 2.3096352955165322e-11
eight O 0 2.6749194872999205e-11
unrelated O 0 1.3035428292340612e-10
patients O 0 4.1593783972615483e-11
studied O 0 7.894848108591646e-10
, O 0 1.2003188720743907e-10
an O 0 6.512491934618225e-11
allele O 0 3.3807219246284603e-09
frequency O 0 5.787192947082076e-08
of O 0 2.650960162497995e-08
37 O 0 8.934530342230573e-07
. O 0 7.158233188420127e-07

5 O 0 2.6788250124809565e-06
% O 0 1.834579066439801e-08
, O 0 3.0327187983125725e-10
which O 0 6.362707236085008e-12
is O 0 7.435534393057663e-13
considerably O 0 4.711368101206759e-11
higher O 0 2.485029959586882e-10
than O 0 6.780485461294061e-12
those O 0 1.3991903122234639e-11
in O 0 4.1765573638441467e-11
other O 0 1.4654784330492276e-10
Asian O 0 2.135239896006169e-08
populations O 0 8.930622907854513e-10
. O 0 1.8954304792373478e-08

The O 0 9.279640522663613e-08
novel O 0 4.659922225869195e-09
single O 0 2.4791699804183054e-09
nucleotide O 0 1.291524540647515e-07
deletion O 0 8.828135378280422e-08
, O 0 7.040141802860944e-10
2304delC O 0 5.831114435750351e-08
, O 0 3.099330514455545e-10
was O 0 2.9085669428496885e-09
found O 0 1.8800254408812833e-10
in O 0 3.361943778923404e-10
one O 0 4.4632655904486285e-10
patient O 0 3.0655500360410315e-09
. O 0 2.2143856526213312e-08

Since O 0 4.4514614216950577e-08
a O 0 1.010905359422054e-09
mutation O 0 2.5907524389690018e-11
at O 0 1.912255909175542e-10
cDNA O 0 2.9962905490066305e-09
nucleotide O 0 3.907730317109781e-08
2302 O 0 1.01865480246488e-05
( O 0 2.3743457200353646e-10
2302insC O 0 3.79642735026664e-08
) O 0 1.385218467708782e-10
had O 0 6.474410452206314e-10
been O 0 2.481879979310264e-10
previously O 0 7.545928881746988e-10
described O 0 1.4570224193821701e-10
, O 0 4.428409462048366e-12
this O 0 5.405915732420441e-12
region O 0 4.8121787804555893e-11
of O 0 5.11250597412527e-10
the O 0 1.601607069190436e-09
ATP7B O 0 2.27092004934093e-06
gene O 0 3.371153578513031e-09
may O 0 9.90640547371413e-09
be O 0 1.1470302041516334e-08
susceptible O 0 1.03270778595288e-08
to O 0 3.045561669523522e-08
gene O 0 9.243833432037718e-08
rearrangements O 0 1.4881675269862171e-05
causing O 0 1.369543383589189e-06
Wilson B-Disease 0 0.00012139143655076623
disease I-Disease 0 1.212598704114498e-06
. O 0 2.2510388930641057e-07

Disruption O 0 3.5988574381917715e-05
of O 0 3.3251572517656314e-07
splicing O 0 4.3492228485320084e-08
regulated O 0 7.947507896233219e-08
by O 0 8.718788468975447e-10
a O 0 4.225567895588256e-09
CUG O 0 6.468109745583206e-07
- O 0 2.1128032656747564e-09
binding O 0 1.2760091872010548e-09
protein O 0 7.123621692528559e-09
in O 0 1.1590247872561577e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 3.68280743714422e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.854161150229629e-07
DM B-Disease 1 1.0
) O 0 1.5919715323775563e-08
is O 0 8.172005849793607e-10
caused O 0 2.0360130248420205e-10
by O 0 2.752686099893875e-11
a O 0 1.0314120668653004e-09
CTG O 0 4.631498740081952e-08
expansion O 0 3.6440432893414254e-09
in O 0 6.329644031133341e-10
the O 0 4.1656922356025916e-10
3 O 0 1.8684405134195003e-09
untranslated O 0 2.580046327693708e-07
region O 0 4.963679245406638e-09
of O 0 5.233448785446626e-09
the O 0 5.4848296571208266e-08
DM B-Disease 1 1.0
gene O 0 1.1513964182086056e-06
. O 0 1.4119959814706817e-06

One O 0 4.318157831306735e-09
model O 0 6.069227787008913e-09
of O 0 9.915554599615461e-09
DM B-Disease 1 1.0
pathogenesis O 1 0.9999990463256836
suggests O 0 5.3437812397305606e-08
that O 0 6.0628091089198755e-12
RNAs O 0 1.1693801482692834e-10
from O 0 1.3764749340339222e-09
the O 0 4.5077128696391355e-09
expanded O 0 1.0966354047070581e-08
allele O 0 6.452097189857398e-10
create O 0 1.2078603742193827e-11
a O 0 6.416810832687858e-11
gain O 0 5.13892484121925e-09
- O 0 5.699652749768802e-09
of O 0 1.998477827669376e-09
- O 0 1.3116991937067723e-09
function O 0 8.669273077188677e-10
mutation O 0 6.961702048169371e-11
by O 0 3.7362214017067075e-12
the O 0 1.6961694548900397e-10
inappropriate O 0 2.4036459489451545e-09
binding O 0 1.5490831950515371e-09
of O 0 3.3378957375873597e-09
proteins O 0 2.4398845790973844e-11
to O 0 1.7693648768357662e-09
the O 0 8.491323200132683e-09
CUG O 0 1.6169653463293798e-05
repeats O 0 1.0591922716685076e-07
. O 0 1.4559022076809924e-07

Data O 0 2.5836018835434515e-07
presented O 0 1.0375171832777141e-08
here O 0 6.50533538149034e-09
indicate O 0 1.2752847666774869e-08
that O 0 2.1434148900212335e-10
the O 0 7.752402608751652e-10
conserved O 0 7.289271852783941e-09
heterogeneous O 0 3.203797760420457e-08
nuclear O 0 1.685762072156649e-06
ribonucleoprotein O 0 1.312614244852739e-06
, O 0 5.459682927977383e-09
CUG O 0 4.0287392266691313e-07
- O 0 4.846615553333322e-09
binding O 0 3.6189415908438605e-09
protein O 0 1.0559275676058633e-09
( O 0 8.99080896538118e-12
CUG O 0 1.477304181207728e-07
- O 0 1.0116214532729373e-08
BP O 0 3.178447371965376e-08
) O 0 4.030400319043892e-11
, O 0 1.9969670014829966e-11
may O 0 3.8000527724513233e-10
mediate O 0 1.2894489920256547e-08
the O 0 2.054038272802927e-09
trans O 0 2.2388562115338573e-08
- O 0 2.386142838872729e-08
dominant O 0 3.9680703167732645e-09
effect O 0 8.761602998674789e-09
of O 0 8.018470332160632e-10
the O 0 5.218683263308321e-10
RNA O 0 5.341272313330592e-09
. O 0 8.752487445917723e-08

CUG O 0 0.00016913651779759675
- O 0 3.963779363402864e-06
BP O 0 1.5988860013749218e-06
was O 0 1.9255582017763118e-08
found O 0 4.420681529171411e-11
to O 0 5.637303991667952e-12
bind O 0 8.754239520791796e-12
to O 0 3.902884682105423e-10
the O 0 5.148448334324485e-10
human O 0 7.753856223757793e-09
cardiac O 0 0.008466043509542942
troponin O 0 7.163018017308787e-05
T O 0 2.1023179215262644e-06
( O 0 2.794324771571155e-10
cTNT O 0 8.16163918671009e-08
) O 0 3.941544313157408e-11
pre O 0 4.32247766468663e-08
- O 0 1.580431674419458e-09
messenger O 0 1.445943698108465e-09
RNA O 0 2.686906530602329e-10
and O 0 6.715467071316539e-11
regulate O 0 2.888045358417912e-10
its O 0 2.3169387242116812e-10
alternative O 0 1.6215537357311405e-08
splicing O 0 6.887788117637683e-08
. O 0 2.0802234246275475e-07

Splicing O 0 2.5032005623870646e-07
of O 0 1.8660556122540584e-07
cTNT O 0 2.5755621209100354e-06
was O 0 6.378637351645011e-08
disrupted O 0 1.737841728299827e-07
in O 0 3.695659955837982e-08
DM B-Disease 1 1.0
striated O 0 4.178694143774919e-05
muscle O 0 5.290770559440716e-07
and O 0 3.5535510090056732e-09
in O 0 8.657177752446898e-10
normal O 0 7.553953018657467e-09
cells O 0 1.439122931934378e-09
expressing O 0 4.437528677847524e-10
transcripts O 0 4.292209254685986e-09
that O 0 7.09032610402005e-10
contain O 0 7.808203861259244e-09
CUG O 0 8.208900908357464e-06
repeats O 0 3.8426074411290756e-07
. O 0 6.805413477195543e-07

Altered O 0 1.6251309716608375e-05
expression O 0 3.7684033031837316e-06
of O 0 5.133108516020002e-08
genes O 0 1.1521341658493611e-09
regulated O 0 2.8469308688272577e-08
posttranscriptionally O 0 2.7497600285641965e-07
by O 0 3.4388238923099834e-09
CUG O 0 6.333505007205531e-05
- O 0 1.8322189134778455e-06
BP O 0 2.4228208417298447e-07
therefore O 0 1.1992874471289383e-09
may O 0 1.9917337223951392e-10
contribute O 0 8.312008303867913e-10
to O 0 1.2750098754565897e-08
DM B-Disease 1 1.0
pathogenesis O 0 0.0010825956705957651
. O 0 5.63688544730212e-08
. O 0 1.256004793503962e-07

Identification O 0 1.8712590872382862e-06
of O 0 6.430627763620578e-08
a O 0 2.257051656684439e-09
novel O 0 9.067267825457748e-09
nonsense O 0 7.734671925163639e-08
mutation O 0 5.397267077711376e-10
and O 0 6.506383626314616e-11
a O 0 2.466312154503214e-10
missense O 0 5.752641696332716e-10
substitution O 0 1.6120763612903488e-09
in O 0 1.3261514109075279e-09
the O 0 3.00874658520911e-09
vasopressin O 0 3.689202117129753e-07
- O 0 2.657754372137333e-08
neurophysin O 0 1.2161095241935982e-07
II O 0 5.682807682205748e-07
gene O 0 1.2109642177904334e-09
in O 0 1.7477742586535783e-09
two O 0 6.662371210275353e-10
Spanish O 0 1.874724659955973e-07
kindreds O 0 4.682832695834804e-06
with O 0 9.773565068371681e-09
familial B-Disease 1 0.9997838139533997
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 2.087432221742347e-05

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 8.160704823012566e-08
FNDI B-Disease 1 1.0
) O 0 2.5460893837703225e-08
is O 0 3.853136920639599e-09
an O 0 3.273584736618318e-09
autosomal B-Disease 1 0.999220609664917
dominant I-Disease 1 0.9999452829360962
disease I-Disease 0 0.15458856523036957
caused O 0 2.1431789676285007e-09
by O 0 3.3603266003101595e-11
deficiency O 0 1.0286227869471531e-08
in O 0 3.367453160763034e-08
the O 0 3.024940724571934e-07
antidiuretic O 0 3.7364541185525013e-06
hormone O 0 1.0902829927772473e-07
arginine O 0 9.45131972684976e-08
vasopressin O 0 1.0920938109393319e-07
( O 0 5.276703726742049e-11
AVP O 0 2.290966421014673e-07
) O 0 6.312662632207422e-12
encoded O 0 3.971276432701565e-11
by O 0 2.3318961345220046e-11
the O 0 2.5952453519551e-09
AVP O 0 2.3505588615080342e-05
- O 0 2.532738960780989e-07
neurophysin O 0 4.148477273702156e-06
II O 0 0.039218612015247345
( O 0 8.445789845268337e-09
AVP O 0 0.00017419848882127553
- O 0 1.3766994300112856e-07
NPII O 0 2.393951035628561e-06
) O 0 1.184559811351349e-10
gene O 0 6.042288891450198e-10
on O 0 3.2192339460834773e-08
chromosome O 0 1.6092884891349968e-07
20p13 O 0 1.634333239053376e-05
. O 0 5.098085011923104e-07

In O 0 6.062575330645359e-09
this O 0 1.8182599870186777e-10
study O 0 1.383407138844106e-10
, O 0 8.845984708627519e-12
we O 0 7.905542193098469e-11
analyzed O 0 4.424217936449537e-10
two O 0 6.267005664417624e-11
families O 0 4.462293035079057e-11
with O 0 4.2185255288984536e-11
FNDI B-Disease 1 1.0
using O 0 5.5703499590720185e-09
direct O 0 1.4492854027992053e-08
automated O 0 1.6897942600735405e-07
fluorescent O 0 5.1445567805785686e-08
, O 0 1.563503548851486e-09
solid O 0 5.316878048944318e-09
phase O 0 3.922484115292946e-09
, O 0 3.6714714601870924e-11
single O 0 1.6378055855970075e-10
- O 0 2.472746452042429e-10
stranded O 0 6.998638335531382e-10
DNA O 0 2.1367033142816183e-11
sequencing O 0 5.260657465200325e-10
of O 0 2.5921484958502106e-09
PCR O 0 1.2618580740308971e-06
- O 0 5.694456376659218e-06
amplified O 0 4.553987309918739e-05
AVP O 0 0.0007337682764045894
- O 0 1.5242641211443697e-06
NPII O 0 2.556756226113066e-05
DNA O 0 2.0340553419373464e-07
. O 0 1.399470619389831e-07

In O 0 9.836740311186531e-09
one O 0 1.8834782344878676e-10
of O 0 1.1100648872330865e-10
the O 0 8.190726569212714e-11
families O 0 1.0222958764238843e-11
, O 0 9.47012260277269e-12
affected O 0 1.8172362920010343e-11
individuals O 0 2.685392706813783e-12
presented O 0 4.319360424887009e-09
a O 0 1.972108032433084e-09
novel O 0 9.036657644401203e-09
nonsense O 0 2.5328469988039615e-08
mutation O 0 6.927502321785184e-11
in O 0 6.129634994023192e-11
exon O 0 3.604390674816216e-10
3 O 0 5.012495307710196e-09
of O 0 2.045253966187488e-09
the O 0 5.693435167763994e-10
gene O 0 5.923010693020814e-11
, O 0 1.4860650904280348e-11
consisting O 0 5.438980429234297e-12
in O 0 1.9204351650592422e-11
a O 0 9.992894012267328e-11
G O 0 8.724381217461996e-09
to O 0 1.7295722187782303e-08
T O 0 1.468897465883856e-07
transition O 0 4.3013411499259746e-08
at O 0 1.7836786270208904e-08
nucleotide O 0 1.0937527328280794e-08
2101 O 0 5.437912022898672e-07
, O 0 3.7591132984182707e-10
which O 0 1.6020995294296903e-12
produces O 0 1.3884009773031808e-13
a O 0 1.2196688971288783e-12
stop O 0 4.7869309210968325e-11
signal O 0 8.22203582995229e-10
in O 0 3.4175602348085476e-09
codon O 0 1.5687204779624153e-07
82 O 0 4.089241087967821e-07
( O 0 6.027041088429996e-09
Glu O 0 2.6276302378391847e-05
) O 0 5.453604678962165e-09
of O 0 1.6335706121139992e-08
NPII O 0 5.394591062213294e-05
. O 0 3.03059437101183e-07

The O 0 2.903558709022036e-07
premature O 0 6.162837848933123e-07
termination O 0 3.729223152504346e-08
eliminates O 0 4.1092562241829e-08
part O 0 3.4003166948792796e-09
of O 0 2.35848283125506e-08
the O 0 1.2383916114799831e-08
C O 0 2.776921448344183e-08
- O 0 3.098503120746443e-10
terminal O 0 2.2804189647729345e-09
domain O 0 2.2813161137946736e-08
of O 0 6.411455255594944e-10
NPII O 0 7.767667966618319e-07
, O 0 9.81768624730428e-11
including O 0 1.637935967413462e-11
a O 0 6.538168617620244e-11
cysteine O 0 7.11400174879806e-11
residue O 0 1.1459631465982056e-08
in O 0 9.683381874125985e-10
position O 0 3.857720685118693e-07
85 O 0 1.4951558569009649e-06
, O 0 2.849220304135258e-10
which O 0 2.570295322065763e-12
could O 0 6.092566121745913e-12
be O 0 8.066936875439357e-12
involved O 0 6.357042062893337e-12
in O 0 9.997775524128727e-11
the O 0 1.9033308262805804e-09
correct O 0 3.671330546239915e-07
folding O 0 2.4143511723195843e-07
of O 0 8.018551156396825e-09
the O 0 3.915564050771536e-08
prohormone O 0 0.00026618814445100725
. O 0 1.2285350976526388e-06

In O 0 2.538049104217066e-09
the O 0 2.24220975120204e-09
second O 0 9.090177499615493e-09
family O 0 2.136068683045167e-10
, O 0 3.445425195147678e-11
a O 0 1.5976693926167407e-11
G279A O 0 2.944776644753233e-10
substitution O 0 3.112594626486498e-10
at O 0 6.582416833822435e-10
position O 0 1.526190063216859e-09
- O 0 1.428939966352516e-09
1 O 0 1.0746166623221143e-08
of O 0 8.234685711094869e-10
the O 0 4.2323738957961154e-10
signal O 0 3.1091726970799982e-09
peptide O 0 5.630518273846974e-10
was O 0 3.932656866822981e-09
observed O 0 5.796897961651837e-10
in O 0 3.178049767793567e-10
all O 0 2.8358287940122295e-10
affected O 0 1.61112873042768e-10
individuals O 0 4.413916107615101e-11
. O 0 3.596894870838696e-08

This O 0 4.5088330580256297e-07
missense O 0 2.2207561414688826e-05
mutation O 0 1.0927563209861546e-07
, O 0 3.7455598622671005e-09
which O 0 6.055361212453647e-10
replaces O 0 4.690734556334064e-07
Ala O 0 9.408576443092898e-05
with O 0 2.9544717783380747e-09
Thr O 1 0.99992835521698
, O 0 6.87053125503212e-09
is O 0 6.225878146359776e-11
frequent O 0 1.006819627669131e-10
among O 0 1.413501538038986e-10
FNDI B-Disease 1 1.0
patients O 0 1.7302429000665143e-07
and O 0 1.9978291243560875e-10
is O 0 6.577794559037287e-11
thought O 0 5.4153742601315e-10
to O 0 5.140892711530398e-10
reduce O 0 2.679885868772658e-09
the O 0 3.6869982622533826e-09
efficiency O 0 6.93331472234604e-08
of O 0 9.538425160826591e-09
cleavage O 0 1.232330792966252e-09
by O 0 1.099902613432846e-09
signal O 0 4.3162947349628666e-07
peptidases O 0 2.642200342961587e-06
. O 0 7.704326776547532e-08
. O 0 2.997933279402787e-07

Genetic O 0 3.1986084536583803e-07
heterogeneity O 0 3.744140713024535e-07
of O 0 1.4713819496137148e-07
Saethre B-Disease 1 0.9993507266044617
- I-Disease 1 0.9999998807907104
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.318657627535913e-09
due O 0 6.078742131876425e-08
to O 0 6.973446886604506e-08
TWIST O 0 9.33094725041883e-06
and O 0 2.6633497896000335e-07
FGFR O 0 0.00867354217916727
mutations O 0 3.846845970656432e-07
. O 0 6.492446118500084e-07

Thirty O 0 7.050481144688092e-06
- O 0 2.6809616429090966e-06
two O 0 1.438845709245129e-09
unrelated O 0 2.393215625673406e-09
patients O 0 2.367237239564446e-10
with O 0 1.7756698617987093e-13
features O 0 4.4256531772646213e-10
of O 0 6.437694377581238e-09
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 5.771944255883454e-09
a O 0 1.084148593122336e-08
common O 0 2.4975588530651294e-07
autosomal B-Disease 0 1.7561213098815642e-05
dominant I-Disease 0 0.0022283175494521856
condition I-Disease 1 1.0
of O 1 0.9851456880569458
craniosynostosis B-Disease 1 1.0
and O 0 8.649384426462348e-07
limb B-Disease 1 0.999916672706604
anomalies I-Disease 0 0.0007653849897906184
, O 0 1.4073175957918238e-09
were O 0 3.8505634791796695e-10
screened O 0 1.365994983792973e-09
for O 0 3.1426079516450045e-09
mutations O 0 5.219718546278784e-10
in O 0 5.203250719176822e-09
TWIST O 0 6.591317287529819e-07
, O 0 8.63291038655234e-09
FGFR2 O 0 6.765707439626567e-06
, O 0 2.6437936284651187e-09
and O 0 2.8000450846832337e-09
FGFR3 O 0 3.880105577991344e-05
. O 0 4.6912535367482633e-07

Nine O 0 8.551220531671788e-08
novel O 0 6.627735693598424e-09
and O 0 1.338241295556486e-09
three O 0 3.417982008535603e-10
recurrent O 0 1.5750879711617927e-08
TWIST O 0 1.7352880377075053e-07
mutations O 0 2.1840824704355555e-09
were O 0 6.492910653577155e-10
found O 0 1.0986860726758252e-10
in O 0 1.4488057975547974e-10
12 O 0 1.4419454075209615e-08
families O 0 9.170874060160372e-10
. O 0 2.5546459170300295e-08

Seven O 0 3.0232904180138576e-08
families O 0 7.076622621227102e-11
were O 0 5.72180185176574e-11
found O 0 2.146646055356527e-11
to O 0 2.0001625355980934e-10
have O 0 3.8434827542843664e-10
the O 0 5.353103293970207e-09
FGFR3 O 0 7.770568481646478e-05
P250R O 0 8.876168976712506e-06
mutation O 0 1.5775142969687295e-08
, O 0 3.1569649672213984e-10
and O 0 1.9618424940137658e-10
one O 0 1.5730537705760383e-10
individual O 0 4.993157970423212e-11
was O 0 3.0744153889372683e-09
found O 0 1.2155038087158232e-10
to O 0 1.0952801998698192e-09
have O 0 6.904724014766828e-10
an O 0 1.982054798066457e-10
FGFR2 O 0 9.115041166296578e-07
VV269 O 0 6.078886940485972e-07
- O 0 7.740412399925845e-08
270 O 0 5.668713498607758e-08
deletion O 0 3.6314452245278517e-07
. O 0 4.1957267171710555e-07

To O 0 2.721736258592955e-08
date O 0 1.6528021262729453e-07
, O 0 7.054443695864165e-10
our O 0 5.741723763108553e-10
detection O 0 1.2270863214425276e-09
rate O 0 1.2898583590104096e-10
for O 0 1.747502489934938e-11
TWIST O 0 4.2606131955835735e-08
or O 0 8.29304411809062e-08
FGFR O 0 3.4554515877971426e-05
mutations O 0 1.179316755361981e-09
is O 0 1.4090136175870516e-11
68 O 0 6.086369741531428e-10
% O 0 3.1379329690217617e-11
in O 0 4.156800598176247e-11
our O 0 4.259798291883499e-09
Saethre B-Disease 0 4.5776647311868146e-05
- I-Disease 0 0.0008523383876308799
Chotzen I-Disease 1 0.9991798996925354
syndrome I-Disease 1 0.9999996423721313
patients O 0 9.052479299498373e-08
, O 0 8.569097688371219e-12
including O 0 4.245305062350324e-12
our O 0 2.0900849939664568e-09
five O 0 2.352635586344576e-10
patients O 0 2.8785957992272238e-11
elsewhere O 0 8.27897084221263e-10
reported O 0 1.3654454233957836e-09
with O 0 4.893353500179387e-10
TWIST O 0 4.576865831040777e-05
mutations O 0 1.4448879710471374e-06
. O 0 3.924000793631421e-06

More O 0 1.4630502143120339e-08
than O 0 4.86511830821712e-10
35 O 0 8.6994900172499e-09
different O 0 8.450443123031448e-10
TWIST O 0 1.0817612405844557e-07
mutations O 0 5.089916044198617e-09
are O 0 8.678914531490278e-11
now O 0 6.891418685706086e-11
known O 0 2.0168421099864275e-10
in O 0 1.5984170931293562e-10
the O 0 2.835039147885965e-10
literature O 0 5.351061371783317e-09
. O 0 2.338134841295414e-08

The O 0 1.4691443084302591e-06
most O 0 4.860130520256689e-09
common O 0 6.178125788736111e-10
phenotypic O 0 3.42966655075827e-09
features O 0 3.2989073694977833e-09
, O 0 3.191959890846974e-11
present O 0 1.808139749037707e-11
in O 0 3.014706193016359e-11
more O 0 1.6084129471002906e-12
than O 0 1.1870873208030819e-12
a O 0 3.879844362453255e-11
third O 0 1.3469658721732003e-09
of O 0 4.558167454593587e-10
our O 0 5.194385810369795e-09
patients O 0 6.44292341700492e-10
with O 0 2.4630953526783017e-11
TWIST O 0 6.704188422190782e-07
mutations O 0 7.5633565188582e-08
, O 0 5.635786060054215e-09
are O 0 1.6708995298486684e-09
coronal B-Disease 0 9.962589047063375e-07
synostosis I-Disease 0 8.801872354524676e-06
, O 0 2.2192566007106507e-08
brachycephaly B-Disease 0 2.7845706426887773e-05
, O 0 1.2313215336234862e-07
low B-Disease 0 0.0003032950626220554
frontal I-Disease 1 0.9999998807907104
hairline I-Disease 1 1.0
, O 0 0.00015539684682153165
facial B-Disease 1 1.0
asymmetry I-Disease 1 1.0
, O 0 1.0974995348078664e-06
ptosis B-Disease 1 0.9989902377128601
, O 0 4.8098552696274055e-08
hypertelorism B-Disease 0 0.00013695353118237108
, O 0 1.262901161425134e-08
broad B-Disease 0 6.493288537967601e-07
great I-Disease 0 0.0006487464997917414
toes I-Disease 0 0.3094783127307892
, O 0 3.073894916383324e-08
and O 0 4.718720525431763e-09
clinodactyly B-Disease 0 1.9388351574889384e-05
. O 0 5.707618129235925e-07

Significant O 0 1.490042905061273e-06
intra O 0 5.559565397561528e-05
- O 0 1.914365384436678e-06
and O 0 9.970515080226505e-09
interfamilial O 0 8.822326890367549e-06
phenotypic O 0 9.950874613195992e-08
variability O 0 7.433464954686997e-09
is O 0 1.4290802048677609e-11
present O 0 1.1653183626392227e-11
for O 0 1.3832619771836363e-10
either O 0 4.112343354734094e-09
TWIST O 0 4.6340082349161094e-07
mutations O 0 2.6747807524429845e-08
or O 0 2.464240900224013e-08
FGFR O 0 1.6997786588035524e-05
mutations O 0 9.251770194396158e-08
. O 0 2.2281831491000048e-07

The O 0 3.5213562910030305e-07
overlap O 0 4.088832383786212e-09
in O 0 6.064861945986877e-10
clinical O 0 5.808651892813543e-10
features O 0 8.354218705708405e-11
and O 0 3.487061117288248e-12
the O 0 7.23549137271462e-11
presence O 0 1.0357762564305872e-10
, O 0 1.1494332395611817e-11
in O 0 3.73405056874887e-11
the O 0 1.4164648620695885e-10
same O 0 7.081739361591843e-11
genes O 0 2.7109983702366947e-10
, O 0 4.2535605593307935e-10
of O 0 7.189245865291127e-10
mutations O 0 6.893745990721456e-11
for O 0 5.921926837793023e-11
more O 0 1.3383650090958987e-11
than O 0 4.37287255017349e-11
one O 0 2.0894859453779446e-10
craniosynostotic B-Disease 0 3.5051129998464603e-07
condition I-Disease 0 1.6893269503270858e-06
- O 0 3.645045865141583e-08
such O 0 3.4685723182548145e-09
as O 0 1.547435291016086e-09
Saethre B-Disease 0 5.752273750658787e-07
- I-Disease 0 2.6680039511006726e-08
Chotzen I-Disease 0 1.0421790648251772e-06
, I-Disease 0 1.088345635835708e-09
Crouzon I-Disease 0 8.57253235153621e-06
, I-Disease 0 3.155955274891653e-09
and I-Disease 0 1.8469930029851866e-09
Pfeiffer I-Disease 0 2.071555172733497e-05
syndromes I-Disease 0 0.001473587122745812
- O 0 0.12570476531982422
support O 0 0.2726339101791382
the O 0 2.6414722924528178e-06
hypothesis O 0 1.1869289551214024e-08
that O 0 7.375423188848984e-12
TWIST O 0 2.2665598287119337e-09
and O 0 7.909015664608887e-10
FGFRs O 0 1.9688474139911705e-07
are O 0 5.965550275988107e-11
components O 0 3.252585534241348e-09
of O 0 1.4774802492567574e-09
the O 0 1.0677777551038048e-09
same O 0 5.833666882892885e-10
molecular O 0 1.3855090685854776e-10
pathway O 0 6.113277939423511e-11
involved O 0 1.0972571809486631e-11
in O 0 5.2203831535369005e-11
the O 0 5.568446259651694e-10
modulation O 0 1.4445282658925862e-06
of O 0 2.984201330491487e-07
craniofacial O 1 1.0
and O 0 2.092807136477859e-07
limb O 0 2.236169166280888e-06
development O 0 4.5518298463775864e-08
in O 0 4.118880236880784e-10
humans O 0 2.1806846606242658e-10
. O 0 1.7193872714482694e-10
. O 0 8.37733171721311e-09

Mutation O 0 2.1797054827743523e-08
analysis O 0 1.5628595084749008e-09
of O 0 2.4939483811436958e-09
UBE3A O 0 0.002738324459642172
in O 0 3.746942093130201e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.6415842765127309e-06
. O 0 2.4356429761951404e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.5977207112882752e-08
AS B-Disease 1 1.0
) O 0 4.271528408761327e-10
is O 0 3.578086091304833e-11
caused O 0 3.187725083897419e-11
by O 0 1.2165607930769706e-11
chromosome O 0 9.185304072900635e-09
15q11 O 0 7.948377742650337e-07
- O 0 2.245794092914366e-07
q13 O 0 1.5578001466565183e-06
deletions O 0 7.321155237605126e-08
of O 0 1.733577725815394e-09
maternal O 0 2.97541440374971e-08
origin O 0 2.125389420015722e-09
, O 0 7.111043698326824e-11
by O 0 2.69140369713039e-11
paternal O 0 0.21965253353118896
uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999924898147583
( O 0 3.217969535285192e-08
UPD B-Disease 1 1.0
) O 0 1.9094650305362393e-09
15 O 0 1.6709703842821e-08
, O 0 1.983597869292808e-10
by O 0 1.0697626812161687e-10
imprinting O 0 3.9787235436961055e-05
defects O 0 2.0038158254465088e-05
, O 0 1.1961028834051035e-09
and O 0 1.347368605575383e-10
by O 0 5.240535436157323e-11
mutations O 0 2.05316375012643e-10
in O 0 1.1930543220017853e-09
the O 0 1.7961772513785945e-08
UBE3A O 0 2.2596414055442438e-05
gene O 0 1.256361912282955e-07
. O 0 1.7727829799696337e-06

UBE3A O 0 0.0020428462885320187
encodes O 0 5.43597309388133e-07
a O 0 2.3859291431449492e-08
ubiquitin O 0 1.7182218314815145e-08
- O 0 1.3680634403101521e-08
protein O 0 5.666372371315731e-10
ligase O 0 4.197965530750025e-09
and O 0 2.420511791001445e-09
shows O 0 1.482150082665612e-07
brain O 0 1.541214260214474e-06
- O 0 1.8746175101114204e-07
specific O 0 3.497206364500016e-07
imprinting O 0 0.0006863336311653256
. O 0 6.033961199136684e-06

Here O 0 1.1431986735033206e-07
we O 0 9.9901988903639e-09
describe O 0 1.8184630690143422e-08
UBE3A O 0 4.942858140566386e-05
coding O 0 0.00010172223119297996
- O 0 5.1807604904752225e-05
region O 0 6.108542720539845e-07
mutations O 0 9.078070206669508e-08
detected O 0 2.289083411710635e-08
by O 0 7.263852019878669e-11
SSCP O 0 5.819392185912875e-07
analysis O 0 5.546800241340577e-10
in O 0 3.945442583752623e-10
13 O 0 3.971661044488428e-08
AS B-Disease 1 1.0
individuals O 0 4.75772997388102e-11
or O 0 2.6154595156313576e-10
families O 0 8.73303027115746e-11
. O 0 2.8424473885735324e-09

Two O 0 6.858384438146459e-08
identical O 0 1.0873834277447259e-08
de O 0 4.152290671299852e-07
novo O 0 2.77070853371697e-07
5 O 0 5.995776746203774e-07
- O 0 2.817641302499396e-07
bp O 0 9.943569523329643e-08
duplications O 0 1.1909353503369857e-07
in O 0 1.9918497073945218e-08
exon O 0 1.2802802018541115e-07
16 O 0 2.47240024009443e-07
were O 0 2.8351609060450755e-08
found O 0 8.530641082415968e-09
. O 0 8.649676175309651e-08

Among O 0 1.1213337813842372e-08
the O 0 1.7403992691455983e-09
other O 0 8.620807540049569e-11
11 O 0 1.0061232957880861e-09
unique O 0 9.171084447423539e-10
mutations O 0 6.92565615967311e-10
, O 0 1.4109829971076238e-10
8 O 0 3.4332877874021506e-08
were O 0 2.827719036702092e-08
small O 0 5.933125546420115e-09
deletions O 0 3.524393150655669e-07
or O 0 4.7444252970763046e-08
insertions O 0 7.508707255965419e-08
predicted O 0 1.1698185531372474e-08
to O 0 1.0981670017784495e-09
cause O 0 1.1033864932841198e-09
frameshifts O 0 4.642598838699996e-08
, O 0 9.114752702599205e-11
1 O 0 6.506142291584638e-09
was O 0 1.0654528814768582e-08
a O 0 6.280531095192998e-10
mutation O 0 2.776048835251288e-11
to O 0 7.375637600670615e-11
a O 0 1.4079344634598812e-10
stop O 0 9.027935066185933e-10
codon O 0 4.006934339884083e-09
, O 0 2.84680834461426e-10
1 O 0 9.552152846481476e-09
was O 0 5.3669072741513446e-08
a O 0 1.1621259510263826e-08
missense O 0 1.5714635992480908e-07
mutation O 0 9.473402062809555e-10
, O 0 4.005692305630859e-11
and O 0 4.383327381618507e-11
1 O 0 1.2424989925818863e-08
was O 0 1.3548200783475295e-08
predicted O 0 2.457700931657314e-09
to O 0 7.676448920967971e-10
cause O 0 7.957860481688783e-10
insertion O 0 4.546274467998046e-09
of O 0 7.855168959736147e-09
an O 0 2.9976554571931047e-10
isoleucine O 0 4.299389217976568e-07
in O 0 3.009492655081658e-09
the O 0 9.915479104449787e-09
hect O 0 1.508324487531354e-07
domain O 0 1.0050900556279885e-08
of O 0 1.8307050320132134e-09
the O 0 1.5265859687474403e-09
UBE3A O 0 2.5427077616768656e-06
protein O 0 1.8241732568924363e-09
, O 0 7.621589470652168e-11
which O 0 3.4368517146804445e-12
functions O 0 2.0905145670102598e-10
in O 0 2.1111624948222385e-10
E2 O 0 1.7132020246890534e-08
binding O 0 3.5727840685950696e-09
and O 0 8.277233898290604e-10
ubiquitin O 0 1.5079729465128366e-08
transfer O 0 1.29301474771637e-06
. O 0 7.117240556908655e-07

Eight O 0 6.531646477014874e-07
of O 0 9.723659211147151e-09
the O 0 8.0707313054873e-10
cases O 0 4.350659763008302e-11
were O 0 3.1018854151909636e-10
familial O 0 2.222898753956315e-09
, O 0 1.3882184290991972e-09
and O 0 3.273476767429173e-10
five O 0 1.8449578531587463e-09
were O 0 3.1629094898733e-09
sporadic O 0 3.251607552101632e-07
. O 0 1.382205255140434e-06

In O 0 3.2190226306738623e-07
two O 0 4.797007679968601e-09
familial O 0 3.1356628404921594e-09
cases O 0 1.5391571350775735e-10
and O 0 2.2905734600731087e-11
one O 0 6.241025057862615e-11
sporadic O 0 6.006934505364825e-09
case O 0 2.328112147509387e-09
, O 0 1.311339037357584e-09
mosaicism O 0 2.3820017304387875e-05
for O 0 2.3772307145009108e-07
UBE3A O 0 8.631853415863588e-05
mutations O 0 5.795862012547559e-09
was O 0 2.8094071513606877e-09
detected O 0 2.3205742882836944e-10
in O 0 2.9404367829499733e-11
the O 0 1.7424908738128408e-10
mother O 0 7.629622489346843e-10
of O 0 1.219921941242319e-09
three O 0 1.8429663350971737e-10
AS B-Disease 1 1.0
sons O 0 5.324786300775486e-08
, O 0 3.166129511344984e-11
in O 0 3.2513353120933175e-11
the O 0 5.5973753410043514e-11
maternal O 0 4.0160495018426445e-07
grandfather O 0 0.00348408124409616
of O 1 0.9999933242797852
two O 0 0.0004149344749748707
AS B-Disease 1 1.0
first O 0 1.1694090744640562e-06
cousins O 0 1.2479371491735947e-07
, O 0 1.2800184523431568e-10
and O 0 9.732179472032865e-12
in O 0 2.0881751883194966e-10
the O 0 2.481795657871544e-09
mother O 0 8.79717010349168e-09
of O 0 4.425783828310159e-08
an O 0 2.7715441053288714e-09
AS B-Disease 1 1.0
daughter O 0 0.0005360676441341639
. O 0 2.9816814276273362e-05

The O 0 4.242137379151245e-07
frequencies O 0 4.806214448649371e-08
with O 0 6.876292590884958e-11
which O 0 9.548425938810112e-11
we O 0 3.117628821769358e-09
detected O 0 2.5548392290630773e-09
mutations O 0 2.2557465617634165e-10
were O 0 7.085891873259698e-10
5 O 0 3.76244368993639e-09
( O 0 7.575415295058008e-11
14 O 0 3.0282987228957836e-09
% O 0 4.28221243187199e-11
) O 0 1.3606292308121493e-11
of O 0 4.581087939548034e-11
35 O 0 3.464907527561678e-10
in O 0 2.3531456297409825e-11
sporadic O 0 1.5849719314786626e-09
cases O 0 1.3085392144840391e-11
and O 0 4.545506679387579e-11
8 O 0 6.978699840232139e-09
( O 0 8.441643217782513e-11
80 O 0 2.2640451735611578e-09
% O 0 4.592811894688076e-11
) O 0 2.230711622364101e-11
of O 0 8.08965255894023e-11
10 O 0 3.479862231703379e-10
in O 0 1.294519214045664e-10
familial O 0 2.4508570728443146e-09
cases O 0 4.489880134350699e-10
. O 0 1.4217300670082977e-09
. O 0 4.3488078915743245e-08

The O 0 1.7316242519882508e-06
hemochromatosis B-Disease 1 1.0
845 O 0 2.1589599441540486e-07
G O 0 1.4071357412603902e-08
- O 0 1.751154443674352e-09
- O 0 1.9652739435827016e-09
> O 0 1.3760504735671475e-08
A O 0 9.679818058216938e-10
and O 0 1.4403619356256891e-12
187 O 0 1.4490786175158643e-11
C O 0 1.5928363072958973e-09
- O 0 3.3807090460413747e-09
- O 0 7.308165805852695e-08
> O 0 4.278620963305002e-06
G O 0 1.9207000150345266e-06
mutations O 0 1.9568739517694667e-08
: O 0 7.036433241625062e-11
prevalence O 0 2.8286237796493197e-09
in O 0 4.700866085283195e-11
non O 0 9.08234838448152e-08
- O 0 9.342402051970566e-08
Caucasian O 0 5.759256538340196e-08
populations O 0 2.1908260094960497e-08
. O 0 4.216022020386845e-08

Hemochromatosis B-Disease 0 0.00038454585592262447
, O 0 4.668206443625422e-08
the O 0 3.905356606992427e-06
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 2.3234935042637517e-07
leads O 0 8.713690817785391e-07
, O 0 4.694455491005556e-09
if O 0 6.170547095507573e-08
untreated O 0 2.5900305899995146e-07
, O 0 5.576821782149466e-10
to O 0 1.0604011180248563e-07
progressive O 0 0.4893980026245117
iron B-Disease 1 1.0
overload I-Disease 1 0.9970269799232483
and O 0 8.734809853194747e-08
premature B-Disease 0 2.5774197638384067e-06
death I-Disease 0 6.334384465844778e-07
. O 0 6.14877819771209e-07

The O 0 2.937937642855104e-05
hemochromatosis B-Disease 1 1.0
gene O 0 3.5578434562921757e-06
, O 0 9.915251730774344e-09
HFE O 0 0.001345322118140757
, O 0 1.5800166508483926e-08
recently O 0 3.2274108718866046e-08
has O 0 6.928982387854887e-11
been O 0 4.530239378075507e-11
identified O 0 2.2974135094333548e-10
, O 0 3.8483296410651846e-11
and O 0 8.116281952075255e-11
characterization O 0 1.4833712924655629e-08
of O 0 1.4656448499295038e-08
this O 0 1.2209135924479142e-09
gene O 0 9.778110543479102e-10
has O 0 1.182528103216285e-10
shown O 0 9.74489031135839e-11
that O 0 8.716285505860899e-12
it O 0 4.162161500870232e-12
contains O 0 4.913812846202292e-12
two O 0 3.79130364255853e-12
mutations O 0 2.9277147112899415e-12
that O 0 5.651080731833291e-13
result O 0 4.5215697505596175e-12
in O 0 4.409809670202769e-11
amino O 0 7.634625570629439e-11
acid O 0 9.229862533988165e-12
substitutions O 0 1.907013436053262e-11
- O 0 1.6899684776583435e-11
cDNA O 0 6.408092945164867e-10
nucleotides O 0 7.686350167457334e-11
845 O 0 7.895254450218658e-10
G O 0 7.482423569626917e-10
- O 0 1.2581760078234083e-09
- O 0 2.6837529976120322e-09
> O 0 2.592555503611038e-08
A O 0 1.2809967309124204e-08
( O 0 3.5697814062402022e-12
C282Y O 0 4.167044931335795e-09
) O 0 2.4202404403511624e-12
and O 0 1.949159150055335e-12
187 O 0 8.098482995322343e-11
C O 0 6.318020329132423e-09
- O 0 1.5806797648565407e-08
- O 0 9.144908830194254e-08
> O 0 5.294218112794624e-07
G O 0 2.1259383231608808e-07
( O 0 2.5518334667573583e-10
H63D O 0 1.7075441292035975e-06
) O 0 1.0520035953476281e-09
. O 0 1.8337638962862002e-08

Although O 0 2.3970964321051724e-05
hemochromatosis B-Disease 1 1.0
is O 0 2.546763022692744e-09
common O 0 2.6334889130508188e-11
in O 0 6.128392932014393e-12
Caucasians O 0 2.1121906446097682e-09
, O 0 2.9032430973185974e-11
affecting O 0 1.4714696128237392e-10
> O 0 5.761341181909074e-09
= O 0 6.353354731203353e-09
1 O 0 2.0961934410479444e-09
/ O 0 9.667201261720493e-09
300 O 0 1.1389655885096772e-09
individuals O 0 7.470408840137832e-12
of O 0 9.512615695150828e-11
northern O 0 6.225477355847886e-10
European O 0 8.886681945874386e-10
origin O 0 4.055690450144311e-09
, O 0 3.07733560855894e-10
it O 0 3.3322244269440304e-11
has O 0 1.9559258726542517e-12
not O 0 8.473578609613508e-12
been O 0 4.3495644586055704e-11
recognized O 0 3.096529699320172e-10
in O 0 2.0401100253586435e-10
other O 0 1.7539079910644517e-10
populations O 0 6.242647510035226e-10
. O 0 1.1995557436250692e-08

The O 0 2.066028059743985e-07
present O 0 5.4395701276632735e-09
study O 0 7.295930526396432e-10
used O 0 3.8542521951789865e-10
PCR O 0 1.4862513886271245e-08
and O 0 3.9703845766680956e-10
restriction O 0 4.549069743120526e-08
- O 0 3.0969904418753913e-10
enzyme O 0 1.4328056102685949e-11
digestion O 0 3.094109135570733e-10
to O 0 3.105636928180111e-11
analyze O 0 1.320479281474718e-10
the O 0 4.15101703010734e-11
frequency O 0 4.064975911433066e-09
of O 0 1.4504757117617118e-10
the O 0 7.5876194216562e-11
845 O 0 3.985377028392634e-10
G O 0 3.8948605451949447e-10
- O 0 3.136743920162388e-10
- O 0 4.0910541621030916e-10
> O 0 5.89946402840269e-09
A O 0 4.3087433621025184e-10
and O 0 5.782863879595646e-13
187 O 0 2.701297085322407e-12
C O 0 9.428008374001706e-11
- O 0 1.5429812982858948e-10
- O 0 4.245862328389194e-09
> O 0 3.104967163380934e-07
G O 0 2.1355091917030222e-07
mutations O 0 4.2334415972788975e-09
in O 0 5.311969197840938e-10
HLA O 0 3.3224623052774405e-08
- O 0 3.669817516538387e-08
typed O 0 9.143722223825534e-08
samples O 0 5.897618837735763e-09
from O 0 4.010631063366965e-11
non O 0 3.106530499508153e-08
- O 0 1.1833100721503342e-08
Caucasian O 0 5.632798227850344e-09
populations O 0 1.4327197206398523e-09
, O 0 2.759783027106444e-11
comprising O 0 6.695796000988352e-11
Australian O 0 6.559534249106491e-09
Aboriginal O 0 2.057740999816815e-08
, O 0 4.8986183165400377e-11
Chinese O 0 3.7438294131497685e-10
, O 0 2.0881862211608038e-11
and O 0 1.4104736476006074e-11
Pacific O 0 4.327144420557261e-09
Islanders O 0 1.1550065437404555e-07
. O 0 2.6231058214420955e-08

Results O 0 4.1987806298493524e-07
showed O 0 2.738441118310675e-08
that O 0 5.269170516575272e-11
the O 0 9.885726959257823e-11
845 O 0 2.096985030064502e-09
G O 0 1.6410812264666674e-08
- O 0 1.9595406186567743e-08
- O 0 2.9950523838806475e-08
> O 0 2.7895833909497014e-07
A O 0 1.200107213605861e-08
mutation O 0 1.5543447084986894e-10
was O 0 5.895971211256068e-11
present O 0 1.0264928664016626e-11
in O 0 3.105104021128291e-11
these O 0 2.094744343261734e-11
populations O 0 2.928960242745693e-12
( O 0 2.8061359659548035e-12
allele O 0 2.458890868695107e-10
frequency O 0 1.13738729545787e-09
0 O 0 3.2192304377787195e-10
. O 0 6.59935925351185e-11
32 O 0 7.099582588487863e-10
% O 0 2.640797303055109e-11
) O 0 1.861832563121446e-11
, O 0 1.5558061783327304e-11
and O 0 1.4506659762325569e-11
, O 0 4.759107170848598e-12
furthermore O 0 2.54302440216847e-10
, O 0 6.672665458368199e-12
it O 0 5.0412517042797145e-12
was O 0 6.104483585289699e-10
always O 0 8.529335571161312e-10
seen O 0 5.609711584142474e-10
in O 0 3.595353181840011e-11
conjunction O 0 1.4835401795920689e-09
with O 0 7.293324971735515e-11
HLA O 0 3.5782327358901966e-06
haplotypes O 0 1.0784690829268584e-07
common O 0 1.3952156097118973e-09
in O 0 4.7695965232907866e-11
Caucasians O 0 1.3818307609270164e-09
, O 0 7.68897098768484e-12
suggesting O 0 1.7078170821971383e-10
that O 0 2.428207157914586e-12
845 O 0 7.490305597990243e-10
G O 0 1.2027125961822094e-08
- O 0 4.135841180641364e-08
- O 0 1.3243301566490118e-07
> O 0 2.0467125523282448e-06
A O 0 1.0701662489509545e-07
may O 0 3.1017923785015e-09
have O 0 1.3626193229310246e-10
been O 0 4.337477252369659e-11
introduced O 0 4.994151203696617e-10
into O 0 1.903150900761652e-11
these O 0 8.666189293959903e-12
populations O 0 4.964325391737523e-12
by O 0 1.474545138768768e-11
Caucasian O 0 6.053703316410974e-08
admixture O 0 3.9351957070721255e-07
. O 0 1.1766524039558135e-06

187 O 0 2.582714131449393e-08
C O 0 2.6376952177997737e-08
- O 0 2.6923152596225464e-09
- O 0 4.2165266833649184e-09
> O 0 3.206108445397149e-08
G O 0 2.0725632765561386e-08
was O 0 1.093651946781904e-09
present O 0 4.7623786858519424e-11
at O 0 3.6677846870780684e-10
an O 0 8.381090960130066e-12
allele O 0 9.209350504413294e-10
frequency O 0 1.7064122559418138e-08
of O 0 4.7550496873327575e-09
2 O 0 3.0799992600805126e-07
. O 0 1.29244142499374e-06

68 O 0 8.560209039387701e-07
% O 0 1.9134536177745076e-09
in O 0 4.3808809357948064e-10
the O 0 5.491366250609531e-10
two O 0 4.4278629374172596e-11
populations O 0 3.256020800201931e-11
analyzed O 0 8.185077615685543e-10
( O 0 1.1421743550954488e-09
Australian O 0 1.5793649481565808e-06
Aboriginal O 0 1.1765268936869688e-06
and O 0 1.5555673416045579e-09
Chinese O 0 1.6699253535534808e-08
) O 0 1.8232931831008159e-09
. O 0 2.550794420130842e-08

In O 0 2.2196799065454798e-08
the O 0 1.3131291609624896e-08
Australian O 0 2.9562768233404313e-08
Aboriginal O 0 6.0703277959817115e-09
samples O 0 2.2382178055391222e-10
, O 0 2.0514393135606657e-12
187 O 0 2.595470713351311e-11
C O 0 1.8669763512946247e-09
- O 0 1.7294724541372375e-09
- O 0 1.8679033431112657e-08
> O 0 2.394989166987216e-07
G O 0 8.268815321343936e-08
was O 0 2.9472448925815797e-09
found O 0 1.8398676679409753e-11
to O 0 4.203297432336939e-11
be O 0 6.726645629395733e-11
associated O 0 1.7397221441228794e-09
with O 0 3.1908534148250567e-10
HLA O 0 5.1677136070793495e-05
haplotypes O 0 1.8606656340125483e-06
common O 0 2.5270466608162678e-08
in O 0 2.8733748713705154e-10
Caucasians O 0 9.705426684547547e-09
, O 0 5.2905603509234567e-11
suggesting O 0 8.347787461282508e-10
that O 0 1.6382858611385664e-11
it O 0 9.231816699983852e-12
was O 0 2.4001994836098106e-10
introduced O 0 1.5432587430197486e-09
by O 0 7.15245015991961e-11
recent O 0 2.2579387248811145e-09
admixture O 0 1.3633460582695989e-08
. O 0 5.541835434996756e-08

In O 0 1.0109868497920615e-08
the O 0 3.8012362146844225e-09
Chinese O 0 3.7491907356468346e-09
samples O 0 5.288515181334219e-10
analyzed O 0 7.036892735179379e-10
, O 0 2.0856148405523633e-11
187 O 0 7.64093371907748e-11
C O 0 1.3728043146699065e-09
- O 0 8.755951519390237e-10
- O 0 4.809871168021118e-09
> O 0 4.499640482436007e-08
G O 0 1.5112668450001365e-08
was O 0 3.5295286138214976e-10
present O 0 1.0537697450740957e-11
in O 0 2.6930777052847077e-11
association O 0 3.88906094828112e-11
with O 0 1.680267361879595e-12
a O 0 2.511666985505201e-10
wide O 0 6.865838453329332e-10
variety O 0 1.2152493455985791e-09
of O 0 2.811551214065844e-09
HLA O 0 3.501705236885755e-07
haplotypes O 0 1.0914482118096203e-07
, O 0 1.2258627446470882e-09
showing O 0 3.802890002901904e-09
this O 0 3.4332630488576044e-11
mutation O 0 9.068050130234262e-12
to O 0 3.09445594148805e-11
be O 0 3.062059772407366e-10
widespread O 0 6.740747543476644e-11
and O 0 4.525245195924343e-12
likely O 0 8.270917284391999e-11
to O 0 3.533853210058169e-10
predate O 0 4.468218861575224e-08
the O 0 2.902277085325977e-09
more O 0 3.67261325517898e-11
genetically O 0 4.550173779427347e-11
restricted O 0 1.86418921965803e-10
845 O 0 2.1138510941653976e-09
G O 0 2.8412241448450004e-08
- O 0 1.1906480779089179e-07
- O 0 1.3346648586320953e-07
> O 0 1.2200794117234182e-06
A O 0 8.330616907414878e-08
mutation O 0 9.245064269691738e-09
. O 0 5.5676308008401065e-09

Genotype O 0 1.0083822417072952e-05
- O 0 1.591973614267772e-06
phenotype O 0 5.293314231380464e-08
correlations O 0 1.0708150810501138e-08
in O 0 4.691996124961406e-08
attenuated B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.0001594455388840288

Germ O 0 0.00011546360474312678
- O 0 9.049093932844698e-06
line O 0 2.422037823635037e-07
mutations O 0 1.8826396441795623e-08
of O 0 7.987472017134678e-09
the O 0 1.3123454323249462e-08
tumor B-Disease 0 1.795410469185299e-07
suppressor O 0 2.3833513296267483e-06
APC O 0 1.282009094438763e-07
are O 0 2.759189821066599e-10
implicated O 0 9.735351191864083e-09
in O 0 4.019137378463711e-08
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 1.078146212307729e-07
AAPC B-Disease 1 1.0
) O 0 2.3955266659214658e-09
, O 0 7.239246008206024e-11
a O 0 1.7060133861157567e-10
variant O 0 2.150961364577597e-07
of O 0 2.1006322640459985e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 5.353391685503084e-08
FAP B-Disease 0 1.5272440805347287e-06
) O 0 3.441179563523633e-09
. O 0 9.040970638807266e-08

AAPC B-Disease 1 1.0
is O 0 2.910460850102936e-08
recognized O 0 2.6428610411244335e-09
by O 0 2.441616353543452e-11
the O 0 4.287199484309667e-10
occurrence O 0 3.68216279689193e-09
of O 0 1.7874342006507504e-09
< O 0 1.888701945063076e-06
100 O 0 3.2884560141610564e-07
colonic B-Disease 0 1.660060661379248e-06
adenomas I-Disease 0 3.071120886488643e-07
and O 0 4.057150726488601e-10
a O 0 1.1842254954430587e-10
later O 0 1.1887567596957638e-09
onset O 0 3.0822343433101196e-06
of O 0 2.627477897476638e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.6761048104996235e-10
age O 0 6.236554050964571e-10
> O 0 1.1875743055611565e-08
40 O 0 4.454567825717959e-09
years O 0 4.0188724570455747e-10
) O 0 5.966031557669282e-10
. O 0 5.5219675942908e-08

The O 0 8.735142387195083e-08
aim O 0 2.3204354704375874e-07
of O 0 1.5027608046835894e-09
this O 0 2.5390247196388493e-11
study O 0 6.463549834245796e-11
was O 0 3.141192306266305e-10
to O 0 6.215546410892614e-10
assess O 0 6.595819712629236e-08
genotype O 0 7.589460437884554e-07
- O 0 8.145671927195508e-06
phenotype O 0 3.988446337643836e-07
correlations O 0 7.616398534082691e-08
in O 0 8.805265139244511e-08
AAPC B-Disease 1 1.0
families O 0 1.925095638455332e-08
. O 0 2.3406871108022642e-08

By O 0 3.141270299433785e-10
protein O 0 3.171921336697636e-10
- O 0 2.5685547022646915e-09
truncation O 0 5.967755356550697e-08
test O 0 1.8080873687154053e-08
( O 0 6.754058423652509e-10
PTT O 0 6.601621862500906e-07
) O 0 2.7848416281339716e-11
assay O 0 2.344582306079701e-09
, O 0 5.752704909656181e-11
the O 0 5.772852335050871e-11
entire O 0 3.3571637136908805e-10
coding O 0 2.9221919106703353e-08
region O 0 5.084695775536829e-09
of O 0 6.9967467375420256e-09
the O 0 1.1998920967926097e-08
APC B-Disease 0 2.0583888371561443e-08
gene O 0 3.2544950068214007e-10
was O 0 1.8211626651165602e-09
screened O 0 1.6547719861037535e-09
in O 0 2.208600524689075e-10
affected O 0 5.077964437827376e-11
individuals O 0 1.6884790007137829e-12
from O 0 7.871718554763873e-11
11 O 0 1.344563287375422e-07
AAPC B-Disease 1 1.0
kindreds O 0 1.035478021549352e-06
, O 0 8.105874305108784e-10
and O 0 1.0145188161780894e-10
their O 0 7.637775967239691e-10
phenotypic O 0 3.9567506604498703e-08
differences O 0 1.0954270379670561e-08
were O 0 5.8350750009594776e-08
examined O 0 2.2085694695306302e-07
. O 0 8.282135013359948e-07

Five O 0 4.942567244370366e-08
novel O 0 6.085932202637423e-09
germ O 0 1.8127753946828307e-06
- O 0 3.990839445577876e-07
line O 0 1.6663466340105515e-07
APC B-Disease 0 6.704188137973688e-08
mutations O 0 6.456640222474164e-10
were O 0 7.887668296291395e-10
identified O 0 1.6413652659252875e-09
in O 0 5.0172013210669775e-09
seven O 0 3.068394605065805e-08
kindreds O 0 1.0701187420636415e-06
. O 0 3.157579726575932e-07

Mutations O 0 1.9690314445597323e-07
were O 0 7.934161772027437e-09
located O 0 1.0715052178866813e-09
in O 0 1.5298323718937468e-10
three O 0 1.0389257162901622e-11
different O 0 2.2799980219784244e-12
regions O 0 3.2005193634221385e-11
of O 0 1.6152681414638437e-09
the O 0 1.085597123307025e-08
APC B-Disease 0 6.014514752905598e-08
gene O 0 1.5307204392911444e-09
( O 0 4.9498051490903805e-11
1 O 0 6.4453606896108795e-09
) O 0 6.818670628128132e-11
at O 0 2.2119150955290934e-09
the O 0 2.1313883991069815e-10
5 O 0 6.375043271056313e-10
end O 0 2.9385949229521202e-09
spanning O 0 3.062094744432642e-10
exons O 0 5.010151182816003e-10
4 O 0 3.7149852638584946e-10
and O 0 9.141599977002812e-11
5 O 0 2.062663817525845e-09
, O 0 1.1414507533613616e-10
( O 0 6.469886258686497e-12
2 O 0 4.2668216182484286e-10
) O 0 3.004534468442621e-11
within O 0 2.164655676928362e-10
exon O 0 2.5863309272011747e-09
9 O 0 5.834059013665183e-09
, O 0 2.7891594589490865e-10
and O 0 4.4913676944258185e-11
( O 0 2.640277319693185e-12
3 O 0 2.6959262600101397e-10
) O 0 1.5957934626498194e-11
at O 0 4.836971378985311e-10
the O 0 1.165225554933258e-10
3 O 0 6.830688792369699e-10
distal O 0 4.154981692039428e-09
end O 0 2.519544182177924e-07
of O 0 1.5728394586744798e-08
the O 0 1.0043024190053984e-08
gene O 0 6.256143603167175e-09
. O 0 1.0594732202662271e-07

Variability O 0 1.1494814344814586e-07
in O 0 3.5298266531924583e-09
the O 0 5.688010507043373e-09
number O 0 6.7906302803066865e-09
of O 0 1.6844333572407777e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 1.6743558717280393e-06
most O 0 3.3093860984934054e-10
apparent O 0 6.53566534225547e-10
in O 0 4.493612773548428e-11
individuals O 0 2.1831380019737834e-12
with O 0 7.159622829495949e-13
mutations O 0 1.9200542197839177e-11
in O 0 3.5205391379911077e-10
region O 0 7.26403959205868e-09
1 O 0 9.019584467750974e-06
, O 0 8.837431231256687e-09
and O 0 2.9165901693772867e-08
upper O 1 0.9999511241912842
- O 1 0.9995869994163513
gastrointestinal O 0 0.0003113718703389168
manifestations O 0 3.4247245821461547e-06
were O 0 5.620882648216252e-10
more O 0 1.1294135765504976e-11
severe O 0 4.0923008037818676e-11
in O 0 8.613920687849941e-11
them O 0 4.038759604529929e-10
. O 0 4.2801612920584375e-08

In O 0 3.215833999092865e-08
individuals O 0 1.1385740267266797e-10
with O 0 9.2354093123026e-12
mutations O 0 4.21390145000089e-11
in O 0 1.0478336948116507e-10
either O 0 9.079949570001133e-10
region O 0 1.7305646915488637e-09
2 O 0 1.231215396302332e-08
or O 0 1.0648631976195588e-09
region O 0 3.987840613284277e-10
3 O 0 4.015824561776071e-09
, O 0 8.707134319108079e-11
the O 0 2.2574639380046335e-10
average O 0 4.900078121039542e-10
number O 0 4.973902956173504e-10
of O 0 4.982875778658524e-10
adenomas B-Disease 0 8.113320291158743e-07
tended O 0 1.6363684096631914e-07
to O 0 1.2049031994365578e-08
be O 0 1.0104851400072334e-09
lower O 0 4.720023261128858e-10
than O 0 1.4549888203985173e-11
those O 0 1.801162864689676e-11
in O 0 1.1951599432347138e-11
individuals O 0 2.8524253271877686e-12
with O 0 1.070243286355188e-12
mutations O 0 2.2005805164204695e-11
in O 0 1.8786945957249834e-11
region O 0 1.493533352547871e-10
1 O 0 3.914382151748441e-09
, O 0 6.066247504321609e-11
although O 0 1.070573005246267e-10
age O 0 5.27773269531906e-10
at O 0 3.134813519878321e-09
diagnosis O 0 1.0684448170650285e-07
was O 0 2.6929518615048664e-09
similar O 0 8.382170513243636e-10
. O 0 8.64596430005804e-08

In O 0 1.8019819663095404e-06
all O 0 1.7106832501667668e-06
AAPC B-Disease 1 1.0
kindreds O 0 1.1975428606092464e-05
, O 0 4.228825289942506e-09
a O 0 1.2348388978011826e-09
predominance O 0 3.321468113881565e-07
of O 0 5.960849875918939e-07
right O 1 0.9999994039535522
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999979734420776
rectal B-Disease 1 1.0
polyp I-Disease 0 0.00024663584190420806
sparing O 0 2.230030560212981e-07
was O 0 1.9318560973147214e-08
observed O 0 1.1773373387313768e-08
. O 0 2.8199201196343893e-08

No O 0 0.0001487638510297984
desmoid B-Disease 0 0.023453759029507637
tumors I-Disease 1 1.0
were O 0 1.6443546257960406e-07
found O 0 8.870053025411551e-10
in O 0 5.625194199332384e-10
these O 0 1.4849160789864868e-09
kindreds O 0 1.0679145816538949e-06
. O 0 3.7055914958727953e-07

Our O 0 1.555291237309575e-05
data O 0 1.3406452126218937e-07
suggest O 0 2.77713185781181e-09
that O 0 2.5255490407327663e-11
, O 0 3.566815939826107e-11
in O 0 1.0211276268989877e-09
AAPC B-Disease 1 1.0
families O 0 3.1102981301600607e-10
, O 0 5.897250136138732e-12
the O 0 1.7770031973673994e-11
location O 0 3.0470357348377775e-09
of O 0 6.765639604111584e-09
the O 0 6.371195837573396e-08
APC B-Disease 0 3.3744504435162526e-06
mutation O 0 1.89813658124649e-08
may O 0 3.3697151735623265e-08
partially O 0 1.0262402128091708e-07
predict O 0 6.509679462141094e-09
specific O 0 2.6636806094160193e-09
phenotypic O 0 1.8467902407337533e-07
expression O 0 1.21270738873136e-06
. O 0 1.395604272147466e-06

This O 0 3.780729951330386e-09
should O 0 2.471097104717046e-09
help O 0 1.3448865354703798e-09
in O 0 1.883988520745561e-10
the O 0 6.15726858388399e-10
design O 0 6.763242765828181e-08
of O 0 1.3153927724829373e-08
tailored O 0 1.1076024719613997e-07
clinical O 0 2.616001495425735e-07
- O 0 6.08437886739921e-08
management O 0 7.641831167859436e-09
protocols O 0 4.035379959077545e-07
in O 0 3.341983911830937e-10
this O 0 5.623239374141775e-11
subset O 0 9.895900765499732e-10
of O 0 2.240913288265034e-10
FAP B-Disease 0 2.4152004840516383e-08
patients O 0 8.194293577012957e-10
. O 0 7.627934395237901e-10
. O 0 2.1860007137775028e-08

Wilms B-Disease 1 0.9993810653686523
' I-Disease 0 9.748338197823614e-05
tumor I-Disease 0 1.917636154757929e-06
1 O 0 1.553764406025948e-07
and O 0 1.691389028835033e-09
Dax O 0 3.995498627773486e-05
- O 0 3.377629909095958e-08
1 O 0 9.653643928686506e-08
modulate O 0 7.952752412165864e-07
the O 0 4.535165132324437e-08
orphan O 0 6.208538394503194e-08
nuclear O 0 3.2189635845725206e-08
receptor O 0 4.434933309482858e-09
SF O 0 1.5801814470250974e-06
- O 0 1.0572707509481916e-07
1 O 0 2.5093807920484323e-08
in O 0 4.0319017569068194e-10
sex O 0 2.79106987521871e-10
- O 0 5.827358734444843e-11
specific O 0 6.241560740471996e-11
gene O 0 9.718148508142121e-10
expression O 0 8.470977519436929e-08
. O 0 3.9211326452459616e-07

Products O 0 5.006602350476896e-07
of O 0 1.4826046168536777e-08
steroidogenic O 0 4.3316887854416564e-07
factor O 0 1.7633253079907263e-08
1 O 0 2.3537687354746595e-08
( O 0 1.3524641129247783e-10
SF O 0 3.1852191568759736e-06
- O 0 3.4058362530231534e-07
1 O 0 6.493944937346896e-08
) O 0 1.6302454941552469e-09
and O 0 3.009837046263897e-09
Wilms B-Disease 0 9.44633356994018e-05
tumor I-Disease 0 1.4008340940563357e-06
1 O 0 1.2749679001444747e-07
( O 0 5.849600248630793e-10
WT1 O 0 1.198487552755978e-06
) O 0 2.704501345096588e-10
genes O 0 6.058708396095014e-11
are O 0 6.1021491679080775e-12
essential O 0 1.962082940565324e-09
for O 0 1.3610790272622353e-10
mammalian O 0 1.1130451582630485e-07
gonadogenesis O 0 5.275454100228671e-07
prior O 0 1.1463417592949554e-07
to O 0 2.0197120420561987e-08
sexual O 0 5.530470748027483e-09
differentiation O 0 2.9075033936010186e-08
. O 0 3.2760471668780156e-08

In O 0 2.6524370255742724e-08
males O 0 7.545053470892071e-09
, O 0 1.9259750738687131e-10
SF O 0 2.054417336694314e-06
- O 0 1.7050952294539456e-07
1 O 0 4.5439712437200797e-08
participates O 0 5.343534503765568e-09
in O 0 3.078533261646754e-10
sexual O 0 7.307360966324339e-11
development O 0 3.297243034161568e-11
by O 0 2.284585931891514e-12
regulating O 0 1.9894339509107795e-09
expression O 0 3.4398489390241593e-08
of O 0 9.340652695755125e-09
the O 0 1.5540319253659618e-08
polypeptide O 0 5.717195108445594e-07
hormone O 0 5.02700345350604e-07
Mullerian O 0 4.854606686421903e-06
inhibiting O 0 3.6098370514991984e-07
substance O 0 2.5118811208812986e-07
( O 0 7.123672207676179e-10
MIS O 0 1.923593481478747e-05
) O 0 5.159411564648053e-09
. O 0 5.469087227538694e-08

Here O 0 5.2435029829212e-07
, O 0 2.0620305463125987e-09
we O 0 2.0519903554117036e-09
show O 0 4.0575085513694376e-09
that O 0 1.7393629592188375e-10
WT1 O 0 9.08012043510098e-06
- O 0 3.0924834391043987e-06
KTS O 0 2.8779399144696072e-05
isoforms O 0 3.007555164913356e-07
associate O 0 3.5422658584138844e-07
and O 0 7.014835934349151e-10
synergize O 0 1.0314916920606265e-07
with O 0 1.8112611410714408e-10
SF O 0 9.050837434187997e-06
- O 0 5.150506581230729e-07
1 O 0 2.3707285379259702e-07
to O 0 2.4574209334105035e-08
promote O 0 3.5380659824113536e-07
MIS O 0 0.00031646492425352335
expression O 0 1.2311822956689866e-06
. O 0 4.315640467211779e-07

In O 0 4.6815014087542295e-08
contrast O 0 6.12459283289013e-09
, O 0 5.368583355647161e-09
WT1 O 0 0.00016895985754672438
missense O 0 8.65211768541485e-06
mutations O 0 3.08422549721854e-08
, O 0 3.251926228298174e-10
associated O 0 3.768208522991756e-10
with O 0 2.0036359724140418e-11
male B-Disease 0 5.914460032840907e-09
pseudohermaphroditism I-Disease 1 1.0
in O 0 4.6293877176140086e-08
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.0533613981067447e-08
fail O 0 1.4672075110411242e-07
to O 0 1.2476569999364528e-08
synergize O 0 1.1309132332826266e-06
with O 0 4.4819419287023265e-09
SF O 1 0.9997872710227966
- O 0 0.07537393271923065
1 O 0 0.0007216297672130167
. O 0 2.3952434275997803e-06

Additionally O 0 5.503366651282704e-07
, O 0 1.4390213465276247e-09
the O 0 1.4118101132609695e-09
X O 0 1.6551364296901738e-06
- O 0 1.366204713804109e-07
linked O 0 2.259521636460704e-07
, O 0 1.223327966703991e-10
candidate O 0 5.035529770935909e-10
dosage O 0 4.662734340854513e-07
- O 0 4.358972205409373e-08
sensitive O 0 2.8961912335034867e-07
sex O 0 8.410440344164272e-09
- O 0 2.070266846843083e-09
reversal O 0 1.4547321125490953e-09
gene O 0 3.6236783018672725e-10
, O 0 2.17647955214062e-10
Dax O 0 1.8564878700999543e-05
- O 0 4.7661480095939623e-08
1 O 0 3.5018512534179536e-08
, O 0 2.4882168547790684e-10
antagonizes O 0 1.890584133690254e-09
synergy O 0 2.685390243506447e-10
between O 0 4.5001228438090735e-11
SF O 0 1.95326629182091e-06
- O 0 1.775069193854506e-07
1 O 0 9.176341819738809e-08
and O 0 4.774716622080177e-09
WT1 O 0 9.541286999592558e-06
, O 0 3.1148691959081987e-10
most O 0 1.0710626829890657e-11
likely O 0 1.0678641998440597e-11
through O 0 3.784923763294756e-12
a O 0 2.563236949082448e-11
direct O 0 1.0234396663477696e-10
interaction O 0 2.1631037239178141e-10
with O 0 4.299562789134015e-11
SF O 0 5.8499197621131316e-05
- O 0 1.0642651432135608e-05
1 O 0 3.834707513306057e-06
. O 0 5.970943561806052e-07

We O 0 5.708652679459192e-07
propose O 0 2.0931524602474383e-07
that O 0 1.541467176124911e-09
WT1 O 0 8.382564374187496e-06
and O 0 4.924124397120977e-08
Dax O 0 0.004528739023953676
- O 0 9.874434425682921e-08
1 O 0 2.5798684077926737e-08
functionally O 0 7.3083996632306025e-09
oppose O 0 4.072674641975027e-09
each O 0 2.0854398069536373e-11
other O 0 4.0804769285696096e-11
in O 0 5.172651751372825e-10
testis O 0 1.0692093610487063e-07
development O 0 7.040625304988168e-10
by O 0 4.1703324821229515e-11
modulating O 0 4.988624624502336e-08
SF O 0 2.1859001208213158e-05
- O 0 7.616622497153003e-07
1 O 0 5.85201576086547e-07
- O 0 9.343435891651097e-08
mediated O 0 1.5222929050651146e-07
transactivation O 0 3.6171193187328754e-06
. O 0 3.4135094750809e-08
. O 0 3.87120877576308e-08

A O 0 1.7252830275538145e-06
mouse O 0 4.695236910379208e-08
model O 0 1.529466331362528e-08
for O 0 7.990325201490123e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9999219179153442
centre O 0 1.156069993157871e-05
mutations O 0 9.981627080435374e-09
. O 0 5.386964652132065e-09

Imprinting O 0 9.155297448160127e-06
in O 0 7.105793287109918e-08
the O 0 2.057160308766015e-08
15q11 O 0 7.745388757030014e-07
- O 0 3.368005607740088e-08
q13 O 0 3.180782641720725e-07
region O 0 5.169577210750731e-09
involves O 0 1.955492434646544e-09
an O 0 4.927501184859295e-10
imprinting O 0 1.2961263564648107e-05
centre O 0 4.409368102642475e-06
( O 0 3.6239478085065e-10
IC O 0 9.703357761736697e-08
) O 0 3.179074503645296e-10
, O 0 2.999987758212086e-11
mapping O 0 2.0615298357284928e-10
in O 0 3.056870381823451e-11
part O 0 6.56831672385394e-11
to O 0 1.1892647977518322e-09
the O 0 7.071067065211878e-10
promoter O 0 1.3542878818384452e-08
and O 0 7.296435455828032e-09
first O 0 7.091455245245015e-08
exon O 0 1.1406884681264273e-07
of O 0 2.5589521612801036e-08
SNRPN O 0 2.6090501705766656e-05
. O 0 7.715324841228721e-07

Deletion O 0 2.2378842459147563e-06
of O 0 1.300049916608259e-07
this O 0 5.6560742756062155e-09
IC O 0 6.498256652776035e-07
abolishes O 0 1.029366558213951e-06
local O 0 6.048555434290392e-08
paternally O 0 9.801235023587651e-08
derived O 0 2.2051374060083617e-09
gene O 0 2.7285529391463115e-10
expression O 0 2.3326757192521086e-10
and O 0 4.46894301078804e-12
results O 0 5.817008680297775e-11
in O 0 4.6024974942326935e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.513836865451594e-07
PWS B-Disease 1 1.0
) O 0 3.96714092687489e-08
. O 0 1.0281014795054944e-07

We O 0 2.094062807600494e-07
have O 0 9.93565563156551e-10
created O 0 3.505844226037169e-10
two O 0 3.803526105183863e-10
deletion O 0 7.325579254313652e-09
mutations O 0 7.147517577799078e-10
in O 0 3.806525761262947e-09
mice O 0 3.412767313193399e-08
to O 0 2.420864042562698e-08
understand O 0 5.633413024952461e-07
PWS B-Disease 1 1.0
and O 0 2.104477374587077e-07
the O 0 8.454480848740786e-08
mechanism O 0 2.8802375595660124e-07
of O 0 4.520283258813151e-09
this O 0 1.7181226441564945e-09
IC O 0 1.078250647879031e-06
. O 0 4.2421331158948306e-07

Mice O 0 0.00011907273437827826
harbouring O 0 1.4646950148744509e-05
an O 0 6.926848428179255e-09
intragenic O 0 4.761931904795347e-06
deletion O 0 3.4978469898305775e-07
in O 0 2.5852571639006783e-08
Snrpn O 0 1.4364862181537319e-05
are O 0 8.705926535235164e-10
phenotypically O 0 1.927892441244694e-07
normal O 0 4.7203073449963995e-07
, O 0 1.6207799546918977e-09
suggesting O 0 2.4774601925514617e-08
that O 0 3.4483854660649627e-10
mutations O 0 2.729220627273321e-09
of O 0 6.139938335536499e-09
SNRPN O 0 1.482932134422299e-06
are O 0 1.791563286612785e-10
not O 0 3.1297459068824196e-10
sufficient O 0 8.504160931011029e-09
to O 0 2.4073267823609967e-08
induce O 0 8.400555088883266e-06
PWS B-Disease 1 1.0
. O 0 6.431530346162617e-05

Mice O 0 6.866669082228327e-06
with O 0 3.0593044764160027e-10
a O 0 3.0078628476815084e-09
larger O 0 4.8611688008293186e-09
deletion O 0 3.933131509370469e-08
involving O 0 8.409409280041302e-10
both O 0 1.1335669070078325e-09
Snrpn O 0 2.6418803145134007e-07
and O 0 1.0295172492291726e-09
the O 0 4.362064043306191e-09
putative O 0 4.770741384163557e-07
PWS O 1 1.0
- O 0 1.7034876691468526e-06
IC O 0 7.167523108364549e-07
lack O 0 2.43393486698551e-07
expression O 0 1.4839202755467795e-08
of O 0 1.8399256562773303e-09
the O 0 9.8893349065321e-10
imprinted O 0 8.119634742342896e-09
genes O 0 3.3559361956037037e-09
Zfp127 O 0 1.8305038338439772e-06
( O 0 3.2774329916662737e-09
mouse O 0 1.5475222880922956e-07
homologue O 0 1.7194404335896252e-06
of O 0 1.092322889917341e-07
ZNF127 O 0 2.448671693855431e-05
) O 0 4.13960377088074e-09
, O 0 5.07444530839507e-09
Ndn O 0 4.198666829324793e-06
and O 0 5.400709213176924e-09
Ipw O 0 2.7210280677536502e-05
, O 0 7.927535961016474e-09
and O 0 5.459097063287288e-10
manifest O 0 2.167648993633975e-08
several O 0 7.303880833475773e-10
phenotypes O 0 9.340599405049943e-09
common O 0 1.9517327753959535e-09
to O 0 7.779353694559177e-08
PWS B-Disease 1 1.0
infants O 0 0.0025481912307441235
. O 0 1.0174458111578133e-06

These O 0 5.2906290903820263e-08
data O 0 2.5279514037634954e-09
demonstrate O 0 8.643549209708112e-10
that O 0 5.5678031629646796e-12
both O 0 1.4828711175640663e-11
the O 0 2.868293380586806e-10
position O 0 1.5478788029099633e-08
of O 0 2.5542108428311394e-09
the O 0 9.159930591806642e-10
IC O 0 4.5634069856248516e-09
and O 0 4.84849695114864e-11
its O 0 1.4693850303171274e-11
role O 0 1.1984933878661508e-10
in O 0 1.16419929252487e-10
the O 0 5.006492442838351e-10
coordinate O 0 1.9043811860797177e-08
expression O 0 1.563299178997113e-07
of O 0 2.4771672713086446e-08
genes O 0 2.1699479990644477e-09
is O 0 1.176337360853097e-10
conserved O 0 1.7535131680013194e-10
between O 0 2.6612670400716354e-10
mouse O 0 1.1240687314284514e-07
and O 0 7.763233944579895e-10
human O 0 6.971246357956318e-10
, O 0 3.008594415265797e-11
and O 0 2.994653483523457e-11
indicate O 0 9.358142039062045e-10
that O 0 3.90369438163507e-11
the O 0 1.777089808641108e-09
mouse O 0 6.910751437771978e-08
is O 0 1.2420309225547044e-10
a O 0 3.643538942776914e-11
suitable O 0 8.650773430929348e-10
model O 0 4.787992780030947e-10
system O 0 7.263685486424976e-11
in O 0 4.777162346258912e-11
which O 0 1.834037435810565e-11
to O 0 7.796146506144908e-10
investigate O 0 4.122929997407709e-09
the O 0 1.6309918970947024e-09
molecular O 0 1.8193676565303463e-09
mechanisms O 0 6.315516287713763e-08
of O 0 3.4923379743645455e-09
imprinting O 0 1.543762806477389e-08
in O 0 2.1237715752686626e-10
this O 0 1.0848404813357249e-10
region O 0 6.637334015735519e-10
of O 0 4.664250652375301e-10
the O 0 2.6432930844144664e-10
genome O 0 8.420351221838374e-11
. O 0 3.4520311609220755e-10
. O 0 2.4597937908765743e-08

Mutations O 0 6.420027034437226e-07
of O 0 2.0129594702211762e-07
the O 0 4.7951257187150986e-08
ATM O 0 2.3500265342590865e-06
gene O 0 1.5925607499411853e-08
detected O 0 1.1825383339214568e-08
in O 0 3.771770007432451e-09
Japanese O 1 0.9999998807907104
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999998807907104
: O 0 5.780156908663514e-11
possible O 0 2.201210221042249e-11
preponderance O 0 1.3221306272015454e-09
of O 0 7.64127316976726e-10
the O 0 3.175082641249105e-09
two O 0 1.570928720440179e-09
founder O 0 1.6259181734312733e-07
mutations O 0 3.0164346576100343e-09
4612del165 O 0 4.225046268402366e-07
and O 0 4.322483704299884e-09
7883del5 O 0 7.4979539022024255e-06
. O 0 1.185966993944021e-06

The O 0 6.088349380206637e-08
ATM O 0 3.5690850381797645e-06
( O 0 3.2186445508841643e-08
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 3.497517386819027e-09
mutated O 0 3.9136935359174174e-10
) O 0 2.7627060361634648e-11
gene O 0 2.0929401267633096e-10
on O 0 6.522867135316801e-09
human O 0 4.174929291167473e-09
chromosome O 0 4.6868354530715806e-08
11q22 O 0 9.62668036663672e-06
. O 0 8.053114584072318e-07

3 O 0 6.121446858742274e-06
has O 0 4.659131302986452e-09
recently O 0 2.044973079762258e-09
been O 0 1.2223645706743724e-10
identified O 0 1.898268625621924e-10
as O 0 9.023851110789849e-11
the O 0 4.702318742721978e-11
gene O 0 7.843688372421997e-12
responsible O 0 1.3508392321393003e-11
for O 0 1.5051716817371386e-11
the O 0 6.525937013002192e-10
human O 0 1.2261082815712143e-07
recessive B-Disease 1 0.9999966621398926
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9976373910903931
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.172879393607218e-08
. O 0 4.870665648581962e-08

In O 0 7.21422210858691e-09
order O 0 1.3503665963199296e-09
to O 0 2.4399740561342753e-10
define O 0 4.7366830457917786e-09
the O 0 5.53420365090318e-10
types O 0 1.7077820269051358e-09
of O 0 4.832526601106224e-10
disease O 0 1.7732908474954456e-09
- O 0 9.60835944141536e-09
causing O 0 1.5634736838521235e-09
ATM O 0 1.1220080864404736e-07
mutations O 0 1.034090452156633e-10
in O 0 8.552920177651302e-11
Japanese O 0 3.292262044851668e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.678582606245982e-08
as O 0 5.76285200115656e-11
well O 0 1.7703151444781184e-11
as O 0 1.3461272894976783e-11
to O 0 3.941860032830036e-11
look O 0 8.858450084581193e-11
for O 0 3.419486568900787e-11
possible O 0 9.646953236241984e-10
mutational O 0 4.5327394104788254e-07
hotspots O 0 3.387676201782597e-07
, O 0 8.18982492933884e-10
reverse O 0 4.55686599565297e-09
- O 0 9.296055036855932e-10
transcribed O 0 6.674734653877579e-10
RNA O 0 3.780293439392679e-11
derived O 0 5.081626786029858e-11
from O 0 1.2597548872117503e-11
ten O 0 1.9222427816156795e-10
patients O 0 8.536113656198996e-12
belonging O 0 8.21284273228029e-12
to O 0 4.582084364712635e-11
eight O 0 2.1561493909749707e-11
unrelated O 0 1.3743650661979245e-10
Japanese O 0 3.836978976323735e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 2.1206840727927556e-09
was O 0 2.4684214672276994e-09
analyzed O 0 9.345727525200687e-10
for O 0 1.2669312821067535e-10
mutations O 0 2.7446661610142087e-10
by O 0 1.4582345053693047e-10
the O 0 4.893785376935966e-09
restriction O 0 5.774050393370089e-08
endonuclease O 0 2.486265060497317e-08
fingerprinting O 0 8.523810102190055e-09
method O 0 1.8787082112226017e-08
. O 0 5.786056433976228e-08

As O 0 1.11762098242707e-07
has O 0 2.518964481446062e-10
been O 0 1.9250046001673127e-11
reported O 0 9.417579563408829e-12
by O 0 1.7317540630668038e-12
others O 0 2.450281089139139e-10
, O 0 7.881453822911055e-11
mutations O 0 2.6899715094286236e-11
that O 0 3.5953736515770274e-11
lead O 0 5.201878372496083e-10
to O 0 7.323190498453869e-09
exon O 0 3.3936380816612655e-08
skipping O 0 6.853598222278379e-08
or O 0 1.7268561691707873e-08
premature O 0 1.4080545440720016e-07
protein O 0 4.1871301981188935e-09
truncation O 0 5.773532762987088e-08
were O 0 4.250659380033994e-09
also O 0 5.764119737072804e-10
predominant O 0 2.849438907048807e-09
in O 0 8.055168199128104e-10
our O 0 2.6972557520821283e-08
mutants O 0 1.7362563653477991e-07
. O 0 8.491749525774139e-08

Six O 0 2.943051242709771e-07
different O 0 5.790897206203738e-10
mutations O 0 1.5278553422426455e-10
were O 0 8.976865084608932e-11
identified O 0 2.511571228769327e-10
on O 0 2.0545791734605245e-09
12 O 0 1.107031799563174e-08
of O 0 1.5811372211516073e-09
the O 0 2.7608757502406434e-09
16 O 0 9.96424489585479e-08
alleles O 0 1.5047836754433774e-08
examined O 0 1.0476647958057583e-06
. O 0 2.7517353373696096e-06

Four O 0 4.302424372326641e-07
were O 0 1.1352161877198341e-08
deletions O 0 2.0649714826959098e-08
involving O 0 3.312234375663081e-10
a O 0 3.247911273263071e-09
loss O 0 1.6063069097072002e-08
of O 0 8.284585817364132e-08
a O 0 1.3187438696604659e-08
single O 0 2.0797466859789893e-08
exon O 0 1.0012119844304834e-07
exon O 0 1.1410757849716902e-07
7 O 0 2.8945944450242678e-06
, O 0 1.7380878958306312e-08
exon O 0 9.055121807932665e-08
16 O 0 4.3837687258019287e-07
, O 0 8.631296566363744e-09
exon O 0 2.2644529451554263e-07
33 O 0 4.6229644112827373e-07
or O 0 1.6897903520884938e-08
exon O 0 3.8783858258284454e-07
35 O 0 2.2297720079222927e-06
. O 0 7.913706099316187e-07

The O 0 3.48603151678617e-07
others O 0 1.6191215479466337e-08
were O 0 4.3602672583631374e-09
minute O 0 4.111216256319494e-08
deletions O 0 9.986734283984333e-08
, O 0 1.6562181626156303e-09
4649delA O 0 3.533991588255958e-08
in O 0 1.5610363002238614e-09
exon O 0 4.309882228881179e-08
33 O 0 7.602668006256863e-08
and O 0 1.0039666875627518e-09
7883del5 O 0 2.9186142569415097e-07
in O 0 6.270957531029353e-09
exon O 0 2.676245856036985e-07
55 O 0 8.985157364804763e-07
. O 0 6.976433155614359e-07

The O 0 2.5385063509020256e-06
mutations O 0 1.4834335537727839e-08
4612del165 O 0 3.0715483489984763e-07
and O 0 4.3757114598363955e-10
7883del5 O 0 3.570033868527389e-08
were O 0 1.0548527606957236e-09
found O 0 1.1662439070025954e-10
in O 0 7.793198031347259e-11
more O 0 5.5122434394760944e-12
than O 0 2.8363019398403022e-12
two O 0 1.9260467786635926e-12
unrelated O 0 9.441212568683799e-12
families O 0 8.665507005532758e-13
; O 0 2.3161145310673925e-12
44 O 0 1.168004720719651e-10
% O 0 1.0207138086137935e-11
( O 0 9.799977669644466e-13
7 O 0 8.616027891150679e-10
of O 0 7.037497251616287e-10
16 O 0 3.3170279856165052e-09
) O 0 3.2951952277926466e-10
of O 0 1.494126711243382e-09
the O 0 6.271408947711166e-10
mutant O 0 3.8961927018021925e-09
alleles O 0 3.808883763944948e-10
had O 0 2.648401498106523e-09
one O 0 2.251787367679725e-10
of O 0 4.2496681174064577e-10
the O 0 1.7340041624791525e-09
two O 0 1.800704252374885e-09
mutations O 0 8.064426459952756e-09
. O 0 1.6106241673696786e-07

The O 0 3.338763860938343e-07
4612del165 O 0 7.270404012160725e-07
mutations O 0 1.5051044854885731e-09
in O 0 1.6246137768405333e-10
three O 0 9.259855902887804e-12
different O 0 8.895555190895077e-13
families O 0 9.872470679503365e-13
were O 0 7.115503932592082e-12
all O 0 1.4411286834020709e-12
ascribed O 0 6.955679920928048e-10
to O 0 2.695038192612742e-09
the O 0 5.371389999453413e-09
same O 0 2.0178205772936053e-09
T O 0 3.700976636267228e-09
- O 0 1.4177197193987467e-09
- O 0 2.6138449182866452e-09
> O 0 2.4028906864259625e-08
A O 0 9.462169936469422e-10
substitution O 0 1.414958816781109e-09
at O 0 9.889089547243657e-10
the O 0 2.4061400094588237e-10
splice O 0 3.917885571524948e-09
donor O 0 1.1417039535999152e-09
site O 0 2.6996183066785306e-08
in O 0 5.335549779772464e-09
intron O 0 4.1664220589154866e-06
33 O 0 5.472453722177306e-06
. O 0 1.111390020014369e-06

Microsatellite O 0 3.897443093592301e-06
genotyping O 0 7.896637725934852e-07
around O 0 5.065625696687448e-09
the O 0 1.1360307361485411e-08
ATM O 0 3.825374733423814e-06
locus O 0 5.143830890119716e-07
also O 0 9.033210623954346e-09
indicated O 0 4.218763116625723e-09
that O 0 2.4974303874936155e-11
a O 0 1.4636794554157007e-10
common O 0 3.131728210092888e-10
haplotype O 0 1.1381387388098574e-08
was O 0 7.677800617500452e-09
shared O 0 6.76003808486314e-10
by O 0 1.9179605820207613e-11
the O 0 1.614078454226231e-10
mutant O 0 1.0915388592991349e-09
alleles O 0 6.042758654567493e-11
in O 0 2.3489318823344263e-10
both O 0 2.3682815708525595e-09
mutations O 0 2.295291601228655e-08
. O 0 3.227811475881026e-07

This O 0 8.19616161606973e-08
suggests O 0 6.274238018022515e-08
that O 0 1.1137231414881654e-10
these O 0 8.358824743481819e-11
two O 0 2.664980180977494e-10
founder O 0 1.3942604937255965e-07
mutations O 0 2.527623665926626e-09
may O 0 3.797641756619896e-09
be O 0 2.1581596509889778e-09
predominant O 0 5.088828913812904e-09
among O 0 1.3898283912627818e-10
Japanese O 0 1.5577094814034353e-07
ATM O 0 3.431335017012316e-06
mutant O 0 4.436348888248176e-07
alleles O 0 4.6972076006568386e-08
. O 0 3.18229979257012e-07

W474C O 0 3.2338643904950004e-06
amino O 0 2.1681328732370275e-08
acid O 0 4.2862019489220415e-10
substitution O 0 5.208768971698419e-10
affects O 0 4.133193440281069e-11
early O 0 3.312189966742096e-10
processing O 0 3.266636294796399e-09
of O 0 2.5387558721945425e-09
the O 0 5.54234824701183e-10
alpha O 0 2.644155172593088e-10
- O 0 2.859595719939545e-11
subunit O 0 1.7461972146026739e-10
of O 0 1.48409409761463e-10
beta O 0 2.0114494514444914e-09
- O 0 2.46908560264103e-09
hexosaminidase O 0 1.888914908931838e-07
A O 0 1.06622346507379e-08
and O 0 3.940521867140667e-11
is O 0 2.983477831106085e-12
associated O 0 1.3166892576244038e-10
with O 0 2.2335810284657143e-11
subacute O 0 8.215463822125457e-06
G B-Disease 0 2.1344076230889186e-05
( I-Disease 0 2.6563442556692962e-09
M2 I-Disease 0 4.146918399783317e-06
) I-Disease 0 1.936127880242111e-08
gangliosidosis I-Disease 0 1.8341073882766068e-05
. O 0 3.070543925787206e-07

Mutations O 0 2.13988773367646e-08
in O 0 3.229059242215726e-09
the O 0 3.762745226509878e-09
HEXA O 0 8.413579166699492e-07
gene O 0 4.105462192427467e-09
, O 0 4.121449848071279e-10
encoding O 0 7.846988059334592e-10
the O 0 1.8881873842246932e-09
alpha O 0 5.510293887844853e-10
- O 0 7.010966113218942e-11
subunit O 0 3.825673666746354e-10
of O 0 2.6121291241132383e-10
beta O 0 8.11630584962586e-09
- O 0 9.591074601189575e-09
hexosaminidase O 0 3.8212806430237833e-07
A O 0 3.0526219774174024e-08
( O 0 5.899941646347884e-11
Hex O 0 5.014821979898443e-08
A O 0 4.563531064150084e-08
) O 0 2.3360818834916586e-10
, O 0 1.425713019864716e-10
that O 0 5.431964947288925e-11
abolish O 0 4.079627728970081e-07
Hex O 0 4.7672344294369395e-07
A O 0 2.4235342621636846e-08
enzyme O 0 2.268333076926865e-09
activity O 0 2.4837671475097522e-08
cause O 0 8.320124834426679e-06
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.449419334553781e-10
TSD B-Disease 0 4.180782980256481e-06
) O 0 1.460238457928753e-10
, O 0 1.0280529899597823e-10
the O 0 9.178504067897109e-10
fatal O 0 1.886867373457335e-08
infantile B-Disease 0 7.108463364602358e-07
form I-Disease 0 1.0836725961027582e-09
of I-Disease 0 8.351968006081734e-08
G I-Disease 0 2.791414317471208e-07
( I-Disease 0 2.9737090567749647e-10
M2 I-Disease 0 3.7768404581584036e-07
) I-Disease 0 1.7303303234683653e-09
gangliosidosis I-Disease 0 4.0418930780106166e-07
, I-Disease 0 3.3263902743385643e-10
Type I-Disease 0 6.9508563349529595e-09
1 I-Disease 0 1.5575683676161134e-07
. O 0 1.6685856962794787e-07

Less O 0 8.087425271696702e-07
severe O 0 5.209569167163863e-07
, O 0 2.668124610138989e-09
subacute O 0 5.637959930027137e-07
( O 0 5.871315933436705e-11
juvenile O 0 2.2345139427670802e-07
- O 0 2.246286641138795e-07
onset O 1 0.6748712658882141
) O 0 1.08340802995599e-09
and O 0 2.448095948182072e-09
chronic O 0 0.0006387702305801213
( O 0 8.49138051539633e-11
adult O 0 1.1394830607969197e-06
- O 0 2.208342095855187e-07
onset O 0 0.00010601914254948497
) O 0 5.302736583168155e-10
variants O 0 5.025610594344698e-09
are O 0 4.3258278903390845e-11
characterized O 0 6.695600237444088e-12
by O 0 1.5619065285923939e-12
a O 0 1.415835365614626e-10
broad O 0 6.203477731503426e-10
spectrum O 0 2.2356632101150353e-09
of O 0 1.1536992888805386e-10
clinical O 0 5.998505026028056e-10
manifestations O 0 5.242467571164866e-10
and O 0 1.0902081321040313e-11
are O 0 2.3393613435285232e-12
associated O 0 4.535418221540688e-11
with O 0 2.536467563762912e-12
residual O 0 9.36231515424879e-07
levels O 0 2.1358735466492362e-05
of O 0 9.131982210419665e-07
Hex O 0 3.868773092108313e-06
A O 0 7.303051461349241e-07
enzyme O 0 2.50407374835504e-08
activity O 0 2.466846638071729e-07
. O 0 1.2660466097713652e-07

We O 0 8.850660293546753e-08
identified O 0 6.982987521553241e-09
a O 0 6.364169746753134e-10
1422 O 0 4.784961902259965e-07
G O 0 1.4069887299683614e-07
- O 0 1.9167352149906947e-07
- O 0 1.1001281308153921e-07
> O 0 3.240401156290318e-07
C O 0 1.7788244122129981e-07
( O 0 7.388503871219587e-12
amino O 0 2.7579744044103904e-10
acid O 0 1.818100392458888e-10
W474C O 0 1.2415223293871236e-09
) O 0 6.39023610502637e-14
substitution O 0 1.5476788253754314e-11
in O 0 1.538434483971951e-11
the O 0 9.616801799339214e-11
first O 0 8.1527001816184e-10
position O 0 9.347888685340422e-09
of O 0 1.0342330325485705e-09
exon O 0 1.6661712010090923e-08
13 O 0 1.405824434641545e-07
of O 0 7.148546643520604e-08
HEXA O 0 0.019534552469849586
of O 0 1.3927416375736357e-06
a O 0 1.141499126333656e-07
non O 0 7.959558388392907e-06
- O 0 2.8255470851945574e-07
Jewish O 0 6.519622957057436e-07
proband O 0 2.838899672497064e-05
who O 0 4.951565824029558e-09
manifested O 0 1.029949903141869e-08
a O 0 2.7529722945729418e-09
subacute O 0 1.9490595093429874e-07
variant O 0 3.025944579349016e-07
of O 0 8.577541734666738e-07
G B-Disease 0 3.3828828236437403e-06
( I-Disease 0 1.0911557213333367e-09
M2 I-Disease 0 1.760932491379208e-06
) I-Disease 0 8.980607368869187e-09
gangliosidosis I-Disease 0 7.427964646922192e-06
. O 0 2.9717708116550057e-07

On O 0 1.2540219813672593e-06
the O 0 4.9966427440040206e-08
second O 0 3.496019189697108e-07
maternally O 0 1.0530929102969822e-05
inherited O 0 3.683250179165043e-05
allele O 0 5.961305191704014e-07
, O 0 2.374363761159515e-10
we O 0 4.0798409095543775e-10
identified O 0 8.188809630382821e-10
the O 0 6.750993097881519e-10
common O 0 1.2035732410708988e-08
infantile O 0 0.01878976821899414
disease O 0 6.0080253660999e-08
- O 0 2.5194857755650446e-08
causing O 0 2.3867254839160523e-08
4 O 0 1.1464065210020635e-05
- O 0 1.84954496944556e-05
bp O 0 2.0081324692000635e-06
insertion O 0 8.086517766514589e-08
, O 0 3.749584198686762e-09
+ O 0 7.28277100847663e-08
TATC O 0 1.7506496305941255e-06
1278 O 0 1.7545322634759941e-06
, O 0 1.597293297628255e-09
in O 0 1.349056311106267e-09
exon O 0 2.3967371021171857e-07
11 O 0 2.1439674924295105e-07
. O 0 2.81085647202417e-07

Pulse O 0 5.295927167026093e-06
- O 0 1.9876604540058906e-07
chase O 0 4.3987526510136377e-08
analysis O 0 6.997293411359351e-09
using O 0 1.0344485268376502e-08
proband O 0 2.316151949344203e-06
fibroblasts O 0 1.265843729925109e-05
revealed O 0 2.034283674845483e-08
that O 0 3.695259723213162e-11
the O 0 6.296792254278927e-11
W474C O 0 4.123103192199551e-09
- O 0 2.2374282981907356e-10
containing O 0 6.702388644086454e-11
alpha O 0 1.4878070997426107e-10
- O 0 2.2872119129213608e-11
subunit O 0 3.8078815101094676e-10
precursor O 0 1.079211884302822e-07
was O 0 7.164543802673506e-08
normally O 0 2.3484669764428645e-09
synthesized O 0 2.503185392299656e-08
, O 0 3.619809729737966e-10
but O 0 8.326316025542013e-11
not O 0 2.0105432596562167e-10
phosphorylated O 0 4.827158672782161e-09
or O 0 9.45643230387816e-10
secreted O 0 1.1845333602877872e-09
, O 0 1.4362676326040713e-10
and O 0 1.28847404967658e-10
the O 0 1.3387340125348146e-09
mature O 0 8.105121018786576e-09
lysosomal O 0 1.5110053652733768e-07
alpha O 0 1.5669375130755725e-08
- O 0 1.7825825260331385e-09
subunit O 0 8.720721922372832e-09
was O 0 5.7691625698907956e-08
not O 0 2.820350353260892e-08
detected O 0 9.765240349679516e-08
. O 0 4.868613245889719e-08

When O 0 3.946364657281265e-08
the O 0 4.7690735804906126e-09
W474C O 0 3.624981204097821e-08
- O 0 1.6266425983957333e-09
containing O 0 1.5632761751760427e-10
alpha O 0 1.2733268606179848e-10
- O 0 1.4198479197924385e-11
subunit O 0 2.497250461974687e-10
was O 0 1.6585164352989068e-09
transiently O 0 1.3185528224823884e-08
co O 0 2.106521845846032e-09
- O 0 1.652079717473498e-08
expressed O 0 1.4845110696271036e-09
with O 0 2.489182904935605e-12
the O 0 5.266427918759753e-11
beta O 0 1.974684304961727e-11
- O 0 4.142678387830667e-12
subunit O 0 6.137142443546351e-12
to O 0 8.379721222473435e-11
produce O 0 5.438312022931768e-10
Hex O 0 4.78196504616335e-08
A O 0 1.9079648438946606e-07
( O 0 1.7905964211362146e-10
alphabeta O 0 1.1611803785172015e-07
) O 0 2.1931430629895665e-11
in O 0 4.262394603937736e-11
COS O 0 2.4606290338624603e-08
- O 0 3.2709508435146972e-09
7 O 0 2.065939641582304e-09
cells O 0 8.699020948021996e-10
, O 0 8.480859764459225e-11
the O 0 1.1310244407702896e-10
mature O 0 1.9535381645674477e-10
alpha O 0 7.496093190617614e-10
- O 0 8.827179959203235e-11
subunit O 0 6.339382352393841e-10
was O 0 1.717244679788621e-09
present O 0 2.685789646239556e-10
, O 0 3.003216425545574e-11
but O 0 1.148876480061567e-11
its O 0 9.124210935407273e-12
level O 0 1.7693843612498483e-10
was O 0 6.892299925231882e-11
much O 0 3.66085668723759e-11
lower O 0 1.0811821576917069e-10
than O 0 1.0046936373131476e-11
that O 0 4.395037285498393e-12
from O 0 1.8091333986447466e-11
normal O 0 1.3414434008041098e-09
alpha O 0 1.631720092376554e-09
- O 0 7.566524073965297e-10
subunit O 0 8.545130159021141e-10
transfections O 0 3.8391565482243095e-08
, O 0 3.404414250507415e-11
although O 0 1.913495403793597e-11
higher O 0 2.63014693357988e-10
than O 0 3.778561664946611e-12
in O 0 9.973923596751089e-12
those O 0 1.7938019125640636e-11
cells O 0 7.837979570934905e-11
transfected O 0 4.327986413699136e-09
with O 0 1.2804963686607884e-11
an O 0 5.393785765250847e-11
alpha O 0 1.4273000559228421e-09
- O 0 6.481453151963024e-10
subunit O 0 2.378712116168913e-09
associated O 0 9.400226019806723e-08
with O 0 5.9864158075129126e-09
infantile O 0 0.1309080570936203
TSD B-Disease 0 0.0018405582522973418
. O 0 1.0271494375047041e-06

Furthermore O 0 2.856880314539012e-07
, O 0 5.047876561192766e-10
the O 0 1.629921336787632e-10
precursor O 0 8.826885000701168e-09
level O 0 9.378269538729e-08
of O 0 2.6531239427640685e-09
the O 0 1.7722797673869195e-09
W474C O 0 2.747287553006572e-08
alpha O 0 2.965865331105988e-09
- O 0 2.4735388737262554e-10
subunit O 0 6.082424564013422e-10
was O 0 4.9279553770986695e-09
found O 0 1.1077593703445743e-10
to O 0 5.6957345090369316e-11
accumulate O 0 4.410987200498262e-11
in O 0 2.5494774694156952e-11
comparison O 0 2.8162619458704796e-10
to O 0 1.54888224468408e-09
the O 0 3.5322984537344837e-09
normal O 0 3.932314029952977e-08
alpha O 0 1.1673354727292917e-08
- O 0 2.508757424024566e-09
subunit O 0 1.3666074938356587e-09
precursor O 0 4.392372687789248e-08
levels O 0 2.5042416496035e-07
. O 0 6.069242175499312e-08

We O 0 2.968130630165433e-08
conclude O 0 1.8179429517317658e-08
that O 0 1.7455178968894813e-10
the O 0 6.162508836560221e-10
1422 O 0 3.0339367640408454e-06
G O 0 9.145953185907274e-07
- O 0 6.833365659986157e-07
- O 0 3.17662340876268e-07
> O 0 1.989002385016647e-06
C O 0 7.737370992799697e-07
mutation O 0 1.5585363555281617e-10
is O 0 2.562082273768751e-12
the O 0 2.2535565427639348e-11
cause O 0 1.5409173936831166e-09
of O 0 7.516757882797265e-09
Hex B-Disease 0 1.0718269550125115e-05
A I-Disease 0 7.033973815850914e-05
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.857856031823758e-07
the O 0 1.9156368580297567e-07
proband O 0 8.495687325194012e-06
. O 0 5.994667162667611e-08

The O 0 5.9585094192016186e-08
resulting O 0 1.2569240093185385e-09
W474C O 0 9.730936056939754e-08
substitution O 0 8.793046646360381e-08
clearly O 0 1.7579287359126283e-08
interferes O 0 2.9500175635632786e-09
with O 0 5.600910013559002e-11
alpha O 0 6.385646234008391e-09
- O 0 6.397004592706423e-10
subunit O 0 1.9487644831173156e-09
processing O 0 2.1491359802894294e-08
, O 0 1.1312034642330104e-10
but O 0 1.5220838478491316e-11
because O 0 9.99593897238471e-12
the O 0 1.4348348897907925e-11
base O 0 1.053396536665474e-10
substitution O 0 2.823803135765246e-10
falls O 0 3.1353861174032716e-10
at O 0 2.2044883973837415e-10
the O 0 4.815807752578394e-10
first O 0 3.25931726052886e-09
position O 0 4.4744105309746374e-08
of O 0 8.91929019530835e-09
exon O 0 6.443249134235884e-08
13 O 0 2.8525030870696355e-07
, O 0 2.750259131545363e-09
aberrant O 0 5.6297051465037384e-09
splicing O 0 1.296242491122257e-08
may O 0 9.699615333147449e-09
also O 0 1.582886599571509e-10
contribute O 0 2.687901012876637e-10
to O 0 4.7817887427470396e-09
Hex B-Disease 0 3.4872857668233337e-06
A I-Disease 0 4.324252586229704e-06
deficiency I-Disease 0 4.633539560927602e-07
in O 0 2.0712274562129096e-08
this O 0 3.898489531195537e-09
proband O 0 2.416219331280445e-07
. O 0 4.340717563167118e-09
. O 0 3.2787600190431476e-08

Two O 0 3.051341224136195e-08
frequent O 0 6.1546301388659685e-09
missense O 0 2.934780241048429e-07
mutations O 0 6.045338096782871e-08
in O 0 6.186008931763354e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 3.637189729488455e-05

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 9.665951949955343e-08
an O 0 1.217597741742793e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 4.358997500730766e-07
by O 0 1.153100271517049e-11
early O 0 1.385719627933213e-07
childhood O 1 0.9996494054794312
deafness B-Disease 1 1.0
and O 0 0.0002507175668142736
goiter B-Disease 1 1.0
. O 0 0.0002391442540101707

A O 0 6.113927497608529e-08
century O 0 2.8660855910800365e-09
after O 0 3.818507454678155e-10
its O 0 4.565820378027441e-12
recognition O 0 1.7617902969835342e-10
as O 0 5.052500084978817e-10
a O 0 4.103004158650947e-09
syndrome O 0 2.055661951771981e-08
by O 0 3.3339473543003706e-11
Vaughan O 0 3.77903042192429e-08
Pendred O 0 2.2141243505302555e-07
, O 0 3.411280424803209e-10
the O 0 1.4642498324946018e-09
disease O 0 7.453934136592011e-10
gene O 0 1.5667028785415482e-10
( O 0 5.134689340380305e-10
PDS O 0 1.821091427700594e-05
) O 0 2.9697089232172402e-09
was O 0 7.705340721031462e-08
mapped O 0 2.640766005868045e-08
to O 0 1.4660949787526079e-08
chromosome O 0 4.561094613109162e-08
7q22 O 0 7.142745289456798e-06
- O 0 8.422465498370002e-07
q31 O 0 8.509357940056361e-06
. O 0 1.4719853425049223e-07

1 O 0 1.0248695616610348e-06
and O 0 4.420837917962217e-09
, O 0 8.909288307101804e-10
recently O 0 6.019872156315387e-09
, O 0 1.6927499679741942e-10
found O 0 6.32453672766431e-11
to O 0 3.7902661564892526e-10
encode O 0 3.43902706312349e-09
a O 0 1.7971608201605704e-08
putative O 0 1.0750122783065308e-06
sulfate O 0 1.598731955709809e-06
transporter O 0 2.347851250306121e-06
. O 0 9.81243715614255e-07

We O 0 1.7833153265200963e-07
performed O 0 2.1430736296679243e-08
mutation O 0 1.041382757804854e-09
analysis O 0 7.613936148231915e-10
of O 0 6.394930140984911e-10
the O 0 4.650643425918588e-09
PDS B-Disease 0 3.8025220305826224e-07
gene O 0 8.750926094869271e-10
in O 0 2.586349467925686e-10
patients O 0 8.918022570414408e-11
from O 0 1.069976399148409e-11
14 O 0 1.948816441554868e-09
Pendred B-Disease 0 3.291147265827021e-08
families O 0 7.857599119975855e-12
originating O 0 1.1257492854577222e-10
from O 0 2.649212273164725e-11
seven O 0 1.6063236851771023e-10
countries O 0 1.877344286971283e-11
and O 0 1.3369878815172598e-10
identified O 0 5.977869310669348e-09
all O 0 4.1877612488860905e-09
mutations O 0 1.8779415356107165e-08
. O 0 1.9295883646464063e-07

The O 0 3.690708581416402e-06
mutations O 0 1.1961218682188246e-08
include O 0 8.030898168698286e-10
three O 0 2.0287795055029534e-10
single O 0 1.899620460932283e-09
base O 0 3.111773310138233e-07
deletions O 0 5.642629048452363e-07
, O 0 3.400720416379954e-08
one O 0 9.053771066191985e-09
splice O 0 5.612628228846006e-07
site O 0 3.6582591178557777e-07
mutation O 0 3.3358589224263824e-09
and O 0 1.4750897170401345e-09
10 O 0 5.634358899442304e-07
missense O 0 7.233235464809695e-06
mutations O 0 3.7406147157525993e-07
. O 0 2.1855769318790408e-06

One O 0 7.971477771206992e-07
missense O 0 5.335137302608928e-06
mutation O 0 1.547689976177935e-08
( O 0 6.389026807607223e-11
L236P O 0 1.9444398091650328e-08
) O 0 5.202630340428449e-11
was O 0 1.2335630295012834e-09
found O 0 4.4458544484760054e-11
in O 0 1.8715666169621947e-11
a O 0 5.0084669050987074e-11
homozygous O 0 9.991788646468436e-11
state O 0 1.3070575871632073e-11
in O 0 1.9080442781316265e-10
two O 0 5.4000238308704596e-11
consanguineous O 0 3.3314335734502265e-09
families O 0 9.470989964510679e-12
and O 0 4.054941712267057e-12
in O 0 3.423088548726305e-11
a O 0 1.7249188188905862e-10
heterozygous O 0 2.217718231278809e-10
state O 0 3.0216142088423936e-11
in O 0 2.8101773685840215e-10
five O 0 1.6198209440432265e-10
additional O 0 8.211488711218351e-10
non O 0 1.3858360148333304e-07
- O 0 2.0542810830193048e-07
consanguineous O 0 2.15312979889859e-06
families O 0 1.6006550751512805e-08
. O 0 7.698333348571396e-08

Another O 0 6.403211614269821e-07
missense O 0 5.998704182275105e-06
mutation O 0 7.338250007649094e-09
( O 0 6.467939378529408e-11
T416P O 0 3.034319107086958e-08
) O 0 6.605252456104438e-11
was O 0 1.0217238166632114e-09
found O 0 3.357840741569085e-11
in O 0 2.3411298941122816e-11
a O 0 2.659809351934772e-11
homozygous O 0 3.4198321258172015e-11
state O 0 1.0534602704059814e-11
in O 0 1.9323996569564628e-10
one O 0 1.125264117995961e-10
family O 0 4.0713342419618215e-11
and O 0 2.1659183127575865e-11
in O 0 8.153738101368546e-11
a O 0 1.0453025944823224e-10
heterozygous O 0 6.853601713929791e-11
state O 0 1.4886692573101712e-11
in O 0 3.969188311359062e-10
four O 0 2.7694077586737365e-10
families O 0 2.5928283825527032e-11
. O 0 5.912339506863873e-09

Pendred B-Disease 0 2.583545574452728e-05
patients O 0 8.542302509795263e-08
in O 0 3.4866257103693954e-10
three O 0 1.3342009441696945e-10
non O 0 3.572417739405864e-08
- O 0 3.112313251563137e-08
consanguineous O 0 8.551755286134721e-07
families O 0 3.426709471732181e-10
were O 0 3.337995713170727e-10
shown O 0 3.6753269871958594e-10
to O 0 1.0124761029572937e-09
be O 0 9.627212360641124e-10
compound O 0 1.999668519658826e-08
heterozygotes O 0 4.1418648066837704e-08
for O 0 1.4584550234175708e-09
L236P O 0 1.8868803408622625e-07
and O 0 2.4115396346502393e-09
T416P O 0 2.468284947099164e-06
. O 0 1.1634637786528401e-07

In O 0 3.6510716228121964e-08
total O 0 6.991117018628756e-09
, O 0 1.405696392620115e-10
one O 0 4.740664111269055e-11
or O 0 3.5543623599920693e-10
both O 0 1.9286043873023573e-09
of O 0 2.7190574236612974e-09
these O 0 6.634545690609173e-11
mutations O 0 1.5310168063886742e-11
were O 0 3.316581731471757e-11
found O 0 1.6043878031668513e-11
in O 0 8.884067786985028e-11
nine O 0 5.944880698827149e-10
of O 0 1.109408676036594e-10
the O 0 2.5119306634735494e-10
14 O 0 6.4522733822514056e-09
families O 0 1.9099156978175102e-10
analyzed O 0 1.5340591019707972e-08
. O 0 1.52199973513234e-07

The O 0 8.510460958177646e-08
identification O 0 1.5815459164514323e-07
of O 0 4.688444832368077e-08
two O 0 1.9128916228794424e-09
frequent O 0 8.37892955019015e-09
PDS B-Disease 0 9.45605904689728e-07
mutations O 0 1.5337656700253888e-09
will O 0 1.6305689021223202e-09
facilitate O 0 8.251736716147207e-08
the O 0 2.0262175937091342e-08
molecular O 0 8.26085440053248e-08
diagnosis O 0 1.091354170057457e-05
of O 0 4.290165520615119e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.6401473809964955e-06

Insertional O 0 0.00017072440823540092
mutation O 0 2.464631165821629e-08
by O 0 2.199104787159456e-10
transposable O 0 1.0897986157942796e-07
element O 0 4.922040020005625e-08
, O 0 2.2556616574576083e-09
L1 O 0 2.411946411484678e-07
, O 0 3.7649111606086194e-10
in O 0 6.978669864210474e-10
the O 0 2.617263561432992e-08
DMD B-Disease 1 1.0
gene O 0 6.496608051520525e-08
results O 0 2.706103607863497e-08
in O 0 1.8717514649324585e-08
X B-Disease 1 1.0
- I-Disease 1 0.9992715716362
linked I-Disease 0 0.0004339163424447179
dilated I-Disease 0 0.010870857164263725
cardiomyopathy I-Disease 1 1.0
. O 0 9.002866863738745e-05

X B-Disease 1 1.0
- I-Disease 1 0.9999977350234985
linked I-Disease 1 0.9997259974479675
dilated I-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
( O 0 4.90401035335708e-08
XLDCM B-Disease 0 0.0002234244457213208
) O 0 3.395998204869244e-10
is O 0 5.0954865327135224e-11
a O 0 1.8809365176508663e-10
clinical O 0 1.29339010612739e-08
phenotype O 0 2.045437099695846e-07
of O 0 3.2760726753622293e-07
dystrophinopathy B-Disease 0 2.6319612516090274e-05
which O 0 3.0575499909701875e-09
is O 0 4.393237509892067e-11
characterized O 0 9.551845425725958e-12
by O 0 5.617511664168795e-12
preferential O 0 1.623107834802795e-07
myocardial B-Disease 0 1.3123979442752898e-05
involvement I-Disease 0 1.240746438924134e-08
without O 0 8.601939160968186e-10
any O 0 2.025500600577601e-10
overt O 0 3.789133007359169e-09
clinical O 0 2.4621783722977852e-08
signs O 0 1.6187239282317023e-07
of O 0 1.3507428775483277e-06
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.002158150775358081

To O 0 3.124154446254579e-08
date O 0 2.1948353889911232e-07
, O 0 7.104946631031339e-10
several O 0 1.9226011407913468e-11
mutations O 0 2.0101739717226508e-11
in O 0 1.7285811670930684e-10
the O 0 5.818182557959517e-08
Duchenne B-Disease 1 0.9999649524688721
muscular I-Disease 0 0.283454567193985
dystrophy I-Disease 1 0.9971750974655151
gene O 0 2.4780263629509136e-05
, O 0 1.7106311815950903e-06
DMD O 1 1.0
, O 0 6.813737130073605e-09
have O 0 7.933562834461227e-11
been O 0 3.32763261390312e-11
identified O 0 3.5826886596312946e-11
in O 0 1.6574236774702378e-11
patients O 0 2.2546140301948903e-11
with O 0 1.6944151160283583e-12
XLDCM B-Disease 0 2.5454203296249034e-06
, O 0 1.3923976416307937e-09
but O 0 5.734609453966755e-10
a O 0 4.836566147581323e-10
pathogenic O 0 1.3898743267404257e-09
correlation O 0 2.328831572029344e-09
of O 0 4.4272256971567e-09
these O 0 1.0921719084677761e-09
cardiospecific O 0 3.485825175175705e-07
mutations O 0 8.48851877677248e-10
in O 0 1.6190588869591238e-09
DMD O 1 1.0
with O 0 1.229297663662976e-09
the O 0 9.186060623278536e-08
XLDCM B-Disease 0 0.013285133987665176
phenotype O 0 4.181202939435025e-07
has O 0 6.477745562172288e-10
remained O 0 5.612037057289854e-09
to O 0 6.201016922169345e-10
be O 0 2.4398310038975524e-09
elucidated O 0 1.6777844393800478e-06
. O 0 7.414564038299432e-07

We O 0 2.5813309889599623e-07
report O 0 4.4372687746374595e-09
here O 0 4.064888703414482e-10
the O 0 9.955226920599358e-11
identification O 0 5.579441353376069e-09
of O 0 2.146492539267797e-09
a O 0 9.126308597728894e-10
unique O 0 2.544971344775604e-09
de O 0 1.337113872068585e-06
novo O 0 1.9892837599400082e-07
L1 O 0 1.1694029211639645e-07
insertion O 0 1.1234847496766065e-09
in O 0 1.265557658669536e-09
the O 0 3.507391044266228e-09
muscle O 0 1.5269820963226266e-09
exon O 0 7.634546328461056e-09
1 O 0 1.584718845037969e-08
in O 0 6.569676358481047e-09
DMD O 1 1.0
in O 0 2.4835349776708426e-08
three O 0 7.757787190421084e-10
XLDCM B-Disease 0 2.4843316737133136e-07
patients O 0 5.019553661611553e-10
from O 0 5.2304098552280465e-11
two O 0 3.976013615569762e-11
unrelated O 0 5.955480553154757e-10
Japanese O 0 1.2032236895720416e-07
families O 0 4.585872237505839e-10
. O 0 1.0650140325196844e-08

The O 0 9.455430927118869e-08
insertion O 0 1.0505363690072045e-08
was O 0 1.9110546034539766e-08
a O 0 7.78259678924087e-10
5 O 0 1.51277734783406e-09
- O 0 8.151394559341441e-10
truncated O 0 2.824407818735608e-09
form O 0 3.019484107191772e-10
of O 0 4.955097443470891e-10
human O 0 1.2567795415474592e-10
L1 O 0 6.037465638542017e-09
inversely O 0 7.726186912471178e-10
integrated O 0 1.1966078794500845e-08
in O 0 1.571171415193362e-09
the O 0 3.154294159202209e-09
5 O 0 8.676126483919688e-09
- O 0 9.510376486332461e-09
untranslated O 0 7.40875350402348e-07
region O 0 1.4915022106265496e-08
in O 0 2.137944710156603e-09
the O 0 2.057586989678839e-09
muscle O 0 9.099592745975826e-10
exon O 0 4.224584682077648e-09
1 O 0 8.581737986901317e-09
, O 0 9.567988762393398e-11
which O 0 7.2583362931144535e-12
affected O 0 3.3336486349178074e-11
the O 0 2.086354873587215e-11
transcription O 0 1.0814792117397332e-10
or O 0 2.1137291916772938e-10
the O 0 1.472989508144451e-09
stability O 0 1.4405360161617864e-05
of O 0 5.433959948675238e-09
the O 0 1.7203197755222277e-09
muscle O 0 1.536090254994349e-09
form O 0 5.422237103758221e-10
of O 0 5.316205253791395e-10
dystrophin O 0 1.7136661867311886e-08
transcripts O 0 5.9041806999005075e-09
but O 0 6.745300151766997e-11
not O 0 1.6950181536135034e-10
that O 0 1.98275718760188e-11
of O 0 4.72041017385294e-10
the O 0 1.3321985292691352e-08
brain O 0 5.817005899189098e-07
or O 0 2.735340132176134e-08
Purkinje O 0 4.423051905177999e-06
cell O 0 7.54266977764928e-08
form O 0 2.391311593186174e-10
, O 0 1.5393421259890516e-10
probably O 0 3.4424987305214927e-09
due O 0 1.3756306316281552e-08
to O 0 1.4826074590246208e-08
its O 0 8.369820947429218e-10
unique O 0 1.103449664974221e-09
site O 0 6.0920410938081204e-09
of O 0 2.985251212894724e-10
integration O 0 1.2111264879877126e-08
. O 0 8.504392212671519e-08

We O 0 3.9246606320375577e-07
speculate O 0 1.1759676965539256e-07
that O 0 7.314388678070216e-11
this O 0 2.6697102861739097e-11
insertion O 0 1.685283357311107e-09
of O 0 3.9573602172993105e-09
an O 0 2.2823060108478899e-10
L1 O 0 9.988011129280494e-08
sequence O 0 1.8590238237692347e-09
in O 0 3.034081430541846e-08
DMD O 1 1.0
is O 0 1.2093945844782183e-09
responsible O 0 2.9808244761397873e-10
for O 0 4.6411749443642236e-11
some O 0 1.5339866529795465e-11
of O 0 4.4793994902203593e-11
the O 0 4.635335865144086e-11
population O 0 9.67164607949822e-13
of O 0 3.5173140441879802e-12
Japanese O 0 1.5592092061922358e-09
patients O 0 4.617661114592053e-11
with O 0 3.966822963857863e-12
XLDCM B-Disease 0 9.554913731335546e-07
. O 0 3.984749952223865e-08
. O 0 5.375706564336724e-07

Severe O 0 1.6602425603196025e-05
early O 1 0.9998071789741516
- O 1 0.9998313188552856
onset O 1 0.9999722242355347
obesity B-Disease 1 1.0
, O 0 2.5691033744834613e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 3.4291849715373246e-07
red O 0 0.0009136704029515386
hair O 1 0.7648356556892395
pigmentation O 1 0.771575927734375
caused O 0 6.945570589778072e-07
by O 0 9.754941743267409e-09
POMC O 0 3.5393259167904034e-05
mutations O 0 5.966262150991497e-09
in O 0 1.8540804447297887e-09
humans O 0 6.4851914949315415e-09
. O 0 1.766856883023138e-08

Sequential O 0 5.082182497062604e-07
cleavage O 0 7.450373828987722e-08
of O 0 1.0189436494556503e-07
the O 0 3.1616909090814715e-09
precursor O 0 9.861894412210859e-09
protein O 0 1.3527228226450916e-09
pre O 0 7.349163411163318e-07
- O 0 2.994321448568371e-07
pro O 0 2.5583481146895792e-06
- O 0 5.702623298020626e-07
opiomelanocortin O 0 1.5237728803185746e-06
( O 0 4.4121675757402556e-10
POMC O 0 3.0918758966436144e-06
) O 0 2.8830643428179314e-10
generates O 0 3.5375216644872864e-10
the O 0 7.963418258150057e-10
melanocortin O 0 1.4974261830502655e-06
peptides O 0 4.175583967480634e-08
adrenocorticotrophin O 0 9.355754855278064e-07
( O 0 2.8867458423675885e-10
ACTH O 0 1.6336723547283327e-06
) O 0 6.876584857096191e-10
, O 0 1.4927993285951402e-09
melanocyte O 0 1.59662540681893e-05
- O 0 1.845309384407301e-06
stimulating O 0 1.4130386034594267e-06
hormones O 0 1.0455189567437628e-06
( O 0 9.574322584748884e-11
MSH O 0 4.308926236262778e-06
) O 0 1.6078746667425037e-10
alpha O 0 5.08872188831333e-09
, O 0 3.1301385094995027e-11
beta O 0 3.600721665275586e-10
and O 0 2.1747686984596726e-11
gamma O 0 1.4084347021992016e-09
as O 0 6.776351701986982e-11
well O 0 1.644727132266155e-10
as O 0 7.507895000147258e-11
the O 0 1.808339936126835e-11
opioid O 0 8.296264231155703e-10
- O 0 1.780566527553873e-10
receptor O 0 2.053030662141353e-10
ligand O 0 7.798128365266166e-09
beta O 0 7.118788403204235e-07
- O 0 2.107373404669488e-07
endorphin O 0 7.714184175711125e-05
. O 0 2.4738625370446243e-07

While O 0 6.32870893468862e-08
a O 0 2.155078560051038e-09
few O 0 5.246859058338771e-10
cases O 0 5.1945985707346765e-11
of O 0 1.1309581049445683e-09
isolated O 0 6.749762349045341e-08
ACTH B-Disease 1 0.999543309211731
deficiency I-Disease 0 1.699073618510738e-05
have O 0 2.090345816441186e-07
been O 0 2.4859899028228938e-08
reported O 0 1.7830246168415442e-09
( O 0 1.0286452939434199e-10
OMIM O 0 4.511531187745277e-06
201400 O 0 5.118814669913263e-07
) O 0 9.204960127462414e-10
, O 0 4.3123116189036637e-10
an O 0 2.4242252649742113e-10
inherited O 1 0.6967743635177612
POMC O 1 1.0
defect O 1 1.0
has O 0 8.469734069649348e-08
not O 0 2.408726329505839e-09
been O 0 6.466536750515672e-10
described O 0 2.6293545118960537e-10
so O 0 5.533147828806761e-10
far O 0 3.6485776622185995e-09
. O 0 3.0886639024174656e-08

Recent O 0 1.8757225461740745e-07
studies O 0 2.2725261672462693e-08
in O 0 5.521845758416077e-10
animal O 0 1.1019284096303039e-10
models O 0 4.55460218151682e-11
elucidated O 0 3.031442430412312e-09
a O 0 4.998382263643464e-10
central O 0 1.3692537770282343e-08
role O 0 1.2411630834208154e-08
of O 0 2.273211130443542e-08
alpha O 0 6.893703385912886e-08
- O 0 3.4775702317801915e-08
MSH O 0 1.001864075078629e-05
in O 0 2.857521330668078e-09
the O 0 3.1221036866924123e-09
regulation O 0 2.2722616677128826e-08
of O 0 1.0719952009408118e-10
food O 0 1.2454159925567865e-10
intake O 0 1.3533124273990005e-11
by O 0 1.1387525850666685e-13
activation O 0 9.936982348079937e-10
of O 0 3.760836531085943e-09
the O 0 1.4110435486713868e-08
brain O 0 1.24993411176888e-08
melanocortin O 0 6.513221251225332e-08
- O 0 4.351095483912104e-09
4 O 0 6.136051666771891e-09
- O 0 4.752184423750805e-09
receptor O 0 1.021988937921492e-09
( O 0 4.533195346878571e-11
MC4 O 0 2.9121601983206347e-06
- O 0 2.143106492269453e-08
R O 0 2.402362531128688e-09
; O 0 3.545734539311951e-11
refs O 0 7.179876693186316e-09
3 O 0 1.021704276737978e-09
- O 0 5.432070904198838e-10
5 O 0 5.398935187805876e-10
) O 0 6.766868315688512e-12
and O 0 7.015363550494369e-12
the O 0 1.0636366787331042e-10
linkage O 0 2.086580863647214e-08
of O 0 1.6395097501842315e-09
human O 0 8.834026843373977e-09
obesity B-Disease 1 1.0
to O 0 1.0995838684024761e-09
chromosome O 0 5.092661292671607e-10
2 O 0 3.8211100950036325e-09
in O 0 9.636765829768024e-10
close O 0 4.062844727314996e-09
proximity O 0 9.635484410353001e-09
to O 0 1.0194973754096281e-08
the O 0 1.2780290603586764e-08
POMC O 0 8.788183549768291e-06
locus O 0 8.646970428571876e-08
, O 0 5.794852375728965e-10
led O 0 2.6280810860868087e-10
to O 0 1.8714962912724786e-10
the O 0 8.53242268505916e-11
proposal O 0 1.4255471803004127e-10
of O 0 1.2379181013599805e-10
an O 0 4.9346190328369843e-11
association O 0 2.647849717263284e-10
of O 0 7.706820959185734e-09
POMC O 0 0.10655085742473602
with O 0 1.4169120987617134e-08
human O 0 5.536147909879219e-06
obesity B-Disease 1 1.0
. O 0 1.8999519113549468e-07

The O 0 2.611215421666202e-08
dual O 0 2.5936444103535905e-07
role O 0 3.832210779819434e-07
of O 0 1.054866288541234e-06
alpha O 0 3.032739186892286e-06
- O 0 6.315926270872296e-07
MSH O 0 0.0001155579011538066
in O 0 4.770638550866124e-09
regulating O 0 1.4729002906221922e-08
food O 0 8.115903504801736e-09
intake O 0 7.283768255206269e-09
and O 0 2.5592911123695217e-10
influencing O 0 5.410792709881207e-06
hair O 0 0.015526292845606804
pigmentation O 0 0.0007434965809807181
predicts O 0 3.786028557328791e-08
that O 0 7.3870840000545e-11
the O 0 1.4329730457784962e-10
phenotype O 0 1.0972038833045872e-09
associated O 0 1.2044292230228848e-09
with O 0 1.337584036587014e-11
a O 0 9.699130387730293e-10
defect O 0 1.294275975283199e-08
in O 0 3.7249279216666764e-09
POMC O 0 3.399295337658259e-06
function O 0 7.775508237273243e-09
would O 0 1.8404310297981397e-09
include O 0 1.3703407297782633e-08
obesity B-Disease 1 1.0
, O 0 6.034446276004246e-10
alteration O 0 3.927502518763504e-07
in O 0 1.4466029085724585e-07
pigmentation O 0 0.004391679540276527
and O 0 2.999569232997601e-07
ACTH B-Disease 1 0.9998729228973389
deficiency I-Disease 0 1.3500575732905418e-05
. O 0 1.703880798231694e-06

The O 0 5.005867365071026e-07
observation O 0 4.39477116742637e-06
of O 0 3.450216112810267e-09
these O 0 4.286005717002439e-10
symptoms O 0 3.114045021845868e-09
in O 0 1.5962843546990513e-10
two O 0 1.0437486291925424e-10
probands O 0 5.4167021090734124e-08
prompted O 0 2.5485271670788734e-09
us O 0 1.3853934666130385e-09
to O 0 5.347653431186927e-09
search O 0 1.3099797691040749e-08
for O 0 1.5648042861471367e-09
mutations O 0 7.468791696219057e-10
within O 0 1.4017774718766418e-09
their O 0 2.881357730188938e-08
POMC O 0 2.6811641873791814e-05
genes O 0 1.663850355271279e-07
. O 0 1.6754963780840626e-06

Patient O 0 9.147433956968598e-06
1 O 0 5.226498842603178e-07
was O 0 6.151006459731434e-08
found O 0 2.5633117850532017e-10
to O 0 3.406975812580981e-10
be O 0 2.866904214027244e-10
a O 0 1.633718438309728e-10
compound O 0 4.345041659803428e-09
heterozygote O 0 3.006338999966829e-08
for O 0 4.0319553251677576e-10
two O 0 6.497268695282443e-11
mutations O 0 7.76835540339249e-11
in O 0 3.0418081942151787e-10
exon O 0 4.1863157385080285e-09
3 O 0 1.3100946105737421e-08
( O 0 4.570442913021111e-10
G7013T O 0 6.817651865276275e-07
, O 0 9.144116019932369e-10
C7133delta O 0 1.232217812230374e-07
) O 0 8.65261681748386e-11
which O 0 1.3720856915921953e-11
interfere O 0 1.1643952468887164e-09
with O 0 2.736253064405947e-12
appropriate O 0 8.42632097430851e-09
synthesis O 0 8.999902689765804e-08
of O 0 2.51945220242078e-08
ACTH O 0 4.2455753828107845e-06
and O 0 2.4230168094163673e-08
alpha O 0 8.238537702709436e-06
- O 0 7.332617315114476e-06
MSH O 0 0.001221874845214188
. O 0 1.0601155508993543e-06

Patient O 0 3.0367793897312367e-06
2 O 0 9.158454616908784e-08
was O 0 1.3215137428801427e-08
homozygous O 0 2.0923427435093345e-09
for O 0 4.2589756721334027e-10
a O 0 4.720473456565344e-10
mutation O 0 4.9653694350615396e-11
in O 0 3.6396721747600225e-10
exon O 0 1.2794973969221246e-08
2 O 0 5.8466053332040246e-08
( O 0 1.0805745187525417e-09
C3804A O 0 3.5637279438560654e-07
) O 0 3.536536896664444e-10
which O 0 3.1294114521962513e-10
abolishes O 0 5.820979822601657e-07
POMC O 0 2.4151227989932522e-05
translation O 0 4.531751073955093e-06
. O 0 1.3217376135798986e-06

These O 0 2.249960751044e-08
findings O 0 3.1181046633577125e-09
represent O 0 1.330927312803709e-10
the O 0 2.677687793717354e-10
first O 0 3.442234552952783e-10
examples O 0 8.313403299098354e-10
of O 0 5.259563895521069e-10
a O 0 4.20159418368371e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 1.2203741128757883e-08
the O 0 1.1774743846615365e-08
POMC O 0 1.296617938351119e-06
gene O 0 1.7428872789437833e-09
and O 0 1.4842499451717117e-10
define O 0 1.0651644011261396e-08
a O 0 3.4591247644044643e-09
new O 0 6.08855827977095e-08
monogenic B-Disease 1 0.9999402761459351
endocrine I-Disease 1 0.9764348864555359
disorder I-Disease 0 0.00019993986643385142
resulting O 0 5.182359541500148e-10
in O 0 1.1976866720608825e-10
early O 0 1.0577937246125657e-06
- O 0 6.8592739808082115e-06
onset O 0 2.192139800172299e-05
obesity B-Disease 1 1.0
, O 0 1.3522377662056329e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 2.314367748113e-06
red O 0 0.00026953592896461487
hair O 0 0.00013638989184983075
pigmentation O 0 0.00011184318282175809
. O 0 3.1094978680812346e-07
. O 0 2.0229821018347138e-07

A O 0 1.030525595524523e-06
European O 0 1.1112357611864354e-07
multicenter O 0 5.529784175450914e-06
study O 0 1.5138365938582865e-07
of O 0 8.530008130946953e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 5.1148912660892165e-08
classification O 0 3.5703591194646833e-09
of O 0 2.0786670162920018e-09
105 O 0 4.186797042393664e-08
mutations O 0 3.1830729718684836e-10
and O 0 1.0442365028229261e-10
a O 0 2.8706208521356302e-09
general O 0 1.0469881317476393e-07
system O 0 7.187508366257589e-09
for O 0 5.665292124312771e-10
genotype O 0 8.807339302308037e-10
- O 0 5.194544350217711e-09
based O 0 1.264411686463518e-09
prediction O 0 4.4284780642556143e-07
of O 0 2.5293984684537918e-09
metabolic O 0 9.721156857267488e-07
phenotype O 0 1.1738846694697713e-07
. O 0 1.1692122114936865e-07

Phenylketonuria B-Disease 0 0.0009570458205416799
( O 0 1.5690847732230395e-08
PKU B-Disease 0 2.549517375882715e-05
) O 0 5.096405075732946e-09
and O 0 2.9867446293962985e-09
mild B-Disease 0 1.4232197145247483e-06
hyperphenylalaninemia I-Disease 1 1.0
( O 0 1.5166667921562293e-08
MHP B-Disease 1 1.0
) O 0 4.463634351026258e-09
are O 0 2.263872422858526e-09
allelic B-Disease 0 1.0902014082603273e-06
disorders I-Disease 0 1.4682517246455973e-07
caused O 0 6.691420750826182e-10
by O 0 8.849056036541736e-12
mutations O 0 8.457110012294322e-12
in O 0 6.134290297943323e-11
the O 0 6.457095969025772e-10
gene O 0 7.559441406179701e-10
encoding O 0 3.172094409364945e-08
phenylalanine O 0 4.9212603698833846e-06
hydroxylase O 0 4.5724162191618234e-05
( O 0 9.526352151567608e-09
PAH O 0 3.490571543807164e-05
) O 0 1.351758882606191e-08
. O 0 2.552216358253645e-07

Previous O 0 1.9672531834658002e-06
studies O 0 4.244860463131772e-08
have O 0 6.705410671159484e-10
suggested O 0 4.964803568263676e-10
that O 0 9.325987031238991e-12
the O 0 2.423730660616741e-10
highly O 0 2.3427148221344396e-08
variable O 0 4.370000169728883e-06
metabolic O 0 0.016555627807974815
phenotypes O 0 0.0011042566038668156
of O 0 1.0327498785045464e-05
PAH B-Disease 1 1.0
deficiency I-Disease 0 0.0013286529574543238
correlate O 0 1.0659859981387854e-05
with O 0 4.710492440551661e-09
PAH O 1 0.9933547973632812
genotypes O 0 3.880459917127155e-05
. O 0 1.043452925841848e-06

We O 0 4.7183634706016164e-06
identified O 0 3.059424784623843e-07
both O 0 4.894830762935953e-09
causative O 0 5.626122856483562e-08
mutations O 0 4.613395887531624e-09
in O 0 1.2716819819402758e-09
686 O 0 1.4857043595384312e-08
patients O 0 3.58754759233193e-09
from O 0 8.831495534877831e-10
seven O 0 1.3456955549884242e-08
European O 0 3.640821688577489e-08
centers O 0 1.8564760750905407e-07
. O 0 1.4705794626479474e-07

On O 0 2.477810596701602e-07
the O 0 1.4784105051290908e-09
basis O 0 3.797496983537485e-09
of O 0 3.825396388545954e-10
the O 0 5.929140511895525e-10
phenotypic O 0 1.5549867171671394e-08
characteristics O 0 9.359452235457866e-08
of O 0 3.434237427768494e-08
297 O 0 1.1028189916828524e-08
functionally O 0 4.234493644617032e-08
hemizygous O 0 8.727781874995344e-08
patients O 0 9.110724952243743e-10
, O 0 7.253353733610579e-12
105 O 0 1.6786339429586405e-08
of O 0 6.8785168672036434e-09
the O 0 6.763395177245002e-09
mutations O 0 1.538417587765295e-10
were O 0 1.0823830026707171e-10
assigned O 0 5.465309538266183e-09
to O 0 2.3235660506770728e-08
one O 0 2.8428703835459146e-09
of O 0 1.4085475008585036e-09
four O 0 1.9272318463325888e-10
arbitrary O 0 7.2260104566623795e-09
phenotype O 0 5.28716581627009e-09
categories O 0 1.7084802905742436e-08
. O 0 1.467083023953819e-07

We O 0 2.9299786774572567e-07
proposed O 0 1.58889239543214e-08
and O 0 1.5477306103406363e-09
tested O 0 7.432727766598646e-09
a O 0 3.6334782405056387e-10
simple O 0 1.7075174607583676e-10
model O 0 7.642522725781475e-11
for O 0 1.2530352623552066e-11
correlation O 0 1.9371445419968936e-11
between O 0 8.261594533487404e-12
genotype O 0 2.450207370330304e-09
and O 0 8.395819039996866e-10
phenotypic O 0 3.200444709250405e-08
outcome O 0 3.764172333831084e-07
. O 0 2.1462005861394573e-06

The O 0 5.337903630220353e-08
observed O 0 6.760325188537308e-09
phenotype O 0 4.266254460816299e-09
matched O 0 3.682050664366443e-09
the O 0 5.28201260507899e-10
predicted O 0 1.6533679980668126e-09
phenotype O 0 2.831558876259521e-10
in O 0 5.851572698611918e-11
79 O 0 4.917383389368979e-09
% O 0 7.616706571011989e-11
of O 0 4.914564935565302e-11
the O 0 2.539935102519042e-11
cases O 0 2.4254947009194616e-12
, O 0 1.4486025226578825e-12
and O 0 1.7821616578317379e-12
in O 0 1.1380067027610963e-11
only O 0 2.4217284427807684e-11
5 O 0 3.5061786807233375e-10
of O 0 7.081753933269042e-11
184 O 0 2.0181582793821207e-10
patients O 0 6.927822759905666e-10
was O 0 1.0934106065008109e-08
the O 0 7.891811648619296e-09
observed O 0 1.5263189823144785e-08
phenotype O 0 4.876454351432358e-09
more O 0 1.328562867358718e-11
than O 0 8.140168226977718e-12
one O 0 2.9344066239389566e-12
category O 0 5.661367902254355e-11
away O 0 1.3162497480845303e-10
from O 0 2.175872329535089e-11
that O 0 2.8598028459225766e-11
expected O 0 1.3299840118108364e-09
. O 0 7.53226103711313e-08

Among O 0 1.758371404037007e-08
the O 0 5.6761111366654404e-09
seven O 0 3.3844879676614426e-10
contributing O 0 1.9813253815392784e-10
centers O 0 3.3036093305405245e-10
, O 0 1.1363193372360136e-11
the O 0 3.50177942198826e-11
proportion O 0 4.4398040799364935e-11
of O 0 1.0376626641273035e-10
patients O 0 1.6535398050798733e-11
for O 0 3.598296313689353e-11
whom O 0 1.7872364699300647e-09
the O 0 1.2144945493730575e-08
observed O 0 5.32611377224157e-09
phenotype O 0 6.29014507147474e-10
did O 0 1.6128698376860484e-09
not O 0 1.087864132109928e-09
match O 0 2.58099897010311e-09
the O 0 1.3793922670757297e-09
predicted O 0 3.116166436001322e-09
phenotype O 0 5.743651665390814e-10
was O 0 3.340632770409968e-10
4 O 0 8.577560328681955e-10
% O 0 4.222840480072598e-11
- O 0 6.118121564924195e-10
23 O 0 1.316657116667841e-09
% O 0 1.2033746221717934e-10
( O 0 4.001049491719755e-11
P O 0 2.6541982833805378e-08
< O 0 9.060750372213988e-09
. O 0 2.0647725196276667e-10
0001 O 0 1.5825280570425093e-06
) O 0 1.7782823824585847e-10
, O 0 4.5623577832332174e-11
suggesting O 0 2.5806728976007776e-10
that O 0 1.9505722991669527e-12
differences O 0 6.006685166620729e-12
in O 0 1.5658268084917104e-11
methods O 0 4.830867927907434e-10
used O 0 2.130762510876849e-10
for O 0 3.7343728109817675e-10
mutation O 0 3.752725241668031e-09
detection O 0 2.5302546191596775e-07
or O 0 7.508822363888612e-08
phenotype O 0 1.2844579089232866e-07
classification O 0 1.1047174286460404e-09
may O 0 6.683703035470501e-10
account O 0 9.972406928016042e-11
for O 0 1.1607906476307495e-11
a O 0 9.410002291265762e-12
considerable O 0 1.0425250246415274e-10
proportion O 0 2.3537216620184154e-10
of O 0 1.4787375768321454e-09
genotype O 0 4.964979325450258e-07
- O 0 1.2585778677021153e-05
phenotype O 0 9.808694585444755e-07
inconsistencies O 0 3.499274896512361e-07
. O 0 6.625121500292153e-07

Our O 0 2.0045652490807697e-05
data O 0 9.310397217632271e-07
indicate O 0 8.117935124118958e-08
that O 0 5.093914734466409e-10
the O 0 3.464578846035238e-09
PAH O 0 1.6758922356530093e-05
- O 0 1.1242375421716133e-06
mutation O 0 2.1559956042693784e-09
genotype O 0 1.5708567779881832e-09
is O 0 2.0429593780568744e-11
the O 0 4.401406322740442e-11
main O 0 1.385821568611334e-09
determinant O 0 9.852498550344535e-08
of O 0 1.1530980970064775e-07
metabolic O 0 0.010441302321851254
phenotype O 0 1.302652350432254e-07
in O 0 3.890786359761478e-09
most O 0 7.171195859356772e-10
patients O 0 5.415436432620879e-10
with O 0 1.6883841547077338e-10
PAH B-Disease 1 0.9999645948410034
deficiency I-Disease 0 0.4040614366531372
. O 0 3.7115143641131e-05

In O 0 2.436047097376104e-08
the O 0 2.393055975602465e-09
present O 0 2.2453972015057388e-10
study O 0 3.827710093329273e-10
, O 0 2.4854930613660287e-11
the O 0 1.4125986491642095e-10
classification O 0 5.471522679378893e-10
of O 0 4.024435895644274e-09
105 O 0 3.118451843420189e-07
PAH O 0 1.560706914460752e-05
mutations O 0 6.566945209840469e-09
may O 0 8.04442068513822e-10
allow O 0 1.8936514578626884e-09
the O 0 1.5949673803916653e-09
prediction O 0 1.3132869014498283e-08
of O 0 8.123395289771906e-10
the O 0 7.799120793627878e-10
biochemical O 0 1.3256943987016712e-08
phenotype O 0 2.024729051086638e-09
in O 0 3.7553798959422124e-10
> O 0 3.619330257720321e-08
10 O 0 5.116683521322329e-09
, O 0 2.1795951155034743e-10
000 O 0 4.8278426589831724e-08
genotypes O 0 4.052343882676723e-08
, O 0 7.935730961250442e-10
which O 0 4.741260856144791e-11
may O 0 1.1638928015811345e-10
be O 0 2.2433796140197693e-11
useful O 0 1.6460545426699724e-10
for O 0 9.538409992404517e-12
the O 0 1.445242675535141e-10
management O 0 5.1835584713444405e-09
of O 0 4.348473581217149e-09
hyperphenylalaninemia B-Disease 1 1.0
in O 0 3.137099824357392e-08
newborns O 0 5.990941076561285e-08
. O 0 2.1733953303737508e-08

Somatic O 0 8.202374374377541e-06
instability O 0 9.131206297752215e-07
of O 0 4.594114955125406e-08
the O 0 2.1216804313439752e-08
CTG O 0 5.165114089322742e-06
repeat O 0 1.764969681516959e-07
in O 0 1.9146591867524876e-08
mice O 0 4.14454959241084e-09
transgenic O 0 1.1866408966554332e-09
for O 0 7.750642905257621e-10
the O 0 6.29658458706217e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 5.57656721866806e-06
is O 0 6.936245466881985e-10
age O 0 5.615760079180632e-10
dependent O 0 3.3917904596059145e-10
but O 0 1.2883014099962509e-11
not O 0 2.811827333470962e-11
correlated O 0 1.4098154588193523e-10
to O 0 3.784891289271286e-10
the O 0 2.203842219827834e-09
relative O 0 1.8371234489222843e-07
intertissue O 0 8.275842446892057e-07
transcription O 0 6.905704452719874e-08
levels O 0 9.340281792447058e-08
and O 0 3.6783374124382817e-09
proliferative O 0 0.00011226567585254088
capacities O 0 0.0002433541667414829
. O 0 9.484178917773534e-06

A O 0 4.433929643710144e-05
( O 0 4.781615547955198e-09
CTG O 0 2.598462288005976e-06
) O 0 6.90399959424326e-10
nexpansion O 0 1.080940350561832e-07
in O 0 1.0105178915864599e-09
the O 0 1.1677068201265683e-09
3 O 0 1.2002995042337261e-08
- O 0 3.762050582167831e-08
untranslated O 0 2.157063590857433e-06
region O 0 9.340011430936102e-09
( O 0 5.1396643885315285e-11
UTR O 0 4.1555790630809497e-07
) O 0 2.6198332392368684e-10
of O 0 1.0030039021557968e-09
the O 0 1.2128810844558302e-08
DM O 1 1.0
protein O 0 6.107668326649218e-08
kinase O 0 2.957315530238702e-07
gene O 0 1.5830270427841242e-08
( O 0 1.8348782215849013e-10
DMPK O 0 1.8122117353414069e-06
) O 0 6.353845227735633e-11
is O 0 7.736442562966683e-12
responsible O 0 8.612770219240673e-11
for O 0 2.666586951249883e-10
causing O 0 1.3445364288600103e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 9.013814405989251e-07
DM B-Disease 1 1.0
) O 0 4.6990624724685404e-08
. O 0 2.6776118033922103e-07

Major O 0 6.236240733414888e-05
instability O 0 0.0030796444043517113
, O 0 1.1025034218903329e-08
with O 0 7.252845546368292e-11
very O 0 4.556038046832356e-10
large O 0 8.159821429654102e-11
expansions O 0 5.53824008875381e-09
between O 0 9.180898402627591e-11
generations O 0 9.082513074964993e-10
and O 0 1.6425671933717467e-10
high O 0 1.3657110997655764e-09
levels O 0 2.146148592174768e-09
of O 0 5.860298357696081e-10
somatic O 0 7.834687210106495e-08
mosaicism O 0 1.6211661204579286e-06
, O 0 1.5215801951740104e-09
is O 0 4.920858859280841e-11
observed O 0 2.0529249133982574e-10
in O 0 2.55015952799198e-10
patients O 0 4.67262062375795e-10
. O 0 7.253350808866799e-09

There O 0 8.30935178441905e-08
is O 0 4.830987831994094e-10
a O 0 1.653115005995076e-10
good O 0 5.421472160094254e-10
correlation O 0 3.1053763727140193e-11
between O 0 9.802937107894483e-12
repeat O 0 3.082383015495793e-09
size O 0 1.7273824592933806e-09
( O 0 1.4391468572405586e-10
at O 0 3.987234098445924e-09
least O 0 1.0880918388522787e-10
in O 0 3.859959227248133e-11
leucocytes O 0 2.659975884000687e-08
) O 0 1.233816659951259e-10
, O 0 2.513357577615949e-11
clinical O 0 8.453925337548185e-10
severity O 0 1.2240753965997442e-09
and O 0 1.876732103056611e-11
age O 0 1.1112729625395446e-09
of O 0 4.849500356840508e-09
onset O 0 9.238929692401143e-07
. O 0 1.1275645306341175e-07

The O 0 3.811460942415579e-07
trinucleotide O 0 6.171047425596043e-05
repeat O 0 2.1834437120560324e-06
instability O 0 2.674801748980826e-07
mechanisms O 0 4.777670525868416e-08
involved O 0 1.1025871327063896e-09
in O 0 9.4016199270186e-09
DM B-Disease 1 1.0
and O 0 1.1209450434535029e-07
other O 0 1.4877858056649984e-08
human O 0 7.622720943345485e-08
genetic B-Disease 1 1.0
diseases I-Disease 1 0.9997541308403015
are O 0 9.142258131089598e-12
unknown O 0 2.362673612310573e-09
. O 0 1.8878932195320886e-08

We O 0 9.94174683910387e-07
studied O 0 4.14689679928415e-07
somatic O 0 2.2944657303014537e-06
instability O 0 7.47786472743428e-08
by O 0 2.0238787035165018e-10
measuring O 0 4.481138571321708e-09
the O 0 8.005511253905695e-10
CTG O 0 7.562447734699163e-08
repeat O 0 3.690304950509926e-09
length O 0 2.4542987087095014e-10
at O 0 2.113053065855297e-09
several O 0 2.971320758882179e-11
ages O 0 3.225093803127521e-10
in O 0 1.6808075764540575e-10
various O 0 6.434744403982506e-10
tissues O 0 2.1993921350826895e-08
of O 0 1.8141108615310486e-09
transgenic O 0 4.387179508569261e-09
mice O 0 4.33629887552911e-09
carrying O 0 3.425574046644897e-09
a O 0 6.900791049702093e-09
( O 0 7.437063742621319e-10
CTG O 0 1.808113552215218e-06
) O 0 2.060744686005478e-09
55expansion O 0 3.55101917648426e-07
surrounded O 0 2.546855393248393e-09
by O 0 3.123220432277307e-11
45 O 0 3.087637701071344e-09
kb O 0 2.792801581108506e-07
of O 0 9.320560323544669e-09
the O 0 8.152206909528559e-09
human O 0 2.6987533985334267e-08
DM B-Disease 1 1.0
region O 0 4.788016099155357e-07
, O 0 1.4125777214601953e-09
using O 0 7.901540755028691e-09
small O 0 1.1014567924405583e-08
- O 0 9.920742627400614e-08
pool O 0 1.5467610126052023e-07
PCR O 0 1.1392234000595636e-06
. O 0 1.857862628185103e-07

These O 0 2.729438790538552e-07
mice O 0 1.1596311111361501e-07
have O 0 1.3814190069627585e-10
been O 0 6.033498700652729e-11
shown O 0 5.273362996272013e-11
to O 0 4.404919207168234e-10
reproduce O 0 6.0467546525444504e-09
the O 0 1.7182570921647766e-09
intergenerational O 0 8.300952814010998e-09
and O 0 1.8818919755858587e-09
somatic O 0 3.351518387262331e-07
instability O 0 1.7683595388007234e-07
of O 0 3.4457046105274003e-09
the O 0 2.2781536657134893e-09
55 O 0 1.4940733095158976e-08
CTG O 0 4.657205749936111e-07
repeat O 0 6.910092764655928e-08
suggesting O 0 2.443688629227836e-08
that O 0 6.294439275356112e-11
surrounding O 0 1.302913887890611e-10
sequences O 0 9.399962058731504e-11
and O 0 2.339037852294723e-10
the O 0 1.0690921481426585e-09
chromatin O 0 1.3510416119189017e-09
environment O 0 1.926807335905778e-08
are O 0 4.5213822269518644e-11
involved O 0 6.933926349761421e-11
in O 0 5.418959725389527e-10
instability O 0 3.710293938752329e-08
mechanisms O 0 1.1418370604587835e-06
. O 0 2.0330740824192617e-07

As O 0 1.695304341353676e-08
observed O 0 2.3740842625130654e-09
in O 0 2.033699736392336e-10
some O 0 6.98966995393846e-11
of O 0 5.367352118312851e-10
the O 0 1.1522088838589184e-09
tissues O 0 1.9422307317995546e-08
of O 0 2.097222129293641e-08
DM B-Disease 1 1.0
patients O 0 1.1915397379880233e-07
, O 0 3.454005137459859e-11
there O 0 2.6409938472249372e-11
is O 0 7.509036795139146e-12
a O 0 1.6494416943402257e-11
tendency O 0 3.7862685209333335e-11
for O 0 4.8317870537939456e-11
repeat O 0 2.484149552728354e-09
length O 0 1.2000584970195405e-09
and O 0 2.522730246923288e-09
somatic O 0 1.500436610513134e-07
mosaicism O 0 8.191629774501052e-08
to O 0 4.456537361363644e-10
increase O 0 9.717550375487605e-11
with O 0 2.4223509483001227e-12
the O 0 2.5208918286168114e-10
age O 0 2.4831452449802782e-09
of O 0 1.3920419261737038e-09
the O 0 4.462144431727211e-09
mouse O 0 4.202814807285904e-07
. O 0 3.051897579098295e-07

Furthermore O 0 1.484630161030509e-06
, O 0 5.009943571110398e-09
we O 0 2.3905695201165145e-09
observed O 0 3.035212914337393e-10
no O 0 2.1920817938614334e-10
correlation O 0 6.927369788911619e-11
between O 0 2.8986230082850284e-11
the O 0 5.578249862026041e-09
somatic O 0 4.913002612738637e-06
mutation O 0 1.058396676967277e-07
rate O 0 1.063526042344165e-06
and O 0 1.5399045594222116e-08
tissue O 0 4.06567579602779e-08
proliferation O 0 1.2808637620764785e-05
capacity O 0 9.686046951173921e-07
. O 0 6.378010652952071e-07

The O 0 4.058912281834637e-07
somatic O 0 3.889181698468747e-06
mutation O 0 1.5081511151038285e-08
rates O 0 3.88750969193552e-08
in O 0 3.0241639747963234e-10
different O 0 2.3223009626427427e-10
tissues O 0 1.1342985217766e-08
were O 0 7.065044549392496e-09
also O 0 1.6191013807453913e-10
not O 0 2.391853382022191e-11
correlated O 0 2.3679236349494204e-10
to O 0 5.590943819022698e-10
the O 0 2.1728303600809795e-09
relative O 0 4.1742543999134796e-07
inter O 0 7.659257050818269e-08
- O 0 1.955093154037968e-07
tissue O 0 7.906214349873153e-09
difference O 0 4.5713319241080796e-10
in O 0 6.0307926187663785e-12
transcriptional O 0 3.783892990605331e-11
levels O 0 1.9355546054811157e-09
of O 0 7.370902221914832e-10
the O 0 2.6655406770714762e-09
three O 0 3.918391722201875e-10
genes O 0 2.699110934756277e-10
( O 0 3.454072861064361e-10
DMAHP O 0 5.7109891713480465e-06
, O 0 2.075165150827729e-09
DMPK O 0 1.5189140185611905e-06
and O 0 4.777082618367956e-10
59 O 0 8.25598434062158e-09
) O 0 9.654827631822016e-11
surrounding O 0 6.540915586938922e-10
the O 0 1.9869690337515067e-09
repeat O 0 1.0632584590553051e-08
. O 0 5.246391321378496e-09
. O 0 5.736519170795873e-08

A O 0 6.45111924768571e-07
novel O 0 1.2530688309198013e-07
missense O 0 1.9975946088379715e-06
mutation O 0 3.504562640088693e-09
in O 0 2.2703532109868974e-10
patients O 0 1.5770251771130006e-10
from O 0 5.1344324625279825e-11
a O 0 9.707421533278193e-10
retinoblastoma B-Disease 0 1.4114224313743762e-06
pedigree O 0 6.270445851441764e-07
showing O 0 1.010069752283016e-07
only O 0 3.2781708458884395e-09
mild O 0 4.321568880527593e-09
expression O 0 3.3847351588178753e-09
of O 0 1.8783419264423173e-09
the O 0 5.121507218319721e-09
tumor B-Disease 0 8.029941511722427e-08
phenotype O 0 5.122447532812657e-08
. O 0 9.460987371312513e-08

We O 0 2.30549986213191e-07
have O 0 3.6244385270833845e-10
used O 0 4.671156864088921e-11
single O 0 7.729218653995673e-11
strand O 0 3.744000942607073e-10
conformation O 0 2.5998667108062534e-10
polymorphism O 0 2.64227972834874e-10
analysis O 0 2.360490969355311e-11
to O 0 9.164155545526853e-11
study O 0 1.7551796127612818e-10
the O 0 3.0690647245812386e-10
27 O 0 4.734093295155617e-08
exons O 0 2.5123597424681066e-08
of O 0 3.4624914047043376e-09
the O 0 6.3810565720245904e-09
RB1 O 0 1.8760819102681126e-06
gene O 0 1.4273490167582281e-09
in O 0 1.7536938567985771e-10
individuals O 0 3.1035391270806123e-12
from O 0 4.038564621611229e-11
a O 0 4.812015785837787e-10
family O 0 1.6403512992368974e-09
showing O 0 4.113678997441639e-08
mild O 0 8.621984015633188e-09
expression O 0 5.706941141880861e-09
of O 0 3.123402203542014e-09
the O 0 1.2132536753028944e-08
retinoblastoma B-Disease 0 5.350540504878154e-06
phenotype O 0 1.8744511010027054e-07
. O 0 3.2960289786387875e-07

In O 0 2.87002031029715e-08
this O 0 3.3758764672597863e-09
family O 0 1.0605498701465876e-09
affected O 0 2.0352906859866238e-10
individuals O 0 1.1613819281275362e-11
developed O 0 3.50883655464429e-09
unilateral B-Disease 0 0.00016302512085530907
tumors I-Disease 1 1.0
and O 0 1.473878263880124e-08
, O 0 1.146228667536775e-10
as O 0 1.045099284890938e-10
a O 0 7.263740997576207e-11
result O 0 9.786090687802229e-11
of O 0 2.4512672447407624e-10
linkage O 0 6.700887400512556e-09
analysis O 0 7.523728307035071e-09
, O 0 1.69052460918806e-09
unaffected O 0 7.92575534092066e-08
mutation O 0 3.7839242850168375e-10
carriers O 0 2.5229698885631535e-10
were O 0 1.001350558027525e-09
also O 0 7.200938734186479e-10
identified O 0 7.546763769461506e-10
within O 0 1.6354931853257426e-09
the O 0 7.995963002827011e-09
pedigree O 0 7.11512313955609e-07
. O 0 2.842151616277988e-07

A O 0 4.1767953007365577e-07
single O 0 1.0552315465872653e-08
band O 0 1.654138515050363e-08
shift O 0 1.7674702590397828e-08
using O 0 1.6904053712352152e-09
SSCP O 0 5.427027645055205e-07
was O 0 1.1173050928903194e-08
identified O 0 3.0420419516730135e-09
in O 0 6.842229005599165e-10
exon O 0 2.4508757245911283e-09
21 O 0 3.063223896759837e-09
which O 0 7.217610623749815e-12
resulted O 0 4.745114717819021e-11
in O 0 4.6985262902587976e-11
a O 0 5.955684834191288e-10
missense O 0 2.4496992878653145e-08
mutation O 0 2.240178181844854e-10
converting O 0 2.696652678935152e-09
a O 0 3.6600991126789495e-09
cys O 0 3.1520430638920516e-06
- O 0 2.2212357180251274e-06
- O 0 7.771973287162837e-07
> O 0 6.450061391660711e-07
arg O 0 1.7864694257241354e-07
at O 0 4.736402825500363e-09
nucleotide O 0 5.323828933256891e-09
position O 0 2.6537527730852162e-08
28 O 0 1.901857160646614e-07
in O 0 1.63388218510363e-08
the O 0 1.4009567905759468e-07
exon O 0 1.8095971654474852e-06
. O 0 1.0408015214125044e-06

The O 0 3.3505095871078083e-06
mutation O 0 5.04776629384196e-08
destroyed O 0 1.2762601500071469e-06
an O 0 1.028407048409008e-08
NdeI O 0 9.018715900310781e-06
restriction O 0 5.17913406383741e-07
enzyme O 0 1.7439090171933458e-08
site O 0 1.698566052255046e-07
. O 0 8.853277222442557e-08

Analysis O 0 4.7401105263134014e-08
of O 0 5.207678732688237e-09
all O 0 3.845558038673147e-10
family O 0 5.204417105608705e-11
members O 0 3.849722624016394e-12
demonstrated O 0 7.660682088683757e-10
that O 0 2.062394179047633e-11
the O 0 3.9038375310163076e-10
missense O 0 1.565177285556274e-07
mutation O 0 2.2581370107133125e-09
co O 0 1.1710151071042674e-08
- O 0 4.48519386964108e-07
segregated O 0 9.741484063852113e-08
with O 0 1.1316825254681362e-10
patients O 0 6.526613027801886e-09
with O 0 4.0243471749468185e-11
tumors B-Disease 1 1.0
or O 0 1.3333374404567166e-08
who O 0 9.638383424714903e-10
, O 0 4.8394607765622766e-11
as O 0 4.71703509585808e-10
a O 0 8.277833973835413e-10
result O 0 3.0602804734769506e-09
of O 0 6.949451236692994e-09
linkage O 0 2.798850751162263e-08
analysis O 0 3.4217997324503813e-09
had O 0 6.426088550171016e-09
been O 0 1.5530828845200517e-09
predicted O 0 2.0990740257076368e-09
to O 0 5.932861979474069e-10
carry O 0 9.165283643142175e-09
the O 0 1.8455359906965896e-08
predisposing O 0 4.500757768255426e-06
mutation O 0 1.0840911812692866e-07
. O 0 4.140222529258608e-07

These O 0 1.620895062615091e-08
observations O 0 1.5417148446772444e-08
point O 0 2.2018002976409434e-09
to O 0 1.219660761275776e-10
another O 0 5.993195523190664e-11
region O 0 3.6654210222586414e-10
of O 0 3.1736597794207455e-09
the O 0 7.86197418278789e-09
RB1 O 0 1.0782037861645222e-05
gene O 0 2.029052303953449e-08
where O 0 1.0089332924678729e-08
mutations O 0 2.8278562824723963e-10
only O 0 2.8162028264944183e-10
modify O 0 4.037059575523472e-09
the O 0 3.899463862921948e-09
function O 0 2.2031793278642908e-08
of O 0 5.578483897039632e-09
the O 0 1.0463723221221244e-09
gene O 0 1.9507082060776781e-10
and O 0 1.7641475780205695e-10
raise O 0 4.723637481163223e-09
important O 0 7.654420208780266e-09
questions O 0 4.801896213990631e-09
for O 0 5.126479241113202e-10
genetic O 0 1.3172901658364822e-09
counseling O 0 1.436317620395755e-09
in O 0 1.0724609568468768e-11
families O 0 4.822457971148664e-12
with O 0 8.044960639504162e-13
these O 0 9.052174287926817e-11
distinctive O 0 1.4664633951610995e-09
phenotypes O 0 2.023834255737711e-08
. O 0 7.676058011441e-09
. O 0 7.74431114791696e-08

Maternal B-Disease 0 0.0001776246790541336
disomy I-Disease 0 0.0026655239053070545
and O 0 1.5123709090403281e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9999996423721313
with O 0 1.3066295267982753e-10
gamete O 0 5.5281113020555495e-08
complementation O 0 4.840724088239767e-08
in O 0 5.838821093284707e-10
a O 0 9.605404249768412e-10
case O 0 1.287221995660559e-09
of O 0 1.801875870732772e-09
familial O 0 2.0882759965701325e-09
translocation O 0 6.160161269974651e-09
( O 0 1.182410246103327e-11
3 O 0 7.290574810525641e-10
; O 0 3.474170257034004e-11
15 O 0 2.7286273240889614e-09
) O 0 2.2508243532892713e-11
( O 0 1.1211588081538881e-11
p25 O 0 2.7450406392404147e-08
; O 0 6.778912153837524e-11
q11 O 0 3.3297517632036033e-08
. O 0 1.3995994641025078e-10
2 O 0 3.06237102343232e-09
) O 0 6.93190671530175e-10
. O 0 1.876494870600709e-08

Maternal B-Disease 1 0.9999978542327881
uniparental I-Disease 1 1.0
disomy I-Disease 1 1.0
( I-Disease 0 4.287028332328191e-07
UPD I-Disease 1 1.0
) I-Disease 0 3.864677466935973e-09
for I-Disease 0 1.7325958445724154e-09
chromosome I-Disease 0 1.8233045295801276e-08
15 I-Disease 0 5.3346468575909967e-08
is O 0 6.39148872716433e-11
responsible O 0 6.40271446972207e-11
for O 0 3.120296729330896e-11
an O 0 8.63358863567587e-12
estimated O 0 9.665638081579608e-12
30 O 0 5.892342724855837e-10
% O 0 1.886871735246043e-11
of O 0 6.186504000055271e-12
cases O 0 4.834356439470389e-12
of O 0 5.191532981285718e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.4047098413102503e-07
PWS B-Disease 1 1.0
) O 0 2.5142579573866897e-08
. O 0 5.054760876532782e-08

We O 0 2.359284536623818e-07
report O 0 4.0418672853093085e-09
on O 0 1.1742664618452636e-09
an O 0 1.2000779710252818e-11
unusual O 0 1.784418723893566e-10
case O 0 1.04046149473902e-09
of O 0 3.3254659026482614e-09
maternal B-Disease 0 3.1189269066089764e-05
disomy I-Disease 0 6.157715688459575e-05
15 I-Disease 0 2.113120217472897e-06
in O 0 2.0646984921768308e-07
PWS B-Disease 1 1.0
that O 0 3.28118119341525e-08
is O 0 6.303930294437876e-11
most O 0 9.911568961407102e-12
consistent O 0 1.9986104438096675e-10
with O 0 1.0736632530304949e-13
adjacent O 0 5.664651386849684e-11
- O 0 2.5348754206788726e-09
1 O 0 9.121162491965151e-09
segregation O 0 6.023825704914998e-08
of O 0 4.743135884055505e-10
a O 0 6.539643271352702e-10
paternal O 0 7.427653144986834e-06
t O 0 6.275746500250534e-08
( O 0 1.0907260337977842e-11
3 O 0 3.024314132460404e-10
; O 0 3.3884395289618396e-11
15 O 0 1.3414126476263277e-09
) O 0 7.419317764323363e-12
( O 0 3.1994370260773897e-12
p25 O 0 7.617993347253105e-09
; O 0 1.758231060744464e-11
q11 O 0 3.882009380618001e-09
. O 0 8.062260928309861e-12
2 O 0 5.3156250234831504e-11
) O 0 4.245467258995328e-12
with O 0 9.485682638671333e-13
simultaneous O 0 1.1450935311074772e-08
maternal O 0 8.513721923009143e-07
meiotic O 0 6.817393114033621e-06
nondisjunction O 0 2.590658141343738e-06
for O 0 2.330810033868147e-08
chromosome O 0 5.995719476459271e-08
15 O 0 9.907823823596118e-07
. O 0 4.94338735279598e-07

The O 0 7.600680191899301e-07
patient O 0 1.670663436925679e-06
( O 0 2.3525231762633325e-10
J O 0 2.6809053110810055e-07
. O 0 6.059496793220376e-10
B O 0 2.6558389265574078e-08
. O 0 8.552654244542435e-12
) O 0 3.91569068836084e-12
, O 0 3.5445355418134428e-12
a O 0 2.425297115915548e-11
17 O 0 9.751769530774723e-11
- O 0 5.333549921160419e-11
year O 0 1.7648947581161423e-10
- O 0 4.075254356195046e-09
old O 0 1.3376422636213192e-08
white O 0 7.61140983573938e-10
male O 0 6.058525903185341e-10
with O 0 9.359881793236102e-12
PWS B-Disease 1 1.0
, O 0 1.0721020737847198e-09
was O 0 2.9776665577685435e-09
found O 0 7.576730215452798e-11
to O 0 8.348806646019113e-10
have O 0 2.008589294888452e-09
47 O 0 3.525710567942042e-08
chromosomes O 0 6.811515351756725e-09
with O 0 2.9000346568608393e-10
a O 0 2.7040707450964874e-08
supernumerary O 0 9.096619032789022e-05
, O 0 3.693855887831887e-08
paternal O 0 3.5337779991095886e-05
der O 1 0.7301190495491028
( O 0 2.327730008744311e-09
15 O 0 4.055560864912877e-08
) O 0 4.717446919211277e-11
consisting O 0 1.4613529830675986e-10
of O 0 3.6824560067927337e-10
the O 0 1.3522738484539332e-09
short O 0 3.1464586491836144e-09
arm O 0 1.4247332202899088e-08
and O 0 2.0806580902643645e-09
the O 0 3.153369476649459e-08
proximal O 0 2.1007047052989947e-06
long O 0 3.494472764487e-07
arm O 0 3.2474548561367556e-07
of O 0 5.468544372888573e-08
chromosome O 0 5.7043076928664505e-09
15 O 0 3.823372196620767e-08
, O 0 4.001662334829348e-10
and O 0 6.394345053450934e-10
distal O 0 2.1292640894898796e-07
chromosome O 0 1.0945876056212e-05
arm O 0 4.672814975492656e-05
3p O 0 0.008137695491313934
. O 0 7.34907598598511e-06

The O 0 1.1683661796269007e-05
t O 0 7.098032028807211e-08
( O 0 1.097759556867306e-11
3 O 0 2.5127069869235186e-10
; O 0 8.946657650832357e-12
15 O 0 5.294469862526796e-10
) O 0 1.1194153243243576e-11
was O 0 3.0045299581615836e-10
present O 0 1.8966789944174778e-11
in O 0 1.859695730743738e-11
the O 0 2.0161180017130853e-11
balanced O 0 5.6553890043220534e-11
state O 0 5.368206747180526e-12
in O 0 3.0030273406866925e-11
the O 0 1.2434625551449585e-10
patients O 0 3.723730698790284e-11
father O 0 4.5593676056832066e-10
and O 0 4.3104203539812147e-10
a O 0 1.0357574353747623e-08
sister O 0 1.4266007610785891e-06
. O 0 3.6097239899390843e-06

Fluorescent O 0 4.1597462541176355e-07
in O 0 1.3464271475527312e-08
situ O 0 1.916517646805005e-07
hybridization O 0 9.900582575994576e-10
analysis O 0 1.3996581671449349e-10
demonstrated O 0 9.425837887988564e-10
that O 0 2.7711076489023156e-11
the O 0 8.717441213335064e-10
PWS B-Disease 1 1.0
critical O 0 2.869763875423814e-07
region O 0 2.8348730030103297e-09
resided O 0 1.4429750194722146e-07
on O 0 3.11942130792886e-07
the O 0 2.905339968606313e-09
derivative O 0 7.645213351281654e-09
chromosome O 0 5.232131172761001e-09
3 O 0 9.501419206969786e-09
and O 0 1.2155153272797037e-10
that O 0 2.0020584148849885e-11
there O 0 1.6824265938741867e-11
was O 0 9.961271807412686e-10
no O 0 1.163354079736223e-09
deletion O 0 1.3999605918968427e-09
of O 0 1.1844384362191818e-09
the O 0 4.101525785671356e-09
PWS B-Disease 1 1.0
region O 0 1.3241705509869917e-08
on O 0 1.290748219417992e-08
the O 0 7.337406238150379e-10
normal O 0 9.146474688748185e-09
pair O 0 1.8624665143462948e-09
of O 0 8.378541749287649e-10
15s O 0 8.857652034066632e-08
present O 0 1.2593908138569532e-09
in O 0 2.0643808440468092e-08
J O 0 6.132476846687496e-05
. O 0 1.1509747537274961e-06

B O 0 0.0011349249398335814
. O 0 1.044332975652651e-06

Methylation O 0 1.546775791894106e-07
analysis O 0 2.6457875890173455e-08
at O 0 1.2035594743053935e-08
exon O 0 3.0054427835324304e-09
alpha O 0 1.0181138598852613e-08
of O 0 1.5260211982948135e-09
the O 0 1.995522191933219e-09
small O 0 4.041895984574495e-10
nuclear O 0 4.9183142891706666e-08
ribonucleoprotein O 0 3.457501236425742e-07
- O 0 6.923125397406693e-07
associated O 0 5.622951562145317e-07
polypeptide O 0 1.5420685883782426e-07
N O 0 6.785531070363504e-08
( O 0 2.350795079431034e-11
SNRPN O 0 9.822588253882714e-08
) O 0 5.1755412455722904e-11
gene O 0 1.0800326188942222e-09
showed O 0 4.943658371558968e-09
a O 0 5.391957991207619e-10
pattern O 0 9.379818033394827e-10
characteristic O 0 1.0663916416575603e-09
of O 0 1.4511545298745432e-09
only O 0 3.787375413288885e-10
the O 0 3.4181713015613013e-10
maternal O 0 1.8575968852019287e-07
chromosome O 0 1.6023228965877934e-08
15 O 0 2.3221622313940316e-07
in O 0 9.248418564311578e-08
J O 0 0.0001103049871744588
. O 0 2.2875526610732777e-06

B O 0 0.0013440721668303013
. O 0 1.1733759492926765e-06

Maternal B-Disease 0 0.0003227689885534346
disomy I-Disease 0 0.00011208181240363047
was O 0 5.8619639276003e-07
confirmed O 0 7.707821048086316e-09
by O 0 2.6903000660549736e-11
polymerase O 0 1.0518109716528556e-09
chain O 0 1.0007872308648302e-09
reaction O 0 5.580947509686851e-11
analysis O 0 9.636393072387506e-11
of O 0 1.0523964338871039e-10
microsatellite O 0 5.035656780449926e-09
repeats O 0 1.239539471065143e-09
at O 0 4.892124039201917e-09
the O 0 1.432039375970362e-09
gamma O 0 1.4431891237620675e-08
- O 0 1.5807399833533964e-08
aminobutyric O 0 1.0807176664684448e-07
acid O 0 4.132630238018464e-09
receptor O 0 8.843058507679302e-10
beta3 O 0 7.078347152855713e-08
subunit O 0 5.390623503132019e-09
( O 0 3.882525967391359e-10
GABRB3 O 0 3.9268761611310765e-06
) O 0 2.7361737320319435e-09
locus O 0 4.877285277871124e-07
. O 0 1.4115259716618311e-07

A O 0 4.2172341636614874e-05
niece O 0 0.0011467759031802416
( O 0 1.4307678597447193e-08
B O 0 6.343645964079769e-07
. O 0 8.334419265842996e-11
B O 0 2.71259281703351e-09
. O 0 2.9969434052479205e-12
) O 0 2.547901126193075e-12
with O 0 2.730481639401372e-12
45 O 0 1.7946661934331587e-09
chromosomes O 0 6.261500207216386e-10
and O 0 2.2486715267611146e-10
the O 0 9.028968128710346e-10
derivative O 0 2.2340775895912657e-09
3 O 0 1.8757713160511003e-09
but O 0 1.0411519563158222e-10
without O 0 7.200938734186479e-10
the O 0 4.840922107618439e-10
der O 0 6.466764830292959e-07
( O 0 1.5325425650747349e-10
15 O 0 3.537780068896268e-09
) O 0 1.1652033504727655e-10
demonstrated O 0 8.481871205390235e-09
a O 0 1.2346034194976596e-09
phenotype O 0 6.542066888215459e-09
consistent O 0 6.5022840445294605e-09
with O 0 1.6736910251821668e-12
that O 0 4.561972761357724e-12
reported O 0 7.178797487017441e-12
for O 0 7.659710539453801e-12
haploinsufficiency O 0 3.4988868691243624e-08
of O 0 6.471006841479721e-09
distal O 0 8.946262255449255e-07
3 O 0 0.0005524099105969071
p O 0 0.00011407625424908474
. O 0 2.8814079655603564e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 6.325764161374536e-07
with O 0 9.219169871954591e-11
unbalanced O 0 4.065412895215559e-07
segregation O 0 1.3783582289761398e-05
of O 0 1.519338468369824e-07
non O 0 4.2304354792577215e-06
- O 0 3.894367637258256e-07
Robertsonian O 0 7.390092378045665e-06
translocations O 0 2.03825857170159e-06
has O 0 6.296939081273933e-10
been O 0 9.871313488840627e-11
reported O 0 9.347290996775115e-11
previously O 0 7.034155480312165e-10
but O 0 1.4801308789724743e-10
has O 0 2.5484661256292007e-11
not O 0 4.259184324673093e-11
, O 0 1.0317986916252853e-11
to O 0 8.36297531225938e-10
our O 0 8.653055161289558e-09
knowledge O 0 3.1128294608606666e-08
, O 0 1.480904704420638e-10
been O 0 1.0747508438768705e-10
observed O 0 9.938228018313566e-11
in O 0 1.2679152172623276e-10
a O 0 8.384968830377204e-10
case O 0 3.1111775378178663e-09
of O 0 2.6692459798027812e-08
PWS B-Disease 1 1.0
. O 0 1.9160630472470075e-05

Furthermore O 0 5.721668912883615e-06
, O 0 1.1536916311172263e-08
our O 0 3.334250919806436e-08
findings O 0 7.094063114720939e-09
are O 0 4.472595210858188e-11
best O 0 1.0879802614383038e-09
interpreted O 0 3.2846423358989796e-09
as O 0 7.322935591247415e-10
true O 0 8.99682639499133e-09
gamete O 0 2.430040524359356e-07
complementation O 0 1.5374311601590307e-07
resulting O 0 2.3945032623373663e-09
in O 0 3.777918422542825e-09
maternal B-Disease 0 0.0024691158905625343
UPD I-Disease 1 1.0
15 I-Disease 0 0.0005695220897905529
and O 0 4.8947213144856505e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999988079071045
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 3.874046115015517e-07
2 I-Disease 0 2.0496841557360312e-07
and O 0 1.3578255186885713e-09
Stuve B-Disease 1 0.9999996423721313
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 1.146500938631334e-08
a O 0 1.076696509727526e-09
case O 0 1.0366340424949883e-10
for O 0 2.8194210854870505e-11
" O 0 1.7198277246777138e-09
lumping O 0 4.311705215087613e-09
" O 0 9.834474212766509e-08
. O 0 9.392948641107068e-08

Recent O 0 2.0614768558857577e-08
studies O 0 2.371748797358464e-09
demonstrated O 0 5.026147498199407e-09
the O 0 6.702252086654426e-10
existence O 0 4.534877806605664e-09
of O 0 6.09408612461948e-09
a O 0 4.06475875180945e-09
genetically O 0 4.730119407270195e-09
distinct O 0 7.221349629382701e-10
, O 0 1.1401669886001997e-10
usually O 0 1.5699566646709684e-11
lethal O 0 3.873825218936311e-11
form O 0 5.039578563487135e-12
of O 0 1.469663141184796e-10
the O 0 2.9896858322331354e-09
Schwartz B-Disease 1 0.9979375600814819
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.4207867105042737e-09
SJS B-Disease 0 0.025207724422216415
) O 0 5.256189439251102e-08
of O 0 8.386909939872567e-07
myotonia B-Disease 1 1.0
and O 0 2.0312989363446832e-05
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 1.0473476663719339e-07
which O 0 1.8162956694212085e-09
we O 0 1.3318530278638718e-08
called O 0 4.6632056438511427e-08
SJS B-Disease 0 0.00019843870541080832
type I-Disease 0 0.0005525368032976985
2 I-Disease 0 0.00029022336821071804
. O 0 3.6970673136238474e-06

This O 0 4.197387397653074e-07
disorder O 0 7.103613461367786e-05
is O 0 1.570089197544533e-10
reminiscent O 0 1.8382559918705965e-09
of O 0 4.706861567171927e-10
another O 0 9.460360966828674e-11
rare O 0 5.300936911645238e-10
condition O 0 2.9817206836924015e-07
, O 0 4.2676029377020086e-10
the O 0 2.249617558902628e-08
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.8375283161731204e-07
SWS B-Disease 1 1.0
) O 0 5.126606361649522e-10
, O 0 8.426263853333893e-11
which O 0 3.776445128833572e-11
comprises O 0 6.711842887030528e-11
campomelia B-Disease 0 1.1503078489738527e-08
at O 0 4.538026843192711e-09
birth O 0 3.823876113528968e-07
with O 0 3.0769202741254276e-09
skeletal B-Disease 1 0.9996572732925415
dysplasia I-Disease 1 0.99973064661026
, O 0 3.8418960457420326e-08
contractures B-Disease 0 6.108780326030683e-06
, O 0 8.464573486577365e-10
and O 0 5.640017272656728e-11
early B-Disease 0 4.573168155275198e-08
death I-Disease 0 1.0772972558470428e-07
. O 0 1.0733592148426396e-07

To O 0 5.089510679567866e-08
test O 0 8.847849675142072e-10
for O 0 2.9082090902132762e-11
possible O 0 3.377033930274109e-10
nosologic O 0 2.7139094527228735e-07
identity O 0 2.372012453122352e-08
between O 0 7.942954627360166e-10
these O 0 2.365563744888277e-09
disorders O 0 2.8449642641703576e-09
, O 0 2.3943351641630972e-12
we O 0 1.4218019123157788e-11
reviewed O 0 7.980813787611396e-10
the O 0 6.400495133895845e-10
literature O 0 5.023317317665033e-10
and O 0 6.499176891106018e-11
obtained O 0 1.1267401456294124e-09
a O 0 1.1014009843046679e-10
follow O 0 2.2297512447533308e-10
- O 0 4.4159392809106635e-10
up O 0 1.5894636995472666e-10
of O 0 8.329556488995138e-11
the O 0 1.0628315588734338e-10
only O 0 6.514728340123455e-11
two O 0 8.428027373219571e-12
surviving O 0 7.543586200142727e-09
patients O 0 9.012176005462891e-10
, O 0 5.813259942866189e-11
one O 0 1.2418770178879157e-10
with O 0 5.1865199635070525e-11
SJS B-Disease 0 0.0001561692770337686
type I-Disease 1 0.9997005462646484
2 I-Disease 0 0.00010580603702692315
at O 0 1.040180706013416e-07
age O 0 6.818621778315048e-10
10 O 0 1.3809975385470352e-10
years O 0 1.7039637062454815e-11
and O 0 1.3149869214357235e-11
another O 0 1.9979966292549278e-10
with O 0 7.225010867362158e-11
SWS B-Disease 0 3.181626743753441e-05
at O 0 4.648940343798813e-09
age O 0 1.972529473093232e-09
7 O 0 2.9591316064170314e-08
years O 0 1.3979867041769012e-08
. O 0 1.047114039920416e-07

Patients O 0 2.321010867945006e-07
reported O 0 2.3699342488470165e-10
as O 0 4.2308379022415465e-11
having O 0 3.239384038788984e-10
either O 0 2.8857025213824272e-08
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 1 1.0
SWS B-Disease 1 0.9999998807907104
presented O 0 1.9286236607740648e-08
a O 0 4.173024148457216e-10
combination O 0 4.0649431043426887e-10
of O 0 2.644281460462139e-10
a O 0 1.8977545923615224e-10
severe O 0 5.112973933130149e-10
, O 0 1.9244549009922451e-10
prenatal O 0 2.1682193619199097e-05
- O 0 3.6190513128531165e-06
onset O 0 1.8216436728835106e-05
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
( O 0 1.436377128349875e-10
with O 0 2.5529042768646093e-10
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9921280145645142
feeding O 1 0.9999995231628418
difficulties O 1 0.8883464932441711
, O 0 3.654093472249542e-09
tendency O 0 7.622440456600543e-09
to O 0 2.0707298986621936e-08
hyperthermia B-Disease 0 2.6405077733215876e-06
, O 0 1.4230751299582067e-10
and O 0 1.1817700464045178e-11
frequent O 0 1.2715182205746967e-11
death O 0 1.1633335267324796e-10
in O 0 6.600768542863733e-11
infancy O 0 9.047453453092658e-09
) O 0 3.566516526554153e-11
with O 0 4.80531586743993e-12
a O 0 1.2706636853820896e-09
distinct O 0 5.117913204344404e-09
campomelic B-Disease 1 0.8656050562858582
- I-Disease 1 0.9654252529144287
metaphyseal I-Disease 1 0.9999053478240967
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.003735015634447336

The O 0 1.524687291976079e-07
similarity O 0 3.1528884392173495e-08
of O 0 5.3101917529829734e-08
the O 0 1.2366049517709143e-08
clinical O 0 3.301628126450851e-08
and O 0 9.066036255056531e-10
radiographic O 0 6.928595212229993e-06
findings O 0 5.416680437519972e-07
is O 0 1.7667480811667247e-09
so O 0 1.1394891696880904e-09
extensive O 0 2.3083881472985013e-08
that O 0 6.725853207711907e-10
these O 0 8.70380101325452e-10
disorders O 0 6.212669489968903e-09
appear O 0 1.8788721689588783e-09
to O 0 1.167023366832609e-09
be O 0 2.0007357992568586e-09
a O 0 2.185970293666628e-09
single O 0 8.760699721221954e-09
entity O 0 4.385307761367585e-08
. O 0 1.232204340340104e-06

The O 0 2.572444657289452e-07
follow O 0 2.3666844484182548e-08
- O 0 1.6413661541037072e-08
up O 0 2.1494381829967324e-09
observation O 0 2.953110538328474e-07
of O 0 1.3162153589263426e-09
an O 0 3.37061004107575e-11
identical O 0 6.816203157455902e-10
and O 0 2.2471879912444592e-10
unique O 0 3.945363857837947e-08
pattern O 0 4.1778469039854826e-07
of O 0 9.300247683086127e-08
progressive O 0 0.0018483607564121485
bone B-Disease 0 0.0007665484445169568
dysplasia I-Disease 0 2.2360411549016135e-06
in O 0 6.395838880735027e-08
the O 0 8.847317900517737e-08
two O 0 6.832031052006471e-10
patients O 0 1.3172141155592954e-10
( O 0 3.019573306672907e-12
one O 0 2.460137302207066e-11
with O 0 6.114463969864037e-12
SJS B-Disease 0 6.389099326042924e-06
type I-Disease 0 1.9486542441882193e-05
2 I-Disease 0 5.724043148802593e-06
, O 0 3.3983065250708933e-09
one O 0 8.602366041721154e-10
with O 0 8.38637215228033e-11
SWS B-Disease 0 6.797231617383659e-05
) O 0 7.080879216303515e-10
surviving O 0 2.031980699257474e-07
beyond O 0 6.562139560628566e-07
infancy O 0 1.3689740399058792e-06
adds O 0 2.3689832318041226e-08
to O 0 1.726153997516633e-09
the O 0 8.511994442628179e-10
evidence O 0 3.306862284002676e-10
in O 0 8.080646568542349e-11
favor O 0 6.802932883687163e-09
of O 0 1.764209001109407e-09
identity O 0 1.409263017393414e-08
. O 0 7.072503649396822e-08

The O 0 1.8019716208073078e-06
hypothesis O 0 1.8724604160524905e-06
that O 0 6.1786598060109554e-09
SWS B-Disease 0 0.00033062329748645425
and O 0 1.9637687032059148e-08
SJS B-Disease 0 8.034372149268165e-05
type I-Disease 0 1.8434257071930915e-05
2 I-Disease 0 2.2808496851212112e-06
are O 0 2.3034389950993273e-09
the O 0 4.967344313655531e-09
same O 0 1.975715946400669e-08
disorder O 0 1.044118462800725e-07
should O 0 1.35109834431546e-09
be O 0 5.006396963658233e-10
testable O 0 2.2341457572849777e-09
by O 0 2.7090999582535247e-11
molecular O 0 3.1425945179464065e-10
methods O 0 5.9270401919775395e-09
. O 0 3.324134301152526e-09
. O 0 4.1639481196398265e-08

A O 0 2.520921725590597e-06
mouse O 0 1.3515725072466012e-07
model O 0 5.4677517624668326e-08
of O 0 1.493053503054398e-08
severe O 0 4.485785211727489e-06
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.004029055126011372
defects O 0 0.0001672711077844724
in O 0 2.816346409417747e-07
hemostasis O 0 0.00024025794118642807
and O 0 4.1634560687953126e-08
thrombosis B-Disease 0 3.7560428722827055e-07
. O 0 1.3418936362086242e-07

von B-Disease 0 0.3119373619556427
Willebrand I-Disease 0 0.003991411533206701
factor I-Disease 0 2.169462459278293e-05
( I-Disease 0 7.968561277493791e-08
vWf I-Disease 0 0.0022882178891450167
) I-Disease 0 3.047969812541851e-06
deficiency I-Disease 1 0.999907374382019
causes O 1 0.9978912472724915
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9256136417388916
humans O 0 5.385661552281817e-07
. O 0 5.056477192511011e-08

We O 0 4.3979898123325256e-07
generated O 0 1.799650206635306e-09
a O 0 1.3148302446808202e-09
mouse O 0 3.8985117356560295e-09
model O 0 1.4002169423932287e-09
for O 0 2.3087468048466064e-10
this O 0 2.1583890230658653e-10
disease O 0 1.5466024294585878e-10
by O 0 4.5584412980415046e-12
using O 0 6.651146855496393e-10
gene O 0 1.6192689411553829e-09
targeting O 0 1.1509052200153747e-07
. O 0 3.6013986459693115e-07

vWf B-Disease 0 0.000715392641723156
- I-Disease 0 0.0011596472468227148
deficient I-Disease 0 2.2643223928753287e-05
mice O 0 3.730127218659618e-06
appeared O 0 5.3032582769674264e-08
normal O 0 6.097320692788344e-08
at O 0 3.903005474370502e-09
birth O 0 6.654500506186878e-09
; O 0 5.952630055539032e-10
they O 0 2.140503108094549e-09
were O 0 1.7519963257939253e-09
viable O 0 9.545653512077479e-08
and O 0 3.077419208352694e-09
fertile O 0 3.66636243143148e-07
. O 0 4.805233970728295e-07

Neither O 0 4.0259976231027395e-05
vWf O 0 0.00035931216552853584
nor O 0 0.00010050620039692149
vWf O 0 0.00021134178678039461
propolypeptide O 0 0.00036934169474989176
( O 0 5.075667175447052e-08
von B-Disease 0 0.0006964937783777714
Willebrand I-Disease 0 0.00019671386689879
antigen O 0 7.639501404810289e-07
II O 1 0.9627541899681091
) O 0 4.413299592442854e-08
were O 0 4.5745291998855464e-08
detectable O 0 1.1352037176948215e-07
in O 0 2.82328077583216e-10
plasma O 0 2.799735554503968e-09
, O 0 1.5280593457234204e-10
platelets O 0 2.3515733804657657e-09
, O 0 2.9013844105030273e-10
or O 0 4.514352780482511e-10
endothelial O 0 2.8122593143109498e-09
cells O 0 5.066215003068919e-09
of O 0 1.0831807673028493e-09
the O 0 2.5775059864230343e-09
homozygous O 0 1.0101025083031345e-07
mutant O 0 3.2277867489938217e-07
mice O 0 3.198303204499098e-07
. O 0 2.2184275394465658e-07

The O 0 2.8039457902195863e-06
mutant O 0 1.9685840015881695e-05
mice O 0 3.3882622574310517e-06
exhibited O 0 1.130552050199185e-06
defects O 0 2.4081959963950794e-06
in O 0 2.070453497537983e-08
hemostasis O 0 2.916718358392245e-06
with O 0 3.1086849761052804e-10
a O 0 1.2156347928282685e-08
highly O 0 1.3725163228173187e-07
prolonged O 0 1.965070805454161e-05
bleeding O 0 1.5900404832791537e-06
time O 0 1.525864036011626e-06
and O 0 3.143808768868439e-08
spontaneous O 0 8.224898095932076e-08
bleeding O 0 6.0463158924051186e-09
events O 0 1.0753044288325242e-10
in O 0 3.6494789829033536e-11
approximately O 0 1.0599254763807298e-12
10 O 0 7.504487309351049e-11
% O 0 6.030369953391457e-11
of O 0 4.804853181994417e-10
neonates O 0 1.5613414916515467e-07
. O 0 2.323626659972433e-07

As O 0 9.190806338210677e-09
in O 0 4.881952619939511e-10
the O 0 3.7527803087300526e-10
human O 0 1.065925403498369e-10
disease O 0 4.893369737191122e-11
, O 0 3.324928223372159e-12
the O 0 1.8048881833543362e-10
factor O 0 6.5948859706566054e-09
VIII O 0 0.0001384962088195607
level O 1 0.9998806715011597
in O 0 7.206289609484884e-08
these O 0 2.4554251965014373e-08
mice O 0 5.037455608203345e-08
was O 0 6.009661657202514e-09
reduced O 0 1.4363779055059922e-09
strongly O 0 4.606904302484338e-10
as O 0 2.2960290613216472e-10
a O 0 2.625215322904495e-10
result O 0 2.4994570302361296e-10
of O 0 3.1014593671052637e-10
the O 0 9.313446680536686e-10
lack O 0 7.57444063026469e-09
of O 0 3.3615077388304826e-10
protection O 0 1.2862280129866122e-09
provided O 0 3.957977001700641e-10
by O 0 1.0836761349386492e-10
vWf O 0 3.66628160008986e-06
. O 0 1.4892287936163484e-06

Defective O 0 0.00020892710017506033
thrombosis B-Disease 0 2.428953484923113e-05
in O 0 1.4495513767087687e-07
mutant O 0 9.826446785154985e-07
mice O 0 1.0087047286333473e-07
was O 0 2.943598698124106e-09
also O 0 1.2099246604613256e-10
evident O 0 2.593522341332033e-10
in O 0 1.1550864431608687e-10
an O 0 1.2188043109484514e-11
in O 0 5.465043001473546e-11
vivo O 0 9.706540993192903e-08
model O 0 9.657198063450778e-08
of O 0 9.832186265157361e-08
vascular B-Disease 1 0.9999768733978271
injury I-Disease 1 0.9999996423721313
. O 0 1.639642687223386e-05

In O 0 1.3816917387998728e-08
this O 0 4.1124198491004904e-10
model O 0 2.020770883959244e-09
, O 0 1.9804148598812077e-10
the O 0 1.2996060894110428e-09
exteriorized O 0 6.739933837707213e-07
mesentery O 0 4.363682819530368e-06
was O 0 8.087057068451031e-08
superfused O 0 5.197614996177435e-07
with O 0 3.0909064197004454e-10
ferric O 0 7.487212201340299e-07
chloride O 0 6.825094374107721e-07
and O 0 3.22219477766339e-08
the O 0 1.8938246171273931e-07
accumulation O 0 1.684913513599895e-06
of O 0 3.882434214119712e-07
fluorescently O 0 3.719506366905989e-06
labeled O 0 9.130548050961806e-08
platelets O 0 2.475169580407055e-08
was O 0 2.185783820607412e-08
observed O 0 3.0604325740313243e-09
by O 0 2.456294057040509e-10
intravital O 0 1.2180252042526263e-06
microscopy O 0 4.544890998658957e-06
. O 0 4.5270718374013086e-07

We O 0 7.476708674403199e-07
conclude O 0 1.1590665280891699e-06
that O 0 9.87086634651746e-10
these O 0 1.056427278989247e-09
mice O 0 1.8286330671912765e-08
very O 0 1.597872278935597e-09
closely O 0 3.944844451098106e-08
mimic O 0 0.001296170405112207
severe O 0 0.013976000249385834
human O 1 0.6907016634941101
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 5.878484807908535e-05
will O 0 1.301449259472065e-07
be O 0 4.011996956876374e-09
very O 0 1.0783421378057767e-10
useful O 0 2.6548030440665116e-10
for O 0 1.758791202954857e-11
investigating O 0 2.3800574358578963e-11
the O 0 2.647925489984715e-10
role O 0 9.855558147364718e-09
of O 0 8.614192914535579e-09
vWf O 0 2.589099779015669e-07
in O 0 7.971567406173108e-09
normal O 0 5.381513119573356e-07
physiology O 0 4.116859031455533e-07
and O 0 6.610310077093118e-10
in O 0 3.1676167244754083e-10
disease O 0 6.877329261634202e-11
models O 0 3.0325800204344944e-10
. O 0 7.512998001502069e-10
. O 0 5.115085954798815e-08

Oral O 0 1.1506978808029089e-05
contraceptives O 0 2.966862666653469e-06
and O 0 1.7618476122471805e-10
the O 0 4.3240730440707864e-10
risk O 0 8.347667801444913e-08
of O 0 6.82404106555623e-06
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.07600421458482742

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 0 2.129434324160684e-05
Study O 0 8.372156301561517e-09
Group O 0 4.5653023028613404e-10
. O 0 7.820365688360198e-09

BACKGROUND O 0 1.3587580724561121e-05
Women O 0 2.9138767843051028e-08
with O 0 8.365121095810224e-12
mutations O 0 1.1599341279144859e-11
in O 0 3.060773509644399e-11
either O 0 1.3696658252015936e-09
the O 0 2.486720340755255e-08
BRCA1 O 0 5.4186035214343065e-08
or O 0 6.07748944503328e-08
the O 0 1.684557133785347e-07
BRCA2 O 0 5.160753246968852e-08
gene O 0 8.427312736536408e-10
have O 0 1.5234032091360206e-10
a O 0 6.709782035541068e-11
high O 0 4.0639039355916395e-10
lifetime O 0 1.0827434060445285e-08
risk O 0 4.834947162635217e-07
of O 0 4.6106279114610516e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0010097407503053546

Oral O 0 1.0466787898621988e-05
contraceptives O 0 0.0007647305610589683
protect O 0 9.683146799943643e-07
against O 0 0.10612337291240692
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.5273524522781372
general O 0 1.1079338037234265e-05
, O 0 2.0087427277104553e-09
but O 0 5.102705480375391e-10
it O 0 9.569503522932621e-11
is O 0 6.02703217195133e-12
not O 0 2.16847286654831e-11
known O 0 8.132258061399611e-11
whether O 0 1.6413613523891257e-10
they O 0 1.1678650269075774e-09
also O 0 2.402435805848313e-09
protect O 0 2.5739211650943616e-08
against O 0 1.216657796732079e-08
hereditary B-Disease 0 0.00011088257451774552
forms I-Disease 0 6.419833516702056e-05
of I-Disease 0 0.009594705887138844
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.215001798816957e-06

METHODS O 0 1.2251813075181417e-07
We O 0 5.853003637312781e-10
enrolled O 0 4.922504071025458e-10
207 O 0 1.5291213850687768e-09
women O 0 8.996804967686955e-10
with O 0 2.0257875377183154e-09
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 9.033274683822867e-10
161 O 0 4.405574516308519e-10
of O 0 1.0654198634441059e-09
their O 0 4.018813282158362e-09
sisters O 0 6.211593728266962e-08
as O 0 7.94064103359915e-09
controls O 0 8.01826374186021e-08
in O 0 1.7310763933409135e-09
a O 0 2.1473522959780666e-09
case O 0 1.3847012425571847e-09
- O 0 1.8955606861936758e-08
control O 0 8.809902141138082e-08
study O 0 2.22023039953001e-08
. O 0 2.9688100866565037e-08

All O 0 1.0300977493216124e-07
the O 0 3.883550370176181e-09
patients O 0 2.75652806136506e-10
carried O 0 2.495041395711439e-10
a O 0 4.4034973584183845e-11
pathogenic O 0 1.383488879014294e-10
mutation O 0 1.3999439107958978e-10
in O 0 7.653029321375016e-10
either O 0 2.319178449283754e-08
BRCA1 O 0 7.751401298605742e-09
( O 0 4.091660690819232e-11
179 O 0 3.2860583143445865e-09
women O 0 1.323033793632078e-09
) O 0 1.38341768596284e-10
or O 0 2.352573691410953e-09
BRCA2 O 0 5.34122399642456e-08
( O 0 5.824247334418331e-11
28 O 0 2.2087627726818937e-08
women O 0 1.8884036556698902e-09
) O 0 8.692420117029087e-10
. O 0 2.4562869072042304e-08

The O 0 4.119937955238129e-07
control O 0 1.5700240396654408e-07
women O 0 3.7079417314345164e-10
were O 0 1.8958543068769984e-11
enrolled O 0 3.0556243646451264e-10
regardless O 0 2.007961352745724e-09
of O 0 1.1652083742319519e-09
whether O 0 7.665768575471077e-10
or O 0 1.5620370552582585e-09
not O 0 7.574252336439713e-09
they O 0 1.40388600744501e-09
had O 0 6.34838803748039e-09
either O 0 7.603593310534507e-09
mutation O 0 3.046467966782984e-08
. O 0 1.2151808448379597e-07

Lifetime O 0 1.1050634611819987e-06
histories O 0 7.721574206698278e-07
of O 0 5.73755869481829e-08
oral O 0 2.977606357035256e-07
- O 0 2.415320210502614e-08
contraceptive O 0 3.70143027339509e-08
use O 0 3.3210717509390975e-10
were O 0 5.825358251332347e-11
obtained O 0 3.5509067908279235e-10
by O 0 3.237652854148898e-11
interview O 0 3.396906755881446e-09
or O 0 1.0670218181241253e-10
by O 0 6.056140398197352e-12
written O 0 2.304539718778198e-11
questionnaire O 0 1.3677580118845456e-12
and O 0 8.292233002679672e-13
were O 0 1.8265868418493314e-12
compared O 0 1.8371105418163447e-12
between O 0 6.579833249434341e-13
patients O 0 9.077169571547472e-12
and O 0 4.227536723466763e-12
control O 0 6.7923271451775236e-09
women O 0 2.3849768826522677e-09
, O 0 5.509051201335602e-11
after O 0 1.2145003058794401e-10
adjustment O 0 2.226743456290592e-09
for O 0 5.4467798327184624e-11
year O 0 2.883669414366352e-10
of O 0 1.44017936465346e-10
birth O 0 3.4031131246337054e-09
and O 0 1.7400075824625105e-09
parity O 0 9.57217821451195e-07
. O 0 8.527099026878204e-08

RESULTS O 0 3.0515570870193187e-07
The O 0 1.1002011746086282e-08
adjusted O 0 1.0039330788913503e-07
odds O 0 8.523293359985473e-08
ratio O 0 5.508538833964849e-07
for O 0 1.1639598596957512e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.8912865016318392e-06
with O 0 9.0133407681936e-11
any O 0 1.5882826165380948e-09
past O 0 8.14831702111718e-10
use O 0 4.171752721049415e-09
of O 0 1.1671211774810786e-09
oral O 0 1.5394640229260403e-08
contraceptives O 0 1.7786820194487518e-07
was O 0 4.587466850836108e-09
0 O 0 8.031518916595815e-08
. O 0 7.756521824830998e-08

5 O 0 1.7130999196979246e-07
( O 0 4.84684403723179e-10
95 O 0 4.6747646820222144e-07
percent O 0 2.8560897646912053e-08
confidence O 0 4.0286845859327514e-08
interval O 0 1.7560913834202552e-09
, O 0 8.126086609161476e-11
0 O 0 3.143781623915487e-10
. O 0 2.2377771510817546e-11
3 O 0 2.3305590790556607e-10
to O 0 3.4311697927336127e-10
0 O 0 3.9702938159358325e-10
. O 0 7.923144085264511e-11
8 O 0 6.0801075285610295e-09
) O 0 1.5222506588585816e-09
. O 0 3.561342154512204e-08

The O 0 2.1443621278649516e-07
risk O 0 1.440439145738992e-08
decreased O 0 8.197014178534801e-10
with O 0 1.9408926505912194e-13
increasing O 0 1.214858769138516e-11
duration O 0 4.83948436880155e-09
of O 0 2.2007076716512586e-10
use O 0 4.6788297680677715e-09
( O 0 4.0643072241053346e-10
P O 0 9.829859948240482e-08
for O 0 3.5076902493713646e-10
trend O 0 3.721206676132738e-09
, O 0 1.5709331405155957e-11
< O 0 2.5837523232041804e-09
0 O 0 5.566502259135575e-10
. O 0 2.880287154616301e-11
001 O 0 2.729970471904153e-09
) O 0 1.0599477025252657e-12
; O 0 1.7199815790375217e-13
use O 0 2.786531248799573e-11
for O 0 1.1406666410029853e-11
six O 0 6.74367593017644e-12
or O 0 2.958798353894232e-12
more O 0 5.299109133265201e-13
years O 0 9.081240100183852e-12
was O 0 1.0379339054900072e-10
associated O 0 1.675411198664989e-10
with O 0 3.132746666245634e-12
a O 0 1.785521591690653e-10
60 O 0 7.690518222247533e-10
percent O 0 1.666871154992755e-11
reduction O 0 1.8936217871523553e-10
in O 0 1.111573832979218e-09
risk O 0 7.137102642218451e-08
. O 0 4.004510856248089e-07

Oral O 0 6.285346898948774e-05
- O 0 6.551215960826084e-07
contraceptive O 0 1.1080753665737575e-06
use O 0 3.751467403390052e-08
protected O 0 0.02080206759274006
against O 1 0.9999399185180664
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 9.525462196791068e-09
for O 0 8.705423187871375e-11
carriers O 0 3.595531164468646e-11
of O 0 4.291224597885446e-10
the O 0 1.0783658410673524e-08
BRCA1 O 0 6.001096863883504e-08
mutation O 0 3.826417793728609e-10
( O 0 1.898524740195917e-11
odds O 0 1.2628553314186775e-08
ratio O 0 7.694465065100076e-10
, O 0 2.5626797559019643e-11
0 O 0 4.5442153512320616e-11
. O 0 2.2743688442988796e-12
5 O 0 2.0403503539490053e-11
; O 0 3.4370611825401687e-12
95 O 0 1.6195167873434002e-08
percent O 0 1.8185557504324379e-09
confidence O 0 9.626556440878176e-09
interval O 0 8.29480872877042e-10
, O 0 8.088911485071293e-11
0 O 0 2.505256002649503e-10
. O 0 2.674868312957379e-11
3 O 0 2.022342848739811e-10
to O 0 3.838596385197235e-10
0 O 0 2.6506086214794777e-10
. O 0 3.088247019222834e-11
9 O 0 8.81673511976544e-10
) O 0 9.424911372180045e-12
and O 0 4.998758351693056e-12
for O 0 2.9372062507887486e-12
carriers O 0 2.179116088962818e-11
of O 0 2.416119526671423e-10
the O 0 1.0310859721585075e-08
BRCA2 O 0 1.730333224259084e-06
mutation O 0 1.113895753412919e-09
( O 0 2.0096910247069388e-11
odds O 0 1.6909961431110787e-08
ratio O 0 1.9506423143411666e-09
, O 0 3.7600509511515057e-11
0 O 0 5.827891641496663e-11
. O 0 1.4472768686615844e-12
4 O 0 2.6620729925985742e-11
; O 0 7.898183843058071e-12
95 O 0 2.429059797748323e-08
percent O 0 5.218278253948938e-09
confidence O 0 9.091114527848276e-09
interval O 0 8.044205856982956e-10
, O 0 6.456526285836262e-11
0 O 0 1.3204767834729125e-10
. O 0 1.4451894542188981e-11
2 O 0 7.488730469074056e-11
to O 0 2.2226262497149207e-10
1 O 0 4.175078338608529e-10
. O 0 1.9237024473373054e-10
1 O 0 5.7604401249022885e-09
) O 0 2.4387609709464186e-09
. O 0 5.117721357805749e-08

CONCLUSIONS O 0 0.00029440844082273543
Oral O 0 6.724674312863499e-05
- O 0 6.250904220905795e-07
contraceptive O 0 1.2383721070818865e-07
use O 0 1.4898829392429036e-10
may O 0 2.8055915229918682e-11
reduce O 0 9.896122116215267e-11
the O 0 2.1137937233906e-10
risk O 0 4.3247041503491346e-08
of O 0 3.8933202972657455e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 4.120982310951149e-08
women O 0 1.0657572602212895e-09
with O 0 2.6003255538392667e-12
pathogenic O 0 6.23574178404418e-11
mutations O 0 5.111265230506312e-11
in O 0 1.454696030300795e-09
the O 0 8.531768003194884e-08
BRCA1 O 0 4.930590193907847e-07
or O 0 8.757569389672426e-07
BRCA2 O 0 1.0177711374126375e-05
gene O 0 2.2428412194130942e-06

A O 0 6.610970899600943e-07
Japanese O 0 8.084278988462756e-07
family O 0 8.20311818472419e-09
with O 0 1.6338805308713233e-10
adrenoleukodystrophy B-Disease 1 1.0
with O 0 2.663227138821611e-10
a O 0 9.53689127669577e-10
codon O 0 2.06915853340206e-08
291 O 0 5.742395003949241e-09
deletion O 0 4.392037666889337e-08
: O 0 2.3340789301329323e-09
a O 0 3.0478379819953716e-09
clinical O 0 4.5284750171958876e-08
, O 0 4.80519235512844e-10
biochemical O 0 4.4560316325714666e-08
, O 0 2.2183750392201773e-09
pathological O 0 1.7049846690042614e-07
, O 0 2.7433852967106986e-09
and O 0 1.038332309022394e-09
genetic O 0 7.851798322633385e-09
report O 0 3.0935691341937854e-08
. O 0 1.7393389839526208e-07

We O 0 1.8282186431406444e-07
report O 0 6.23761620133223e-09
a O 0 3.687249394701553e-10
Japanese O 0 6.430799004419896e-08
family O 0 6.180074230144328e-09
with O 0 2.5416340143635807e-09
adrenoleukodystrophy B-Disease 1 1.0
( O 0 2.029521226631914e-07
ALD B-Disease 1 1.0
) O 0 1.7086447534619964e-10
with O 0 5.172015593579715e-12
a O 0 1.0060403204947832e-10
three O 0 1.4258890942975277e-11
base O 0 5.313573137044614e-09
pair O 0 4.812055198755161e-09
deletion O 0 3.956220684386835e-09
( O 0 6.049331868762664e-11
delGAG O 0 2.1649633197284857e-08
291 O 0 3.5640024265148895e-10
) O 0 1.3429523985919456e-11
in O 0 3.692992855963695e-10
the O 0 2.5163881645084984e-08
ALD B-Disease 1 1.0
gene O 0 5.084679060018971e-07
. O 0 8.264706252703036e-07

A O 0 1.6890594451979268e-06
variety O 0 7.029279913695063e-08
of O 0 1.5412679132964513e-08
phenotypes O 0 1.0880639500499001e-08
were O 0 1.5948700138324057e-09
observed O 0 3.1580249526541593e-10
within O 0 1.4335690967648418e-10
this O 0 3.4614858201997833e-10
family O 0 4.1175862719455836e-09
. O 0 7.74998554220474e-08

While O 0 1.1548291922736098e-07
the O 0 1.5651572482511256e-08
proband O 0 2.4322691842826316e-06
( O 0 2.390450060119065e-10
patient O 0 2.969013834785983e-08
1 O 0 2.8210173752540868e-08
) O 0 4.3951928208052493e-10
was O 0 1.0524014548707328e-08
classified O 0 2.9668951739836302e-09
as O 0 6.64452826093509e-10
having O 0 9.254674249170591e-10
a O 0 8.796842421165962e-11
rare O 0 5.958795262772654e-11
intermediate O 0 1.7510466687742365e-10
type O 0 1.991673936885263e-09
of O 0 1.4117697011428731e-09
adult O 0 1.7622214443235862e-07
cerebral O 0 2.3115207525847836e-08
and O 0 5.7460427527189495e-09
cerebello O 1 0.9847790598869324
- O 0 0.000656307500321418
brain O 0 9.369664621772245e-05
stem O 0 4.9688818393178735e-08
forms O 0 1.1762250895497317e-10
, O 0 7.898756301805143e-12
his O 0 2.88456064589937e-10
younger O 0 4.9307571359236135e-09
brother O 0 1.1019657364386148e-07
( O 0 2.192512560394988e-10
patient O 0 8.381711325000651e-09
2 O 0 3.614967880594122e-09
) O 0 6.933027763000865e-11
and O 0 2.848666025290214e-10
nephew O 0 2.4783290427876636e-05
( O 0 1.8975347959582223e-09
patient O 0 9.945521242116229e-07
3 O 0 1.1515453479660209e-07
) O 0 9.81589476367617e-10
had O 0 2.667617238216735e-08
a O 0 2.2689746970172564e-08
childhood O 0 3.0189457902451977e-05
ALD B-Disease 1 1.0
type O 0 0.0005330992862582207
. O 0 5.331922693585511e-06

Another O 0 1.0021326488640625e-06
nephew O 0 8.99673905223608e-05
( O 0 2.638559593037826e-09
patient O 0 6.384327662090072e-07
4 O 0 1.3074577509541996e-07
) O 0 6.746602720930639e-10
of O 0 6.430870946871892e-09
patient O 0 1.6700440141903528e-07
1 O 0 2.849378688551951e-07
was O 0 9.729748029485563e-08
classified O 0 1.819941175540407e-08
as O 0 1.1450673298440961e-08
having O 0 2.067091564583734e-08
an O 0 6.177536815421547e-10
adolescent O 0 3.1992911431188986e-08
form O 0 3.4157726647165987e-10
. O 0 1.552601069931825e-08

The O 0 9.04683545854823e-08
tau O 0 1.13391349643166e-08
level O 0 5.006342451707724e-09
in O 0 7.49992568049862e-10
the O 0 4.262954078626535e-08
cerebrospinal O 0 2.807202008625609e-06
fluid O 0 1.0028193031530463e-07
( O 0 2.022243483779107e-09
CSF O 0 6.824521392445604e-07
) O 0 3.1260230515250953e-10
in O 0 1.2132390647678903e-09
patient O 0 1.3302857837516058e-07
1 O 0 4.470179604254554e-08
was O 0 2.3810828864156974e-08
as O 0 8.239461890546806e-10
high O 0 9.100807885076279e-10
as O 0 7.772594373678388e-11
that O 0 8.614178814703166e-12
of O 0 1.8322822425975716e-11
patients O 0 2.169301266397028e-10
with O 0 1.7402722318760055e-10
Alzheimers B-Disease 1 1.0
disease I-Disease 0 4.932207957608625e-07
( O 0 2.521313713366169e-11
AD B-Disease 0 1.4375195860338863e-06
) O 0 5.583018491961411e-09
. O 0 1.9923214722439297e-07

His O 0 1.036995672620833e-05
brain O 0 6.1075916164554656e-06
magnetic O 0 2.1022567864292796e-07
resonance O 0 8.166154685795846e-08
image O 0 6.1385236449496e-08
( O 0 1.448400288595053e-09
MRI O 0 0.00013595166092272848
) O 0 1.029553242659631e-08
showed O 0 4.3486089396083116e-08
abnormalities B-Disease 0 2.3523146097659264e-08
in I-Disease 0 9.93618631817128e-10
the I-Disease 0 5.21071941150808e-09
bilateral I-Disease 0 2.649781890795566e-05
cerebellar I-Disease 1 0.9993122816085815
hemispheres I-Disease 1 0.9998668432235718
and O 0 2.644885057634383e-07
brain O 0 9.434044727640867e-07
stem O 0 1.2554534301045805e-08
, O 0 1.1562364780892675e-11
but O 0 4.243273267479086e-12
not O 0 5.436753477972012e-11
in O 0 2.1765127200534806e-10
the O 0 4.685027477080439e-09
cerebral O 0 5.708566064299703e-08
white O 0 3.449531771337888e-09
matter O 0 1.6047075890313067e-09
, O 0 2.3820830724607944e-11
where O 0 1.1795135181069671e-11
marked O 0 6.102498281007618e-12
reductions O 0 6.674963359820651e-10
of O 0 8.654502670069064e-10
the O 0 2.035959623114536e-09
cerebral O 0 3.1326918836782625e-09
blood O 0 4.109526330342561e-10
flow O 0 1.3907520690636943e-09
and O 0 4.729016622739834e-10
oxygen O 0 2.0733925687466126e-09
metabolism O 0 3.509713408789139e-09
were O 0 2.1612285294736466e-09
clearly O 0 3.6159331084917312e-09
demonstrated O 0 1.7032830701424473e-09
by O 0 1.775168068096633e-10
positron O 0 3.3317146375111406e-08
emission O 0 1.267441973595851e-07
tomography O 0 4.584692760545295e-06
( O 0 8.120857764026823e-09
PET O 0 9.780031177797355e-06
) O 0 5.098923505642006e-09
. O 0 5.69442910602902e-08

In O 0 1.6571574334989236e-08
patients O 0 1.8122020550848106e-09
2 O 0 5.314299555969626e-10
and O 0 3.1426528046551994e-11
3 O 0 3.892850042319651e-09
, O 0 1.7823369169445158e-10
the O 0 7.917392297329684e-10
autopsy O 0 3.5590741020996575e-08
findings O 0 1.7171210231481382e-08
showed O 0 2.476472893420123e-08
massive O 0 1.3307509760807079e-08
demyelination B-Disease 1 1.0
of I-Disease 0 4.534621439233888e-06
the I-Disease 0 3.9419720110345224e-07
cerebral I-Disease 0 6.102766860749398e-07
white I-Disease 0 1.339020005985958e-09
matter I-Disease 0 2.290557049589026e-10
with O 0 3.16773273193946e-13
sparing O 0 9.313446680536686e-10
of O 0 3.3067439897394024e-09
the O 0 3.153609995365514e-08
U O 0 4.3417800043243915e-05
- O 0 2.164729721698677e-06
fibers O 0 1.8130188905729483e-08
, O 0 3.1158081670312754e-10
compatible O 0 2.210612848330129e-08
with O 0 1.217719241414228e-11
the O 0 5.8116027545906945e-09
findings O 0 4.044282775339525e-08
of O 0 4.875527181980033e-08
childhood O 0 0.002646473702043295
ALD B-Disease 1 1.0
. O 0 6.67999847792089e-05

Oleic O 0 0.0006177515024319291
and O 0 5.801338716082682e-07
erucic O 0 0.0013927810359746218
acids O 0 5.48307980352547e-06
( O 0 8.934047945885482e-10
Lorenzos O 0 7.952289706736337e-07
Oil O 0 8.11488476415434e-08
) O 0 6.791581186327278e-11
were O 0 9.663670558213155e-11
administered O 0 6.813574010555712e-11
to O 0 9.118543420338909e-11
patients O 0 2.8871351490100672e-11
1 O 0 1.7244056182974532e-10
and O 0 1.634790774973638e-10
4 O 0 1.4444889728792987e-08
, O 0 2.34286451350485e-10
but O 0 3.5829759298389163e-11
sufficient O 0 1.9764838654623418e-09
effectiveness O 0 4.4881351968228955e-09
was O 0 2.9245936783439674e-09
not O 0 2.608510740742531e-09
obtained O 0 6.508179950515114e-08
. O 0 2.339609892487715e-07

The O 0 4.828855253435904e-07
findings O 0 4.352807891905286e-08
in O 0 1.6534248414856734e-09
this O 0 1.8189025841053308e-09
family O 0 1.190758269764558e-09
suggest O 0 3.5571314782600894e-09
that O 0 4.1250006882487256e-12
delGAG291 O 0 1.054870857331025e-09
is O 0 9.14497817749993e-12
part O 0 4.1005122908277514e-11
of O 0 1.046100983614906e-09
the O 0 1.7316047484783326e-09
cause O 0 1.2412998406929887e-09
of O 0 2.1576986863891534e-09
Japanese O 0 1.9092747152171796e-06
ALD B-Disease 1 1.0
with O 0 1.685945605345296e-09
phenotypic O 0 1.9072115264862077e-07
variations O 0 1.9889877478362905e-07
. O 0 5.070244242233457e-07

Moreover O 0 1.2688376216374309e-07
, O 0 1.0245177622936197e-10
although O 0 3.6201531355972705e-11
the O 0 4.14846802743174e-11
scale O 0 1.2295133799966607e-09
of O 0 6.027199295211005e-10
the O 0 1.180342934503642e-09
study O 0 4.497164862726777e-10
is O 0 5.125476865847078e-12
limited O 0 8.771882109570583e-10
, O 0 7.910580523962096e-11
there O 0 2.1767536384498243e-10
is O 0 1.130002272309305e-10
a O 0 6.353400028302758e-10
possibility O 0 7.921731715043734e-09
that O 0 1.9252561767046927e-09
PET O 0 5.619383955490775e-06
can O 0 2.910594787408627e-07
detect O 0 3.4118022540496895e-06
an O 0 3.048246455250592e-08
insidious B-Disease 0 4.903076478512958e-05
lesion I-Disease 1 0.9999985694885254
which O 0 1.2316170305837204e-08
is O 0 6.836563259948747e-11
undetectable O 0 8.413259533490702e-10
by O 0 3.326222110244803e-12
computed O 0 2.418767186540549e-09
tomogram O 0 5.266255129754427e-07
( O 0 2.0832463532016732e-10
CT O 0 0.0001548829604871571
) O 0 2.383149011464525e-09
or O 0 8.141795682092834e-09
MRI O 0 2.9011529477429576e-05
analysis O 0 5.183696583088704e-09
, O 0 1.171381915077152e-11
and O 0 4.413215452803154e-12
that O 0 1.3158367624666045e-12
the O 0 1.9865198028212738e-11
higher O 0 2.044996394445775e-09
level O 0 7.14959380587743e-09
of O 0 8.991538069658134e-10
tau O 0 4.1107592885225586e-09
reflects O 0 8.987783295388851e-10
the O 0 3.670794224142071e-10
process O 0 1.2562098028467972e-09
of O 0 2.0203854145250943e-09
neuronal B-Disease 0 2.07171569854836e-06
degeneration I-Disease 0 0.00013784875045530498
in O 0 1.0923353954694903e-07
ALD B-Disease 1 1.0
. O 0 1.6703065739420708e-06

Lorenzos O 0 3.996935993200168e-05
Oil O 0 2.953499347313482e-07
should O 0 8.456279565471903e-10
be O 0 3.250857916192729e-11
given O 0 2.3118302411306857e-11
in O 0 1.6010250417086702e-11
the O 0 4.963702712745821e-11
early O 0 1.367113311445678e-09
stage O 0 5.23536325403029e-10
. O 0 3.0609168533146658e-09
. O 0 5.423938986837129e-08

Nonsense O 0 1.3847589798388071e-05
mutation O 0 3.168804596498376e-08
in O 0 5.03256503137095e-09
exon O 0 1.0703499242481485e-07
4 O 0 1.0945623216684908e-06
of O 0 5.9460546708578477e-08
human O 0 4.823872856718481e-09
complement O 0 7.357031961419125e-08
C9 O 0 7.2231368903885596e-06
gene O 0 4.77284345379303e-08
is O 0 9.543023038460774e-10
the O 0 1.117311021481271e-09
major O 0 2.567878576442695e-09
cause O 0 2.7972695271216708e-09
of O 0 6.330686197486557e-09
Japanese O 0 8.71349129738519e-07
complement B-Disease 0 2.383560422458686e-05
C9 I-Disease 1 0.8282354474067688
deficiency I-Disease 0 1.9696937670232728e-05
. O 0 2.2312651708489284e-06

Deficiency B-Disease 0 6.963465239095967e-06
of I-Disease 0 1.4404289458980202e-06
the I-Disease 0 4.6559443944715895e-07
ninth I-Disease 0 1.1660091558951535e-06
component I-Disease 0 1.2570185958793445e-07
of I-Disease 0 5.247952739040329e-09
human I-Disease 0 6.227971471872706e-10
complement I-Disease 0 4.308320455947978e-08
( O 0 1.9621726465857137e-09
C9 O 0 6.161980127217248e-05
) O 0 2.515868624541895e-09
is O 0 2.3944013438637057e-10
the O 0 2.1752427636911875e-10
most O 0 5.891755139320054e-11
common O 0 8.923744521105448e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.8095035187192252e-09
Japan O 0 2.8824844733321697e-08
but O 0 5.09708039664325e-11
is O 0 5.4900203307062245e-12
rare O 0 1.988733830393663e-11
in O 0 2.2376619654429497e-11
other O 0 1.2382055450399498e-11
countries O 0 6.878182051694992e-11
. O 0 1.7862728185491505e-08

We O 0 2.552211526563042e-07
studied O 0 1.1174653735679385e-07
the O 0 1.7087760095790827e-09
molecular O 0 8.304116283497365e-10
basis O 0 7.112420874477721e-09
of O 0 5.211941989102797e-09
C9 B-Disease 0 0.03523897007107735
deficiency I-Disease 0 2.8191782348585548e-06
in O 0 2.558903986482619e-07
four O 0 2.0871141259704018e-08
Japanese O 0 5.000227929485845e-07
C9 B-Disease 0 1.179492028313689e-05
- I-Disease 0 2.9117666144884424e-07
deficient I-Disease 0 7.805363821944411e-08
patients O 0 9.73085789723882e-09
who O 0 4.825959076804054e-10
had O 0 6.962559417900138e-09
suffered O 0 3.448287770879688e-07
from O 0 6.880579235257755e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.0591237042945068e-07

Direct O 0 6.40709671984041e-08
sequencing O 0 1.3510370600045007e-08
of O 0 2.6902732486178138e-08
amplified O 0 6.82185401501556e-08
C9 O 0 4.341353303516371e-07
cDNA O 0 2.5315911145185055e-08
and O 0 3.7222858129126735e-09
DNA O 0 4.028759548191374e-09
revealed O 0 8.286811237212532e-09
a O 0 1.6061989516202857e-09
nonsense O 0 2.5702306949426657e-09
substitution O 0 1.3228546036359035e-09
( O 0 8.47589498587098e-11
CGA O 0 2.4165510126294976e-07
- O 0 8.941368179193887e-08
- O 0 6.602012092571385e-08
> O 0 1.0127647698254805e-07
TGA O 0 1.8231605736218626e-06
) O 0 6.509496067175213e-12
at O 0 1.048553466276303e-10
codon O 0 5.388359758384809e-10
95 O 0 3.4018929895296424e-09
in O 0 9.255499838767278e-11
exon O 0 2.463144799236261e-09
4 O 0 1.1938562138880116e-08
in O 0 3.813014348708066e-09
the O 0 2.77312111052197e-08
four O 0 7.134064450298183e-09
C9 B-Disease 0 3.1572708394378424e-05
- I-Disease 0 2.7603616672422504e-06
deficient I-Disease 0 3.4116649771931407e-07
individuals O 0 2.361997708533181e-09
. O 0 8.06562994171145e-08

An O 0 4.045254797802045e-08
allele O 0 2.0505986242369545e-08
- O 0 1.7479418801258362e-08
specific O 0 3.456930031120464e-08
polymerase O 0 1.3560021727698768e-07
chain O 0 6.070515468081794e-08
reaction O 0 2.9089550768190975e-09
system O 0 8.108704818710066e-10
designed O 0 5.725672824752337e-09
to O 0 6.296894561330646e-09
detect O 0 1.036776886564894e-09
exclusively O 0 6.423021559065489e-10
only O 0 2.1033531860670251e-10
one O 0 4.502552844454222e-11
of O 0 4.491744823309496e-11
the O 0 1.3278896038304566e-10
normal O 0 3.790766811562207e-09
and O 0 2.1995660848261878e-10
mutant O 0 1.1273662892108405e-08
alleles O 0 7.355580589063493e-10
indicated O 0 1.2668883719868518e-09
that O 0 1.3286135212842165e-11
all O 0 3.8096959614764003e-11
the O 0 8.572502430137519e-11
four O 0 2.8556004783020228e-11
patients O 0 8.023266079293379e-12
were O 0 8.813548849073705e-12
homozygous O 0 9.41489039507637e-11
for O 0 2.8707236587877105e-10
the O 0 1.7607634239524828e-09
mutation O 0 1.8109089228168784e-10
in O 0 2.6273791475794894e-10
exon O 0 4.219938176674987e-09
4 O 0 2.042775371080552e-08
and O 0 1.3738618576120132e-10
that O 0 1.8011113434024395e-11
the O 0 1.1018800455397937e-10
parents O 0 2.1853314990938344e-10
of O 0 1.9628566827467608e-10
patient O 0 1.4360711508842883e-09
2 O 0 1.3620905292555108e-08
were O 0 4.3491066747947116e-08
heterozygous O 0 1.289581064156664e-07
. O 0 7.752453257126035e-07

The O 0 1.4031296302619012e-07
common O 0 1.363073032223383e-08
mutation O 0 8.184234956409853e-10
at O 0 1.6819116099853204e-09
codon O 0 2.262285114795759e-08
95 O 0 1.8785439692692307e-07
in O 0 1.599074472835582e-08
exon O 0 8.043108579158798e-08
4 O 0 8.321628541807513e-08
might O 0 8.521078953549477e-09
be O 0 5.375835332444012e-10
responsible O 0 3.797103742542163e-10
for O 0 3.502181877834687e-10
most O 0 8.885207569697684e-10
Japanese O 0 2.5618612653488526e-06
C9 B-Disease 0 0.0015433559892699122
deficiency I-Disease 0 1.1174829523952212e-06
. O 0 1.882524713892053e-08
. O 0 7.241286681392012e-08

BRCA1 O 0 2.742968945312896e-07
required O 0 1.484911216209639e-08
for O 0 1.8790371481003376e-09
transcription O 0 4.4169379975755874e-07
- O 0 3.3237192837987095e-06
coupled O 0 2.226703372798511e-06
repair O 0 0.0006479299627244473
of O 0 5.883846370124957e-07
oxidative O 0 3.3325873118883464e-06
DNA O 0 1.61361597861287e-07
damage O 0 2.801912160066422e-07
. O 0 7.46277407870366e-07

The O 0 1.5214527593343519e-05
breast B-Disease 1 1.0
and I-Disease 1 0.9999887943267822
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 1.1323388662276557e-06
gene O 0 1.2281077488296432e-08
BRCA1 O 0 3.314013241606517e-08
encodes O 0 6.882177938649647e-09
a O 0 3.5748310978078734e-08
zinc O 0 1.9299472114653327e-05
finger O 0 9.77119043454877e-07
protein O 0 1.1625184370700481e-08
of O 0 3.990071828496866e-09
unknown O 0 4.9725038309134106e-08
function O 0 2.4845489221547723e-08
. O 0 8.789693595190329e-08

Association O 0 1.0181569365386167e-07
of O 0 1.4428395367360736e-08
the O 0 8.987101729474034e-09
BRCA1 O 0 5.094206168010373e-10
protein O 0 2.7000568447732576e-11
with O 0 1.0955376146190576e-12
the O 0 1.9479420854118246e-10
DNA O 0 5.291299620679979e-10
repair O 0 2.8488971182127898e-08
protein O 0 1.3173002688660063e-09
Rad51 O 0 1.7820463327211655e-08
and O 0 5.604565075922885e-11
changes O 0 3.780627477745213e-10
in O 0 1.4129704350995809e-10
the O 0 1.4357225130989804e-10
phosphorylation O 0 7.512940825016301e-10
and O 0 2.4497434636394644e-10
cellular O 0 7.777792632168712e-09
localization O 0 5.469221946441394e-07
of O 0 6.412767206143144e-09
the O 0 2.310743596467546e-09
protein O 0 1.5594470159641105e-09
after O 0 3.943057824695728e-10
exposure O 0 1.27384804926578e-08
to O 0 2.803657972449969e-09
DNA O 0 3.093121136998889e-08
- O 0 2.3810244442756812e-07
damaging O 0 4.396160946384953e-08
agents O 0 2.9514653832052318e-08
are O 0 2.8090466064334407e-10
consistent O 0 2.2485140416250715e-09
with O 0 4.5443927483915236e-13
a O 0 1.6887375178797903e-11
role O 0 4.4859421732823535e-10
for O 0 2.3362167755891505e-09
BRCA1 O 0 9.877387796564108e-09
in O 0 8.463802991798275e-09
DNA O 0 4.213337234659775e-08
repair O 0 8.675384378875606e-06
. O 0 7.534683845733525e-06

Here O 0 1.082982976186031e-06
, O 0 1.5931916896860798e-09
it O 0 3.4790975655951684e-11
is O 0 4.758290116091413e-12
shown O 0 1.8883847263673204e-10
that O 0 9.026106251308619e-11
mouse O 0 1.0167010344730443e-08
embryonic O 0 4.329623237708802e-08
stem O 0 6.635008098498929e-09
cells O 0 2.1466277644321963e-09
deficient B-Disease 0 1.7865215085066666e-08
in I-Disease 0 1.1298698865402912e-08
BRCA1 I-Disease 0 9.752039176191829e-09
are O 0 1.313826825111164e-10
defective O 0 2.8905597915240833e-09
in O 0 7.183105776853438e-10
the O 0 9.20891030098403e-10
ability O 0 7.713317762281235e-10
to O 0 1.1456238180329592e-09
carry O 0 1.2828836881695338e-09
out O 0 1.3302141332882655e-10
transcription O 0 5.423535753834585e-08
- O 0 2.0601464711944573e-06
coupled O 0 7.876662493799813e-06
repair O 0 0.01463590282946825
of O 0 1.768889177355959e-07
oxidative O 0 2.835307952864241e-07
DNA O 0 1.4739008236119844e-08
damage O 0 2.3504579615973853e-08
, O 0 3.608449095082733e-10
and O 0 4.1206954515260463e-10
are O 0 6.279536335362934e-10
hypersensitive O 0 3.6828853353654267e-06
to O 0 3.926561475964263e-06
ionizing O 0 0.0027843492571264505
radiation O 0 0.00012930207594763488
and O 0 8.610808066578102e-09
hydrogen O 0 1.0139007855514137e-08
peroxide O 0 6.088558848205139e-07
. O 0 2.652053296969825e-07

These O 0 1.3898198858441901e-07
results O 0 5.268706360084252e-08
suggest O 0 9.894549890532289e-08
that O 0 3.621910771300918e-09
BRCA1 O 0 1.3971150458758075e-08
participates O 0 2.1116026704959268e-09
, O 0 3.3161848267404537e-10
directly O 0 1.0019064466959549e-09
or O 0 1.3947314414508583e-09
indirectly O 0 7.618400132969327e-09
, O 0 4.070107445519611e-11
in O 0 1.1556770818099693e-10
transcription O 0 1.1637323638069574e-07
- O 0 1.6829750393299037e-06
coupled O 0 4.677093329519266e-06
repair O 0 0.0002659547608345747
of O 0 8.927072059350394e-08
oxidative O 0 1.915706349109314e-07
DNA O 0 1.3193527159671703e-08
damage O 0 9.155917801706437e-09
. O 0 8.934682327321752e-09
. O 0 5.305939509980817e-08

Truncation O 0 2.484573769834242e-06
mutations O 0 1.6968247251725188e-08
in O 0 1.8806434187723653e-09
the O 0 1.543715155705172e-09
transactivation O 0 1.004381033453683e-06
region O 0 5.079076004221861e-08
of O 0 6.265580054787279e-08
PAX6 O 0 0.0002565618196967989
result O 0 1.0186852250626544e-07
in O 0 1.3646493712826668e-08
dominant O 0 9.977880921496762e-08
- O 0 1.1234879337962411e-07
negative O 0 3.849720986437433e-09
mutants O 0 1.0069651068533858e-07
. O 0 9.215279561658463e-08

PAX6 O 0 0.001000265241600573
is O 0 3.936291292916394e-08
a O 0 2.604767068703495e-09
transcription O 0 2.387964137540166e-08
factor O 0 1.4350204580182435e-08
with O 0 7.911455518483379e-11
two O 0 4.223245086976135e-10
DNA O 0 1.5592508395556592e-09
- O 0 3.744945686889878e-09
binding O 0 4.0778980192612835e-09
domains O 0 7.286269365636144e-09
( O 0 9.786987192894614e-11
paired O 0 2.321947745187458e-09
box O 0 9.55424717119513e-09
and O 0 4.74745298628676e-10
homeobox O 0 8.151324948357797e-08
) O 0 6.257402235254617e-11
and O 0 6.114735107143332e-11
a O 0 4.805476572222744e-10
proline O 0 5.1174087190020145e-08
- O 0 7.93640175800192e-09
serine O 0 1.1844169023333961e-07
- O 0 1.3403486320839875e-07
threonine O 0 4.4541113197738014e-07
( O 0 5.443591410969617e-11
PST O 0 8.58049861562904e-06
) O 0 2.934467113746564e-09
- O 0 6.845119315812553e-08
rich O 0 2.5770996003871005e-08
transactivation O 0 2.9602058930322528e-05
domain O 0 2.7399933060223702e-06
. O 0 1.472250659162455e-07

PAX6 O 0 0.00624535046517849
regulates O 0 4.430329681781586e-06
eye O 0 5.787799091194756e-05
development O 0 1.4944131976335484e-07
in O 0 2.642125185303712e-09
animals O 0 3.8943184788031715e-10
ranging O 0 2.4970459033824e-10
from O 0 6.0864598083743e-11
jellyfish O 0 3.460977615610261e-10
to O 0 3.3819087530417846e-09
Drosophila O 0 2.032701296172945e-08
to O 0 1.2456406572880496e-08
humans O 0 2.185958969391777e-08
. O 0 6.59734240571197e-08

Heterozygous O 0 2.840000377091201e-07
mutations O 0 7.86165410548989e-10
in O 0 6.573433464218681e-10
the O 0 1.3441300295014003e-09
human O 0 1.896333534645578e-09
PAX6 O 0 5.694857918570051e-06
gene O 0 1.939764970870783e-08
result O 0 8.239811499777261e-09
in O 0 3.8334104779380596e-09
various O 0 2.6415809539770407e-09
phenotypes O 0 2.803595400280301e-08
, O 0 1.5955993470928576e-10
including O 0 4.563038835669886e-10
aniridia B-Disease 1 1.0
, O 0 6.267827501460488e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 9.831301213125698e-07
autosomal B-Disease 0 0.00022330369392875582
dominant I-Disease 0 2.2107236873125657e-05
keratitis I-Disease 1 0.9999998807907104
, O 0 3.486143640429873e-08
and O 0 1.300842011886516e-08
familial B-Disease 0 0.36592409014701843
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9999998807907104

It O 0 1.9576392062958803e-08
is O 0 1.4474274556697253e-10
believed O 0 8.747922386476148e-10
that O 0 1.5956808790962285e-11
the O 0 1.581033914899166e-10
mutated O 0 1.237088564920441e-08
allele O 0 9.211764506744657e-08
of O 0 2.999076897935993e-08
PAX6 O 0 0.00023024578695185483
produces O 0 1.7451334599627444e-08
an O 0 6.116791517740694e-10
inactive O 0 2.2910576547019446e-08
protein O 0 3.4321860908903545e-09
and O 0 1.8158211601004837e-09
aniridia B-Disease 1 1.0
is O 0 1.4788900104534264e-09
caused O 0 3.6146352577759444e-10
due O 0 1.4953754901014804e-09
to O 0 1.616215072886007e-08
genetic O 0 1.4634129463786394e-08
haploinsufficiency O 0 2.641008677528589e-06
. O 0 4.0679645962882205e-07

However O 0 2.76392341902465e-07
, O 0 3.548288329824345e-09
several O 0 2.253179309796849e-10
truncation O 0 5.078301512639882e-08
mutations O 0 3.6935701719365e-10
have O 0 2.1779650999365074e-11
been O 0 1.0821058459009603e-11
found O 0 1.5101832544911487e-12
to O 0 9.357543385990486e-12
occur O 0 1.0368826457163305e-11
in O 0 3.3105018726331537e-11
the O 0 2.266800774863853e-10
C O 0 2.800654153034543e-09
- O 0 2.4365931494685356e-10
terminal O 0 1.248018133281903e-09
half O 0 4.712592538425042e-10
of O 0 1.071198060809131e-10
PAX6 O 0 9.459453309546006e-08
in O 0 2.984704705610852e-10
patients O 0 3.133467096905207e-10
with O 0 4.082903719976327e-12
Aniridia B-Disease 1 1.0
resulting O 0 1.1625938434178806e-08
in O 0 1.1578795700017963e-09
mutant O 0 1.7678604136150966e-09
proteins O 0 3.438518567100424e-11
that O 0 1.1567664881528827e-10
retain O 0 2.881808391919094e-08
the O 0 7.956715109003198e-08
DNA O 0 2.6479586523464604e-08
- O 0 2.1874937417010187e-08
binding O 0 1.084785683502787e-08
domains O 0 1.1193422189137436e-08
but O 0 5.045085460508858e-10
have O 0 2.3085706957193253e-10
lost O 0 7.074052454925095e-09
most O 0 6.166718247158087e-10
of O 0 1.4901706535397352e-09
the O 0 4.893561555974202e-09
transactivation O 0 1.9712479115696624e-05
domain O 0 6.494282388302963e-06
. O 0 7.805443260622269e-07

It O 0 6.774601324366358e-09
is O 0 1.1018275181129411e-10
not O 0 1.7718800038313276e-10
clear O 0 3.003092219344694e-10
whether O 0 2.2928826892698595e-10
such O 0 4.5053813457762715e-10
mutants O 0 1.1599982485677174e-07
really O 0 2.700555690182682e-08
behave O 0 4.957763088953016e-10
as O 0 1.0877936329478644e-09
loss O 0 1.3301640899854306e-09
- O 0 1.0039461706412567e-08
of O 0 1.5114686391370924e-08
- O 0 4.105110029684056e-09
function O 0 1.3621158645449327e-09
mutants O 0 1.3316668878715632e-09
as O 0 2.725650538604185e-10
predicted O 0 2.1571060493386085e-09
by O 0 2.0016736879124863e-10
haploinsufficiency O 0 5.99334589423961e-06
. O 0 1.2101772881578654e-06

Contrary O 0 9.388396620124695e-07
to O 0 4.549779220042183e-09
this O 0 4.499041764138845e-11
theory O 0 8.84541995205268e-10
, O 0 1.7894245113447838e-11
our O 0 8.304560372707215e-10
data O 0 1.1714217151848061e-08
showed O 0 2.8596531809199632e-09
that O 0 3.187032235341114e-11
these O 0 8.487558572634057e-11
mutants O 0 3.5101417328320395e-09
are O 0 1.1530085913813437e-10
dominant O 0 3.6467411312912645e-09
- O 0 1.1196389593237654e-08
negative O 0 2.4604589476950878e-09
in O 0 7.122286649341447e-10
transient O 0 1.1834726088011394e-08
transfection O 0 1.1438661573492936e-07
assays O 0 1.932117754677165e-08
when O 0 1.2072166599708112e-09
they O 0 9.140697643239548e-10
are O 0 3.58085124052554e-11
coexpressed O 0 7.825293835139746e-08
with O 0 1.1672719735233983e-10
wild O 0 1.7055930356946192e-07
- O 0 2.8889249392705096e-07
type O 0 8.174707772923284e-07
PAX6 O 1 0.625524640083313
. O 0 1.7538015526952222e-05

We O 0 7.276800317868037e-08
found O 0 7.238035171219792e-10
that O 0 2.8656781808633625e-11
the O 0 4.0384051658293174e-10
dominant O 0 2.5883212018129598e-08
- O 0 6.115210737789312e-08
negative O 0 2.0366430764084953e-09
effects O 0 1.872990829099308e-08
result O 0 1.2065192178667417e-09
from O 0 8.217395097709357e-10
the O 0 2.3425439366064893e-09
enhanced O 0 1.2419303807575943e-08
DNA O 0 4.827643840243923e-10
binding O 0 4.905726380677322e-10
ability O 0 6.465010748968325e-09
of O 0 7.346063757296406e-09
these O 0 2.550598621198219e-09
mutants O 0 6.722935097513982e-08
. O 0 2.794346585233143e-07

Kinetic O 0 3.8954891579123796e-07
studies O 0 1.1948942812978203e-07
of O 0 2.3727397824302443e-09
binding O 0 2.4469894999157304e-09
and O 0 5.881765074988721e-10
dissociation O 0 2.2130260290964543e-08
revealed O 0 5.3545328171367146e-09
that O 0 2.2362580537338417e-11
various O 0 7.640803267872087e-11
truncation O 0 1.4109519774763157e-08
mutants O 0 4.508536044500744e-10
have O 0 6.7352950473831275e-12
3 O 0 4.729772129508092e-11
- O 0 1.7409294839065836e-10
5 O 0 2.9727293959780354e-09
- O 0 9.771589759566268e-09
fold O 0 6.6779977103692545e-09
higher O 0 7.982095873160233e-09
affinity O 0 2.3594310949448527e-09
to O 0 4.990430291229586e-09
various O 0 6.287242393376857e-10
DNA O 0 4.571855116708434e-10
- O 0 2.245191671468305e-10
binding O 0 1.735201149433152e-10
sites O 0 3.762800626638807e-10
when O 0 3.9802244833353484e-11
compared O 0 9.643343068521659e-11
with O 0 5.12664043161859e-12
the O 0 9.499530051471083e-10
wild O 0 2.3866890686008446e-08
- O 0 4.151513621764025e-08
type O 0 1.4176885088090785e-07
PAX6 O 0 0.0005580082070082426
. O 0 4.420074674271746e-06

These O 0 5.852697526620432e-08
results O 0 6.044851730280243e-09
provide O 0 1.6259352753067446e-09
a O 0 1.5013075504999307e-10
new O 0 3.131519210608502e-10
insight O 0 5.004700209809698e-09
into O 0 6.484059122957575e-11
the O 0 8.835669695894666e-11
role O 0 9.95637128298199e-10
of O 0 2.8313875688468215e-09
mutant O 0 7.83408964366572e-08
PAX6 O 0 1.4806478247919586e-05
in O 0 5.4101974455988966e-08
causing O 0 2.469411697347823e-08
aniridia B-Disease 1 1.0
. O 0 7.117404265954974e-08
. O 0 1.81290516820809e-07

Reversal O 0 2.1691087113140384e-06
of O 0 1.924369144035154e-07
severe O 0 1.959408336915658e-06
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 4.091412847628817e-06
excellent O 0 4.72394589223768e-07
neuropsychologic O 0 3.3827561196630995e-07
outcome O 0 5.539109082519644e-08
in O 0 5.3526640897416655e-09
very B-Disease 0 2.026251388898004e-09
- I-Disease 0 6.891507808859387e-08
long I-Disease 0 8.607051427134138e-08
- I-Disease 0 3.297305397609307e-07
chain I-Disease 0 4.363818391084351e-07
acyl I-Disease 0 1.296326627198141e-05
- I-Disease 0 3.566138389032858e-07
coenzyme I-Disease 0 6.296419996942859e-06
A I-Disease 0 8.647058962196752e-07
dehydrogenase I-Disease 0 8.533786603948101e-05
deficiency I-Disease 0 0.0004508157726377249
. O 0 2.9144105155864963e-06

Very B-Disease 0 9.571068204650146e-08
- I-Disease 0 5.860919216615912e-08
long I-Disease 0 7.707982696558702e-09
- I-Disease 0 1.4340272080914929e-08
chain I-Disease 0 1.2926551384850882e-08
acyl I-Disease 0 1.4863853436963836e-07
- I-Disease 0 1.065444799053239e-08
coenzyme I-Disease 0 7.29286284695263e-08
A I-Disease 0 7.163407644839026e-09
dehydrogenase I-Disease 0 8.167817533433208e-09
( I-Disease 0 1.0639226999398232e-10
VLCAD I-Disease 0 3.1816123282624176e-06
) I-Disease 0 9.222463348557142e-10
deficiency I-Disease 0 4.386629370856099e-08
is O 0 3.5729597058775653e-10
a O 0 3.453139330034105e-09
disorder O 0 3.5558525269152597e-05
of O 0 6.633846538761645e-08
fatty O 0 1.3046029323504627e-07
acid O 0 6.981631628377727e-08
beta O 0 3.4685214700402867e-08
oxidation O 0 2.8178233080211612e-08
that O 0 2.4733559644829484e-09
reportedly O 0 2.3182142427913277e-08
has O 0 5.7158024840964217e-11
high O 0 4.067502445970206e-10
rates O 0 5.752622378452088e-09
of O 0 7.173722726960818e-11
morbidity O 0 7.786552913557898e-08
and O 0 2.3399748805275067e-10
mortality O 0 2.5785530510802346e-07
. O 0 3.121378711057332e-08

We O 0 1.2301614837895158e-08
describe O 0 1.714247077622133e-09
the O 0 9.278441903681767e-11
outcome O 0 1.1585820081094766e-09
of O 0 2.1136092875906343e-09
a O 0 3.7769948280086396e-10
5 O 0 2.8649146943671155e-10
- O 0 4.1531788425031024e-11
year O 0 3.463967654382394e-11
- O 0 1.7001273999728284e-10
old O 0 1.0478503620348079e-09
girl O 0 1.1220804729816791e-08
with O 0 1.1699557989075515e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 3.134109860525314e-08
was O 0 2.0099777842119693e-08
first O 0 3.5388261210300698e-09
seen O 0 1.3877736737555324e-09
at O 0 6.244993411286259e-10
5 O 0 4.204327996859547e-09
months O 0 8.526602757186197e-10
of O 0 8.571080650776608e-11
age O 0 3.660662883930854e-10
with O 0 1.808001838521367e-11
severe O 0 9.280504364994613e-09
hypertrophic B-Disease 1 0.9977806210517883
cardiomyopathy I-Disease 1 1.0
, O 0 0.09580926597118378
hepatomegaly B-Disease 1 1.0
, O 0 0.00011256561265327036
encephalopathy B-Disease 0 3.1439034501090646e-05
, O 0 1.4273770609918301e-08
and O 0 1.2123560821919455e-08
hypotonia B-Disease 1 0.9994779229164124
. O 0 0.0003925911441911012

Biochemical O 0 3.0030605557840317e-06
studies O 0 2.079034629787202e-06
indicated O 0 0.00018525753694120795
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 3.943611375234468e-07
by O 0 3.878085352848615e-10
a O 0 1.2002697502566662e-08
stable O 0 1.82405437954003e-06
yet O 0 2.881956895350868e-08
inactive O 0 5.3709626968156954e-08
enzyme O 0 4.032997935610183e-08
. O 0 4.4977957713854266e-07

Molecular O 0 2.476152474173432e-07
genetic O 0 8.668912698794884e-09
analysis O 0 3.138139748060098e-09
of O 0 2.2322204085156727e-09
her O 0 9.465387584839391e-09
VLCAD O 0 0.00012605030497070402
gene O 0 1.804329343713107e-07
revealed O 0 5.634079229821509e-07
a O 0 3.016263860899926e-08
T1372C O 0 6.328140784717107e-07
( O 0 9.324075955774447e-10
F458L O 0 6.134966383797291e-07
) O 0 5.239281453128797e-09
missense O 0 8.855352575665165e-07
mutation O 0 6.806359476030366e-09
and O 0 1.0218700330355546e-09
a O 0 1.897043588883207e-08
1668 O 0 0.0003962625050917268
ACAG O 0 0.01121836993843317
1669 O 0 0.0002570971264503896
splice O 0 1.8741913663689047e-05
site O 0 2.2754941255698213e-06
mutation O 0 6.676611974398838e-08
. O 0 4.322659208355617e-08

After O 0 4.399163699986275e-08
initial O 0 1.51518353419533e-08
treatment O 0 4.5865593989447007e-08
with O 0 1.369808849682741e-10
intravenous O 0 2.107932495221121e-09
glucose O 0 6.30070262630511e-09
and O 0 2.890117312137619e-10
carnitine O 0 1.449015059051817e-07
, O 0 1.1377908615273213e-09
the O 0 1.715261888080022e-08
patient O 0 1.934466631325904e-08
has O 0 1.4167585507540714e-11
thrived O 0 1.947436795157742e-10
on O 0 4.567165812208174e-10
a O 0 7.961231118791545e-10
low O 0 5.507042288854791e-08
- O 0 4.786043561466613e-08
fat O 0 2.4201628434639133e-07
diet O 0 2.1115839388130553e-07
supplemented O 0 7.042724181616222e-09
with O 0 1.984350010697522e-11
medium O 0 1.2686403749739839e-07
- O 0 8.487344871355162e-08
chain O 0 3.526598391090374e-08
triglyceride O 0 3.9078798863556585e-07
oil O 0 1.9778806858994358e-07
and O 0 3.557043326551934e-09
carnitine O 0 2.4801062181722955e-07
and O 0 3.6563924110666335e-10
avoidance O 0 2.1559806384630065e-07
of O 0 9.328954497789255e-09
fasting O 0 1.1059769633448013e-07
. O 0 1.0002209727133504e-08

Her O 0 6.057805512682535e-05
ventricular O 1 0.9999979734420776
hypertrophy O 1 0.99998939037323
resolved O 0 5.355730650080659e-07
significantly O 0 1.4104999834785303e-08
over O 0 5.462844412940093e-11
1 O 0 1.6975133521057728e-09
year O 0 4.900844730038045e-10
, O 0 1.2601880650109365e-10
and O 0 7.571557963936826e-11
cognitively O 0 5.335756014801518e-08
, O 0 1.813847128051549e-10
she O 0 4.3502054736244133e-10
is O 0 1.5203139094865925e-11
in O 0 1.1749845887920607e-11
the O 0 3.829555422774078e-11
superior O 0 5.587319495958809e-10
range O 0 3.0947895357513744e-09
for O 0 2.42006747974699e-10
age O 0 1.404695648687948e-08
. O 0 3.6650754964284715e-07

Clinical O 0 4.390121375763556e-06
recognition O 0 3.5663939343066886e-05
of O 1 0.998437225818634
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.2938804161422013e-07
important O 0 1.257279436117642e-08
because O 0 1.4823459126844796e-10
it O 0 1.4692056599097114e-11
is O 0 2.775168766663838e-12
one O 0 7.202345924522957e-12
of O 0 1.1327559029661316e-10
the O 0 1.331778687330143e-09
few O 0 8.935160167311551e-09
directly O 0 4.403930109475596e-09
treatable O 0 3.713366680813124e-08
causes O 0 5.652534551536803e-10
of O 0 1.2767443768879616e-09
cardiomyopathy B-Disease 1 1.0
in O 0 2.1432899757201085e-06
children O 0 4.864934677328847e-09
. O 0 5.39870814719734e-10
. O 0 5.741967790129365e-09

Cloning O 0 2.8534382181533147e-06
of O 0 1.136967053838589e-08
a O 0 4.2457629079173387e-10
novel O 0 1.0241314463144136e-09
member O 0 6.152857778829457e-09
of O 0 2.224800077499367e-08
the O 0 3.6402727943141144e-08
low O 0 5.937022606872233e-08
- O 0 3.6128584568473343e-09
density O 0 3.2345312539483473e-10
lipoprotein O 0 3.197095210794032e-08
receptor O 0 1.9082717699347995e-06
family O 0 1.775148234628432e-06
. O 0 6.775095698685618e-06

A O 0 3.118255449408025e-07
gene O 0 3.058378217346558e-09
encoding O 0 1.573298291646097e-08
a O 0 1.0098477609687961e-08
novel O 0 6.457185897090767e-09
transmembrane O 0 3.4685196936834473e-09
protein O 0 8.290584885273233e-10
was O 0 8.164838805058139e-10
identified O 0 8.264073453334575e-11
by O 0 2.6000180741031498e-12
DNA O 0 3.304029619344284e-11
sequence O 0 1.0153933249767988e-11
analysis O 0 1.9732875056188703e-11
within O 0 1.227585914864715e-11
the O 0 7.189767115001189e-10
insulin B-Disease 1 0.9996064305305481
- I-Disease 1 1.0
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 3.05472869222001e-09
IDDM B-Disease 0 4.450580490811262e-06
) O 0 2.495955386816462e-10
locus O 0 1.905689295256252e-08
IDDM4 O 0 1.1741661865016795e-06
on O 0 2.3849509034334915e-08
chromosome O 0 4.000849784802085e-08
11q13 O 0 6.163629223010503e-06
. O 0 2.2598405280405132e-07

Based O 0 1.4716170504414094e-08
on O 0 2.681840705065497e-08
its O 0 9.7685659561364e-10
chromosomal O 0 1.0199022426604643e-07
position O 0 2.8636926799663343e-05
, O 0 3.4801030945885714e-09
this O 0 2.350213634816356e-10
gene O 0 1.5305211265026486e-10
is O 0 1.8016402605902648e-11
a O 0 2.3733709442197437e-11
candidate O 0 1.1965541057978868e-10
for O 0 7.81054942944337e-11
conferring O 0 1.8747776664440607e-08
susceptibility O 0 2.9939732826278487e-07
to O 0 4.888470357400365e-07
diabetes B-Disease 0 0.0007574578048661351
. O 0 2.4929379378590966e-06

The O 0 1.2030658353978652e-06
gene O 0 4.0139198631550244e-08
, O 0 3.829581540770732e-09
termed O 0 5.2773355463386906e-08
low O 0 4.90399187924595e-08
- O 0 3.0794977678993973e-09
density O 0 4.552317897643654e-11
lipoprotein O 0 7.142856861541702e-10
receptor O 0 1.873547317288171e-09
related O 0 4.211400650433461e-08
protein O 0 1.3247130059568235e-09
5 O 0 3.5879719195719417e-09
( O 0 2.770462852186295e-11
LRP5 O 0 9.674123191416584e-08
) O 0 3.371085702252863e-11
, O 0 3.186199568072645e-11
encodes O 0 2.8279304245537595e-11
a O 0 1.5334168657066272e-10
protein O 0 2.613365079895402e-10
of O 0 1.8507980703574844e-09
1615 O 0 6.1734713199257385e-06
amino O 0 2.3436764706730173e-07
acids O 0 6.791901796532329e-08
that O 0 7.074844599053165e-10
contains O 0 9.21417733779073e-11
conserved O 0 1.3970682943842405e-10
modules O 0 1.4950531923574317e-09
which O 0 2.3915704486232592e-11
are O 0 9.685107750512234e-12
characteristic O 0 4.1374390025161745e-10
of O 0 1.101330138197909e-09
the O 0 4.4577972424519885e-09
low O 0 7.960434089682167e-08
- O 0 7.897442699800195e-09
density O 0 3.1988484083811386e-10
lipoprotein O 0 5.8902780430969415e-09
( O 0 2.1456154908339187e-10
LDL O 0 1.534235281042129e-07
) O 0 3.15366843750553e-09
receptor O 0 1.6630159507258213e-06
family O 0 5.708445769414539e-07
. O 0 7.82427719059342e-07

These O 0 1.853487496816797e-08
modules O 0 6.351028147832949e-09
include O 0 1.2221460510275506e-09
a O 0 1.4037144779877053e-09
putative O 0 6.725910850491346e-08
signal O 0 4.099994654893635e-08
peptide O 0 2.2144859279649154e-09
for O 0 8.873453638535977e-10
protein O 0 3.922152880253549e-10
export O 0 4.446098600396908e-08
, O 0 2.5154367477853157e-09
four O 0 1.4785741520029205e-09
epidermal O 0 1.1972174362995247e-08
growth O 0 2.022803036183518e-09
factor O 0 4.238238648923698e-10
( O 0 2.4207909982143505e-11
EGF O 0 1.138117440291353e-07
) O 0 1.619743783543015e-10
repeats O 0 4.3051802123272864e-09
with O 0 2.501081806938199e-11
associated O 0 2.7325452123250216e-08
spacer O 0 3.372602748186182e-07
domains O 0 1.9257920769177872e-07
, O 0 4.847334200697162e-10
three O 0 1.8735023948890372e-11
LDL O 0 3.465264464264095e-10
- O 0 2.572584811844081e-09
receptor O 0 8.536985007800979e-10
( O 0 1.8257942380195402e-10
LDLR O 0 8.0250638347934e-06
) O 0 1.9203225121167122e-10
repeats O 0 4.726800728604985e-09
, O 0 1.9149494490111607e-10
a O 0 1.023629625507283e-09
single O 0 6.101879002073929e-09
transmembrane O 0 7.1032157933359485e-09
spanning O 0 3.83175136065006e-09
domain O 0 3.998034614483004e-08
, O 0 5.738767239193976e-10
and O 0 2.141821164869384e-10
a O 0 1.6409676950601693e-09
cytoplasmic O 0 2.993162340203526e-08
domain O 0 4.7123103286139667e-07
. O 0 1.236612376942503e-07

The O 0 1.0169530924031278e-06
encoded O 0 2.2381774655855224e-08
protein O 0 1.906809288243494e-08
has O 0 2.2473765903807674e-10
a O 0 1.149753972584655e-10
unique O 0 9.981888648979975e-10
organization O 0 3.568677353626981e-09
of O 0 3.555103322838704e-09
EGF O 0 7.713618288107682e-06
and O 0 2.112401276122e-08
LDLR O 0 0.00045551275252364576
repeats O 0 1.339283794976609e-08
; O 0 9.331508482590678e-11
therefore O 0 3.591614561315737e-09
, O 0 6.58763807392937e-11
LRP5 O 0 2.543874018101633e-07
likely O 0 2.2562081092303288e-09
represents O 0 2.1607358263731058e-11
a O 0 9.549350893367503e-12
new O 0 1.2008037793276305e-11
category O 0 6.005671515652011e-10
of O 0 7.235647081493823e-10
the O 0 5.991041440722711e-09
LDLR O 0 8.712565613677725e-05
family O 0 2.221340622554635e-07
. O 0 4.980468020221451e-07

Both O 0 2.4361153805330105e-07
human O 0 4.1421014174147786e-08
and O 0 7.48034345576798e-09
mouse O 0 1.811747125657348e-07
LRP5 O 0 1.5555286154267378e-05
cDNAs O 0 7.533050165875466e-07
have O 0 3.245198998413912e-09
been O 0 1.7038128685697984e-09
isolated O 0 2.9645306209857836e-09
and O 0 3.0372862558358804e-10
the O 0 3.0235371983877712e-09
encoded O 0 1.2643055491423638e-09
mature O 0 1.6284802395460929e-09
proteins O 0 1.5183838561472207e-11
are O 0 2.3777423172749446e-12
95 O 0 3.3398062093681347e-09
% O 0 7.749235281240274e-11
identical O 0 1.1409413691598758e-10
, O 0 1.557543156949226e-11
indicating O 0 8.680507423974859e-10
a O 0 8.642259130553498e-11
high O 0 5.717626927470576e-10
degree O 0 6.54658762755389e-08
of O 0 4.901857142414201e-09
evolutionary O 0 1.0158055729903026e-08
conservation O 0 2.169538326768361e-09
. O 0 7.524614265008722e-10
. O 0 2.0829423519330703e-08

The O 0 1.1494216778373811e-06
APC B-Disease 0 2.5547586801621947e-07
variants O 0 3.273598636610586e-08
I1307K O 0 7.893641509326699e-07
and O 0 4.019700405866189e-10
E1317Q O 0 5.164711680549772e-08
are O 0 3.190036776401506e-11
associated O 0 5.953204151865066e-08
with O 0 6.609760703213396e-07
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 4.181665147484637e-08
but O 0 1.4773153186875554e-11
not O 0 3.050789482150762e-11
always O 0 5.417727030887498e-11
with O 0 8.903668275751786e-13
a O 0 8.700016818075085e-10
family O 0 2.5478370524467664e-09
history O 0 4.3633477275761834e-08
. O 0 1.2050564635046612e-07

Classical O 0 0.05629315972328186
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.599418280624377e-08
FAP B-Disease 0 6.203968609952426e-07
) O 0 1.5047879609042525e-10
is O 0 6.833669047301427e-11
a O 0 2.6310313927524476e-09
high O 1 0.9999828338623047
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999958276748657
that O 0 9.653815247201436e-11
predisposes O 0 1.7550767505980502e-09
to O 0 1.1309402719872352e-10
hundreds O 0 1.1079706596639483e-10
or O 0 1.0585647636229822e-10
thousands O 0 2.8470759083631947e-09
of O 0 3.145752103250743e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9996646642684937
carcinoma I-Disease 1 1.0
and O 0 9.128402034264127e-09
that O 0 1.847752333083985e-11
results O 0 1.5558625568456996e-11
from O 0 9.235110072502994e-12
truncating O 0 2.7543378688932307e-09
mutations O 0 1.1361919738384074e-10
in O 0 6.384680562021572e-10
the O 0 1.238285385340987e-08
APC B-Disease 0 1.2215785716307437e-07
gene O 0 3.589937946912869e-08
. O 0 1.7055164107659948e-06

A O 0 5.433785759123566e-07
variant O 0 1.2516260028405668e-07
of O 0 2.2677371092072462e-08
FAP B-Disease 0 6.652573460996791e-07
is O 0 1.2201786248056123e-08
attenuated B-Disease 1 0.9999678134918213
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 1.652385250849875e-08
which O 0 9.988130461602296e-11
results O 0 1.0072768313884595e-10
from O 0 2.933333784205239e-11
germ O 0 3.8961129433801034e-08
- O 0 1.333235655209819e-08
line O 0 1.6494119403631657e-09
mutations O 0 2.2695859080990033e-11
in O 0 2.146531390134765e-11
the O 0 8.803438533711017e-11
5 O 0 5.120351920240296e-10
and O 0 4.9227084214509276e-11
3 O 0 1.7290766596289586e-09
regions O 0 5.205174069544682e-10
of O 0 2.0813806234087906e-09
the O 0 6.956506037880672e-09
APC B-Disease 0 1.1142198275138071e-07
gene O 0 4.161431377269764e-08
. O 0 9.82118081083172e-07

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 1.3695818779524416e-05
have O 0 1.1826234436185246e-09
" O 0 4.242114215458059e-09
multiple O 0 1.0286738572062859e-08
" O 1 0.9996614456176758
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 1.1560397084053875e-08
typically O 0 5.364527710938205e-10
fewer O 0 1.15118626436983e-11
than O 0 2.891702285609532e-12
100 O 0 6.27791985063908e-10
) O 0 2.28534101365252e-11
without O 0 3.50757867195739e-09
the O 0 7.699152426710043e-09
florid O 0 5.386606858337473e-07
phenotype O 0 2.3000684024054863e-08
of O 0 1.9561490205433074e-09
classical O 0 1.2691195649949805e-07
FAP B-Disease 0 1.3420195728031103e-06
. O 0 1.8350782227116724e-07

Another O 0 1.5483254856007989e-07
group O 0 1.4547737459125187e-09
of O 0 5.567022953734124e-10
patients O 0 5.736512931342475e-10
with O 0 7.22084675039425e-12
multiple O 0 5.393194779657051e-09
adenomas B-Disease 1 0.9999768733978271
has O 0 8.274303695543495e-07
no O 0 8.815666774353303e-08
mutations O 0 1.7051221545827389e-10
in O 0 1.1767732344125648e-09
the O 0 5.168137917621607e-09
APC B-Disease 0 4.4647752162063625e-09
gene O 0 7.863498741045305e-10
, O 0 5.446844641987525e-10
and O 0 1.8504618670700523e-10
their O 0 7.439219795735141e-10
phenotype O 0 7.298338045025332e-10
probably O 0 3.41091571653962e-10
results O 0 1.557805273666446e-10
from O 0 6.587612400021925e-11
variation O 0 1.0109613146624952e-09
at O 0 1.1232967445096165e-08
a O 0 4.477746617936873e-09
locus O 0 1.8640061938413055e-08
, O 0 4.1049277865745637e-10
or O 0 2.8994148748573423e-10
loci O 0 1.7729247236975e-10
, O 0 3.083961905292476e-11
elsewhere O 0 4.861018809698692e-10
in O 0 2.1143341244478364e-10
the O 0 2.406802090959559e-09
genome O 0 2.870473192473355e-09
. O 0 7.611722452338654e-08

Recently O 0 8.097466093204275e-07
, O 0 8.267971862707668e-10
however O 0 5.589611551393148e-10
, O 0 1.213882050432602e-10
a O 0 2.7772789623625727e-10
missense O 0 2.901326645599056e-08
variant O 0 1.6894334464723215e-07
of O 0 3.159220113957417e-06
APC B-Disease 0 2.906882627939922e-06
( O 0 4.605166914473102e-09
I1307K O 0 1.752069510985166e-05
) O 0 3.0333393574721867e-09
was O 0 5.618755594127833e-08
described O 0 3.430700390438801e-09
that O 0 2.041097672822456e-11
confers O 0 1.9585384425369057e-09
an O 0 8.356653043162243e-12
increased O 0 4.550714249873522e-10
risk O 0 2.612231497778339e-08
of O 0 6.569415518242749e-07
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 4.8806818142566044e-08
including O 0 2.6647159478976334e-10
multiple O 0 7.766625675920125e-10
adenomas B-Disease 0 6.160798875498585e-07
, O 0 7.157397785562125e-09
in O 0 4.671733933037103e-08
Ashkenazim O 0 4.730618093162775e-05
. O 0 6.022447109899076e-07

We O 0 4.282366319330322e-07
have O 0 1.1389372778225493e-09
studied O 0 6.740163094320906e-09
a O 0 1.0593671495584545e-09
set O 0 1.2923142556076073e-09
of O 0 1.1592490856138227e-10
164 O 0 6.104436400811153e-10
patients O 0 4.749282633831342e-10
with O 0 5.322178808775391e-11
multiple O 0 1.6549121937714517e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999948740005493
/ I-Disease 1 1.0
or I-Disease 1 0.9392064809799194
carcinoma I-Disease 1 1.0
and O 0 1.6895713272901958e-08
analyzed O 0 2.064206583440864e-09
codons O 0 7.149157266184147e-09
1263 O 0 2.753305352598545e-07
- O 0 7.802609758300605e-08
1377 O 0 7.192392672550341e-07
( O 0 6.497965499008274e-10
exon O 0 4.940493880667418e-08
15G O 0 1.0372906444899854e-06
) O 0 3.6273015147081367e-10
of O 0 2.4555735222975272e-09
the O 0 1.2580758657065871e-08
APC B-Disease 0 1.4248016100282257e-07
gene O 0 1.5081340620781702e-08
for O 0 9.833926561952921e-09
germ O 0 2.190027225879021e-05
- O 0 1.2795311477020732e-06
line O 0 1.457755587352949e-07
variants O 0 9.312957161000668e-08
. O 0 1.0557312180026202e-07

Three O 0 1.4242957924182065e-08
patients O 0 7.861549744525576e-10
with O 0 3.116161625613123e-12
the O 0 1.2066757593132138e-09
I1307K O 0 4.898139991382777e-07
allele O 0 1.5143022835673037e-08
were O 0 6.455683099204634e-09
detected O 0 3.7100233996056886e-09
, O 0 9.302648235065547e-11
each O 0 5.308967848671742e-11
of O 0 9.572154180403913e-10
Ashkenazi O 0 2.644938206231018e-07
descent O 0 4.998311169401859e-07
. O 0 7.492840268241707e-07

Four O 0 7.097192167293542e-08
patients O 0 4.303735590127644e-09
had O 0 1.5851140400258146e-09
a O 0 3.6006941872557263e-10
germ O 0 3.0606094014729024e-07
- O 0 2.4633555995023926e-07
line O 0 2.7945520741923247e-07
E1317Q O 0 4.028334387840005e-06
missense O 0 2.425768741431966e-07
variant O 0 6.108402885729447e-07
of O 0 1.3500613249561866e-07
APC O 0 8.200555612347671e-08
that O 0 1.5991152846339673e-10
was O 0 1.5140994014117837e-09
not O 0 2.999199499864602e-10
present O 0 1.2640252733397972e-10
in O 0 2.7382815459553456e-10
controls O 0 8.664169826033685e-09
; O 0 2.794644515802247e-10
one O 0 1.031620566749325e-09
of O 0 1.1611610978290443e-10
these O 0 6.6985644461836635e-12
individuals O 0 1.9439391502756864e-12
had O 0 1.145892603027221e-09
an O 0 9.203778711386335e-11
unusually O 0 1.1722302017957986e-09
large O 0 3.204393417277629e-10
number O 0 1.0428502505988035e-08
of O 0 1.342923727776224e-08
metaplastic B-Disease 0 1.9033272110391408e-05
polyps I-Disease 0 5.4564029596804176e-06
of I-Disease 0 8.75273755696071e-08
the I-Disease 0 1.060890681969795e-07
colorectum I-Disease 0 1.9746512407436967e-05
. O 0 4.568738916077564e-07

There O 0 5.649941954288806e-07
is O 0 1.4495057376606724e-09
increasing O 0 3.926037273060956e-10
evidence O 0 1.1352503381800716e-09
that O 0 1.0809429740188392e-10
there O 0 1.1194862398200556e-10
exist O 0 7.324751916115702e-10
germ O 0 4.476988735291343e-08
- O 0 3.768720890917621e-09
line O 0 2.111288255335353e-09
variants O 0 5.7272231401839235e-09
of O 0 2.554303435431393e-09
the O 0 3.2655025350436517e-09
APC B-Disease 0 1.8175198235326206e-08
gene O 0 5.681783932232065e-10
that O 0 5.339229405820767e-11
predispose O 0 4.509914219852362e-09
to O 0 1.770999014105712e-09
the O 0 7.234005061640403e-10
development O 0 8.255290673275795e-09
of O 0 4.976106637855082e-09
multiple O 0 4.918642298434861e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 6.8184951018679385e-09
but O 0 6.943468716658074e-11
without O 0 4.2569370251044347e-10
the O 0 6.419690334880102e-10
florid O 0 1.346446936167922e-07
phenotype O 0 1.4809626414091781e-08
of O 0 5.0656834282847285e-09
classical O 0 5.4386493530955704e-08
FAP B-Disease 0 1.2343514299573144e-07
, O 0 9.416255275507268e-11
and O 0 4.026080250435493e-12
possibly O 0 6.998741863828428e-11
with O 0 7.186191745833792e-13
importance O 0 3.531505683440628e-07
for O 0 3.830530840787105e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 3.375195234411876e-08
in O 0 1.799199678131913e-10
the O 0 5.767693544989072e-10
general O 0 1.6933030533294868e-09
population O 0 1.2575556915250807e-11
. O 0 2.7987942519125397e-10
. O 0 1.4045160590114847e-08

Genomic O 0 3.3763672746545126e-08
structure O 0 2.059251658081962e-09
of O 0 1.2525444015309972e-09
the O 0 3.5396630071460322e-09
human O 0 1.5034474643016438e-07
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 3.483342823074054e-07
CLD B-Disease 1 0.9999933242797852
) O 0 5.06359967289427e-08
gene O 0 7.202620366797419e-08
. O 0 7.582522698612593e-07

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 1.1506765318358703e-08
CLD B-Disease 1 0.9999152421951294
) O 0 5.480528919576955e-09
is O 0 6.108397121451503e-10
caused O 0 5.685382720166388e-10
by O 0 4.4012047478725336e-11
mutations O 0 2.2580108616221395e-10
in O 0 1.4361806188745163e-09
a O 0 3.216175992193371e-09
gene O 0 5.110945555664159e-10
which O 0 5.908278311039794e-10
encodes O 0 3.3616378569689687e-09
an O 0 1.763896029238765e-09
intestinal O 0 8.734873517823871e-07
anion O 0 3.0629746561317006e-07
transporter O 0 5.730930183744931e-07
. O 0 2.8165933940726973e-07

We O 0 2.3256285430761636e-07
report O 0 6.463975132930955e-09
here O 0 1.5077248338712934e-09
the O 0 9.063788053431665e-10
complete O 0 3.968062767256697e-09
genomic O 0 1.5742408265850827e-08
organization O 0 5.180711415420092e-09
of O 0 2.6315682966071563e-09
the O 0 5.280000880958369e-09
human O 0 2.755453287761611e-08
CLD B-Disease 0 0.00010108906280947849
gene O 0 1.322196929720576e-08
which O 0 1.0908519643137993e-09
spans O 0 4.691212973639836e-10
approximately O 0 2.5648606502559623e-11
39kb O 0 4.433413280935383e-08
, O 0 4.4027018142323016e-10
and O 0 7.103835297783689e-10
comprises O 0 3.591477559794498e-09
21 O 0 2.4296073775076366e-07
exons O 0 4.6539824438696087e-07
. O 0 2.596619310679671e-07

All O 0 3.6143566717328213e-07
exon O 0 8.656605245960236e-07
/ O 0 1.4986105725256493e-06
intron O 0 3.175145479872299e-07
boundaries O 0 1.900881896332862e-09
conform O 0 2.6382286577586456e-08
to O 0 9.620095831053277e-09
the O 0 1.2232288959523885e-08
GT O 0 1.23990739666624e-05
/ O 0 1.1710569197020959e-05
AG O 0 1.33708826979273e-05
rule O 0 6.349896011670353e-06
. O 0 6.992025873842067e-07

An O 0 6.509530692255794e-09
analysis O 0 1.6938749292094712e-09
of O 0 1.4199685871574275e-09
the O 0 9.630077846267682e-10
putative O 0 1.0926267002275836e-08
promoter O 0 1.8310203131477465e-08
region O 0 1.2826983031288819e-08
sequence O 0 3.215648414212069e-09
shows O 0 1.8112974231598855e-08
a O 0 8.849913690767153e-09
putative O 0 5.467114760904224e-07
TATA O 0 1.2868700878243544e-06
box O 0 1.656516701586952e-07
and O 0 1.6971865024473232e-09
predicts O 0 1.6792199630799587e-08
multiple O 0 6.352091075356725e-10
transcription O 0 2.170544988189249e-08
factor O 0 1.2941155702606011e-08
binding O 0 3.899227607462308e-08
sites O 0 4.392896642002597e-07
. O 0 3.358954643317702e-07

The O 0 4.920378273709503e-07
genomic O 0 8.916062910202527e-08
structure O 0 1.1902411500841481e-08
was O 0 1.3722605274324451e-08
determined O 0 2.4086483918495105e-09
using O 0 9.806088163699656e-10
DNA O 0 2.3197610499181565e-09
from O 0 3.229082001787731e-10
several O 0 6.171233662977116e-11
sources O 0 2.4667637377184803e-10
including O 0 1.2097256356369268e-11
multiple O 0 8.376412757860052e-11
large O 0 8.004534257644025e-10
- O 0 1.578583379568954e-07
insert O 0 1.7311386955043417e-06
libaries O 0 9.610165534468251e-07
and O 0 8.360120373751556e-10
genomic O 0 6.401182250925785e-09
DNA O 0 2.4976329893178217e-09
from O 0 9.210140428095315e-10
Finnish O 0 1.3924853874414111e-06
CLD B-Disease 1 0.9054816365242004
patients O 0 2.0388770280987956e-06
and O 0 1.4046902307995879e-08
controls O 0 7.086720870574936e-06
. O 0 2.382937736911117e-06

Exon O 0 6.020977707521524e-07
- O 0 3.845517682066202e-08
specific O 0 1.4645179513550488e-09
primers O 0 1.1741417615951377e-08
developed O 0 6.774869554249108e-10
in O 0 1.244271630174154e-10
this O 0 6.464634383362977e-11
study O 0 3.563864828248775e-11
will O 0 1.8794651598930123e-11
facilitate O 0 1.7626551329641416e-09
mutation O 0 5.6521214791827035e-11
screening O 0 1.779721231498499e-10
studies O 0 6.473895641789795e-09
of O 0 4.1268780059944277e-10
patients O 0 9.574286502500584e-11
with O 0 5.448044793077145e-12
the O 0 2.516540309471793e-09
disease O 0 2.0846862014423095e-09
. O 0 1.2437271657006477e-08

Genomic O 0 4.96898628910003e-08
sequencing O 0 1.4010137050490812e-08
of O 0 1.1364597263252563e-08
a O 0 3.43242980704872e-08
BAC O 0 0.00012351584155112505
clone O 0 1.977165084099397e-05
H O 1 1.0
_ O 0 7.818933944747641e-09
RG364P16 O 0 7.987338790371723e-08
revealed O 0 1.2731187215564432e-09
the O 0 1.821998940609859e-10
presence O 0 3.2892299994813357e-10
of O 0 2.1191879362447708e-09
another O 0 8.800370987493977e-10
, O 0 1.2391324077931642e-10
highly O 0 4.974216039066448e-10
homologous O 0 2.8137384089355066e-10
gene O 0 1.0846528120111998e-09
3 O 0 7.67036780757735e-08
of O 0 2.5738474462855265e-08
the O 0 2.6012237697159435e-08
CLD B-Disease 0 2.928097455878742e-05
gene O 0 1.3150415867357879e-08
, O 0 1.2464789200805626e-09
with O 0 2.8125246923083047e-11
a O 0 9.480090046309897e-10
similar O 0 2.743221483303415e-10
genomic O 0 7.482826802629461e-09
structure O 0 3.4736968856918793e-09
, O 0 2.383238606462612e-10
recently O 0 7.929164547171297e-10
identified O 0 4.998067515415983e-10
as O 0 3.8966291304731726e-10
the O 0 4.1544289786088484e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 6.493561244269586e-08
( O 0 6.087623738437742e-10
PDS B-Disease 0 1.0595838375593303e-06
) O 0 3.9225570014345124e-10
. O 0 2.1117312343221784e-09
. O 0 1.383741032867647e-08

The O 0 2.6756081297207857e-06
APCI1307K O 1 0.9969684481620789
allele O 0 5.644390512316022e-06
and O 0 2.7282005543582954e-09
cancer B-Disease 0 1.9469485579293178e-08
risk O 0 2.3007167282429464e-09
in O 0 2.571916291049803e-10
a O 0 5.828817983832835e-10
community O 0 3.9910899585215986e-10
- O 0 1.055919574000086e-09
based O 0 2.643741892072171e-10
study O 0 9.858787120009538e-10
of O 0 1.8350077013451482e-10
Ashkenazi O 0 2.3235704915691713e-08
Jews O 0 7.303999183250198e-08
. O 0 1.4752598076483991e-07

Mutations O 0 1.092068259822554e-06
in O 0 8.140308693782572e-08
APC O 0 3.304983806629025e-07
are O 0 7.253956324504429e-10
classically O 0 5.437476602310198e-07
associated O 0 7.170285130086995e-07
with O 0 8.106067639346293e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 6.73170896803299e-09
FAP B-Disease 0 1.3498758733021532e-07
) O 0 1.1483994311056733e-10
, O 0 7.02680344466522e-11
a O 0 3.590251651530707e-09
highly O 0 0.032376479357481
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 1.7497883391115465e-06
by O 0 2.9844654525490455e-10
multiple O 0 6.75519551407433e-09
intestinal O 0 4.799052021553507e-06
polyps B-Disease 0 1.411999903666583e-07
and O 0 1.2275608307632524e-10
, O 0 1.8270615922966194e-11
without O 0 1.108655597881203e-10
surgical O 0 3.171985341055006e-08
intervention O 0 6.548748956447525e-07
, O 0 2.0940701950245e-10
the O 0 1.6308644434914754e-09
development O 0 3.262936729697685e-07
of O 0 0.018719011917710304
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.3107569252213125e-08
CRC B-Disease 0 5.070653969596606e-06
) O 0 7.518219824476091e-09
. O 0 1.3451442271161795e-07

APC B-Disease 0 2.3907678041723557e-05
is O 0 1.5908907968764652e-08
a O 0 2.0793422095266578e-08
tumour O 1 1.0
- O 0 1.5300403219953296e-06
suppressor O 0 9.135474670074473e-07
gene O 0 1.0842478914696585e-08
, O 0 2.677641719461832e-10
and O 0 1.4797017777734567e-10
somatic O 0 2.753867249793984e-07
loss O 0 3.502746537265011e-08
occurs O 0 1.3170597057410305e-08
in O 0 9.537554745975285e-08
tumours B-Disease 1 1.0
. O 0 8.321584573423024e-06

The O 0 1.390151510349824e-06
germline O 0 1.310691573053191e-06
T O 0 2.1165794450439535e-08
- O 0 9.944679524309663e-10
to O 0 3.373827606178992e-10
- O 0 7.017271208553666e-10
A O 0 9.670498846148234e-10
transversion O 0 4.080807691764221e-09
responsible O 0 1.6346722586657592e-10
for O 0 1.5687422194599066e-10
the O 0 5.4905520130432706e-09
APC O 0 3.6613445786315424e-07
I1307K O 0 4.529849775281036e-06
allele O 0 2.736895332589029e-08
converts O 0 6.608233071858649e-09
the O 0 3.459652564430371e-09
wild O 0 1.3617573735302813e-09
- O 0 1.774920904695776e-10
type O 0 1.6179034501018208e-10
sequence O 0 7.70269889538433e-11
to O 0 1.8091869113945336e-09
a O 0 1.499157420425945e-08
homopolymer O 0 2.7887428586836904e-05
tract O 0 1.5647893860659678e-06
( O 0 2.0776045328574355e-09
A8 O 0 5.590820819634246e-07
) O 0 1.1708352343209327e-10
that O 0 3.3203793881053656e-11
is O 0 1.265891991925061e-11
genetically O 0 3.785411151202567e-10
unstable O 0 6.413280573269731e-09
and O 0 6.9547954062443296e-09
prone O 0 7.215381003788934e-08
to O 0 1.7716359934638604e-07
somatic O 0 1.2594903637364041e-05
mutation O 0 2.399465870439599e-07
. O 0 2.3500372492435417e-07

The O 0 8.730343097340665e-07
I1307K O 0 4.400189482112182e-06
allele O 0 3.296148065601301e-08
was O 0 6.115044914878354e-09
found O 0 3.414860616501869e-10
in O 0 4.4167311474829773e-10
6 O 0 2.725144554460712e-07
. O 0 1.9318125055178825e-07

1 O 0 5.614616384264082e-06
% O 0 8.879980839537893e-08
of O 0 5.2252726590040766e-08
unselected O 0 0.00018825082224793732
Ashkenazi O 0 5.773857537860749e-06
Jews O 0 2.2327799342747312e-07
and O 0 1.1547698353098212e-09
higher O 0 5.722135210106671e-09
proportions O 0 1.3136871590546662e-09
of O 0 3.497030443000426e-09
Ashkenazim O 0 3.975204663220211e-07
with O 0 5.518687173911019e-10
family O 0 1.7475016989010328e-08
or O 0 7.410107638605723e-09
personal O 0 5.627404675578873e-07
histories O 0 2.9435116744025436e-07
of O 0 1.229038559813489e-07
CRC B-Disease 0 5.6553348258603364e-05
( O 0 1.638072011367342e-09
ref O 0 3.5889638638764154e-06
. O 0 1.0427387842071312e-08
2 O 0 7.610589847217852e-08
) O 0 2.7709308181300685e-09
. O 0 4.7908109479521954e-08

To O 0 1.5605786884975714e-08
evaluate O 0 2.2221367856900542e-08
the O 0 2.360475370721815e-09
role O 0 2.3767404044860996e-08
of O 0 5.345045650528846e-08
I1307K O 0 2.5899860247591278e-06
in O 0 2.5988120544440108e-09
cancer B-Disease 0 2.680519806119719e-09
, O 0 9.195759431701589e-11
we O 0 1.2503149626752474e-09
genotyped O 0 1.2852824227138626e-07
5 O 0 1.2962998141574644e-07
, O 0 8.564454034853952e-09
081 O 0 6.699441200908041e-06
Ashkenazi O 0 2.1221302404228481e-07
volunteers O 0 4.333721292937298e-08
in O 0 1.0141923967310618e-09
a O 0 1.775971703033008e-09
community O 0 2.4395518938291616e-09
survey O 0 6.905346516816735e-09
. O 0 1.847258168652388e-08

Risk O 0 2.3819925445422996e-06
of O 0 1.2318707831582287e-08
developing O 0 2.182214444701458e-07
colorectal B-Disease 1 1.0
, I-Disease 0 1.4679028936370742e-05
breast I-Disease 1 0.9996949434280396
and I-Disease 0 1.2465359588986757e-07
other I-Disease 0 2.7859297091481494e-08
cancers I-Disease 0 9.995958549779971e-08
were O 0 4.044743651121507e-09
compared O 0 1.1566346769242841e-09
between O 0 2.5351207244561635e-10
genotyped O 0 1.4536281867094658e-07
I1307K O 0 3.855418029274915e-08
carriers O 0 4.0175543447595885e-10
and O 0 8.275887614095367e-11
non O 0 7.448196726045353e-09
- O 0 5.104068279138119e-10
carriers O 0 6.160578297498276e-11
and O 0 7.489040637631561e-12
their O 0 4.2782530990104206e-11
first O 0 1.772008512146428e-10
- O 0 2.527246745209766e-10
degree O 0 5.703263195044883e-09
relatives O 0 1.4069962084306553e-08
. O 0 3.373702384124044e-08

Sperm O 0 2.3107448399173336e-08
DNA O 0 1.2433137852596587e-09
analysis O 0 5.611456299625672e-10
in O 0 9.636692555048398e-10
a O 0 2.0362403319040823e-08
Friedreich B-Disease 0 0.00028094451408833265
ataxia I-Disease 0 0.0028289358597248793
premutation O 0 0.0007036598399281502
carrier O 0 2.855088325759425e-07
suggests O 0 1.7584056877240073e-07
both O 0 1.1075318440134652e-09
meiotic O 0 3.591455595142179e-07
and O 0 2.2732447035878067e-09
mitotic O 0 8.887584890260314e-09
expansion O 0 1.4858461128142153e-08
in O 0 1.5640463368882251e-09
the O 0 3.6632212818688004e-09
FRDA B-Disease 0 1.3514129477698589e-06
gene O 0 1.1462122806449315e-08
. O 0 1.4452047025770298e-07

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 1.4147092315397458e-06
usually O 0 1.403688631995692e-08
caused O 0 3.4807318138874166e-10
by O 0 3.357556854072241e-12
an O 0 3.015981561715897e-12
expansion O 0 1.2257248549474298e-09
of O 0 1.8311975269469372e-09
a O 0 8.926416827925721e-10
GAA O 0 1.501773105871962e-08
trinucleotide O 0 1.351728400322827e-07
repeat O 0 4.917851903485371e-09
in O 0 3.0874669487701567e-09
intron O 0 3.391858527379554e-08
1 O 0 8.302983900421168e-08
of O 0 1.4006076298755943e-08
the O 0 2.7551640968681568e-08
FRDA B-Disease 0 1.8689155695028603e-05
gene O 0 6.084541581685698e-08
. O 0 7.299611297639785e-07

Occasionally O 0 6.901161668793065e-07
, O 0 3.319585051286822e-09
a O 0 3.4444429530822163e-09
fully O 0 1.796513515728293e-07
expanded O 0 7.35648484351259e-08
allele O 0 5.3687294609972014e-08
has O 0 1.3779742624731028e-10
been O 0 1.1238977803973427e-10
found O 0 1.0532593894274633e-11
to O 0 4.329880898268357e-11
arise O 0 1.0237286018899283e-10
from O 0 3.079201130185005e-11
a O 0 2.574969404367522e-10
premutation O 0 2.2137353283824268e-08
of O 0 5.829918214850238e-10
100 O 0 6.532515861579213e-09
or O 0 4.667267128333208e-10
less O 0 9.97766758104035e-09
triplet O 0 8.444390573458804e-07
repeats O 0 6.871490541016101e-07
. O 0 8.867859833117109e-07

We O 0 1.1363067642378155e-06
have O 0 3.8614800246250525e-09
examined O 0 1.6009634506986004e-08
the O 0 1.1531652299723305e-09
sperm O 0 1.0019886031997771e-09
DNA O 0 2.604776838666112e-09
of O 0 2.647613683848249e-09
a O 0 1.094053114769622e-08
premutation O 0 3.1255008252628613e-06
carrier O 0 1.389806669749305e-07
. O 0 6.847031954748672e-07

This O 0 2.0432390002156353e-08
mans O 0 3.030056916486501e-07
leucocyte O 0 7.438886484578688e-08
DNA O 0 6.286142717470966e-09
showed O 0 5.8513327516607205e-09
one O 0 1.6815450420981648e-10
normal O 0 6.9503527377889895e-09
allele O 0 3.2755831380626432e-09
and O 0 6.154990961348972e-10
one O 0 4.251451968251274e-10
allele O 0 1.3668003395750361e-09
of O 0 5.060698526904162e-10
approximately O 0 1.3221072847624527e-10
100 O 0 2.6217202631073633e-08
repeats O 0 2.9780656163325148e-08
. O 0 1.240337610397546e-07

His O 0 1.6476227528983145e-06
sperm O 0 6.427519565477269e-07
showed O 0 3.537187964752775e-08
an O 0 3.266932210865825e-11
expanded O 0 1.2535720239625903e-09
allele O 0 2.2646240438461973e-09
in O 0 1.3600909287703189e-09
a O 0 8.234674275797715e-09
tight O 0 7.817789793307384e-08
range O 0 1.1295013813139576e-08
centering O 0 1.8427880332794189e-09
on O 0 2.08238915000436e-09
a O 0 2.2360033269386292e-10
size O 0 1.5608210557349622e-10
of O 0 6.859891821253683e-11
approximately O 0 1.9163479830774932e-11
320 O 0 2.563171008773679e-09
trinucleotide O 0 9.507955383014632e-07
repeats O 0 2.1592728671748773e-07
. O 0 1.1993621455985704e-06

His O 0 3.395391331650899e-06
affected O 0 3.971752562392794e-07
son O 0 1.4517910130962264e-05
has O 0 4.1520027416197536e-09
repeat O 0 1.3316897584658705e-09
sizes O 0 6.5566574392050825e-09
of O 0 2.7807787184030985e-09
1040 O 0 4.504655493065002e-08
and O 0 7.3111601217590305e-09
540 O 0 5.281162316350674e-07
. O 0 2.497032198789384e-07

These O 0 1.2847299046825356e-07
data O 0 3.488119304506654e-08
suggest O 0 1.2246825775719117e-09
that O 0 1.3001744863030962e-12
expansion O 0 1.8448435487594672e-11
occurs O 0 1.1560947511812802e-12
in O 0 1.6219867246189401e-12
two O 0 8.789805363597358e-13
stages O 0 3.455387018180822e-12
, O 0 6.3552600682026394e-12
the O 0 5.6059549363718375e-11
first O 0 2.628502138168898e-10
during O 0 4.6167736300617435e-10
meiosis O 0 7.956464931346829e-10
followed O 0 1.3457840397634868e-10
by O 0 1.5558625568456996e-11
a O 0 6.838314914325849e-10
second O 0 2.6635382788242623e-09
mitotic O 0 9.686973356792805e-08
expansion O 0 8.601420518061786e-07
. O 0 8.113892704386672e-07

We O 0 2.8124438244958583e-07
also O 0 1.7973038612950631e-09
show O 0 1.957332074198348e-09
that O 0 2.2027388593692798e-11
in O 0 1.1682431411141891e-10
all O 0 1.2410955596564577e-10
informative O 0 1.2332878052134788e-09
carrier O 0 3.4763858458575214e-10
father O 0 6.284104792086964e-09
to O 0 2.2972974633717058e-08
affected O 0 7.230298137983482e-09
child O 0 2.0010954671079162e-08
transmissions O 0 1.378233775994886e-07
, O 0 9.863483640959458e-11
with O 0 9.474584311552903e-12
the O 0 9.783837073840118e-10
notable O 0 1.1458838322653264e-09
exception O 0 1.0431445929270922e-08
of O 0 1.6173736794300453e-09
the O 0 1.0802468919379749e-09
premutation O 0 7.708824512064893e-08
carrier O 0 1.8132356727207366e-09
, O 0 3.82267578702411e-10
the O 0 1.0915971460079277e-09
expansion O 0 2.3917063884937306e-08
size O 0 2.4709088108920696e-09
decreases O 0 2.9742834861679057e-09
. O 0 2.2972743707327936e-09
. O 0 1.0627499591464584e-07

The O 0 6.194332513587142e-07
R496H O 0 9.3234930318431e-06
mutation O 0 3.450408669891658e-08
of O 0 5.5332143311659365e-09
arylsulfatase O 0 2.3375876025966136e-06
A O 0 5.668150606652489e-07
does O 0 1.4135675741044906e-08
not O 0 1.4264571746025467e-08
cause O 0 5.863367391611973e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 1.1217988685530145e-05

Deficiency B-Disease 0 4.4244683522265404e-05
of I-Disease 0 2.614759523567045e-06
arylsulfatase I-Disease 0 0.0009702043025754392
A I-Disease 0 5.0353846745565534e-05
( O 0 1.8675329727102508e-08
ARSA O 0 0.00017668027430772781
) O 0 3.3633051899073507e-09
enzyme O 0 2.577782787227534e-08
activity O 0 4.166769826952077e-07
causes O 0 6.619108603445056e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 2.1824178020324325e-08
MLD B-Disease 1 1.0
) O 0 2.7375218536462853e-08
. O 0 1.5011636378403637e-07

A O 0 7.354253739322303e-07
number O 0 1.893999268531843e-08
of O 0 3.127636460931171e-08
ARSA O 0 0.0002880201209336519
gene O 0 2.7331037699696026e-07
mutations O 0 2.532054743653589e-08
responsible O 0 3.3484695904917317e-08
for O 0 1.4538458970037027e-07
MLD B-Disease 1 1.0
have O 0 7.546410074610321e-07
been O 0 6.369953897689129e-09
identified O 0 7.373816668376776e-09
. O 0 4.924171292941537e-08

Recently O 0 4.762667629165662e-07
, O 0 8.463685863269177e-10
the O 0 1.2365241053302611e-09
R496H O 0 8.806539426586824e-07
mutation O 0 1.1756879914059937e-08
of O 0 1.4508148460379289e-08
ARSA O 0 0.00014960883709136397
was O 0 3.9011624153317825e-07
proposed O 0 6.933933871522413e-09
to O 0 1.5833584443569748e-09
be O 0 8.556497732570278e-10
a O 0 5.429336424889186e-10
cause O 0 3.126769954064912e-09
of O 0 1.175091668415007e-08
MLD B-Disease 1 1.0
( O 0 1.6694444937570552e-08
Draghia O 0 2.590574013083824e-06
et O 0 9.302161174673529e-07
al O 0 8.748437494432437e-07
. O 0 9.338777529066533e-10
, O 0 6.975366118044946e-11
1997 O 0 3.018967298373809e-09
) O 0 9.63437662981903e-10
. O 0 2.3008757565889937e-08

We O 0 2.724677017340582e-07
have O 0 2.5018571658819155e-09
investigated O 0 2.6975992550859473e-09
the O 0 3.3792519893438566e-09
R496H O 0 9.021330811265216e-07
mutation O 0 6.643020578067649e-10
and O 0 3.097237050164736e-11
found O 0 5.0838954573917405e-11
this O 0 5.500315480855278e-11
mutation O 0 7.709107657793979e-11
at O 0 4.38851621709091e-10
a O 0 1.2140001504068465e-10
relatively O 0 9.552506702315e-11
high O 0 3.064588166568072e-11
frequency O 0 6.086088577550441e-11
in O 0 2.1219767262770084e-11
an O 0 4.520054816548047e-11
African O 0 1.0301458575057154e-09
American O 0 9.451310845065564e-10
population O 0 4.426121361783553e-12
( O 0 6.995264285360181e-13
f O 0 1.4453811481018874e-09
= O 0 5.140738057463068e-09
0 O 0 5.094653032777785e-10
. O 0 7.016705272366863e-11
09 O 0 2.388533459907194e-08
, O 0 1.8128787360183196e-10
n O 0 3.3108018548944074e-09
= O 0 7.881691033162497e-08
61 O 0 1.514920633383099e-08
subjects O 0 5.8548632608790285e-08
) O 0 3.3662062026706963e-09
. O 0 5.458123908397283e-08

The O 0 3.3660871849860996e-05
ARSA O 0 9.910509834298864e-05
enzyme O 0 3.178356422495199e-08
activity O 0 3.1750662543572616e-08
in O 0 3.6504271827553225e-10
subjects O 0 2.6508981676443e-09
with O 0 1.5489152929010208e-12
and O 0 4.259223182478955e-12
without O 0 1.4469554721063815e-10
the O 0 2.7092614263146686e-10
R496H O 0 1.1036842550993242e-07
mutation O 0 7.497909515485901e-10
was O 0 1.538747018692277e-09
determined O 0 3.148103333572294e-09
and O 0 1.291146412008004e-09
found O 0 8.383497229758063e-10
to O 0 1.2588842190908167e-09
be O 0 2.210873262242785e-09
normal O 0 8.94998493095045e-08
. O 0 1.361135417710102e-07

It O 0 4.154143695700441e-08
is O 0 9.813155843474419e-11
therefore O 0 1.3999572334721933e-10
concluded O 0 3.0128108341465065e-10
that O 0 1.0331751947034729e-11
the O 0 2.603474380524773e-10
R496H O 0 6.323459729173919e-07
mutation O 0 1.9968595665886824e-08
of O 0 7.304441496103209e-09
ARSA O 0 3.5930759622715414e-05
does O 0 1.7839099086813803e-08
not O 0 3.566914985597691e-09
negatively O 0 1.5570129630049223e-09
influence O 0 1.672762550697371e-08
the O 0 2.0502699982216654e-08
activity O 0 1.069492796546001e-07
of O 0 3.2213329781427547e-09
ARSA O 0 9.193523510475643e-06
and O 0 1.0850127463157833e-09
is O 0 3.416787339172167e-11
not O 0 6.930964829843234e-11
a O 0 1.6585281759073922e-10
cause O 0 2.7244513312041363e-09
of O 0 9.400172018558806e-08
MLD B-Disease 1 1.0

Down O 0 1.9719527699635364e-06
- O 0 2.3556063410978823e-07
regulation O 0 3.091381586273201e-07
of O 0 3.1238446496217875e-08
transmembrane O 0 3.5327378355987094e-08
carbonic O 0 7.871285561122932e-06
anhydrases O 0 8.050439646467566e-05
in O 0 1.1004466387021239e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999994039535522
lines O 0 9.455102478739263e-09
by O 0 5.644927303372071e-10
wild O 0 1.8308602989236533e-07
- O 0 5.519060550795984e-07
type O 0 1.1870298294525128e-05
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 0 0.17856590449810028
Lindau I-Disease 0 0.010149057023227215
transgenes O 0 0.001206158776767552
. O 0 7.4631116149248555e-06

To O 0 1.8655410940482398e-06
discover O 0 4.2967496938217664e-07
genes O 0 6.253304096759393e-09
involved O 0 8.184363409213802e-09
in O 0 2.0307869164071235e-08
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999971389770508
( O 0 7.175717087193334e-08
VHL B-Disease 0 0.00030424349824897945
) O 0 2.2363638052524948e-08
- O 0 1.5115530516141007e-07
mediated O 0 1.535678677555552e-07
carcinogenesis O 0 6.531654071295634e-05
, O 0 1.4703115391867527e-09
we O 0 2.8375399807600843e-09
used O 0 4.161772793054297e-08
renal B-Disease 1 0.999997615814209
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 5.394534241531801e-07
stably O 0 1.461412466596812e-06
transfected O 0 3.3276475619459234e-07
with O 0 1.9292914488211466e-10
wild O 0 5.0770424309121154e-08
- O 0 6.888576820074377e-08
type O 0 5.20343235166365e-07
VHL O 0 0.011137678287923336
- O 0 5.3224237490212545e-05
expressing O 0 4.5407608695313684e-07
transgenes O 0 3.400480272830464e-05
. O 0 8.590139941588859e-07

Large O 0 3.8119111422929564e-08
- O 0 1.15244249698776e-08
scale O 0 1.3506737950308434e-08
RNA O 0 2.00997014587756e-08
differential O 0 5.508208289484173e-08
display O 0 4.541144349445858e-09
technology O 0 9.109967891163251e-08
applied O 0 3.0094889780230005e-07
to O 0 1.0565406327600613e-08
these O 0 4.2330519645084053e-10
cell O 0 2.0380264142971782e-09
lines O 0 4.886974158679891e-10
identified O 0 4.515698925899869e-09
several O 0 1.2597729526220292e-09
differentially O 0 3.231714060802915e-07
expressed O 0 6.529575991010006e-09
genes O 0 8.976869803056786e-10
, O 0 6.438795607799364e-10
including O 0 4.251808627397935e-10
an O 0 3.1889976770393957e-10
alpha O 0 1.5891743032625527e-08
carbonic O 0 4.875801664638857e-07
anhydrase O 0 7.691295650147367e-06
gene O 0 2.3327899612013425e-07
, O 0 3.5971691403346995e-08
termed O 0 3.141692104691174e-06
CA12 O 0 0.0004909423878416419
. O 0 1.6333576695615193e-06

The O 0 1.0221939419352566e-06
deduced O 0 1.6110635669974727e-07
protein O 0 2.6465130087416355e-09
sequence O 0 2.504735308050954e-10
was O 0 3.128852066325294e-09
classified O 0 1.283647299565871e-09
as O 0 1.296860063781935e-09
a O 0 2.9642139853791605e-09
one O 0 2.4126114439582125e-09
- O 0 1.0236811931463308e-07
pass O 0 2.195863402221221e-07
transmembrane O 0 2.9258711720103747e-07
CA O 0 0.0003033002431038767
possessing O 0 3.3676897146506235e-06
an O 0 2.6864686475391863e-08
apparently O 0 3.472016771866038e-07
intact O 0 9.902461073352242e-08
catalytic O 0 1.4112373492025654e-08
domain O 0 6.439010746817075e-08
in O 0 1.0749979573176915e-08
the O 0 1.7269648822093586e-08
extracellular O 0 9.549040669298847e-08
CA O 0 7.594589078507852e-06
module O 0 1.8469186215952504e-06
. O 0 5.553781647904543e-07

Reintroduced O 0 1.1263516171311494e-05
wild O 0 1.4543578572556726e-06
- O 0 4.39991964640285e-07
type O 0 2.0528375443973346e-07
VHL B-Disease 0 0.0001394758583046496
strongly O 0 8.859375810743586e-08
inhibited O 0 1.3965281198125012e-07
the O 0 2.0866684380393963e-08
overexpression O 0 1.2225306988966622e-07
of O 0 1.928850856813824e-09
the O 0 1.16244458503445e-09
CA12 O 0 1.1105788644272252e-07
gene O 0 2.606962701268145e-10
in O 0 7.089825948547457e-10
the O 0 5.500216282428028e-09
parental O 0 0.00042771847802214324
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 1.22345841191418e-06
. O 0 2.096575826726621e-06

Similar O 0 4.74455177368327e-08
results O 0 6.864558699248846e-09
were O 0 7.465345563950621e-10
obtained O 0 2.258834674861987e-09
with O 0 7.691364906081688e-11
CA9 O 0 4.120202356716618e-05
, O 0 1.1825857626490688e-08
encoding O 0 4.3402891947152966e-08
another O 0 4.780149964744851e-08
transmembrane O 0 1.0304553654805204e-07
CA O 0 0.00015309981245081872
with O 0 3.6752936249939694e-09
an O 0 6.10243766629992e-09
intact O 0 2.1336546751626884e-07
catalytic O 0 4.889123488283076e-07
domain O 0 3.6187132081977325e-06
. O 0 2.833075427588483e-07

Although O 0 3.5122204167237214e-07
both O 0 2.0617196838657037e-09
domains O 0 8.481887192601789e-09
of O 0 9.24485288322785e-09
the O 0 5.713367112747392e-09
VHL B-Disease 0 1.041311747940199e-06
protein O 0 8.001878604169121e-10
contribute O 0 2.396577603036576e-09
to O 0 5.641615175022707e-09
regulation O 0 8.190541507246962e-07
of O 0 3.839801649974106e-07
CA12 O 0 0.0002489321050234139
expression O 0 2.9552742830674106e-07
, O 0 3.6449885332245913e-09
the O 0 5.41099920425836e-09
elongin O 0 2.1267737793095876e-07
binding O 0 1.3196950199301227e-08
domain O 0 6.752414805077933e-08
alone O 0 7.1062786766162844e-09
could O 0 1.178822039982208e-09
effectively O 0 1.3599619208548575e-08
regulate O 0 8.672274276477765e-08
CA9 O 0 0.0054746512323617935
expression O 0 8.539453119738027e-05
. O 0 7.651717169210315e-06

We O 0 7.1013737397152e-06
mapped O 0 1.5382994433821295e-06
CA12 O 0 1.9723518562386744e-05
and O 0 3.948472837578265e-08
CA9 O 0 0.00010438618483021855
loci O 0 2.8112316385886515e-07
to O 0 1.0600836475305186e-07
chromosome O 0 1.5288071253394264e-08
bands O 0 2.972139441226318e-07
15q22 O 0 5.25243922311347e-06
and O 0 1.8667494217083913e-08
17q21 O 0 1.2006486940663308e-05
. O 0 3.2737554533923685e-07

2 O 0 5.699600365005608e-07
respectively O 0 1.6772088429206633e-07
, O 0 2.0425250379929594e-09
regions O 0 1.6383626677551888e-09
prone O 0 4.464332015174932e-09
to O 0 3.098670209311649e-09
amplification O 0 9.228541841821425e-08
in O 0 1.3041042734585062e-07
some O 0 4.0336363582582635e-08
human O 0 6.4532478916135e-08
cancers B-Disease 0 6.692370106975432e-07
. O 0 1.7939865415428358e-07

Additional O 0 5.567973175857333e-07
experiments O 0 6.735705682103799e-08
are O 0 1.3504793117125047e-10
needed O 0 2.051548042558693e-09
to O 0 4.0674946744090335e-10
define O 0 4.249889329344114e-09
the O 0 2.843553614795269e-09
role O 0 9.9595141023201e-08
of O 0 3.982501652899373e-07
CA O 0 6.5844210439536255e-06
IX O 0 7.880481280153617e-05
and O 0 1.4709061701978499e-07
CA O 0 8.305616574943997e-06
XII O 0 1.644730787120352e-06
enzymes O 0 7.321622752520796e-10
in O 0 3.3956630840492608e-09
the O 0 3.733363396207778e-09
regulation O 0 2.5165512340663554e-08
of O 0 1.5634648020679265e-09
pH O 0 1.1202113903152622e-08
in O 0 6.592719703490957e-10
the O 0 1.2723030407002511e-09
extracellular O 0 2.7533557656056473e-09
microenvironment O 0 2.0258008248674741e-07
and O 0 1.9439409804089536e-10
its O 0 3.725691283262833e-11
potential O 0 4.772690576082539e-11
impact O 0 3.2215294876181133e-09
on O 0 5.531106594958146e-08
cancer B-Disease 0 2.6813086861920965e-08
cell O 0 6.988639711380529e-08
growth O 0 4.3935457938459876e-08
. O 0 6.79433824757325e-08

A O 0 4.783424287779781e-07
gene O 0 1.4656168723092833e-08
encoding O 0 8.297221398834154e-08
a O 0 7.869973472907077e-08
transmembrane O 0 3.335847864605057e-08
protein O 0 1.1520864262593022e-08
is O 0 1.307973590547462e-10
mutated O 0 2.645169361326083e-10
in O 0 2.330625692437138e-10
patients O 0 2.1156945084754852e-09
with O 0 3.040874219095713e-10
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.0015462884912267327
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 1.4439650612985133e-06
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 5.847829331884213e-09
. O 0 3.9565993148471534e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.424853337539389e-07
WFS B-Disease 0 0.0007610186003148556
; O 0 1.844107622162028e-08
OMIM O 0 2.5692776034702547e-05
222300 O 0 3.293684756044968e-07
) O 0 4.1233527703354866e-10
is O 0 4.4420847555848297e-10
an O 0 5.960074656030656e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 1.17822249734445e-08
by O 0 2.141730195970304e-11
young O 0 1.2720506870067538e-09
- O 0 1.3959461853119137e-07
onset O 1 0.9999996423721313
non O 1 1.0
- O 0 0.06461333483457565
immune O 1 0.9974784255027771
insulin B-Disease 1 1.0
- I-Disease 1 1.0
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 4.861470733885653e-05
progressive O 1 0.9999867677688599
optic B-Disease 0 0.0003613350563682616
atrophy I-Disease 0 3.1394276447826996e-05
. O 0 2.4510159164492507e-06

Linkage O 0 8.470636885249405e-07
to O 0 2.594128645228011e-08
markers O 0 8.344830604301023e-09
on O 0 3.893193323278865e-08
chromosome O 0 7.264236501214327e-08
4p O 0 7.763353096379433e-06
was O 0 8.334431811363174e-08
confirmed O 0 1.3449743541116277e-08
in O 0 9.297987380030293e-10
five O 0 2.141993915572016e-09
families O 0 1.9979815024662173e-10
. O 0 7.250501532496401e-09

On O 0 5.253143058325804e-07
the O 0 4.420543042726877e-09
basis O 0 1.6408183256544362e-08
of O 0 4.916970386403818e-09
meiotic O 0 6.773453060304746e-05
recombinants O 0 0.48854532837867737
and O 0 1.1106720876341569e-07
disease O 0 2.781247587790858e-07
- O 0 4.531455743972401e-08
associated O 0 1.9660291172840516e-07
haplotypes O 0 1.0089083843922708e-06
, O 0 3.346673826953861e-09
the O 0 3.891730671057303e-08
WFS B-Disease 0 4.715079558081925e-05
gene O 0 6.689802933834699e-09
was O 0 1.097710988773315e-08
localized O 0 6.02021676954223e-09
to O 0 7.908899313235906e-09
a O 0 2.508854457516918e-08
BAC O 0 0.00013990742445457727
/ O 0 9.466288247494958e-06
P1 O 0 1.400294536324509e-06
contig O 0 6.175655926199397e-06
of O 0 6.390958873225827e-09
less O 0 1.0159116881069963e-09
than O 0 1.0337986716679737e-10
250 O 0 8.845796095613423e-09
kb O 0 3.4561107895569876e-06
. O 0 6.532163183692319e-07

Mutations O 0 4.1869647304793034e-08
in O 0 1.9482997437592076e-09
a O 0 2.831018752758041e-10
novel O 0 2.9395297307388546e-10
gene O 0 3.640491519352196e-10
( O 0 1.5336888703476603e-10
WFS1 O 0 1.755283733473334e-06
) O 0 1.0541225670124277e-09
encoding O 0 2.6642814177080254e-08
a O 0 3.276584692457618e-08
putative O 0 2.597783179680846e-07
transmembrane O 0 3.3032392376952657e-09
protein O 0 4.688502919236726e-10
were O 0 5.070376757343453e-11
found O 0 1.68816419177098e-11
in O 0 1.6945131062207075e-11
all O 0 1.9069808232519136e-11
affected O 0 1.1530805824055967e-11
individuals O 0 4.463131253462649e-13
in O 0 2.1115209580813143e-10
six O 0 3.2233979929685574e-09
WFS B-Disease 0 9.903404134092852e-06
families O 0 4.199997849507753e-10
, O 0 1.413585082321589e-10
and O 0 4.8471095193125535e-11
these O 0 1.0451312038028959e-10
mutations O 0 1.3572862278543596e-10
were O 0 5.173994011009597e-10
associated O 0 3.0794859995353363e-09
with O 0 2.4316118563127986e-10
the O 0 4.477449877526851e-08
disease O 0 8.481402247184633e-09
phenotype O 0 9.094548225618837e-09
. O 0 2.3641353763537154e-08

WFS1 O 0 3.9311678847298026e-05
appears O 0 9.23019261023228e-09
to O 0 6.139361796719811e-10
function O 0 6.888820069939072e-10
in O 0 7.997483786326143e-10
survival O 0 1.034693923429586e-05
of O 0 5.2010480366959655e-09
islet O 0 3.992380470663193e-08
beta O 0 1.560595705996093e-07
- O 0 6.820878439839362e-08
cells O 0 6.973776667251741e-09
and O 0 1.2010363814596303e-09
neurons O 0 1.8108829991092534e-08
. O 0 1.5215114501643257e-08
. O 0 1.461518195355893e-07

Stable O 0 7.1500921876577195e-06
interaction O 0 1.2536056637202364e-09
between O 0 1.849310635182455e-11
the O 0 7.130547541311927e-11
products O 0 2.2259524778966977e-10
of O 0 2.729406700652248e-10
the O 0 1.8123506029255054e-09
BRCA1 O 0 3.1532114697085944e-09
and O 0 5.727398555421814e-09
BRCA2 O 0 2.0321662574929178e-08
tumor B-Disease 0 4.433292843941672e-09
suppressor O 0 2.2448940484309787e-08
genes O 0 3.960552164006259e-10
in O 0 1.5565407851525492e-09
mitotic O 0 9.333567874136861e-08
and O 0 1.5866090663507748e-08
meiotic O 0 1.8263729089085246e-06
cells O 0 3.421071141929133e-07
. O 0 6.503923373202269e-07

BRCA1 O 0 4.965279731550254e-05
and O 0 1.0497636537820654e-07
BRCA2 O 0 2.1742624767284724e-07
account O 0 8.895432723754482e-10
for O 0 7.555328584984977e-11
most O 0 1.1224726009784192e-11
cases O 0 6.067285562849634e-12
of O 0 3.470163739693888e-11
familial O 0 2.694296730165746e-10
, O 0 6.4510355390901e-11
early O 0 5.413476777960113e-09
onset O 0 1.042848111865169e-06
breast B-Disease 0 1.2453898534658947e-06
and I-Disease 0 1.09308837181743e-06
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.22057394694275e-07
encode O 0 1.0018433860281561e-09
products O 0 2.322957826095262e-09
that O 0 4.941994036222752e-11
each O 0 6.047263818170778e-12
interact O 0 1.1722876835928986e-10
with O 0 1.1407238348359883e-10
hRAD51 O 0 1.6549342944927048e-06
. O 0 3.925854628050729e-07

Results O 0 6.012187014903247e-08
presented O 0 2.220298078725591e-08
here O 0 1.0316013820954595e-08
show O 0 2.234257578948018e-08
that O 0 6.044352240941464e-10
BRCA1 O 0 5.507438505247819e-09
and O 0 3.993985586703275e-09
BRCA2 O 0 2.600558701715272e-08
coexist O 0 2.9188147454561886e-09
in O 0 1.3926765296545796e-09
a O 0 7.578049299183931e-10
biochemical O 0 4.5667154502382346e-09
complex O 0 1.948360228709589e-08
and O 0 6.8825327659283175e-09
colocalize O 0 1.2614249271791778e-06
in O 0 1.6362648125323176e-08
subnuclear O 0 1.34938852625055e-06
foci O 0 1.6378642442305136e-07
in O 0 1.1267229371725307e-09
somatic O 0 1.5764486382963128e-09
cells O 0 2.749691030423662e-10
and O 0 5.7915238577122e-11
on O 0 4.6313637369621574e-09
the O 0 7.710434513086284e-10
axial O 0 1.586883735527067e-09
elements O 0 9.888019292247918e-09
of O 0 1.2644509439496687e-08
developing O 0 3.3406742261377076e-08
synaptonemal O 0 7.881989176894422e-07
complexes O 0 1.4384450253146497e-07
. O 0 2.1513265835437778e-07

Like O 0 1.82005953774933e-06
BRCA1 O 0 1.1329187827868736e-06
and O 0 5.263322577775398e-08
RAD51 O 0 4.529814395937137e-05
, O 0 1.0764879476710121e-07
BRCA2 O 0 1.197640386862986e-07
relocates O 0 3.102752543782117e-08
to O 0 1.4256356983821661e-08
PCNA O 0 2.0126023514421831e-07
+ O 0 6.0794116407691945e-09
replication O 0 6.732497892514289e-11
sites O 0 2.9109020749373826e-10
following O 0 1.9460295874740297e-10
exposure O 0 5.118225843148139e-09
of O 0 5.048473306068502e-10
S O 0 3.003885495900249e-08
phase O 0 1.0260754024216112e-08
cells O 0 1.0431764785323594e-08
to O 0 4.507302620027076e-08
hydroxyurea O 0 6.939069407962961e-06
or O 0 1.870695598427119e-07
UV O 0 0.00020973104983568192
irradiation O 0 4.133833044761559e-06
. O 0 4.651045344417071e-07

Thus O 0 3.470209151146264e-07
, O 0 1.5573732525808737e-08
BRCA1 O 0 1.9415121954580172e-08
and O 0 2.0873838213475437e-09
BRCA2 O 0 1.420532669271779e-08
participate O 0 4.628820438057346e-09
, O 0 1.1478191314084896e-10
together O 0 1.0459802295137433e-11
, O 0 1.878960008416808e-11
in O 0 3.4914685725917494e-11
a O 0 7.107830296559925e-11
pathway O 0 2.1118713722234617e-10
( O 0 3.6373317552351736e-11
s O 0 7.650493571986772e-09
) O 0 2.0730981167838003e-11
associated O 0 3.882733301541208e-10
with O 0 3.113393006945464e-12
the O 0 1.0095714542135426e-10
activation O 0 1.050123099588518e-09
of O 0 1.431743612556602e-10
double O 0 7.255585021681554e-11
- O 0 3.6301392447590786e-10
strand O 0 4.699703404220656e-10
break O 0 7.93240584329169e-09
repair O 0 2.0385412824452942e-07
and O 0 1.821872253060519e-08
/ O 0 3.902683602063917e-06
or O 0 1.1635654217911906e-08
homologous O 0 4.787720886412217e-09
recombination O 0 2.894410711107298e-09
. O 0 2.457561620872184e-08

Dysfunction O 1 0.9999732971191406
of O 0 9.1013680503238e-06
this O 0 2.834629642123332e-09
pathway O 0 3.250861357884105e-09
may O 0 3.33150812492633e-10
be O 0 1.8395808487614573e-10
a O 0 2.3065239995734288e-10
general O 0 1.9903905190687965e-09
phenomenon O 0 5.461991969823998e-10
in O 0 2.5312203721927773e-11
the O 0 1.1710943326193046e-10
majority O 0 5.946916136617686e-12
of O 0 3.750617871833839e-11
cases O 0 2.6100061348288683e-11
of O 0 5.490214394221482e-10
hereditary B-Disease 0 0.2903759479522705
breast I-Disease 1 1.0
and I-Disease 1 0.9999383687973022
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.2088013136235531e-05
. O 0 7.388855465251254e-07

A O 0 2.7958421355833707e-07
novel O 0 2.16987867673879e-08
Arg362Ser O 0 1.0994983767886879e-06
mutation O 0 1.1719215597949528e-09
in O 0 1.0790231902424452e-10
the O 0 2.5591154195758747e-10
sterol O 0 1.782678538120308e-08
27 O 0 1.7208906228916021e-06
- O 0 4.2331896565883653e-07
hydroxylase O 0 8.097017598629463e-06
gene O 0 1.352718381752993e-08
( O 0 3.936075076982348e-11
CYP27 O 0 2.892872998927487e-07
) O 0 2.3085826653113095e-11
: O 0 8.771655277128865e-12
its O 0 7.846082290818845e-12
effects O 0 3.211742261033379e-10
on O 0 9.104962117589821e-09
pre O 0 1.1625765239386965e-07
- O 0 5.454884099975743e-09
mRNA O 0 2.4241804119640165e-09
splicing O 0 1.052116438415851e-08
and O 0 4.091297967079299e-09
enzyme O 0 1.5025802824197854e-09
activity O 0 3.004922888294459e-08
. O 0 6.951495379325934e-08

A O 0 1.469543349230662e-07
novel O 0 8.017541297533626e-09
C O 0 1.1619989948030707e-07
to O 0 5.389099722030721e-10
A O 0 1.6690265836061258e-09
mutation O 0 6.404509561575011e-11
in O 0 5.3761606277902274e-11
the O 0 2.800369658384483e-10
sterol O 0 1.6587195617034922e-08
27 O 0 7.918197866274568e-07
- O 0 2.528356333186821e-07
hydroxylase O 0 1.7225819419763866e-06
gene O 0 5.681505044208279e-09
( O 0 5.0182205613147346e-11
CYP27 O 0 3.085861806084722e-07
) O 0 7.896530651585465e-11
was O 0 8.925395422743065e-10
identified O 0 2.729500514497829e-10
by O 0 1.1756099566051503e-11
sequencing O 0 4.667643604960858e-09
amplified O 0 2.0895843988455454e-07
CYP27 O 0 8.83226948644733e-06
gene O 0 4.985692747538906e-09
products O 0 8.862683920085601e-09
from O 0 2.18941170748721e-10
a O 0 6.950428566021571e-10
patient O 0 1.7061249080185803e-09
with O 0 1.4661942493443547e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 2.0904527886500546e-08
CTX B-Disease 0 0.000102205180155579
) O 0 1.2967890761217404e-08
. O 0 1.3944307397650846e-07

The O 0 7.897519367361383e-07
mutation O 0 1.0982848408502832e-08
changed O 0 8.351792502026001e-08
the O 0 6.165921551115616e-09
adrenodoxin O 0 2.2436789492985554e-07
cofactor O 0 2.840757851174658e-08
binding O 0 1.456907128272178e-08
residue O 0 6.051221390634964e-08
362Arg O 0 5.294172211733894e-08
to O 0 6.172004685112142e-09
362Ser O 0 2.2728258386450761e-07
( O 0 5.520455759189247e-10
CGT O 0 2.6555355248092383e-07
362Arg O 0 2.928883304775809e-07
to O 0 2.4455911074028336e-08
AGT O 0 1.565698221384082e-05
362Ser O 0 1.854764661857189e-07
) O 0 7.883889374671327e-11
, O 0 8.289533122429749e-12
and O 0 2.3060730842267008e-12
was O 0 1.086414153084192e-10
responsible O 0 6.239048860878782e-11
for O 0 2.5832730399244497e-10
deficiency O 0 1.511731824166418e-07
in O 0 1.455960614293872e-07
the O 0 5.088700731903373e-07
sterol O 0 4.5806319803887163e-07
27 O 0 5.496954145201016e-06
- O 0 9.526464594955542e-08
hydroxylase O 0 4.842418093176093e-07
activity O 0 6.069517333173735e-09
, O 0 5.4478370599408965e-12
as O 0 4.660226631675313e-12
confirmed O 0 1.5491732896499855e-11
by O 0 9.305620510269286e-13
expression O 0 5.968398553157783e-10
of O 0 1.7877775648766914e-10
mutant O 0 3.1567362612783256e-10
cDNA O 0 7.0281247488424015e-09
into O 0 1.3059524572867076e-09
COS O 0 7.554531862297154e-07
- O 0 2.138280734698128e-07
1 O 0 5.2392440608173274e-08
cells O 0 2.5077635967818424e-08
. O 0 1.362356130130138e-07

Quantitative O 0 2.2439967324316967e-06
analysis O 0 2.2191718684894113e-08
showed O 0 4.082863380716617e-09
that O 0 1.87311659238798e-11
the O 0 1.46680403934063e-10
expression O 0 1.3261438613909604e-09
of O 0 1.0204384004453004e-09
CYP27 O 0 1.4014948312990327e-08
gene O 0 5.930581980367888e-12
mRNA O 0 3.830578215735514e-11
in O 0 5.176224449066069e-10
the O 0 1.5269645547988375e-09
patient O 0 4.359768102091266e-09
represented O 0 4.2542929179489875e-09
52 O 0 3.7681485309803975e-07
. O 0 7.508234034503403e-07

5 O 0 2.750835506049043e-07
% O 0 3.2117009052257117e-09
of O 0 1.6474185349224513e-09
the O 0 1.6186637585846597e-09
normal O 0 1.0712322051631418e-07
level O 0 4.48273937081467e-07
. O 0 2.4704345946702233e-07

As O 0 2.3770079238261133e-08
the O 0 2.50384335487297e-09
mutation O 0 3.2544748146401403e-11
occurred O 0 2.7180502293333575e-10
at O 0 2.7182522899238393e-10
the O 0 4.309940945801394e-11
penultimate O 0 1.0640875958145557e-09
nucleotide O 0 1.2390342973844781e-08
of O 0 9.265117562051728e-09
exon O 0 6.120937534603854e-09
6 O 0 1.5591266944170457e-08
( O 0 3.9486774960906246e-11
- O 0 2.1854658083242384e-09
2 O 0 8.872426349171292e-09
position O 0 7.336251428569085e-08
of O 0 2.2931985199647897e-09
exon O 0 1.4628659172899461e-08
6 O 0 1.0135376982134403e-07
- O 0 1.030781717759055e-07
intron O 0 7.727106208221812e-07
6 O 0 1.0433321051550593e-07
splice O 0 4.481645277110147e-08
site O 0 1.2602036747466627e-08
) O 0 1.0625680196829634e-10
of O 0 6.384985318241831e-10
the O 0 3.623175537370571e-09
gene O 0 5.093781396681152e-09
, O 0 2.5121236202352293e-09
we O 0 6.868068336274291e-09
hypothesized O 0 9.448973159464913e-09
that O 0 3.632314171664319e-10
the O 0 1.762130774629611e-09
mutation O 0 7.664423540276744e-10
may O 0 1.0231044900166353e-09
partially O 0 6.521634787759467e-09
affect O 0 1.3169535462154158e-09
the O 0 2.5576710194208374e-10
normal O 0 1.8491776165863172e-10
splicing O 0 2.0824597601887262e-10
efficiency O 0 3.98487731700925e-09
in O 0 1.841955143966345e-09
exon O 0 2.6509905381999488e-08
6 O 0 8.14543383853561e-08
and O 0 1.7512680194897712e-09
cause O 0 3.548009108733652e-10
alternative O 0 7.543439206614266e-10
splicing O 0 4.684328480664135e-10
elsewhere O 0 3.402548465203381e-09
, O 0 6.246551192967686e-11
which O 0 1.6303487422944518e-12
resulted O 0 1.2977371781353053e-11
in O 0 8.462757404570365e-12
decreased O 0 2.582051517041606e-10
transcript O 0 1.0408703898789895e-09
in O 0 4.027490008162715e-10
the O 0 3.378800794706649e-09
patient O 0 1.9830626030170606e-08
. O 0 5.077158604649412e-08

Transfection O 0 2.8848642614320852e-05
of O 0 2.2433923163589498e-07
constructed O 0 3.742933785133573e-08
minigenes O 0 3.5218198490838404e-07
, O 0 7.425493553370188e-11
with O 0 4.4278583620840917e-13
or O 0 1.3858940904609707e-11
without O 0 7.520768452451421e-10
the O 0 1.3172751778256497e-09
mutation O 0 2.1027996011113714e-10
, O 0 5.2939822664521685e-11
into O 0 3.258432967889746e-10
COS O 0 1.164286800303671e-06
- O 0 4.799335329153109e-07
1 O 0 7.02965579080228e-08
cells O 0 5.711449091450049e-09
confirmed O 0 3.722470331979366e-09
that O 0 2.4635274722961675e-11
the O 0 1.0930759075655772e-10
mutant O 0 6.516040151893776e-09
minigene O 0 1.5520716090122733e-07
was O 0 5.049275220159188e-09
responsible O 0 6.586108325379314e-10
for O 0 2.0363663533196075e-10
a O 0 2.27466614988181e-10
mRNA O 0 3.0240043802365335e-09
species O 0 5.288815219106624e-11
alternatively O 0 3.2939573291201896e-10
spliced O 0 4.905663875121036e-09
at O 0 2.5314317753100113e-08
an O 0 1.8862618134107834e-09
activated O 0 2.092524709951249e-06
cryptic O 0 3.7914128370175604e-07
5 O 0 3.5578658241774974e-08
splice O 0 6.147639908249403e-08
site O 0 4.235996087231797e-08
88 O 0 5.548668013943825e-08
bp O 0 9.897962449656461e-09
upstream O 0 8.098394732591885e-10
from O 0 1.8812737478945962e-10
the O 0 1.1946506006665913e-09
3 O 0 9.395024314073908e-09
end O 0 9.90637119002713e-08
of O 0 7.458972106633155e-09
exon O 0 5.667751068472171e-08
6 O 0 4.0875411855267885e-07
. O 0 4.390329308989749e-07

Our O 0 5.282678330331692e-07
data O 0 2.359729300849267e-08
suggest O 0 6.587189127493787e-10
that O 0 4.108746329278823e-12
the O 0 4.410835932611157e-11
C O 0 9.051423610628717e-09
to O 0 3.934613190814673e-10
A O 0 2.0973089931430877e-09
mutation O 0 2.710438644359936e-11
at O 0 3.0925634275646985e-10
the O 0 9.538687895105369e-11
penultimate O 0 9.171783887929053e-10
nucleotide O 0 1.5673671249771814e-09
of O 0 1.8060115625218032e-09
exon O 0 3.2774956082448625e-09
6 O 0 4.166919964632143e-08
of O 0 1.3206998161763295e-08
the O 0 8.886127389473586e-09
CYP27 O 0 1.2208115549583454e-06
gene O 0 2.3322366260458693e-09
not O 0 1.2776627533739315e-09
only O 0 1.9608473178500674e-10
causes O 0 2.1965392005274254e-10
the O 0 8.18220602383235e-10
deficiency B-Disease 0 2.2725435755432954e-08
in I-Disease 0 1.4055586028405287e-08
the I-Disease 0 9.716432458617419e-08
sterol I-Disease 0 6.388469273588271e-07
27 I-Disease 0 1.2870509635831695e-05
- I-Disease 0 3.89540730338922e-07
hydroxylase I-Disease 0 1.1472598089312669e-06
activity I-Disease 0 3.7562930543799666e-08
, O 0 1.6130713084705484e-11
but O 0 7.438645185930959e-12
also O 0 3.476052778950134e-11
partially O 0 1.679613115257439e-09
leads O 0 5.8189397744712323e-11
to O 0 2.323558186134722e-11
alternative O 0 4.8842063726795e-10
pre O 0 5.181620910121865e-09
- O 0 1.803621696438995e-10
mRNA O 0 2.544271182625124e-10
splicing O 0 6.753082537613864e-09
of O 0 7.467727769494559e-09
the O 0 6.852183709327164e-09
gene O 0 1.09149986826651e-08
. O 0 2.5774835421543685e-07

To O 0 1.9105485193904315e-07
our O 0 2.4887036431664455e-08
knowledge O 0 1.0593677046699668e-08
, O 0 1.3256417664975206e-11
this O 0 1.2692276700129734e-12
is O 0 5.256006133796953e-13
the O 0 4.314182691644852e-12
first O 0 1.3280061772480423e-10
report O 0 1.8095830389697198e-10
regarding O 0 7.466527396360334e-10
effects O 0 6.0082863129196085e-09
on O 0 8.603683099295267e-09
pre O 0 5.822275994660231e-09
- O 0 9.999224365175863e-11
mRNA O 0 9.724836214086707e-11
splicing O 0 2.026452339265461e-09
of O 0 6.029820531772145e-10
a O 0 2.7653751510925417e-10
mutation O 0 4.2707601344282864e-11
at O 0 3.9206868307495313e-10
the O 0 1.98816213492492e-10
- O 0 1.6902602650858967e-09
2 O 0 4.1800842787154124e-09
position O 0 1.4606807496875263e-07
of O 0 8.446353838564846e-09
a O 0 7.738431229142861e-09
5 O 0 8.433028853005453e-08
splice O 0 8.652322094349074e-07
site O 0 1.0238213690172415e-06
. O 0 3.580959457849531e-07

ATM O 0 0.00013362805475480855
germline O 0 0.0001045591343427077
mutations O 0 2.7406461100554225e-08
in O 0 7.223777576115253e-09
classical O 1 0.997329831123352
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 1.0
in O 0 9.270048728637903e-09
the O 0 1.3785506070007614e-09
Dutch O 0 9.621970775697264e-08
population O 0 6.405499047845709e-11
. O 0 2.5923465596378037e-09

Germline O 0 3.58919205609709e-05
mutations O 0 8.67298233231395e-09
in O 0 3.6972231942655753e-09
the O 0 2.5289548233331516e-09
ATM O 0 3.146232074868749e-08
gene O 0 1.2331248522290394e-10
are O 0 1.3842820119347454e-12
responsible O 0 7.198102357219849e-12
for O 0 8.76771225066797e-11
the O 0 7.66353405197151e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.8797728671415825e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.8274387275928348e-08
. O 0 1.5758608640226157e-07

In O 0 1.4968314587804343e-08
our O 0 1.1576814173963612e-08
study O 0 2.1311608033869334e-10
, O 0 3.0422578518873866e-12
we O 0 2.2747168731962475e-11
have O 0 1.877676399780759e-12
determined O 0 1.485175871174249e-10
the O 0 6.890528148062458e-10
ATM O 0 3.65564733328938e-06
mutation O 0 1.4156039673807186e-09
spectrum O 0 2.622407568875218e-10
in O 0 3.020064406888956e-11
19 O 0 7.767974041783532e-10
classical O 0 2.5464640884820255e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.427345138921737e-08
, O 0 8.971007096902905e-12
including O 0 1.456243003787605e-12
some O 0 1.4245563279349782e-12
immigrant O 0 4.8856665241236996e-11
populations O 0 2.6505922456898645e-11
, O 0 6.229699481968831e-12
as O 0 4.457878163832696e-11
well O 0 1.0478657525014867e-10
as O 0 2.321039055397378e-10
12 O 0 2.1684460893567348e-09
of O 0 2.157360123877794e-10
Dutch O 0 2.50731400086579e-08
ethnic O 0 1.393879595079639e-10
origin O 0 9.516491594752097e-09
. O 0 7.239960808647083e-08

Both O 0 1.4588814600813294e-08
the O 0 2.6338631275990565e-09
protein O 0 1.163444410257064e-10
truncation O 0 8.780205007496988e-09
test O 0 3.4244764801627525e-09
( O 0 6.938957741731144e-10
PTT O 0 4.196609097562032e-06
) O 0 2.0509798026591142e-10
and O 0 8.454920097378249e-11
the O 0 1.6409168468456414e-10
restriction O 0 9.782965548765787e-09
endonuclease O 0 6.293138454793734e-08
fingerprinting O 0 9.69775157955155e-08
( O 0 4.2318570869781524e-10
REF O 0 1.4164412220907252e-07
) O 0 2.0543067247302815e-11
method O 0 3.540593096484912e-10
were O 0 4.911097917226215e-11
used O 0 6.04960942451882e-11
and O 0 3.5223358518104986e-12
compared O 0 3.2095055779723936e-11
for O 0 2.900226760138569e-11
their O 0 6.871703900346304e-11
detection O 0 2.128253351330045e-09
efficiency O 0 1.1452698789327087e-09
, O 0 1.1576250374956132e-10
identifying O 0 2.9858677752514495e-09
76 O 0 6.7000307524267555e-09
% O 0 4.557939095595209e-11
and O 0 7.911225494150464e-12
60 O 0 4.5731982090124745e-10
% O 0 6.174977890127664e-11
of O 0 2.6727789426139736e-10
the O 0 5.958866733379864e-10
mutations O 0 8.03426936091256e-10
, O 0 8.913316751346656e-10
respectively O 0 8.358772873862108e-08
. O 0 6.819010991421237e-07

Most O 0 3.285872551828106e-08
patients O 0 1.6222242438246326e-09
were O 0 1.8335452600659607e-10
found O 0 4.404513559430612e-11
to O 0 3.699154038638852e-10
be O 0 1.5948458109704688e-09
compound O 0 2.868937372113578e-07
heterozygote O 0 3.1502638648817083e-06
. O 0 4.0625718611408956e-07

Seventeen O 0 5.60499711355078e-06
mutations O 0 5.691418003550552e-09
were O 0 7.775118882058507e-10
distinct O 0 1.9937483608511997e-10
, O 0 1.795462944986781e-10
of O 0 1.8054389927524284e-10
which O 0 5.646364886063848e-12
10 O 0 1.7597719115247656e-10
were O 0 8.288193742433947e-11
not O 0 1.2591314657584007e-09
reported O 0 1.790139814161762e-09
previously O 0 6.862008916641571e-08
. O 0 4.419019319357176e-07

Mutations O 0 1.0369928986619925e-06
are O 0 6.57840359963302e-09
small O 0 3.874043308371711e-09
deletions O 0 6.17688328929944e-07
or O 0 5.916120926485746e-07
point O 0 1.0598490916891024e-05
mutations O 0 8.683529983954941e-08
frequently O 0 2.717047387079674e-08
affecting O 0 1.4265441272698354e-08
splice O 0 4.342107047250465e-07
sites O 0 5.982160473649856e-07
. O 0 3.033173641142639e-07

Moreover O 0 6.633327416238899e-07
, O 0 4.011461385289294e-09
a O 0 6.971768495844799e-09
16 O 0 9.738530337699558e-08
. O 0 2.2127923671177996e-07

7 O 0 3.802830178756267e-06
- O 0 6.178237867970893e-07
kb O 0 5.094501830171794e-06
genomic O 0 2.773942071598867e-07
deletion O 0 3.522739433492461e-08
of O 0 2.4432864620393957e-09
the O 0 8.266063389328338e-10
3 O 0 5.16732967525968e-09
end O 0 5.8809746406041086e-08
of O 0 1.92803417675691e-09
the O 0 3.6263883562703825e-10
gene O 0 9.54027065680485e-11
, O 0 2.3338938420769395e-11
most O 0 1.0569703966234467e-11
likely O 0 1.1199668276118402e-10
a O 0 5.069003897184565e-11
result O 0 9.607433598679549e-11
of O 0 2.072794574869974e-10
recombination O 0 1.1019761492203628e-11
between O 0 2.26169499795148e-11
two O 0 7.901020115941293e-11
LINE O 0 9.282695168089106e-10
elements O 0 5.937220159957235e-10
, O 0 1.8887665043099133e-10
was O 0 4.638170736370739e-09
identified O 0 1.2893309531136765e-08
. O 0 6.23204101657393e-08

The O 0 1.1630744012336436e-07
most O 0 8.485960267812231e-10
frequently O 0 4.4152151379428517e-10
found O 0 2.1875947234240023e-11
mutation O 0 2.6582827952759125e-11
, O 0 5.9879362752923715e-12
identified O 0 1.2286360817626019e-10
in O 0 1.2634925050658552e-10
three O 0 2.6450468551542095e-11
unrelated O 0 2.0997936722721988e-10
Turkish O 0 6.879057679043399e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 8.849702221036537e-11
, O 0 1.3891546767064167e-11
was O 0 5.679053893814512e-10
previously O 0 6.462221313618954e-10
described O 0 2.2841253194405553e-11
to O 0 1.650993404489487e-11
be O 0 1.5031463920789356e-11
a O 0 4.264964423295048e-11
Turkish O 0 2.908346452556998e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 1.6096602848847397e-05
mutation O 0 9.761590291645916e-08
. O 0 3.0561579933419125e-08

The O 0 1.580332167350207e-07
presence O 0 3.410880466958588e-08
of O 0 3.50988251796025e-08
a O 0 2.2767693508285447e-08
founder O 0 1.7992276752920588e-06
mutation O 0 3.0050701926853662e-09
among O 0 7.904814823544992e-12
relatively O 0 2.9726075767566584e-11
small O 0 7.974125700027646e-12
ethnic O 0 7.612168274190312e-13
population O 0 1.4319272221945123e-13
groups O 0 6.371517354518408e-14
in O 0 1.2707924990085218e-12
Western O 0 4.511409301688474e-10
Europe O 0 6.93649637728555e-10
could O 0 1.7396690754623023e-09
indicate O 0 3.439138751559767e-09
a O 0 2.62151272911737e-10
high O 0 2.5801116798618295e-10
carrier O 0 9.342941698076146e-11
frequency O 0 3.4325984277217003e-09
in O 0 1.8052460915018997e-10
such O 0 3.11824566168184e-10
communities O 0 2.5756632382467615e-09
. O 0 7.648366562307274e-08

In O 0 1.7692512344069655e-08
patients O 0 3.6910507983378693e-09
of O 0 1.639740565551051e-10
Dutch O 0 3.0835781927862627e-08
ethnic O 0 1.0089535457113996e-10
origin O 0 1.846204078503888e-09
, O 0 1.1326413418277781e-10
however O 0 4.1969869246649694e-10
, O 0 1.9387938476889133e-10
no O 0 2.579866986707202e-09
significant O 0 4.456615965153787e-09
founder O 0 1.606940429610404e-07
effect O 0 4.249315921356356e-08
could O 0 5.580633732904516e-09
be O 0 7.072446628342277e-09
identified O 0 6.378697747777551e-08
. O 0 3.4568353157737874e-07

The O 0 3.6823934124186053e-07
observed O 0 5.257021840066045e-08
genetic O 0 4.386850882553972e-10
heterogeneity O 0 4.205817638602838e-10
including O 0 1.1611272707212628e-11
the O 0 2.2340977678947382e-10
relative O 0 1.8111806809884e-07
high O 0 6.023361152074358e-07
percentage O 0 4.004662059742259e-06
of O 0 9.920609755909027e-08
splice O 0 9.172647423838498e-07
- O 0 7.478291763618472e-07
site O 0 3.463438247308659e-07
mutations O 0 4.361722982793026e-09
had O 0 6.082961245823526e-09
no O 0 4.555762433966493e-09
reflection O 0 7.684627156834267e-09
on O 0 4.840889999968567e-08
the O 0 1.3155056599600812e-08
phenotype O 0 9.503851572389976e-08
. O 0 1.9977116494374059e-07

All O 0 8.8921288110555e-09
patients O 0 1.2916383240746399e-10
manifested O 0 5.844991157744062e-11
classical O 0 1.99126848343667e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 1.732659526965108e-08
increased O 0 1.4153434335639759e-07
cellular O 0 4.606118153560601e-08
radioresistant O 0 2.544371398016665e-07
DNA O 0 5.811015668655273e-09
synthesis O 0 3.59428923957239e-07
. O 0 5.117603905091528e-07

Determination O 0 1.8638926349012763e-06
of O 0 2.792399413920066e-07
the O 0 1.1980031189295914e-08
genomic O 0 1.2342414201782503e-08
structure O 0 4.687199073316606e-09
of O 0 6.377880445995743e-09
the O 0 4.029912403780145e-09
COL4A4 O 0 1.0261302350045298e-06
gene O 0 3.582781404887214e-09
and O 0 1.0846279430154482e-09
of O 0 8.71127880941458e-09
novel O 0 5.897295523027424e-07
mutations O 0 7.441195066348882e-06
causing O 0 2.859638470908976e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00034719693940132856

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 4.382180662787505e-08
a O 0 1.6679264192021037e-08
progressive O 0 0.00025405874475836754
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 9.825933375395834e-06
by O 0 5.670462321916148e-09
glomerular B-Disease 1 0.997787594795227
basement I-Disease 1 1.0
membrane I-Disease 1 0.9999545812606812
abnormalities I-Disease 0 9.386290003021713e-06
and O 0 1.3149424604730342e-10
associated O 0 4.471900183489197e-09
with O 0 3.099145939877701e-11
mutations O 0 6.351724701758599e-11
in O 0 1.7269401186847944e-10
either O 0 8.585515631764906e-10
the O 0 9.637689757369117e-09
COL4A3 O 0 4.138701115152799e-06
or O 0 7.4216215395495055e-09
the O 0 1.6043166795043362e-08
COL4A4 O 0 1.7943954162547016e-06
gene O 0 2.6628117488769476e-09
, O 0 2.8049509936955985e-10
which O 0 1.4553663829630636e-11
encode O 0 4.641248219083849e-10
the O 0 3.214262633832732e-09
alpha3 O 0 2.1094838302815333e-06
and O 0 1.2780437153026014e-08
alpha4 O 0 4.902828368358314e-05
type O 0 8.002715730981436e-06
IV O 1 0.9999961853027344
collagen O 0 2.4092934836517088e-05
chains O 0 1.4066537914914079e-05
, O 0 5.04950659063752e-09
respectively O 0 4.5483758981390565e-08
. O 0 5.322156582110438e-08

To O 0 2.8156097897635846e-08
date O 0 2.1731555932547053e-07
, O 0 5.418081538977049e-10
mutation O 0 8.011858537715355e-12
screening O 0 1.3273578070016612e-10
in O 0 1.4327332653607527e-09
the O 0 5.6025001526904816e-08
two O 0 2.4433144396596163e-09
genes O 0 1.0307079634230831e-09
has O 0 1.626424411815819e-10
been O 0 1.2254157411017985e-10
hampered O 0 4.2766151731044033e-10
by O 0 2.392738611411982e-11
the O 0 6.526911455750906e-09
lack O 0 4.189225322193124e-08
of O 0 1.3208402149800236e-09
genomic O 0 9.706996317859762e-10
structure O 0 3.6771921618772296e-10
information O 0 2.7737123708959643e-09
. O 0 1.8874793283885083e-08

We O 0 1.1005919020590227e-07
report O 0 2.068794469067825e-09
here O 0 4.3756279155537925e-10
the O 0 1.2749162836556138e-10
complete O 0 4.74586869803062e-10
characterization O 0 4.44034808921856e-10
of O 0 3.2882763179031826e-10
the O 0 7.856992279009489e-10
48 O 0 3.124190328662735e-08
exons O 0 1.4472521847608277e-08
of O 0 5.1071284978831955e-09
the O 0 9.622206142978484e-09
COL4A4 O 0 1.0557494533713907e-05
gene O 0 2.121130293630813e-08
, O 0 1.2401212279300466e-09
a O 0 9.875649187307545e-10
comprehensive O 0 9.068634732045666e-09
gene O 0 1.7399202911771994e-10
screen O 0 5.667402547260281e-09
, O 0 1.5142322951078313e-09
and O 0 5.028925609273927e-10
the O 0 5.286537874127362e-10
subsequent O 0 3.7561387333795437e-10
detection O 0 5.672582847893182e-09
of O 0 5.9782165329203e-11
10 O 0 1.1447647690898677e-10
novel O 0 1.581613034984386e-10
mutations O 0 8.853112687390308e-11
in O 0 1.8133904100547937e-10
eight O 0 1.2362952883648859e-09
patients O 0 1.2351238920516039e-09
diagnosed O 0 5.12905664606933e-08
with O 0 1.2212589162174936e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.420752884470858e-05

Furthermore O 0 8.731225307201385e-07
, O 0 5.181225226635888e-09
we O 0 4.325799274340625e-09
identified O 0 1.7526983198123958e-09
a O 0 6.921799799997075e-10
glycine O 0 1.2203088317619404e-08
to O 0 1.4711988960414146e-08
alanine O 0 6.740139468774942e-08
substitution O 0 3.7731788893324847e-07
in O 0 1.5491082194785122e-07
the O 0 1.2127624415825267e-07
collagenous O 0 2.4494102035532705e-07
domain O 0 4.262285191458659e-09
that O 0 9.73892060746051e-12
is O 0 1.318057316936072e-12
apparently O 0 3.4140513333058564e-11
silent O 0 6.256570261875538e-10
in O 0 2.5774410383760937e-10
the O 0 8.06205380232683e-10
heterozygous O 0 1.2530025628176844e-10
carriers O 0 4.462497385504527e-11
, O 0 2.8199480944790523e-11
in O 0 1.880161720757556e-10
11 O 0 2.1695724328196775e-08
. O 0 7.281076364051842e-08

5 O 0 3.621923667651572e-07
% O 0 7.813448554827573e-09
of O 0 4.98292607176154e-09
all O 0 5.825105398038488e-10
control O 0 2.9794731126742136e-09
individuals O 0 3.294873054948688e-11
, O 0 3.240618537403428e-11
and O 0 4.019115942832663e-11
in O 0 3.453901609162813e-10
one O 0 2.0277658718814706e-10
control O 0 1.409810712615922e-09
individual O 0 4.980320045255837e-10
homozygous O 0 2.1347743572874833e-09
for O 0 1.205934796466579e-09
this O 0 9.775946718804107e-10
glycine O 0 4.292587973964146e-08
substitution O 0 1.5606030956405448e-07
. O 0 3.428043839903694e-07

There O 0 1.4344203691507573e-07
has O 0 7.113896693944355e-10
been O 0 1.029968541010895e-10
no O 0 1.7938849017351544e-10
previous O 0 4.448112989052788e-10
finding O 0 1.901512947100059e-09
of O 0 1.6850905115717296e-09
a O 0 3.7150632570259745e-10
glycine O 0 6.55894627499265e-09
substitution O 0 1.2721075393073988e-07
that O 0 1.9331674039335667e-09
is O 0 8.834338122154506e-11
not O 0 9.501010395096543e-11
associated O 0 3.1677857559309075e-10
with O 0 8.117283754882632e-12
any O 0 8.862882094895497e-10
obvious O 0 7.753871322790928e-09
phenotype O 0 3.3160347800986756e-09
in O 0 1.2707800367550703e-09
homozygous O 0 6.5089600376211365e-09
individuals O 0 1.3311812763205921e-10
. O 0 3.092648981350976e-08

Founder O 0 9.242183296009898e-05
BRCA1 O 0 2.2487781734525925e-06
and O 0 2.5901437439301844e-08
BRCA2 O 0 6.36342250004418e-08
mutations O 0 2.929969045162295e-10
in O 0 6.048377354517243e-10
French O 0 2.4193411718442803e-07
Canadian O 0 0.00016904011135920882
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.3765813378086023e-07
. O 0 3.070792615744722e-07

We O 0 1.0449572585002898e-07
have O 0 5.160560312411633e-10
identified O 0 4.828215049990092e-10
four O 0 2.785765888801972e-11
mutations O 0 5.555010444691089e-12
in O 0 1.3303556173349662e-11
each O 0 1.6730153720723173e-11
of O 0 5.694803517641844e-10
the O 0 1.4714282770000864e-07
breast B-Disease 0 0.0008588866330683231
cancer I-Disease 0 2.3020598746370524e-05
- O 0 9.901543307933025e-06
susceptibility O 0 7.392992529275944e-07
genes O 0 6.117345208167535e-08
, O 0 5.4027520235422344e-08
BRCA1 O 0 3.6472297182399416e-08
and O 0 9.69863567235052e-09
BRCA2 O 0 9.938730727299117e-09
, O 0 1.343568034606335e-10
in O 0 1.2118463177390737e-10
French O 0 2.8370866544946693e-08
Canadian O 0 4.39154376863371e-07
breast B-Disease 0 9.533914635539986e-07
cancer I-Disease 0 1.9158635211624642e-07
and O 0 1.6111400782392593e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.965047005114684e-07
from O 0 6.8181957857404996e-09
Quebec O 0 5.436201035990962e-07
. O 0 2.9920266797489603e-07

To O 0 7.403251629511942e-07
identify O 0 4.0511005749976903e-07
founder O 0 8.561842150811572e-07
effects O 0 2.4479570129187778e-05
, O 0 8.696620312775849e-09
we O 0 2.638822493850057e-08
examined O 0 1.2296453633098281e-08
independently O 0 2.418408762139279e-08
ascertained O 0 1.157283918473695e-06
French O 0 2.664932594598213e-07
Canadian O 0 1.3834196010975575e-07
cancer B-Disease 0 3.99314004084772e-09
families O 0 2.2391719554926137e-12
for O 0 3.2715447104841866e-12
the O 0 4.913512739040948e-12
distribution O 0 3.544665602706054e-11
of O 0 1.282359357590579e-10
these O 0 5.746193521005694e-10
eight O 0 5.246681311632528e-09
mutations O 0 7.68251684490906e-09
. O 0 2.9268448997754604e-07

Mutations O 0 9.40713107411284e-08
were O 0 3.736334353021675e-09
found O 0 1.1667912469537356e-10
in O 0 9.634298914207307e-11
41 O 0 1.2721337760979168e-08
of O 0 4.722294999481846e-09
97 O 0 8.572937417739013e-07
families O 0 9.02816399417361e-09
. O 0 1.4085702559896163e-07

Six O 0 7.022284194135864e-07
of O 0 1.515648939687253e-08
eight O 0 1.8100567711343274e-09
mutations O 0 4.445091517091271e-11
were O 0 8.030990872320842e-10
observed O 0 1.1890334272735004e-09
at O 0 1.2736682819536327e-08
least O 0 4.179613544152971e-09
twice O 0 4.8956739107097746e-08
. O 0 3.1467999406231684e-07

The O 0 3.4893052998086205e-06
BRCA1 O 0 1.490309955443081e-06
C4446T O 0 1.34555136810377e-06
mutation O 0 3.4623854894277883e-09
was O 0 4.7756727461489845e-09
the O 0 1.239889413362505e-09
most O 0 1.2365683477177924e-10
common O 0 1.2096754153922973e-10
mutation O 0 7.973628007862388e-11
found O 0 1.201516316995388e-11
, O 0 6.645130192634019e-12
followed O 0 9.621260732561865e-11
by O 0 3.6564046929088434e-11
the O 0 2.4623192373951497e-08
BRCA2 O 0 3.557045715751883e-07
8765delAG O 0 1.0325640005248715e-06
mutation O 0 2.7986532202817216e-08
. O 0 1.0090010960084328e-07

Together O 0 6.040462352530085e-08
, O 0 1.588046250056152e-09
these O 0 5.888182996738323e-11
mutations O 0 3.7678114100936355e-11
were O 0 5.164240562960387e-11
found O 0 1.1231236426989533e-11
in O 0 1.6707545069660767e-11
28 O 0 2.2505961538854535e-08
of O 0 2.502640095158881e-09
41 O 0 5.022026794421208e-09
families O 0 1.5006941869732948e-11
identified O 0 4.5224021749668e-10
to O 0 2.443137470109491e-09
have O 0 6.637210780979785e-09
a O 0 2.1288229845595197e-08
mutation O 0 1.731400800508709e-08
. O 0 1.5501973393838853e-07

The O 0 5.501173063748865e-07
odds O 0 1.6172239156730939e-06
of O 0 8.33938962330194e-09
detection O 0 6.686348541506959e-08
of O 0 3.515233881756785e-09
any O 0 4.4014778488588036e-09
of O 0 2.3186297326560634e-08
the O 0 4.567693778767534e-08
four O 0 3.3344548455715994e-08
BRCA1 O 0 2.0280348067558407e-08
mutations O 0 1.7782563199730816e-09
was O 0 5.5228209561164476e-08
18 O 0 3.994811095253681e-07
. O 0 7.380038482551754e-07

7x O 0 0.0003567251842468977
greater O 0 1.8696412098506698e-06
if O 0 2.5263670266895133e-08
one O 0 1.869170374035889e-10
or O 0 1.896809098678176e-11
more O 0 1.7812135230318993e-12
cases O 0 3.221378719331369e-11
of O 0 5.899902788542022e-09
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 6.198410460456216e-07
also O 0 4.1112904747286905e-10
present O 0 2.6523975724113136e-11
in O 0 5.432920779924189e-10
the O 0 1.127998583427825e-08
family O 0 3.39474510724358e-08
. O 0 2.2325328075112338e-07

The O 0 4.656224348309479e-07
odds O 0 4.6791535623924574e-07
of O 0 4.566750533285813e-09
detection O 0 2.2016166667526704e-08
of O 0 1.1029404056728254e-09
any O 0 2.1111032921794504e-09
of O 0 1.0708150810501138e-08
the O 0 3.6472297182399416e-08
four O 0 3.3781709873892396e-08
BRCA2 O 0 8.383249650023572e-08
mutations O 0 3.3257829823440943e-09
was O 0 6.271665853319064e-08
5 O 0 7.387573077721754e-07
. O 0 5.837713388245902e-07

3x O 0 0.0004028537077829242
greater O 0 2.830809364695597e-07
if O 0 6.422706366748798e-09
there O 0 1.4316671459457808e-10
were O 0 1.7674044172633074e-10
at O 0 2.4297802658779233e-10
least O 0 3.3116700354218764e-11
five O 0 3.838599577088431e-12
cases O 0 2.9869908629853725e-12
of O 0 7.034675619799202e-11
breast B-Disease 0 1.357833934179098e-08
cancer I-Disease 0 8.139156904007905e-09
in O 0 1.7359178983156198e-08
the O 0 1.3104165645927424e-06
family O 0 5.998653591632319e-07
. O 0 3.5084417504549492e-06

Interestingly O 0 6.298891008782448e-08
, O 0 1.3826209621647934e-10
the O 0 7.989139905184572e-11
presence O 0 2.4619034588724276e-10
of O 0 2.609162663702591e-09
a O 0 1.406863958663962e-07
breast B-Disease 0 3.8573412894038484e-05
cancer I-Disease 0 4.6796532870985175e-08
case O 0 8.683008201337827e-10
< O 0 1.7418072673081042e-07
36 O 0 2.0735676287131355e-08
years O 0 3.5254128505357585e-09
of O 0 6.945896080523539e-10
age O 0 5.002884218008319e-10
was O 0 1.8288728309556745e-09
strongly O 0 1.271288352366895e-10
predictive O 0 2.249255892650126e-09
of O 0 3.1226560226471634e-10
the O 0 2.183931369081904e-10
presence O 0 6.879156133621223e-10
of O 0 2.6813776199396955e-10
any O 0 4.2657963272851873e-10
of O 0 4.3099759872156085e-10
the O 0 1.1990747283974201e-09
eight O 0 9.154481617201782e-10
mutations O 0 1.0753167800636731e-10
screened O 0 3.2190619947414234e-08
. O 0 5.064314905212086e-07

Carriers O 0 1.5299738365115445e-08
of O 0 8.548232344196549e-09
the O 0 2.574047419656722e-09
same O 0 1.8727113193506284e-09
mutation O 0 1.2335835131160877e-10
, O 0 5.64787322812621e-12
from O 0 1.789375722247022e-12
different O 0 2.0699754844227813e-12
families O 0 6.933697973415809e-12
, O 0 1.0207547480878265e-11
shared O 0 6.077713332608425e-11
similar O 0 4.874162531920412e-11
haplotypes O 0 1.863575294080988e-09
, O 0 1.4387296909390557e-10
indicating O 0 3.427913730646992e-09
that O 0 1.2790520032002206e-10
the O 0 3.218377231384295e-10
mutant O 0 1.934303384132363e-09
alleles O 0 8.250308075608004e-11
were O 0 7.185965711364872e-11
likely O 0 9.359707453526767e-11
to O 0 6.844652622461922e-11
be O 0 6.202836161373071e-11
identical O 0 2.484147262893366e-11
by O 0 2.3425404411386852e-12
descent O 0 5.664427260576588e-10
for O 0 4.704330813787294e-10
a O 0 3.8709613292553513e-10
mutation O 0 6.623394194216203e-11
in O 0 8.431295939193006e-11
the O 0 9.910559040093858e-10
founder O 0 6.337840829928609e-08
population O 0 1.6075497877299227e-10
. O 0 8.024808373363612e-09

The O 0 3.039549412164888e-08
identification O 0 5.196886121439093e-08
of O 0 1.789078929448351e-08
common O 0 7.581352434726796e-08
BRCA1 O 0 2.2980891856150265e-07
and O 0 5.9559976506307066e-08
BRCA2 O 0 8.275284102410296e-08
mutations O 0 3.403637094390177e-10
will O 0 4.700940192670089e-10
facilitate O 0 6.061650736910451e-09
carrier O 0 4.154805111067361e-10
detection O 0 1.347274913854335e-08
in O 0 1.0664730210052653e-09
French O 0 2.2839725488665863e-07
Canadian O 0 1.4224381175154122e-06
breast B-Disease 0 3.1723652682558168e-06
cancer I-Disease 0 7.689614562877978e-07
and O 0 1.229703798344417e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.459020834066905e-06
. O 0 1.2308159966778476e-06

Are O 0 6.392814100308897e-08
Dp71 O 0 9.950616004061885e-06
and O 0 2.828835654611339e-08
Dp140 O 0 1.7445900084567256e-05
brain O 0 3.304531219328055e-06
dystrophin O 0 1.3309055475474452e-06
isoforms O 0 8.876052959294611e-08
related O 0 2.687811573309773e-08
to O 0 9.977363824020813e-09
cognitive B-Disease 0 2.341152594453888e-06
impairment I-Disease 0 1.4642788300989196e-05
in O 0 3.0293194868136197e-06
Duchenne B-Disease 1 1.0
muscular I-Disease 1 0.9999531507492065
dystrophy I-Disease 1 1.0
? O 1 0.9998229146003723

Molecular O 0 2.477007683410193e-06
study O 0 3.2928110016428036e-08
and O 0 9.059571426384139e-10
neuropsychological O 0 3.53135014563577e-08
analysis O 0 2.820897737620953e-09
were O 0 1.5743752967978253e-09
performed O 0 1.4470307174718755e-09
concurrently O 0 2.5160891148345854e-09
on O 0 7.3403074729583295e-09
49 O 0 1.3175572632917465e-08
patients O 0 1.743868272008342e-09
with O 0 7.939728319250605e-10
Duchenne B-Disease 1 0.9999737739562988
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 0 1.1984921002294868e-06
DMD B-Disease 1 1.0
) O 0 1.1037358804699693e-09
in O 0 2.0570445347090072e-10
order O 0 1.7639321947537923e-10
to O 0 1.7328329049437485e-10
find O 0 3.6063507735661915e-10
a O 0 3.5189597763496394e-11
molecular O 0 1.7369924942833848e-10
explanation O 0 1.4941609061125405e-09
for O 0 4.932175223792967e-10
the O 0 3.90129395455574e-09
cognitive B-Disease 0 1.150409616457182e-06
impairment I-Disease 0 9.414005575081319e-08
observed O 0 2.498157014585445e-09
in O 0 9.081542740041471e-10
most O 0 3.969182760243939e-09
DMD B-Disease 1 1.0
patients O 0 1.1208146588614909e-07
. O 0 3.158618611109887e-08

Complete O 0 9.599130379456255e-08
analysis O 0 6.086988690867656e-09
of O 0 1.0012893847388682e-09
the O 0 2.178557112486601e-09
dystrophin O 0 4.181386259460851e-08
gene O 0 3.5589637903399307e-09
was O 0 1.1994985449348405e-08
performed O 0 5.821209736467381e-09
to O 0 5.664301028218688e-09
define O 0 4.736116565595694e-08
the O 0 1.945215188925431e-08
localization O 0 2.2106372853158973e-05
of O 0 1.6870120589373983e-07
deletions O 0 7.618388764285555e-08
and O 0 3.484500021855297e-09
duplications O 0 1.5734544334122802e-08
in O 0 1.4316079433029927e-09
relation O 0 2.1396580063282045e-09
to O 0 3.294430062084075e-09
the O 0 3.669430759245529e-09
different O 0 9.94396387454799e-09
DMD B-Disease 1 1.0
promoters O 0 8.50076958158752e-06
. O 0 1.9420215267018648e-06

Qualitative O 0 7.889028097451956e-07
analysis O 0 1.7660886086900973e-08
of O 0 7.347380925892821e-09
the O 0 7.327046969152207e-09
Dp71 O 0 1.6949800283327932e-06
transcript O 0 1.0813671735832031e-07
and O 0 3.273695203809268e-10
testing O 0 2.55391735537458e-10
for O 0 5.075979567226163e-11
the O 0 1.9566255560210521e-10
specific O 0 8.377104010470759e-10
first O 0 8.299085862972788e-09
exon O 0 1.5458901714282547e-08
of O 0 9.4922540938569e-09
Dp140 O 0 2.1443457853820291e-07
were O 0 6.1093321512828425e-09
also O 0 1.3010992283568612e-09
carried O 0 1.5769989758496195e-09
out O 0 6.920070627636221e-10
. O 0 1.760841428222193e-08

Neuropsychological O 0 7.674957487324718e-06
analysis O 0 8.263439355005175e-08
assessed O 0 1.8465682671831019e-07
verbal O 0 1.1977238045801641e-07
and O 0 1.425070195182343e-08
visuospatial O 0 2.8738422770402394e-05
intelligence O 0 2.7220587526244344e-06
, O 0 1.2122636228184547e-08
verbal O 0 6.753806047754551e-08
memory O 0 3.22656960634049e-05
, O 0 9.021949409770968e-09
and O 0 1.8353656372482874e-09
reading O 0 2.4124753394971776e-07
skills O 0 2.348981251998339e-05
. O 0 1.3815674719808158e-06

Comparison O 0 2.38300594901375e-06
of O 0 1.2895971224224922e-07
molecular O 0 8.549279328917692e-08
and O 0 9.05031871667461e-09
psychometric O 0 1.0051869139715564e-05
findings O 0 5.418106638899189e-07
demonstrated O 0 7.962580639286898e-07
that O 0 6.887719727899366e-09
deletions O 0 9.223685282222505e-08
and O 0 3.779446533513919e-09
duplications O 0 1.6478216124937717e-08
that O 0 1.4420320493258032e-10
were O 0 6.585904044342783e-11
localized O 0 2.0110110798832181e-10
in O 0 1.0983906145733968e-10
the O 0 4.169507517026716e-10
distal O 0 6.414748732197495e-09
part O 0 4.292825650509258e-08
of O 0 6.759940447409463e-07
the O 0 1.2014864125831082e-07
gene O 0 5.384376056127849e-09
seemed O 0 1.938071214624415e-08
to O 0 1.019345163832952e-09
be O 0 4.1115727489327014e-10
preferentially O 0 1.3784927643811784e-09
associated O 0 2.4945968846168398e-08
with O 0 1.7461981860478204e-09
cognitive B-Disease 0 0.0002067196910502389
impairment I-Disease 0 2.511059574317187e-05
. O 0 5.335018613550346e-07

Two O 0 3.667893366809949e-08
altered O 0 5.5696627754286965e-08
Dp71 O 0 1.3569351722253487e-06
transcripts O 0 9.248206822576321e-08
and O 0 1.4887502342020298e-09
two O 0 3.261517167452155e-10
deleted O 0 7.921278744049687e-09
Dp140 O 0 2.1432985164437923e-08
DNA O 0 5.823825449668973e-11
sequences O 0 5.695905119090794e-12
were O 0 1.142339417503635e-10
found O 0 4.937584716091514e-11
in O 0 5.628840449301009e-11
four O 0 1.4740596243623116e-10
patients O 0 4.16647653878055e-11
with O 0 1.1322995492613064e-11
severe O 0 3.3914961505843166e-08
cerebral B-Disease 0 1.3278767255542334e-05
dysfunction I-Disease 0 0.00015126937068998814
. O 0 1.1270735740254167e-05

These O 0 1.6828020932280197e-07
findings O 0 7.454126205175271e-08
suggest O 0 6.612305369912974e-09
that O 0 3.657520467048592e-11
some O 0 3.1151455113370696e-12
sequences O 0 6.255895541179557e-12
located O 0 1.3262595188745507e-10
in O 0 2.1626334056890073e-10
the O 0 7.490433828749588e-10
distal O 0 5.021356219714335e-09
part O 0 2.4199776404998374e-08
of O 0 3.1619098450619276e-08
the O 0 1.8285902791959074e-09
gene O 0 8.36005223381342e-11
and O 0 7.241787031153635e-11
, O 0 1.887721055859881e-11
in O 0 2.6418249532422777e-11
particular O 0 2.589409797693065e-10
, O 0 4.514023876911466e-11
some O 0 1.3277984267645593e-10
DMD B-Disease 1 1.0
isoforms O 0 9.165427172774798e-08
expressed O 0 8.18036838268199e-09
in O 0 3.3800899856828437e-09
the O 0 3.16631521002364e-08
brain O 0 7.443115634941933e-08
may O 0 1.5614203263680793e-09
be O 0 9.148542340353671e-11
related O 0 1.675136279688516e-10
to O 0 8.102999382586518e-10
the O 0 3.6551670579143547e-09
cognitive B-Disease 0 1.0303643875886337e-06
impairment I-Disease 0 4.5540271997879245e-08
associated O 0 7.965700987710989e-09
with O 0 1.3762176953591165e-09
DMD B-Disease 1 1.0
. O 0 3.14757727437609e-07
. O 0 7.515513544831265e-08

I1307K O 0 4.405643994687125e-05
APC O 0 2.0744498669955647e-06
and O 0 5.948740167127653e-09
hMLH1 O 0 5.02750197028945e-07
mutations O 0 4.470118053490069e-09
in O 0 1.2099991009151267e-09
a O 0 2.39444841731995e-09
non O 0 1.924369144035154e-07
- O 0 5.4639880175955113e-08
Jewish O 0 1.313531612368024e-07
family O 0 3.834588202522582e-09
with O 0 5.45799065665431e-11
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9987762570381165

We O 0 3.966839017266466e-07
describe O 0 1.0429700125769159e-07
a O 0 7.420319025897015e-09
French O 0 1.1845049385783568e-07
Canadian O 0 7.238261332531692e-07
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.9131543399785187e-08
HNPCC B-Disease 0 0.0016518105985596776
) O 0 1.398711479971837e-09
kindred O 0 1.4195798314631247e-07
which O 0 5.20652167212976e-11
carries O 0 3.483167573814505e-11
a O 0 1.0280485664149186e-11
novel O 0 2.386067732285113e-10
truncating O 0 1.6128645086155302e-08
mutation O 0 6.727418067065116e-10
in O 0 2.599208626108407e-09
hMLH1 O 0 2.7830728868138976e-06
. O 0 3.035619045022031e-07

Interestingly O 0 6.399817493729643e-07
, O 0 4.863404345911704e-09
the O 0 6.57609522392022e-09
I1307K O 0 1.1392701253498672e-06
APC O 0 1.69785181469706e-07
polymorphism O 0 6.357951320978827e-08
, O 0 2.0857034155330467e-10
associated O 0 5.603391639574795e-10
with O 0 2.948038731534486e-12
an O 0 3.2022513980767275e-12
increased O 0 1.4347945054282718e-10
risk O 0 6.6856569169715385e-09
of O 0 3.1163349945018126e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.1479598544260625e-08
is O 0 2.443065194590588e-11
also O 0 6.99716283178442e-12
present O 0 2.1086372665318764e-12
in O 0 6.405621172378417e-11
this O 0 5.734259733713998e-10
family O 0 7.87423370951501e-09
. O 0 9.108908471944233e-08

The O 0 1.409278524988622e-06
I1307K O 0 4.22309904024587e-06
polymorphism O 0 1.2595088492162176e-06
has O 0 8.897163561449872e-10
previously O 0 5.102744338181253e-10
only O 0 4.2847777409482646e-11
been O 0 8.749699749455164e-12
identified O 0 3.7545185710419204e-11
in O 0 9.074019313715098e-12
individuals O 0 2.0004579590060523e-12
of O 0 1.7583494382744647e-10
self O 0 1.348487614905025e-07
- O 0 8.11702136616077e-08
reported O 0 2.435126322808401e-09
Ashkenazi O 0 4.212710535966835e-08
Jewish O 0 2.3168793106265184e-08
origins O 0 7.982556127217322e-08
. O 0 2.5055690855424473e-08

In O 0 6.822866271960493e-09
addition O 0 1.3818359789752321e-09
, O 0 3.730668898804801e-11
in O 0 5.923903728666247e-11
this O 0 1.2312070807318776e-10
family O 0 3.3624825146461035e-10
, O 0 1.0106908365781209e-10
there O 0 2.280625167883077e-11
appears O 0 1.2387330050600553e-10
to O 0 2.252904390820376e-10
be O 0 2.9374798149461867e-09
no O 0 1.4971513806472103e-08
relationship O 0 4.433949873927645e-10
between O 0 2.884885386134073e-10
the O 0 1.2026318829683191e-09
I1307K O 0 5.797973656740396e-09
polymorphism O 0 6.661519669215465e-10
and O 0 4.2997928134669294e-11
the O 0 5.068465092072927e-10
presence O 0 3.1920239784710702e-09
or O 0 1.914998826180181e-08
absence O 0 7.358112270594575e-07
of O 0 2.7373325828250472e-09
cancer B-Disease 0 1.2337276755758353e-09
. O 0 1.3311158841844417e-09
. O 0 1.846979813535654e-08

Identification O 0 4.986636668036226e-07
of O 0 2.360638617915356e-08
a O 0 4.922682816932422e-10
novel O 0 5.241287959201202e-10
mutation O 0 3.553007055234758e-10
of O 0 5.621097476371517e-10
the O 0 3.4475124977007e-09
CPO O 0 3.7808945307915565e-07
gene O 0 1.7224243142877071e-09
in O 0 8.657577765802671e-09
a O 0 2.990018188597787e-08
Japanese O 0 5.186367161513772e-06
hereditary B-Disease 0 0.004221954848617315
coproporphyria I-Disease 1 0.5399813652038574
family O 0 5.080239589005942e-07
. O 0 3.6806275716116943e-07

Hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 0.9999635219573975
( O 0 1.6169920513675606e-08
HCP B-Disease 0 0.0032133562490344048
) O 0 2.3904295431975697e-08
is O 0 1.0511818082648006e-08
an O 0 1.8263465406676005e-08
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999769926071167
characterized O 0 7.093545750791463e-10
by O 0 1.8087401368327427e-11
a O 0 1.351067369093073e-09
deficiency B-Disease 0 1.1423954759948174e-07
of I-Disease 0 2.253766950843783e-07
coproporphyrinogen I-Disease 0 2.2096986640463e-07
oxidase I-Disease 0 4.292405986205949e-09
( O 0 5.476552544791957e-11
CPO O 0 1.8973317139625578e-07
) O 0 1.1988156300990482e-10
caused O 0 1.0120044385830695e-10
by O 0 5.242232429397697e-12
a O 0 8.405043327996964e-11
mutation O 0 1.3225101569425135e-11
in O 0 8.429640319107534e-11
the O 0 2.859238623642568e-09
CPO O 0 3.3361234272888396e-06
gene O 0 5.303955674662575e-08
. O 0 1.322007392445812e-06

Only O 0 1.5589250779157737e-07
11 O 0 1.2058703191542008e-07
mutations O 0 8.562755837715486e-09
of O 0 1.2184343312071633e-08
the O 0 5.812156977924587e-09
gene O 0 1.0665238692197931e-09
have O 0 1.118590442494849e-09
been O 0 3.4914438007405124e-10
reported O 0 2.1047458220735393e-10
in O 0 4.0211417529079085e-10
HCP B-Disease 0 0.00031927815871313214
patients O 0 2.540065793255053e-07
. O 0 4.508007691583771e-07

We O 0 2.698596972550149e-07
report O 0 5.643713496539249e-09
another O 0 1.5065426683946725e-10
mutation O 0 7.4490982826525e-11
in O 0 2.5580318419038406e-10
a O 0 1.8783381516840336e-09
Japanese O 0 5.628515395983413e-07
family O 0 1.9828206632155343e-08
. O 0 1.8434802484534885e-07

Polymerase O 0 2.7718476758309407e-07
chain O 0 1.3567536427672167e-07
reaction O 0 3.0128584072031117e-09
- O 0 3.6616003562528476e-09
single O 0 1.0086192991920484e-09
strand O 0 9.48003564538169e-10
conformational O 0 4.99956465116469e-10
polymorphism O 0 1.7420190290273752e-10
and O 0 3.0474264604840595e-12
direct O 0 4.626467958734892e-11
sequence O 0 3.489642602660936e-12
analyses O 0 5.3429583674047265e-11
demonstrated O 0 2.4942040099951157e-10
a O 0 7.833260706746614e-10
C O 0 9.280645585363345e-09
to O 0 3.084210387083175e-10
T O 0 4.880695292364123e-10
substitution O 0 1.1820004697238318e-10
in O 0 7.032971427456403e-11
exon O 0 4.762871763652754e-10
1 O 0 1.573549734956714e-09
of O 0 6.82567447007898e-10
the O 0 1.9255499417170086e-09
CPO O 0 2.633146891639626e-07
gene O 0 9.031690395566727e-10
at O 0 9.981169668549228e-09
nucleotide O 0 2.5053729757473775e-08
position O 0 1.8251439826144633e-07
85 O 0 1.4770631651117583e-07
, O 0 5.186324703032597e-10
which O 0 3.7756096860075417e-11
lies O 0 4.141060758189319e-11
in O 0 2.3317892755558844e-11
the O 0 3.3934277610114805e-10
putative O 0 2.5711587525734103e-08
presequence O 0 2.781008845431643e-07
for O 0 3.416152472013323e-09
targeting O 0 1.0965897700998539e-07
to O 0 4.3769095015022685e-08
mitochondria O 0 2.2290532797342166e-06
. O 0 8.398732234127237e-07

This O 0 1.132906124468036e-08
mutation O 0 7.073495122966733e-10
changes O 0 3.4443362051383986e-10
the O 0 2.1396652505334401e-10
codon O 0 1.0698305574763367e-09
for O 0 6.916042738502881e-11
glutamine O 0 1.6576056083295043e-09
to O 0 1.2348341238421767e-09
a O 0 5.173501071986664e-10
termination O 0 5.112294143572171e-09
codon O 0 2.5219618393634846e-08
at O 0 9.900473330048953e-09
amino O 0 2.480409211358392e-09
acid O 0 4.0425454095327495e-09
position O 0 2.0820882795646867e-08
29 O 0 1.252915012628364e-06
. O 0 7.685201239837625e-07

MaeI O 0 4.072916999575682e-05
restriction O 0 1.4162374100123998e-06
analysis O 0 4.190895808164896e-08
showed O 0 9.65124691276742e-09
two O 0 1.8344364222100396e-11
other O 0 7.855482215234078e-13
carriers O 0 4.812185372404798e-12
in O 0 7.949058078438043e-11
the O 0 6.391385642956493e-09
family O 0 4.509761808435542e-08
. O 0 3.427563228797226e-07

The O 0 1.5459161204489646e-06
C O 0 0.0001365814678138122
- O 0 1.2097701073798817e-05
T O 0 2.316421387149603e-06
mutation O 0 2.5139115233940856e-09
is O 0 1.5888750384829287e-11
located O 0 3.51829537725834e-11
within O 0 5.6874515513838375e-11
a O 0 2.4062501990940177e-10
recently O 0 3.456775143906299e-10
proposed O 0 1.0860019133973609e-10
putative O 0 9.10903907858085e-10
alternative O 0 2.4238011597788045e-09
translation O 0 2.518451447386383e-09
initiation O 0 7.624094133795722e-10
codon O 0 2.115126562785008e-08
( O 0 4.2808243061465134e-11
TIC O 0 6.4966063639815275e-09
- O 0 8.27215629328748e-09
1 O 0 1.3542517329767634e-08
) O 0 8.028321757391765e-11
, O 0 1.1431146827722838e-11
supporting O 0 2.1011317685726283e-10
that O 0 1.528740675715845e-11
TIC O 0 3.471577247893265e-09
- O 0 2.8220616954399702e-08
1 O 0 6.523591196128109e-07
is O 0 2.1165138530676586e-09
the O 0 3.6282303828016893e-09
real O 0 7.755353692573408e-08
TIC O 0 3.683991849356971e-07
rather O 0 5.608484343611053e-09
than O 0 2.892080186445156e-10
TIC O 0 1.0361684843473995e-08
- O 0 1.421329631767776e-08
2 O 0 1.0680818007813286e-08
. O 0 4.208596582344626e-09
. O 0 2.2365300722526626e-08

Human B-Disease 0 1.0048507448345845e-07
complement I-Disease 0 2.4035375645325985e-07
factor I-Disease 0 3.288281732238829e-06
H I-Disease 1 1.0
deficiency I-Disease 0 9.551174116495531e-06
associated O 0 8.057724016907741e-07
with O 0 4.209336879057446e-08
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 1.0

This O 0 1.5803450992279977e-08
study O 0 2.500235352087543e-09
reports O 0 1.6469589581014077e-10
on O 0 4.0927319866490564e-10
six O 0 1.0090805274698411e-10
cases O 0 8.373165875930066e-12
of O 0 5.5710352997451196e-11
deficiency B-Disease 0 5.21696186250864e-10
in I-Disease 0 2.186483216704005e-09
the I-Disease 0 7.2451378230198316e-09
human I-Disease 0 1.2480461109021235e-10
complement I-Disease 0 1.2208105359956534e-10
regulatory I-Disease 0 1.3562776457476389e-09
protein I-Disease 0 7.771975285564281e-10
Factor I-Disease 0 9.948668555637141e-09
H I-Disease 1 0.9985194802284241
( O 0 1.9453505473165933e-10
FH O 0 5.638196967083786e-07
) O 0 3.628586667248079e-11
in O 0 2.912694391232762e-11
the O 0 2.7121502960136823e-11
context O 0 4.5139486593015477e-10
of O 0 2.4863370043370914e-11
an O 0 1.585835109063627e-11
acute B-Disease 0 5.191159857531602e-08
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.353658030391671e-05

Five O 0 4.0611038798488153e-07
of O 0 4.71085215281164e-09
the O 0 5.668015501392176e-10
cases O 0 6.7408982042105325e-12
were O 0 2.523959860556424e-11
observed O 0 2.3158154213720472e-11
in O 0 1.4719038488042457e-11
children O 0 6.546915787275509e-11
presenting O 0 4.571802936226277e-10
with O 0 9.895334551757173e-10
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.3255346402729629e-06
HUS B-Disease 1 1.0
) O 0 1.6906133737393247e-07
. O 0 6.959879215173714e-07

Two O 0 3.906267753706061e-09
of O 0 7.557610093300582e-10
the O 0 3.140341597873686e-10
children O 0 7.368804177954047e-11
exhibited O 0 4.942913189864839e-09
a O 0 7.970689352987392e-08
homozygous O 0 1.0472479516465683e-05
deficiency O 0 6.481162273530572e-08
characterized O 0 1.2404874349947193e-10
by O 0 1.3120332077731778e-11
the O 0 4.683597953913932e-09
absence O 0 7.958900738458397e-08
of O 0 1.5567338529365315e-09
the O 0 1.4692427829920973e-10
150 O 0 1.4098261447159643e-10
- O 0 6.613774805597217e-11
kD O 0 1.382653991299776e-08
form O 0 1.7203516389230344e-10
of O 0 6.981186184695787e-10
Factor O 0 1.2906202329077132e-08
H O 1 1.0
and O 0 1.9509240056780897e-10
the O 0 4.250892415846863e-10
presence O 0 1.1601360150326201e-10
, O 0 4.726685189082591e-12
upon O 0 4.2352807372303403e-10
immunoblotting O 0 6.01551306544934e-08
, O 0 4.917171878005e-11
of O 0 1.0577715786608266e-10
the O 0 1.1488639900525399e-10
42 O 0 6.028280097325478e-10
- O 0 4.232785510982495e-10
kD O 0 7.655503964087984e-08
Factor O 0 4.02994508874599e-08
H O 1 0.9999868869781494
- O 0 1.3240315510643086e-08
like O 0 6.057090246036623e-11
protein O 0 3.479263405159472e-11
1 O 0 3.3443880997907627e-10
( O 0 1.0309193602953126e-11
FHL O 0 2.28518189260285e-07
- O 0 1.8161960824158996e-08
1 O 0 1.004718264141502e-08
) O 0 9.312448034926035e-11
and O 0 6.585552936311245e-11
other O 0 5.034412817184197e-11
FH O 0 8.587895763412234e-07
- O 0 1.4703488204759196e-08
related O 0 5.651933143724364e-09
protein O 0 5.735834585074429e-10
( O 0 1.5108438805588875e-11
FHR O 0 2.708893021008407e-07
) O 0 1.86382312361566e-10
bands O 0 1.2305937957535207e-07
. O 0 1.1190181936626686e-07

Southern O 0 3.965469204558758e-06
blot O 0 2.0495524495345308e-06
and O 0 8.241347604354132e-10
PCR O 0 1.0035154041077021e-08
analysis O 0 6.898892013218472e-10
of O 0 1.164305873935234e-10
DNA O 0 2.791256392686847e-10
of O 0 2.8688296183077e-10
one O 0 2.7809046732052423e-10
patient O 0 6.6691892008918785e-09
with O 0 5.544324999107175e-10
homozygous O 0 1.449172486900352e-05
deficiency O 0 1.944345768833955e-07
ruled O 0 2.2339380123526098e-08
out O 0 1.3360810235951703e-09
the O 0 3.2986429143733176e-09
presence O 0 2.495280648773246e-09
of O 0 9.779043130819787e-10
a O 0 1.668293697631995e-10
large O 0 1.0061515509640628e-10
deletion O 0 1.1977746794400446e-08
of O 0 1.2275925165283752e-08
the O 0 3.1262050725899826e-08
FH O 0 9.032298294187058e-06
gene O 0 6.954012476967364e-09
as O 0 4.7028798633164115e-09
the O 0 3.2731475307912206e-09
underlying O 0 6.806958907645821e-08
defect O 0 3.382535851415014e-08
for O 0 3.29343752270006e-09
the O 0 1.868463215259908e-07
deficiency O 0 1.0874376130232122e-05
. O 0 1.516041811555624e-05

The O 0 1.0744736300694058e-07
other O 0 6.155824738840465e-10
four O 0 4.240524945076096e-11
children O 0 1.15979699802371e-11
presented O 0 6.430842525162461e-10
with O 0 3.785331770256306e-10
heterozygous O 0 1.0359017323935404e-06
deficiency O 0 1.4005800608174468e-07
and O 0 4.957254606807737e-09
exhibited O 0 7.397598551506235e-07
a O 0 3.9365090742649045e-08
normal O 0 2.3051504172144632e-07
immunoblotting O 0 8.160393605294303e-08
pattern O 0 8.590069211500406e-10
of O 0 1.9913463933374231e-10
proteins O 0 9.802469599917707e-12
of O 0 6.879248282132266e-10
the O 0 6.446442490926074e-09
FH O 0 0.0002500432019587606
family O 0 1.1488699414030634e-07
. O 0 2.5455022978349007e-07

Factor B-Disease 0 0.0005625085323117673
H I-Disease 1 1.0
deficiency I-Disease 0 1.6627176592010073e-05
is O 0 7.99367128045958e-10
the O 0 1.2408309935096895e-09
only O 0 1.0818825835201551e-08
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 3.1697284157417016e-06
with O 0 1.1858405812859019e-08
HUS B-Disease 1 1.0
. O 0 0.00012028709170408547

These O 0 3.299579702797928e-07
observations O 0 8.25535764192864e-08
suggest O 0 4.519317808870937e-09
a O 0 2.634238660537136e-10
role O 0 1.2316445641147311e-09
for O 0 2.4202349013791036e-09
FH O 0 6.733812915626913e-05
and O 0 7.880021968276196e-08
/ O 0 2.437674265820533e-05
or O 0 3.007227888929265e-08
FH O 0 2.783529225780512e-06
receptors O 0 5.5048343661212584e-09
in O 0 2.0187675975336106e-09
the O 0 4.045083379367043e-09
pathogenesis O 0 7.065451086418761e-07
of O 0 2.1172730235718973e-09
idiopathic O 0 4.304806680011097e-06
HUS B-Disease 1 0.9996240139007568
. O 0 5.76130041451961e-08
. O 0 5.311812145691874e-08

Further O 0 2.4133913711921195e-07
evidence O 0 7.006188074143438e-09
for O 0 4.277871668012523e-10
a O 0 3.5157682320985373e-10
major O 0 2.1741488609450244e-09
ancient O 0 2.956960258870822e-07
mutation O 0 7.475032930415182e-07
underlying O 0 4.454847839951981e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 3.177010654553669e-08
linkage O 0 3.124136682686185e-08
disequilibrium O 0 9.209828455425395e-09
studies O 0 1.2671880211811981e-09
in O 0 1.3042888991066093e-10
the O 0 1.809762478766075e-10
Japanese O 0 6.046362077682943e-09
population O 0 1.456643833330773e-11
. O 0 1.0014804541214062e-09

The O 0 6.7112773649569135e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.50891910475093e-08
DM B-Disease 1 1.0
) O 0 4.397316288873299e-09
mutation O 0 8.409650198437646e-10
is O 0 5.974477856884874e-11
an O 0 2.9993584005350016e-11
unstable O 0 7.005960700467995e-09
( O 0 5.733034602606324e-10
CTG O 0 7.878231258473534e-07
) O 0 3.569703699302096e-10
n O 0 2.375261765052983e-09
repeat O 0 1.898809109945887e-09
, O 0 4.5600436621162643e-11
present O 0 2.877108100374226e-11
at O 0 3.7919581363787813e-10
a O 0 2.7428278398522465e-11
copy O 0 1.6866983365559918e-09
number O 0 2.7568209867712135e-11
of O 0 1.1189840720682298e-11
5 O 0 9.977124681981309e-11
- O 0 8.976356880019409e-10
37 O 0 2.4350332861189372e-09
repeats O 0 1.2017283834708792e-09
on O 0 3.8251650735787734e-09
normal O 0 1.1247782261136763e-08
chromosomes O 0 1.279299000067624e-09
but O 0 3.820919136643397e-10
amplified O 0 9.023808367203401e-09
to O 0 5.00685759519115e-09
50 O 0 8.282007080140374e-09
- O 0 1.702315399754184e-09
3000 O 0 6.052407908185842e-09
copies O 0 3.509112644906054e-08
on O 0 2.015072055883138e-07
DM B-Disease 1 0.9999997615814209
chromosomes O 0 3.364083909218607e-07
. O 0 4.4900301077177573e-07

Previous O 0 1.3572001478223683e-07
findings O 0 3.7010612352617045e-09
in O 0 1.323045700774017e-10
Caucasian O 0 2.359791251294041e-09
populations O 0 1.3752383953846703e-10
of O 0 3.0719168875315006e-10
a O 0 5.287448701096764e-09
DM B-Disease 1 1.0
founder O 0 2.256116204080172e-06
chromosome O 0 2.8574191901498125e-08
raise O 0 1.078666223008895e-08
a O 0 1.23613497216013e-09
question O 0 1.8063698314918497e-09
about O 0 2.6902898311864654e-11
the O 0 1.320642900592972e-10
molecular O 0 2.259807341253861e-10
events O 0 1.3699054390858834e-10
involved O 0 1.4768709866164187e-10
in O 0 3.248578628323173e-10
the O 0 2.8967965803872175e-09
expansion O 0 1.4184675478645659e-07
mutation O 0 1.2347264544132486e-08
. O 0 3.1720215787345296e-08

To O 0 2.847708060471632e-07
investigate O 0 2.8234506288526973e-08
whether O 0 6.592672630034713e-09
a O 0 1.2487237022185127e-08
founder O 0 1.2434786356152472e-07
chromosome O 0 1.835345564416002e-08
for O 0 6.208144220920531e-09
the O 0 5.720664830732858e-08
DM B-Disease 1 1.0
mutation O 0 1.5540874143127326e-09
exists O 0 4.7727998636615254e-11
in O 0 9.64826916277639e-12
the O 0 3.937283832300409e-11
Japanese O 0 4.799991959458794e-09
population O 0 5.573923701068795e-12
, O 0 9.735261208287938e-12
we O 0 2.522565489826434e-10
genotyped O 0 5.839425387677011e-09
families O 0 1.4710954676644405e-11
using O 0 6.187356876852235e-11
polymorphic O 0 5.212903442242123e-10
markers O 0 1.7705196198036788e-09
near O 0 6.427929832852897e-08
the O 0 1.7605929159003608e-08
( O 0 1.9964195574484478e-10
CTG O 0 3.134358337320009e-07
) O 0 3.4295799533623494e-10
n O 0 9.786175425574584e-09
repeat O 0 1.0426930430185166e-08
region O 0 2.2335620020186298e-09
and O 0 5.326050156462259e-10
constructed O 0 1.5201037228962377e-07
haplotypes O 0 2.4095811568258796e-06
. O 0 2.025536218752677e-07

Six O 0 4.5069931786656525e-08
different O 0 1.6997123153394966e-10
haplotypes O 0 1.1633435548219495e-08
were O 0 1.9929471406499033e-09
found O 0 4.671479869600148e-10
and O 0 5.250603285489319e-10
DM B-Disease 1 1.0
alleles O 0 2.0603213357617278e-08
were O 0 1.1292256907324827e-08
always O 0 3.354005073674671e-08
haplotype O 0 2.5888724053402257e-07
A O 0 1.1849812153741368e-06
. O 0 9.969926395569928e-07

To O 0 2.8136128094047308e-08
find O 0 2.5161661643124944e-09
an O 0 3.8038270450124756e-12
origin O 0 4.028955294388403e-11
of O 0 2.6519841878069883e-10
the O 0 5.84153891924899e-10
( O 0 1.6680583303507746e-10
CTG O 0 3.427563228797226e-07
) O 0 9.096555730891964e-10
n O 0 2.6278030418325216e-08
repeat O 0 1.7982236144575836e-08
mutation O 0 7.286459768884868e-10
and O 0 3.6947521431240915e-11
to O 0 1.3830172562734333e-09
investigate O 0 2.3799329174067907e-09
the O 0 8.796293138324529e-10
mechanism O 0 3.545509841273997e-08
of O 0 1.9614505575304975e-09
the O 0 3.743586829418888e-10
expansion O 0 2.094298956478724e-09
mutation O 0 1.6500143265596456e-11
in O 0 1.5141325693246444e-11
the O 0 3.7802358465732766e-11
Japanese O 0 2.174555202572037e-09
population O 0 1.5154002185047144e-12
we O 0 1.6761262516817865e-11
have O 0 3.3962474759591244e-12
studied O 0 1.5074595738351348e-10
90 O 0 1.7221977177683812e-09
Japanese O 0 1.0202227258560015e-06
DM B-Disease 1 1.0
families O 0 5.00004393444442e-09
comprising O 0 1.4614839893845044e-10
190 O 0 1.4290925109960995e-09
affected O 0 4.970165945472615e-10
and O 0 1.468522803360628e-10
130 O 0 1.7207078428782552e-08
unaffected O 0 1.12763551385342e-07
members O 0 5.385484946884844e-09
. O 0 1.6103847144677275e-07

The O 0 9.10142091470334e-07
results O 0 5.5517379138336764e-08
suggest O 0 8.834498466114837e-09
that O 0 2.52203501138748e-11
a O 0 2.1622129087184305e-10
few O 0 6.392308904423771e-10
common O 0 2.97788099734575e-10
ancestral O 0 5.3789587894925717e-08
mutations O 0 1.8063285311953337e-09
in O 0 5.196285624009533e-10
both O 0 5.354060528262039e-10
Caucasian O 0 4.9545705316234034e-09
and O 0 2.1211614686933444e-09
Japanese O 0 2.36035575085225e-07
populations O 0 8.42327527172948e-11
have O 0 4.047176222626847e-12
originated O 0 3.552169842990782e-12
by O 0 1.443837996210895e-13
expansion O 0 2.340238280940099e-10
of O 0 5.856529844416869e-11
an O 0 5.123062564449388e-12
ancestral O 0 1.7632872939543631e-09
n O 0 1.9361416914165375e-09
= O 0 6.5051866116050405e-09
5 O 0 6.879025127304317e-10
repeat O 0 1.678252092851551e-09
to O 0 1.5623706772771584e-09
n O 0 6.282594444684264e-09
= O 0 5.323455809502775e-08
19 O 0 3.1419983059777223e-08
- O 0 3.2999786014897836e-08
37 O 0 2.467255555416159e-08
copies O 0 2.8657109396590386e-07
. O 0 2.2757191686650913e-07

These O 0 1.2651722336443072e-08
data O 0 5.0236552695537284e-09
support O 0 2.7880531217050475e-10
multistep O 0 1.6331343388742425e-08
models O 0 2.827229081958649e-07
of O 0 2.745397580383724e-07
triplet O 0 3.567587782526971e-06
repeat O 0 8.407090490436531e-07
expansion O 0 6.078927867747552e-07
that O 0 1.9621418378967803e-10
have O 0 8.718579677657878e-12
been O 0 2.8848657403907074e-12
proposed O 0 5.635562329298072e-12
for O 0 2.571537253970302e-11
both O 0 1.4446701612769175e-09
DM B-Disease 1 1.0
and O 0 2.3683151084696874e-07
Friedreichs B-Disease 0 0.00015589107351843268
ataxia I-Disease 0 4.664213702199049e-05
. O 0 1.7666116036707535e-07
. O 0 2.0399318145791767e-07

The O 0 6.419059417339668e-08
molecular O 0 6.051276812968354e-09
basis O 0 5.7082939264319066e-08
of O 0 2.0057541405549273e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.985470359817555e-08
the O 0 1.6307774020063448e-09
western O 0 5.991872553678945e-10
Cape O 0 6.953243314455904e-09
, O 0 1.178942273666328e-11
South O 0 3.0650867954840066e-10
Africa O 0 1.3381162844439132e-09
. O 0 1.5096873751119233e-09

Deficiency B-Disease 0 3.0492228688672185e-06
of I-Disease 0 3.520003133417049e-07
the I-Disease 0 1.158242852739022e-07
sixth I-Disease 0 3.9235865756381827e-07
component I-Disease 0 9.217529850502615e-08
of I-Disease 0 4.245101159483511e-09
human I-Disease 0 4.701030120735084e-10
complement I-Disease 0 8.581447730193759e-08
( O 0 3.593341180163634e-09
C6 O 0 0.0021563812624663115
) O 0 4.922429130971295e-10
has O 0 3.759326877572633e-11
been O 0 1.656472355116012e-11
reported O 0 3.5416363852042165e-12
in O 0 2.847239805037205e-12
a O 0 8.852567116857113e-12
number O 0 4.532362766346276e-12
of O 0 6.537139536286207e-13
families O 0 6.876439793013917e-14
from O 0 6.312779617621833e-13
the O 0 8.937413309428877e-12
western O 0 1.2077389088815949e-10
Cape O 0 5.403223202193885e-09
, O 0 3.153316496806724e-11
South O 0 1.2338218224883235e-09
Africa O 0 3.010124149938065e-09
. O 0 3.200217202348199e-09

Meningococcal B-Disease 0 0.0010764837497845292
disease I-Disease 0 7.63623802413349e-07
is O 0 7.747550517800406e-11
endemic O 0 5.745421065989076e-12
in O 0 7.467046946041389e-12
the O 0 3.4089386868885185e-10
Cape O 0 2.2577072655849406e-08
and O 0 6.509139061083857e-11
almost O 0 3.058451061854761e-11
all O 0 3.4030881411462044e-12
pedigrees O 0 3.7460437529723833e-10
of O 0 2.854725345002862e-10
total O 0 1.0711892883819019e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 5.709053230162908e-09
C6Q0 O 0 3.2823307265061885e-05
) O 0 5.395249802475632e-10
have O 0 2.0748593121400205e-10
been O 0 5.1102802545166526e-11
ascertained O 0 1.2041403429918773e-08
because O 0 4.6250583918272525e-10
of O 0 1.4808035908586703e-09
recurrent O 0 5.253764356893953e-07
disease O 0 5.411611070371691e-08
. O 0 7.702328730374575e-08

We O 0 9.455177973904938e-08
have O 0 2.887748096203069e-10
sequenced O 0 2.109324270804791e-09
the O 0 1.3898371342691007e-09
expressed O 0 5.736472630246681e-09
exons O 0 2.4004354060025435e-08
of O 0 7.119288714108052e-09
the O 0 6.967288967985041e-09
C6 O 0 5.202747388466378e-07
gene O 0 1.246688308143007e-09
from O 0 1.300793361913577e-10
selected O 0 6.872992175388504e-10
cases O 0 2.2860690770953873e-11
and O 0 1.8265632062419712e-11
have O 0 1.541198835219859e-10
found O 0 8.312828203571598e-11
three O 0 1.0170200792636308e-10
molecular O 0 1.143234218403677e-08
defects O 0 2.3632208012713818e-07
leading O 0 1.4995292119124315e-08
to O 0 2.5158848870887596e-07
total O 0 5.779736056865659e-06
deficiency O 0 2.2642339899903163e-05
879delG O 0 1.0710891729104333e-05
, O 0 1.678568950502779e-09
which O 0 6.360308113517732e-11
is O 0 1.3304748795739396e-11
the O 0 4.594230898491425e-11
common O 0 4.22177744152652e-11
defect O 0 9.169405235098793e-10
in O 0 1.6914913913979035e-10
the O 0 1.7143843011879767e-09
Cape O 0 1.020846127630648e-07
and O 0 3.2153646412069747e-10
hitherto O 0 2.0368384312519083e-08
unreported O 0 1.0868443034439679e-08
, O 0 8.791084180059805e-12
and O 0 6.693583187722396e-12
1195delC O 0 1.122163872935289e-08
and O 0 1.0770614955468716e-10
1936delG O 0 6.930921614412e-08
, O 0 5.651561163499963e-11
which O 0 4.646167998945128e-12
have O 0 2.3463503275727993e-12
been O 0 1.0423793772584844e-11
previously O 0 5.3034319991152046e-11
reported O 0 1.4811299756112284e-11
in O 0 4.6714240115042216e-11
African O 0 1.1945942013369404e-08
- O 0 1.981195119071799e-08
Americans O 0 1.5101862871347294e-08
. O 0 3.138237048005976e-08

We O 0 8.443593060292187e-07
also O 0 5.926904744768535e-09
show O 0 2.9790356848025112e-09
that O 0 8.228024511724996e-11
the O 0 3.55651924577316e-10
879delG O 0 7.296090842601188e-08
and O 0 3.5957889998883275e-09
1195delC O 0 1.9347842226125067e-06
defects O 0 2.7382955636312545e-07
are O 0 1.5392334629105164e-10
associated O 0 3.6666885083747047e-09
with O 0 2.0766686981144034e-10
characteristic O 0 1.2667775308727869e-06
C6 O 1 0.9999926090240479
/ O 0 0.06619624048471451
C7 O 0 0.00010259820555802435
region O 0 7.930215417673026e-08
DNA O 0 5.956054849320935e-08
marker O 0 6.259452334234084e-08
haplotypes O 0 9.595323291478053e-08
, O 0 9.288362856629817e-10
although O 0 5.553215109976861e-10
small O 0 9.102764375601424e-11
variations O 0 3.1064442684858307e-10
were O 0 1.3390251130118713e-09
observed O 0 1.2580135155815242e-08
. O 0 1.5219808346955688e-07

The O 0 3.424086969516793e-07
1936delG O 0 2.447306769681745e-06
defect O 0 3.653650082924287e-06
was O 0 5.162003091641054e-08
observed O 0 1.5219633331398086e-09
only O 0 3.167035383944139e-11
once O 0 4.812105228180208e-11
in O 0 2.1329328928065827e-11
the O 0 1.5520931762047496e-10
Cape O 0 1.0990622634210467e-08
, O 0 6.258298046457611e-11
but O 0 3.776718868198081e-11
its O 0 3.8848351618936405e-11
associated O 0 1.1542281574961066e-09
haplotype O 0 1.8387899203275992e-08
could O 0 5.704590577693125e-09
be O 0 1.0142489514919362e-08
deduced O 0 4.99699581268942e-07
. O 0 3.561927144346555e-07

The O 0 2.0767309649727395e-07
data O 0 2.4430267586694754e-08
from O 0 4.320346580488632e-10
the O 0 1.4810522808161863e-09
haplotypes O 0 3.710060525463632e-08
indicate O 0 2.0986906434927732e-08
that O 0 8.386723954201258e-11
these O 0 1.5086187854507216e-10
three O 0 6.230582022537234e-11
molecular O 0 7.771797094768829e-10
defects O 0 5.554669169072213e-09
account O 0 1.4507220424953005e-10
for O 0 5.339629294276449e-10
the O 0 1.3135524667973186e-08
defects O 0 4.2062873717441107e-07
in O 0 1.0255530646929856e-08
all O 0 6.712566502642403e-09
the O 0 1.0359728186415396e-08
38 O 0 8.065722312267098e-08
unrelated O 0 1.0695985430686505e-08
C6Q0 O 0 1.543974121887004e-06
individuals O 0 7.862145656734043e-11
we O 0 1.9033490339381842e-09
have O 0 7.796885359567796e-11
studied O 0 1.933897708639165e-09
from O 0 1.386784131973684e-09
the O 0 2.2013939116050096e-08
Cape O 0 1.2554496606753673e-06
. O 0 3.18329227866343e-07

We O 0 3.989827064287965e-07
have O 0 1.3623548955621345e-09
also O 0 1.347880140833979e-10
observed O 0 7.66116059480737e-11
the O 0 1.8655409161905112e-10
879delG O 0 5.5884765259861524e-08
defect O 0 1.9839669462839993e-08
in O 0 1.874018940029032e-09
two O 0 3.811632787176222e-09
Dutch O 1 0.9997425675392151
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 2.6637017072062008e-05
, O 0 2.8776694915855217e-10
but O 0 2.263637020882836e-11
the O 0 1.1998405047286553e-10
879delG O 0 2.5632507671957683e-08
defect O 0 4.5112845015182756e-08
in O 0 3.207366594537575e-09
the O 0 4.4411489596996034e-08
Cape O 0 4.2354631091257033e-07
probably O 0 8.159238618077325e-09
did O 0 1.3366214801635579e-09
not O 0 6.016077913617579e-11
come O 0 1.8722816352845228e-10
from O 0 4.4810228444491784e-11
The O 0 1.1343953554288078e-09
Netherlands O 0 5.8739907160543225e-08
. O 0 1.4572155926373398e-08
. O 0 1.9891129454663314e-07

Complement B-Disease 1 0.999826967716217
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 8.432256493051682e-08
seven O 0 6.869299795653205e-09
further O 0 5.9754641235088e-09
molecular O 0 3.1059972371849653e-08
defects O 0 2.415481787920726e-07
and O 0 8.160199738149743e-10
their O 0 1.1045919023899842e-07
associated O 0 8.666544090374373e-06
marker O 0 4.578388143272605e-06
haplotypes O 0 1.3390229014476063e-06
. O 0 1.2977598089491948e-06

Seven O 0 1.5939592401537084e-07
further O 0 5.58710899767334e-09
molecular O 0 5.551692883187798e-09
bases O 0 1.836034044799817e-07
of O 0 1.7591481764611672e-06
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 6.554496678745636e-08
described O 0 8.109314819648716e-08
. O 0 7.415794556209221e-08

All O 0 9.752786667149849e-08
these O 0 1.7272309138505193e-09
new O 0 1.3120075692540922e-08
molecular O 0 4.2363030416936454e-08
defects O 0 5.877475928173226e-08
involve O 0 1.6337816655109805e-09
single O 0 2.144090682776323e-09
- O 0 1.0771858960367808e-08
nucleotide O 0 5.330430781214091e-07
events O 0 6.423419449674839e-07
, O 0 3.674305304457448e-09
deletions O 0 6.205164027051069e-08
and O 0 3.741811305246756e-09
substitutions O 0 3.056490527342248e-08
, O 0 3.7848263412243455e-10
some O 0 3.136582382712305e-10
of O 0 1.0634221281335954e-09
which O 0 5.1269752332494534e-11
alter O 0 2.0184296900538357e-08
splice O 0 5.4450641329140126e-08
sites O 0 3.147504656908495e-08
, O 0 6.484569547993146e-10
and O 0 2.388544917408808e-10
others O 0 2.5847823881264276e-09
codons O 0 2.4262197939606267e-07
. O 0 4.588948456785147e-07

They O 0 1.7073107372311824e-08
are O 0 1.1998787380340659e-11
distributed O 0 3.418469327054474e-11
along O 0 1.203223076728932e-10
the O 0 4.679329812518063e-09
C7 O 0 3.3439432627346832e-06
gene O 0 7.215846142827331e-09
, O 0 3.776137458277873e-10
but O 0 1.1624278796473764e-11
predominantly O 0 4.003871886815169e-12
towards O 0 1.5093641614338793e-10
the O 0 1.480435773970612e-10
3 O 0 2.8394024909061955e-09
end O 0 7.221052555905771e-08
. O 0 1.1060803473128544e-07

All O 0 1.2125612158797594e-07
were O 0 1.1029114510563431e-08
found O 0 4.92484275582683e-10
in O 0 4.1182912635662206e-10
compound O 0 7.575093974310221e-08
heterozygous O 0 7.387810363468361e-09
individuals O 0 7.181143180101657e-11
. O 0 1.4742324694339004e-08

The O 0 8.140406862366945e-06
C6 O 1 0.9615187644958496
/ O 0 0.11167875677347183
C7 O 0 0.0008522255229763687
marker O 0 2.487864776412607e-06
haplotypes O 0 3.003138431267871e-07
associated O 0 1.3624341477225244e-07
with O 0 4.3772471758352083e-10
most O 0 3.560391093060389e-08
C7 B-Disease 1 0.9999982118606567
defects I-Disease 0 0.0013974540634080768
are O 0 1.0312433573744784e-08
tabulated O 0 6.216571790673697e-08
. O 0 2.31126495719991e-08
. O 0 1.0919625026417634e-07

A O 0 9.884776090984815e-07
genome O 0 5.672669001199893e-09
- O 0 1.3788985064877579e-08
wide O 0 9.782569199145996e-10
search O 0 4.769307726526506e-10
for O 0 3.0287692492914076e-11
chromosomal O 0 2.1581605835763185e-08
loci O 0 6.669267804682022e-08
linked O 0 5.7492792393532e-07
to O 0 1.9614141422152898e-08
mental O 0 2.0140696506132372e-05
health O 0 2.1073296441187495e-09
wellness O 0 4.772185313584032e-09
in O 0 1.4375665935428827e-10
relatives O 0 1.1062608606948743e-09
at O 0 5.75501513111476e-09
high O 0 4.6319140523110036e-08
risk O 0 7.349191832872748e-08
for O 0 9.25982064359232e-08
bipolar B-Disease 1 1.0
affective I-Disease 0 0.008803066797554493
disorder I-Disease 0 7.574185019620927e-06
among O 0 2.2124835297177015e-10
the O 0 7.456778527981101e-10
Old O 0 2.2531558840910293e-08
Order O 0 6.102952454511978e-08
Amish O 0 3.5763223422691226e-06
. O 0 9.464903882872022e-08

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 2.951983368859601e-08
BPAD B-Disease 1 1.0
; O 0 0.0001418333558831364
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 2.0307714621026207e-08
is O 0 2.161577861148345e-10
characterized O 0 2.0270996686777565e-11
by O 0 5.8849461762044974e-12
episodes O 0 6.7126304514886215e-09
of O 0 1.7311094779870473e-09
mania B-Disease 0 7.193529771853946e-09
and O 0 6.147434783443373e-10
/ O 0 1.4505845911116921e-06
or O 0 1.197459553736735e-08
hypomania B-Disease 0 1.0821838714036858e-06
interspersed O 0 5.335282216023529e-10
with O 0 1.6741636289091533e-12
periods O 0 8.689175601261923e-09
of O 0 3.4997396092251165e-09
depression B-Disease 0 1.8649771504897217e-08
. O 0 7.260271939202312e-09

Compelling O 0 2.1341218143788865e-06
evidence O 0 8.222529856993788e-08
supports O 0 8.428298059470762e-09
a O 0 2.6504215488998284e-10
significant O 0 4.4805381627099905e-10
genetic O 0 4.1829376073998503e-10
component O 0 2.4458604030996867e-09
in O 0 4.878024650878388e-10
the O 0 9.716517590518947e-10
susceptibility O 0 2.9188926831125173e-09
to O 0 1.407817773468878e-08
develop O 0 5.953850745754607e-07
BPAD B-Disease 1 1.0
. O 0 5.327867984306067e-05

To O 0 1.4057408570522512e-08
date O 0 8.720226674086007e-08
, O 0 7.905757715143125e-10
however O 0 4.0743197704529166e-10
, O 0 2.3198175325145343e-10
linkage O 0 8.367893933325377e-09
studies O 0 1.2329514076370174e-09
have O 0 6.2756654040097e-11
attempted O 0 2.8986093525418255e-09
only O 0 2.452791858509329e-10
to O 0 1.574204100407428e-09
identify O 0 2.1818102879933576e-08
chromosomal O 0 2.1129064862179803e-06
loci O 0 8.442715397904976e-07
that O 0 8.535458562164422e-09
cause O 0 1.8264674217505217e-09
or O 0 5.380633785745381e-11
increase O 0 2.1277206385672542e-10
the O 0 5.66282909453264e-10
risk O 0 3.9652405803281e-09
of O 0 3.0576898790712903e-09
developing O 0 2.1020201756982715e-07
BPAD B-Disease 1 1.0
. O 0 1.2531741049315315e-05

To O 0 3.0587884225496964e-08
determine O 0 1.343341260451325e-08
whether O 0 2.3943569349427207e-09
there O 0 6.728214096973772e-10
could O 0 4.257377561600606e-09
be O 0 5.3239608277522166e-09
protective O 0 6.213454639691918e-08
alleles O 0 2.9765649944835104e-09
that O 0 8.916593852159593e-11
prevent O 0 1.9513855809005776e-10
or O 0 2.025855004583743e-11
reduce O 0 1.904720825507411e-10
the O 0 2.464868309459689e-10
risk O 0 1.3516497920917914e-09
of O 0 2.261066472941664e-10
developing O 0 3.2087252854751114e-09
BPAD B-Disease 1 1.0
, O 0 1.1269200850261285e-10
similar O 0 4.554321763466929e-12
to O 0 2.758609313202598e-11
what O 0 1.271765592142371e-11
is O 0 5.692231625289979e-13
observed O 0 1.122339894632507e-11
in O 0 6.233245170017554e-11
other O 0 1.3263266929186557e-08
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 8.813888507930301e-11
we O 0 1.267047300412827e-10
used O 0 1.933569304668481e-09
mental O 0 7.315236416616244e-08
health O 0 5.983923356822629e-10
wellness O 0 6.872078017750027e-09
( O 0 3.799615830302194e-11
absence O 0 3.399475190235535e-08
of O 0 7.396918633162386e-09
any O 0 3.785075364248769e-08
psychiatric B-Disease 0 2.2826428903499618e-05
disorder I-Disease 0 2.9361355569079706e-09
) O 0 1.786167025917551e-12
as O 0 1.388857865519677e-11
the O 0 3.167905174294994e-11
phenotype O 0 9.26115018007323e-11
in O 0 2.2817968348132212e-10
our O 0 7.142669122828238e-09
genome O 0 9.337566275746667e-10
- O 0 1.3947161647820394e-08
wide O 0 1.1788181986105428e-08
linkage O 0 8.212543320951227e-07
scan O 0 0.001124842674471438
of O 0 1.5349188231539301e-07
several O 0 1.7585314315837763e-09
large O 0 1.1700120872149e-09
multigeneration O 0 9.198401471621764e-07
Old O 0 1.4473744158749469e-07
Order O 0 1.087711609670805e-07
Amish O 0 4.959433113072009e-07
pedigrees O 0 4.710009804398396e-08
exhibiting O 0 2.1212555267879907e-08
an O 0 6.752383652219862e-10
extremely O 0 1.3636658913185329e-08
high O 0 1.0954567386534109e-07
incidence O 0 8.653865393171145e-07
of O 0 1.6772565913925064e-06
BPAD B-Disease 1 1.0
. O 0 2.3927066649775952e-05

We O 0 2.4196397134801373e-06
have O 0 8.261591410985147e-09
found O 0 4.919575302686496e-10
strong O 0 3.615476251717098e-10
evidence O 0 2.9725807926261893e-10
for O 0 8.701207115935361e-11
a O 0 3.86330495372178e-10
locus O 0 1.4479314636162144e-08
on O 0 4.0031320480693466e-08
chromosome O 0 7.272387847478967e-08
4p O 0 7.42252632335294e-06
at O 0 2.118072188750375e-07
D4S2949 O 0 3.1651865128878853e-07
( O 0 6.680105774092837e-11
maximum O 0 2.9066717033288114e-08
GENEHUNTER O 0 1.889017653411429e-07
- O 0 2.2453692238855183e-08
PLUS O 0 3.0777083992461485e-08
nonparametric O 0 2.0707780379325413e-07
linkage O 0 8.099387827087412e-09
score O 0 6.525439077975648e-10
= O 0 1.5099120842521074e-09
4 O 0 4.5545350824127695e-10
. O 0 8.237618920325929e-11
05 O 0 9.675543566345368e-08
, O 0 1.1393582605156993e-10
P O 0 6.495020077323943e-09
= O 0 1.6412462500170477e-09
5 O 0 1.9171567111619936e-10
. O 0 2.4144044402651943e-11
22 O 0 5.263578461978113e-10
x O 0 1.7722435075029352e-08
10 O 0 4.526806041127429e-09
( O 0 2.3128842591146892e-11
- O 0 4.360865890618015e-09
4 O 0 2.9467390749715605e-09
) O 0 8.549332075613592e-11
; O 0 1.6338431996221203e-10
SIBPAL O 0 4.945650857735018e-07
Pempirical O 0 5.46149792057804e-08
value O 0 4.0317865712680145e-10
< O 0 1.5384065132906244e-09
3 O 0 4.0576150772686503e-10
x O 0 1.0993662868941101e-08
10 O 0 1.5859940027951325e-09
( O 0 1.2731100895724268e-11
- O 0 1.6424237525569652e-09
5 O 0 1.6725065776768133e-09
) O 0 1.0867602651121189e-10
) O 0 6.854503770137299e-11
and O 0 4.0560031028258337e-11
suggestive O 0 3.0016904517538023e-09
evidence O 0 9.222089064619965e-11
for O 0 1.0363725502782195e-11
a O 0 1.0142866407880646e-10
locus O 0 4.8281623143964225e-09
on O 0 2.398819631821425e-08
chromosome O 0 1.3611276017400087e-07
4q O 0 5.155566668690881e-06
at O 0 2.0635621211795296e-08
D4S397 O 0 9.757755492501019e-08
( O 0 4.680128160017283e-11
maximum O 0 3.3409293109798455e-08
GENEHUNTER O 0 3.8747776898162556e-07
- O 0 2.5176458251507938e-08
PLUS O 0 6.088140480642323e-08
nonparametric O 0 1.9168101061950438e-07
linkage O 0 3.0466231759618267e-09
score O 0 4.528271924097993e-10
= O 0 8.657771721765073e-10
3 O 0 1.2025026807638284e-10
. O 0 2.2850315389844056e-11
29 O 0 1.930414939010916e-09
, O 0 6.782377437453135e-11
P O 0 8.16197776032368e-09
= O 0 1.3645498064818185e-09
2 O 0 1.18006535099191e-10
. O 0 2.559299473736676e-11
57 O 0 8.358302938660245e-10
x O 0 9.895113173286063e-09
10 O 0 1.5438681444379654e-09
( O 0 1.2489456517605912e-11
- O 0 3.445625784692652e-09
3 O 0 1.3812325727613484e-09
) O 0 3.105045040530108e-11
; O 0 6.241179795196672e-11
SIBPAL O 0 1.0965102603677224e-07
Pempirical O 0 5.936170222042847e-09
value O 0 1.494607632102074e-10
< O 0 4.531139907726356e-10
1 O 0 3.252099978201528e-10
x O 0 1.1864695004248915e-08
10 O 0 2.2843018587792585e-09
( O 0 2.225471543160218e-11
- O 0 3.218213029398953e-09
3 O 0 2.9921616295780495e-09
) O 0 8.573696613778381e-11
) O 0 1.7912102356909543e-11
that O 0 1.4410461756167448e-12
are O 0 2.9947719651368665e-12
linked O 0 1.2619540967762077e-09
to O 0 4.048896773412025e-09
mental O 0 4.8935635277302936e-06
health O 0 3.027837891522722e-08
wellness O 0 1.1740766012735548e-06
. O 0 3.444944240982295e-08

These O 0 2.1618113521526539e-07
findings O 0 3.906314205437411e-08
are O 0 1.6925175150284133e-10
consistent O 0 7.02922386963678e-09
with O 0 2.4797114014929456e-11
the O 0 1.7642157734698571e-09
hypothesis O 0 2.4776054541320036e-09
that O 0 4.357891218026433e-12
certain O 0 9.484462520914505e-11
alleles O 0 3.919685132025563e-10
could O 0 3.728310993267314e-09
prevent O 0 2.4415720556447695e-09
or O 0 1.9651915650342744e-09
modify O 0 1.0218260371175347e-07
the O 0 7.1996235639915085e-09
clinical O 0 8.027350340000794e-09
manifestations O 0 1.2128741566641565e-08
of O 0 3.2658140636243616e-09
BPAD B-Disease 1 1.0
and O 0 8.786767979884758e-10
perhaps O 0 5.415229931138299e-10
other O 0 2.6262856472891727e-11
related O 0 5.962780935675482e-09
affective B-Disease 0 1.4162307024889742e-06
disorders I-Disease 0 1.1403808457544073e-05
. O 0 3.530886374392139e-07

Segregation O 0 3.188174741808325e-05
distortion O 0 1.9566914488677867e-05
in O 0 6.717589826621406e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 9.353809582535177e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.561499113402533e-07
DM B-Disease 1 1.0
) O 0 2.6553475862556297e-08
is O 0 7.3226877894683184e-09
an O 0 3.4252340963547567e-09
autosomal B-Disease 1 0.5144628286361694
dominant I-Disease 0 0.42282235622406006
disease I-Disease 0 0.004258376080542803
which O 0 1.6575596797907544e-11
, O 0 4.445561486206978e-13
in O 0 4.9352657377488285e-12
the O 0 1.0668427946614045e-10
typical O 0 5.690243276568197e-10
pedigree O 0 1.2755395628616384e-09
, O 0 5.7635778094589085e-11
shows O 0 6.598959712000863e-10
a O 0 9.864730143860356e-10
three O 0 2.605943516531539e-10
generation O 0 3.705597961811691e-08
anticipation O 0 1.8148807612305973e-07
cascade O 0 4.45809774873851e-07
. O 0 1.4760607882635668e-06

This O 0 6.058714863144132e-09
results O 0 4.119895979926014e-09
in O 0 2.572761559349601e-09
infertility B-Disease 0 9.113927262660582e-06
and O 0 5.169284733597124e-08
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 7.181461536553968e-10
CDM B-Disease 0 1.2628071033304877e-08
) O 0 8.361978644233492e-12
with O 0 2.1773160531479707e-12
the O 0 3.6352754140267507e-09
disappearance O 0 2.8705139243356825e-07
of O 0 1.2228485779530729e-08
DM B-Disease 1 1.0
in O 0 3.705909179529954e-08
that O 0 2.305012403169826e-09
pedigree O 0 2.2078955908000353e-07
. O 0 7.038403282422223e-08

The O 0 4.013376297962168e-08
concept O 0 6.535123020512401e-08
of O 0 3.3183569225769816e-09
segregation O 0 5.0713321542161793e-08
distortion O 0 4.1523055216430294e-08
, O 0 7.05411701273917e-11
where O 0 3.0337878043074085e-11
there O 0 3.210556603558401e-12
is O 0 3.4415333538713455e-13
preferential O 0 3.9456835021489667e-10
transmission O 0 3.9628664794122415e-09
of O 0 6.054875489880374e-10
the O 0 3.402527148921308e-10
larger O 0 6.883234260346427e-11
allele O 0 4.1666775585369464e-10
at O 0 1.6454652085329258e-09
the O 0 1.2816858685482657e-08
DM B-Disease 1 1.0
locus O 0 4.235091637383448e-07
, O 0 1.1689659240587957e-09
has O 0 3.2935345423146245e-11
been O 0 2.495268575097853e-11
put O 0 8.438166138047265e-11
forward O 0 3.1589542093257705e-09
to O 0 3.9115910510645335e-09
explain O 0 1.1676406508343007e-08
partially O 0 6.23365821184052e-08
the O 0 6.226926196895022e-10
maintenance O 0 1.0766193980771277e-07
of O 0 1.57369743902791e-08
DM B-Disease 1 1.0
in O 0 1.2230072066188313e-08
the O 0 4.184024682274412e-09
population O 0 2.587927268316026e-11
. O 0 1.3083933936286485e-09

In O 0 2.5013147109120837e-08
a O 0 4.393418073789235e-09
survey O 0 2.1002712902173926e-09
of O 0 5.37065947270321e-10
DM B-Disease 1 1.0
in O 0 1.2213427602603133e-08
Northern O 0 6.362888882449624e-08
Ireland O 0 1.018828665877436e-08
, O 0 1.096525981125751e-09
59 O 0 2.3390178682802798e-08
pedigrees O 0 9.558334568282589e-08
were O 0 3.26630136271433e-08
ascertained O 0 1.68464032412885e-06
. O 0 4.1195804101334943e-07

Sibships O 0 4.162292043474736e-06
where O 0 1.5792865903918596e-09
the O 0 1.2407737337571945e-10
status O 0 2.291414835653427e-09
of O 0 9.649014920398713e-10
all O 0 8.026683484541053e-11
the O 0 1.0454979937346565e-10
members O 0 3.580366211841657e-11
had O 0 4.966167477249428e-10
been O 0 1.392396892230252e-10
identified O 0 2.816750999112827e-10
were O 0 2.3246765623596843e-10
examined O 0 5.509537270853571e-10
to O 0 8.283646546480838e-10
determine O 0 1.6291762383602304e-09
the O 0 2.275660992978601e-09
transmission O 0 4.735375824793664e-08
of O 0 2.776189278463903e-09
the O 0 1.65437192833906e-08
DM B-Disease 1 1.0
expansion O 0 3.4854096497838327e-07
from O 0 1.4631499345441057e-09
affected O 0 4.858080049352509e-10
parents O 0 1.9441449838897285e-10
to O 0 7.616681729771813e-10
their O 0 1.5955394783162546e-09
offspring O 0 1.0386521864802489e-07
. O 0 2.4079153604361636e-07

Where O 0 5.0194437051231944e-08
the O 0 1.002073268807635e-08
transmitting O 0 2.011065447504734e-07
parent O 0 7.849836336504268e-09
was O 0 6.516265926848064e-08
male O 0 1.7710068078713448e-08
, O 0 2.8881128599778094e-09
58 O 0 1.2809665861368558e-07
. O 0 1.4587540420052392e-07

3 O 0 2.4384280550293624e-07
% O 0 3.39255579184794e-09
of O 0 1.0570279096455693e-09
the O 0 1.952871198085404e-10
offspring O 0 8.824592168110712e-10
were O 0 4.382827989424243e-10
affected O 0 1.0368397113103e-10
, O 0 8.6701574739112e-12
and O 0 6.3689483374707034e-12
in O 0 4.959690297345887e-11
the O 0 1.415155076456287e-10
case O 0 2.254717246241711e-11
of O 0 3.317897692700633e-11
a O 0 9.670732964428552e-11
female O 0 4.2259204469097256e-10
transmitting O 0 1.2019031991883367e-08
parent O 0 3.948305238310468e-09
, O 0 6.68192168262749e-09
68 O 0 8.426732165389694e-07
. O 0 1.2715148614006466e-06

7 O 0 1.8368308474236983e-06
% O 0 1.0886783918806486e-08
were O 0 6.419571096927257e-09
affected O 0 1.9612222956766345e-09
. O 0 4.7194159691343884e-08

Studies O 0 2.4346635996153054e-07
on O 0 3.91702812407857e-08
meiotic O 0 3.6276966852710757e-07
drive O 0 2.1798183524879278e-07
in O 0 9.742149309488468e-09
DM B-Disease 1 1.0
have O 0 2.499892071128329e-09
shown O 0 1.4370951650910513e-10
increased O 0 9.668501416149056e-11
transmission O 0 4.313940316080789e-10
of O 0 3.338580106815314e-11
the O 0 6.804871943710822e-11
larger O 0 7.365038440232397e-11
allele O 0 1.5316432566692129e-09
at O 0 4.04008693166702e-09
the O 0 1.539651961479649e-08
DM B-Disease 1 1.0
locus O 0 1.14815257745704e-07
in O 0 3.7515515138863975e-09
non O 0 2.5462263693043496e-06
- O 0 3.7766603782074526e-06
DM O 1 1.0
heterozygotes O 0 2.494709588063415e-05
for O 0 2.8328797085919177e-08
CTGn O 0 9.794349352887366e-06
. O 0 5.542015202308903e-08

This O 0 3.9807017060411454e-07
study O 0 2.1687698747996365e-08
provides O 0 2.6867530422691743e-10
further O 0 4.460080915702491e-11
evidence O 0 1.5763305938332195e-10
that O 0 3.275673829405967e-11
the O 0 1.3936311660245337e-08
DM B-Disease 1 1.0
expansion O 0 6.206209491210757e-06
tends O 0 1.6028616300900467e-07
to O 0 2.4398962850114003e-09
be O 0 1.9194483780182736e-09
transmitted O 0 1.2362440848789902e-08
preferentially O 0 1.1366396712730875e-08
. O 0 1.0963429986077244e-07

Diagnosis O 1 1.0
of O 0 2.7999405574519187e-05
hemochromatosis B-Disease 1 1.0
. O 0 0.0005530031630769372

If O 0 1.6241775711023365e-06
untreated O 0 1.2201702702441253e-05
, O 0 2.9593332229183034e-09
hemochromatosis B-Disease 1 1.0
can O 0 4.561172772810096e-07
cause O 0 3.4117786640308623e-07
serious O 0 5.286856463726508e-08
illness O 0 5.136526581850376e-08
and O 0 3.4898972600672096e-11
early B-Disease 0 1.9062480483000854e-09
death I-Disease 0 4.515421092587957e-10
, O 0 1.4508098715448892e-11
but O 0 2.4798153114291566e-11
the O 0 5.213380838142712e-10
disease O 0 1.9157678221581875e-10
is O 0 2.3202399203337e-12
still O 0 3.904891167361146e-12
substantially O 0 1.6476950914778854e-09
under O 0 2.2102214813912724e-07
- O 1 0.5436198711395264
diagnosed O 0 2.382497041253373e-05
. O 0 2.1330799881980056e-06

The O 0 8.102950346255966e-07
cornerstone O 0 1.2784402315446641e-05
of O 0 1.917199021761462e-08
screening O 0 4.35504743379056e-09
and O 0 3.312019547507816e-10
case O 0 1.698007984218819e-10
detection O 0 3.556738015220162e-09
is O 0 5.085932022752537e-11
the O 0 3.7678926645412503e-10
measurement O 0 1.908067837064209e-08
of O 0 3.17044723807669e-09
serum O 0 1.6821498860508655e-08
transferrin O 0 1.0524621529839351e-07
saturation O 0 2.743589107012667e-07
and O 0 2.7661148926938495e-09
the O 0 1.978630947974125e-08
serum O 0 6.247774564371866e-08
ferritin O 0 3.5136676501679176e-07
level O 0 3.235318786209973e-07
. O 0 1.888300857899594e-07

Once O 0 1.6721235169825377e-06
the O 0 1.8620696096149914e-08
diagnosis O 0 2.5891959012369625e-06
is O 0 9.718828519744704e-11
suspected O 0 3.462055309100265e-09
, O 0 5.443946959893253e-10
physicians O 0 1.869215005001479e-08
must O 0 1.9199399403646566e-08
use O 0 2.3307929097882152e-07
serum O 0 1.3402557215158595e-06
ferritin O 0 1.3687802493222989e-05
levels O 0 1.2333762242633384e-05
and O 0 4.120259688988881e-08
hepatic O 0 5.79907646169886e-06
iron O 0 7.71124177845195e-05
stores O 0 1.771545794326812e-05
on O 0 9.043770887728897e-07
liver O 0 1.096545858558784e-07
biopsy O 0 5.620963179353566e-07
specimens O 0 6.40584785216447e-09
to O 0 1.0915304216041477e-09
assess O 0 1.352615086602782e-08
patients O 0 3.6167455141900007e-10
for O 0 1.6723269991025802e-10
the O 0 1.691588980001768e-09
presence O 0 1.831980966926494e-08
of O 0 1.0407344319673939e-07
iron B-Disease 0 0.00012886068725492805
overload I-Disease 0 4.658692705561407e-05
. O 0 1.6268531908281147e-06

Liver O 1 0.9999997615814209
biopsy O 1 1.0
is O 0 3.747305399315337e-08
also O 0 2.1502284675012362e-10
used O 0 7.573956045670016e-11
to O 0 2.1401222460859515e-10
establish O 0 1.6529840607404367e-08
the O 0 3.6017950844069446e-09
presence O 0 2.8091834636256863e-08
or O 0 4.2388657561787113e-07
absence O 1 0.8818010091781616
of O 0 1.4649006629952055e-07
cirrhosis B-Disease 0 5.314365694175649e-07
, O 0 4.132202358064774e-10
which O 0 6.153258891999913e-12
can O 0 1.925345993747385e-11
affect O 0 5.20050946750672e-10
prognosis O 0 2.579677129688207e-07
and O 0 4.369400397052914e-09
management O 0 3.385356990293076e-07
. O 0 5.31476132437092e-07

A O 0 5.220750267653784e-07
DNA O 0 3.807418824663955e-09
- O 0 1.3330366810393457e-09
based O 0 1.1080213829783858e-10
test O 0 2.4317090008274533e-10
for O 0 2.1547898187979087e-10
the O 0 6.015763442945854e-09
HFE O 0 0.0005207103095017374
gene O 0 1.3393864151112211e-07
is O 0 1.9407991880271425e-10
commercially O 0 6.256108076030387e-09
available O 0 2.0260513267089664e-08
, O 0 3.344775498237418e-11
but O 0 5.621563110846939e-12
its O 0 2.7289978003081083e-12
place O 0 3.603633016990848e-11
in O 0 3.0176056098341064e-11
the O 0 1.1122053972245638e-10
diagnosis O 0 3.5200801562496054e-07
of O 0 2.9001576695719677e-09
hemochromatosis B-Disease 1 1.0
is O 0 7.320090755769115e-09
still O 0 4.981232093470567e-10
being O 0 3.104702883671706e-10
evaluated O 0 2.1392226656757884e-08
. O 0 1.7195276313941577e-07

Currently O 0 4.0285084423885564e-07
, O 0 1.296763585401095e-09
the O 0 1.4134401427057242e-09
most O 0 1.7360939075228288e-11
useful O 0 1.301972418765729e-10
role O 0 7.946420604865168e-11
for O 0 6.69566832534052e-11
this O 0 5.346668940919841e-11
test O 0 1.1742569416828275e-10
is O 0 2.9152051866238038e-12
in O 0 1.1175635070137524e-11
the O 0 7.849379479729635e-11
detection O 0 1.346869016316532e-08
of O 0 1.4244226909099211e-09
hemochromatosis B-Disease 1 1.0
in O 0 1.573033472368479e-07
the O 0 7.954408687282921e-08
family O 0 4.0081243879441786e-10
members O 0 7.027325943376184e-11
of O 0 5.812583400710558e-11
patients O 0 1.776285021848345e-11
with O 0 3.9324842210711197e-13
a O 0 1.3988335489933945e-10
proven O 0 1.561853046894157e-08
case O 0 3.191823028103613e-09
of O 0 2.349579553140302e-08
the O 0 2.51245637628017e-07
disease O 0 4.247031171189519e-08
. O 0 8.02068029770453e-08

It O 0 1.1177612613266774e-08
is O 0 4.0606187856617737e-10
crucial O 0 1.917122283146e-08
to O 0 1.3618313232655055e-07
diagnose O 0 0.17610159516334534
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 4.994241820099887e-08
because O 0 4.594128133472708e-10
phlebotomy O 0 1.2015499351036851e-06
therapy O 0 2.9443876314871886e-07
can O 0 5.069566988424867e-10
avert O 0 8.164628439999433e-08
serious O 0 4.7014250981192163e-07
chronic O 1 0.552534818649292
disease O 0 3.7214431358734146e-07
and O 0 5.013083004268282e-11
can O 0 9.647372484211658e-11
even O 0 1.8134044266204796e-10
lead O 0 5.007027015224708e-10
to O 0 1.428836271522016e-09
normal O 0 5.208036224502166e-09
life O 0 1.4964196548561404e-09
expectancy O 0 1.4796630587454729e-09
. O 0 4.617081716951077e-10
. O 0 4.502198791556111e-08

Prevalence O 0 1.2288279322092421e-05
of O 0 2.994915249132646e-08
the O 0 3.08173184748739e-08
I1307K O 0 3.398682338229264e-06
APC B-Disease 0 2.7461356921776314e-07
gene O 0 2.2945549904562768e-09
variant O 0 5.026377536410109e-09
in O 0 1.022530948802114e-09
Israeli O 0 7.10534564518639e-08
Jews O 0 3.366141809735268e-09
of O 0 4.876821863009084e-11
differing O 0 5.744313878730534e-12
ethnic O 0 7.919510316631295e-13
origin O 0 3.206201276695353e-11
and O 0 1.2518576453235397e-11
risk O 0 1.331103227641961e-09
for O 0 1.4934608216776724e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0005178675055503845

BACKGROUND O 0 0.00011601466394495219
& O 0 8.488431376463268e-06
AIMS O 0 4.042076852783794e-06
Israeli O 0 2.771303115878254e-07
Jews O 0 2.0796356636765267e-08
of O 0 2.4623367789189388e-09
European O 0 1.0942987627160505e-09
birth O 0 8.27645152412515e-08
, O 0 2.147659827755888e-09
i O 0 2.9551154412388314e-08
. O 0 1.906942825868896e-09
e O 0 1.7309320199387912e-08
. O 0 8.219840363921094e-10
, O 0 2.1149712536860932e-10
Ashkenazim O 0 5.634509747665106e-08
, O 0 1.2024063689164421e-10
have O 0 1.0748205797606047e-10
the O 0 1.0153750062968925e-09
highest O 0 6.2805816014588345e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.0008670263341628015
of O 0 3.373327617239852e-09
any O 0 3.39917516356536e-09
Israeli O 0 5.270845122140599e-06
ethnic O 0 3.1759668228659166e-09
group O 0 3.6072813625054323e-09
. O 0 9.186464211552448e-08

The O 0 2.39480732489028e-06
I1307K O 0 2.731083623075392e-05
APC B-Disease 0 6.736913178428949e-07
gene O 0 3.393630043646567e-09
variant O 0 4.096484929050348e-08
was O 0 4.1634322656136646e-08
found O 0 2.999531456548965e-10
in O 0 4.5280382221513094e-10
6 O 0 4.273395006748615e-07
. O 0 3.147277141124505e-07

1 O 0 1.9967383479979617e-07
% O 0 1.6118796297703852e-09
of O 0 2.0451984550362567e-10
American O 0 1.5317126733638275e-10
Jews O 0 1.6843056116488953e-10
, O 0 3.952322844003042e-12
28 O 0 3.0936961326055723e-10
% O 0 9.320799687628778e-11
of O 0 7.046644379116174e-10
their O 0 4.00391080290774e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 9.370935458719032e-07
, O 0 8.329747308577495e-11
but O 0 3.808228385415724e-11
not O 0 5.853160733870766e-10
in O 0 8.1309287081055e-10
non O 0 9.195106542847498e-08
- O 0 4.5318188313103747e-08
Jews O 0 9.869707895404645e-08
. O 0 1.1989226322839386e-07

We O 0 2.552181967985234e-07
assessed O 0 2.6882995030064194e-07
the O 0 1.038758767890613e-08
I1307K O 0 6.629583140238537e-07
prevalence O 0 2.0945636336477946e-08
in O 0 3.1222316398960004e-11
Israeli O 0 7.294667980772829e-09
Jews O 0 1.6060855978494715e-09
of O 0 6.250364809057274e-11
differing O 0 7.957276330905483e-12
ethnic O 0 1.3091178531834946e-12
origin O 0 4.421010432742456e-11
and O 0 2.969122517293421e-11
risk O 0 1.4186989361064661e-09
for O 0 1.7260198603707977e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0006156601593829691

METHODS O 0 8.111772444863163e-07
DNA O 0 9.12875020020465e-09
samples O 0 2.313063074410593e-09
from O 0 7.854127070938688e-11
500 O 0 2.40915376537032e-09
unrelated O 0 9.738094775002537e-10
Jews O 0 1.0280147400010264e-08
of O 0 6.812697517233346e-09
European O 0 3.2404485761361457e-09
or O 0 1.3314968017041906e-09
non O 0 6.124525242512391e-08
- O 0 5.527939883620547e-09
European O 0 4.327183333874274e-10
origin O 0 3.2827993101669506e-10
, O 0 1.1956226807219306e-11
with O 0 1.116494863142442e-13
or O 0 2.471838272261051e-12
without O 0 4.280611975993054e-11
a O 0 2.5824144905817192e-11
personal O 0 9.326566186018681e-10
and O 0 8.347974395084279e-11
/ O 0 8.854862016960396e-07
or O 0 4.0872361495303267e-08
family O 0 2.658148590128917e-09
history O 0 8.263671524844085e-09
of O 0 2.0213403173485744e-10
neoplasia B-Disease 0 1.5320180679623263e-08
, O 0 1.6534429381209748e-10
were O 0 2.284213651559952e-10
examined O 0 8.2343715179789e-10
for O 0 2.5187482655120164e-10
the O 0 9.866499839361609e-10
I1307K O 0 1.9657399263905972e-08
variant O 0 1.5415289045250802e-09
by O 0 6.968026156073392e-11
the O 0 2.165540413656686e-09
allele O 0 3.4524807457358975e-09
- O 0 4.217700855235762e-09
specific O 0 4.583259993751199e-09
oligonucleotide O 0 1.243117480953515e-06
( O 0 1.1655111542552277e-08
ASO O 0 2.659845631569624e-05
) O 0 5.68601221662135e-10
method O 0 2.703266233083923e-08
. O 0 2.0031384551089104e-08

RESULTS O 0 2.1488844481609704e-07
In O 0 1.1915989306388042e-09
persons O 0 4.738677783500123e-10
at O 0 2.57143556448014e-10
average O 0 4.4512107888472485e-10
risk O 0 4.2592598892277067e-10
for O 0 1.2885097433468218e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.179715468424547e-06
I1307K O 0 1.3512479881683248e-06
was O 0 1.0946667572397928e-08
found O 0 9.8415720017897e-11
in O 0 1.6075191178188675e-10
5 O 0 4.4185554770592717e-08
. O 0 8.432401443769777e-08

0 O 0 6.916275765433966e-07
% O 0 1.7761444537356397e-09
of O 0 5.374789502354815e-10
120 O 0 4.1976773168528325e-09
European O 0 1.0364803459950167e-09
and O 0 2.2606363447863487e-09
1 O 0 1.1380061550880782e-06
. O 0 1.1505973134262604e-06

6 O 0 8.364201562471862e-07
% O 0 4.482489046608862e-09
of O 0 1.330420329459514e-09
188 O 0 2.4279469545973598e-09
non O 0 3.596288422613725e-07
- O 0 2.2094374685366347e-07
European O 0 2.3219314471134567e-08
Jews O 0 5.974873573677542e-08
( O 0 8.269465667787301e-11
P O 0 3.057673936268657e-08
= O 0 7.2249766169818486e-09
0 O 0 8.699236886400286e-10
. O 0 8.025136805089872e-11
08 O 0 2.8654257633320412e-08
) O 0 4.2428646707115547e-10
. O 0 8.41379410587706e-09

It O 0 5.2644844039662075e-09
occurred O 0 6.67419053357321e-09
in O 0 1.0274497919127157e-09
15 O 0 4.726514646336e-08
. O 0 7.539116353427744e-08

4 O 0 2.316906346777614e-07
% O 0 2.0149590884699364e-09
of O 0 7.630786558188163e-10
52 O 0 4.932892316844573e-09
Ashkenazi O 0 3.531660297539929e-08
Israelis O 0 6.196211188580492e-07
with O 0 8.94746832180715e-10
familial O 0 7.101675873855129e-05
cancer B-Disease 1 0.9999747276306152
( O 0 2.1984504494643176e-10
P O 0 5.077207561043906e-07
= O 0 5.237885147835186e-08
0 O 0 2.5139210713120974e-09
. O 0 1.1533737159785673e-10
02 O 0 8.362871284361972e-08
) O 0 2.768735588021265e-11
and O 0 9.451626113710088e-12
was O 0 4.72889061242654e-10
not O 0 2.327533582535679e-10
detected O 0 1.0153788920774787e-09
in O 0 3.404325432665445e-10
51 O 0 1.5003729814111466e-08
non O 0 2.3536263142887037e-06
- O 0 4.547734135940118e-07
European O 0 3.6077370424436594e-08
Jews O 0 7.704547044795618e-08
at O 0 2.379698038623701e-08
increased O 0 5.2559365748550135e-09
cancer B-Disease 0 2.8631896853426042e-09
risk O 0 1.210733180379009e-09
. O 0 1.3877161642028568e-08

Colorectal B-Disease 0 0.1824464052915573
neoplasia I-Disease 0 0.00010522146476432681
occurred O 0 5.073652573628351e-06
personally O 0 1.2184575126639174e-08
or O 0 2.2753071995951224e-11
in O 0 9.85580540791009e-12
the O 0 8.133711586200132e-12
families O 0 3.531139139770212e-13
of O 0 1.3642673796221416e-11
13 O 0 2.185174041713367e-09
of O 0 9.550184643103421e-09
20 O 0 1.347777924820548e-07
Ashkenazi O 0 5.0077201052545206e-08
I1307K O 0 7.436247528858075e-08
carriers O 0 1.0979444436953756e-10
, O 0 6.469963453881178e-11
8 O 0 8.950578944677545e-09
of O 0 1.333733568031903e-09
whom O 0 4.557509480918043e-09
also O 0 1.8270981394508112e-09
had O 0 2.3592330311572596e-09
a O 0 1.10560693933337e-09
personal O 0 1.385614041282679e-07
or O 0 1.3069723081571283e-08
family O 0 2.4311814783573027e-09
history O 0 9.520938704099535e-09
of O 0 5.910354872185053e-09
noncolonic O 0 2.4493358523614006e-06
neoplasia B-Disease 0 0.00017143107834272087
. O 0 2.6643720048014075e-05

CONCLUSIONS O 0 1.826674815674778e-05
The O 0 6.556821858794137e-07
I1307K O 0 1.7830236174631864e-05
APC O 0 9.188844956042885e-07
variant O 0 9.33864257035566e-08
may O 0 2.915022001559464e-08
represent O 0 7.698696791180737e-09
a O 0 3.0458098265739864e-09
susceptibility O 0 5.052656515402987e-09
gene O 0 4.685098975443225e-09
for O 0 6.250468942425869e-08
colorectal B-Disease 1 1.0
, I-Disease 0 4.276630079402821e-06
or I-Disease 0 6.763899591533118e-07
other I-Disease 0 4.6187338398340216e-08
, I-Disease 0 1.9420298702499394e-09
cancers I-Disease 0 1.9232787806799934e-08
in O 0 1.657523451825682e-09
Ashkenazi O 0 3.486057309487478e-08
Jews O 0 1.5908149464394228e-08
, O 0 4.0075207041745387e-10
and O 0 7.867560769536652e-11
partially O 0 6.883701164639433e-09
explains O 0 6.589853107641375e-10
the O 0 9.767554820516722e-11
higher O 0 3.271127013704245e-08
incidence O 0 5.171306156626088e-07
of O 0 9.320951903646346e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 5.90266324707045e-07
European O 0 5.0493934367068505e-08
Israelis O 0 6.876315410409006e-07
. O 0 1.3475118976202793e-07

Systematic O 0 6.552009494953381e-07
analysis O 0 5.223976984325418e-08
of O 0 1.9480182800180046e-08
coproporphyrinogen O 0 2.4661746920173755e-06
oxidase O 0 8.550965162612556e-07
gene O 0 6.166512775962474e-07
defects O 0 4.067796908202581e-05
in O 0 9.960983788914746e-07
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
and O 0 1.5236436468057946e-07
mutation O 0 2.0622911378609388e-08
update O 0 4.064965651195962e-06
. O 0 3.74215602505501e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999983310699463
( O 0 1.7338926738830196e-08
HC B-Disease 0 0.00013198457600083202
) O 0 9.949731705205522e-09
is O 0 9.958498470297172e-10
an O 0 3.3554478640063223e-10
acute O 0 4.443735178938368e-06
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9999969005584717
autosomal O 1 1.0
dominant O 0 0.27885040640830994
inheritance O 0 1.4238632957130903e-06
caused O 0 2.3568910378912733e-08
by O 0 1.0544614660601415e-11
deficient B-Disease 0 7.621157038784077e-10
activity I-Disease 0 2.883511429629948e-09
of I-Disease 0 2.7211637387836163e-09
coproporphyrinogen I-Disease 0 1.2385349634769227e-07
III I-Disease 0 4.0698182601772714e-06
oxidase I-Disease 0 1.9663667671920848e-07
( O 0 3.497484302172893e-09
CPO O 0 4.727993200503988e-06
) O 0 7.336444340921844e-09
. O 0 9.823132529618306e-08

Clinical O 0 1.5171032828220632e-05
manifestations O 0 2.8407851004885742e-06
of O 0 9.603781592204541e-08
the O 0 1.3353428585105576e-08
disease O 0 1.3858956204870765e-09
are O 0 1.4572294109241324e-12
characterized O 0 3.1121106126158482e-12
by O 0 1.5892257128335974e-12
acute O 0 1.772722746373745e-09
attacks O 0 2.2504844210402553e-08
of O 0 2.1440450836962555e-07
neurological B-Disease 1 0.9999505281448364
dysfunction I-Disease 0 7.3381856964260805e-06
often O 0 5.850615547586813e-10
precipitated O 0 7.196448437163383e-10
by O 0 1.2945819546569814e-12
drugs O 0 1.6395809709912612e-10
, O 0 2.2693694146092014e-11
fasting O 0 1.322146392368495e-08
, O 0 4.5178502605658366e-10
cyclical O 0 4.1519899696140783e-07
hormonal O 0 2.097579681503703e-06
changes O 0 1.279599473491544e-06
, O 0 2.853312963679855e-08
or O 0 6.37354133914414e-08
infectious B-Disease 0 3.802507819727907e-07
diseases I-Disease 0 6.542967412315193e-08
. O 0 2.760645578803178e-08

Skin O 1 1.0
photosensitivity O 1 0.9999996423721313
may O 0 4.427123349159956e-05
also O 0 7.315596128876223e-09
be O 0 3.7948016951006025e-10
present O 0 8.357697312000312e-10
. O 0 4.0120447408753535e-08

The O 0 6.259505767047813e-07
seven O 0 1.7138523489279578e-08
exons O 0 8.104023230259827e-09
, O 0 7.092057496826953e-10
the O 0 2.5848811979756192e-09
exon O 0 7.319437145270058e-08
/ O 0 4.6779666718066437e-07
intron O 0 2.3673260329815093e-07
boundaries O 0 6.022901066771169e-10
and O 0 8.203422663388693e-11
part O 0 3.0511052018233897e-10
of O 0 1.5642521722369906e-09
3 O 0 2.7405193669949313e-09
noncoding O 0 1.0791245674823813e-09
sequence O 0 9.914226106744195e-10
of O 0 7.911630461876484e-09
the O 0 2.540336119238873e-08
CPO O 0 8.565288567297102e-07
gene O 0 6.164216692639002e-09
were O 0 1.5463562874629133e-08
systematically O 0 1.6508163724893166e-08
analyzed O 0 3.122770708685607e-09
by O 0 6.443755945495511e-11
an O 0 7.950877456419647e-11
exon O 0 6.803629881702022e-10
- O 0 1.7508338112648403e-09
by O 0 4.4963671674835837e-10
- O 0 2.8447596278624587e-08
exon O 0 6.276632547042027e-08
denaturing O 0 9.45355168369133e-07
gradient O 0 2.7234085209215664e-08
gel O 0 9.078814855456585e-08
electrophoresis O 0 3.420879579607572e-09
( O 0 1.907126366551548e-11
DGGE O 0 6.743560021504891e-08
) O 0 1.3671952459048953e-11
strategy O 0 7.205526730835743e-10
followed O 0 9.91630180746661e-11
by O 0 5.150002061089787e-13
direct O 0 9.759933312925018e-12
sequencing O 0 9.816076423918574e-11
in O 0 6.863363766207442e-10
seven O 0 2.8652440420273706e-09
unrelated O 0 1.6910833622318933e-08
heterozygous O 0 2.9319734196064928e-08
HC B-Disease 0 5.435517209662066e-07
patients O 0 2.8402324048215633e-08
from O 0 1.3455228042857925e-09
France O 0 1.750951561518832e-08
, O 0 3.6963751504082154e-10
Holland O 0 2.334169124651453e-08
, O 0 4.3085460199598913e-10
and O 0 1.9749905877386453e-10
Czech O 0 5.603654429364724e-08
Republic O 0 6.700736321363365e-07
. O 0 1.9277283627161523e-06

Seven O 0 2.3916797431411396e-07
novel O 0 7.439904692319033e-09
mutations O 0 1.1744838435134852e-09
and O 0 1.0802463090708869e-10
two O 0 6.19947704283419e-11
new O 0 7.55155826759335e-10
polymorphisms O 0 3.600948730309028e-07
were O 0 2.563187990745064e-07
detected O 0 3.16986870529945e-07
. O 0 8.595089866503258e-07

Among O 0 1.0593014820869939e-07
these O 0 7.00884772442123e-09
mutations O 0 2.4816491084322934e-09
two O 0 3.5129393838317924e-10
are O 0 8.676944579510959e-11
missense O 0 3.310254470534346e-08
( O 0 6.89127754860408e-10
G197W O 0 1.427754909855139e-06
, O 0 1.4440447726471461e-09
W427R O 0 1.58148864670693e-07
) O 0 2.720436098613277e-10
, O 0 2.054648673421866e-10
two O 0 7.746043390044477e-11
are O 0 2.3471212820536103e-11
nonsense O 0 6.6558460964927235e-09
( O 0 1.2531220505707097e-10
Q306X O 0 3.069091576435312e-07
, O 0 6.419690334880102e-10
Q385X O 0 1.0363982028138707e-07
) O 0 1.3820515565310387e-10
, O 0 1.2759913958770852e-10
two O 0 1.6089905449656605e-11
are O 0 6.458530325131884e-12
small O 0 7.57966467368476e-11
deletions O 0 1.1081239925658792e-08
( O 0 2.6967747479567095e-10
662de14bp O 0 7.189663620010833e-08
; O 0 2.498255768923485e-10
1168del3bp O 0 1.3849481206307246e-07
removing O 0 2.019284472964955e-08
a O 0 7.867624329804812e-10
glycine O 0 3.602193654472785e-09
at O 0 1.1443381353615223e-08
position O 0 4.1436090114643775e-09
390 O 0 1.6199671604155697e-09
) O 0 1.544267144715228e-11
, O 0 5.242572435198989e-12
and O 0 1.3627010761116387e-12
one O 0 2.319969953992751e-12
is O 0 9.508651461695439e-13
a O 0 9.541649588495904e-12
splicing O 0 1.3025203138283814e-08
mutation O 0 1.515856329348253e-09
( O 0 4.969547343081082e-11
IVS1 O 0 1.8265700418851338e-07
- O 0 8.646422244851237e-09
15c O 0 8.279000098809774e-07
- O 0 3.888176891564399e-08
- O 0 1.6356782595039476e-08
> O 0 3.2330234489563736e-08
g O 0 7.8666229086366e-09
) O 0 1.4540344622782087e-11
which O 0 3.431964998648618e-12
creates O 0 1.5597549293810964e-11
a O 0 7.581153760316539e-11
new O 0 2.7319482787113714e-10
acceptor O 0 1.4605958664759555e-09
splice O 0 2.0571630443555478e-07
site O 0 4.741535235552874e-07
. O 0 2.4185868596759974e-07

The O 0 1.8259848388879618e-07
pathological O 0 6.486010306616663e-08
significance O 0 8.797693595852252e-08
of O 0 2.2141364297567634e-08
the O 0 7.581030914138864e-09
point O 0 5.677629388856076e-08
mutations O 0 6.89150070343203e-10
G197W O 0 6.814636321905709e-08
, O 0 1.4702604411720444e-10
W427R O 0 5.846716888413539e-08
, O 0 1.7702755927828662e-10
and O 0 5.714451134508636e-11
the O 0 3.910188617339827e-09
in O 0 2.84384671367377e-09
- O 0 3.0331094080793264e-08
frame O 0 1.8805084778250603e-07
deletion O 0 4.1467338007805665e-08
390delGly O 0 1.6927646839803856e-08
were O 0 1.4157598704489516e-10
assessed O 0 2.1233947933296804e-10
by O 0 5.802932353388135e-12
their O 0 2.920773622960837e-10
respective O 0 3.154438710240015e-09
expression O 0 4.330182434841845e-09
in O 0 4.749445836615962e-10
a O 0 3.8251701806046867e-10
prokaryotic O 0 9.800735917275816e-11
system O 0 2.3094469392415107e-10
using O 0 5.343368525423386e-10
site O 0 2.660776043938995e-09
- O 0 3.79164699637613e-10
directed O 0 1.1024014340277333e-10
mutagenesis O 0 1.6296004901050765e-07
. O 0 1.9600011569309572e-07

These O 0 3.8553519488004895e-08
mutations O 0 6.314475053947888e-10
resulted O 0 3.782055224554881e-10
in O 0 8.87485432365942e-11
the O 0 2.8826521725200394e-10
absence O 0 1.4497546496627933e-09
or O 0 1.0519488752303019e-10
a O 0 8.51453907380062e-11
dramatic O 0 3.7288497289900135e-10
decrease O 0 4.457984648098545e-09
of O 0 4.628593330835429e-08
CPO O 0 2.0181860236334614e-05
activity O 0 6.737170679116389e-07
. O 0 6.313632070487074e-07

The O 0 4.098247927686316e-07
two O 0 2.3147579408799857e-09
polymorphisms O 0 2.4848805679766883e-08
were O 0 1.0559799701326256e-09
localized O 0 2.541541865852537e-09
in O 0 4.976388745525639e-10
noncoding O 0 3.4212515043208214e-09
part O 0 7.496083753721905e-09
of O 0 1.5426326882561625e-08
the O 0 1.50255163866575e-09
gene O 0 4.262638506058458e-11
1 O 0 1.2503388324702769e-09
) O 0 7.348929104145085e-11
a O 0 8.634585269007289e-10
C O 0 2.8240000560231238e-08
/ O 0 1.6016201698221266e-08
G O 0 8.42196623551672e-09
polymorphism O 0 3.128452163991824e-09
in O 0 4.568063427523583e-10
the O 0 1.9741479562185305e-09
promotor O 0 1.4915924566594185e-06
region O 0 2.5056932528855214e-08
, O 0 1.1374827746379879e-09
142 O 0 4.122018282259887e-09
bp O 0 4.774862283341008e-09
upstream O 0 9.987239923958668e-10
from O 0 5.575991890438559e-10
the O 0 7.860244677360129e-10
transcriptional O 0 3.5396141573329487e-10
initiation O 0 1.0639780168020252e-09
site O 0 4.390996899417132e-09
( O 0 7.908781268772813e-12
- O 0 7.96831101101958e-10
142C O 0 3.602298193072784e-08
/ O 0 7.418847758344782e-09
G O 0 3.4777538626684645e-09
) O 0 8.476132989931884e-12
, O 0 3.886419398108076e-12
and O 0 1.8707305669829477e-12
2 O 0 1.2754756972821468e-10
) O 0 2.591088281433951e-11
a O 0 7.108850730297434e-10
6 O 0 2.792494591119521e-08
bp O 0 1.600905363829952e-08
deletion O 0 8.677709661952804e-10
polymorphism O 0 5.340230480044283e-10
in O 0 2.0338782047435444e-10
the O 0 1.9190811439973032e-10
3 O 0 5.997486396402962e-10
noncoding O 0 7.30820071126459e-10
part O 0 5.515109480214164e-10
of O 0 2.037470636651051e-09
the O 0 1.9596295697255073e-09
CPO O 0 4.668474105073983e-07
gene O 0 3.308756824083048e-09
, O 0 1.2940210014633635e-09
574 O 0 2.1654258830494655e-08
bp O 0 1.623116396842761e-08
downstream O 0 1.981541819517929e-09
of O 0 1.363717250235652e-09
the O 0 4.657582652889403e-10
last O 0 2.3447957464561853e-10
base O 0 1.2570245955245696e-09
of O 0 3.800108838714067e-11
the O 0 2.5976944553751657e-11
normal O 0 9.430476399785448e-10
termination O 0 6.776824434950868e-09
codon O 0 2.1897564650430468e-08
( O 0 7.913935062831001e-10
+ O 0 3.0980987730799825e-07
574 O 0 2.921434827385383e-07
delATTCTT O 0 1.3914552710048156e-06
) O 0 5.752205822773249e-09
. O 0 6.213940650923178e-08

Five O 0 1.7386170156896696e-06
intragenic O 0 5.583740858128294e-06
dimorphisms O 0 4.902134605799802e-06
are O 0 9.85861725588677e-10
now O 0 6.662968510262601e-10
well O 0 2.7804486490978775e-10
characterized O 0 8.241815563359012e-11
and O 0 2.7787504935927743e-11
the O 0 2.5987412222150397e-10
high O 0 5.674505865194135e-10
degree O 0 1.177896713500104e-08
of O 0 3.699537121093499e-09
allelic O 0 9.018990887454947e-09
heterogeneity O 0 7.995806239335934e-10
in O 0 3.922586699900421e-10
HC B-Disease 0 3.735873121968325e-07
is O 0 5.915223866281849e-10
demonstrated O 0 5.9763189952377616e-09
with O 0 6.171724589720817e-12
seven O 0 7.397785856122496e-11
new O 0 6.932471957599162e-11
different O 0 2.457145424628049e-11
mutations O 0 1.6286369822204882e-11
making O 0 1.4687490806908343e-11
a O 0 1.0564348007502389e-10
total O 0 2.539403687329411e-10
of O 0 6.206909985984055e-10
nineteen O 0 1.926649986216944e-07
CPO O 0 0.00018678004562389106
gene B-Disease 0 4.6364225454453845e-06
defects I-Disease 0 0.00010705454042181373
reported O 0 1.9656280869639886e-07
so O 0 2.7630882026841164e-09
far O 0 1.3725373060324841e-09
. O 0 1.5796782770749473e-09
. O 0 4.042477996790694e-08

Coincidence O 0 9.918137493514223e-07
of O 0 4.017451260551752e-08
two O 0 1.7811270514034305e-10
novel O 0 4.275220732985474e-10
arylsulfatase O 0 1.0036535513791023e-07
A O 0 1.9150572683201972e-08
alleles O 0 2.1865667054754567e-09
and O 0 3.153897365493208e-09
mutation O 0 7.742713137304236e-09
459 O 0 2.5709576689791902e-08
+ O 0 6.629501285715378e-07
1G O 0 3.0579535632568877e-06
> O 0 1.4926384039881668e-07
A O 0 7.22405335551457e-09
within O 0 2.290784367753318e-10
a O 0 8.192637124260216e-10
family O 0 6.168530131134276e-10
with O 0 5.590731211313482e-10
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 1.5036811795710037e-09
molecular O 0 2.0277038381699697e-10
basis O 0 1.0066090183613596e-09
of O 0 3.628145839318364e-10
phenotypic O 0 3.102841361624087e-08
heterogeneity O 0 5.043214628130954e-07
. O 0 2.9876180178689538e-06

In O 0 1.9798353179112382e-08
a O 0 1.0955065299356193e-08
family O 0 4.88777573970367e-10
with O 0 3.4768618539793295e-11
three O 0 4.6245646201370505e-10
siblings O 0 2.7028539406614982e-08
, O 0 3.8854966466495e-10
one O 0 3.343525109555934e-11
developed O 0 2.616576955105643e-10
classical O 0 3.8319438999678823e-07
late O 1 0.9999847412109375
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 4.055141111791727e-09
MLD B-Disease 1 1.0
) O 0 6.920057304959926e-10
, O 0 5.0265638873447926e-11
fatal O 0 3.9605066448622495e-10
at O 0 1.6441633610142503e-09
age O 0 1.652787906536446e-09
5 O 0 1.048310505069594e-08
years O 0 2.410725619128584e-09
, O 0 2.254202519091919e-10
with O 0 2.511838480268036e-11
deficient O 0 7.614220010054851e-08
arylsulfatase O 0 7.511639068980003e-06
A O 0 4.18460422224598e-06
( O 0 3.307198293001079e-09
ARSA O 0 1.1730956430255901e-05
) O 0 3.152632599423555e-10
activity O 0 1.9277033302955715e-09
and O 0 2.4717642863048006e-11
increased O 0 4.785344898117216e-10
galactosylsulfatide O 0 6.815078279487352e-08
( O 0 5.00359031985198e-10
GS O 0 0.452284574508667
) O 0 6.611965197578229e-09
excretion O 0 1.240452434103645e-07
. O 0 3.9309945520926703e-08

The O 0 1.8208581877843244e-06
two O 0 1.824924766857805e-09
other O 0 4.3936229654484293e-11
siblings O 0 6.9566259419673315e-09
, O 0 2.0694565505685603e-10
apparently O 0 1.452262754497724e-08
healthy O 0 2.8661091278081585e-08
at O 0 1.903847390849478e-08
12 O 0 7.164845072793469e-08
( O 0 1.3186972347423165e-10
1 O 0 5.1300347081451037e-08
/ O 0 2.0272541689791979e-07
2 O 0 1.7657921347336014e-08
) O 0 5.167147265616734e-11
and O 0 2.3066902554713664e-11
15 O 0 1.5600352953892838e-10
years O 0 3.617598928751242e-11
, O 0 9.86163494615111e-12
respectively O 0 1.1042659148197131e-10
, O 0 8.422307122557537e-12
and O 0 7.030688097681148e-12
their O 0 1.7519753703343355e-10
father O 0 1.647337732890719e-08
, O 0 1.1987431047799646e-09
apparently O 0 1.0396487226671525e-08
healthy O 0 8.714071242366117e-09
as O 0 1.5911927331302422e-10
well O 0 3.2473518318809624e-10
, O 0 1.8224263764743398e-10
presented O 0 3.445995488959852e-08
ARSA O 0 0.0001347101351711899
and O 0 1.1576818792491395e-07
GS O 1 0.9999998807907104
values O 0 5.712342598940268e-09
within O 0 1.0956662660488448e-10
the O 0 6.532321905616811e-11
range O 0 5.348344545019756e-10
of O 0 3.1328037386479934e-10
MLD B-Disease 1 1.0
patients O 0 7.969979947120009e-07
. O 0 2.0993456928408705e-07

Mutation O 0 1.0048024634556896e-08
screening O 0 2.8499607118703807e-09
and O 0 1.3999651438112437e-10
sequence O 0 9.245195581319976e-11
analysis O 0 1.4234062539753012e-10
disclosed O 0 7.023488013402357e-09
the O 0 1.1534975197236008e-09
involvement O 0 1.656715120645913e-08
of O 0 4.38952296732964e-09
three O 0 2.207273808174648e-10
different O 0 2.5860535934896234e-10
ARSA O 0 1.195003369502956e-05
mutations O 0 7.498885956636059e-09
being O 0 2.561187040228674e-09
the O 0 7.943575242030931e-10
molecular O 0 1.1945776590138735e-09
basis O 0 9.443783532958605e-09
of O 0 5.129112690127613e-09
intrafamilial O 0 5.545447493204847e-06
phenotypic O 0 1.1149101055707433e-06
heterogeneity O 0 5.572272129938938e-06
. O 0 7.3416504164924845e-06

The O 0 7.828786863228743e-08
late O 0 3.4334921110712457e-06
infantile O 0 2.414432628938812e-06
patient O 0 6.253400020028721e-09
inherited O 0 1.681873085246366e-09
from O 0 6.790716877702607e-10
his O 0 5.821135218297968e-08
mother O 0 9.21633080963602e-09
the O 0 4.7372519240695965e-09
frequent O 0 8.93844498417451e-10
0 O 0 1.511857838920605e-08
- O 0 2.1025851282274743e-08
type O 0 2.1809286465668265e-07
mutation O 0 3.108877777435737e-08
459 O 0 1.4371679846192364e-08
+ O 0 1.2225891055095417e-07
1G O 0 2.839973376467242e-07
> O 0 2.9023615510936907e-08
A O 0 4.044450552243006e-09
, O 0 6.553821721433373e-12
and O 0 1.2422500094561029e-12
from O 0 2.239053734087726e-11
his O 0 1.1852203662954253e-09
father O 0 1.9904522474689657e-08
a O 0 1.047402720111279e-09
novel O 0 4.3621950496230966e-10
, O 0 4.142490517278219e-11
single O 0 3.1410365974871013e-10
basepair O 0 3.20252695473755e-08
microdeletion O 0 5.626348098530798e-08
of O 0 7.21736048703292e-09
guanine O 0 8.067534196243287e-09
at O 0 5.557456272953232e-09
nucleotide O 0 4.617956239627574e-09
7 O 0 2.1519293014193863e-08
in O 0 1.6822645498848487e-09
exon O 0 7.5630932627746e-09
1 O 0 1.540368721464347e-08
( O 0 3.9992356648532734e-10
7delG O 0 4.0131013179234287e-07
) O 0 3.872233644841572e-09
. O 0 4.9679726998874685e-08

The O 0 2.512250034669705e-07
two O 0 7.682971592259946e-09
clinically O 0 3.7362685816333396e-06
unaffected O 0 2.1179566545015405e-08
siblings O 0 5.499198874048261e-09
carried O 0 2.368475859881869e-09
the O 0 1.5669815445207291e-09
maternal O 0 9.679706636234187e-06
mutation O 0 1.708926689047985e-08
459 O 0 1.1234295271833616e-08
+ O 0 2.5457694619035465e-07
1G O 0 1.8657225382412435e-06
> O 0 1.1678883282684183e-07
A O 0 8.732473411043884e-09
and O 0 3.39877639921049e-11
, O 0 8.343577564962068e-12
on O 0 3.1550026480253734e-10
their O 0 3.2243802072784433e-10
paternal O 0 3.2559998999204254e-06
allele O 0 2.367682228054946e-08
, O 0 3.563227490843701e-10
a O 0 2.0124692190481852e-10
novel O 0 7.896143183749871e-10
cytosine O 0 2.6792061902369824e-09
to O 0 1.5503830164131926e-10
thymidine O 0 2.508481067309276e-08
transition O 0 1.3633122186718083e-08
at O 0 6.487529624621402e-09
nucleotide O 0 1.5445433376726214e-08
2435 O 0 7.985615297911863e-07
in O 0 5.661589863592553e-09
exon O 0 2.426364886787269e-08
8 O 0 2.749977134897108e-08
, O 0 2.2376586694683454e-10
resulting O 0 5.854308010588838e-11
in O 0 3.334901452212158e-11
substitution O 0 2.886064276452771e-09
of O 0 8.015595409638365e-10
alanine O 0 1.836770735508253e-08
464 O 0 1.42018601323457e-08
by O 0 2.4320441216474364e-09
valine O 0 1.6603344192844816e-05
( O 0 9.371002862579303e-10
A464V O 0 9.041149269251036e-07
) O 0 1.7254462303384344e-09
. O 0 2.3236815138716338e-08

The O 0 5.716748319173348e-07
fathers O 0 1.3675203263119329e-06
genotype O 0 3.3818650990724564e-08
thus O 0 7.992302819559427e-09
was O 0 3.5032407197377324e-08
7delG O 0 3.848089818347944e-06
/ O 0 1.8080108930007555e-05
A464V O 0 5.6984859838848934e-05
. O 0 5.605631372418429e-07

Mutation O 0 6.303374107119453e-07
A464V O 0 1.0034782462753356e-06
was O 0 1.0730436983408254e-08
not O 0 7.504333265906382e-10
found O 0 3.680713026033011e-11
in O 0 4.216056323502748e-11
18 O 0 5.585404583285936e-09
unrelated O 0 5.545451742250407e-08
MLD B-Disease 1 1.0
patients O 0 2.888065466777334e-07
and O 0 2.2529398346904372e-09
50 O 0 2.6776194772537565e-07
controls O 0 2.6932311811833642e-06
. O 0 3.241568265366368e-06

A464V O 0 2.5247511075576767e-05
, O 0 8.338211898717418e-09
although O 0 3.311869667399492e-09
clearly O 0 3.609526899595039e-08
modifying O 0 1.8656514839676674e-06
ARSA O 0 0.03179014474153519
and O 0 1.3721344203077024e-06
GS O 1 1.0
levels O 0 7.214194283733377e-06
, O 0 4.0159758851743277e-10
apparently O 0 6.228259685769899e-09
bears O 0 1.6426000115643546e-08
little O 0 7.431561477311277e-10
significance O 0 2.8948690111718633e-09
for O 0 1.908531943595193e-10
clinical O 0 1.5637541261881438e-09
manifestation O 0 8.031209475234391e-09
of O 0 8.718227029191894e-09
MLD B-Disease 1 1.0
, O 0 8.904433634882025e-09
mimicking O 0 1.17788481190928e-07
the O 0 3.696830219723779e-08
frequent O 0 1.3759880346242426e-07
ARSA O 0 0.002184106269851327
pseudodeficiency O 0 0.0001695450337138027
allele O 0 1.0105657111125765e-06
. O 0 4.859039677285182e-07

Our O 0 4.192102949218679e-07
results O 0 7.460424278349365e-09
demonstrate O 0 1.7342026703559554e-09
that O 0 1.1458674287201376e-11
in O 0 1.1128859986331285e-11
certain O 0 8.492027914197564e-11
genetic O 0 7.689667236299158e-10
conditions O 0 8.602436096794008e-09
MLD B-Disease 1 1.0
- O 0 4.070346403750591e-05
like O 0 3.0474072332253854e-07
ARSA O 1 0.9998699426651001
and O 0 1.2171078651590506e-06
GS O 1 1.0
values O 0 2.3612061639255444e-08
need O 0 1.0670672123680447e-09
not O 0 3.29544481980637e-11
be O 0 4.07470585050973e-11
paralleled O 0 1.0555269991385785e-09
by O 0 6.194394303049577e-11
clinical O 0 3.3153597200907825e-08
disease O 0 2.9008659918616786e-09
, O 0 3.0467770667508276e-11
a O 0 1.5533606345652373e-10
finding O 0 2.074448834932241e-09
with O 0 4.319981872225043e-11
serious O 0 5.904788658028792e-09
diagnostic O 0 1.703513589745853e-06
and O 0 2.026159329204802e-08
prognostic O 0 4.370159513200633e-05
implications O 0 9.288562523579458e-07
. O 0 4.642058399895177e-07

Moreover O 0 5.850866386936104e-07
, O 0 7.898075082835021e-09
further O 0 2.8946217867087398e-08
ARSA O 0 3.817337710643187e-05
alleles O 0 1.5565714051035684e-08
functionally O 0 1.6778017197793815e-08
similar O 0 1.4831553762917338e-09
to O 0 2.448184543979437e-09
A464V O 0 7.902900733824936e-08
might O 0 7.351765307639369e-10
exist O 0 6.362494975320487e-10
which O 0 1.268676570048699e-11
, O 0 3.6008143081828203e-12
together O 0 1.1832940226622068e-12
with O 0 4.6802865402706395e-12
0 O 0 1.460766441141459e-08
- O 0 3.540178283856221e-08
type O 0 3.906493262206823e-08
mutations O 0 3.101036583075256e-08
, O 0 3.276168780708133e-10
may O 0 5.687858628533604e-09
cause O 0 2.4429057887687122e-08
pathological O 0 1.4112878261585138e-06
ARSA O 0 0.0028395659755915403
and O 0 1.7254824058454687e-07
GS O 1 1.0
levels O 0 1.9000203792529646e-06
, O 0 3.831674214027636e-11
but O 0 4.277206193392669e-12
not O 0 2.3348602565254062e-11
clinical O 0 3.283801286446675e-10
outbreak O 0 1.1426553453430799e-10
of O 0 6.684005432466833e-11
the O 0 5.053772400565038e-10
disease O 0 3.4660840864120246e-10
. O 0 4.329337999209315e-10
. O 0 1.9511045223907786e-08

Human O 0 9.405607124790549e-05
MLH1 O 1 0.9999998807907104
deficiency O 1 0.915945291519165
predisposes O 0 0.00020120551926083863
to O 0 2.209105332440231e-06
hematological B-Disease 1 0.9999991655349731
malignancy I-Disease 1 0.9999955892562866
and O 0 6.360061632904035e-08
neurofibromatosis B-Disease 0 0.000855339749250561
type I-Disease 0 1.3673502508027013e-05
1 I-Disease 0 0.2377890795469284
. O 0 6.5952431214100216e-06

Heterozygous O 0 2.6972540467795625e-07
germ O 0 2.414098844383261e-06
- O 0 2.3449909747341735e-07
line O 0 2.6079501225240165e-08
mutations O 0 5.27789367765763e-10
in O 0 1.4567834438761196e-10
the O 0 3.2579047792857807e-10
DNA O 0 1.2130169091406628e-09
mismatch O 0 5.6351225907746993e-08
repair O 0 1.9317733404022874e-06
genes O 0 1.532004034743295e-07
lead O 0 6.032977125869365e-06
to O 0 2.6241719751851633e-05
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00011214690312044695

The O 0 4.0864654238248477e-07
disease O 0 2.959464318053051e-08
susceptibility O 0 4.71437511251338e-09
of O 0 6.687133624616592e-10
individuals O 0 6.80700079636054e-11
who O 0 1.3455800029760212e-08
constitutionally O 0 7.899847696535289e-05
lack O 0 0.00015172759594861418
both O 0 6.950939024363834e-08
wild O 0 1.8074258889555495e-07
- O 0 7.258267231691207e-08
type O 0 2.253710285060606e-08
alleles O 0 1.90890059315052e-09
is O 0 1.4909518064598615e-10
unknown O 0 4.233088191085699e-08
. O 0 8.368615311837857e-08

We O 0 1.6564030147492304e-07
have O 0 8.636429904562704e-10
identified O 0 4.697068289871709e-10
three O 0 1.2113556685511284e-11
offspring O 0 2.0760390628815628e-10
in O 0 2.3855761810409604e-10
a O 0 6.073129998895865e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9773750901222229
who O 0 2.2035743896253734e-08
developed O 0 3.57056499922237e-08
hematological B-Disease 0 0.00970458984375
malignancy I-Disease 0 2.8128966732765548e-05
at O 0 9.769711084572918e-08
a O 0 1.0570359032513466e-09
very O 0 5.5175055496681225e-11
early O 0 2.4592718972371586e-09
age O 0 1.0538030448259406e-09
, O 0 6.179525641192285e-11
and O 0 3.8524568951592286e-11
at O 0 1.11486286868967e-09
least O 0 1.3941137133599568e-10
two O 0 2.150674603684788e-11
of O 0 2.554388645048533e-11
them O 0 2.74430356911326e-11
displayed O 0 3.2906701363799584e-08
signs O 0 3.790476625908923e-07
of O 0 6.068442814921582e-08
neurofibromatosis B-Disease 0 0.0001563467230880633
type I-Disease 0 2.7022485937777674e-06
1 I-Disease 0 1.2228728337504435e-05
( O 0 6.617201009362361e-09
NF1 B-Disease 0 2.7854313884745352e-05
) O 0 5.065927766167988e-08
. O 0 3.3362366025357915e-07

DNA O 0 7.030081849990211e-09
sequence O 0 2.174272151211909e-10
analysis O 0 2.980756197423773e-10
and O 0 3.804859205480682e-11
allele O 0 2.622853045863849e-10
- O 0 2.1995408272523775e-10
specific O 0 1.6066974140027668e-10
amplification O 0 2.012907840409639e-09
in O 0 3.2612432199208286e-10
two O 0 1.342837924189766e-10
siblings O 0 1.030720309103117e-08
revealed O 0 1.57642237041955e-08
a O 0 1.3635021112179402e-08
homozygous O 0 1.3302964134709327e-06
MLH1 O 0 0.00035734171979129314
mutation O 0 3.673774529033835e-08
( O 0 2.664624354498102e-10
C676T O 0 1.262823502656829e-06
- O 0 1.1799855883509736e-06
- O 0 6.434542001443333e-07
> O 0 1.77768265530176e-06
Arg226Stop O 0 7.666441888432018e-06
) O 0 9.766255582022154e-10
. O 0 9.520793931017124e-09

Thus O 0 3.8571985783164564e-07
, O 0 4.2598875538146785e-09
a O 0 2.369189733286703e-09
homozygous O 0 1.1472140570845113e-08
germ O 0 8.978452569863293e-06
- O 0 5.123975370224798e-06
line O 0 1.507079332441208e-06
MLH1 O 0 0.0005112425424158573
mutation O 0 1.0436501440835855e-08
and O 0 2.2287903467255177e-10
consequent O 0 6.583822482753021e-07
mismatch O 0 6.188432598719373e-05
repair O 1 0.999784529209137
deficiency O 0 7.850927795516327e-05
results O 0 9.139710073213791e-07
in O 0 3.266799808443466e-08
a O 0 2.2555596501661057e-08
mutator O 0 2.696981573535595e-05
phenotype O 0 2.651182740009972e-08
characterized O 0 7.204561947027344e-11
by O 0 5.264255611286961e-12
leukemia B-Disease 0 8.035901544189983e-08
and O 0 5.094986210707475e-09
/ O 1 1.0
or O 1 0.9945747256278992
lymphoma B-Disease 1 1.0
associated O 1 0.9999978542327881
with O 0 3.3731279991400243e-09
neurofibromatosis B-Disease 1 0.9730165004730225
type I-Disease 0 0.0004253346414770931
1 I-Disease 0 0.037207815796136856
. O 0 4.2651421949813084e-07
. O 0 4.4372291085892357e-07

Missense O 0 1.090222576749511e-05
mutations O 0 3.004905479997433e-08
in O 0 6.9804571012355154e-09
the O 0 4.88971751977374e-09
most O 0 8.997606826266491e-11
ancient O 0 8.016971531077388e-10
residues O 0 8.410360408106499e-09
of O 0 3.958726679798019e-09
the O 0 2.154705747159369e-08
PAX6 O 0 6.378399120876566e-05
paired O 0 2.5126720970547467e-07
domain O 0 4.159559523486678e-07
underlie O 0 1.6164759699677234e-06
a O 0 5.851946482948733e-09
spectrum O 0 5.474367981150863e-08
of O 0 4.381150109367127e-09
human O 0 1.6853154249929503e-07
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 0.9999998807907104
. O 0 0.0008209723164327443

Mutations O 0 2.3497905488056858e-07
of O 0 3.1896032481881775e-08
the O 0 4.6160804068051675e-09
human O 0 2.7142386116452144e-09
PAX6 O 0 0.00010999345249729231
gene O 0 5.307342689775396e-06
underlie O 1 0.9999997615814209
aniridia B-Disease 1 1.0
( O 0 8.239598173531704e-06
congenital B-Disease 1 1.0
absence I-Disease 1 1.0
of I-Disease 0 0.00016828280058689415
the I-Disease 0 4.188546256500558e-07
iris I-Disease 0 3.299803097434051e-07
) O 0 5.378676393164028e-10
, O 0 2.2940462029996667e-10
a O 0 2.653741448810365e-09
rare O 0 5.154781774763251e-07
dominant O 1 0.9999995231628418
malformation B-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 1.0
eye I-Disease 1 1.0
. O 0 3.993811333202757e-05

The O 0 4.2822108525797375e-07
spectrum O 0 4.912211011287582e-07
of O 0 6.790062911932182e-08
PAX6 O 0 0.0005788528942503035
mutations O 0 1.661871209535093e-07
in O 0 5.831881821904972e-08
aniridia B-Disease 1 1.0
patients O 0 8.857060151967744e-08
is O 0 1.2857484174566558e-11
highly O 0 7.258035145119024e-11
biased O 0 6.038510247385886e-10
, O 0 1.0505428124640837e-11
with O 0 1.4478401116901907e-12
92 O 0 2.0607851425324952e-08
% O 0 1.5479068027346443e-10
of O 0 1.0281196727301989e-10
all O 0 3.0111257237619427e-11
reported O 0 5.2937602218472435e-11
mutations O 0 5.7236358014245425e-11
leading O 0 2.2906271324174554e-10
to O 0 1.5101020434116208e-09
premature O 0 3.6321313245935016e-07
truncation O 0 3.813420335063711e-06
of O 0 1.5791600844750064e-06
the O 0 1.5657238350286207e-07
protein O 0 4.331785152800194e-09
( O 0 3.210804955244839e-10
nonsense O 0 4.821704280288941e-08
, O 0 3.118894031928221e-10
splicing O 0 1.0113744508544187e-08
, O 0 1.777930691559959e-09
insertions O 0 2.074327021261979e-08
and O 0 6.916560657543869e-10
deletions O 0 1.8770598408934802e-09
) O 0 9.735150185985475e-12
and O 0 2.2273188501897856e-11
just O 0 1.3271679588644503e-10
2 O 0 1.1685957757023857e-09
% O 0 9.675622109073245e-11
leading O 0 7.647757427342583e-11
to O 0 7.807958446459651e-11
substitution O 0 6.873834390574984e-09
of O 0 1.747738487267725e-08
one O 0 1.3893229899863968e-09
amino O 0 6.715880629393212e-10
acid O 0 1.7264230323110752e-10
by O 0 1.4432888044424441e-11
another O 0 1.5114275386807208e-09
( O 0 6.086219306311591e-10
missense O 0 3.6617007026507054e-07
) O 0 4.5892609712439025e-09
. O 0 7.271056290392153e-08

The O 0 8.585654853732194e-08
extraordinary O 0 1.0885247370140405e-08
conservation O 0 1.7868657664621423e-08
of O 0 1.6192566176798096e-09
the O 0 1.1270689936893064e-09
PAX6 O 0 4.396261772399157e-07
protein O 0 2.817880817573837e-09
at O 0 1.5439690415064433e-08
the O 0 4.760331240305504e-09
amino O 0 2.880484117895321e-08
acid O 0 3.0279707630143093e-08
level O 0 3.537148245413846e-07
amongst O 0 5.472091757496855e-08
vertebrates O 0 2.9145051030354807e-06
predicts O 0 1.559516960014662e-07
that O 0 2.3736044241218224e-09
pathological O 0 9.015706154968939e-07
missense O 0 1.3029671208641957e-06
mutations O 0 5.0143311725037165e-09
should O 0 1.5508214712411927e-09
in O 0 5.739949626715202e-10
fact O 0 7.66582686217987e-10
be O 0 7.647236177632522e-10
common O 0 3.488049016286965e-10
even O 0 1.1219894457958901e-10
though O 0 3.734869358229531e-11
they O 0 7.411188329697893e-11
are O 0 2.807347410094252e-11
hardly O 0 5.775071976188428e-09
ever O 0 2.1051400622695837e-09
seen O 0 6.290796328300985e-09
in O 0 6.586689860199613e-09
aniridia B-Disease 1 1.0
patients O 0 2.710748390200024e-07
. O 0 1.0002671757547432e-07

This O 0 6.673403163404146e-08
indicates O 0 4.0677623047713496e-08
that O 0 4.021584801283673e-11
there O 0 1.8992852429677853e-11
is O 0 3.352156443051091e-12
a O 0 1.222305676812363e-11
heavy O 0 2.5517663537755197e-09
ascertainment O 0 8.826011708151782e-07
bias O 0 1.3999025938460363e-08
in O 0 1.6602635932727594e-09
the O 0 2.038664126402523e-09
selection O 0 3.308693541370644e-09
of O 0 4.0746850338280183e-10
patients O 0 8.157985398327128e-11
for O 0 5.4526421572331785e-11
PAX6 O 0 1.2395187241054373e-06
mutation O 0 6.587038137162438e-10
analysis O 0 2.5150229121528866e-10
and O 0 5.915423706426282e-11
that O 0 7.856704176134599e-11
the O 0 2.4050490488036758e-09
missing O 0 3.492180553621438e-07
PAX6 O 0 0.0009622685029171407
missense O 0 5.1427992730168626e-05
mutations O 0 2.944179584574158e-07
frequently O 0 2.4763121331261573e-08
may O 0 2.04373424850246e-08
underlie O 0 8.347442985723319e-07
phenotypes O 0 5.5900752471416126e-08
distinct O 0 8.409634655315301e-10
from O 0 1.6847080397397463e-09
textbook O 0 6.569192009919789e-06
aniridia B-Disease 1 1.0
. O 0 8.386126069126476e-07

Here O 0 5.819059083478351e-07
we O 0 3.764555955854121e-08
present O 0 1.1041443315207289e-09
four O 0 1.2607271893116945e-09
novel O 0 1.6607266672963306e-08
PAX6 O 0 0.0002321149077033624
missense O 0 2.0508374291239306e-05
mutations O 0 1.2789806191904063e-07
, O 0 3.1510349884911193e-09
two O 0 7.22735760128046e-10
in O 0 8.541741203238473e-10
association O 0 3.9062061918393454e-10
with O 0 3.3174296643068146e-11
atypical O 0 1.1427016488596564e-07
phenotypes O 0 1.833437295317708e-06
ectopia B-Disease 0 8.676659490447491e-06
pupillae I-Disease 0 3.38625295626116e-06
( O 0 1.2288046968844668e-10
displaced B-Disease 0 7.82711140345782e-09
pupils I-Disease 0 1.1391029453022838e-08
) O 0 2.779325880553074e-09
and O 0 9.520470456436669e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9998652935028076
( O 0 1.6507203937088377e-10
searching B-Disease 0 3.426660555305716e-08
gaze I-Disease 0 1.5393825947285222e-07
) O 0 2.0592035021582689e-10
, O 0 1.2096754153922973e-10
and O 0 6.184183026780588e-11
two O 0 9.617297236363953e-11
in O 0 2.553099121005431e-10
association O 0 1.291778767287255e-10
with O 0 1.0224616292520139e-11
more O 0 4.673815223732447e-10
recognizable O 0 1.3084909369354136e-06
aniridia B-Disease 1 1.0
phenotypes O 0 4.670108864957001e-06
. O 0 6.216287147253752e-07

Strikingly O 0 1.53019827848766e-05
, O 0 3.538159631943927e-08
all O 0 5.020935223143397e-09
four O 0 5.900935295954923e-10
mutations O 0 2.4234935239175748e-11
are O 0 1.2476313385190174e-11
located O 0 6.363086446636856e-11
within O 0 5.339781949942335e-10
the O 0 2.5816110138521253e-08
PAX6 O 0 2.9610444471472874e-05
paired O 0 3.06551100948127e-07
domain O 0 3.3959506140490703e-07
and O 0 4.302586287252552e-09
affect O 0 2.062649073764078e-08
amino O 0 2.4958899391691602e-09
acids O 0 8.829239006580281e-10
which O 0 7.88135962742631e-12
are O 0 6.991702681223566e-13
highly O 0 1.4648685042750742e-11
conserved O 0 1.8408725932506087e-10
in O 0 1.9111994209453087e-09
all O 0 2.6666748809134333e-09
known O 0 5.345899722897229e-09
paired O 0 1.331037857710271e-08
domain O 0 3.478611532159448e-08
proteins O 0 1.7464113488685484e-09
. O 0 2.593811743167862e-08

Our O 0 1.4730823068020982e-06
results O 0 4.241744377964096e-08
support O 0 1.3149160871250842e-08
the O 0 1.1838646729600555e-09
hypothesis O 0 6.779328765027515e-10
that O 0 2.3273182426369887e-12
the O 0 7.674977840765873e-12
under O 0 4.878105558381307e-11
- O 0 7.76474495811641e-10
representation O 0 2.7588857864913052e-09
of O 0 8.368133741498696e-09
missense O 0 1.8066226630253368e-06
mutations O 0 3.196650055770078e-08
is O 0 2.4552776478614646e-10
caused O 0 2.861026693334878e-10
by O 0 1.0989375381909028e-10
ascertainment O 0 4.7132100007729605e-05
bias O 0 1.4621483046539652e-07
and O 0 3.603098652771308e-10
suggest O 0 1.7720669376330989e-09
that O 0 4.011286962313232e-12
a O 0 8.808338607113608e-12
substantial O 0 8.677197294026939e-10
burden O 0 1.7216821390775294e-07
of O 0 7.414443530251447e-07
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9997950196266174
related I-Disease 0 0.004952539689838886
disease I-Disease 0 2.3531223632744513e-05
remains O 0 2.3999902065696688e-09
to O 0 1.2809588112450143e-10
be O 0 6.160464360860374e-10
uncovered O 0 1.3889978056624841e-08
. O 0 1.0563632635296472e-08
. O 0 1.1541565214656657e-07

The O 0 2.366883649074225e-07
chromosomal O 0 1.232793778171981e-07
order O 0 3.6275334736046716e-08
of O 0 1.2814976635411313e-08
genes O 0 1.3789451802637132e-09
controlling O 0 1.8166499415883663e-08
the O 0 1.947299779203604e-06
major O 0 7.579206794616766e-06
histocompatibility O 0 0.1968238651752472
complex O 1 0.9999829530715942
, O 0 5.4740101340655656e-09
properdin O 0 2.1063989663616667e-07
factor O 0 1.9991270860941768e-08
B O 0 7.551095677627018e-07
, O 0 2.3523381159629153e-11
and O 0 2.433958243286405e-11
deficiency B-Disease 0 6.282932929480012e-08
of I-Disease 0 3.3141488529508933e-05
the I-Disease 0 0.00242607481777668
second I-Disease 0 5.3152798500377685e-06
component I-Disease 0 4.2227986796206096e-07
of I-Disease 0 5.9257661888523216e-08
complement I-Disease 0 1.2762187679982162e-06
. O 0 1.5947847487041145e-06

The O 0 8.260460759856869e-08
relationship O 0 1.709545172090543e-09
of O 0 5.610516939924537e-09
the O 0 7.992939643486352e-10
genes O 0 4.546773027525042e-11
coding O 0 2.7162014859527517e-09
for O 0 2.973102319892007e-10
HLA O 0 6.427709564604811e-08
to O 0 1.4719847563071653e-08
those O 0 2.298085055585375e-09
coding O 0 2.1078010448150053e-08
for O 0 8.636759640801017e-10
properdin O 0 6.177318567779366e-08
Factor O 0 7.1288415171011366e-09
B O 0 6.978303446203427e-08
allotypes O 0 1.3888283412200053e-08
and O 0 1.1692033625998466e-11
for O 0 7.44796238572043e-11
deficiency B-Disease 0 9.277526524797963e-10
of I-Disease 0 1.4103385126418289e-08
the I-Disease 0 1.868106380698009e-08
second I-Disease 0 9.58803880735104e-09
component I-Disease 0 9.925091859486201e-09
of I-Disease 0 7.406730340164813e-09
complement I-Disease 0 2.658931350651983e-07
( O 0 4.921342888764002e-09
C2 O 0 1.1553845070011448e-05
) O 0 1.5588098867258537e-10
was O 0 2.6720565760030013e-09
studied O 0 1.3575666146792287e-09
in O 0 1.3150251720883688e-10
families O 0 1.6792301923973518e-11
of O 0 6.414252462505488e-11
patients O 0 2.9004770807361524e-10
with O 0 3.033777673522309e-10
connective O 0 0.00021650624694302678
tissue O 1 0.9999998807907104
disorders O 1 0.9999979734420776
. O 0 2.3762249838910066e-06

Patients O 0 1.4265964409787557e-07
were O 0 1.040525110518331e-09
selected O 0 1.4100285383733535e-09
because O 0 7.54480228293275e-11
they O 0 1.6494772214770137e-10
were O 0 1.3900413042833293e-09
heterozygous O 0 8.029892306637976e-09
or O 0 1.4232610645592558e-08
homozygous O 0 5.119818524690345e-06
for O 0 1.3918447621108498e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.9846575014526024e-06

12 O 0 7.023905368441774e-07
families O 0 5.865990471143334e-10
with O 0 4.748935619747208e-11
15 O 0 1.4463911846007704e-08
matings O 0 5.996303116262425e-07
informative O 0 1.2562193660414778e-05
for O 0 8.105283995973878e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 1.5688820553805272e-07
found O 0 4.046889046094293e-09
. O 0 9.823203583891882e-09

Of O 0 3.40473616233794e-06
57 O 0 1.7693239442451159e-06
informative O 0 3.987841523667157e-07
meioses O 0 4.9974619287240785e-06
, O 0 1.1874016214719063e-09
two O 0 3.403323803330416e-11
crossovers O 0 2.2328920656899953e-10
were O 0 7.266775375880385e-11
noted O 0 3.2301294972114647e-10
between O 0 4.419646593145643e-10
the O 0 7.264316536748083e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 8.351450642152258e-10
and O 0 8.628456282799846e-11
the O 0 1.100099900064322e-09
HLA O 0 3.797426373353119e-08
- O 0 1.9104282955595409e-07
B O 0 4.1524492644384736e-07
gene O 0 1.342451150243562e-10
, O 0 7.230342193020878e-12
with O 0 2.0628798961998956e-13
a O 0 9.66246787442726e-12
recombinant O 0 1.6773990182961107e-11
fraction O 0 7.053663209077854e-10
of O 0 8.126591843904407e-09
0 O 0 3.2932106819316687e-07
. O 0 2.558201117608405e-07

035 O 0 0.004843839444220066
. O 0 2.5608604119042866e-05

A O 0 3.741264151813084e-07
lod O 0 1.6476651580887847e-05
score O 0 3.278423150732124e-07
of O 0 1.650035841294084e-08
13 O 0 2.147824673670584e-08
was O 0 7.803361290470434e-10
calculated O 0 4.287706856231921e-10
for O 0 1.1835164792639574e-10
linkage O 0 7.647417419320846e-07
between O 0 4.007661118521355e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.2674539195955958e-09
HLA O 0 5.6250286206704914e-08
- O 0 3.6285644711142595e-08
B O 0 1.324777230138352e-07
at O 0 2.8614086100553493e-10
a O 0 5.071853527438552e-12
maximum O 0 7.969218340786455e-11
likelihood O 0 2.9458088746103783e-11
value O 0 7.954598091330922e-10
of O 0 7.545597480174138e-10
the O 0 3.6432629135774164e-10
recombinant O 0 9.495104702494928e-11
fraction O 0 1.6507936129173117e-09
of O 0 2.994559489266635e-09
0 O 0 6.432946264567363e-08
. O 0 8.966798503706741e-08

04 O 0 0.0028565817046910524
. O 0 1.180619619844947e-05

18 O 0 2.2022386758635548e-07
families O 0 2.0668530775758143e-10
with O 0 8.489983022164083e-12
21 O 0 1.011331995925957e-08
informative O 0 4.023507305106477e-09
matings O 0 9.518578814038392e-09
for O 0 2.4731248160492214e-09
both O 0 2.0957935387144744e-09
properdin O 0 1.1719376971086604e-06
Factor O 0 1.4163452988213976e-07
B O 0 9.79769083642168e-07
allotype O 0 2.6198139835287293e-07
and O 0 6.219448289712659e-10
HLA O 0 2.7052578843722586e-07
- O 0 4.80992866869201e-07
B O 0 2.2602378066949314e-06
were O 0 2.686641575877502e-09
found O 0 6.069861835378276e-10
. O 0 8.882416580036079e-09

Of O 0 3.7359411635407014e-06
72 O 0 3.931601440854138e-06
informative O 0 2.180664466777671e-07
meioses O 0 2.0874581423413474e-06
, O 0 1.1443571645841644e-09
three O 0 2.1305186781450658e-10
recombinants O 0 9.778156595530163e-08
were O 0 5.961393600983911e-09
found O 0 7.336468654806083e-10
, O 0 5.7260703123507284e-11
giving O 0 2.6352287019193454e-10
a O 0 7.09917263863602e-11
recombinant O 0 6.910399336090833e-11
fraction O 0 1.9400157036386645e-09
of O 0 1.9719209376489744e-08
0 O 0 5.131620355314226e-07
. O 0 3.105624557520059e-07

042 O 0 0.0013347904896363616
. O 0 1.1264547538303304e-05

A O 0 1.485350935581664e-07
lod O 0 4.752595032186946e-06
score O 0 7.445756722290753e-08
of O 0 5.962348836874298e-09
16 O 0 2.7507640609769624e-08
between O 0 4.833780598012538e-10
HLA O 0 5.119625257066218e-07
- O 0 2.1922026007814566e-06
B O 0 3.6627800454880344e-06
and O 0 9.220788022012982e-11
Factor O 0 2.0726256266812015e-09
B O 0 8.013554975150328e-08
allotypes O 0 3.2808248562332665e-08
was O 0 8.971700604654131e-10
calculated O 0 1.491589740609811e-09
at O 0 5.406271541552599e-10
a O 0 3.733046510800975e-11
maximum O 0 3.0209357237964696e-10
likelihood O 0 4.163664552025992e-11
value O 0 6.815812914062747e-10
of O 0 4.362020189496718e-10
the O 0 1.5677491249643793e-10
recombinant O 0 2.1188474585986938e-10
fraction O 0 1.083492739972769e-09
of O 0 1.5931552743708721e-09
0 O 0 6.331775637136161e-08
. O 0 1.1965650514866866e-07

04 O 0 0.0031942634377628565
. O 0 1.349125614069635e-05

A O 0 4.515218776646179e-08
crossover O 0 2.9486055819205603e-09
was O 0 6.161756660461037e-10
shown O 0 1.1245303993545619e-10
to O 0 8.130304068876271e-11
have O 0 1.0543588571665374e-11
occurred O 0 1.0434481056975642e-10
between O 0 2.2004787315205165e-12
genes O 0 7.53121089797082e-12
for O 0 2.2170616037486823e-11
Factor O 0 3.86486759262894e-10
B O 0 1.598488807985632e-08
and O 0 1.939658503258279e-11
HLA O 0 5.02483432640588e-09
- O 0 2.1218019341517902e-08
D O 0 4.36956071325767e-08
, O 0 1.833727059086243e-10
in O 0 4.124931646254382e-11
which O 0 4.681034206088786e-13
HLA O 0 9.281279078621196e-10
- O 0 6.26732266084673e-09
D O 0 5.000275393740594e-08
segregared O 0 1.245912471858901e-06
with O 0 1.407483296578249e-10
HLA O 0 8.265817541541765e-07
- O 0 2.0715774553536903e-06
A O 0 4.830997113458579e-06
and O 0 8.20693646375048e-09
B O 0 3.863563506456558e-06
. O 0 8.788281213867322e-09

These O 0 1.8839401150216872e-08
studies O 0 4.0105430088033245e-09
suggest O 0 8.311786259262988e-10
that O 0 7.626559106466146e-12
the O 0 1.7973088295430983e-11
genes O 0 2.343506812219065e-11
for O 0 1.8014006952782324e-10
Factor O 0 2.0554018931306928e-07
B O 1 0.9999477863311768
and O 0 1.1046609870390967e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 9.21092646599675e-11
located O 0 2.407841981355574e-11
outside O 0 8.113975463741596e-11
those O 0 7.353777309315745e-12
for O 0 1.2250644942923827e-11
HLA O 0 9.86855575035861e-09
, O 0 5.615714837592378e-11
that O 0 9.94914740870545e-12
the O 0 7.156680803532822e-11
order O 0 1.0417323670353085e-09
of O 0 4.1476949652619055e-10
genese O 0 5.316049112025212e-08
is O 0 1.862812681885373e-11
HLA O 0 1.1049828829712283e-09
- O 0 5.354236609633745e-09
A O 0 6.060403734409192e-08
, O 0 3.9745044061456625e-11
- O 0 3.524503466856288e-10
B O 0 7.618705666345704e-09
, O 0 4.3508816341408796e-12
- O 0 1.1746333072881754e-10
D O 0 2.002698229475186e-09
, O 0 6.826555987160532e-11
Factor O 0 3.6385372936820204e-08
B O 0 6.638468221353833e-06
allotype O 0 3.790855043916963e-05
, O 0 2.783094430469646e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 4.961667535163805e-11
that O 0 8.873795795394379e-13
the O 0 4.585107033633351e-12
genes O 0 2.7322285059416807e-11
coding O 0 5.3390341037129474e-08
for O 0 1.2973016794148862e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.7511193323448424e-09
Factor O 0 3.733336839673029e-08
B O 0 6.752994607950313e-08
allotypes O 0 1.203685151551781e-09
are O 0 3.8529232972497884e-13
approximately O 0 7.379566521661246e-14
3 O 0 4.584407072710794e-12
- O 0 2.3836555992917674e-11
- O 0 5.987302875709588e-10
5 O 0 3.488835886855668e-09
centimorgans O 0 5.928671598098845e-08
from O 0 1.5101819794693938e-10
the O 0 1.5341686254721765e-10
HLA O 0 8.185269351201896e-09
- O 0 2.2427029122695785e-08
A O 0 5.252712043102292e-08
and O 0 3.007620541506384e-10
HLA O 0 7.632904441834398e-08
- O 0 4.8782617056986055e-08
B O 0 1.1630888252511795e-07
loci O 0 6.678503861046181e-10
, O 0 6.9029127032493864e-12
and O 0 5.334816247613838e-13
that O 0 2.6411422419762853e-13
the O 0 9.217020376095508e-12
apparent O 0 5.015457493762199e-10
lack O 0 6.681261766061652e-08
of O 0 1.0203669020825146e-08
recombinants O 0 4.3677193417579474e-08
between O 0 8.131854911663794e-11
the O 0 8.039481302901663e-10
Factor O 0 7.117455957939001e-09
B O 0 1.1861819757541525e-06
gene O 0 1.982153889912297e-07
and O 0 2.2516924218507484e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.955020394461826e-07
suggests O 0 1.0234211700321794e-08
that O 0 7.705280857805974e-12
these O 0 8.486939449825481e-12
two O 0 1.8662980882933056e-11
genes O 0 1.7690603149045359e-10
lie O 0 2.9948450386285685e-09
in O 0 7.128198586947576e-10
close O 0 2.2340872263271194e-08
proximity O 0 5.000894987006177e-08
to O 0 7.837019211365259e-08
one O 0 1.576674968362113e-08
another O 0 3.573419604663286e-08
. O 0 4.0625062069921114e-07

Distribution O 0 2.4179152902092937e-08
of O 0 2.265558229908038e-08
emerin O 0 8.773912441029097e-07
and O 0 2.4872266468634052e-09
lamins O 0 7.960090442793444e-06
in O 0 2.791466791052244e-08
the O 0 4.41587602040272e-08
heart O 0 3.594199782241958e-08
and O 0 2.886558492232183e-10
implications O 0 6.233287219714612e-09
for O 0 4.624540750342021e-09
Emery B-Disease 1 0.9997542500495911
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 0.9999974966049194
dystrophy I-Disease 1 0.9999996423721313
. O 0 7.552318129455671e-05

Emerin O 0 0.0002663811028469354
is O 0 4.379021945055683e-08
a O 0 4.40326664019608e-09
nuclear O 0 1.0779919534797955e-07
membrane O 0 2.9431904025045696e-08
protein O 0 3.1487279450459482e-09
which O 0 5.592178109470325e-11
is O 0 2.580331955048809e-11
missing O 0 2.759591000156547e-09
or O 0 3.4029359885501265e-10
defective O 0 5.8924161550066856e-08
in O 0 4.7679485248863784e-08
Emery B-Disease 1 1.0
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.709968510179351e-08
EDMD B-Disease 1 1.0
) O 0 1.351459744114436e-08
. O 0 6.85927403765163e-08

It O 0 1.0879809053676581e-08
is O 0 7.228057041785974e-11
one O 0 1.2024103067387326e-11
member O 0 1.3572759582913818e-10
of O 0 3.4019256300865663e-09
a O 0 3.98032149462324e-08
family O 0 1.385454169167133e-07
of O 0 3.85532274549405e-07
lamina O 1 0.9900504350662231
- O 0 8.782726217759773e-05
associated O 0 9.784682788449572e-07
proteins O 0 4.314829049612001e-10
which O 0 3.167011097815475e-11
includes O 0 5.939800040710708e-11
LAP1 O 0 2.0189423821648234e-07
, O 0 7.686118963512456e-10
LAP2 O 0 4.119523509871215e-06
and O 0 2.9889804409322096e-08
lamin O 0 4.727831037598662e-05
B O 0 6.65287188894581e-07
receptor O 0 1.346617306552389e-08
( O 0 6.636435290197085e-10
LBR O 0 8.72341297508683e-06
) O 0 6.1408638174498265e-09
. O 0 9.817138391099434e-08

A O 0 1.092968614102574e-05
panel O 0 1.7126718887539027e-07
of O 0 2.7152964321430773e-08
16 O 0 9.411794010816266e-09
monoclonal O 0 6.741882607741445e-10
antibodies O 0 1.9059563649559408e-10
( O 0 8.813518664885223e-11
mAbs O 0 5.175816113478504e-07
) O 0 1.2918804914718862e-09
has O 0 1.880893357730784e-10
been O 0 1.3873813209386299e-10
mapped O 0 6.99506119694604e-10
to O 0 3.9236194848690786e-10
six O 0 1.2594263132381656e-10
specific O 0 5.1860848948592775e-11
sites O 0 3.6447850293441775e-10
throughout O 0 2.383775121739262e-10
the O 0 6.472336555596314e-10
emerin O 0 6.718804623773167e-09
molecule O 0 1.7998337195623826e-11
using O 0 8.138950624569929e-10
phage O 0 1.5166493838592032e-08
- O 0 8.144684926492118e-09
displayed O 0 1.659554982325062e-08
peptide O 0 1.744919653212662e-09
libraries O 0 5.630778954213156e-09
and O 0 1.748603623008549e-10
has O 0 1.0059093315251122e-11
been O 0 6.611829139746561e-12
used O 0 5.621866513982887e-11
to O 0 4.50335380097755e-10
localize O 0 1.606379669283342e-07
emerin O 0 8.641247291052423e-07
in O 0 6.573888100547265e-09
human O 0 1.1637185437507469e-08
and O 0 7.983161687263873e-09
rabbit O 0 2.220765509264311e-06
heart O 0 1.3744624084210955e-05
. O 0 9.696022971183993e-06

Several O 0 1.1170605063171024e-07
mAbs O 0 7.389845904981485e-06
against O 0 1.2871589127882999e-08
different O 0 1.915677394492832e-09
emerin O 0 2.1524851945287082e-06
epitopes O 0 1.3726330507779494e-06
did O 0 2.040916484702393e-07
not O 0 1.1330832272449243e-08
recognize O 0 1.2220675138507886e-08
intercalated O 0 3.4334064480390225e-07
discs O 0 1.024209950628574e-06
in O 0 1.4189459385249847e-08
the O 0 2.01924592602154e-08
heart O 0 1.1254417131567607e-07
, O 0 3.7404462860379795e-10
though O 0 1.1802207822153576e-10
they O 0 3.6042394069291106e-10
recognized O 0 6.232942162398558e-09
cardiomyocyte O 0 3.48370178926416e-07
nuclei O 0 2.1114429671342805e-07
strongly O 0 4.151463315338333e-07
, O 0 1.8183372585411917e-09
both O 0 3.5296248146465814e-09
at O 0 1.1505387931265432e-07
the O 0 2.941495580444098e-08
rim O 0 8.36536031556534e-08
and O 0 1.7801828067209868e-10
in O 0 7.224270626160489e-10
intranuclear O 0 2.843813717845478e-07
spots O 0 7.214197239591158e-08
or O 0 5.190345042649369e-09
channels O 0 1.2848940400544961e-07
. O 0 1.5007671549938095e-07

A O 0 2.840091838152148e-06
polyclonal O 0 7.862207894504536e-06
rabbit O 0 6.065897650842089e-07
antiserum O 0 1.5165473996603396e-06
against O 0 1.0763192115348375e-08
emerin O 0 7.740205205664097e-07
did O 0 1.4994095920428663e-07
recognize O 0 3.378023620825843e-07
both O 0 2.4936404940945067e-08
nuclear O 0 1.5559797930109198e-06
membrane O 0 3.0460182642855216e-07
and O 0 1.0640186509647265e-09
intercalated O 0 9.288672231377859e-08
discs O 0 1.2015576089652313e-07
but O 0 2.1065008071197155e-10
, O 0 2.345138840065264e-11
after O 0 3.0606624873419364e-11
affinity O 0 1.0538909328561274e-10
purification O 0 1.0505739611588183e-09
against O 0 5.099105582218044e-10
a O 0 5.765889987685568e-10
pure O 0 1.6808701985837615e-08
- O 0 8.385932837029486e-09
emerin O 0 2.3518262537436385e-07
band O 0 7.98671422330699e-08
on O 0 1.424907125624486e-08
a O 0 1.1476862793458054e-09
western O 0 7.653909506188938e-09
blot O 0 3.59238413238927e-07
, O 0 9.270380019188451e-10
it O 0 1.9076111523741446e-10
stained O 0 5.2504280034781914e-08
only O 0 2.700482060191689e-09
the O 0 9.323969374364083e-10
nuclear O 0 5.954918691486455e-08
membrane O 0 3.3075409078264784e-07
. O 0 4.88894613681623e-07

These O 0 1.1014383005658601e-07
results O 0 1.2803957893936513e-08
would O 0 7.961064030226339e-10
not O 0 1.490613327215229e-10
be O 0 1.4454687446985304e-10
expected O 0 7.436268822935688e-10
if O 0 2.3295201323492165e-09
immunostaining O 0 6.425098604267987e-07
at O 0 2.6341005820995633e-08
intercalated O 0 1.6620677456558042e-07
discs O 0 4.1815457052507554e-07
were O 0 1.9327028866200635e-09
due O 0 4.754160620734638e-09
to O 0 1.9080161894891035e-09
a O 0 2.604129967220814e-10
product O 0 2.7023355775313007e-10
of O 0 3.1074398609831633e-10
the O 0 1.1356552365171524e-09
emerin O 0 3.459011850281968e-07
gene O 0 8.514808413906394e-09
and O 0 1.1272888400526426e-08
, O 0 7.483622610493512e-10
therefore O 0 3.4565197370994838e-09
, O 0 8.599769507622312e-11
cast O 0 5.99658322997243e-10
some O 0 1.7089314685581058e-10
doubt O 0 1.1801584154369493e-09
upon O 0 2.5341113651933256e-09
the O 0 3.254273517327988e-09
hypothesis O 0 1.037307484352823e-08
that O 0 7.391481177121406e-11
cardiac B-Disease 0 2.8023098366247723e-06
defects I-Disease 0 5.798352162855736e-07
in O 0 3.7553046894345243e-08
EDMD B-Disease 1 1.0
are O 0 1.3929023490177883e-09
caused O 0 4.438313605525934e-11
by O 0 1.5773283720821318e-11
absence O 0 4.390321066694014e-07
of O 0 2.709595889882621e-07
emerin O 0 7.377571819233708e-06
from O 0 1.2787166880912082e-08
intercalated O 0 1.1747121789085213e-05
discs O 0 6.400846177712083e-05
. O 0 6.436763442252413e-07

Although O 0 2.421076885639195e-07
emerin O 0 2.1839664441358764e-06
was O 0 2.013346644957892e-08
abundant O 0 1.2033391172394658e-08
in O 0 1.8543069302268123e-09
the O 0 2.406390287035265e-08
membranes O 0 3.058502784369921e-07
of O 0 1.4176203322335823e-08
cardiomyocyte O 0 1.0403351069498967e-08
nuclei O 0 1.2966300255712326e-09
, O 0 1.7866323698267905e-10
it O 0 1.1233470403881896e-10
was O 0 9.122066657596406e-09
absent O 0 2.633724704992346e-07
from O 0 2.095785545108697e-09
many O 0 2.442689106540996e-10
non O 0 1.4910670032008966e-08
- O 0 2.6675244235718765e-09
myocyte O 0 1.3062339121461264e-07
cells O 0 1.444317443421994e-09
in O 0 3.0246083415619296e-10
the O 0 1.3255267994338737e-09
heart O 0 3.566080053474252e-08
. O 0 4.232430512729479e-07

This O 0 3.685824090382539e-09
distribution O 0 1.1835847857355475e-09
of O 0 5.921206303050042e-10
emerin O 0 1.671125744451274e-07
was O 0 5.88394488687527e-09
similar O 0 1.4313504548280065e-10
to O 0 6.96444180103839e-10
that O 0 5.856987811414527e-11
of O 0 5.945470782364737e-10
lamin O 0 2.428287643851945e-06
A O 0 1.637686182220932e-07
, O 0 9.290028746278267e-10
a O 0 8.587349720201587e-10
candidate O 0 2.659730879983613e-09
gene O 0 1.6126022739371138e-09
for O 0 9.067804285223247e-09
an O 0 1.8922110545105397e-09
autosomal O 0 6.756731352197676e-08
form O 0 4.425522703854767e-08
of O 0 1.2853802218160126e-05
EDMD B-Disease 1 1.0
. O 0 4.416560841491446e-06

In O 0 1.8933714329705253e-07
contrast O 0 7.730940154715427e-08
, O 0 1.307378738601983e-08
lamin O 0 0.000240558001678437
B1 O 0 0.0003201135841663927
was O 0 4.261919457348995e-06
absent O 0 7.068550985422917e-06
from O 0 1.3650138797061118e-08
cardiomyocyte O 0 2.0414050538875017e-07
nuclei O 0 1.0685259788090207e-08
, O 0 1.944824523647526e-09
showing O 0 8.301542209210311e-08
that O 0 1.1841228442222018e-08
lamin O 0 0.00014979239495005459
B1 O 0 1.763564250722993e-05
is O 0 5.153537596669366e-10
not O 0 1.1598639410026479e-10
essential O 0 6.655236806096809e-09
for O 0 1.5090906302361873e-10
localization O 0 8.346106028511713e-07
of O 0 1.260117166168584e-08
emerin O 0 9.969469374482287e-07
to O 0 2.163964296642007e-08
the O 0 1.8732373874286168e-08
nuclear O 0 9.663109494795208e-07
lamina O 0 0.001533969771116972
. O 0 7.735815415799152e-06

Lamin O 1 0.9989616870880127
B1 O 0 0.0020134232472628355
is O 0 2.511712970942881e-08
also O 0 1.8146438796051712e-09
almost O 0 4.280303611547964e-10
completely O 0 3.5089922079123426e-08
absent O 0 3.466055034095916e-07
from O 0 2.1567615249296068e-08
skeletal O 0 6.091049272072269e-06
muscle O 0 1.244148819523616e-07
nuclei O 0 2.787860182706936e-07
. O 0 5.756554060099006e-07

In O 0 1.2730315575026907e-06
EDMD B-Disease 1 1.0
, O 0 4.60822491277213e-09
the O 0 7.079352659644655e-10
additional O 0 4.176290868684873e-09
absence O 0 2.3613553423729172e-07
of O 0 1.8232145748697803e-07
lamin O 0 0.09121175855398178
B1 O 0 0.01567917689681053
from O 0 1.7598466683921288e-07
heart O 1 0.999995231628418
and O 0 9.94166202872293e-06
skeletal O 1 0.6660670042037964
muscle O 0 1.0169443385166232e-06
nuclei O 0 6.587157486137585e-08
which O 0 4.927071639571068e-09
already O 0 3.2155256235455454e-09
lack O 0 3.4231852907851135e-08
emerin O 0 7.133494932531903e-07
may O 0 6.5888761113797045e-09
offer O 0 2.673861132507227e-09
an O 0 5.2476846652826925e-12
alternative O 0 1.2971891338864339e-09
explanation O 0 2.8131728058156114e-08
of O 0 2.644817476138428e-09
why O 0 2.8024512488400433e-08
these O 0 2.479799032784058e-09
tissues O 0 1.7337603352984843e-08
are O 0 1.386064041319912e-10
particularly O 0 1.9284747410086567e-10
affected O 0 7.225231524188303e-11
. O 0 6.425717735680792e-10
. O 0 5.190318574932462e-08

Genetic O 0 1.0242143844152451e-07
mapping O 0 3.223074074298893e-08
of O 0 7.210039676408542e-09
the O 0 1.5373514017369416e-08
copper B-Disease 0 3.3212129437742988e-06
toxicosis I-Disease 0 0.0016793188406154513
locus O 0 6.050056526873959e-07
in O 0 3.3930689369299216e-08
Bedlington O 0 7.109478701750049e-06
terriers O 0 9.251970141122001e-07
to O 0 4.8798252549886456e-08
dog O 0 5.794427693217585e-08
chromosome O 0 2.4758528560653303e-09
10 O 0 2.4669908338381674e-09
, O 0 1.9493904754308566e-11
in O 0 6.764575011253271e-11
a O 0 3.0746247214885614e-10
region O 0 8.903138781768405e-10
syntenic O 0 1.7474424396368704e-07
to O 0 7.512371169582366e-09
human O 0 3.6309999451589192e-09
chromosome O 0 2.517953312519694e-08
region O 0 3.061946074467414e-08
2p13 O 0 2.5339822968817316e-05
- O 0 1.9567939943954116e-06
p16 O 0 4.226431428833166e-06
. O 0 4.834140554521582e-07

Abnormal O 1 0.9999921321868896
hepatic B-Disease 1 0.9999549388885498
copper I-Disease 0 0.00015338737284764647
accumulation I-Disease 0 6.632430995523464e-06
is O 0 6.638625205113158e-10
recognized O 0 8.506167992194946e-10
as O 0 6.030487775809945e-10
an O 0 7.156357173521144e-10
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 3.6175669038129854e-07
man O 0 2.6125702490276126e-08
, O 0 8.025830000590872e-10
mouse O 0 3.542697513125859e-08
, O 0 6.820329190304619e-09
rat O 0 3.0123137548798695e-06
and O 0 5.061500019110099e-07
dog O 0 0.00022092522704042494
. O 0 4.292762605473399e-05

The O 0 4.529278214704391e-07
major O 0 1.8165050619245449e-07
cause O 0 1.2518481184997654e-07
of O 0 6.708997801752048e-08
hepatic B-Disease 0 0.0001172182965092361
copper I-Disease 0 0.0373867005109787
accumulation I-Disease 1 0.8838738203048706
in O 0 1.866425373009406e-05
man O 0 1.3502586853064713e-06
is O 0 1.7448230638095197e-09
a O 0 1.991423248526303e-09
dysfunctional O 0 1.2820624561982186e-08
ATP7B O 0 1.416721261193743e-05
gene O 0 6.756305737098955e-08
, O 0 9.779103748996931e-09
causing O 0 2.0861111948988764e-08
Wilson B-Disease 0 9.409350241185166e-06
disease I-Disease 0 2.4667333065053754e-08
( O 0 1.6969524396781566e-10
WD B-Disease 0 1.675682869972661e-05
) O 0 3.8568888527379386e-08
. O 0 5.476262572301493e-07

Mutations O 0 3.0268452633208653e-07
in O 0 3.722571406683528e-08
the O 0 7.838872306820122e-08
ATP7B O 0 1.2027666343783494e-05
genes O 0 4.934953334867487e-09
have O 0 8.157025055410827e-10
also O 0 1.870161664419001e-10
been O 0 8.610798879482573e-11
demonstrated O 0 8.522976768787771e-10
in O 0 3.100159906566091e-09
mouse O 0 5.385846293393115e-07
and O 0 6.726975243509514e-08
rat O 0 1.2136364603065886e-05
. O 0 2.537961790949339e-06

The O 0 6.591759756702231e-06
ATP7B O 0 0.0007641609408892691
gene O 0 4.0055536487670906e-07
has O 0 1.1507769182017569e-09
been O 0 9.92898194218661e-11
excluded O 0 1.102057223256736e-09
in O 0 1.5822887444727485e-10
the O 0 3.9038228205612313e-10
much O 0 2.7816471348529603e-10
rarer O 0 8.456352418306778e-08
human O 0 3.396779035824693e-08
copper B-Disease 0 2.575243343017064e-05
overload I-Disease 0 0.000227217489737086
disease O 0 9.161001798929647e-06
non B-Disease 0 7.419780558848288e-06
- I-Disease 0 4.996500138076954e-07
Indian I-Disease 0 6.479355718624902e-09
childhood I-Disease 0 4.1401517592021264e-07
cirrhosis I-Disease 0 7.365006240434013e-07
, O 0 9.813423407223354e-10
indicating O 0 1.224645895803178e-08
genetic O 0 4.42094760799705e-09
heterogeneity O 0 1.1670555011278338e-07
. O 0 4.0230725062428974e-07

By O 0 2.41090036823266e-09
investigating O 0 7.036279114913668e-09
the O 0 1.134757354748217e-08
common O 0 2.8112961558690586e-07
autosomal O 0 0.000778627407271415
recessive O 0 4.5694614527747035e-05
copper B-Disease 0 0.36734989285469055
toxicosis I-Disease 1 0.9999942779541016
( O 0 3.5206420001543393e-09
CT B-Disease 0 0.00035548166488297284
) O 0 7.388933909169282e-10
in O 0 6.438123811847163e-09
Bedlington O 0 3.120804103673436e-05
terriers O 0 9.763722118805163e-06
, O 0 2.669122478593522e-09
we O 0 2.1205546207880843e-09
have O 0 9.173563991771161e-11
identified O 0 1.3285533784213044e-10
a O 0 5.8022267546142814e-11
new O 0 2.92939894563915e-10
locus O 0 3.723208852335347e-09
involved O 0 1.2932858117764567e-09
in O 0 2.544710397955896e-08
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 6.930933977855602e-07

We O 0 6.255060043258709e-07
examined O 0 2.604828637231549e-07
whether O 0 1.6864738938693336e-08
the O 0 3.517301294664321e-08
WD B-Disease 0 0.00040188635466620326
gene O 0 3.2709142487874487e-06
ATP7B O 1 0.6196913123130798
was O 0 1.3395823543760343e-06
also O 0 1.3904868367831114e-09
causative O 0 2.3211286226398897e-09
for O 0 8.460183664737997e-10
CT B-Disease 0 5.087888894195203e-06
by O 0 1.8678622537571243e-10
investigating O 0 1.810750882569323e-09
the O 0 7.316628636289124e-09
chromosomal O 0 2.870048660952307e-07
co O 0 3.138632962418342e-07
- O 0 8.698778515281447e-07
localization O 0 0.06124025583267212
of O 0 4.009428948847926e-07
ATP7B O 0 6.002395366522251e-06
and O 0 3.461769759738331e-10
C04107 O 0 6.566609300762138e-08
, O 0 1.9824357433417816e-11
using O 0 4.335930225973783e-11
fluorescence O 0 3.1588096582879643e-09
in O 0 2.7608757502406434e-09
situ O 0 6.119166187090741e-07
hybridization O 0 1.1951867939785643e-08
( O 0 5.930226310013609e-10
FISH O 0 3.9916653804539237e-07
) O 0 2.0318862148371863e-09
. O 0 4.7572292771747016e-08

C04107 O 0 6.177065370138735e-05
is O 0 1.0404859196455618e-08
an O 0 1.5563679511831907e-10
anonymous O 0 3.6839824524292908e-09
microsatellite O 0 2.2810512234627822e-07
marker O 0 2.4185570168810955e-07
closely O 0 4.633557182387449e-08
linked O 0 3.94715954143976e-07
to O 0 4.009245344605006e-07
CT B-Disease 1 0.9999998807907104
. O 0 1.9752878870349377e-05

However O 0 1.6092883470264496e-06
, O 0 3.6574004269596117e-08
BAC O 0 4.238147994328756e-06
clones O 0 9.591919791773762e-08
containing O 0 1.3292138056897329e-08
ATP7B O 0 6.590173029508151e-07
and O 0 7.999070295028332e-10
C04107 O 0 2.7067056862506433e-07
mapped O 0 4.6750948001772485e-08
to O 0 2.31616343882024e-08
the O 0 4.2440511549557414e-08
canine O 0 6.079611694076448e-07
chromosome O 0 2.629402899856359e-07
regions O 0 2.0399953726268905e-08
CFA22q11 O 0 2.5274041490774835e-06
and O 0 4.055543012526641e-09
CFA10q26 O 0 1.2208511179778725e-06
, O 0 1.1990358705915583e-09
respectively O 0 3.2073179667690965e-09
, O 0 1.1597400123575241e-10
demonstrating O 0 3.493690670097749e-09
that O 0 2.719786201810237e-11
WD B-Disease 0 3.221482529625064e-07
cannot O 0 3.7910652395112265e-08
be O 0 3.80595199800382e-09
homologous O 0 6.316309253406871e-09
to O 0 1.538591476446527e-07
CT B-Disease 0 0.004334707278758287
. O 0 6.145480710983975e-06

The O 0 3.7066201912239194e-06
copper O 0 1.9062983938056277e-06
transport O 0 7.32235605482856e-08
genes O 0 4.184824575759194e-08
CTR1 O 0 4.102285311091691e-05
and O 0 1.3466326720390498e-08
CTR2 O 0 6.933003896847367e-05
were O 0 3.736328579861947e-08
also O 0 1.7359036430519836e-09
excluded O 0 1.0245027048938482e-09
as O 0 2.6443017220323384e-10
candidate O 0 6.977098898630629e-10
genes O 0 7.227078657745523e-11
for O 0 4.523247609800052e-10
CT B-Disease 0 3.374423977220431e-05
since O 0 1.3523330721909588e-07
they O 0 7.608032426276168e-09
both O 0 4.2449390669219156e-09
mapped O 0 9.268408973639453e-08
to O 0 5.113603762652019e-08
canine O 0 9.66929519563564e-07
chromosome O 0 5.129477358423173e-07
region O 0 4.20175666704381e-07
CFA11q22 O 0 0.00041756208520382643
. O 0 3.6535664094117237e-06

2 O 0 1.8809654420692823e-06
- O 0 1.7833369838626822e-06
22 O 0 1.2286745914025232e-06
. O 0 3.6911097822667216e-07

5 O 0 2.2530828573508188e-05
. O 0 2.6830791739484994e-06

A O 0 3.9174176436063135e-07
transcribed O 0 2.3448056829522557e-09
sequence O 0 7.425663556270834e-11
identified O 0 2.851699432149246e-10
from O 0 1.0246819365233861e-10
the O 0 5.338723352288355e-10
C04107 O 0 2.0634203679037455e-08
- O 0 3.3134488486297187e-09
containing O 0 6.069328928326456e-10
BAC O 0 1.5084410733834375e-06
was O 0 9.36489552572084e-09
found O 0 8.739296092352689e-11
to O 0 8.072081891796756e-11
be O 0 3.2041352210354646e-11
homologous O 0 4.05131761471722e-11
to O 0 1.3820679045650763e-09
a O 0 2.0067398853740315e-09
gene O 0 1.2066303511915066e-08
expressed O 0 1.0325738486471892e-08
from O 0 2.0578931891890306e-09
human O 0 5.921695578336994e-09
chromosome O 0 4.680650533828157e-09
2p13 O 0 1.4653352309323964e-07
- O 0 1.2862998666207659e-08
p16 O 0 1.5076278003789412e-08
, O 0 1.7603292434831275e-10
a O 0 1.8917518940231304e-10
region O 0 4.967835032232415e-10
devoid O 0 1.1018521917094404e-07
of O 0 7.980417993103117e-10
any O 0 3.754248023568607e-10
positional O 0 3.227718821108283e-07
candidate O 0 1.2076725397491828e-07
genes O 0 5.2896300672955476e-08
. O 0 1.5965257489369833e-06

Molecular O 0 3.34541816471301e-08
analysis O 0 6.394958784738947e-09
of O 0 3.213821209158141e-09
the O 0 2.9712214910659895e-09
APC B-Disease 0 6.515418871089196e-09
gene O 0 2.401893961501145e-10
in O 0 2.4246785135240145e-10
205 O 0 3.00776958894744e-10
families O 0 5.5567727502703335e-11
: O 0 1.8035459237175644e-10
extended O 0 3.967375761249059e-08
genotype O 0 1.9991428246157739e-07
- O 0 6.374563099598163e-07
phenotype O 0 2.2535083132879663e-08
correlations O 0 1.4370190593027132e-09
in O 0 4.1025641217551367e-10
FAP B-Disease 0 4.579275625360424e-09
and O 0 6.2626527227993556e-12
evidence O 0 3.1281206791522465e-11
for O 0 1.7258318255400362e-12
the O 0 4.642272677379822e-11
role O 0 2.3155790618289984e-09
of O 0 3.679707560877432e-08
APC B-Disease 0 1.1923889076115302e-07
amino O 0 1.465899224228906e-08
acid O 0 1.3649200880649914e-08
changes O 0 9.537590983654809e-08
in O 0 0.00021616653248202056
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.000106376814073883
. O 0 5.878551974092261e-07

BACKGROUND O 0 6.005029263178585e-06
/ O 0 1.6936678548518103e-06
AIMS O 0 3.2380813763666083e-07
The O 0 1.7530760176853732e-09
development O 0 1.1411209754896845e-08
of O 0 2.376933707637363e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.303768008639963e-09
a O 0 3.16353526708113e-10
variable O 0 8.67958094286081e-10
range O 0 6.096547711109679e-10
of O 0 2.5388127711245545e-10
extracolonic O 0 4.391694119476597e-08
manifestations O 0 8.965344733269376e-08
in O 0 2.6769811256599496e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.0306540893244573e-09
FAP B-Disease 0 6.508688699113918e-08
) O 0 4.2991037813022714e-11
is O 0 1.1325522117355824e-11
the O 0 2.6203664238444446e-11
result O 0 7.80676634448696e-11
of O 0 2.5783812862556488e-09
the O 0 8.44361558449691e-09
dominant O 0 7.830249870721673e-08
inheritance O 0 6.651013245573267e-05
of O 0 0.44848138093948364
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 2.495075923647505e-09
APC B-Disease 0 6.696699017538776e-08
) O 0 9.99778038135446e-10
gene O 0 5.1774717846342355e-09
mutations O 0 3.557011041266378e-08
. O 0 4.3232446955698833e-07

In O 0 1.575045871504699e-08
this O 0 3.226601208439206e-10
study O 0 1.312086411742186e-10
, O 0 1.4627068002995292e-12
direct O 0 3.661987726943927e-11
mutation O 0 4.155419064399979e-12
analysis O 0 4.272357467804966e-11
of O 0 2.8126012630025343e-10
the O 0 2.5237505418829187e-09
APC B-Disease 0 7.807757107514135e-09
gene O 0 7.814636715508527e-10
was O 0 1.03209734092502e-08
performed O 0 5.981621864492581e-09
to O 0 4.424169919303722e-09
determine O 0 2.930115705623848e-09
genotype O 0 1.9228021841399823e-08
- O 0 2.1569759667272592e-07
phenotype O 0 1.1752821826860327e-08
correlations O 0 8.996650646686533e-10
for O 0 1.2867139576044906e-09
nine O 0 2.566106216406183e-09
extracolonic O 0 2.029888435117755e-08
manifestations O 0 2.0748405216153287e-09
and O 0 2.4701617487576932e-11
to O 0 4.321813740215674e-10
investigate O 0 1.0646905579392296e-09
the O 0 1.5948640186280727e-09
incidence O 0 3.1833135949455027e-07
of O 0 4.360984817708413e-08
APC B-Disease 0 2.530032645609026e-07
mutations O 0 1.2530755100215174e-08
in O 0 5.662046476118121e-08
non O 1 1.0
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.2495702069136314e-05

METHODS O 0 7.500986612285487e-06
The O 0 3.860212132167362e-07
APC B-Disease 0 3.535833172918501e-07
gene O 0 2.966851297969697e-08
was O 0 1.035086469869384e-07
analysed O 0 2.1151429052679305e-08
in O 0 8.869595613525405e-10
190 O 0 2.273374821726293e-09
unrelated O 0 1.5672835251834272e-09
FAP B-Disease 0 2.8445535704690883e-08
and O 0 3.797132608340803e-10
15 O 0 1.6282706383208279e-07
non O 1 0.995762050151825
- O 1 0.9999980926513672
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 5.508418610133958e-08
using O 0 1.1481170181237843e-10
denaturing O 0 1.0359668678461276e-08
gradient O 0 8.539785545380596e-10
gel O 0 3.656875469104648e-09
electrophoresis O 0 7.838222293443664e-10
, O 0 9.257123539940793e-11
the O 0 1.7579336597517425e-10
protein O 0 7.589211897807147e-11
truncation O 0 1.4230928435665646e-08
test O 0 1.553847495117111e-09
, O 0 6.954960218852335e-11
and O 0 1.632901452941482e-11
direct O 0 8.06239242034934e-10
sequencing O 0 3.368763756839144e-08
. O 0 1.356912804340027e-07

RESULTS O 0 6.329019925033208e-06
Chain O 0 3.870315623544229e-08
terminating O 0 1.756433931632273e-08
signals O 0 4.9520412659376234e-08
were O 0 4.899632255472852e-09
only O 0 8.762484071667132e-10
identified O 0 6.109259209630125e-10
in O 0 8.024250014448953e-11
patients O 0 3.572848614186164e-11
belonging O 0 7.953426112150552e-11
to O 0 1.5047025847536588e-09
the O 0 4.901015149272325e-09
FAP B-Disease 0 1.0078527878931709e-07
group O 0 7.533920709512643e-10
( O 0 5.800434438318902e-11
105 O 0 1.0724465226985558e-07
patients O 0 2.137831778270538e-08
) O 0 1.2133918314560788e-09
. O 0 1.3372013540902117e-07

Amino O 0 1.626630137252505e-07
acid O 0 5.121321144940794e-09
changes O 0 3.7630734639471086e-10
were O 0 1.53570572924977e-10
identified O 0 5.657009860549067e-10
in O 0 1.157967402520832e-10
four O 0 8.059036771257411e-11
patients O 0 1.1372515776320036e-11
, O 0 1.4917325187602248e-12
three O 0 2.194477759231983e-11
of O 0 9.126900346601019e-10
whom O 0 8.518187044614933e-09
belonged O 0 2.2937306312087458e-06
to O 0 1.1510820513649378e-05
the O 0 8.758379976825381e-07
non O 0 0.0002956054813694209
- O 0 1.9388276086829137e-06
FAP O 0 1.1957739843637682e-05
group O 0 2.8095639592606858e-08
of O 0 6.986439871070615e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.00015332787006627768
. O 0 1.1474312344716964e-07

Genotype O 0 0.00015785355935804546
- O 0 2.742133438005112e-05
phenotype O 0 7.406902824413919e-08
correlations O 0 1.6829962978803792e-09
identified O 0 1.0966640928700144e-09
significant O 0 1.6030801130995087e-09
differences O 0 5.988501916576183e-10
in O 0 3.663402914355629e-09
the O 0 9.507546749887297e-09
nature O 0 2.885987226974862e-09
of O 0 2.280784228148036e-09
certain O 0 5.2899298275121964e-09
extracolonic O 0 2.2623720496994792e-07
manifestations O 0 3.605425646924232e-08
in O 0 1.555395257035741e-09
FAP B-Disease 0 4.265215025611724e-08
patients O 0 5.496605948174249e-10
belonging O 0 5.682780912508179e-10
to O 0 4.867273695197127e-09
three O 0 5.383965273608737e-09
mutation O 0 8.345100610540612e-09
subgroups O 0 6.085168280378639e-08
. O 0 8.326121303525724e-08

CONCLUSIONS O 0 3.0518672247126233e-06
Extended O 0 1.3311745306054945e-06
genotype O 0 4.865949563281902e-07
- O 0 3.8172666450009274e-07
phenotype O 0 1.1758494622426952e-08
correlations O 0 8.050421995697832e-10
made O 0 3.2338404176712743e-10
in O 0 7.578305344368985e-11
this O 0 2.852470516734318e-11
study O 0 2.996876358185574e-11
may O 0 4.1356380126034153e-11
have O 0 1.5252486773587037e-11
the O 0 1.616379079194541e-11
potential O 0 8.245615995550182e-12
to O 0 2.7734781138377684e-10
determine O 0 1.6359863463932811e-09
the O 0 9.42294775541086e-09
most O 0 1.2760845713444269e-09
appropriate O 0 1.0458344945618592e-07
surveillance O 0 4.239423390117736e-07
and O 0 3.546360094475176e-09
prophylactic O 0 1.7463843278164859e-06
treatment O 0 1.1701555280296816e-08
regimens O 0 3.603952913877606e-09
for O 0 3.936360265521799e-11
those O 0 4.349779911261287e-11
patients O 0 6.555950227138396e-11
with O 0 1.0763417067349845e-12
mutations O 0 7.69294974944934e-11
associated O 0 6.688803955157141e-10
with O 0 1.1940957771183758e-11
life O 0 3.848648955084855e-09
threatening O 0 3.890593625044403e-09
conditions O 0 2.734620352384809e-08
. O 0 1.1992806037142145e-07

This O 0 9.292730140941785e-08
study O 0 3.868586340161073e-09
also O 0 2.305880660025128e-11
provided O 0 2.4600436271393633e-11
evidence O 0 1.0767118099885842e-11
for O 0 2.3743489813154994e-11
the O 0 7.827136716542782e-10
pathological O 0 3.1114762322204115e-08
nature O 0 5.586533902146584e-09
of O 0 1.952086492451599e-09
amino O 0 4.149704746492233e-10
acid O 0 3.369833856403659e-10
changes O 0 6.831352705738425e-10
in O 0 2.897437401117031e-09
APC O 0 1.1788298337478409e-07
associated O 0 6.87579131408711e-08
with O 0 7.625719500303774e-11
both O 0 5.246839074324328e-10
FAP B-Disease 0 2.182043346010687e-08
and O 0 9.565475078687768e-10
non O 1 0.8485000729560852
- O 1 0.9999481439590454
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.1472762935227365e-06
. O 0 1.8351801189808725e-09
. O 0 9.10588315861105e-09

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 3.971324076701421e-06
cancer B-Disease 0 5.4359355999622494e-05
risk O 0 1.2790610526280943e-07
of O 0 1.583147053452194e-07
the O 0 1.1700393542923848e-06
APC O 0 3.328280627101776e-06
I1307K O 0 1.2582275303429924e-05
polymorphism O 0 5.534092224479537e-07
. O 0 2.7152583470524405e-07

Germ O 0 1.3450737242237665e-05
- O 0 5.139437462275964e-07
line O 0 2.3491134371056432e-08
and O 0 4.439806300382543e-10
somatic O 0 3.640710133367975e-08
truncating O 0 8.162946585343889e-08
mutations O 0 2.8342512781165397e-09
of O 0 4.424043353878915e-09
the O 0 1.7754169689965238e-08
APC B-Disease 0 6.333418411941238e-08
gene O 0 3.4580163177366785e-09
are O 0 6.273012664870237e-10
thought O 0 1.7585859879432064e-08
to O 0 1.4820533245085699e-08
initiate O 0 1.2724974567390746e-06
colorectal B-Disease 1 1.0
tumor I-Disease 0 1.650027115829289e-05
formation O 0 2.0911032549975062e-07
in O 0 5.401535076998698e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 5.335643891157815e-07
sporadic O 0 0.21404920518398285
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 6.399545327440137e-06
respectively O 0 1.8693610400077887e-05
. O 0 2.07785114980652e-06

Recently O 0 5.349303933144256e-07
, O 0 1.411171957066415e-09
an O 0 1.1170377123281838e-10
isoleucine O 0 3.058960942325939e-07
- O 0 3.496965561566867e-08
- O 0 6.144978925703981e-08
> O 0 1.7795439077872288e-07
lysine O 0 1.9640159720779593e-08
polymorphism O 0 1.8238253129965187e-09
at O 0 1.4743273268891244e-09
codon O 0 6.307713462661013e-09
1307 O 0 7.490940845400473e-08
( O 0 6.89909934736832e-11
I1307K O 0 5.995661922497675e-08
) O 0 2.9452318361933294e-10
of O 0 2.1324875199013604e-09
the O 0 1.65694267195704e-08
APC B-Disease 0 1.0506850145475255e-07
gene O 0 5.736931818489666e-09
has O 0 1.3367533469033077e-10
been O 0 1.671477886655559e-11
identified O 0 2.4897918796118468e-11
in O 0 1.767437238231473e-11
6 O 0 1.9982340226931683e-09
% O 0 2.9443315840982365e-11
- O 0 2.732620518752782e-10
7 O 0 2.2020185674875847e-09
% O 0 2.027402273840906e-10
of O 0 3.71557340450579e-10
the O 0 5.324892193847575e-10
Ashkenazi O 0 1.4236466228112477e-08
Jewish O 0 2.324439485335006e-08
population O 0 1.4411466464636646e-10
. O 0 3.5578981982808955e-09

To O 0 7.483543384978475e-08
assess O 0 6.577283215847274e-07
the O 0 1.0069205913509904e-08
risk O 0 1.0247259929485608e-08
of O 0 8.978719434615812e-10
this O 0 2.636364737629293e-10
common O 0 8.953546237755461e-10
APC B-Disease 0 3.120259961519878e-08
allelic O 0 2.9417988045565835e-08
variant O 0 1.0189553734107903e-07
in O 0 7.349486708108088e-08
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 6.157274157203574e-08
we O 0 2.159989165306797e-08
have O 0 6.322308232498131e-10
analyzed O 0 2.965424128476002e-09
a O 0 7.789323630547074e-10
large O 0 1.3361727280170044e-09
cohort O 0 3.445470611040946e-07
of O 0 3.751786437078408e-07
unselected O 0 0.0006916841375641525
Ashkenazi O 0 6.689725705655292e-05
Jewish O 0 4.403850198286818e-06
subjects O 0 1.1246643225604203e-05
with O 0 5.197200003692615e-09
adenomatous B-Disease 0 8.26598479761742e-05
polyps I-Disease 0 1.8456879843142815e-05
and O 0 5.8726432605737955e-09
. O 0 3.404523241101742e-08
or O 0 0.000262313085841015
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 4.704925338216981e-09
for O 0 2.2786275089003993e-09
the O 0 7.983226879559879e-08
APC O 0 1.0011191307057743e-06
I1307K O 0 3.3879389320645714e-06
polymorphism O 0 3.6297456063039135e-07
. O 0 3.3142097777272284e-07

The O 0 2.597728780528996e-06
APC O 0 2.3299226086237468e-06
I1307K O 0 2.958047844003886e-06
allele O 0 2.7137327052173532e-08
was O 0 4.330711345090776e-09
identified O 0 8.954160746199591e-10
in O 0 4.2377373832280796e-10
48 O 0 1.0102697345359957e-08
( O 0 2.3547263097722926e-11
10 O 0 6.03156913303593e-10
. O 0 4.7546820647337285e-11
1 O 0 1.7055783452235573e-09
% O 0 7.418528291669446e-11
) O 0 6.233982080550149e-11
of O 0 2.727699732751887e-10
476 O 0 7.3128898492313965e-09
patients O 0 9.132825162794234e-09
. O 0 3.412897342514043e-08

Compared O 0 1.1717875558758806e-09
with O 0 2.113694852826087e-12
the O 0 2.1764782684452477e-11
frequency O 0 6.269423868943136e-10
in O 0 3.419082031386189e-11
two O 0 7.631419801645833e-12
separate O 0 2.16457927970648e-12
population O 0 2.677305534388996e-13
control O 0 3.3894994450056615e-11
groups O 0 9.722086850849632e-12
, O 0 3.737463463715507e-11
the O 0 2.156254508278721e-09
APC O 0 5.957650728305453e-07
I1307K O 0 4.169737167103449e-06
allele O 0 2.4620375072004208e-08
is O 0 8.25326751385802e-11
associated O 0 1.8743254170949797e-10
with O 0 1.44680773438155e-12
an O 0 1.0347997415546817e-12
estimated O 0 1.3689689572909947e-12
relative O 0 1.3164455636704986e-10
risk O 0 6.216684389492855e-10
of O 0 4.755945082202118e-10
1 O 0 3.7870978530918364e-07
. O 0 1.1478507531137438e-06

5 O 0 1.1949222198381904e-06
- O 0 4.397734016947652e-07
1 O 0 6.773627774236957e-07
. O 0 3.788290143802442e-07

7 O 0 2.7143880743096815e-06
for O 0 1.8154381109525275e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 0.0027544228360056877
( O 0 1.0206452571992486e-08
both O 0 1.0946793693733525e-08
P O 0 9.9590749869094e-07
= O 0 7.805036261743226e-08
. O 0 6.168882626944594e-10
01 O 0 1.4609565823775483e-07
) O 0 4.279291365705262e-10
. O 0 8.366536796700075e-09

Furthermore O 0 5.38114363735076e-07
, O 0 1.7723947864922707e-09
compared O 0 1.2352723288699963e-09
with O 0 1.1420190487720916e-10
noncarriers O 0 3.146237759210635e-06
, O 0 2.4888935357125774e-08
APC O 0 3.6628497923629766e-07
I1307K O 0 7.321978046093136e-07
carriers O 0 3.5953979793390545e-09
had O 0 1.7014584186014758e-09
increased O 0 1.1099129393343787e-09
numbers O 0 1.2248133618442125e-09
of O 0 1.3780405705432486e-09
adenomas B-Disease 0 0.0005422875401563942
and O 0 2.6259192964062095e-05
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9281163811683655
per O 0 9.239197140686883e-08
patient O 0 1.37291294777242e-07
( O 0 1.5147080811850344e-10
P O 0 7.097340244399675e-07
= O 0 1.1787084730485731e-07
. O 0 1.0449323628591856e-09
03 O 0 2.0454720583984454e-07
) O 0 7.54449974715854e-11
, O 0 1.1448559981974693e-11
as O 0 7.32410139481221e-12
well O 0 7.307134064493681e-12
as O 0 1.3864177167421943e-11
a O 0 3.8902478460833834e-11
younger O 0 2.3731243636859745e-09
age O 0 8.846167354192858e-09
at O 0 8.083309666062632e-08
diagnosis O 0 7.246450422826456e-06
. O 0 2.7327024554324453e-07

We O 0 9.252035937379333e-08
conclude O 0 1.4109983226262557e-07
that O 0 1.8010030133908117e-09
the O 0 1.0441319808762728e-08
APC O 0 1.1119052487629233e-06
I1307K O 0 8.530206287105102e-06
variant O 0 2.399301592959091e-06
leads O 0 5.161009042353726e-08
to O 0 1.4916274437837274e-08
increased O 0 1.9917433746741153e-06
adenoma B-Disease 1 1.0
formation O 0 5.436506853584433e-07
and O 0 5.525649382498443e-10
directly O 0 1.6459980600735946e-10
contributes O 0 1.364238756684788e-11
to O 0 1.0255006913095777e-11
3 O 0 1.6697326854497874e-10
% O 0 1.4313715143710048e-11
- O 0 3.1210067863440827e-10
4 O 0 8.092249648150585e-10
% O 0 1.1552186290897382e-10
of O 0 4.966411309981211e-11
all O 0 9.135464607012977e-11
Ashkenazi O 0 6.077490297684562e-07
Jewish O 0 3.206676774425432e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.378834768838715e-06

The O 0 1.0729089439109885e-07
estimated O 0 3.89347398765949e-09
relative O 0 4.0593217676132554e-08
risk O 0 5.0254573835673e-09
for O 0 1.92007715282827e-10
carriers O 0 1.9288132202532893e-10
may O 0 2.980701019339449e-09
justify O 0 8.836454234995017e-09
specific O 0 1.5837593736467426e-10
clinical O 0 3.2370110064627866e-11
screening O 0 3.087809738802627e-12
for O 0 1.9646199597711522e-11
the O 0 4.891988897304245e-11
360 O 0 8.841304355300394e-10
, O 0 6.9108434253006834e-12
000 O 0 5.252827062207643e-10
Americans O 0 4.843634868190172e-11
expected O 0 3.644887516807138e-11
to O 0 5.5137602816834885e-11
harbor O 0 5.721611628928258e-09
this O 0 6.081171677330133e-10
allele O 0 6.223450643716433e-09
, O 0 1.3525001951730786e-10
and O 0 4.6106288925651384e-11
genetic O 0 2.000428295234613e-11
testing O 0 9.765781065762535e-12
in O 0 3.562952016755716e-12
the O 0 8.759020592163935e-11
setting O 0 1.092126056256859e-09
of O 0 2.121144232480887e-10
long O 0 2.0801719721741385e-11
- O 0 3.682238125524151e-10
term O 0 2.059971748735734e-08
- O 0 1.7081047687383943e-09
outcome O 0 2.4334442794149425e-10
studies O 0 2.231001910990571e-10
may O 0 3.461233036294864e-11
impact O 0 6.679978098445005e-11
significantly O 0 6.4698344459657164e-09
on O 0 1.3075480637780856e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 6.696546250850588e-08
in O 0 7.1570592334591066e-12
this O 0 8.387839901813354e-12
population O 0 5.0666033868385085e-12
. O 0 3.425351779995367e-09

Localization O 0 2.121476791216992e-05
of O 0 1.5869321146055881e-07
human O 0 7.657734890642587e-09
BRCA1 O 0 2.0086086127690805e-09
and O 0 3.357622860300502e-11
its O 0 9.125502437035138e-11
loss O 0 4.5845519047738037e-10
in O 0 3.4433506046482876e-10
high O 0 6.1664273687256355e-09
- O 0 2.45239561991184e-09
grade O 0 7.582972472164329e-08
, O 0 2.8849636013461577e-09
non B-Disease 1 0.9999419450759888
- I-Disease 1 0.9999969005584717
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 1 0.9587405920028687

Although O 0 2.8639995264256868e-08
the O 0 9.544461887500688e-10
link O 0 1.6765306920518697e-09
between O 0 2.7768697064001202e-11
the O 0 6.7664527314548195e-09
BRCA1 O 0 5.2748600154473024e-08
tumour B-Disease 1 1.0
- O 0 1.2901038815016364e-07
suppressor O 0 7.623525561939459e-07
gene O 0 2.98422939692955e-08
and O 0 7.765104115264876e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 2.2078786798829242e-07
established O 0 1.3645974128451144e-08
, O 0 1.103356503384667e-10
the O 0 4.5491349576209927e-10
role O 0 2.168351054265827e-09
, O 0 1.3252909880634434e-10
if O 0 1.9333729062154248e-10
any O 0 7.792518852411945e-10
, O 0 3.108714397015433e-10
of O 0 1.7586589962093058e-09
BRCA1 O 0 2.283963240756748e-08
in O 0 2.2111189323936742e-08
non B-Disease 1 0.999995231628418
- I-Disease 1 0.9169662594795227
familial I-Disease 0 5.8207500842399895e-05
cancers I-Disease 1 0.9999997615814209
is O 0 2.314899161248718e-09
unclear O 0 5.76932777107686e-08
. O 0 1.0224947999404321e-07

BRCA1 O 0 2.3362203137367032e-05
mutations O 0 4.3000532912174094e-08
are O 0 4.2807121736210263e-10
rare O 0 1.7968171395210675e-09
in O 0 2.3379016500513217e-09
sporadic B-Disease 0 1.1771604135901725e-07
cancers I-Disease 0 1.4276933768542222e-07
, O 0 6.075711045383514e-10
but O 0 1.9473189727392537e-09
loss O 0 3.0779840898276234e-08
of O 0 1.4446659690747765e-07
BRCA1 O 0 3.431734230119332e-09
resulting O 0 3.870959455753997e-11
from O 0 1.7489364123601803e-11
reduced O 0 4.957763088953016e-10
expression O 0 2.319433756170497e-09
or O 0 1.2379918201688156e-09
incorrect O 0 5.8284790327434166e-08
subcellular O 0 1.9021106254513143e-06
localization O 0 2.5703069695737213e-05
is O 0 1.386524894897434e-09
postulated O 0 1.1748765516017556e-08
to O 0 6.769586557986429e-10
be O 0 9.747659623915439e-11
important O 0 1.7786386252716113e-10
in O 0 2.6685001430770683e-10
non B-Disease 0 0.0004256503889337182
- I-Disease 1 0.9029171466827393
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 1.0

Epigenetic O 0 0.00011980322597082704
loss O 0 2.9040425943094306e-05
, O 0 8.270356843809168e-09
however O 0 1.609554045600703e-09
, O 0 1.6054782503438503e-10
has O 0 3.351670503637383e-12
not O 0 2.9526079931702087e-12
received O 0 1.308174922554084e-11
general O 0 3.049889230055669e-10
acceptance O 0 2.961377365551243e-09
due O 0 2.5127562253146607e-09
to O 0 4.74609729295139e-09
controversy O 0 9.605111150889911e-10
regarding O 0 2.443389046646871e-09
the O 0 8.202268864110351e-10
subcellular O 0 6.539511900882644e-07
localization O 0 0.0001068014680640772
of O 0 2.7016821491088194e-07
BRCA1 O 0 5.569361860580102e-09
proteins O 0 6.038219230175557e-11
, O 0 1.298683799388911e-10
reports O 0 2.792161502007673e-10
of O 0 7.387548905946062e-11
which O 0 4.585342956026084e-12
have O 0 5.492723029881796e-12
ranged O 0 5.774981048922712e-10
from O 0 4.612396922731854e-11
exclusively O 0 1.0528988791946858e-09
nuclear O 0 6.630544646668568e-08
, O 0 1.6866017471528494e-09
to O 0 1.9451073640652794e-08
conditionally O 0 6.635377758357208e-08
nuclear O 0 3.447770424713781e-08
, O 0 4.1801778705163883e-10
to O 0 2.620743844161666e-09
the O 0 2.957713851614585e-09
ER O 0 1.2113526963730692e-06
/ O 0 4.135284143558238e-06
golgi O 0 6.534925887535792e-06
, O 0 1.0671246997162598e-08
to O 0 6.6346541593986785e-09
cytoplasmic O 0 1.318145415041272e-08
invaginations O 0 5.666734637088666e-07
into O 0 4.976562273384388e-09
the O 0 4.990401869520156e-09
nucleus O 0 2.3339064014749056e-08
. O 0 2.149669455775438e-07

In O 0 1.371224378488023e-08
an O 0 1.4557528793535113e-10
attempt O 0 2.549635613746659e-09
to O 0 1.2920776670810596e-09
resolve O 0 5.775214972914e-09
this O 0 4.745995263455427e-10
issue O 0 2.2884547590251714e-08
, O 0 3.5401948039748277e-10
we O 0 3.127121894763718e-09
have O 0 6.775580096984868e-10
comprehensively O 0 7.373932930931915e-08
characterized O 0 1.3063019999037806e-08
19 O 0 2.3102914781247819e-07
anti O 0 1.6839110230648657e-06
- O 0 3.0885605610819766e-06
BRCA1 O 0 2.8614005387339603e-08
antibodies O 0 2.3313915242795247e-09
. O 0 1.1617630235605247e-07

These O 0 4.24050696778977e-08
reagents O 0 3.029892354788899e-07
detect O 0 4.0324518835177514e-08
a O 0 2.799383169715952e-09
220 O 0 6.2781739806894166e-09
- O 0 1.4247304669368077e-08
kD O 0 2.061888721982541e-07
protein O 0 1.2120132675264017e-09
localized O 0 9.902513475879005e-09
in O 0 2.6429400334926356e-10
discrete O 0 6.214302405993521e-10
nuclear O 0 9.948668555637141e-09
foci O 0 1.1865208904282554e-07
in O 0 2.4475136584101165e-08
all O 0 3.3951839117918325e-09
epithelial O 0 1.1161890078881243e-08
cell O 0 7.0128591822538056e-09
lines O 0 1.6966256177752825e-10
, O 0 8.555656183517613e-12
including O 0 1.8853093999154913e-12
those O 0 1.0514689813279077e-11
derived O 0 9.255998745238969e-10
from O 0 4.678651688294622e-09
breast B-Disease 0 4.268104305538145e-07
malignancies I-Disease 0 3.6996559629187686e-06
. O 0 5.707639729735092e-07

Immunohistochemical O 0 0.0004968579160049558
staining O 0 2.4353692424483597e-05
of O 0 5.38679159944877e-07
human O 0 1.9351003288647917e-07
breast O 0 1.6213052731472999e-06
specimens O 0 3.778901316309202e-07
also O 0 6.175951483555764e-08
revealed O 0 1.1060213012115128e-07
BRCA1 O 0 5.438981531824538e-08
nuclear O 0 4.0472428963767015e-07
foci O 0 1.3251353266241495e-05
in O 0 1.096975324799132e-06
benign O 1 1.0
breast O 1 0.9999998807907104
, O 0 3.114457172159746e-07
invasive B-Disease 1 0.9817662239074707
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999997615814209
and O 0 1.0000112524721771e-05
low B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.04519805684685707

Conversely O 0 4.82685754832346e-06
, O 0 8.063629763910285e-08
BRCA1 O 0 1.6422467297161347e-07
expression O 0 5.3325919679991785e-08
was O 0 2.4321474612065686e-08
reduced O 0 2.395727394244318e-09
or O 0 1.9317585031597417e-10
undetectable O 0 7.972632332098328e-09
in O 0 6.402347402234554e-11
the O 0 2.3162273488086527e-10
majority O 0 2.5741136652768226e-11
of O 0 4.0526804134799477e-10
high O 0 2.8154005349279032e-08
- O 0 8.499948478402075e-08
grade O 0 4.456866463442566e-06
, O 0 1.1960732138049934e-07
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 2.1846503273081908e-08
suggesting O 0 1.458775678031543e-08
that O 0 6.165680466185819e-11
absence O 0 6.887512427056208e-08
of O 0 2.250381569979254e-08
BRCA1 O 0 2.79749357012804e-09
may O 0 2.0552952395558322e-10
contribute O 0 4.578155354817426e-10
to O 0 1.372500557650369e-09
the O 0 2.2780972663838384e-09
pathogenesis O 0 9.253337793779792e-07
of O 0 1.1538010546985333e-09
a O 0 1.3590892300463508e-10
significant O 0 1.1868106497558983e-09
percentage O 0 3.4436368423484964e-08
of O 0 4.066123882040529e-09
sporadic B-Disease 0 2.1146173821762204e-05
breast I-Disease 0 2.337118348805234e-05
cancers I-Disease 0 1.3632073205371853e-05
. O 0 4.37495418736944e-06
. O 0 9.161962225334719e-06

